Citrus Sinensis ID: 005731
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 680 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZT07 | 833 | G-type lectin S-receptor- | yes | no | 0.941 | 0.768 | 0.417 | 1e-143 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.951 | 0.761 | 0.424 | 1e-142 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.939 | 0.754 | 0.431 | 1e-142 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.960 | 0.769 | 0.416 | 1e-141 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.941 | 0.757 | 0.421 | 1e-139 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.891 | 0.773 | 0.406 | 1e-138 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.938 | 0.756 | 0.422 | 1e-136 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.955 | 0.758 | 0.402 | 1e-132 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.933 | 0.774 | 0.389 | 1e-130 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.941 | 0.760 | 0.388 | 1e-130 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function desciption |
|---|
Score = 509 bits (1311), Expect = e-143, Method: Compositional matrix adjust.
Identities = 285/682 (41%), Positives = 407/682 (59%), Gaps = 42/682 (6%)
Query: 23 LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPD-TVVWVANRDR 81
++ DT+ +RDGE + S+ +RF GFFS G S+ RY+GIW+ ++ T+VWVANRD
Sbjct: 17 ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 82 PISGRNAVLTISNNGNLVLLSQTNGT--IWSTNVSSDVKNP--VAQLRDDGNLVIRDNSS 137
PI+ + ++ SN GNL + + N T IWSTNVS + P VA L D GNLV+ D
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFD--- 133
Query: 138 DSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVL 197
T S+ W+SFDHP+DT L M+LG+ K GL+R L+SW+S DP G ++
Sbjct: 134 PVTGRSF-WESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGF 192
Query: 198 PKMCTFNGSVKFTCSGQWDGTGFVSALSY-TNFIYKQFMTENKDEFVYWYEAYNRPSIMT 256
P++ + G + G W G + +I+ N+DE + Y + I
Sbjct: 193 PQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITR 252
Query: 257 LKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSL--DQTPMCECLEGF 314
+N +G + R W +W++ +SVP + C Y +CG N C +T C CL GF
Sbjct: 253 TMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGF 312
Query: 315 KLKSQ----VNQTRPIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAE 370
+ K + + ++ +S C+ F KL +K PD + S++ ++ L++C
Sbjct: 313 EPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQR 372
Query: 371 CLKNCTCKAYANS--NVTEGS-GCLMWYGDLLDSRRPIRNFTGQSVYLQVPTSE------ 421
CLKNC+C AYA++ G+ GCL W+G +LD+R + +GQ Y++V E
Sbjct: 373 CLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLN--SGQDFYIRVDKEELARWNR 430
Query: 422 ---SGNKKLLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFDINMGIT 478
SG +++L IL+ L+ ++LL + +FC R + K ++ N + FD
Sbjct: 431 NGLSGKRRVLLILISLIAAVMLL-TVILFCVVRERRKSNRHRSSSANFAPVPFD------ 483
Query: 479 TRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQ 538
F E +DK ++ LPLF L ++ AAT NFS Q KLG GGFGPVYKG L N
Sbjct: 484 -----FDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRM 538
Query: 539 EVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDV 598
E+AVKRLS SGQG++EFKNE+ LI++LQHRNLVRILGCCVE EK+L+ EY+PNKSLD
Sbjct: 539 EIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDY 598
Query: 599 YLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISD 658
++F ++ LDW R+ I++GIA+G+LYLHQ SRLRIIHRDLKASN+LLD +M PKISD
Sbjct: 599 FIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISD 658
Query: 659 FGLARMFGGDELQGNTKRIVGT 680
FG+AR+FGG++++G T R+VGT
Sbjct: 659 FGMARIFGGNQMEGCTSRVVGT 680
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 506 bits (1304), Expect = e-142, Method: Compositional matrix adjust.
Identities = 288/678 (42%), Positives = 408/678 (60%), Gaps = 31/678 (4%)
Query: 22 SLAADTMTTAS--FIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPD-TVVWVAN 78
S++A+T++ + I + S FELGFF PG YLGIW++ + T VWVAN
Sbjct: 26 SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85
Query: 79 RDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSS-DVKNP-VAQLRDDGNLVIRDNS 136
RD P+S L IS++ NLV+L Q++ +WSTN++ DV++P VA+L D+GN V+RD S
Sbjct: 86 RDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-S 143
Query: 137 SDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHV 196
+S + LWQSFD P+DTLL +MKLGWD K+G R + SW+S +DPS G +++ L+
Sbjct: 144 KNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEG 203
Query: 197 LPKMCTFNGSVKFTCSGQWDGTGFVSALSYTNFIYKQF-MTENKDEFVYWYEAYNRPSIM 255
P++ +N + SG W+G F F Y F T +K+E Y +
Sbjct: 204 FPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYS 263
Query: 256 TLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCECLEGFK 315
L ++ SG + R W E + W++ + P C +Y CG C + +P+C C++GFK
Sbjct: 264 RLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFK 323
Query: 316 LKS-QVNQTRPIK--CERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECL 372
++ QV R C R C G F +L +K PD S+++ + +++C +CL
Sbjct: 324 PRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCL 383
Query: 373 KNCTCKAYANSNVT-EGSGCLMWYGDLLDSRRPIRNFT--GQSVYLQVPTSESGNKKLLW 429
++C C A+AN+++ GSGC+ W G+L D IRN+ GQ +Y+++ ++ +K+
Sbjct: 384 RDCNCTAFANTDIRGSGSGCVTWTGELFD----IRNYAKGGQDLYVRLAATDLEDKRNRS 439
Query: 430 ILVV---LVLPLVLLPSFYIFCRRRRKCKEK-ETENTETNQDLLAFDINMG---ITTRTN 482
++ + + ++LL SF IF +RK K E + L + D+ M I++R +
Sbjct: 440 AKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRH 499
Query: 483 EFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAV 542
E N D D LPL VA AT NFS KLG+GGFG VYKG+L +GQE+AV
Sbjct: 500 ISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAV 553
Query: 543 KRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD 602
KRLS S QG EFKNE+ LIA LQH NLVR+L CCV+ GEK+LI EY+ N SLD +LFD
Sbjct: 554 KRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFD 613
Query: 603 PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
+ L+W+ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK M PKISDFG+A
Sbjct: 614 KSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMA 673
Query: 663 RMFGGDELQGNTKRIVGT 680
R+FG DE + NT+++VGT
Sbjct: 674 RIFGRDETEANTRKVVGT 691
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 504 bits (1299), Expect = e-142, Method: Compositional matrix adjust.
Identities = 298/691 (43%), Positives = 415/691 (60%), Gaps = 52/691 (7%)
Query: 17 FSMKAS--LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVP-DTV 73
FS+ AS A +++T +S + + S SQ FELGFF+P S YLGIW++ +P T
Sbjct: 23 FSVYASNFSATESLTISS----NKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTY 78
Query: 74 VWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSS-DVKNPVA-QLRDDGNLV 131
VWVANRD P+S N L IS+N NLV+ Q++ +WSTN++ DV++PVA +L D GN V
Sbjct: 79 VWVANRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFV 137
Query: 132 IRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSG-LERLLSSWQSAEDPSPGRYTY 190
+RD S ++ +LWQSFD P+DTLL DMK+GWD KSG R+L SW++ +DPS G ++
Sbjct: 138 LRD-SKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFST 196
Query: 191 GLDIHVLPKMCTFNGSVKFTCSGQWDGTGF--VSALSYTNFIYKQFMTENKDEFVYWYEA 248
L P+ +N SG W G F V + ++I F TEN + VY Y
Sbjct: 197 KLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSF-TENNQQVVYSYRV 255
Query: 249 YNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVP----DQY--CGKYGYCGANTICSL 302
L L+ +G + R W E + W +L+ P D Y CG YGYC ANT
Sbjct: 256 NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANT---- 311
Query: 303 DQTPMCECLEGFKLKSQVNQTR--PIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQ 360
+P+C C++GF+ ++ R + C R C F +L ++ PD S+++
Sbjct: 312 --SPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDK 369
Query: 361 SMNLEQCAAECLKNCTCKAYANSNVTEG-SGCLMWYGDLLDSRRPIRNFT--GQSVYLQV 417
+ L++C CLK C C A+AN+++ G SGC++W G L D IRN+ GQ +Y++V
Sbjct: 370 GIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFD----IRNYAKGGQDLYVRV 425
Query: 418 PTSESGNKKLLWILVV---LVLPLVLLPSFYIFCRRRRKCKEKETENTET-----NQDLL 469
+ +K++ ++ + + ++LL SF IF +RK K T T +QD L
Sbjct: 426 AAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSL 485
Query: 470 AFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPV 529
++ + T++ ++K LPL ++A AT NFS KLG+GGFG V
Sbjct: 486 MNELVKASRSYTSK--------ENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIV 537
Query: 530 YKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589
YKG L +G+E+AVKRLS S QG EF NE+ LIA+LQH NLVR+LGCCV++GEK+LI E
Sbjct: 538 YKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYE 597
Query: 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649
Y+ N SLD +LFD + L+W+ R II GIA+GLLYLHQ SR RIIHRDLKASNVLLD
Sbjct: 598 YLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLD 657
Query: 650 KDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
K+M PKISDFG+AR+FG +E + NT+R+VGT
Sbjct: 658 KNMTPKISDFGMARIFGREETEANTRRVVGT 688
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1297), Expect = e-141, Method: Compositional matrix adjust.
Identities = 290/696 (41%), Positives = 425/696 (61%), Gaps = 43/696 (6%)
Query: 13 LIFLFSMKASLAADTMTTASFIRDG---EKLTSSSQRFELGFFSPGKSKSRYLGIWFRRV 69
++ F ++S+AA+T+ +RDG + L S + FELGFFSPG S R+LGIW+ +
Sbjct: 14 FLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNI 73
Query: 70 PD-TVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDV---KNPVAQLR 125
D VVWVANR PIS ++ VL ISN+GNLVLL N T+WS+N+ S N V +
Sbjct: 74 EDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIH 133
Query: 126 DDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSP 185
D GN V+ + +D +W+SF+HP+DT L M++ + ++G SW+S DPSP
Sbjct: 134 DTGNFVLSETDTDRP----IWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSP 189
Query: 186 GRYTYGLDIHVLPKMCTFNGS-VKFTCSGQWDG---TGFVSALSYTNFIYKQFMTENKDE 241
G Y+ G+D P++ + G+ + SGQW+ TG + TN++Y ++ DE
Sbjct: 190 GNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDE 249
Query: 242 F--VYWYEAYNRPSIM-TLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANT 298
VY+ + PS++ K+ +G W+E KW + S PD C +Y CG
Sbjct: 250 TGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFG 309
Query: 299 ICSLDQT-PMCECLEGFKLKSQVNQTR------PIKCERSHSSECTRGTQFKKLDNVKAP 351
IC + + +C C+ G++ S N +R P+KCER+ S +F L +VK P
Sbjct: 310 ICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNIS---VGEDEFLTLKSVKLP 366
Query: 352 DFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEGSGCLMWYGDLLDSRRPIRNFT-- 409
DF + + ++ E C CL+NC+C AY+ + G GC++W DL+D ++ F
Sbjct: 367 DF-EIPEHNLVDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVD----LQQFEAG 418
Query: 410 GQSVYLQVPTSESGN--KKLLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQD 467
G S+++++ SE G K + ++V +++ ++L+ F + R ++ K+ N D
Sbjct: 419 GSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTD 478
Query: 468 --LLAFDINMGITTRTNEFGEVNGDGKDKGKD-SWLPLFSLASVAAATENFSMQCKLGEG 524
++ D+ T + G V+ + K + S LP+FSL ++A AT +F + +LG G
Sbjct: 479 TSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRG 538
Query: 525 GFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584
GFGPVYKG L +G+E+AVKRLS +SGQG+ EFKNE++LIA+LQHRNLVR+LGCC E EK
Sbjct: 539 GFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEK 598
Query: 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKAS 644
+L+ EYMPNKSLD +LFD K+ L+DW+ R II+GIA+GLLYLH+ SRLRIIHRDLK S
Sbjct: 599 MLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVS 658
Query: 645 NVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
NVLLD +MNPKISDFG+AR+FGG++ + NT R+VGT
Sbjct: 659 NVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGT 694
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 496 bits (1277), Expect = e-139, Method: Compositional matrix adjust.
Identities = 287/681 (42%), Positives = 414/681 (60%), Gaps = 41/681 (6%)
Query: 26 DTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPD-TVVWVANRDRPIS 84
+T+ + ++DG+ + S +RF GFFS G SK RY+GIW+ +V + T+VWVANRD PI+
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 85 GRNAVLTISNNGNLVLLSQTNGT--IWSTNVSSDVKNP--VAQLRDDGNLVIRDNSSDST 140
+ ++ S GNL + + NGT IWST+V ++ P VA+L D GNLV+ D T
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLD---PVT 139
Query: 141 AESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKM 200
+S+ W+SF+HP++TLL MK G+ +SG++R+++SW+S DP G TY ++ P+M
Sbjct: 140 GKSF-WESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQM 198
Query: 201 CTFNGSVKFTCSGQWDGTGFVSALSYTN-FIYKQFMTENKDEFVYWYEAYNRPSIMTLKL 259
+ G + +G W G + TN FI+ N DE Y + + L
Sbjct: 199 MMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVL 258
Query: 260 NPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPM--CECLEGFKLK 317
N +G + R W+ KW +S P+ C Y +CG N C T C CL G++ K
Sbjct: 259 NETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPK 318
Query: 318 SQVN---QTRPIKCERSHSSECTRGTQ-FKKLDNVKAPDFINVSLNQSMNLEQCAAECLK 373
+ + + C R + G + F KL VK P+ V+++ ++ L++C CLK
Sbjct: 319 TPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLK 378
Query: 374 NCTCKAYANS---NVTEGSGCLMWYGDLLDSRRPIRNFTGQSVYLQVPTSE--------- 421
NC+C AYA++ + GCL W+G++LD+R + +GQ YL+V SE
Sbjct: 379 NCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLS--SGQDFYLRVDKSELARWNGNGA 436
Query: 422 SGNKKLLWILVVLV-LPLVLLPSFYIFCRRRR-KCKEKETENTETNQDLLAFDINMGITT 479
SG K+L+ IL+ L+ + ++LL SF+ + R+RR + + ++ +FD+
Sbjct: 437 SGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFIL 496
Query: 480 RTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQE 539
E DK + LPLF L+++A AT NF+ Q KLG GGFGPVYKG L NG E
Sbjct: 497 EELE---------DKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGME 547
Query: 540 VAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVY 599
+AVKRLS SGQG++EFKNE+ LI++LQHRNLVRILGCCVE EK+L+ EY+PNKSLD +
Sbjct: 548 IAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYF 607
Query: 600 LFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659
+F ++ LDW R+ II+GI +G+LYLHQ SRLRIIHRDLKASNVLLD +M PKI+DF
Sbjct: 608 IFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADF 667
Query: 660 GLARMFGGDELQGNTKRIVGT 680
GLAR+FGG++++G+T R+VGT
Sbjct: 668 GLARIFGGNQIEGSTNRVVGT 688
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 491 bits (1264), Expect = e-138, Method: Compositional matrix adjust.
Identities = 277/682 (40%), Positives = 397/682 (58%), Gaps = 76/682 (11%)
Query: 13 LIFLFS-MKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVP- 70
+I LFS + + A D + ++DG+ + S FE+GFFSPG S++RYLGIW++++
Sbjct: 11 IISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISL 70
Query: 71 DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNV-----SSDVKNPVAQLR 125
TVVWVANRD P+ + L +S NG+L L + N IWS++ + ++NP+ Q+
Sbjct: 71 QTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQIL 130
Query: 126 DDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSP 185
D GNLV+R++ D + Y+WQS D+P D L MK G +F +GL R L+SW++ +DPS
Sbjct: 131 DTGNLVVRNSGDD---QDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPST 187
Query: 186 GRYTYGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFVSALSYT-NFIYKQFMTENKDEFVY 244
G YT +D + +P+ SV +G W+G F + N IY+ ++E Y
Sbjct: 188 GNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYY 247
Query: 245 WYEAYNRPSIMT-LKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLD 303
Y+ N PS++T ++LNP+G + R W +N W+ S C +Y CG+ C+++
Sbjct: 248 TYKLEN-PSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNIN 306
Query: 304 QTPMCECLEGFKLKSQ---VNQTRPIKCERSHSSECTRGTQ-FKKLDNVKAPDFINVSLN 359
++P C CL+GF K+ V C R +C +G F K+ +K PD +
Sbjct: 307 ESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYD 366
Query: 360 QSMNLEQCAAECLKNCTCKAYANSNVTEGS-GCLMWYGDLLDSRRPIRNFTGQSVYLQVP 418
++M+L +C CL+NCTC AY+ ++ +G GC++W+GDL+D R N GQ +Y+++
Sbjct: 367 KNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE--YNENGQDLYVRLA 424
Query: 419 TSESGNKKLLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFDINMGIT 478
+SE I +R + + E + +L D++
Sbjct: 425 SSE------------------------IETLQRESSRVSSRKQEEEDLELPFLDLD---- 456
Query: 479 TRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQ 538
+V+ AT FS KLG+GGFGPVYKG L GQ
Sbjct: 457 ----------------------------TVSEATSGFSAGNKLGQGGFGPVYKGTLACGQ 488
Query: 539 EVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDV 598
EVAVKRLS S QG++EFKNE+ LIA+LQHRNLV+ILG CV++ E++LI EY PNKSLD
Sbjct: 489 EVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDS 548
Query: 599 YLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISD 658
++FD ++R LDW R+ II+GIA+G+LYLH+ SRLRIIHRDLKASNVLLD DMN KISD
Sbjct: 549 FIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISD 608
Query: 659 FGLARMFGGDELQGNTKRIVGT 680
FGLAR GGDE + NT R+VGT
Sbjct: 609 FGLARTLGGDETEANTTRVVGT 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1252), Expect = e-136, Method: Compositional matrix adjust.
Identities = 284/672 (42%), Positives = 401/672 (59%), Gaps = 34/672 (5%)
Query: 24 AADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVP-DTVVWVANRDRP 82
A +++T +S + + S SQ FELGFF+P S YLGIW++ +P T VWVANRD P
Sbjct: 32 ATESLTISS----NKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNP 87
Query: 83 ISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSS-DVKNPVA-QLRDDGNLVIRDNSSDST 140
+S N L IS N NLV+ Q++ +WSTN++ DV++PVA +L D+GN ++RD+++
Sbjct: 88 LSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSNN--- 143
Query: 141 AESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKM 200
LWQSFD P+DTLL +MKLGWD K+G R+L SW++ +DPS G ++ L+ P+
Sbjct: 144 --RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEF 201
Query: 201 CTFNGSVKFTCSGQWDGTGFVSALSYTNFIYKQF-MTENKDEFVYWYEAYNRPSIMTLKL 259
+ SG W+G F S Y + T +K+E Y Y L L
Sbjct: 202 YICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRLYL 261
Query: 260 NPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCECLEGFK-LKS 318
N +G + R W E + W +L+ P C Y CG C + P C C++GFK +
Sbjct: 262 NSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNE 321
Query: 319 QVNQTR--PIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLKNCT 376
Q R C R C F +L +K PD +++ + L+ C CL++C
Sbjct: 322 QAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCN 381
Query: 377 CKAYANSNVTEG-SGCLMWYGDLLDSRRPIRNFT--GQSVYLQVPTSESGNKKLLWILVV 433
C A+AN+++ G SGC++W ++LD +RN+ GQ +Y+++ +E +K++ ++
Sbjct: 382 CTAFANADIRNGGSGCVIWTREILD----MRNYAKGGQDLYVRLAAAELEDKRIKNEKII 437
Query: 434 ---LVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFD--INMGITTRTNEFGEVN 488
+ + ++LL SF IF +RK K T T + + D IN + +R +
Sbjct: 438 GSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSK-- 495
Query: 489 GDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ 548
+ K + LPL L ++A AT NFS KLG+GGFG VYKGRL +G+E+AVKRLS
Sbjct: 496 ---EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKM 552
Query: 549 SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRL 608
S QG EF NE+ LIA+LQH NLVR+LGCCV++GEK+LI EY+ N SLD +LFD +
Sbjct: 553 SSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN 612
Query: 609 LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
L+W+ R II GIA+GLLYLHQ SR RIIHRDLKASNVLLDK+M PKISDFG+AR+FG +
Sbjct: 613 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 672
Query: 669 ELQGNTKRIVGT 680
E + NT+R+VGT
Sbjct: 673 ETEANTRRVVGT 684
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 472 bits (1214), Expect = e-132, Method: Compositional matrix adjust.
Identities = 283/703 (40%), Positives = 412/703 (58%), Gaps = 53/703 (7%)
Query: 7 FGIFCSLIFLFSMKASLAADTM--TTASFIRDGEKLTSSSQRFELGFFSPGKSKSR-YLG 63
F + ++ L S+ +T+ T + I + L S FE+GFF ++ SR YLG
Sbjct: 15 FLLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFF---RTNSRWYLG 71
Query: 64 IWFRRVPD-TVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVS-SDVKNPV 121
+W+++V D T VWVANRD P+S L IS N NLVLL +N +W TN++ + ++PV
Sbjct: 72 MWYKKVSDRTYVWVANRDNPLSNAIGTLKISGN-NLVLLDHSNKPVWWTNLTRGNERSPV 130
Query: 122 -AQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSA 180
A+L +GN V+RD SS++ A YLWQSFD+P+DTLL +MKLG++ K+GL R L+SW+S+
Sbjct: 131 VAELLANGNFVMRD-SSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSS 189
Query: 181 EDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFV-----SALSYT--NFIYKQ 233
+DPS G ++Y L+ LP+ + SG W+G F LSY NFI
Sbjct: 190 DDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFI--- 246
Query: 234 FMTENKDEFVYWYEAYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVP-DQYCGKYG 292
EN +E Y + N L L G+ R W + W+ +S P D C Y
Sbjct: 247 ---ENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYI 303
Query: 293 YCGANTICSLDQTPMCECLEGFKLKSQVNQTRPI---KCERSHSSECTRGTQFKKLDNVK 349
CG C ++ +P+C C++GF ++ + + C R C+ G F ++ +K
Sbjct: 304 MCGPYAYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSCS-GDGFTRMKKMK 362
Query: 350 APDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEG-SGCLMWYGDLLDSRRPIRNF 408
P+ ++++S+ +++C C+ +C C A+AN+++ G SGC++W L D IRN+
Sbjct: 363 LPETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLED----IRNY 418
Query: 409 T-----GQSVYLQVPTSESGNKK----LLWILVVLVLPLVLLPSFYIFCRRRRKCKEKET 459
GQ +Y+++ ++ K+ + L V V L+LL F ++ R++++ K
Sbjct: 419 ATDAIDGQDLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAI 478
Query: 460 E--NTETNQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSM 517
NT+ NQ+L +N + + EF G+ K ++ LPL + +V ATENFS
Sbjct: 479 SIANTQRNQNL---PMNEMVLSSKREFS-----GEYKFEELELPLIEMETVVKATENFSS 530
Query: 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGC 577
KLG+GGFG VYKGRL +G+E+AVKRLS S QG EF NE+ LIA LQH NLV++LGC
Sbjct: 531 CNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGC 590
Query: 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRII 637
C+E EK+LI EY+ N SLD YLF ++ L+W R I G+A+GLLYLHQ SR RII
Sbjct: 591 CIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRII 650
Query: 638 HRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
HRDLK SN+LLDK+M PKISDFG+AR+F DE + NT ++VGT
Sbjct: 651 HRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGT 693
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 466 bits (1199), Expect = e-130, Method: Compositional matrix adjust.
Identities = 272/698 (38%), Positives = 404/698 (57%), Gaps = 63/698 (9%)
Query: 11 CSLIF-LFSMKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRV 69
C L+ F + SLA + + + D E + SS + F GFFSP S SRY GIW+ V
Sbjct: 12 CILVLSCFFLSVSLAQERAFFSGKLNDSETIVSSFRTFRFGFFSPVNSTSRYAGIWYNSV 71
Query: 70 P-DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVS--SDVKNPVAQLRD 126
TV+WVAN+D+PI+ + V+++S +GNLV+ +WSTNVS + + VA+L D
Sbjct: 72 SVQTVIWVANKDKPINDSSGVISVSQDGNLVVTDGQRRVLWSTNVSTQASANSTVAELLD 131
Query: 127 DGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERL-LSSWQSAEDPSP 185
GNLV+++ SSD+ YLW+SF +P+D+ L +M +G + + G + ++SW+S DPSP
Sbjct: 132 SGNLVLKEASSDA----YLWESFKYPTDSWLPNMLVGTNARIGGGNVTITSWKSPSDPSP 187
Query: 186 GRYTYGLDIHVLPKMCTFNGSVKFTC---SGQWDGTGF--VSALSYTNFIYKQFMTENKD 240
G YT L + P++ N + + SG W+G F + + F+Y+ + ++ +
Sbjct: 188 GSYTAALVLAAYPELFIMNNNNNNSTVWRSGPWNGQMFNGLPDVYAGVFLYRFIVNDDTN 247
Query: 241 EFVYWYEAYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTIC 300
V A N ++ ++ G V R+ W E W VP C Y CG C
Sbjct: 248 GSVTMSYA-NDSTLRYFYMDYRGSVIRRDWSETRRNWTVGLQVPATECDNYRRCGEFATC 306
Query: 301 SLDQTPMCECLEGFKLKSQV-----------NQTRPIKCERSHSSECTRGTQFKKLDNVK 349
+ + P+C C+ GF+ ++ + + P++CER +++ G F +L +K
Sbjct: 307 NPRKNPLCSCIRGFRPRNLIEWNNGNWSGGCTRRVPLQCERQNNNGSADG--FLRLRRMK 364
Query: 350 APDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEGSGCLMWYGDLLDSRRPIRNFT 409
PDF S + +C CL+ C+C A A+ G GC++W G L+DS+ + +
Sbjct: 365 LPDFARRS---EASEPECLRTCLQTCSCIAAAHG---LGYGCMIWNGSLVDSQE--LSAS 416
Query: 410 GQSVYLQVPTSESGNKKLLWILV-------VLVLPLVLLPSFYIFCRRRRKCKEKETENT 462
G +Y+++ SE K IL+ + V+ +L + I ++R K K ++ E
Sbjct: 417 GLDLYIRLAHSEIKTKDKRPILIGTILAGGIFVVAACVLLARRIVMKKRAKKKGRDAEQI 476
Query: 463 ETNQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLG 522
+ LA G +KGK LPLF +AAAT NFS++ KLG
Sbjct: 477 FERVEALA--------------------GGNKGKLKELPLFEFQVLAAATNNFSLRNKLG 516
Query: 523 EGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG 582
+GGFGPVYKG+L GQE+AVKRLS SGQGL+E NE+++I++LQHRNLV++LGCC+
Sbjct: 517 QGGFGPVYKGKLQEGQEIAVKRLSRASGQGLEELVNEVVVISKLQHRNLVKLLGCCIAGE 576
Query: 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642
E++L+ E+MP KSLD YLFD + +LLDW+ R II GI +GLLYLH+ SRLRIIHRDLK
Sbjct: 577 ERMLVYEFMPKKSLDYYLFDSRRAKLLDWKTRFNIINGICRGLLYLHRDSRLRIIHRDLK 636
Query: 643 ASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
ASN+LLD+++ PKISDFGLAR+F G+E + NT+R+VGT
Sbjct: 637 ASNILLDENLIPKISDFGLARIFPGNEDEANTRRVVGT 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 465 bits (1197), Expect = e-130, Method: Compositional matrix adjust.
Identities = 268/690 (38%), Positives = 394/690 (57%), Gaps = 50/690 (7%)
Query: 18 SMKASLAADTMTTASFIRDGEK--LTSSSQRFELGFFSPGKSKSR--YLGIWFRRVP-DT 72
S + D +T +S I+D E L S F GFF+P S +R Y+GIW+ ++P T
Sbjct: 23 SRRLCFGEDRITFSSPIKDSESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIPIQT 82
Query: 73 VVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVA---QLRDDGN 129
VVWVAN+D PI+ + V++I +GNL + N +WSTNVS V P A QL D GN
Sbjct: 83 VVWVANKDSPINDTSGVISIYQDGNLAVTDGRNRLVWSTNVSVPVA-PNATWVQLMDSGN 141
Query: 130 LVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYT 189
L+++DN ++ LW+SF HP D+ + M LG D ++G L+SW S +DPS G YT
Sbjct: 142 LMLQDNRNNG---EILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYT 198
Query: 190 YGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFVSALSYTNFIYKQFMTENKDEFVYWYEAY 249
G+ P++ + +V SG W+G F+ + + ++ N D +Y
Sbjct: 199 AGIAPFTFPELLIWKNNVPTWRSGPWNGQVFIGLPNMDSLLFLDGFNLNSDNQGTISMSY 258
Query: 250 NRPSIM-TLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMC 308
S M L+P G + ++ W + W P C YG CG C + P C
Sbjct: 259 ANDSFMYHFNLDPEGIIYQKDWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGENPPC 318
Query: 309 ECLEGFKLKSQVN-----------QTRPIKCER----SHSSECTRGTQFKKLDNVKAPDF 353
+C++GF K+ + P++CER S+ + F KL +K P
Sbjct: 319 KCVKGFVPKNNTEWNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVP-- 376
Query: 354 INVSLNQSMNLEQ-CAAECLKNCTCKAYANSNVTEGSGCLMWYGDLLDSRRPIRNFTGQS 412
+S +S EQ C CL NC+C AYA G GC++W GDL+D +++F G
Sbjct: 377 --ISAERSEASEQVCPKVCLDNCSCTAYA---YDRGIGCMLWSGDLVD----MQSFLGSG 427
Query: 413 V--YLQVPTSESGNKKLLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLA 470
+ +++V SE L +++ + V+L + RK K++ + + +L+
Sbjct: 428 IDLFIRVAHSELKTHSNLAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELM- 486
Query: 471 FDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVY 530
R N ++ K LPLF +A +T++FS++ KLG+GGFGPVY
Sbjct: 487 -------FKRMEALTSDNESASNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVY 539
Query: 531 KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590
KG+L GQE+AVKRLS +SGQGL+E NE+++I++LQHRNLV++LGCC+E E++L+ EY
Sbjct: 540 KGKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEY 599
Query: 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK 650
MP KSLD YLFDP+K+++LDW+ R I++GI +GLLYLH+ SRL+IIHRDLKASN+LLD+
Sbjct: 600 MPKKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDE 659
Query: 651 DMNPKISDFGLARMFGGDELQGNTKRIVGT 680
++NPKISDFGLAR+F +E + NT+R+VGT
Sbjct: 660 NLNPKISDFGLARIFRANEDEANTRRVVGT 689
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 680 | ||||||
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.913 | 0.574 | 0.471 | 1e-167 | |
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.941 | 0.798 | 0.471 | 1e-167 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.939 | 0.764 | 0.470 | 1e-164 | |
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.917 | 0.760 | 0.462 | 1e-164 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.935 | 0.783 | 0.449 | 1e-162 | |
| 359493730 | 770 | PREDICTED: G-type lectin S-receptor-like | 0.894 | 0.789 | 0.461 | 1e-162 | |
| 359493723 | 867 | PREDICTED: G-type lectin S-receptor-like | 0.942 | 0.739 | 0.462 | 1e-162 | |
| 147816068 | 819 | hypothetical protein VITISV_030742 [Viti | 0.942 | 0.782 | 0.462 | 1e-162 | |
| 356545297 | 824 | PREDICTED: G-type lectin S-receptor-like | 0.948 | 0.782 | 0.473 | 1e-161 | |
| 356514895 | 821 | PREDICTED: G-type lectin S-receptor-like | 0.957 | 0.792 | 0.469 | 1e-161 |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 597 bits (1538), Expect = e-167, Method: Compositional matrix adjust.
Identities = 315/668 (47%), Positives = 416/668 (62%), Gaps = 47/668 (7%)
Query: 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPIS 84
AD++ I D E L SS Q FELGFFSPG SK+RYLGIW++ P T VWVANR+ PI+
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 85 GRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESY 144
VLTI NNG LVLL+Q+ IWS N+S +NPVAQL + GNLV+RD S++ T++SY
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRDGSNE-TSKSY 414
Query: 145 LWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFN 204
+WQSFD PSDT+L MK+GW+ K+GL+R L+SW+S++DPS G ++YG DI+VLP +
Sbjct: 415 IWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLGV 474
Query: 205 GSVKFTCSGQWDGTGFVSALSYTNFIYKQFMTENKDEFVYWYEAYNRPSIMTLKLNPSGF 264
GS K SG W+G F N +YK N DE YE+ N I L LN SGF
Sbjct: 475 GSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSGF 534
Query: 265 VTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCECLEGFKLKSQVNQ-- 322
+ R + + S+ WDEL+S+P + C YG+CGAN IC + + +CECL GF KSQ
Sbjct: 535 LQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQEEWDM 594
Query: 323 -TRPIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYA 381
C R +C F K+ VK PD I+ + ++L +C CL NC+C AYA
Sbjct: 595 FNTSSGCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCTAYA 654
Query: 382 NSNVTEGSGCLMWYGDLLDSRRPIRNFTGQSVYLQVPTSESG------NKKLLWILVVLV 435
+N GCLMW GDL+D R + +Y+++ TSE G KKL+ ILV+
Sbjct: 655 YTNPNGSGGCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIILVIST 714
Query: 436 LPLVL---LPSFYIFCRRRRKCKEKETENTETNQDLLAFDINMGITTRTNEFGEVNGDGK 492
+L L ++ F ++R ++E++ + N +L FD
Sbjct: 715 FSGILTLGLSFWFRFWKKRTMGTDQESK--KENLELPLFD-------------------- 752
Query: 493 DKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQG 552
L ++A AT NFS K+G GGFG VYKG L G VAVKRLS S QG
Sbjct: 753 ------------LPTIATATNNFSNTNKIGAGGFGSVYKGNLPEGVAVAVKRLSKNSAQG 800
Query: 553 LKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWE 612
++EFKNE +LIA+LQH+NLVR+LGCC++ E+IL+ EYMPNKSLD ++FD ++ LL W+
Sbjct: 801 VQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFIFDQNRRALLAWD 860
Query: 613 ARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672
R I+ GIA+GLLYLHQ SR +IIHRDLK SN+LLD ++NPKISDFGLAR+FG +E++
Sbjct: 861 KRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLARIFGENEMET 920
Query: 673 NTKRIVGT 680
TKRIVGT
Sbjct: 921 RTKRIVGT 928
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1534), Expect = e-167, Method: Compositional matrix adjust.
Identities = 325/690 (47%), Positives = 424/690 (61%), Gaps = 50/690 (7%)
Query: 1 MAILPCFGIFCSLIFLFSMK-ASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKS 59
M LP F IF S +F+ S+ S +AD +T ++DG+ L S SQ FELGFFSPG SK
Sbjct: 1 MESLPFF-IFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKY 59
Query: 60 RYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKN 119
RY+GIW+++ P+TVVWVANR+ P++ VLTI N GNLVLL Q IWS+N SS +
Sbjct: 60 RYVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAG 119
Query: 120 PVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQS 179
PVAQL D GNLV+RDN S ESY WQSFD PSDTLL MKLGW+ K+G ER L +W+S
Sbjct: 120 PVAQLLDSGNLVVRDNGSSRNTESYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRS 179
Query: 180 AEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFVSALSYTNFIYKQFMTENK 239
DPSPG +TY LDIH LP++ GSVK SG W+G F N +++ + N+
Sbjct: 180 ISDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNE 239
Query: 240 DEFVYWYEAYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTI 299
DE Y Y N L LN SG V R + ++ W ++SVP C YG CGAN I
Sbjct: 240 DEIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGI 299
Query: 300 CSLDQTPMCECLEGFKLKSQ-----VNQTRPIKCERSHSSECTRGTQFKKLDNVKAPDFI 354
C +P+CECL+GFK + N KCE + +C G F KL VK PD +
Sbjct: 300 CRTRTSPICECLKGFKSIPEEELDIQNFYGSRKCETRLTLDCQSGEGFLKLPGVKLPDLL 359
Query: 355 NVSLNQSMNLEQCAAECLKNCTCKAYANSNVT---EGSGCLMWYGDLLDSRRPIRNFTGQ 411
LN+SMNL++C AEC KNC+C A+A +N++ +GSGCLMW+G+L+D R + GQ
Sbjct: 360 EFRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIGQ 419
Query: 412 SVYLQVPTSESGNKKLLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAF 471
++++VP SE R K K+ T + A
Sbjct: 420 DIHIRVPASE--------------------------LEMARSSKRKKMLKTALVASMSAL 453
Query: 472 DINMGITTRTNEFGEVNGDGKDKGKDSW-LPLFSLASVAAATENFSMQCKLGEGGFGPVY 530
+GI G D+ K+ PLF L ++A AT NF+ +G GGFG VY
Sbjct: 454 ---LGIFV----------SGMDRRKEGMEAPLFDLDTIATATNNFAPDSIIGAGGFGSVY 500
Query: 531 KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590
KG+L GQE+AVK+LS SGQG++EF+NE++LIA+LQHRNLV +LG C+ + E++LI EY
Sbjct: 501 KGKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGSCIHREERMLIYEY 560
Query: 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK 650
MPNKSLD ++FD + LL W+ R II GIA+GLLYLHQ S+L+I+HRDLK SNVLLD
Sbjct: 561 MPNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLHQDSKLQIVHRDLKPSNVLLDS 620
Query: 651 DMNPKISDFGLARMFGGDELQGNTKRIVGT 680
++ PKISDFGLAR+ G D + T+R++GT
Sbjct: 621 NLIPKISDFGLARISGDDGKETKTRRVIGT 650
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1509), Expect = e-164, Method: Compositional matrix adjust.
Identities = 322/684 (47%), Positives = 436/684 (63%), Gaps = 45/684 (6%)
Query: 24 AADTMTTASFIRDG--EKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVP-DTVVWVANRD 80
A+T+T + IRDG L S FELGFFSPG S++RY+GIW++ +P TVVWVANR+
Sbjct: 18 TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 77
Query: 81 RPISGRNAVLTISNNGNLVLLSQTNGTI-WSTNVSSDVKNPVAQLRDDGNLVIRDNSSDS 139
PI+ + L + N GNLVL+S N T+ WS+N ++ + +L D GNLV+RD D
Sbjct: 78 NPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMGELLDSGNLVLRD-EKDV 136
Query: 140 TAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPK 199
+ SYLWQSFD+PSDT+L MKLGWD + GL+R LS+W+S +DPS G +T+G + P+
Sbjct: 137 NSGSYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 196
Query: 200 MCTFNGSVKFTCSGQWDGTGFV--SALSYTNFIYKQFMTENKDEFVYWYEAYNRPSIMTL 257
+ + GS K+ SG W+G GF +AL Y F+ +N +E Y Y N+ I L
Sbjct: 197 LVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFV-DNGEEVYYTYNLKNKSLITRL 255
Query: 258 KLN-PSGFV-TRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCECLEGFK 315
+N +GF+ R W+E S W+ VP YC Y CGA C + Q+P+CECLE F
Sbjct: 256 VMNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGNCIISQSPVCECLEKFT 315
Query: 316 LKS-----QVNQTRPIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAE 370
KS +N ++ C R+ +C +G F K +K PD N +N++MNL++C ++
Sbjct: 316 PKSPESWNSMNWSQ--GCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSK 373
Query: 371 CLKNCTCKAYANSNVTEGSGCLMWYGDLLDSRRPIRNFT--GQSVYLQVPTSESGN---- 424
CL+NC+C AY +++ E SGC +W+GDL+D IR F GQ +Y+++ SES
Sbjct: 374 CLQNCSCMAYTATDIKERSGCAIWFGDLID----IRQFPDGGQEIYIRMNASESSECLSL 429
Query: 425 --KKLLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAF----DINMGIT 478
++ L + V +LL ++YIF K TE + + L D + ++
Sbjct: 430 IKMEMGIALSIFVACGMLLVAYYIF---------KRTEKLKAHYSFLLVYHVCDSHSLLS 480
Query: 479 TRTNEFGEVNGDGKDKG--KDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFN 536
+T E N D D G +D LPLF ++A AT FS+ K+GEGGFGPVYKG L +
Sbjct: 481 EKTGGNREEN-DQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIGEGGFGPVYKGTLED 539
Query: 537 GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596
GQE+AVK LS SGQGL EFKNE++LI +LQHRNLV++LGCC++ EKIL+ EYMPN+SL
Sbjct: 540 GQEIAVKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNRSL 599
Query: 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656
D ++FD + +LLDW R II GIA+GLLYLHQ SRLRI+HRDLKASNVLLDKDMNPKI
Sbjct: 600 DSFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKI 659
Query: 657 SDFGLARMFGGDELQGNTKRIVGT 680
SDFGLARM GGD+ +GNT R++GT
Sbjct: 660 SDFGLARMVGGDQTEGNTTRVIGT 683
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1505), Expect = e-164, Method: Compositional matrix adjust.
Identities = 313/677 (46%), Positives = 421/677 (62%), Gaps = 53/677 (7%)
Query: 24 AADTMTTASFIRDG--EKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVP-DTVVWVANRD 80
A+T+T + IRDG L S FELGFFSPG S++RY+GIW++ +P TVVWVANR+
Sbjct: 24 TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 83
Query: 81 RPISGRNAVLTISNNGNLVLLSQTNGTI-WSTNVSSDVKNPVAQLRDDGNLVIRDNSSDS 139
PI+ + L + N GN VL+S N T+ WS+N ++ + +L+D GNLV+RD D+
Sbjct: 84 NPINDSSGFLMLDNTGNFVLVSNNNSTVVWSSNSKKAAQSAMGELQDSGNLVLRDEKDDN 143
Query: 140 TAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPK 199
+ YLWQSFD+PSDTLL MKLGWD + GL+R LS+W+S +DPS G +T+G + P+
Sbjct: 144 SG-IYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 202
Query: 200 MCTFNGSVKFTCSGQWDGTGFVSALSY-TNFIYKQFMTENKDEFVYWYEAYNRPSIMTLK 258
+ + GS K+ SG W+G GF L+ N ++ ++ +E Y Y N+ I +
Sbjct: 203 LVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDFVDDGEEVYYTYNLKNKSLITRIV 262
Query: 259 LNPSG-FVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCECLEGFKLK 317
+N + F R W+E + W +VP YC Y CGA C + Q+P+C+CLE F +
Sbjct: 263 MNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNCIMSQSPVCQCLEKFTPR 322
Query: 318 SQVNQTR---PIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLKN 374
S + C R+ +C +G F K +K PD N +N++MNL++C ++CL+N
Sbjct: 323 SPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSKCLQN 382
Query: 375 CTCKAYANSNVTEGSGCLMWYGDLLDSRRPIRNFT--GQSVYLQVPTSESGNKKLLWI-- 430
C+C AY +N+ E SGC +W+GDL+D IR F+ GQ +Y+++ SES K I
Sbjct: 383 CSCMAYTATNIKERSGCAVWFGDLID----IRQFSAAGQEIYIRLNASESRAKAASKIKM 438
Query: 431 -----LVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFDINMGITTRTNEFG 485
L + V +LL ++YIF R+ + EN
Sbjct: 439 TVGSALSIFVACGILLVAYYIFKRKAKHIGGNREEN------------------------ 474
Query: 486 EVNGDGKDKG--KDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVK 543
D D G +D LPLF ++A AT FS KLGEGGFGPVYKG L +GQE+A K
Sbjct: 475 ----DQIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAK 530
Query: 544 RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDP 603
LS SGQGL EFKNE++LI +LQHRNLV++LGCC++ EKIL+ EYMPNKSLD ++FD
Sbjct: 531 TLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQ 590
Query: 604 IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ +LLDW R II GIA+GLLYLHQ SRLRI+HRDLKASNVLLDKDMNPKISDFGLAR
Sbjct: 591 TRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLAR 650
Query: 664 MFGGDELQGNTKRIVGT 680
MFGGD+ +GNT R+VGT
Sbjct: 651 MFGGDQTEGNTTRVVGT 667
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1491), Expect = e-162, Method: Compositional matrix adjust.
Identities = 310/689 (44%), Positives = 419/689 (60%), Gaps = 53/689 (7%)
Query: 9 IFCSLIFLFSMKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRR 68
IF +F +K S A D M T +RDGE L S+ FELGFF+P S SRYLG+W+++
Sbjct: 7 IFVYSLFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGLWYKK 66
Query: 69 VPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDG 128
P TVVWVANR PIS + L +++ G LVLL+ TN +WS+N S+ V+NPVAQL D G
Sbjct: 67 SPQTVVWVANRGIPISNKFGTLNVTSQGILVLLNGTNNIVWSSNTSTTVQNPVAQLLDSG 126
Query: 129 NLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRY 188
NLV+RD +D+ A+++LWQSFD+P DTLL MKLG + +GL LSSW+ E+P+PG++
Sbjct: 127 NLVVRD-GNDNKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPAPGQF 185
Query: 189 TYGLDIHVLPKMCTFNGSVKFTCSGQWDG---TGFVSALSYTNFIYKQFMTENKDEFVYW 245
T G+D+ P++ + G W+G TGF + IY N++E +
Sbjct: 186 TLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPEL--KPDPIYTFEFVFNRNEVYFK 243
Query: 246 YEAYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQT 305
+E N L + PSG V W +N W + C Y CGAN C + +
Sbjct: 244 FELQNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFATAVVDRCENYALCGANARCDSNSS 303
Query: 306 PMCECLEGFKLKSQV---NQTRPIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSM 362
P+C+CL+GF KS +Q C R +CT F+ VK PD + + S
Sbjct: 304 PVCDCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDTSSSWYDDSF 363
Query: 363 NLEQCAAECLKNCTCKAYANSNVT-EGSGCLMWYGDLLDSRRPIRNFTGQSVYLQVPTSE 421
+L +C C++NC+C AYAN + GSGCL W+GDL+D+RR GQ +Y+++ S+
Sbjct: 364 SLVECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEG--GQDIYIRLAASQ 421
Query: 422 SG------NKKLLWILVV---LVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFD 472
SG KK V+ ++L +L +FC RRRK ++
Sbjct: 422 SGVTGEKKRKKKTHAGVIGGAVILGSSILILGIVFCIRRRKHRK---------------- 465
Query: 473 INMGITTRTNEFGEVNGDGKDKGKDSW-LPLFSLASVAAATENFSMQCKLGEGGFGPVYK 531
NG+ +D+ ++ LP+ L ++ AT+NFS KLGEGGFG VYK
Sbjct: 466 ---------------NGNFEDRKEEEMELPMLDLTTIEHATDNFSSSKKLGEGGFGAVYK 510
Query: 532 GRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591
G L GQE+AVKRLS SGQGL EFKNE++LIA+LQHRNLV++LGCC+ + EK+LI EYM
Sbjct: 511 GELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDEKMLIYEYM 570
Query: 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD 651
PN+SLD ++FDP +++ LDW R II GIA+GLLYLHQ SRLRIIHRD+KASN+LLD +
Sbjct: 571 PNRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKASNILLDNE 630
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGT 680
+NPKISDFGLARMFGGD+ + NTKR+VGT
Sbjct: 631 LNPKISDFGLARMFGGDQTEANTKRVVGT 659
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493730|ref|XP_003634656.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1488), Expect = e-162, Method: Compositional matrix adjust.
Identities = 316/685 (46%), Positives = 418/685 (61%), Gaps = 77/685 (11%)
Query: 10 FCSLIFLFS-----MKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGI 64
+++F+FS ++ S A DT+ IRDGE +TS+ F+LGFFSPG SK+RYLGI
Sbjct: 4 LATVVFIFSYVFSLLRISTAVDTINVNQHIRDGETITSAGGTFQLGFFSPGDSKNRYLGI 63
Query: 65 WFRRV-PDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQ 123
W+++V P TVVWVANR+ P++ + VL ++ G LV++S TNG +W++N S ++P AQ
Sbjct: 64 WYKKVAPQTVVWVANRESPLTDSSGVLKVTQQGTLVVVSGTNGILWNSNSSRSAQDPNAQ 123
Query: 124 LRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDP 183
L + GNLV+R N +DS E++LWQSFD+P DTLL MK GW+ +GL+R LSSW+SA+DP
Sbjct: 124 LLESGNLVMR-NGNDSDPENFLWQSFDYPCDTLLPGMKFGWNRVTGLDRYLSSWKSADDP 182
Query: 184 SPGRYTYGLDIHVLPKMCTFNG-SVKFTCSGQWDGTGFVSALSYTNFIYKQF-MTENKDE 241
S G +TYG+D+ P+ NG +VKF +G W+G F TN F N+ E
Sbjct: 183 SKGNFTYGIDLSGFPQPFLRNGLTVKFR-AGPWNGVRFGGIPQLTNNSLFTFDYVSNEKE 241
Query: 242 FVYWYEAYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICS 301
+ Y N + L P G+ R W + N+W + C Y CG IC
Sbjct: 242 IYFIYYLVNSSVFVRRVLTPDGYSRRFTWTDKKNEWTLYSTAQRDDCDNYAICGVYGICK 301
Query: 302 LDQTPMCECLEGFKLKSQVNQTRP---IKCERSHSSECTRGTQFKKLDNVKAPDFINVSL 358
+D++P CEC++GF+ K Q N C RS +C +G F K VK PD N
Sbjct: 302 IDESPKCECMKGFRPKFQSNWDMADWSKGCVRSTPLDCQKGDGFVKYSGVKLPDTRNSWF 361
Query: 359 NQSMNLEQCAAECLKNCTCKAYANSNVT-EGSGCLMWYGDLLDSRRPIRNFT--GQSVYL 415
++SMNL++CA+ CL+NC+C AYANS++ GSGCL+W+ DL+D IR+FT GQ Y
Sbjct: 362 DESMNLKECASLCLRNCSCTAYANSDIRGGGSGCLLWFDDLID----IRDFTQNGQEFYA 417
Query: 416 QVPTSESGNKKLLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFDINM 475
++ SESG Y+ K KE EN E + L
Sbjct: 418 RMAASESG---------------------YM------DHKSKEGENNEGQEHLD------ 444
Query: 476 GITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLF 535
LPLF+LA++ AT NFS + KLGEGGFGPVYKG L
Sbjct: 445 ------------------------LPLFNLATLLNATNNFSEENKLGEGGFGPVYKGILQ 480
Query: 536 NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKS 595
GQE+AVK +S S QGLKEFKNE+ I +LQHRNLV++LGCC+ E++LI EYMPNKS
Sbjct: 481 EGQEIAVKMMSKTSRQGLKEFKNEVESITKLQHRNLVKLLGCCIHGRERLLIYEYMPNKS 540
Query: 596 LDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPK 655
LD+Y+FD ++ R+LDW R II GIA+GLLYLHQ SRLRIIHRDLKA N+LLD +M PK
Sbjct: 541 LDLYIFDHMRSRVLDWPKRFLIINGIARGLLYLHQDSRLRIIHRDLKAENILLDNEMTPK 600
Query: 656 ISDFGLARMFGGDELQGNTKRIVGT 680
ISDFG+AR FGG+E + NT R+VGT
Sbjct: 601 ISDFGIARSFGGNETEANTTRVVGT 625
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493723|ref|XP_002280706.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1487), Expect = e-162, Method: Compositional matrix adjust.
Identities = 318/687 (46%), Positives = 429/687 (62%), Gaps = 46/687 (6%)
Query: 15 FLFSM-KASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRR-VPDT 72
++FS+ + S+ DT+T I D E +TS+ FELGFFSP SK RYLGI +++ +
Sbjct: 13 YVFSLLRISIGVDTITVNQLITDAETITSAGGSFELGFFSPANSKHRYLGIRYKKELNRA 72
Query: 73 VVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVI 132
VVWVANR+ P++ + VL +++ G LV+L N T+WS+ S +NP AQL D GNLV+
Sbjct: 73 VVWVANRENPLNDSSGVLKVTSQGILVVLDGANKTLWSSTSSRPAQNPNAQLLDSGNLVM 132
Query: 133 RDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGL 192
+ N +D E++LWQSFD+P +TLL MKLGW+ +GL+R LSSW+SA+DPS G +TYG+
Sbjct: 133 K-NGNDGNPENFLWQSFDYPCNTLLPGMKLGWNRVTGLDRYLSSWKSADDPSIGTFTYGI 191
Query: 193 DIHVLPKMCTFNGSVKFTCSGQWDGTGFVSALSYT-NFIYKQFMTENKDEFVYWYEAYNR 251
D P++ N SV SG W+G F +T N +Y N+ E + Y N
Sbjct: 192 DPSGSPQIFVRNVSVVTFRSGPWNGIRFSGYPHFTPNPVYTYDFVLNEKEIYFIYYLVNS 251
Query: 252 PSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCECL 311
+ L L P G+ R W + +W + SV + C Y CGAN IC +DQ+P CEC+
Sbjct: 252 SLLTRLVLTPDGYAQRFTWIDEKGQWVKYSSVQNDDCDNYALCGANGICKIDQSPKCECM 311
Query: 312 EGFKLKSQVNQTRPI---KCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCA 368
+GF+ + Q N C RS +C +G +F K VK PD N+SMNL++CA
Sbjct: 312 KGFRPRFQSNWDMADWSDGCVRSTPLDCQKGDRFVKFSGVKLPDTRTSWFNESMNLKECA 371
Query: 369 AECLKNCTCKAYANSNVT-EGSGCLMWYGDLLDSRRPIRNFTGQSVYLQVPTSES----- 422
+ CL+NC+C AY NSN++ EGSGCL+W+G+L D R N GQ Y+++ SES
Sbjct: 372 SLCLRNCSCTAYVNSNISGEGSGCLLWFGNLTDIREFAEN--GQEFYVRMSASESDAFSS 429
Query: 423 ----GNKKLLWILVVLV-----LPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFDI 473
KK ++V+ + + L+L+ ++Y+ + +++ K K E N D
Sbjct: 430 TNISSKKKQKQVIVISISITGIVLLILVLTWYMLKKMKQQLKRKGY--MEHNSD------ 481
Query: 474 NMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGR 533
G T+ E E LPLF LA++ AT NFS KLGEGGFGPVYKG
Sbjct: 482 -GGETSEGQEHLE-------------LPLFELATLLNATNNFSSDNKLGEGGFGPVYKGI 527
Query: 534 LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593
L +G+E+AVKRLS S QGLKEFKNE+ IA+LQHRNLV++LGCC+ EK+LI EY+PN
Sbjct: 528 LEDGEEIAVKRLSKTSRQGLKEFKNEVESIAKLQHRNLVKLLGCCICGREKMLIYEYLPN 587
Query: 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN 653
KSLD+++FD ++ +LDW R II GIA+GLLYLHQ SRLRIIHRDLKA NVLLD DMN
Sbjct: 588 KSLDLFIFDQMRGIVLDWPKRFLIINGIARGLLYLHQDSRLRIIHRDLKAENVLLDNDMN 647
Query: 654 PKISDFGLARMFGGDELQGNTKRIVGT 680
PKISDFG+AR FGG+EL +T R+ GT
Sbjct: 648 PKISDFGIARSFGGNELGASTTRVAGT 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147816068|emb|CAN61538.1| hypothetical protein VITISV_030742 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1487), Expect = e-162, Method: Compositional matrix adjust.
Identities = 318/687 (46%), Positives = 429/687 (62%), Gaps = 46/687 (6%)
Query: 15 FLFSM-KASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRR-VPDT 72
++FS+ + S+ DT+T I D E +TS+ FELGFFSP SK RYLGI +++ +
Sbjct: 13 YVFSLLRISIGVDTITVNQLITDAETITSAGGSFELGFFSPANSKHRYLGIRYKKELNRA 72
Query: 73 VVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVI 132
VVWVANR+ P++ + VL +++ G LV+L N T+WS+ S +NP AQL D GNLV+
Sbjct: 73 VVWVANRENPLNDSSGVLKVTSQGILVVLDGANKTLWSSTSSRPAQNPNAQLLDSGNLVM 132
Query: 133 RDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGL 192
+ N +D E++LWQSFD+P +TLL MKLGW+ +GL+R LSSW+SA+DPS G +TYG+
Sbjct: 133 K-NGNDGNPENFLWQSFDYPCNTLLPGMKLGWNRVTGLDRYLSSWKSADDPSIGTFTYGI 191
Query: 193 DIHVLPKMCTFNGSVKFTCSGQWDGTGFVSALSYT-NFIYKQFMTENKDEFVYWYEAYNR 251
D P++ N SV SG W+G F +T N +Y N+ E + Y N
Sbjct: 192 DPSGSPQIFVRNVSVVTFRSGPWNGIRFSGYPHFTPNPVYTYDFVLNEKEIYFIYYLVNS 251
Query: 252 PSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCECL 311
+ L L P G+ R W + +W + SV + C Y CGAN IC +DQ+P CEC+
Sbjct: 252 SLLTRLVLTPDGYAQRFTWIDEKGQWVKYSSVQNDDCDNYALCGANGICKIDQSPKCECM 311
Query: 312 EGFKLKSQVNQTRPI---KCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCA 368
+GF+ + Q N C RS +C +G +F K VK PD N+SMNL++CA
Sbjct: 312 KGFRPRFQSNWDMADWSDGCVRSTPLDCQKGDRFVKFSGVKLPDTRTSWFNESMNLKECA 371
Query: 369 AECLKNCTCKAYANSNVT-EGSGCLMWYGDLLDSRRPIRNFTGQSVYLQVPTSES----- 422
+ CL+NC+C AY NSN++ EGSGCL+W+G+L D R N GQ Y+++ SES
Sbjct: 372 SLCLRNCSCTAYVNSNISGEGSGCLLWFGNLTDIREFAEN--GQEFYVRMSASESDAFSS 429
Query: 423 ----GNKKLLWILVVLV-----LPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFDI 473
KK ++V+ + + L+L+ ++Y+ + +++ K K E N D
Sbjct: 430 TNISSKKKQKQVIVISISITGIVLLILVLTWYMLKKMKQQLKRKGY--MEHNSD------ 481
Query: 474 NMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGR 533
G T+ E E LPLF LA++ AT NFS KLGEGGFGPVYKG
Sbjct: 482 -GGETSEGQEHLE-------------LPLFELATLLNATNNFSSDNKLGEGGFGPVYKGI 527
Query: 534 LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593
L +G+E+AVKRLS S QGLKEFKNE+ IA+LQHRNLV++LGCC+ EK+LI EY+PN
Sbjct: 528 LEDGEEIAVKRLSKTSRQGLKEFKNEVESIAKLQHRNLVKLLGCCICGREKMLIYEYLPN 587
Query: 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN 653
KSLD+++FD ++ +LDW R II GIA+GLLYLHQ SRLRIIHRDLKA NVLLD DMN
Sbjct: 588 KSLDLFIFDQMRGIVLDWPKRFLIINGIARGLLYLHQDSRLRIIHRDLKAENVLLDNDMN 647
Query: 654 PKISDFGLARMFGGDELQGNTKRIVGT 680
PKISDFG+AR FGG+EL +T R+ GT
Sbjct: 648 PKISDFGIARSFGGNELXASTTRVAGT 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545297|ref|XP_003541080.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 575 bits (1481), Expect = e-161, Method: Compositional matrix adjust.
Identities = 335/707 (47%), Positives = 434/707 (61%), Gaps = 62/707 (8%)
Query: 1 MAILPCFGIFCSLIFLFSMKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGK-SKS 59
MA+L F + LIF FS K + A DT+ + D L S+ FELGFF PG S +
Sbjct: 1 MAMLTIFLLVSKLIFFFS-KFAAATDTINQFESLEDNTTLVSNDGTFELGFFIPGSTSPN 59
Query: 60 RYLGIWFRRVP-DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVK 118
RYLGIW++ +P TVVWVANR+ PI ++ L I+ G+LVLL+Q IWS N ++
Sbjct: 60 RYLGIWYKNIPIRTVVWVANRETPIKDNSSKLNITPEGSLVLLNQNKTVIWSANPTTKGV 119
Query: 119 NPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQ 178
VAQL D GNLV+RD D+ E+YLWQSFD+P+DT L MKLGWD K GL +L++W+
Sbjct: 120 VVVAQLLDSGNLVLRD-EKDTNPENYLWQSFDNPTDTFLPGMKLGWDLKKGLNTVLTAWK 178
Query: 179 SAEDPSPGRYTYGLDIHV---LPKMCTFNGSVKFTCSGQWDGTGFVSALSY-TNFIYKQF 234
+ +DPSPG +T DI + P+ + G+ K+ SG WDGT F S +N I
Sbjct: 179 NWDDPSPGDFT---DITLRTNYPEEVMWKGTTKYWRSGPWDGTKFSGNPSVPSNAIVNYT 235
Query: 235 MTENKDEFVYWYEAYNRPSIMTLKLNPSGFVTRQI-WDENSNKWDELFSVPDQYCGKYGY 293
+ NKDEF Y ++ I + +N S +V +++ W+ +S W +P C Y
Sbjct: 236 IVSNKDEFYATYSMTDKSIISRIVMNQSLYVRQRLTWNTDSQTWRVSSELPGDLCDHYNT 295
Query: 294 CGANTICSLDQTPMCECLEGFKLKS-----QVNQTRPIKCERSHSSECTRGTQ--FKKLD 346
CGA IC Q P+C+CL+GFK KS Q+N + C + + C + F K
Sbjct: 296 CGAFGICVAGQAPVCKCLDGFKPKSPRNWNQMNWNQ--GCVHNQTWSCREKNKDGFTKFS 353
Query: 347 NVKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVT-EGSGCLMWYGDLLDSRRPI 405
NVKAPD +N SM L +C +C +NC+C AYANSN+ EGSGC +W GDLLD R +
Sbjct: 354 NVKAPDTERSWVNASMTLGECRVKCWENCSCMAYANSNIRGEGSGCAIWIGDLLDIR--L 411
Query: 406 RNFTGQSVYLQVPTSESG----------NKKLLWILVVL--VLPLVLLPSFYIFCRRRRK 453
GQ +Y+++ SE+ NKK++ I + V+ ++L+ +I+ R K
Sbjct: 412 MPNAGQDLYIRLAVSETAQQSHDQKDNSNKKVVVIASTISSVIAMILI-FIFIYWSYRNK 470
Query: 454 CKEKETENTETNQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATE 513
KE I GI ++NE + +D LPLF L +A AT+
Sbjct: 471 NKE----------------IITGIEGKSNE---------SQQEDFELPLFDLVLIAQATD 505
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVR 573
+FS KLGEGGFGPVYKG L +GQEVAVKRLS S QGLKEFKNE+ML AELQHRNLV+
Sbjct: 506 HFSDHKKLGEGGFGPVYKGTLPDGQEVAVKRLSQTSRQGLKEFKNEVMLCAELQHRNLVK 565
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
+LGCC + EK+LI EYM NKSLDV+LFD + +LLDW R II GIA+GLLYLHQ SR
Sbjct: 566 VLGCCFQDDEKLLIYEYMSNKSLDVFLFDSSRSKLLDWPKRFCIINGIARGLLYLHQDSR 625
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
LRIIHRDLKASNVLLD +MNPKISDFGLARM GGD+++G T RIVGT
Sbjct: 626 LRIIHRDLKASNVLLDNEMNPKISDFGLARMCGGDQIEGETSRIVGT 672
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514895|ref|XP_003526137.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1478), Expect = e-161, Method: Compositional matrix adjust.
Identities = 327/697 (46%), Positives = 431/697 (61%), Gaps = 46/697 (6%)
Query: 1 MAILPCFGIFCSLIFLFSMKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGK-SKS 59
MA L + LIF FS A D + + D L S+ FELGFF+PG S +
Sbjct: 1 MAFLVIVILVSKLIF-FSSNFLAATDMINQFQSLEDNTTLVSNDGTFELGFFTPGSTSPN 59
Query: 60 RYLGIWFRRVP-DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGT-IWSTNVSSDV 117
RYLGIW++ +P TVVWVANRD PI ++ L+I+ GN +LL+Q N T IWSTN ++
Sbjct: 60 RYLGIWYKNIPIRTVVWVANRDNPIKDNSSKLSINTAGNFILLNQNNNTVIWSTNTTTKA 119
Query: 118 KNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSW 177
VAQL D GNLV+RD D+ E+Y WQSFD+PSDT L MK GWD K GL R+L++W
Sbjct: 120 SLVVAQLLDSGNLVLRD-EKDNNPENYSWQSFDYPSDTFLPGMKAGWDLKKGLNRVLTAW 178
Query: 178 QSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFVSALSY-TNFIYKQFMT 236
++ +DPS G +T P+ + G+ ++ SG WDG F + S TN I +
Sbjct: 179 KNWDDPSSGDFTANSSRTNFPEEVMWKGTSEYYRSGPWDGRKFSGSPSVPTNSIVNYSVV 238
Query: 237 ENKDEFVYWYEAYNRPSIMTLKLNPSGFVTRQI-WDENSNKWDELFSVPDQYCGKYGYCG 295
NKDEF Y ++ I + +N + +V +++ W+E+S W +P C Y CG
Sbjct: 239 SNKDEFYATYSMIDKSLISRVVVNQTLYVRQRLTWNEDSQTWRVSSELPGDLCDNYSTCG 298
Query: 296 ANTICSLDQTPMCECLEGFKLKSQVNQTR---PIKCERSHSSECTRGTQ--FKKLDNVKA 350
A IC Q P+C CL+GFK KS N T+ C + + C + FKK N+KA
Sbjct: 299 AFGICVAGQAPVCNCLDGFKPKSTRNWTQMNWNQGCVHNQTWSCMEKNKDGFKKFSNLKA 358
Query: 351 PDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVT-EGSGCLMWYGDLLDSRRPIRNFT 409
PD +N SM L++C +C +NC+C AYAN ++ EGSGC +W+GDLLD R I N
Sbjct: 359 PDTERSWVNASMTLDECKNKCRENCSCTAYANFDMRGEGSGCAIWFGDLLDIRL-IPN-A 416
Query: 410 GQSVYLQVPTSESG----NKKLLWILVVLVLPLV--LLPSFYIFCRRRRKCKEKETENTE 463
GQ +Y+++ SE+ +KK + ++ +V +V LL +I+ + KE
Sbjct: 417 GQDLYIRLAVSETDEKDDSKKKVVVIASIVSSVVATLLIFIFIYWSNAKNIKE------- 469
Query: 464 TNQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGE 523
I +GI + NE + +D LPLF L S+A AT++FS KLGE
Sbjct: 470 ---------IILGIEVKNNE---------SQQEDFELPLFDLVSIAQATDHFSDHNKLGE 511
Query: 524 GGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583
GGFGPVYKG L +G EVAVKRLS SGQGLKEFKNE+ML A+LQHRNLV++LGCC+++ E
Sbjct: 512 GGFGPVYKGTLPDGLEVAVKRLSQTSGQGLKEFKNEVMLCAKLQHRNLVKVLGCCIQENE 571
Query: 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKA 643
K+LI EYM NKSLDV+LFD + +LLDW R II IA+GLLYLHQ SRLRIIHRDLKA
Sbjct: 572 KLLIYEYMANKSLDVFLFDSDRSKLLDWPKRFYIINRIARGLLYLHQDSRLRIIHRDLKA 631
Query: 644 SNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
SNVLLD +MNPKISDFGLARM GGD+++G T+R+VGT
Sbjct: 632 SNVLLDNEMNPKISDFGLARMCGGDQIEGKTRRVVGT 668
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 680 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.592 | 0.514 | 0.368 | 2.7e-139 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.589 | 0.473 | 0.389 | 2.2e-135 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.967 | 0.774 | 0.414 | 3.4e-132 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.595 | 0.477 | 0.356 | 4.2e-132 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.967 | 0.780 | 0.413 | 1e-130 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.586 | 0.489 | 0.361 | 8.8e-130 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.266 | 0.225 | 0.651 | 3.5e-124 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.266 | 0.214 | 0.651 | 2.8e-122 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.269 | 0.226 | 0.612 | 2.5e-119 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.280 | 0.237 | 0.612 | 1.4e-118 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 750 (269.1 bits), Expect = 2.7e-139, Sum P(2) = 2.7e-139
Identities = 156/423 (36%), Positives = 244/423 (57%)
Query: 13 LIFLFS-MKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVP- 70
+I LFS + + A D + ++DG+ + S FE+GFFSPG S++RYLGIW++++
Sbjct: 11 IISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISL 70
Query: 71 DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVS-----SDVKNPVAQLR 125
TVVWVANRD P+ + L +S NG+L L + N IWS++ S + ++NP+ Q+
Sbjct: 71 QTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQIL 130
Query: 126 DDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSP 185
D GNLV+R NS D + Y+WQS D+P D L MK G +F +GL R L+SW++ +DPS
Sbjct: 131 DTGNLVVR-NSGDD--QDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPST 187
Query: 186 GRYTYGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFVSALSYT-NFIYKQFMTENKDEFVY 244
G YT +D + +P+ SV +G W+G F + N IY+ ++E Y
Sbjct: 188 GNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYY 247
Query: 245 WYEAYNRPSIMT-LKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLD 303
Y+ N PS++T ++LNP+G + R W +N W+ S C +Y CG+ C+++
Sbjct: 248 TYKLEN-PSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNIN 306
Query: 304 QTPMCECLEGFKLKSQ---VNQTRPIKCERSHSSECTRGTQ-FKKLDNVKAPDFINVSLN 359
++P C CL+GF K+ V C R +C +G F K+ +K PD +
Sbjct: 307 ESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYD 366
Query: 360 QSMNLEQCAAECLKNCTCKAYANSNVTEGS-GCLMWYGDLLDSRRPIRNFTGQSVYLQVP 418
++M+L +C CL+NCTC AY+ ++ +G GC++W+GDL+D R N GQ +Y+++
Sbjct: 367 KNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE--YNENGQDLYVRLA 424
Query: 419 TSE 421
+SE
Sbjct: 425 SSE 427
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 746 (267.7 bits), Expect = 2.2e-135, Sum P(2) = 2.2e-135
Identities = 172/442 (38%), Positives = 256/442 (57%)
Query: 7 FGIFCSLIFL-FSMKAS--LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLG 63
F +F ++FL FS+ AS A +++T +S + + S SQ FELGFF+P S YLG
Sbjct: 12 FILFIIILFLAFSVYASNFSATESLTISS----NKTIISPSQIFELGFFNPDSSSRWYLG 67
Query: 64 IWFRRVP-DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSS-DVKNPV 121
IW++ +P T VWVANRD P+S N L IS+N NLV+ Q++ +WSTN++ DV++PV
Sbjct: 68 IWYKIIPIRTYVWVANRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPV 126
Query: 122 A-QLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSG-LERLLSSWQS 179
A +L D GN V+RD S ++ +LWQSFD P+DTLL DMK+GWD KSG R+L SW++
Sbjct: 127 AAELLDYGNFVLRD-SKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKT 185
Query: 180 AEDPSPGRYTYGLDIHVLPKMCTFNG-SVKFTCSGQWDGTGF--VSALSYTNFIYKQFMT 236
+DPS G ++ L P+ +N S+ + SG W G F V + ++I F T
Sbjct: 186 TDDPSSGDFSTKLRTSGFPEFYIYNKESITYR-SGPWLGNRFSSVPGMKPVDYIDNSF-T 243
Query: 237 ENKDEFVYWYEAYNRPSIMT-LKLNPSGFVTRQIWDENSNKWDELFSVP----DQY--CG 289
EN + VY Y N+ +I + L L+ +G + R W E + W +L+ P D Y CG
Sbjct: 244 ENNQQVVYSYRV-NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECG 302
Query: 290 KYGYCGANTICSLDQTPMCECLEGFKLKSQVNQTRP--IKCERSHSSECTRGTQFKKLDN 347
YGYC ANT +P+C C++GF+ ++ R + C R C F +L
Sbjct: 303 NYGYCDANT------SPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKK 356
Query: 348 VKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEG-SGCLMWYGDLLDSRRPIR 406
++ PD S+++ + L++C CLK C C A+AN+++ G SGC++W G L D IR
Sbjct: 357 MRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFD----IR 412
Query: 407 NFT--GQSVYLQVPTSESGNKK 426
N+ GQ +Y++V + +K+
Sbjct: 413 NYAKGGQDLYVRVAAGDLEDKR 434
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1296 (461.3 bits), Expect = 3.4e-132, P = 3.4e-132
Identities = 286/690 (41%), Positives = 398/690 (57%)
Query: 10 FCSLIFLFSMKASLAADTMTTASF--IRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFR 67
F L+ LF S++A+T++ + I + S FELGFF PG YLGIW++
Sbjct: 15 FFFLLILFPAY-SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYK 73
Query: 68 RVPD-TVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSS-DVKNP-VAQL 124
+ T VWVANRD P+S L IS++ NLV+L Q++ +WSTN++ DV++P VA+L
Sbjct: 74 AISKRTYVWVANRDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAEL 132
Query: 125 RDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPS 184
D+GN V+RD S +S + LWQSFD P+DTLL +MKLGWD K+G R + SW+S +DPS
Sbjct: 133 LDNGNFVLRD-SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPS 191
Query: 185 PGRYTYGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFVSALSYTNFIYKQF-MTENKDEFV 243
G +++ L+ P++ +N + SG W+G F F Y F T +K+E
Sbjct: 192 SGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVT 251
Query: 244 YWYEAYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLD 303
Y + L ++ SG + R W E + W++ + P C +Y CG C +
Sbjct: 252 YSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSN 311
Query: 304 QTPMCECLEGFKLKS-QVNQTRPIK--CERSHSSECTRGTQFKKLDNVKAPDFINVSLNQ 360
+P+C C++GFK ++ QV R C R C G F +L +K PD S+++
Sbjct: 312 TSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDR 371
Query: 361 SMNLEQCAAECLKNCTCKAYANSNVT-EGSGCLMWYGDLLDSRRPIRNFT--GQSVYLQV 417
+ +++C +CL++C C A+AN+++ GSGC+ W G+L D IRN+ GQ +Y+++
Sbjct: 372 GIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFD----IRNYAKGGQDLYVRL 427
Query: 418 PTSE---SGNKKXXXXXXXXXXXXXXXPSFYIFXXXXXXXXXXXXXXX-XXXQDLLAFDI 473
++ N+ SF IF L + D+
Sbjct: 428 AATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDL 487
Query: 474 NMG---ITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVY 530
M I++R + E N D D LPL VA AT NFS KLG+GGFG VY
Sbjct: 488 LMNEVVISSRRHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVY 541
Query: 531 KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590
KG+L +GQE+AVKRLS S QG EFKNE+ LIA LQH NLVR+L CCV+ GEK+LI EY
Sbjct: 542 KGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEY 601
Query: 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK 650
+ N SLD +LFD + L+W+ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK
Sbjct: 602 LENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDK 661
Query: 651 DMNPKISDFGLARMFGGDELQGNTKRIVGT 680
M PKISDFG+AR+FG DE + NT+++VGT
Sbjct: 662 YMTPKISDFGMARIFGRDETEANTRKVVGT 691
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 666 (239.5 bits), Expect = 4.2e-132, Sum P(2) = 4.2e-132
Identities = 157/441 (35%), Positives = 243/441 (55%)
Query: 9 IFCSL-IFLFSMKASLAADTMTTASFIRDG---EKLTSSSQRFELGFFSPGKSKSRYLGI 64
++ SL ++ F ++S+AA+T+ +RDG + L S + FELGFFSPG S R+LGI
Sbjct: 9 LYLSLFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGI 68
Query: 65 WFRRVPD-TVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDV---KNP 120
W+ + D VVWVANR PIS ++ VL ISN+GNLVLL N T+WS+N+ S N
Sbjct: 69 WYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNR 128
Query: 121 VAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSA 180
V + D GN V+ + +D +W+SF+HP+DT L M++ + ++G SW+S
Sbjct: 129 VVSIHDTGNFVLSETDTDRP----IWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSE 184
Query: 181 EDPSPGRYTYGLDIHVLPKMCTFNGS-VKFTCSGQWDG---TGFVSALSYTNFIYKQFMT 236
DPSPG Y+ G+D P++ + G+ + SGQW+ TG + TN++Y ++
Sbjct: 185 TDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLS 244
Query: 237 ENKDEF--VYWYEAYNRPSIMT-LKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGY 293
DE VY+ + PS++ K+ +G W+E KW + S PD C +Y
Sbjct: 245 SPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNR 304
Query: 294 CGANTICSLD-QTPMCECLEGFKLKSQVNQTR------PIKCERSHSSECTRGTQFKKLD 346
CG IC + +C C+ G++ S N +R P+KCER+ S +F L
Sbjct: 305 CGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNIS---VGEDEFLTLK 361
Query: 347 NVKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEGSGCLMWYGDLLDSRRPIR 406
+VK PDF + + ++ E C CL+NC+C AY+ + G GC++W DL+D ++
Sbjct: 362 SVKLPDF-EIPEHNLVDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVDLQQ--F 415
Query: 407 NFTGQSVYLQVPTSESG-NKK 426
G S+++++ SE G N+K
Sbjct: 416 EAGGSSLHIRLADSEVGENRK 436
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1282 (456.3 bits), Expect = 1.0e-130, P = 1.0e-130
Identities = 285/690 (41%), Positives = 400/690 (57%)
Query: 7 FGIFCSLIFLFSMKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWF 66
F IF LI + S + T + I + + S SQ FELGFF+P S YLGIW+
Sbjct: 11 FFIFLILILFLAFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWY 70
Query: 67 RRVP-DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSS-DVKNPVA-Q 123
+ +P T VWVANRD P+S N L IS N NLV+ Q++ +WSTN++ DV++PVA +
Sbjct: 71 KIIPIRTYVWVANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAE 129
Query: 124 LRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDP 183
L D+GN ++RD+++ LWQSFD P+DTLL +MKLGWD K+G R+L SW++ +DP
Sbjct: 130 LLDNGNFLLRDSNN-----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDP 184
Query: 184 SPGRYTYGLDIHVLPK--MCTFNGSVKFTCSGQWDGTGFVSALSYTNFIYKQF-MTENKD 240
S G ++ L+ P+ +C+ S+ + SG W+G F S Y + T +K+
Sbjct: 185 SSGEFSTKLETSEFPEFYICS-KESILYR-SGPWNGMRFSSVPGTIQVDYMVYNFTASKE 242
Query: 241 EFVYWYEAYNRPSIMT-LKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTI 299
E Y Y N+ ++ + L LN +G + R W E + W +L+ P C Y CG
Sbjct: 243 EVTYSYRI-NKTNLYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGY 301
Query: 300 CSLDQTPMCECLEGFK-LKSQVNQTRP--IKCERSHSSECTRGTQFKKLDNVKAPDFINV 356
C + P C C++GFK + Q R C R C F +L +K PD
Sbjct: 302 CDSNSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTAT 361
Query: 357 SLNQSMNLEQCAAECLKNCTCKAYANSNVTEG-SGCLMWYGDLLDSRRPIRNFTGQSVYL 415
+++ + L+ C CL++C C A+AN+++ G SGC++W ++LD R + GQ +Y+
Sbjct: 362 IVDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKG--GQDLYV 419
Query: 416 QVPTSESGNKKXXXXXXXXXXXXXXXP---SFYIFXXXXXXXXXXXXXXXXXXQDLLAFD 472
++ +E +K+ SF IF + + D
Sbjct: 420 RLAAAELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQD 479
Query: 473 --INMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVY 530
IN + +R G + + K + + LPL L ++A AT NFS KLG+GGFG VY
Sbjct: 480 SLINDVVVSRR---GYTSKEKKSEYLE--LPLLELEALATATNNFSNDNKLGQGGFGIVY 534
Query: 531 KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590
KGRL +G+E+AVKRLS S QG EF NE+ LIA+LQH NLVR+LGCCV++GEK+LI EY
Sbjct: 535 KGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEY 594
Query: 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK 650
+ N SLD +LFD + L+W+ R II GIA+GLLYLHQ SR RIIHRDLKASNVLLDK
Sbjct: 595 LENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDK 654
Query: 651 DMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+M PKISDFG+AR+FG +E + NT+R+VGT
Sbjct: 655 NMTPKISDFGMARIFGREETEANTRRVVGT 684
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 659 (237.0 bits), Expect = 8.8e-130, Sum P(2) = 8.8e-130
Identities = 156/431 (36%), Positives = 232/431 (53%)
Query: 9 IFCSLIFLFSMKASLAAD--TMTTASFIRDGEKLTSSSQRFELGFFSPGKSKS---RYLG 63
+F +FL S S+A D +T F++DG+ L+S Q F+LGFFS + + R+LG
Sbjct: 7 LFSLSLFLISSSLSVALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLG 66
Query: 64 IWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWS-----TNVSSDVK 118
+W+ P VVWVANR+ P+ G + L +S+ G+L L + +WS T S
Sbjct: 67 LWYME-PFAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTAN 125
Query: 119 NPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQ 178
NP+ ++ GNL+ SSD E+ LWQSFD+P +T+L MKLG +FK+ +E LSSW+
Sbjct: 126 NPLLKISCSGNLI----SSDGE-EAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWK 180
Query: 179 SAEDPSPGRYTYGLDIHVLPKMCTF-NGSVKFTCS-GQWDGTGFVSA--LSYTNFIYKQF 234
+ +DPSPG +T LD LP++ NG ++ G W+G F A + N ++
Sbjct: 181 TLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYK 240
Query: 235 MTENKDEFVYWYEAYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYC 294
T + E Y + +R + L LN +G + R I N+W + P+ C Y C
Sbjct: 241 FTSSAQEVNYSWTPRHR-IVSRLVLNNTGKLHRFI-QSKQNQWILANTAPEDECDYYSIC 298
Query: 295 GANTICSLDQ--TPMCECLEGFKLKS--QVNQTR-PIKCERSHSSECTRGTQFKKLDNVK 349
GA +C ++ TP C CL+GFK KS + N +R C + C + F K +K
Sbjct: 299 GAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLK 358
Query: 350 APD--FINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEGS-GCLMWYGDLLDSRRPIR 406
PD + M LE C +C NC+C AYAN+++ EG GCL+W+GDL+D R
Sbjct: 359 LPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMRE-YS 417
Query: 407 NFTGQSVYLQV 417
+F GQ VY+++
Sbjct: 418 SF-GQDVYIRM 427
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 625 (225.1 bits), Expect = 3.5e-124, Sum P(2) = 3.5e-124
Identities = 118/181 (65%), Positives = 147/181 (81%)
Query: 500 LPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNE 559
L F + ++ AT NFS+ KLG+GGFG VYKG+L +G+E+AVKRLSS SGQG +EF NE
Sbjct: 476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535
Query: 560 MMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQ 619
++LI++LQHRNLVR+LGCC+E+ EK+LI E+M NKSLD +LFD K+ +DW R IIQ
Sbjct: 536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVG 679
GIA+GLLYLH SRLR+IHRDLK SN+LLD+ MNPKISDFGLARM+ G E Q NT+R+VG
Sbjct: 596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655
Query: 680 T 680
T
Sbjct: 656 T 656
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 615 (221.5 bits), Expect = 2.8e-122, Sum P(2) = 2.8e-122
Identities = 118/181 (65%), Positives = 147/181 (81%)
Query: 500 LPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNE 559
LP+FS SVA+AT +F+ + KLG+GGFG VYKG G+E+AVKRLS +S QGL+EFKNE
Sbjct: 510 LPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNE 569
Query: 560 MMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQ 619
++LIA+LQHRNLVR+LGCC+E EK+L+ EYMPNKSLD +LFD K+ LDW R +I
Sbjct: 570 ILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIG 629
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVG 679
GIA+GLLYLH+ SRL+IIHRDLKASN+LLD +MNPKISDFG+AR+F + NT R+VG
Sbjct: 630 GIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVG 689
Query: 680 T 680
T
Sbjct: 690 T 690
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 598 (215.6 bits), Expect = 2.5e-119, Sum P(2) = 2.5e-119
Identities = 112/183 (61%), Positives = 146/183 (79%)
Query: 498 SWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFK 557
S L F + ++ AT+NFS+ KLG+GGFG VYKG+L +G+E+AVKRLSS SGQG +EF
Sbjct: 479 SGLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFM 538
Query: 558 NEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRI 617
NE++LI++LQH+NLVRILGCC+E E++L+ E++ NKSLD +LFD K+ +DW R I
Sbjct: 539 NEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKRLEIDWPKRFNI 598
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI 677
I+GIA+GL YLH+ S LR+IHRDLK SN+LLD+ MNPKISDFGLARM+ G E Q NT+R+
Sbjct: 599 IEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRV 658
Query: 678 VGT 680
GT
Sbjct: 659 AGT 661
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 1.4e-118, Sum P(2) = 1.4e-118
Identities = 117/191 (61%), Positives = 149/191 (78%)
Query: 490 DGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS 549
+G ++ S + F + ++ AT NFS KLG+GGFGPVYKG+L +G+E+ VKRL+S S
Sbjct: 463 NGFERQDVSGVNFFEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSS 522
Query: 550 GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLL 609
GQG +EF NE+ LI++LQHRNLVR+LG C++ EK+LI E+M NKSLD+++FDP K L
Sbjct: 523 GQGTEEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFEL 582
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
DW R IIQGIA+GLLYLH+ SRLR+IHRDLK SN+LLD MNPKISDFGLARMF G +
Sbjct: 583 DWPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQ 642
Query: 670 LQGNTKRIVGT 680
Q NT+R+VGT
Sbjct: 643 YQDNTRRVVGT 653
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00027534001 | SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (814 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 680 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-39 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-38 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 3e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-36 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 1e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-25 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 8e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-19 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 5e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-17 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 2e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-07 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 3e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.001 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.002 | |
| COG1718 | 268 | COG1718, RIO1, Serine/threonine protein kinase inv | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.003 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.004 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.004 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.004 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 4e-42
Identities = 60/154 (38%), Positives = 83/154 (53%), Gaps = 11/154 (7%)
Query: 516 SMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAELQHR 569
++ KLGEG FG VYKG+L EVAVK L S Q ++EF E ++ +L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N+V++LG C E+ +++EYM L YL K L + IA+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE 119
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
IHRDL A N L+ +++ KISDFGL+R
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 4e-42
Identities = 60/154 (38%), Positives = 85/154 (55%), Gaps = 10/154 (6%)
Query: 516 SMQCKLGEGGFGPVYKGRLFNG-----QEVAVKRL-SSQSGQGLKEFKNEMMLIAELQHR 569
++ KLGEG FG VYKG L EVAVK L S Q ++EF E ++ +L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N+V++LG C E+ ++++EYMP L YL + + L + IA+G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE 120
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
IHRDL A N L+ +++ KISDFGL+R
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 61/163 (37%), Positives = 89/163 (54%), Gaps = 10/163 (6%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVRILGCC 578
LGEGGFG VY R G++VA+K + + L E E+ ++ +L H N+V++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
++ L++EY SL L + K L + +RI+ I +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 639 RDLKASNVLLDKD-MNPKISDFGLARMFGGDELQGNTKRIVGT 680
RDLK N+LLD D K++DFGL+++ D+ T IVGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGT 156
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 8e-40
Identities = 63/155 (40%), Positives = 84/155 (54%), Gaps = 14/155 (9%)
Query: 520 KLGEGGFGPVYKGRLFNGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRI 574
KLGEG FG VYKG+L EVAVK L S + K+F E ++ +L H N+VR+
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYL------FDPIKKRLLDWEARIRIIQGIAQGLLYL 628
LG C E+ L+LEYM L YL F +K L + + IA+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ +HRDL A N L+ +D+ KISDFGL+R
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 56/161 (34%), Positives = 83/161 (51%), Gaps = 11/161 (6%)
Query: 515 FSMQCKLGEGGFGPVYKGRLF-----NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQH 568
+ KLGEG FG VYKG L +VAVK L + + +EF E ++ +L H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
N+VR+LG C + ++ EYMP L +L L + +++ IA+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+HRDL A N L+ +++ KISDFGL+R D+
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD 156
|
Length = 258 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-38
Identities = 50/119 (42%), Positives = 68/119 (57%), Gaps = 6/119 (5%)
Query: 34 IRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTIS 93
+ G+ L SS FELGFF Y I ++ TVVWVANRD P SG + LT+
Sbjct: 4 LSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQ 62
Query: 94 NNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHP 152
++GNLV+ + +WS+N + N V L DDGNLV+ D+ ++LWQSFD+P
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-38
Identities = 54/115 (46%), Positives = 68/115 (59%), Gaps = 6/115 (5%)
Query: 70 PDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGN 129
TVVWVANR P++ + L + ++GNLVL +WS+N S VA L+DDGN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 130 LVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPS 184
LV+ DNS LWQSFDHP+DTLL K G + G R L+SW+S DPS
Sbjct: 61 LVLYDNSG-----KVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 7e-38
Identities = 57/164 (34%), Positives = 83/164 (50%), Gaps = 11/164 (6%)
Query: 520 KLGEGGFGPVYKGRLFN-GQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
KLG G FG VYK + G+ VAVK L S+ + + + E+ ++ L H N+VR++
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
++ L++EY L YL + L + +I I +GL YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
IHRDLK N+LLD++ KI+DFGLA+ + VGT
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGT 161
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 58/168 (34%), Positives = 88/168 (52%), Gaps = 11/168 (6%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLV 572
+ + KLGEG FG VY R G+ VA+K + + + +E E+ ++ +L+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
R+ ++ + L++EY L L + RL + EAR ++ I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK--RGRLSEDEAR-FYLRQILSALEYLHS-- 115
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I+HRDLK N+LLD+D + K++DFGLAR E VGT
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGT 159
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 49/120 (40%), Positives = 68/120 (56%), Gaps = 7/120 (5%)
Query: 32 SFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLT 91
+ + G+ L S + FELGFF+ Y I ++ TVVWVANRD P+S + LT
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSSSRTVVWVANRDNPVSD-SCTLT 59
Query: 92 ISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDH 151
+ ++GNLVL +WS+N + N V L DDGNLVI D+ + +LWQSFD+
Sbjct: 60 LQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGN-----FLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 4e-32
Identities = 59/169 (34%), Positives = 86/169 (50%), Gaps = 15/169 (8%)
Query: 519 CKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
LG G FG VY G+ +AVK LS S + L+ + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 576 GCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKK--RLLDWEARIRIIQGIAQGLLYLHQY 631
G ++ + L LEY+ SL +KK +L + R Q I +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLS----SLLKKFGKLPEPVIRKYTRQ-ILEGLAYLH-- 118
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I+HRD+K +N+L+D D K++DFG A+ G E T + GT
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 58/172 (33%), Positives = 88/172 (51%), Gaps = 15/172 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRN 570
N+ + +G G FG VYKG L G VA+K++S + + LK E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYL--FDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+V+ +G +ILEY N SL + F P + L+ + + QGL YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-----AVYVYQVLQGLAYL 115
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H+ +IHRD+KA+N+L KD K++DFG+A + +VGT
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 55/152 (36%), Positives = 83/152 (54%), Gaps = 13/152 (8%)
Query: 520 KLGEGGFGPVYKGRLFN-----GQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRNLVR 573
+LGEG FG V R G++VAVK L+ S Q +F+ E+ ++ L H N+V+
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 574 ILGCCVEQGEKI--LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
G C + G + LI+EY+P+ SL YL + ++ + + I +G+ YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS- 127
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
R IHRDL A N+L++ + KISDFGLA+
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 54/163 (33%), Positives = 90/163 (55%), Gaps = 11/163 (6%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
K+G+GGFG VYK R G+EVA+K + +S + ++ NE+ ++ + +H N+V+ G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIR-IIQGIAQGLLYLHQYSRLRII 637
+++ E +++E+ SL L + L E++I + + + +GL YLH II
Sbjct: 67 LKKDELWIVMEFCSGGSLK-DLLKSTNQTLT--ESQIAYVCKELLKGLEYLHSN---GII 120
Query: 638 HRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
HRD+KA+N+LL D K+ DFGL+ +VGT
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGT 160
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 54/165 (32%), Positives = 87/165 (52%), Gaps = 15/165 (9%)
Query: 520 KLGEGGFGPVYKG-RLFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
K+GEG G VYK G+EVA+K RL Q+ + + NE++++ + +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI-RIIQGIAQGLLYLHQYSRLR 635
+ E +++EYM SL + R+ E +I + + + QGL YLH
Sbjct: 83 SYLVGDELWVVMEYMDGGSL-TDIITQNFVRMN--EPQIAYVCREVLQGLEYLHS---QN 136
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+IHRD+K+ N+LL KD + K++DFG A + + +VGT
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 8e-25
Identities = 28/65 (43%), Positives = 43/65 (66%)
Query: 336 CTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEGSGCLMWY 395
C G F +L N+K PD +++S+ L++C CL NC+C AYA +++ GSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWT 60
Query: 396 GDLLD 400
G+L+D
Sbjct: 61 GELVD 65
|
Length = 66 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 51/178 (28%), Positives = 87/178 (48%), Gaps = 29/178 (16%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-----FKNEMMLIAELQH 568
+ ++GEG +G VYK R G+ VA+K++ ++ KE E+ L+ +L+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRH 57
Query: 569 RNLVRILGCCVE--QGEKILILEYMPN------KSLDVYLFDPIKKRLLDWEARIRIIQG 620
N+VR+ +G ++ EYM + S +V + K + +
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM---------KQ 108
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ +GL YLH I+HRD+K SN+L++ D K++DFGLAR + T R++
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 51/152 (33%), Positives = 85/152 (55%), Gaps = 4/152 (2%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E F+++ KLG G FG V++G N VA+K L S ++F+ E+ + L+H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
+ C +I E M SL +L P + ++L + I + +A+G+ YL +
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQ- 123
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664
IHRDL A N+L+ +D+ K++DFGLAR+
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARL 153
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 66/155 (42%), Positives = 81/155 (52%), Gaps = 15/155 (9%)
Query: 517 MQCKLGEGGFGPV--YKGRLFN---GQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRN 570
LGEG FG V Y N G+ VAVK L + GQ +K E+ ++ L H N
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 571 LVRILGCCVEQGEKI--LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+V+ GCC EQG K LI+EY+P SL YL K L+ + Q I +G+ YL
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
H IHRDL A NVLLD D KI DFGLA+
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 55/158 (34%), Positives = 83/158 (52%), Gaps = 7/158 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ ++ KLG G FG V+ G +VAVK L + + F E ++ +L+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLV 64
Query: 573 RILGCCVEQGEKILIL-EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
++ C + E I I+ EYM SL +L K+L + + IA+G+ YL
Sbjct: 65 QLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE-- 120
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
IHRDL A N+L+ +++ KI+DFGLAR+ DE
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 55/160 (34%), Positives = 85/160 (53%), Gaps = 22/160 (13%)
Query: 521 LGEGGFGPVYKGRLF-----NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRI 574
LG G FG VYKG VA+K L ++ + KE +E ++A + H ++VR+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYLFDPI----KKRLLDWEARIRIIQGIAQGLLYLH 629
LG C+ ++ LI + MP L Y+ + + LL+W +I A+G+ YL
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ R++HRDL A NVL+ + KI+DFGLA++ DE
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 50/175 (28%), Positives = 87/175 (49%), Gaps = 29/175 (16%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
++G+G FG VY R +G+ +K LS+ S + ++ NE+ ++ +L H N+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKR-----------LLDWEARIRIIQGIAQGL 625
E+G+ +++EY L IKK+ +LDW +Q + L
Sbjct: 67 SFEEKGKLCIVMEYADGGDLS----QKIKKQKKEGKPFPEEQILDW-----FVQ-LCLAL 116
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
YLH SR +I+HRD+K N+ L + K+ DFG++++ T +VGT
Sbjct: 117 KYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 58/163 (35%), Positives = 83/163 (50%), Gaps = 23/163 (14%)
Query: 521 LGEGGFGPVYKGRLF--NGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVR 573
LGEG FG VYKG L N + VA+K L + + +EF+ E L+++LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYLF-------------DPIKKRLLDWEARIRIIQG 620
+LG C ++ ++ EY+ + L +L D K LD + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
IA G+ YL S +HRDL A N L+ + + KISDFGL+R
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 52/172 (30%), Positives = 86/172 (50%), Gaps = 16/172 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
E F + KLGEG +G VYK GQ VA+K + + L+E E+ ++ + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIK--KRLLDWEARIRII-QGIAQGLLYL 628
V+ G + + +++EY S+ D +K + L E I I +GL YL
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVS----DIMKITNKTLT-EEEIAAILYQTLKGLEYL 115
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H + IHRD+KA N+LL+++ K++DFG++ + NT ++GT
Sbjct: 116 HS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 9e-23
Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 521 LGEGGFGPVYKGRLFNGQE------VAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVR 573
LGEG FG V+ G ++ + VAVK L + ++ F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYL--FDPIKKRL---------LDWEARIRIIQGIA 622
G C E I++ EYM + L+ +L P L L ++I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
G++YL + +HRDL N L+ D+ KI DFG++R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 53/160 (33%), Positives = 83/160 (51%), Gaps = 14/160 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN-----EMMLIAELQ 567
+ KLGEG + VYK R G+ VA+K++ + K+ N E+ L+ EL+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIR-IIQGIAQGLL 626
H N++ +L + L+ E+M L+ + D K ++ A I+ + +GL
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKD---KSIVLTPADIKSYMLMTLRGLE 116
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
YLH I+HRDLK +N+L+ D K++DFGLAR FG
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 100 bits (248), Expect = 1e-22
Identities = 56/176 (31%), Positives = 89/176 (50%), Gaps = 14/176 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQH-R 569
++ + KLGEG FG VY R + + VA+K L+ + + ++ F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N+V++ ++G L++EY+ SL+ L +K L + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 630 QYSRLRIIHRDLKASNVLLDKDMN-PKISDFGLARMFGGD----ELQGNTKRIVGT 680
IIHRD+K N+LLD+D K+ DFGLA++ + VGT
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
|
Length = 384 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 56/155 (36%), Positives = 84/155 (54%), Gaps = 19/155 (12%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRL-SSQSGQGLKEFKN---EMMLIAELQHRNLVRI 574
KLGEG +G VYK R G+ VA+K++ +G+ E+ L+ EL+H N+V++
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP--STALREISLLKELKHPNIVKL 63
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARI--RIIQGIAQGLLYLHQY 631
L K+ L+ EY + L YL KR + I+ + +GL Y H +
Sbjct: 64 LDVIH-TERKLYLVFEYC-DMDLKKYL----DKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
RI+HRDLK N+L+++D K++DFGLAR FG
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 48/154 (31%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAELQHRN 570
+ LG+G G VYK R G+ A+K++ + K+ E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLLYLH 629
+V+ G ++GE ++LEYM SL D +KK E + I + I +GL YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLA----DLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ IIHRD+K SN+L++ KI+DFG+++
Sbjct: 117 T--KRHIIHRDIKPSNLLINSKGEVKIADFGISK 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 55/161 (34%), Positives = 89/161 (55%), Gaps = 12/161 (7%)
Query: 521 LGEGGFGPVYKGRL-FNGQE---VAVKRLSSQSGQGLK-EFKNEMMLIAELQHRNLVRIL 575
+G G FG V +GRL G++ VA+K L + S + +F E ++ + H N++R+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 576 GCCVEQGEKILIL-EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
G V + ++I+ EYM N SLD +L + K + +++GIA G+ YL S +
Sbjct: 72 GV-VTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL---SEM 125
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK 675
+HRDL A N+L++ ++ K+SDFGL+R E TK
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 51/153 (33%), Positives = 84/153 (54%), Gaps = 11/153 (7%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--EMMLIAELQHRNLVRILG 576
K+GEG +G VYK R G+ VA+K++ + E+ L+ EL H N++++L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIR-IIQGIAQGLLYLHQYSRLR 635
+G+ L+ E+M D+Y ++R L E+ I+ + + QGL + H +
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLP-ESLIKSYLYQLLQGLAFCHSH---G 118
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
I+HRDLK N+L++ + K++DFGLAR FG
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 12/146 (8%)
Query: 521 LGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE 580
+G+G FG V G + GQ+VAVK L S + F E ++ L+H NLV++LG ++
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 581 QGEKILILEYMPNKSLDVYLFDPIKKR---LLDWEARIRIIQGIAQGLLYLHQYSRLRII 637
++ EYM SL YL + R ++ ++ + +G+ YL + +
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL----RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFV 124
Query: 638 HRDLKASNVLLDKDMNPKISDFGLAR 663
HRDL A NVL+ +D+ K+SDFGLA+
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 6e-21
Identities = 52/173 (30%), Positives = 92/173 (53%), Gaps = 15/173 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAELQHRN 570
+F + K+G+G FG V+K R + + A+K+ LS + + +E +E ++A+L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLD---WEARIRIIQGIAQGLLY 627
++R +++G+ +++EY N L L + L + W I+I+ G+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
LH +I+HRD+K+ N+ LD N KI D G+A++ + NT IVGT
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-21
Identities = 60/153 (39%), Positives = 87/153 (56%), Gaps = 13/153 (8%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
K+GEG +G VYKGR GQ VA+K RL S+ E+ L+ ELQH N+V +
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 577 CCVEQGEKILILEYMPNKSLDV--YLFDPIKK-RLLDWEARIRIIQGIAQGLLYLHQYSR 633
+++ LI E++ S+D+ YL D + K + +D E + I QG+L+ H
Sbjct: 67 VLMQESRLYLIFEFL---SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCH---S 119
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
R++HRDLK N+L+D K++DFGLAR FG
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 50/154 (32%), Positives = 85/154 (55%), Gaps = 6/154 (3%)
Query: 516 SMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
+M+ KLG G +G VY+G VAVK L + ++EF E ++ E++H NLV++
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
LG C + +I E+M +L YL + ++ ++ + + I+ + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
IHRDL A N L+ ++ K++DFGL+R+ GD
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 57/156 (36%), Positives = 88/156 (56%), Gaps = 20/156 (12%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFK-NEMMLIAELQHRNLVRIL 575
K+GEG +G VYK R G+ VA+K RL ++ +G+ E+ L+ EL H N+VR+L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLL 64
Query: 576 GCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG----IAQGLLYLHQ 630
V K+ L+ E++ + L Y+ D LD +I+ + QG+ Y H
Sbjct: 65 DV-VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLD----PPLIKSYLYQLLQGIAYCHS 117
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
+ R++HRDLK N+L+D++ K++DFGLAR FG
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 59/162 (36%), Positives = 84/162 (51%), Gaps = 16/162 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E + KLG G FG V+ G +VA+K L S + F E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK-----RLLDWEARIRIIQGIAQGLLY 627
R L V Q +I EYM N SL +L P +L+D A+I A+G+ +
Sbjct: 65 R-LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQI------AEGMAF 117
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ R IHRDL+A+N+L+ + + KI+DFGLAR+ +E
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 54/154 (35%), Positives = 77/154 (50%), Gaps = 7/154 (4%)
Query: 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
+ KLG G FG V++G N VAVK L + K+F E ++ +L+H L+++
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 577 CCVEQGEKILIL-EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
C E I I+ E M SL YL R L I + +A G+ YL +
Sbjct: 69 VCT-LEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQN--- 123
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
IHRDL A NVL+ ++ K++DFGLAR+ D
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 7e-20
Identities = 56/158 (35%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 521 LGEGGFGPVYKG--RLFNGQE--VAVKRLS-SQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
LG G FG V KG + +G+E VAVK L G KEF E ++A+L H +VR++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFD----PIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
G C + +L++E P L YL P+ L + ++ A G+ YL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSD-LKELAHQV------AMGMAYLES- 113
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+HRDL A NVLL KISDFG++R G
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 521 LGEGGFGPVYKGR---LFNGQE---VAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVR 573
+G+G FG V++ R L + VAVK L + S +F+ E L+AE H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYLFD-------------------PIKKRLLDWEAR 614
+LG C L+ EYM L+ +L + L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 615 IRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGDELQGN 673
+ I + +A G+ YL S + +HRDL N L+ ++M KI+DFGL+R ++ D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 62/163 (38%), Positives = 93/163 (57%), Gaps = 20/163 (12%)
Query: 521 LGEGGFGPVYKGRLFNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRI 574
LG G FG VYKG E VA+K L+ +G + EF +E +++A + H +LVR+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLF---DPIKKRLL-DWEARIRIIQGIAQGLLYLHQ 630
LG C+ + L+ + MP+ L Y+ D I +LL +W +I A+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673
R++HRDL A NVL+ + KI+DFGLAR+ GDE + N
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 18/151 (11%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVRILGCC 578
K+G+G FG VYKG L EVAVK S LK F E ++ + H N+V+++G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGI------AQGLLYLHQYS 632
V++ +++E +P SL +L + R+ + + + A G+ YL +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKK--------KNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
IHRDL A N L+ ++ KISDFG++R
Sbjct: 114 ---CIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 47/169 (27%), Positives = 90/169 (53%), Gaps = 23/169 (13%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG------LKEFKNEMMLIAELQHRNLV 572
++GEG G V+K + G+ VA+K+++ + +G L+E K + QH +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR---LLDWEARIRIIQGIAQGLLYLH 629
++L +L++EYMP+ L + ++ L + + + ++ + +G+ Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMH 116
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
I+HRDLK +N+L+ D KI+DFGLAR+F +E + + ++
Sbjct: 117 A---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 5e-19
Identities = 53/163 (32%), Positives = 80/163 (49%), Gaps = 30/163 (18%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--EMMLIAELQ---- 567
+ + +LG+G FG VY R G+ VA+K++ K+F + E M + E++
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRK 53
Query: 568 ---HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR---LLDWEARIR-IIQG 620
H N+V++ E E + EYM + L+ +K R E+ IR II
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFS-ESVIRSIIYQ 107
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
I QGL ++H + HRDLK N+L+ KI+DFGLAR
Sbjct: 108 ILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 5e-19
Identities = 37/112 (33%), Positives = 52/112 (46%), Gaps = 9/112 (8%)
Query: 212 SGQWDGTGF-----VSALSYTNFIYKQFMTENKDEFVYWYEAYNRPSIMTLKLNPSGFVT 266
SG W+G F + LSY + + TEN +E Y Y N L L+ G +
Sbjct: 3 SGPWNGIRFSGIPEMQKLSYYVYNF----TENNEEVYYTYRMTNNSIYSRLTLSSEGSLE 58
Query: 267 RQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCECLEGFKLKS 318
R W NS W+ +S P C YG CG C ++ +P C C++GF K+
Sbjct: 59 RFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 25/167 (14%)
Query: 521 LGEGGFGPVYKGRL----FNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LGEG FG V +G+L + +VAVK +L + ++EF +E + + H N++++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 575 LGCCVEQGEK------ILILEYMPNKSLDVYLFDPIKKRL------LDWEARIRIIQGIA 622
+G C E ++IL +M + L +L RL L + ++ + IA
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---YSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD 668
G+ YL S IHRDL A N +L +DM ++DFGL++ ++ GD
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 45/195 (23%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL---SSQSG---QGLKEFKNEMMLI 563
++ + KLGEG FG VYK R + G+ VA+K++ + + G L+E K ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 564 AELQHRNLVRILGCCVEQGEKI--------LILEYM----------PNKSLDVYLFDPIK 605
+L+H N+V ++ VE+ +K ++ YM P+ L
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYM 121
Query: 606 KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
+LL+ G+ YLH+ I+HRD+KA+N+L+D KI+DFGLAR +
Sbjct: 122 LQLLE-------------GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPY 165
Query: 666 GGDELQGNTKRIVGT 680
G GT
Sbjct: 166 DGPPPNPKGGGGGGT 180
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 53/162 (32%), Positives = 81/162 (50%), Gaps = 24/162 (14%)
Query: 521 LGEGGFGPVYKGRL-----FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
LG+G FG V R G+ VAVK+L + + L++F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 576 GCCVEQGEK--ILILEYMPNKSLDVYL------FDPIKKRLLDWEARIRIIQGIAQGLLY 627
G C G + L++EY+P SL YL D K L + I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
L R +HRDL N+L++ + KI DFGL ++ D+
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 44/155 (28%), Positives = 79/155 (50%), Gaps = 6/155 (3%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV 579
++G G FG V+ G ++VA+K + + ++F E ++ +L H LV++ G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHR 639
E+ L+ E+M + L YL ++ E + + + +G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 640 DLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
DL A N L+ ++ K+SDFG+ R D+ +T
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 59/160 (36%), Positives = 79/160 (49%), Gaps = 20/160 (12%)
Query: 521 LGEGGFGPVYKGRLFN-------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLV 572
LG G FG VY+G + VAVK L + Q KEF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR----LLDWEARIRIIQGIAQGLLYL 628
++LG C+ + +I+E M L YL D +R LL + + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 629 HQYSRLRIIHRDLKASNVLL-----DKDMNPKISDFGLAR 663
Q + IHRDL A N L+ D D KI DFGLAR
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 57/171 (33%), Positives = 80/171 (46%), Gaps = 26/171 (15%)
Query: 521 LGEGGFGPVYK------GRLFNGQEVAVKRLSSQSGQGLKEF---KNEMMLIAELQHRNL 571
LG+G FG V G+L+ A+K L + KE E +++ + H +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLY-----AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 572 VRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGLLYLH 629
V+ L + EK+ L+LEY P LF + K E R R I L YLH
Sbjct: 56 VK-LHYAFQTEEKLYLVLEYAPGG----ELFSHLSKEGRFSEERARFYAAEIVLALEYLH 110
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
L II+RDLK N+LLD D + K++DFGLA+ + + NT GT
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 55/177 (31%), Positives = 91/177 (51%), Gaps = 17/177 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRN 570
+++ + +G G VY L N ++VA+KR+ + + E + E+ +++ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRL----LDWEARI-RIIQGIAQGL 625
+V+ V E L++ Y+ SL D +K LD EA I +++ + +GL
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLD-EAIIATVLKEVLKGL 115
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF--GGDELQGNTKRIVGT 680
YLH + IHRD+KA N+LL +D + KI+DFG++ GGD + K VGT
Sbjct: 116 EYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 57/162 (35%), Positives = 86/162 (53%), Gaps = 15/162 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ + KLG G FG V+ G N +VAVK L + ++ F E L+ LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDP-----IKKRLLDWEARIRIIQGIAQGLLY 627
R+ ++ +I EYM SL +L + +L+D+ A+I A+G+ Y
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI------AEGMAY 118
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ R IHRDL+A+NVL+ + + KI+DFGLAR+ +E
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 56/152 (36%), Positives = 85/152 (55%), Gaps = 18/152 (11%)
Query: 521 LGEGGFGPVYKG-RLFNGQEVAVKRLS----SQSGQG-LKEFKNEMMLIAELQHRNLVRI 574
LG G FG VY+G L +G AVK +S Q+GQ +K+ + E+ L+++LQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYL--FDPIKKRLLDWEARIRI-IQGIAQGLLYLHQY 631
LG E+ + LE +P SL L + E IR+ + I GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFP------EPVIRLYTRQILLGLEYLH-- 119
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
R +HRD+K +N+L+D + K++DFG+A+
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 55/156 (35%), Positives = 85/156 (54%), Gaps = 8/156 (5%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRN 570
NF KLGEG + VYKGR G+ VA+K L ++ G + E+ L+ EL+H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+VR+ + + +L+ EYM +K L Y+ + LD + +G+ + H+
Sbjct: 60 IVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
R++HRDLK N+L++K K++DFGLAR FG
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 58/159 (36%), Positives = 86/159 (54%), Gaps = 17/159 (10%)
Query: 521 LGEGGFGPV----YKGRLFN-GQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQHRNLVRI 574
LGEG FG V Y N G++VAVK L +SG + + K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL--HQ 630
G C E G LI+E++P+ SL YL P K ++ + +++ I +G+ YL Q
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
Y +HRDL A NVL++ + KI DFGL + D+
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 45/154 (29%), Positives = 86/154 (55%), Gaps = 12/154 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
E++ + ++G G +G VYK R + G+ VA+K + + G + + E+ ++ E +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 572 VRILGCCVEQGEKILILEYMPNKSL-DVY--LFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
V G + + + +++EY SL D+Y P+ + + + R + +GL YL
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYL 117
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
H+ IHRD+K +N+LL +D + K++DFG++
Sbjct: 118 HE---TGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 50/156 (32%), Positives = 84/156 (53%), Gaps = 8/156 (5%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRN 570
NF K+GEG +G VYK R G+ VA+K RL +++ E+ L+ EL H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+V++L + + L+ E++ ++ L ++ D + + + QGL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
+ R++HRDLK N+L++ + K++DFGLAR FG
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 9e-18
Identities = 52/153 (33%), Positives = 80/153 (52%), Gaps = 13/153 (8%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV 579
LG+G +G VY R L +A+K + + + ++ E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 580 EQGEKILILEYMPNKSLDVYL---FDPIKKRLLDWEARIRII-QGIAQGLLYLHQYSRLR 635
E G + +E +P SL L + P+K D E I + I +GL YLH +
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLK----DNEQTIIFYTKQILEGLKYLHD---NQ 128
Query: 636 IIHRDLKASNVLLDKDMNP-KISDFGLARMFGG 667
I+HRD+K NVL++ KISDFG ++ G
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 32/184 (17%)
Query: 520 KLGEGGFGPVYKGRLFNGQE-----------------VAVKRL-SSQSGQGLKEFKNEMM 561
KLGEG FG V+ Q+ VAVK L S ++F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 562 LIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL--------FDPIKKRLLDWEA 613
+++ L N+ R+LG C +I+EYM N L+ +L + L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD--EL 670
+ + IA G+ YL L +HRDL N L+ K+ KI+DFG++R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 671 QGNT 674
QG
Sbjct: 189 QGRA 192
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 55/166 (33%), Positives = 83/166 (50%), Gaps = 19/166 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFN---GQE---VAVKRLSSQSGQGLKEFKNEMMLIAELQ 567
N ++ +LGEG FG V+ +N Q+ VAVK L S K+F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEAR----------IRI 617
H ++V+ G CVE I++ EYM + L+ +L +L E + I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
Q IA G++YL + +HRDL N L+ +++ KI DFG++R
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 56/158 (35%), Positives = 82/158 (51%), Gaps = 26/158 (16%)
Query: 521 LGEGGFGPVYKG-RLFNGQEVAVKR--LSSQSGQG-------LKEFKNEMMLIAELQHRN 570
+G G FG VY G +G+ +AVK+ L S S L E+ L+ ELQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 571 LVRILGCCVEQGEKILILEYMPNKS----LDVYLFDPIKKRLLDWEARIR-IIQGIAQGL 625
+V+ LG ++ + LEY+P S L+ Y E +R ++ I +GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE--------ETLVRNFVRQILKGL 119
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
YLH +R IIHRD+K +N+L+D KISDFG+++
Sbjct: 120 NYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-17
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 11/94 (11%)
Query: 325 PIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYANSN 384
P+ C S++ F KL +VK PD + +++LE+C CL NC+C AYA +N
Sbjct: 2 PLNCGGDGSTD-----GFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN 54
Query: 385 VTEGSGCLMWYGDLLDSRRPIRNFTGQSVYLQVP 418
GCL+W G L + R + G ++YL++
Sbjct: 55 G--SGGCLLWNGLLNNLRSL--SSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 24/172 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRL-SSQSGQGLKEFKNEMMLIAE 565
+ ++ LGEG FG V K VAVK L + + L + +EM ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 566 L-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD-----PIKKRLLDWEARIRIIQ 619
+ +H+N++ +LG C ++G +++EY + +L +L + Q
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 620 --------GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+A+G+ +L + IHRDL A NVL+ +D KI+DFGLAR
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 60/178 (33%), Positives = 89/178 (50%), Gaps = 26/178 (14%)
Query: 520 KLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLV 572
+LGE FG VYKG LF Q VA+K L ++ L+E FK+E M+ + LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLF-------------DPIKKRLLDWEARIRIIQ 619
+LG ++ +I Y + L +L D K L+ + I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD--ELQGNT 674
IA G+ +L S ++H+DL NVL+ +N KISD GL R ++ D +L GN+
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 52/175 (29%), Positives = 91/175 (52%), Gaps = 26/175 (14%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLS------SQSGQGLKEFKNEMMLIAELQHRNLVR 573
LG G F Y+ R + G +AVK+++ S+ + ++ + E+ L+A L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYL--FDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
+LG E L +E+M S+ L + K+ ++ I + + +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122
Query: 632 SRLRIIHRDLKASNVLLDKD-MNPKISDFGLA-----RMFGGDELQGNTKRIVGT 680
+IIHRD+K +N+L+D +I+DFG A + G E QG +++GT
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGT 171
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 54/157 (34%), Positives = 71/157 (45%), Gaps = 26/157 (16%)
Query: 520 KLGEGGFGPVYKG-------RLFNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQHRNL 571
KLG+G FG V +G ++ VAVK L S + +F E ++ L H NL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIP---VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK-----RLLDWEARIRIIQGIAQGLL 626
+R+ G V +++ E P SL L L D+ +Q IA G+
Sbjct: 59 IRLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYA-----VQ-IANGMR 111
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
YL R IHRDL A N+LL D KI DFGL R
Sbjct: 112 YLESK---RFIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 49/151 (32%), Positives = 78/151 (51%), Gaps = 16/151 (10%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKR-----LSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+G FG VY + G+E+AVK+ S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR--LLDWEARIRIIQGIAQGLLYLHQYS 632
GC + + +EYMP S+ D +K L + R Q I +G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVK----DQLKAYGALTETVTRKYTRQ-ILEGVEYLH--- 121
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
I+HRD+K +N+L D N K+ DFG ++
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 50/159 (31%), Positives = 86/159 (54%), Gaps = 22/159 (13%)
Query: 521 LGEGGFGPVYKG--RLFNGQEVAVKRLSSQSGQGLKE---FKNEMMLIAELQHRNLVRIL 575
+G G FG V++G ++ +EVAV + + G K+ F +E ++ + H N++R+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 576 GCCVEQGEKILILEYMPNKSLDVYL------FDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
G + ++I EYM N +LD YL F + + +++GIA G+ YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ--------LVGMLRGIAAGMKYL- 123
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
S + +HRDL A N+L++ ++ K+SDFGL+R+ D
Sbjct: 124 --SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 50/149 (33%), Positives = 76/149 (51%), Gaps = 6/149 (4%)
Query: 521 LGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE 580
LG G FG V+ G+ +VA+K + + +F E ++ +L H NLV++ G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 581 QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRD 640
Q ++ EYM N L YL + +K L E + + + + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRE--RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 641 LKASNVLLDKDMNPKISDFGLARMFGGDE 669
L A N L+ +D K+SDFGLAR D+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQ 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 8e-17
Identities = 41/150 (27%), Positives = 80/150 (53%), Gaps = 9/150 (6%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRNLV 572
F++ +G+G FG VYK Q VA+K + ++ +++ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
+ G ++ + +I+EY S D +K LD I++ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
IHRD+KA+N+LL ++ + K++DFG++
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 50/173 (28%), Positives = 95/173 (54%), Gaps = 14/173 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ + + +LG+G FG VYK + G A K + +S + L++F E+ +++E +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLLYLH 629
+V + + + +++E+ +LD + +++ L E +IR + + + + L +LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLT--EPQIRYVCRQMLEALNFLH 120
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR--IVGT 680
+ ++IHRDLKA N+LL D + K++DFG++ LQ KR +GT
Sbjct: 121 SH---KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQ---KRDTFIGT 166
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 49/154 (31%), Positives = 85/154 (55%), Gaps = 22/154 (14%)
Query: 521 LGEGGFGPVYKGRL-FNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAELQHRNLVRIL 575
+G G FG V +GRL G+ VA+K L S + + ++F +E ++ + H N++ +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 576 GCCVEQGEKILILEYMPNKSLDVYL------FDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
G + ++I E+M N +LD +L F I+ + +++GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ--------LVGMLRGIAAGMKYL- 122
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
S + +HRDL A N+L++ ++ K+SDFGL+R
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 16/151 (10%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMM---LIAELQHRNLVRIL 575
+LG G G V K G+ +AVK + + K + ++ + +V
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 576 GCCVEQGEKILILEYMPNKSLDVYL---FDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
G G+ + +EYM SLD L I +R+L +I + +GL YLH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH--E 118
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ +IIHRD+K SN+L++ K+ DFG++
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 50/144 (34%), Positives = 79/144 (54%), Gaps = 8/144 (5%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV 579
+GEG FG V +G + GQ+VAVK + + F E ++ +L H+NLVR+LG +
Sbjct: 13 IIGEGEFGAVLQGE-YTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 580 EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHR 639
G I ++E M +L V + L+ ++ +A+G+ YL +++HR
Sbjct: 70 HNGLYI-VMELMSKGNL-VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124
Query: 640 DLKASNVLLDKDMNPKISDFGLAR 663
DL A N+L+ +D K+SDFGLAR
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 54/158 (34%), Positives = 86/158 (54%), Gaps = 23/158 (14%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAELQHRNLVRILG 576
K+GEG +G VYK R + +A+K++ Q +G+ E+ L+ E+QH N+VR+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRL---LDWEARIRIIQG----IAQGLLYLH 629
+ L+ EY+ LD +KK + D+ R+I+ I +G+ Y H
Sbjct: 69 VVHSEKRLYLVFEYL---DLD------LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMFG 666
+ R++HRDLK N+L+D+ N K++DFGLAR FG
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154
|
Length = 294 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 53/168 (31%), Positives = 77/168 (45%), Gaps = 27/168 (16%)
Query: 521 LGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFK-----NE---MMLIAELQHRNL 571
+GEG F V + +E A+K L + Q +KE K E + + H +
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLN--GHPGI 64
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR-LLDWEARIRIIQGIAQ---GLLY 627
+++ ++ +LEY PN L I+K LD E R A+ L Y
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPNGEL----LQYIRKYGSLD-EKCTRFY--AAEILLALEY 117
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK 675
LH IIHRDLK N+LLDKDM+ KI+DFG A++ + + K
Sbjct: 118 LHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 53/157 (33%), Positives = 89/157 (56%), Gaps = 16/157 (10%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAELQ---HRNLVRI 574
+GEG +G VYK R L G+ VA+K++ S +G+ E+ L+ +L+ H N+VR+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 575 LGCC-VEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
L C + ++ L+ E++ ++ L YL K L E +++ + +G+ +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVDFLH 124
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
+ RI+HRDLK N+L+ D KI+DFGLAR++
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 53/150 (35%), Positives = 81/150 (54%), Gaps = 13/150 (8%)
Query: 520 KLGEGGFGPVYKG-RLFNGQEVAVKRLSSQSGQG--LKEFKNEMMLIAELQHRNLVRILG 576
K+G G FG VY L G+ +AVK + Q +KE +EM ++ L+H NLV+ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRI--IQGIAQGLLYLHQYSRL 634
V + + + +EY +L+ L R+LD E IR+ +Q + +GL YLH +
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEH---GRILD-EHVIRVYTLQ-LLEGLAYLHSH--- 118
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARM 664
I+HRD+K +N+ LD + K+ DFG A
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGL-KEFKNEMMLIAELQHRN 570
E +LGEG G V K RL N + A+K +++ L K+ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 571 LVRILGCCVE--QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI------RIIQGIA 622
+V+ G ++ + +EY SLD I K++ RI +I + +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLD-----SIYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660
+GL YLH +IIHRD+K SN+LL + K+ DFG
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 49/156 (31%), Positives = 82/156 (52%), Gaps = 8/156 (5%)
Query: 509 AAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH 568
A + + +G+G FG V G + G +VAVK + + + + F E ++ +L+H
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 58
Query: 569 RNLVRILGCCVEQ-GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
NLV++LG VE+ G ++ EYM SL YL + +L + ++ + + + Y
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEY 117
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
L + +HRDL A NVL+ +D K+SDFGL +
Sbjct: 118 LEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 10/149 (6%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
++G G FG VY R + + VA+K++S QS + ++ E+ + +L+H N +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
GC + + L++EY + D+ + KK L + E I G QGL YLH + R
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDI--LEVHKKPLQEVEIAA-ICHGALQGLAYLHSHER-- 136
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARM 664
IHRD+KA N+LL + K++DFG A +
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASL 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 53/167 (31%), Positives = 88/167 (52%), Gaps = 22/167 (13%)
Query: 521 LGEGGFGPVYKGRL-FNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAELQHRNLVRIL 575
+G G FG V GRL G+ VA+K L + + + ++F +E ++ + H N++ +
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQ------GIAQGLLYLH 629
G + +++ EYM N SLD +L +K + + +IQ GIA G+ YL
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL----RKH----DGQFTVIQLVGMLRGIASGMKYL- 122
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR 676
S + +HRDL A N+L++ ++ K+SDFGL+R+ D T R
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 16/156 (10%)
Query: 521 LGEGGFGPVYKGRLFNGQE------VAVKRLSSQSGQG-LKEFKNEMMLIAELQHRNLVR 573
LG G FG V+ + +E V VK L + EF+ E+ + +L H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYL------FDPIKKRLLDWEARIRIIQGIAQGLLY 627
+LG C E +ILEY L +L + +K L + ++ + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
L S R +HRDL A N L+ K+S L++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 59/159 (37%), Positives = 87/159 (54%), Gaps = 20/159 (12%)
Query: 521 LGEGGFGPVYKGRLFNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG G FG VYKG E VA+K L + S + KE +E ++A + + ++ R+
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLF---DPIKKR-LLDWEARIRIIQGIAQGLLYLHQ 630
LG C+ + LI + MP L Y+ D I + LL+W +Q IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-----CVQ-IAKGMNYLEE 127
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
R++HRDL A NVL+ + KI+DFGLA++ G DE
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 49/150 (32%), Positives = 82/150 (54%), Gaps = 9/150 (6%)
Query: 520 KLGEGGFGPVYKGRLFNGQE-VAVKRLSSQS-GQGLKEFK-NEMMLIAELQHRNLVRILG 576
K+GEG +G V+K + E VA+KR+ +G+ E+ L+ EL+H+N+VR+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
+ L+ EY ++ L Y FD + + + Q + +GL + H + +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDIDPEIVKSFMFQ-LLKGLAFCHSH---NV 120
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLARMFG 666
+HRDLK N+L++K+ K++DFGLAR FG
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 46/144 (31%), Positives = 87/144 (60%), Gaps = 6/144 (4%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
+LG+G FG VYK + G A K + ++S + L+++ E+ ++A H +V++LG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
G+ +++E+ P ++D + + + + L + + ++ I + + + L YLH ++IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133
Query: 639 RDLKASNVLLDKDMNPKISDFGLA 662
RDLKA NVLL D + K++DFG++
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 54/165 (32%), Positives = 82/165 (49%), Gaps = 21/165 (12%)
Query: 517 MQCKLGEGGFGPVYKGR---LFNGQE---VAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
++ +LGEG FG V+ L Q+ VAVK L S ++F+ E L+ LQH++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYL--FDPIKKRL----------LDWEARIRII 618
+VR G C E +++ EYM + L+ +L P K L L + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
IA G++YL + L +HRDL N L+ + + KI DFG++R
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 54/164 (32%), Positives = 81/164 (49%), Gaps = 23/164 (14%)
Query: 520 KLGEGGFGPVYKGRLF-----NGQEVAVKRLSS-QSGQGLKEFKNEMMLIAELQHRNLVR 573
+LGE FG +YKG L+ + Q VA+K L + Q EF+ E L+AEL H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYLF--------------DPIKKRLLDWEARIRIIQ 619
+LG ++ ++ EY+ L +L D K LD + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
IA G+ YL + +H+DL A N+L+ + ++ KISD GL+R
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 52/167 (31%), Positives = 85/167 (50%), Gaps = 17/167 (10%)
Query: 511 ATENFSMQCKLGEGGFGPVYKG--RLFNG----QEVAVKRL-SSQSGQGLKEFKNEMMLI 563
++ ++ LG G FG VY+G R +G +VAVK L S S Q +F E +++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD----PIKKRLLDWEARIRIIQ 619
++ H+N+VR++G E+ + ++LE M L +L + P + L + + +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLD---KDMNPKISDFGLAR 663
+A+G YL + IHRD+ A N LL KI+DFG+AR
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 54/164 (32%), Positives = 87/164 (53%), Gaps = 26/164 (15%)
Query: 521 LGEGGFGPVYKGRLFNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRI 574
LG G FG V+KG + VA+K + +SG Q +E + M+ + L H +VR+
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYL------FDPIKKRLLDWEARIRIIQGIAQGLLY 627
LG C G + L+ + P SL ++ DP +RLL+W +I A+G+ Y
Sbjct: 75 LGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQI------AKGMYY 124
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671
L ++ R++HR+L A N+LL D +I+DFG+A + D+ +
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 17/165 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQGLK-EFKNEMMLIAE 565
E ++ +LG+G FG VY+G VA+K ++ + + EF NE ++ E
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLF----DPIKKRLLDWEARIRIIQ-- 619
++VR+LG ++++E M L YL + L + IQ
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 620 -GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
IA G+ YL + +HRDL A N ++ +D+ KI DFG+ R
Sbjct: 126 AEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 51/182 (28%), Positives = 81/182 (44%), Gaps = 26/182 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL-------SSQSGQGLKEFKNEMMLI 563
NF ++ K+G+G F VYK L +G+ VA+K++ + LKE L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIK-----KRLLDWEARIRII 618
+L H N+++ L +E E ++LE L IK KRL+ +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRM----IKHFKKQKRLIPERTIWKYF 112
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ L ++H RI+HRD+K +NV + K+ D GL R F ++ V
Sbjct: 113 VQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--V 167
Query: 679 GT 680
GT
Sbjct: 168 GT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 52/166 (31%), Positives = 92/166 (55%), Gaps = 24/166 (14%)
Query: 521 LGEGGFGPVYKGRLFNGQ---EVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
LGEG FG V +G+L +VAVK +++ + +++F +E + + E H N++R++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 576 GCCVEQGEK------ILILEYMPNKSLDVYLFDPIKKRLLDW------EARIRIIQGIAQ 623
G C++ E ++IL +M + L +L + RL D + ++ + IA
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFL---LYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA-RMFGGD 668
G+ YL S IHRDL A N +L+++MN ++DFGL+ +++ GD
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 31/161 (19%)
Query: 521 LGEGGFGPVYKG-RLFNGQEVAVK----------RLSSQSGQGLKEFKNEMMLIAELQHR 569
+G+G +G VY + G+ +AVK R S+ +K ++E+ + +L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 570 NLVRILGCCVEQGEKIL--ILEYMPNKSLDVYL-----FDPIKKRLLDWEARIRIIQGIA 622
N+V+ LG E E+ L LEY+P S+ L F+ R + +
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF--------TEQVL 118
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+GL YLH I+HRDLKA N+L+D D KISDFG+++
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 22/163 (13%)
Query: 520 KLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVR 573
+LGEG FG V+ +N VAVK L + K+F+ E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYL--FDPIKKRLLDWEAR-----------IRIIQG 620
G C + I++ EYM + L+ +L P L+D + R + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
IA G++YL + +HRDL N L+ ++ KI DFG++R
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 24/173 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG-----QEVAVKRLSSQSGQ-GLKEFKNEMMLIAEL 566
+ ++ L EG FG ++ G L + +EV VK + + + + E L+ L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKS-LDVYLFDPIKKRLLDWEARIRI-------- 617
H+N++ IL C+E GE +L N L ++L RL + +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQC---RLGEANNPQALSTQQLVHM 122
Query: 618 -IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD 668
IQ IA G+ YLH + +IH+D+ A N ++D+++ KI+D L+R +F D
Sbjct: 123 AIQ-IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 48/173 (27%), Positives = 84/173 (48%), Gaps = 34/173 (19%)
Query: 515 FSMQCKLGEGGFGPVYKGRLFN---GQEVAVKRL--SSQSGQGLKEFK-NEMMLIAELQH 568
+ ++ +G G +G VYK + N G+E A+K+ + G+ + E+ L+ EL+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 569 RNLVRILGCCVEQGEKI--LILEYMPN----------KSLDVYLFDPIKKRLLDWEARIR 616
N+V ++ +E +K L+ +Y + ++ V + + K LL W+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL-WQ---- 116
Query: 617 IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP----KISDFGLARMF 665
I G+ YLH ++HRDLK +N+L+ + KI D GLAR+F
Sbjct: 117 ----ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 48/144 (33%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 521 LGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAELQHRNLVRILGCCV 579
LG+G FG V+KG L + VAVK Q LK +F +E ++ + H N+V+++G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 580 EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHR 639
++ +++E +P +L KK L + ++ A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 640 DLKASNVLLDKDMNPKISDFGLAR 663
DL A N L+ ++ KISDFG++R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV 579
+LG G FG V G+ +VA+K + S EF E ++ +L H LV++ G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL--HQYSRLRII 637
+Q ++ EYM N L YL + K+ + + + + +G+ YL Q+ I
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESKQF-----I 122
Query: 638 HRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
HRDL A N L+D K+SDFGL+R DE
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 31/178 (17%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNGQ------EVAVKRLSSQSGQG-LKEFKNEMMLIAEL 566
N + LGEG FG V K F + VAVK L + L++ +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIK--------------------- 605
H +++++ G C + G +LI+EY SL +L + K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 606 KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+R L I I++G+ YL + ++++HRDL A NVL+ + KISDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 48/160 (30%), Positives = 86/160 (53%), Gaps = 17/160 (10%)
Query: 514 NFSMQCKLGEGGFGPVYK-GRLFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAELQHRN 570
+F + KLG+G +G VYK RL + Q A+K L S S + ++ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 571 LVR-----ILGCCVEQGEKILILEYMPNKSLDVYLFDPIK-KRLLDWEARIRIIQGIAQG 624
++ + G + +++EY P L + K ++L+ + RI + +G
Sbjct: 61 IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664
L LH+ +I+HRDLK++N+LL + KI D G++++
Sbjct: 116 LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV 152
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 56/177 (31%), Positives = 93/177 (52%), Gaps = 22/177 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL-----SSQSGQGLKEFKNEMMLIAEL 566
+ + KLG+G +G V+K + VA+K++ ++ Q + F+ E+M + EL
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ--RTFR-EIMFLQEL 63
Query: 567 -QHRNLVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
H N+V++L + +K L+ EYM + L I+ +L+ + I+ + +
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLLK 118
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
L Y+H S +IHRDLK SN+LL+ D K++DFGLAR EL+ N + V T
Sbjct: 119 ALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLT 170
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 50/149 (33%), Positives = 82/149 (55%), Gaps = 10/149 (6%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
++G G FG VY R + N + VA+K++S QS + ++ E+ + +L+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
GC + + L++EY + D L + KK L + E + G QGL YLH ++
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAYLHSHN--- 135
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARM 664
+IHRD+KA N+LL + K+ DFG A +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-15
Identities = 51/154 (33%), Positives = 81/154 (52%), Gaps = 10/154 (6%)
Query: 515 FSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLS---SQSGQGLKEFKNEMMLIAELQHRN 570
F+ ++G G FG VY R EV A+K++S QS + ++ E+ + ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+ GC + + L++EY + D L + KK L + E I G QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHS 143
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664
++ +IHRD+KA N+LL + K++DFG A +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKR-LSSQSGQGLKEFK-NEMMLIAELQHR 569
+ + +GEG +G V K R G+ VA+K+ S+ + +K+ E+ ++ +L+H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N+V + +G L+ EY+ L++ P L +A I + Q + Y H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCH 117
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
IIHRD+K N+L+ + K+ DFG AR
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 27/175 (15%)
Query: 521 LGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGC- 577
+GEG +G VYK R GQ VA+K + +E K E ++ + H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 578 -----CVEQGEKILILEYMPNKSL-DVYLFDPIKKRLLDWEARIR------IIQGIAQGL 625
+ L++E S+ D+ K L R++ I++ +GL
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
YLH+ ++IHRD+K N+LL K+ K+ DFG++ + NT +GT
Sbjct: 127 AYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FIGT 176
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 56/174 (32%), Positives = 88/174 (50%), Gaps = 26/174 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE--------VAVKRLSSQ-SGQGLKEFKNEMMLI 563
+ + LGEG FG V + + + VAVK L + + L + +EM L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 564 AEL-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-----------FDPIK--KRLL 609
+ +H+N++ +LG C ++G +I+EY +L +L FD K + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
++ + +A+G+ YL SR R IHRDL A NVL+ +D KI+DFGLAR
Sbjct: 132 SFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 50/149 (33%), Positives = 70/149 (46%), Gaps = 9/149 (6%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVA---VKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
++G G FG V G G A VK L +S + F E+ EL H N+++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI--RIIQGIAQGLLYLHQYSR 633
G C+E +L+LE+ P L YL + + R+ +A GLL+LHQ
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--- 118
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLA 662
IH DL N L D++ KI D+GLA
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 54/149 (36%), Positives = 75/149 (50%), Gaps = 9/149 (6%)
Query: 520 KLGEGGFGPVYKGRLFNG---QEVAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
++G G FG V G + +G +V VK L S S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI--RIIQGIAQGLLYLHQYSR 633
G C E +L++E+ P L YL K L+ + R+ IA GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLA 662
IH DL N LL D+ KI D+GL+
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 16/151 (10%)
Query: 521 LGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGL---KEFKN---EMMLIAELQHRNLVRI 574
LG+G +G VY G GQ +AVK++ + L KE++ E+ L+ L+H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYL--FDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
LG C++ + +E++P S+ L F P+ + + + + I G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF-----CKYTKQILDGVAYLHNNC 122
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
++HRD+K +NV+L + K+ DFG AR
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 51/159 (32%), Positives = 82/159 (51%), Gaps = 6/159 (3%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
E+ + KLG G FG V+ G +VAVK L + + F E ++ +L+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
LV++ E+ I + EYM SL +L D + R L + + +A G+ Y+
Sbjct: 63 LVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE- 119
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
R+ IHRDL+++N+L+ + KI+DFGLAR+ +E
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 53/169 (31%), Positives = 86/169 (50%), Gaps = 41/169 (24%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKR-LSSQSGQG-----LKEFKNEMMLIAELQHRNLV 572
K+G+G FG V+K R Q VA+K+ L +G L+E K ++ L+H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 74
Query: 573 RILGCCVEQGEK--------ILILEY--------MPNKSLDVYLFDPIKKRLLDWEARIR 616
++ C + L+ E+ + NK++ L + IKK
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE-IKK---------- 123
Query: 617 IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
+++ + GL Y+H R +I+HRD+KA+N+L+ KD K++DFGLAR F
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 40/190 (21%)
Query: 520 KLGEGGFGPVYKGRLFNGQE-----------------VAVKRLSSQSGQGLK-EFKNEMM 561
KLGEG FG V+ + N Q+ VAVK L + + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 562 LIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL--------------FDPIKKR 607
+++ L+ N++R+LG CV++ +I EYM N L+ +L P
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 608 LL--DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-M 664
L + + + + IA G+ YL S L +HRDL N L+ +++ KI+DFG++R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 665 FGGD--ELQG 672
+ GD +QG
Sbjct: 189 YAGDYYRIQG 198
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 45/172 (26%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMMLIAELQHRN 570
+G G +G V G++VA+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 571 LVRILGCCVEQGEKILILEYMPNKSL-DVYLFDP---------IK-KRLLDWEARIR--I 617
++ +L IL + DVY+ IK + L + I+ +
Sbjct: 61 IIGLL----------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT-DDHIQYFL 109
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
Q I +GL YLH +IHRDLK SN+L++ + + KI DFGLAR DE
Sbjct: 110 YQ-ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 54/163 (33%), Positives = 86/163 (52%), Gaps = 18/163 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ ++ KLG G FG V+ +VAVK + S ++ F E ++ LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFD------PIKKRLLDWEARIRIIQGIAQGLL 626
+ L V + +I E+M SL +L P+ K L+D+ A+I A+G+
Sbjct: 65 K-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK-LIDFSAQI------AEGMA 116
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
++ Q + IHRDL+A+N+L+ + KI+DFGLAR+ +E
Sbjct: 117 FIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 52/161 (32%), Positives = 76/161 (47%), Gaps = 33/161 (20%)
Query: 521 LGEGGFGPVYKGRL-FNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRILGC 577
+G G +G V G++VA+K+LS QS K E+ L+ + H N++ +L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 578 CVEQGEKILILEYMPNKSL----DVYLFDP---------IK-KRLLDWEARIRIIQGIAQ 623
+ P SL DVYL +K ++L D + + Q I +
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQ-ILR 129
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664
GL Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH 167
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 56/181 (30%), Positives = 89/181 (49%), Gaps = 31/181 (17%)
Query: 520 KLGEGGFGPVY----KGRL---------FNGQE--VAVKRLSSQSGQGLK-EFKNEMMLI 563
KLGEG FG V+ +G F+GQ VAVK L + + + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD-PIKKRL--------LDWEAR 614
+ L++ N++R+LG CV +I EYM N L+ +L I+ +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 615 IRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD--ELQ 671
+ + IA G+ YL + L +HRDL N L+ KI+DFG++R ++ GD +Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 672 G 672
G
Sbjct: 189 G 189
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 47/150 (31%), Positives = 78/150 (52%), Gaps = 6/150 (4%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV 579
+LG G FG V+ G+ +VA+K ++ + ++F E ++ +L H LV++ G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHR 639
+Q ++ E+M N L YL ++ L + + + Q + +G+ YL + S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 640 DLKASNVLLDKDMNPKISDFGLARMFGGDE 669
DL A N L+ K+SDFG+ R DE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 53/163 (32%), Positives = 88/163 (53%), Gaps = 18/163 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ +L+H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64
Query: 573 RILGCCVEQGEKILIL-EYMPNKSLDVYLFDPIKK-----RLLDWEARIRIIQGIAQGLL 626
++ E E I I+ EYM SL +L + K +L+D A+I A G+
Sbjct: 65 QLYAVVSE--EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI------ASGMA 116
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
Y+ R+ +HRDL+A+N+L+ +++ K++DFGLAR+ +E
Sbjct: 117 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 53/160 (33%), Positives = 88/160 (55%), Gaps = 27/160 (16%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
++GEG +G VY+ R +G+ VA+K++ + + G + + E+ L+ L+H N+V +
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72
Query: 576 GCCV-EQGEKI-LILEYMPNKSLDVYLFDPIKKRLLD------WEARIR-IIQGIAQGLL 626
V + + I L++EY D+ LLD E++++ ++ + +GL
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQ---DL-------ASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
YLH+ IIHRDLK SN+LL KI+DFGLAR +G
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 51/171 (29%), Positives = 86/171 (50%), Gaps = 27/171 (15%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNG---QEVAVKRLSSQSGQG-LKEFKNEMMLIAEL-QH 568
+ Q +GEG FG V K R+ + A+KR+ + + ++F E+ ++ +L H
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-------- 620
N++ +LG C +G L +EY P+ +L +L K R+L+ + I
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR---KSRVLETDPAFAIANSTASTLSSQ 124
Query: 621 --------IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+A+G+ YL Q + IHRDL A N+L+ ++ KI+DFGL+R
Sbjct: 125 QLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 521 LGEGGFGPVY------KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+G FG VY GR ++V S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 575 LGCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKKRLLDWEARIR-IIQGIAQGLLYLHQY 631
GC ++ EK L +EYMP S+ D +K E+ R + I +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
I+HRD+K +N+L D N K+ DFG ++
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 52/173 (30%), Positives = 89/173 (51%), Gaps = 25/173 (14%)
Query: 515 FSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQH 568
F++ LG+G FG V + +L + Q+VAVK L + S ++EF E + E H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 569 RNLVRILGCCVEQGEK------ILILEYMPNKSLDVYLF------DPIKKRLLDWEARIR 616
N+++++G + K ++IL +M + L +L +P L + +R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT---LPLQTLVR 117
Query: 617 IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD 668
+ IA G+ YL S IHRDL A N +L+++M ++DFGL++ ++ GD
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 52/157 (33%), Positives = 84/157 (53%), Gaps = 16/157 (10%)
Query: 520 KLGEGGFGPVYKG--RLFNGQ-EVAVKRLSSQSGQGLKEFKNEMMLIAELQHR----NLV 572
+LG G FG V KG ++ Q +VA+K L +++ K ++EMM AE+ H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIV 58
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
R++G C E +L++E L+ +L KK + + ++ ++ G+ YL +
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+HRDL A NVLL KISDFGL++ G D+
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 43/153 (28%), Positives = 86/153 (56%), Gaps = 11/153 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
E+F + ++G G +G VYK R N G+ A+K + + G+ + E++++ + +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 572 VRILGCCVEQGEKILILEYMPNKSL-DVY-LFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
V G + + + + +E+ SL D+Y + P+ + + + +R + QGL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
+ +HRD+K +N+LL + + K++DFG++
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 50/147 (34%), Positives = 80/147 (54%), Gaps = 10/147 (6%)
Query: 520 KLGEGGFGPVYKGRLFNGQE-VAVKRLS---SQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
++G G FG VY + E VAVK++S Q+ + ++ E+ + +L+H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
GC +++ L++EY + D L + KK L + E I G QGL YLH ++
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHSHN--- 141
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLA 662
+IHRD+KA N+LL + K++DFG A
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA 168
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 30/179 (16%)
Query: 520 KLGEGGFGPVYK------GRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV- 572
+G+G FG V K G++ +E+ ++ + Q L +E+ ++ EL+H N+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIVR 63
Query: 573 ---RILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKK-----RLLDWEARIRIIQGIAQ 623
RI+ + + +++EY L I+K + ++ E RI+ +
Sbjct: 64 YYDRII---DRSNQTLYIVMEYCEGGDLAQL----IQKCKKERKYIEEEFIWRILTQLLL 116
Query: 624 GLLYLH--QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
L H ++HRDLK +N+ LD + N K+ DFGLA++ G D K VGT
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 45/153 (29%), Positives = 82/153 (53%), Gaps = 11/153 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
++ + ++G G +G VYK R L G+ AVK + + G + E+ ++ E +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 572 VRILGCCVEQGEKILILEYMPNKSL-DVY-LFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
V G + + + + +EY SL D+Y + P+ + + + R + QGL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
++ HRD+K +N+LL + + K++DFG+A
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 57/161 (35%), Positives = 85/161 (52%), Gaps = 20/161 (12%)
Query: 521 LGEGGFGPVYKGRLFNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG G FG VYKG E VA+K L + S + KE +E ++A + + R+
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLF---DPIKKR-LLDWEARIRIIQGIAQGLLYLHQ 630
LG C+ + L+ + MP L Y+ D I + LL+W +I A+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671
+R++HRDL A NVL+ + KI+DFGLAR+ DE +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 56/182 (30%), Positives = 99/182 (54%), Gaps = 14/182 (7%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRLSSQSGQGLKEFK-NE 559
L ++ SV + ++ K+G+G G VY + GQEVA+K+++ Q Q KE NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINE 66
Query: 560 MMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIR-II 618
++++ E +H N+V L + E +++EY+ SL D + + +D E +I +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMD-EGQIAAVC 121
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ Q L +LH ++IHRD+K+ N+LL D + K++DFG ++ + +T +V
Sbjct: 122 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MV 176
Query: 679 GT 680
GT
Sbjct: 177 GT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 54/166 (32%), Positives = 89/166 (53%), Gaps = 23/166 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL---SSQSG---QGLKEFKNEMMLIAE 565
+ + ++ EG +G VY+ R G+ VA+K+L + G L+E N ++ +
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI-NILL---K 60
Query: 566 LQHRNLVRILGCCVEQG-EKI-LILEYMPN--KSLDVYLFDPIKKRLLDWEARIRIIQGI 621
LQH N+V + V +KI +++EY+ + KSL + +K+ L E + ++Q +
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSL----METMKQPFLQSEVKCLMLQ-L 115
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667
G+ +LH I+HRDLK SN+LL+ KI DFGLAR +G
Sbjct: 116 LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 45/183 (24%), Positives = 77/183 (42%), Gaps = 46/183 (25%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG------------------LKEFKNEMM 561
LGEG +G V K G+ VA+K++ L+E K
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK---- 72
Query: 562 LIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIR----- 616
++ E++H N++ ++ VE L+++ M K+++D +IR
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVD--RKIRLTESQ 120
Query: 617 ---IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673
I+ I GL LH++ +HRDL +N+ ++ KI+DFGLAR +G
Sbjct: 121 VKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 674 TKR 676
+
Sbjct: 178 LSK 180
|
Length = 335 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 55/182 (30%), Positives = 88/182 (48%), Gaps = 32/182 (17%)
Query: 520 KLGEGGFGPVY----KGRL-FNGQE------------VAVKRLSSQSGQGLK-EFKNEMM 561
KLGEG FG V+ +G F ++ VAVK L + + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 562 LIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLF------DPIK--KRLLDWEA 613
+++ L+ N++R+L C+ +I EYM N L+ +L K + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD--EL 670
I + IA G+ YL S L +HRDL N L+ K+ KI+DFG++R ++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 671 QG 672
QG
Sbjct: 189 QG 190
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 52/158 (32%), Positives = 84/158 (53%), Gaps = 8/158 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNL 571
E+ + KLG+G FG V+ G +VA+K L + G + E F E ++ +L+H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
V + E+ I + E+M SL +L + K L + + IA G+ Y+
Sbjct: 64 VPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYL-KLPQLVDMAAQIADGMAYIE-- 119
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
R+ IHRDL+A+N+L+ ++ KI+DFGLAR+ +E
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 53/181 (29%), Positives = 99/181 (54%), Gaps = 12/181 (6%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEM 560
L ++ S+ + ++ K+G+G G V+ + GQEVA+K+++ Q + NE+
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 561 MLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI-RIIQ 619
+++ EL++ N+V L + E +++EY+ SL D + + +D EA+I + +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMD-EAQIAAVCR 122
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVG 679
Q L +LH ++IHRD+K+ NVLL D + K++DFG ++ + +T +VG
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 680 T 680
T
Sbjct: 178 T 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 52/180 (28%), Positives = 96/180 (53%), Gaps = 25/180 (13%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAELQHRN 570
F + ++GEG +G VYK R G+ VA+K++ + + G + + E+ ++ +L HRN
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67
Query: 571 LVRILGCCV----------EQGEKILILEYMPNKSLDVYLFDPIKKRLLDW-EARIR-II 618
+V + ++G L+ EYM D L ++ L+ + E I+ +
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSFM 122
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ + +GL Y H+ + L HRD+K SN+LL+ K++DFGLAR++ +E + T +++
Sbjct: 123 KQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 52/171 (30%), Positives = 95/171 (55%), Gaps = 13/171 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQG-LKEFKNEMMLIAELQHRN 570
E F+ ++G+G FG VYKG +EV A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 571 LVRILGCCVEQGEKILILEYMPNKS-LDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
+ R G ++ + +I+EY+ S LD+ P+++ + I++ I +GL YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLH 118
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
R IHRD+KA+NVLL + + K++DFG+A +++ NT VGT
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 53/166 (31%), Positives = 86/166 (51%), Gaps = 26/166 (15%)
Query: 521 LGEGGFGPVY--------KGRLFNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAEL-QHRN 570
LGEG FG V K + +VAVK L S + + L + +EM ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYL-----------FDP--IKKRLLDWEARIRI 617
++ +LG C + G +I+EY +L YL ++P + + L ++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+A+G+ YL + + IHRDL A NVL+ +D KI+DFGLAR
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 8e-13
Identities = 51/180 (28%), Positives = 94/180 (52%), Gaps = 10/180 (5%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRLSSQSGQGLKEFKNEM 560
L S+ SV + ++ K+G+G G VY + GQEVA+K+++ Q + NE+
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 561 MLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG 620
+++ E ++ N+V L + E +++EY+ SL D + + +D + +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
Q L +LH ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRL-----SSQSGQGLKEFKNEMMLIAELQ 567
N+ + LG+G FG VY G+E+AVK++ S ++ + + + E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 568 HRNLVRILGCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKKRLLDWEARI-----RIIQG 620
H +V+ GC + E+ L +E+MP S IK +L + A + +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS--------IKDQLKSYGALTENVTRKYTRQ 114
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN-TKRIVG 679
I +G+ YLH I+HRD+K +N+L D N K+ DFG ++ L G K + G
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 680 T 680
T
Sbjct: 172 T 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 48/158 (30%), Positives = 86/158 (54%), Gaps = 17/158 (10%)
Query: 520 KLGEGGFGPVYKGR-LFNGQE-VAVKRL---SSQSGQGLKEFKNEMML--IAELQHRNLV 572
++GEG +G V+K R L NG VA+KR+ + + G L + +L + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 573 RILGCCV-----EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
R+ C + + L+ E++ ++ L YL D + + + E ++ + +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
LH + R++HRDLK N+L+ K++DFGLAR++
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 56/178 (31%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRL-----SSQSGQGLKEFKNEMMLIAEL 566
N+ + LG G FG VY G+E+AVK++ S ++ + + + E+ L+ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 567 QHRNLVRILGCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKKR-LLDWEARIRIIQGIAQ 623
+H +V+ GC + EK L +EYMP S+ D +K L R + I Q
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQ 117
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN-TKRIVGT 680
G+ YLH I+HRD+K +N+L D N K+ DFG ++ + G K + GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 50/155 (32%), Positives = 87/155 (56%), Gaps = 23/155 (14%)
Query: 521 LGEGGFGPVYKGRLF--NGQEV--AVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRIL 575
+G+G FG VY G L +GQ++ AVK L+ + + +++F E +++ + H N++ +L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 576 GCCV-EQGEKILILEYMPNKSLDVYLF------DPIKKRLLDWEARIRIIQGIAQGLLYL 628
G C+ +G +++L YM K D+ F +P K L+ + ++ A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYM--KHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYL 114
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ +HRDL A N +LD+ K++DFGLAR
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 44/145 (30%), Positives = 85/145 (58%), Gaps = 8/145 (5%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
+LG+G FG VYK + G A K + ++S + L+++ E+ ++A H N+V++L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLLYLHQYSRLRII 637
+ +++E+ ++D + + +++ L E +IR++ + + L YLH+ +II
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLE-LERPLT--EPQIRVVCKQTLEALNYLHEN---KII 125
Query: 638 HRDLKASNVLLDKDMNPKISDFGLA 662
HRDLKA N+L D + K++DFG++
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 50/180 (27%), Positives = 91/180 (50%), Gaps = 10/180 (5%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEM 560
L S+ SV + ++ K+G+G G VY + GQEVA+++++ Q + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 561 MLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG 620
+++ E ++ N+V L + E +++EY+ SL D + + +D + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
Q L +LH ++IHRD+K+ N+LL D + K++DFG + Q +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 51/159 (32%), Positives = 74/159 (46%), Gaps = 12/159 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQGLKE-FKNEMMLIAE 565
N S LG G FG V + + +VAVK L + +E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 566 L-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
L H N+V +LG C G ++I EY L +L ++ L E + +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKG 153
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ +L + IHRDL A NVLL KI DFGLAR
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 46/152 (30%), Positives = 80/152 (52%), Gaps = 9/152 (5%)
Query: 519 CKLGEGGFGPVYKGR-LFNGQEVAVKR-LSSQSGQGLKEFK-NEMMLIAELQHRNLVRIL 575
K+GEG +G V+K R GQ VA+K+ + S+ +K+ E+ ++ +L+H NLV ++
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
+ + L+ EY + L+ +P R + +II Q + + H+++
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN--- 120
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667
IHRD+K N+L+ K K+ DFG AR+ G
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 521 LGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKE---FKNEMMLIAELQHRNLVRILGC 577
+G G FG V+ R Q++ + + E +NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKR---LLDWEARIRIIQGIAQGLLYLHQYSRL 634
+E ++++EY P +L Y I+KR LLD + I+ Q LL LH
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEY----IQKRCNSLLDEDT---ILHFFVQILLALHHVHTK 120
Query: 635 RIIHRDLKASNVLLDK-DMNPKISDFGLARMFG 666
I+HRDLK N+LLDK M KI DFG++++
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 14/150 (9%)
Query: 519 CKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
KLGEG + VYKGR GQ VA+K RL + G + E L+ +L+H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIV-TL 68
Query: 576 GCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWE-ARIRIIQGIAQGLLYLHQYSR 633
+ + + L+ EY+ + L Y+ D L R+ + Q + +GL Y HQ
Sbjct: 69 HDIIHTKKTLTLVFEYL-DTDLKQYMDD--CGGGLSMHNVRLFLFQ-LLRGLAYCHQR-- 122
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
R++HRDLK N+L+ + K++DFGLAR
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 520 KLGEGGFGPVYKGRLFNGQ----EVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVRI 574
+GEG FG VY+G + + VAVK + + ++E F E ++ + H ++V++
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+G E I ++E P L YL + K LD + I ++ L YL
Sbjct: 73 IGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLAR 663
R +HRD+ A NVL+ K+ DFGL+R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 45/169 (26%), Positives = 84/169 (49%), Gaps = 21/169 (12%)
Query: 521 LGEGGFGP--VYKGRLFNGQ----EVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+G FG +Y+ + EV + RLS + ++ NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPI---KKRLLDWEARIRIIQGIAQGLLYLHQY 631
++ ++ +EY +L +D I K +L + E + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTL----YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I+HRD+K N+ L K K+ DFG++++ G + T +VGT
Sbjct: 121 G---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 21/169 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF---NGQEVAVKRLSSQSGQG-LKEFKNEMMLIAEL-Q 567
E+ + +GEG FG V + + A+K L + + ++F E+ ++ +L
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------FDPIKKR------LLDWEAR 614
H N++ +LG C +G + +EY P +L +L DP + L +
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 615 IRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
++ +A G+ YL S + IHRDL A NVL+ +++ KI+DFGL+R
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 521 LGEGGFGPVY------KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+GGFG V G+++ +++ KRL + G+ + + +++ E +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL---EKVSSRFIVS 57
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGLLYLHQYS 632
L E + + L++ M L ++++ + + EAR I GL +LHQ
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFP-EARAIFYAAQIICGLEHLHQ-- 113
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
RI++RDLK NVLLD N +ISD GLA G K GT
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 39/149 (26%), Positives = 74/149 (49%), Gaps = 8/149 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
K+GEG G V + G++VAVK++ + Q + NE++++ + QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
V + + E +++E++ +L D + ++ E + + + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFG 660
+IHRD+K+ ++LL D K+SDFG
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 50/157 (31%), Positives = 85/157 (54%), Gaps = 16/157 (10%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQ-GLK-EFKNEMMLIAELQ---HRNLVR 573
++G G +G VYK R +G VA+K + Q+ + GL E+ L+ L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 574 ILGCC----VEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
++ C ++ K+ L+ E++ ++ L YL D + L E +++ +GL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
H I+HRDLK N+L+ K++DFGLAR++
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 53/166 (31%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 521 LGEGGFGPVY--------KGRLFNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRN 570
LGEG FG V K + VAVK L + + L + +EM ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYL-----------FDPIK--KRLLDWEARIRI 617
++ +LG C + G +++EY +L YL FD K + L ++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+A+G+ YL + + IHRDL A NVL+ +D KI+DFGLAR
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 48/183 (26%), Positives = 76/183 (41%), Gaps = 16/183 (8%)
Query: 486 EVNGDGKDKGKD-----SWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEV 540
E + D D +P A A+ +++ L G G V+ GQ
Sbjct: 34 EYSDDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPD 92
Query: 541 AVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL 600
V Q G L E ML+ + H +++R+ V ++L P+ S D+Y
Sbjct: 93 PVVLKIGQKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYT 145
Query: 601 FDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660
+ + R L + + I + I +GL YLH RIIHRD+K N+ ++ I D G
Sbjct: 146 YLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG 202
Query: 661 LAR 663
A+
Sbjct: 203 AAQ 205
|
Length = 357 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 50/147 (34%), Positives = 79/147 (53%), Gaps = 10/147 (6%)
Query: 520 KLGEGGFGPVYKGRL-FNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
KLGEG + VYKGR VA+K RL + G + E+ L+ +L+H N+V +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
+ L+ EY+ +K L YL D + ++ + Q + +GL Y H R ++
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLFQ-LLRGLNYCH---RRKV 125
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLAR 663
+HRDLK N+L+++ K++DFGLAR
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 521 LGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEM-MLIAELQHRNLVRILGCCV 579
+G G +G VYKGR ++A ++ +G +E K E+ ML HRN+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 580 EQG------EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
++ + L++E+ S+ L K L E I + I +GL +LHQ+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
++IHRD+K NVLL ++ K+ DFG++ D G +GT
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 174
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 48/162 (29%), Positives = 84/162 (51%), Gaps = 10/162 (6%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
K+GEG G V R +G++VAVK + + Q + NE++++ + QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
+ E +++E++ +L D + + L+ E + + + Q L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 639 RDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
RD+K+ ++LL D K+SDFG D + K +VGT
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGT 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 56/158 (35%), Positives = 86/158 (54%), Gaps = 13/158 (8%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRLSSQSGQGLKEFK--NEMMLIAEL 566
AAT +++ KLGEG + VYKG NGQ VA+K +S ++ +G+ F E L+ L
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60
Query: 567 QHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
+H N+V +L + E + + EYM + L Y+ L + R+ + Q + +GL
Sbjct: 61 KHANIV-LLHDIIHTKETLTFVFEYM-HTDLAQYMIQH-PGGLHPYNVRLFMFQ-LLRGL 116
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
Y+H I+HRDLK N+L+ K++DFGLAR
Sbjct: 117 AYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 7/146 (4%)
Query: 520 KLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAELQHRNLVRILGC 577
++G G FG V+ GRL + VAVK LK +F E ++ + H N+VR++G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRII 637
C ++ +++E + +L + L + I++++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 638 HRDLKASNVLLDKDMNPKISDFGLAR 663
HRDL A N L+ + KISDFG++R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 45/154 (29%), Positives = 79/154 (51%), Gaps = 9/154 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKR-LSSQSGQGLKEFK-NEMMLIAELQHR 569
E + +GEG +G V K + GQ VA+K+ L S+ + +K+ E+ ++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
NLV ++ + L+ E++ + LD P LD + + I +G+ + H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCH 117
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
++ IIHRD+K N+L+ + K+ DFG AR
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 50/147 (34%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 520 KLGEGGFGPVYKGRL-FNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
KLGEG + V+KGR VA+K RL + G + E+ L+ +L+H N+V +
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
L+ EY+ +K L Y+ D + +I + Q I +GL Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYM-DDCGNIMSMHNVKIFLYQ-ILRGLAYCH---RRKV 125
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLAR 663
+HRDLK N+L+++ K++DFGLAR
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 25/163 (15%)
Query: 521 LGEGGFGPVYK------GRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVR 573
+GEG FG V K G + +K +S+ ++F E+ ++ +L H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIIN 60
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYL-------FDPIKKR------LLDWEARIRIIQG 620
+LG C +G L +EY P+ +L +L DP L + +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+A+G+ YL S+ + IHRDL A N+L+ ++ KI+DFGL+R
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 46/168 (27%), Positives = 89/168 (52%), Gaps = 20/168 (11%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQH---RNLVRIL 575
+G G +G VY+G+ + G+ VA+K ++ + + + + E+ L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 576 GCCVEQGEKILILEYMPNKSLDVYL-FDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
G ++ +I+EY S+ + PI ++ + II+ + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVALKYIHKVG-- 121
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI--VGT 680
+IHRD+KA+N+L+ N K+ DFG+A + Q ++KR VGT
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKRSTFVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 20/154 (12%)
Query: 519 CKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--EMMLIAELQ-HRNLVRI 574
K+GEG F V K + G+ A+K + + + L++ N E+ + L H N++R+
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 575 LGCCVEQ--GEKILILEYMPNKSLDVYLFDPIK--KRLLDWEARIR-IIQGIAQGLLYLH 629
+ ++ G L+ E M D+ L++ IK KR L E R++ + + + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMH 117
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
R I HRD+K N+L+ D K++DFG R
Sbjct: 118 ---RNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 33/175 (18%)
Query: 511 ATENFSMQCKLGEGGFGPVY----KGRLFNGQE--VAVKRLS-SQSGQGLKEFKNEMMLI 563
A E +M +LG+G FG VY KG + + E VA+K ++ + S + EF NE ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 564 AELQHRNLVRILGCCVEQGEKIL-ILEYMPNKSLDVYLFD--------------PIKKRL 608
E ++VR+LG V QG+ L I+E M L YL +KK
Sbjct: 64 KEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM- 121
Query: 609 LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
I++ IA G+ YL+ + +HRDL A N ++ +D KI DFG+ R
Sbjct: 122 ------IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 26/171 (15%)
Query: 505 LASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN----- 558
+V T + +G G FG V R GQ VA+K++ +K F
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54
Query: 559 ----EMMLIAELQHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEA 613
E+ L+ L+H N++ + + E I + E + + P++K+ + +
Sbjct: 55 RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-- 112
Query: 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664
+ I +GL Y+H ++HRDLK SN+L++++ + KI DFGLAR+
Sbjct: 113 ---FLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 521 LGEGGFGPVY--------KGRLFNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAEL-QHRN 570
LGEG FG V K + VAVK L + + L + +EM ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYL-----------FD--PIKKRLLDWEARIRI 617
++ +LG C + G +I+EY +L YL +D + + ++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+A+G+ YL + + IHRDL A NVL+ ++ KI+DFGLAR
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 16/157 (10%)
Query: 520 KLGEGGFGPVYKG--RLFNGQE-VAVKRLSSQSGQGLKEFKNEMM----LIAELQHRNLV 572
+LG G FG V KG ++ ++ VAVK L + + K+E++ ++ +L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
R++G C E +L++E L+ +L K + + + ++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+HRDL A NVLL KISDFGL++ G DE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 5e-11
Identities = 55/166 (33%), Positives = 79/166 (47%), Gaps = 19/166 (11%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAELQHRNLVRILG 576
LG G FG V R + A+K LS LK+ NE ++ ++H LV + G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKK--RLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+ L++EY+P L F ++K R + AR Q + L YLH L
Sbjct: 69 SFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPEPVARFYAAQ-VVLALEYLHS---L 120
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I++RDLK N+LLD D KI+DFG A+ ++G T + GT
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 32/157 (20%)
Query: 520 KLGEGGFGPVYK------GRLF------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ 567
++G G G VYK GRL+ E V+R + E+ ++ ++
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR----------QICREIEILRDVN 130
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H N+V+ GE ++LE+M SL+ + D + + + I G+ Y
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-------GTHIADEQFLADVARQILSGIAY 183
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664
LH R I+HRD+K SN+L++ N KI+DFG++R+
Sbjct: 184 LH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI 217
|
Length = 353 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 51/176 (28%), Positives = 80/176 (45%), Gaps = 34/176 (19%)
Query: 524 GGFGPVYKGRLFN-GQEVAVKRLSSQSGQG---LKEFKNEMMLIAELQHRNLVRILGCCV 579
G +G V+ + + G A+K + + + E ++++ Q +V++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF- 62
Query: 580 EQGEKILIL--EYMPNKSLDVYLFDPIKKRLLD-------WEARIRIIQGIAQGLLYLHQ 630
QG+K L L EY+P L LL+ ARI I + I L YLH
Sbjct: 63 -QGKKNLYLVMEYLPGGDL---------ASLLENVGSLDEDVARIYIAE-IVLALEYLHS 111
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLA------RMFGGDELQGNTKRIVGT 680
IIHRDLK N+L+D + + K++DFGL+ R ++ + KRIVGT
Sbjct: 112 NG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 7/148 (4%)
Query: 519 CKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQH-RNLVRIL 575
+LG G +G V K R + G +AVKR+ + + Q K ++ + V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI-RIIQGIAQGLLYLHQYSRL 634
G +G+ + +E M + SLD + K L E + +I I + L YLH S+L
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKL 123
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLA 662
+IHRD+K SNVL++++ K+ DFG++
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 46/176 (26%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQHR 569
NF ++ K+G G F VY+ L + + VA+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLD-VYLFDPIKKRLLD----WEARIRIIQGIAQG 624
N+++ L +E E ++LE L + + +KRL+ W+ +++ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H +SR R++HRD+K +NV + K+ D GL R F ++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQ---SGQGLKEFKNEMMLIAELQHR 569
+F + +G+G FG V + + +++ A+K ++ Q ++ NE ++ EL H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 570 NLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQGLLY 627
LV L + E + L+++ + L +L +K E +++ I I L Y
Sbjct: 61 FLVN-LWYSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFS-EEQVKFWICEIVLALEY 115
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
LH IIHRD+K N+LLD+ + I+DF +A D T GT
Sbjct: 116 LHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGT 162
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 25/163 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAEL 566
+ +GEG +G V G +VA+K++S Q L+E K ++
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 567 QHRNLVRILGC----CVEQGEKI-LILEYMPNKSLDVYLFDPIK-KRLLDWEARIRIIQG 620
+H N++ IL E + ++ E M D+Y IK + L + + + Q
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMET---DLYKL--IKTQHLSNDHIQYFLYQ- 114
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
I +GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 8e-11
Identities = 49/170 (28%), Positives = 90/170 (52%), Gaps = 11/170 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQG-LKEFKNEMMLIAELQHRN 570
E F+ K+G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+ + G ++ + +I+EY+ S D ++ LD I++ I +GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ IHRD+KA+NVLL + K++DFG+A +++ N VGT
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 28/164 (17%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQ------GLKEFKNEMMLIAELQHRNLV 572
K+GEG +G VYK R G+ VA+K+ + + L+E ML +E + +V
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQML-SESIY--IV 64
Query: 573 RILGCCVEQGEK-------ILILEYMPN---KSLDVYLFDPIKKRLLDWEARIRIIQGIA 622
R+L VE E+ L+ EY+ + K +D P R L + + +
Sbjct: 65 RLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGP--GRPLPAKTIKSFMYQLL 120
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMF 665
+G+ + H++ ++HRDLK N+L+DK KI+D GL R F
Sbjct: 121 KGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 25/177 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE---FKNEMMLIAELQH 568
++ +G G FG V+ R + A+K ++ LK+ NE ++ E+ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYL-----FDPIKKRLLDWEARIRIIQGIAQ 623
++R+ +Q +++EY+P L YL F E I
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE--------IVC 112
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
L YLH I++RDLK N+LLDK+ + K++DFG A+ +L+ T + GT
Sbjct: 113 ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 12/153 (7%)
Query: 515 FSMQCKLGEGGFGPVYKGRLFNGQE-VAVKRLSSQSGQGLKEFK---NEMMLIAELQHRN 570
F + ++G+GG+G V+ + + E VA+KR+ L E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLL-DWEARIRIIQGIAQGLLYLH 629
LV++L + L +EY+P L +L + AR + + + LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFE-AVDALH 118
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
L IHRDLK N L+D + K++DFGL+
Sbjct: 119 ---ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 49/147 (33%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 520 KLGEGGFGPVYKGRL-FNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
KLGEG + V+KGR VA+K RL + G + E+ L+ L+H N+V +
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
+ L+ EY+ + L YL D + +I + Q + +GL Y H + +I
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH---KRKI 124
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLAR 663
+HRDLK N+L+++ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 46/161 (28%), Positives = 81/161 (50%), Gaps = 22/161 (13%)
Query: 514 NFSMQCKLGEGGFGPVY--KGRLFNGQEVAVK-RLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ + K+GEG FG +Y K + + V + L+ + + K E++L+A+++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 571 LVRILGCCVEQGEKILILEYMPNKSL-------DVYLFDPIKKRLLDWEARIRIIQGIAQ 623
+V E G +++EY L LF + ++L W +Q I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFS--EDQILSW-----FVQ-ISL 112
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLAR 663
GL ++H +I+HRD+K+ N+ L K+ M K+ DFG+AR
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 29/169 (17%)
Query: 515 FSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKN---------------- 558
+ +Q +LG+G FG VY VK + + + LK K
Sbjct: 2 YILQQRLGKGSFGTVY----------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ 51
Query: 559 EMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII 618
E L+++L H +V+ +E+ +I EY + LD L + K + ++
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEE--LKHTGKTLSENQVC 109
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667
+ Q LL +H + RI+HRDLKA N+ L ++ KI DFG++R+ G
Sbjct: 110 EWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 48/146 (32%), Positives = 70/146 (47%), Gaps = 29/146 (19%)
Query: 537 GQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594
GQ VA+K+LS Q+ K E++L+ + H+N++ +L + P K
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQK 88
Query: 595 SL----DVY----LFDP----IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642
SL DVY L D + + LD E ++ + G+ +LH IIHRDLK
Sbjct: 89 SLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 145
Query: 643 ASNVLLDKDMNPKISDFGLARMFGGD 668
SN+++ D KI DFGLAR G
Sbjct: 146 PSNIVVKSDCTLKILDFGLARTAGTS 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 43/166 (25%), Positives = 73/166 (43%), Gaps = 17/166 (10%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQS--GQGLKE-FKNEMMLIAELQHRNLVRILG 576
LG GGFG V ++ + A+K + + G +E +E ++ E H +V++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKR--LLDWEARIRIIQGIAQGLLYLHQYSRL 634
++ +++EY L + ++ R ++ AR I + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARF-YIACVVLAFEYLH---NR 112
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
II+RDLK N+LLD + K+ DFG A+ + T GT
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGT 155
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 51/147 (34%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 520 KLGEGGFGPVYKGRL-FNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
KLGEG + VYKG+ NG+ VA+K RL + G + E L+ L+H N+V +
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
+ L+ EY+ + L Y+ D L ++ + Q + +GL Y+HQ I
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFLFQ-LLRGLSYIHQRY---I 124
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLAR 663
+HRDLK N+L+ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 47/170 (27%), Positives = 91/170 (53%), Gaps = 11/170 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQG-LKEFKNEMMLIAELQHRN 570
E F+ ++G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+ + G ++ + +I+EY+ S D ++ D +++ I +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ IHRD+KA+NVLL + + K++DFG+A +++ NT VGT
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 18/152 (11%)
Query: 521 LGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMM----LIAELQHRNLVRIL 575
+G G FG V K G +AVKR+ S + KE K +M ++ +V+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 576 GCCVEQGEKILILEYMPNKSLD-----VYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
G +G+ + +E M + SLD VY + K ++ E +I + L YL +
Sbjct: 70 GALFREGDCWICMELM-DISLDKFYKYVYE---VLKSVIPEEILGKIAVATVKALNYLKE 125
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
L+IIHRD+K SN+LLD++ N K+ DFG++
Sbjct: 126 --ELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 48/167 (28%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 511 ATENFSMQCKLGEGGFGPVYKG---RLFNGQ---EVAVKRLS-SQSGQGLKEFKNEMMLI 563
+ E ++ +LG+G FG VY+G + G+ VAVK ++ S S + EF NE ++
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLF-------DPIKKRLLDWEARIR 616
++VR+LG + ++++E M + L YL + + + I+
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 617 IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ IA G+ YL+ + +HRDL A N ++ D KI DFG+ R
Sbjct: 124 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 52/175 (29%), Positives = 87/175 (49%), Gaps = 21/175 (12%)
Query: 521 LGEGGFGPVYKGRLFNGQE--VAVKRLSSQS---GQGLKE-------FKNEMMLIAE-LQ 567
LG G FG VYK R N + +A+K ++ + G+ +E +E+ +I E L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDW-EARI-RIIQGIAQGL 625
H N+VR +E ++++ + L F+ +K++ + E RI I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLG-EHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
YLH+ R I+HRDL +N++L +D I+DFGLA+ + +VGT
Sbjct: 127 RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGT 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 56/169 (33%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 521 LGEGGFGPVY------KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+GGFG V G+L+ +++ KRL + +G + E ++A++ R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVS- 57
Query: 575 LGCCVE-QGEKILILEYMPNKSL--DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
L + + + L++ M L +Y D + A Q I GL +LHQ
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ-IISGLEHLHQR 116
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
RII+RDLK NVLLD D N +ISD GLA + Q TK GT
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGT 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 56/171 (32%), Positives = 81/171 (47%), Gaps = 38/171 (22%)
Query: 521 LGEGGFGPV---YKGRLFNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRIL 575
+G G +G V + + G VAVK+LS QS K E+ L+ ++H N++ +L
Sbjct: 25 VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 576 GCCVEQGEKILILEYMPNKSL----DVYLFDPIK----------KRLLDWEARIRIIQGI 621
+ P +SL DVYL + ++L D + I Q I
Sbjct: 83 DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-I 129
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672
+GL Y+H IIHRDLK SN+ +++D KI DFGLAR DE+ G
Sbjct: 130 LRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 176
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 521 LGEGGFGPV------YKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+GGFG V G+++ +++ KRL +SG+ + + E I E + +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE---ILEKVNSPFIVN 57
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
L E + L++ M L ++++ + +R L+ E I I G+L+LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS--- 113
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLA 662
+ I++RD+K NVLLD N ++SD GLA
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 54/163 (33%), Positives = 84/163 (51%), Gaps = 22/163 (13%)
Query: 521 LGEGGFGPV---YKGRLFNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRIL 575
+G G +G V Y RL Q+VAVK+LS QS + E+ L+ ++H N++ +L
Sbjct: 23 VGSGAYGSVCSAYDTRL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 576 -----GCCVEQGEKILILEYMPNKSLDVYLFDPIK-KRLLDWEARIRIIQGIAQGLLYLH 629
+E ++ Y+ + L + +K ++L D + I Q + +GL Y+H
Sbjct: 81 DVFTPATSIENFNEV----YLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ-LLRGLKYIH 135
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672
IIHRDLK SNV +++D +I DFGLAR DE+ G
Sbjct: 136 SAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG 174
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 53/170 (31%), Positives = 83/170 (48%), Gaps = 19/170 (11%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEM-MLIAELQHRNLVRILGCC 578
+G G +G VYKGR + GQ A+K + + +E K E+ ML HRN+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 579 VEQG------EKILILEYMPNKSLDVYLFDPIKKRLL--DWEARIRIIQGIAQGLLYLHQ 630
+++ + L++E+ S+ L K L DW A I + I +GL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAYI--CREILRGLAHLHA 139
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ ++IHRD+K NVLL ++ K+ DFG++ D G +GT
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 31/146 (21%), Positives = 58/146 (39%), Gaps = 13/146 (8%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV-RILGCC 578
L G VY ++ +K S+ +E + ++ + + V ++L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
G L++E++ ++LD + E + I + +A+ L LHQ L + H
Sbjct: 63 ESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCH 112
Query: 639 RDLKASNVLLDKDMNPKISDFGLARM 664
DL N+L+D I D+ A
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 43/144 (29%), Positives = 74/144 (51%), Gaps = 25/144 (17%)
Query: 537 GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI--------------LGCCVEQG 582
+ VAVK++ Q +K E+ +I L H N+V++ +G E
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWE-ARIRIIQGIAQGLLYLHQYSRLRIIHRDL 641
++ EYM + L + +++ L E AR+ + Q + +GL Y+H + ++HRDL
Sbjct: 90 SVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMYQ-LLRGLKYIHSAN---VLHRDL 140
Query: 642 KASNVLLD-KDMNPKISDFGLARM 664
K +NV ++ +D+ KI DFGLAR+
Sbjct: 141 KPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 43/149 (28%), Positives = 75/149 (50%), Gaps = 18/149 (12%)
Query: 521 LGEGGFGPVYKG--RLFNGQE--VAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
LG G FG + +G +L + +E VA+ L + S + + F E + + + H N+VR+
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDP----IKKRLLDWEARIRIIQGIAQGLLYLHQY 631
G +++ EYM N +LD +L + +L+ ++ G+A G+ YL
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLPGLASGMKYL--- 123
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFG 660
S + +H+ L A VL++ D+ KIS F
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 45/176 (25%), Positives = 82/176 (46%), Gaps = 18/176 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSS---QSGQGLKEFKNEMMLIAELQHR 569
NF ++ K+G G F VY+ L +G VA+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLD-----WEARIRIIQGIAQG 624
N+++ +E E ++LE L + K++ L W+ +++ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H +SR R++HRD+K +NV + K+ D GL R F ++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 39/143 (27%), Positives = 72/143 (50%), Gaps = 8/143 (5%)
Query: 520 KLGEGGFGPV-YKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
K+GEG G V G++VAVK++ + Q + NE++++ + H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
+ E +++E++ +L D + ++ E + + + L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 639 RDLKASNVLLDKDMNPKISDFGL 661
RD+K+ ++LL D K+SDFG
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 50/169 (29%)
Query: 520 KLGEGGFGPVYKG-RLFNGQEVAVKRLSSQSG------QGLKEFKNEMMLIAELQHRNLV 572
+G G +G V +G++VA+K++ + L+E K ++ +H N++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRHFKHDNII 67
Query: 573 RILGCCVEQGEKILILEYMPNKSL--DVYL-FDPIKKRLLDWEARIRIIQG--------- 620
I IL P + DVY+ D ++ L II
Sbjct: 68 AIR--------DIL----RPPGADFKDVYVVMDLMESDLH------HIIHSDQPLTEEHI 109
Query: 621 ------IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ +GL Y+H + +IHRDLK SN+L+++D +I DFG+AR
Sbjct: 110 RYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 20/153 (13%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVA---VKRLSSQSGQGLKEFKNEMMLIAE----LQHRNLV 572
++G G FG V ++ VA VK L + + KE +NE + + LQH N++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKE-QNEFLQQGDPYRILQHPNIL 58
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG----IAQGLLYL 628
+ LG CVE +L+ EY L YL R +++ ++Q IA G+ ++
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHR---RNSQLLLLQRMACEIAAGVTHM 115
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661
H + +H DL N L D+ K+ D+G+
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 18/160 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHR 569
E ++ ++G G +G V G++VA+K+LS QS K E+ L+ +QH
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 570 NLVRILGCCVEQG------EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
N++ +L + L++ YM I L + ++ +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD------LQKIMGHPLSEDKVQYLVYQMLC 128
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
GL Y+H IIHRDLK N+ +++D KI DFGLAR
Sbjct: 129 GLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 31/161 (19%)
Query: 520 KLGEGGFGPVY------KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVR 573
K+GEG FG G+ + +E+ + ++S + + E + E+ +++ ++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQ 63
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR---------LLDWEARIRIIQGIAQG 624
E G ++++Y L + I + +LDW +Q I
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL----YKKINAQRGVLFPEDQILDW-----FVQ-ICLA 113
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
L ++H +I+HRD+K+ N+ L KD K+ DFG+AR+
Sbjct: 114 LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 521 LGEGGFGPVYK-GRLFNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAELQHRNLVRILGCC 578
LG G G V K + G +A K + + + K+ E+ ++ E + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 579 VEQGEKILILEYMPNKSLD-VY-LFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
+ + + +E+M SLD +Y PI +L +I + +GL YL Y+ RI
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL--YNVHRI 125
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLA 662
+HRD+K SN+L++ K+ DFG++
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 48/153 (31%), Positives = 80/153 (52%), Gaps = 20/153 (13%)
Query: 521 LGEGGFGPVYKGRLFN----GQEVAVKRLSSQSGQGLK-----EFKNEMMLIAELQHRNL 571
LG+G FG V+ R GQ A+K L + LK K E ++AE+ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQGLLYLHQ 630
V++ +G+ LIL+++ L F + K ++ E ++ + +A L +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 115
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
L II+RDLK N+LLD++ + K++DFGL++
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 43/135 (31%), Positives = 65/135 (48%), Gaps = 17/135 (12%)
Query: 537 GQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------EKILIL 588
G VAVK+LS Q+ K E++L+ + H+N++ +L Q + L++
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648
E M V + LD E ++ + G+ +LH IIHRDLK SN+++
Sbjct: 106 ELMDANLCQVIHME------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156
Query: 649 DKDMNPKISDFGLAR 663
D KI DFGLAR
Sbjct: 157 KSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 44/162 (27%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 520 KLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
K+GEG G V + +G+ VAVK++ + Q + NE++++ + QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
+ E +++E++ +L D + ++ E + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 639 RDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
RD+K+ ++LL D K+SDFG E+ K +VGT
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVP-RRKSLVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-08
Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 47/232 (20%)
Query: 430 ILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFDINMGITTRTNEFGEVNG 489
L ++ L L+ ++F R R + K EN + +L FD
Sbjct: 635 TLGAFLV-LALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD----------------- 676
Query: 490 DGKDKGKDSWLPLFSLASVAAATENFSMQCK----LGEGGFGPVYKGRLF-NGQEVAVKR 544
S S + + K + G G YKG+ NG + VK
Sbjct: 677 --------------SKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKE 722
Query: 545 LSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI 604
++ + E + + +LQH N+V+++G C + LI EY+ K+L L
Sbjct: 723 INDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL---- 774
Query: 605 KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656
R L WE R +I GIA+ L +LH ++ +L +++D P +
Sbjct: 775 --RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 521 LGEGGFGPVYKG--------RLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
LG+G F ++KG + EV +K L + F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR--LLDWEARIRIIQGIAQGLLYLHQ 630
G CV E I++ EY+ SLD YL KK L++ ++ + + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL----KKNKNLINISWKLEVAKQLAWALHFLED 118
Query: 631 YSRLRIIHRDLKASNVLL-----DKDMNP---KISDFGLA 662
+ H ++ A NVLL K NP K+SD G++
Sbjct: 119 KG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 36/155 (23%), Positives = 64/155 (41%), Gaps = 21/155 (13%)
Query: 516 SMQCKLGE----GGFGPVYKGRLFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAELQHR 569
+ +G+ + K + VAVK+ L S S + LK + E++ +LQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 570 NLVRILGCCVEQGEKILILEYMPNKS----LDVYLFDPIKKRLLDWEARIR-IIQGIAQG 624
N++ + + E ++ M S L + + + E I I++ +
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP------ELAIAFILKDVLNA 113
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659
L Y+H IHR +KAS++LL D +S
Sbjct: 114 LDYIHS---KGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 51/162 (31%), Positives = 76/162 (46%), Gaps = 37/162 (22%)
Query: 521 LGEGGFGPV---YKGRLFNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRIL 575
+G G +G V R G +VA+K+L QS K E+ L+ ++H N++ +L
Sbjct: 23 VGSGAYGTVCSALDRR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 576 GCCVEQGEKILILEYMPNKSLD----VYLFDP---------IKKRLLDWEARIR-IIQGI 621
+ P+ SLD YL P +K L E RI+ ++ +
Sbjct: 81 DV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS-EDRIQFLVYQM 127
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+GL Y+H IIHRDLK N+ +++D KI DFGLAR
Sbjct: 128 LKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 15/167 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNGQE----VAVKRLSS----QSGQGLKEFKNEMMLIAE 565
NF + LG G +G V+ R G + A+K L Q + + + E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 566 LQHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
++ + L + K+ LIL+Y+ L +L+ ++ + E R+ I + I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAE-IVLA 117
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671
L +LHQ L II+RD+K N+LLD + + ++DFGL++ F +E +
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 46/167 (27%), Positives = 83/167 (49%), Gaps = 15/167 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNGQEV----AVKRLSS----QSGQGLKEFKNEMMLIAE 565
NF + LG G +G V+ R +G + A+K L Q + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 566 LQHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
++ + L + K+ LIL+Y+ L +L ++R + E +I + I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ--RERFKEQEVQIYSGE-IVLA 117
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671
L +LH +L II+RD+K N+LLD + + ++DFGL++ F DE++
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 23/160 (14%)
Query: 521 LGEGGFGPVYKGRLFN---------GQEVAVKR-LSSQSGQGLKEFKNEMMLIAELQHRN 570
LG+G F +YKG L GQEV+V + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
LV++ G CV E I++ EY+ LDV+L L W ++ + + +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 631 YSRLRIIHRDLKASNVLLDKDMNP-------KISDFGLAR 663
+++H ++ N+L+ + K+SD G+
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 27/62 (43%), Positives = 37/62 (59%), Gaps = 9/62 (14%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
IA GL +LH II+RDLK NV+LD + + KI+DFG+ + +FGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 679 GT 680
GT
Sbjct: 163 GT 164
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 521 LGEGGFGPVY-KGRLFNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAELQHRNLVRIL 575
+G+G FG V R +G AVK L ++ KE + M +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG-L 61
Query: 576 GCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+ EK+ +L+Y+ L +L ++ L+ AR + +A + YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAE-VASAIGYLHS---L 115
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
II+RDLK N+LLD + ++DFGL + G E + T GT
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 56/187 (29%), Positives = 87/187 (46%), Gaps = 14/187 (7%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYK-GRLFNGQEVAVKRLSSQSGQGLKEFKNEM 560
+ L S+ T+ + + +G+G +G VYK +G AVK L S +E + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 561 MLIAEL-QHRNLVRILGCCVEQ-----GEKILILEYMPNKSLDVYLFDPIKKRLLDWEAR 614
++ L H N+V+ G + G+ L+LE S+ + + EA
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129
Query: 615 IR-IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673
I I+ G GL +LH RIIHRD+K +N+LL + K+ DFG++ L+ N
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 674 TKRIVGT 680
T VGT
Sbjct: 187 TS--VGT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 41/159 (25%), Positives = 77/159 (48%), Gaps = 15/159 (9%)
Query: 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAELQHRNLVRILGC 577
CK+G G +G VYK + +G++ L G G+ E+ L+ EL+H N++ +
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 578 CVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY-----LHQ 630
+ ++ L+ +Y + + F K + +++ +G+ + LLY +H
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHY 123
Query: 631 YSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARMF 665
++HRDLK +N+L+ + KI+D G AR+F
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 44/137 (32%), Positives = 68/137 (49%), Gaps = 17/137 (12%)
Query: 538 QEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------EKILILE 589
+ VA+K+LS Q+ K E++L+ + H+N++ +L Q + L++E
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649
M D L I+ L D E ++ + G+ +LH IIHRDLK SN+++
Sbjct: 103 LM-----DANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153
Query: 650 KDMNPKISDFGLARMFG 666
D KI DFGLAR G
Sbjct: 154 SDCTLKILDFGLARTAG 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 18/150 (12%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSS----QSGQGLKEFKNEMMLIAELQHRNLVRIL 575
+G G FG V+ R + +V A+K L + Q + E ++A+ +V++
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIA-HVRAERDILADADSPWIVKLY 67
Query: 576 GCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKKRLLDWE-ARIRIIQGIAQGLLYLHQYS 632
Q E+ L ++EYMP L L I+K + E AR I A+ +L L
Sbjct: 68 --YSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEETARFYI----AELVLALDSVH 118
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
+L IHRD+K N+L+D D + K++DFGL
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 46/143 (32%), Positives = 69/143 (48%), Gaps = 29/143 (20%)
Query: 538 QEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKS 595
+ VA+K+LS Q+ K E++L+ + H+N++ +L + P KS
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKS 97
Query: 596 L----DVY----LFDP----IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKA 643
L DVY L D + + LD E ++ + G+ +LH IIHRDLK
Sbjct: 98 LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 154
Query: 644 SNVLLDKDMNPKISDFGLARMFG 666
SN+++ D KI DFGLAR G
Sbjct: 155 SNIVVKSDCTLKILDFGLARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 52/166 (31%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAELQHRNLVRIL 575
+G+G FG V + +G+ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG-L 61
Query: 576 GCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+ +K+ +L+Y+ L +L ++ + AR + IA L YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS---L 115
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
II+RDLK N+LLD + ++DFGL + G E T GT
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 33/160 (20%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMMLIAELQHRN 570
+G G +G V + ++VA+K+++ F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIA-------NAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 571 LVRILGC----CVEQGEKILIL-EYMPNKSLDVYLFDPIK--KRLLDWEARIRIIQGIAQ 623
++ I E + I+ E M D L I+ + L D + + Q + +
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQ-LLR 119
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 521 LGEGGFGPV------YKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+GGFG V G+++ +++ KR+ + G+ + NE ++ ++ R +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+ L+L M L +++ + + + + I GL LHQ
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYH-MGEAGFEEGRAVFYAAEICCGLEDLHQE--- 121
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLA 662
RI++RDLK N+LLD + +ISD GLA
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-07
Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 4/61 (6%)
Query: 338 RGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLK-NCTCKAYANSNVTEGSGCLMWYG 396
F +L N K P F + ++ +LE+CA++CL NC+C+++ +N T GCL+W
Sbjct: 2 SDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNNGT--KGCLLWSE 58
Query: 397 D 397
Sbjct: 59 S 59
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 43/167 (25%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 521 LGEGGFGPV------YKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+GGFG V G+++ + + KR+ + G+ + NE ++ ++ + +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+ L+L M L ++++ + + E + I GL LH+ +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDLHREN-- 122
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLA-RMFGGDELQGNTKRIVGT 680
++RDLK N+LLD + +ISD GLA ++ G+ ++G VGT
Sbjct: 123 -TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGT 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 49/150 (32%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 521 LGEGGFGPVYKGRL-FNGQEVAVKRLSS----QSGQGLKEFKNEMMLIAELQHRNLVRIL 575
LG+G FG V RL +G+ AVK L Q + +L H L + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ-L 61
Query: 576 GCCVEQGEKIL-ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGLLYLHQYSR 633
CC + +++ ++E++ L +F K R D EAR R I L++LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSALMFLHDKG- 116
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
II+RDLK NVLLD + + K++DFG+ +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 16/151 (10%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFK-NEMMLIAELQHR----NL 571
+LG+G +G VYK G +A+K RL L E K N++++ ++ H+ +
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSPYI 61
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
V G +G + +EYM SLD + + + RI + +GL +L +
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE- 120
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
IIHRD+K +NVL++ + K+ DFG++
Sbjct: 121 -EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 52/180 (28%), Positives = 79/180 (43%), Gaps = 43/180 (23%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMML-------------IAEL 566
LG+G FG V L E+ AVK L K +++L + L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVL-----------KKDVILQDDDVECTMTEKRVLAL 51
Query: 567 QHRN--LVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IA 622
++ L + L C + +++ ++EY+ L +F + D E R R I
Sbjct: 52 AGKHPFLTQ-LHSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFD-EPRARFYAAEIV 106
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGT 680
GL +LH+ II+RDLK NVLLD + + KI+DFG+ + + GG T GT
Sbjct: 107 LGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 9/146 (6%)
Query: 521 LGEGGFGPVYKGRLFNGQE-VAVKRLS-SQSGQGLKEFK-NEMMLIAELQHRNLVRILGC 577
+GEG +G V K R +E VA+K+ S+ + +KE E+ ++ L+ N+V +
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRII 637
+G+ L+ EY+ L+ L + + + + R I Q I +H + I+
Sbjct: 69 FRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKA----IHWCHKNDIV 122
Query: 638 HRDLKASNVLLDKDMNPKISDFGLAR 663
HRD+K N+L+ + K+ DFG AR
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 15/159 (9%)
Query: 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAELQHRNLVRILGC 577
CK+G G +G VYK + +G++ L G G+ E+ L+ EL+H N++ +
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 578 CVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY-----LHQ 630
+ ++ L+ +Y + + F K + +++ + + + LLY +H
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQLPRSMVKSLLYQILDGIHY 123
Query: 631 YSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARMF 665
++HRDLK +N+L+ + KI+D G AR+F
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 514 NFSMQCKLGEGGFGPV----YKGRLFNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAEL 566
+F M LG G FG V +KG G+ A+K L + +K+ ++ E ++ EL
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK--RLLDWEARIRIIQGIAQG 624
H +V ++ ++ +LE++ L F ++K R + A+ + +
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYHAE-LVLA 130
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
YLH II+RDLK N+LLD + K++DFG A+
Sbjct: 131 FEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 38/147 (25%), Positives = 71/147 (48%), Gaps = 6/147 (4%)
Query: 521 LGEGGFG-PVYKGRLFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
+GEG FG + + + Q+ A+K + +S +++ + E +L+A+++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
G +++EY L IK + I+Q Q L + R++H
Sbjct: 68 EADGHLYIVMEYCDGGDL----MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123
Query: 639 RDLKASNVLLDKDMNPKISDFGLARMF 665
RD+K+ N+ L ++ K+ DFG AR+
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLL 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 43/145 (29%), Positives = 70/145 (48%), Gaps = 12/145 (8%)
Query: 521 LGEGGFGPVYKG-RLFNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAELQHRNLVRILGCC 578
LG G G VYK L + +AVK + L K+ +E+ ++ + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
+ + E+M SLDVY I + +L RI + +GL YL L+I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVY--RKIPEHVLG-----RIAVAVVKGLTYLWS---LKILH 118
Query: 639 RDLKASNVLLDKDMNPKISDFGLAR 663
RD+K SN+L++ K+ DFG++
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 25/58 (43%), Positives = 36/58 (62%), Gaps = 3/58 (5%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
I +GL YLH I+HRD+K N+L++ + KI DFGLAR+ DE + T+ +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 17/166 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNGQEV----AVKRLSS----QSGQGLKEFKNEMMLIAE 565
NF + LG G +G V+ R G + A+K L Q + ++ + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 566 LQHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQ 623
++ + L + K+ LIL+Y+ + +L+ +R E +R G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIIL 116
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
L +LH +L I++RD+K N+LLD + + ++DFGL++ F +E
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 14/149 (9%)
Query: 521 LGEGGFGPV------YKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+GGFG V G+++ +++ KR+ + G+ + NE ++ ++ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVS- 64
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
L E + + L+L M L ++++ + D + I + GL L R
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQ---R 120
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLA 662
RI++RDLK N+LLD + +ISD GLA
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 26/155 (16%)
Query: 521 LGEGGFGPV------YKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+GGFG V G+++ +++ KR+ + G+ + NE ++ ++ R +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYL-------FDPIKKRLLDWEARIRIIQGIAQGLLY 627
+ L+L M L ++ FD ++R + + A I GL
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD--EERAVFYAAEITC------GLED 117
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
LH R RI++RDLK N+LLD + +ISD GLA
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 20/154 (12%)
Query: 521 LGEGGFGPVYKGRLFNGQE----VAVKRLSS----QSGQGLKEFKNEMMLIAELQHRNLV 572
LG+GG+G V++ R G + A+K L ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR---LLDWEARIRIIQGIAQGLLYLH 629
++ G+ LILEY+ L ++L +R ++ A + + I+ L +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLSE-ISLALEHLH 117
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
Q II+RDLK N+LLD + K++DFGL +
Sbjct: 118 Q---QGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILG 576
LG+G FG V L EV A+K L + E ++A + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 577 CCVEQGEKIL-ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGLLYLHQYSRL 634
CC + +++ ++EY+ L +F + R D E R R + L++LH++
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLALMFLHRHG-- 116
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+I+RDLK N+LLD + + K++DFG+ +
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 15/139 (10%)
Query: 537 GQEVAVKRLSSQSGQGLKE---FKNEMMLIAELQHRNLVRIL--GCCVEQGEKILILEYM 591
G EVA+K L + + + + F+ E L A L H N+V +L G G + EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL--- 648
P ++L L L R++ + L H I+HRDLK N+++
Sbjct: 62 PGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115
Query: 649 DKDMNPKISDFGLARMFGG 667
+ K+ DFG+ + G
Sbjct: 116 GVRPHAKVLDFGIGTLLPG 134
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 24/152 (15%)
Query: 521 LGEGGFGPVYKGRLF----NGQEVAVKRLSS----QSGQGLKEFKNEMMLIAELQHRNLV 572
+G G FG V RL G A+K+L + Q + + E ++AE + +V
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVV 64
Query: 573 RILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLL-DWEARIRIIQGIAQGLLYLH 629
++ Q E LI+EY+P + L +KK + E R I A+ +L +
Sbjct: 65 KLY--YSFQDENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYI----AETILAID 115
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 43/170 (25%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGL--KEFKNEMMLIAELQHRN 570
++F +LG G G V K + + ++L + + E+ ++ E
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+V G GE + +E+M SLD L + KR+ + E ++ + +GL YL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKE--AKRIPE-EILGKVSIAVLRGLAYLRE 121
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ +I+HRD+K SN+L++ K+ DFG++ G + VGT
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGT 165
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMM--LIAELQHR--NLVRIL 575
+G G G VYK R G +AVK++ + +E K +M + H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 576 GCCVEQGEKILILEYMPN--KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
G + + + +E M L + PI + +L ++ I + L YL + +
Sbjct: 81 GYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----KMTVAIVKALHYLKE--K 133
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLA 662
+IHRD+K SN+LLD N K+ DFG++
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-06
Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 21/165 (12%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ-SGQGL--KEFKNEMMLIAELQHRNLVRIL 575
+G+GG G VY + VA+K++ S L K F E + A+L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 576 GCCVEQGEKILILEYMPN------KSL--DVYLFDPIKKRLLDWE---ARIRIIQGIAQG 624
C G+ + MP KSL V+ + + K L + A + I I
Sbjct: 69 SIC-SDGD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ Y+H S+ ++HRDLK N+LL I D+G A +E
Sbjct: 126 IEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEE 167
|
Length = 932 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 34/162 (20%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVR---- 573
+G+G +G V R +G++ +K+L+ + S + K + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 574 ----------ILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
++G C E G+ L+ K L + ++++W +Q IA
Sbjct: 68 WEGEDGLLYIVMGFC-EGGDLYHKLKEQKGKLL-------PENQVVEW-----FVQ-IAM 113
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
L YLH+ I+HRDLK NV L + K+ D G+AR+
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 11/157 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQ--EVAVKRLSSQSGQGLKEFK---NEMMLIAELQ 567
E+F+ LG G FG V N VA+KR K+ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H V + G ++ L+LE++ +L +R + + AQ +L
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-----RRNKRFPNDVGCFYA-AQIVLI 143
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664
L I++RDLK N+LLDKD K++DFG A++
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
|
Length = 340 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 17/167 (10%)
Query: 521 LGEGGFGPVYKGRLFNGQEV--AVKRLSSQSGQGLKEFKNEM----MLIAELQHRNLVRI 574
+G+G FG V R +E AVK L ++ KE K+ M +L+ ++H LV +
Sbjct: 3 IGKGSFGKVLLAR-HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGLLYLHQYSR 633
+ +L+Y+ L F +++ E R R IA L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLHS--- 114
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
L I++RDLK N+LLD + ++DFGL + E G T GT
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 17/93 (18%)
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI------RIIQGIAQGLLYLH 629
G GE + +E+M SLD L K+ RI +I + +GL YL
Sbjct: 66 GAFYSDGEISICMEHMDGGSLDQVL-----KKA----GRIPENILGKISIAVLRGLTYLR 116
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
+ + +I+HRD+K SN+L++ K+ DFG++
Sbjct: 117 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 29/83 (34%), Positives = 48/83 (57%), Gaps = 14/83 (16%)
Query: 586 LILEYMPN---KSL-DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDL 641
L++EY+ KSL +Y + D E ++ I +A L YLH++ IIHRDL
Sbjct: 81 LVMEYLIGGDVKSLLHIYGY-------FDEEMAVKYISEVALALDYLHRHG---IIHRDL 130
Query: 642 KASNVLLDKDMNPKISDFGLARM 664
K N+L+ + + K++DFGL+++
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 25/57 (43%), Positives = 35/57 (61%), Gaps = 9/57 (15%)
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
G+ LHQ IIHRD+K N+L+D+ + K++DFGL+R G E K+ VGT
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGT 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 22/45 (48%), Positives = 29/45 (64%), Gaps = 3/45 (6%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
I GL Y+H + ++HRDLK N+L++ D KI DFGLAR F
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
I L YLH +++RDLK N++LDKD + KI+DFGL +
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 48/150 (32%), Positives = 74/150 (49%), Gaps = 15/150 (10%)
Query: 521 LGEGGFGPVY-KGRLFNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAELQHRNLVRIL 575
+G+G FG V R +G+ AVK L + KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG-L 61
Query: 576 GCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQGLLYLHQYSR 633
+ EK+ +L+++ L F ++R E R R IA L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFP-EPRARFYAAEIASALGYLHS--- 114
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ I++RDLK N+LLD + ++DFGL +
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 58/209 (27%), Positives = 83/209 (39%), Gaps = 68/209 (32%)
Query: 521 LGEGGFGPVYKGRLFNGQE------VAVKRLSSQSGQGLKEFKNEM----MLIAELQHRN 570
LG G FG V + F ++ VAVK L + G E+K M +LI H N
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKML--KEGATASEYKALMTELKILIHIGHHLN 72
Query: 571 LVRILGCCVEQGEKIL-ILEYMPNKSLDVYL------FDP---------------IKKRL 608
+V +LG C + G ++ I+EY +L YL F P KK+
Sbjct: 73 VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132
Query: 609 LD--------------WEARIRIIQGIAQG-------------LLYLHQYSR-------L 634
LD + + ++ +G + Y Q +R
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR 192
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ IHRDL A N+LL ++ KI DFGLAR
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 23/43 (53%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
I GL +LH+ II+RDLK NVLLDKD + KI+DFG+ +
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 47/161 (29%), Positives = 68/161 (42%), Gaps = 24/161 (14%)
Query: 521 LGEGGFGPV----YKGRLFNGQEVAVKRL------SSQSGQGLKEFKNEMMLIAELQHRN 570
LG G FG V YK G+ A+K L + + L K +H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGLLYLH 629
LV + C + ++EY L ++ I + E R + GL YLH
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMH----IHTDVFS-EPRAVFYAACVVLGLQYLH 118
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGD 668
+ +I++RDLK N+LLD + KI+DFGL + M GD
Sbjct: 119 EN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 33/160 (20%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLS------SQSGQGLKEFKNEMMLIAELQHRNLVR 573
+G+G +G V G++VA+K+++ S + + L+E K L+ L+H ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIK----LLRLLRHPDIVE 63
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYL-FDPIKKRL---------LDWEARIRIIQGIAQ 623
I K ++L + D+Y+ F+ ++ L L E + + +
Sbjct: 64 I---------KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
L Y+H + + HRDLK N+L + D KI DFGLAR
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 50/168 (29%), Positives = 81/168 (48%), Gaps = 14/168 (8%)
Query: 521 LGEGGFGPVYK-GRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCC 578
+G+G +G V+K NG + AVK L +E + E ++ L H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 579 ----VEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIR-IIQGIAQGLLYLHQYS 632
V+ G+++ L+LE S+ + +K+ E I I+ GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ IHRD+K +N+LL + K+ DFG++ L+ NT VGT
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGT 187
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 28/80 (35%), Positives = 43/80 (53%), Gaps = 6/80 (7%)
Query: 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645
LI+E++P L L IK E R +A+ +L + +L IHRD+K N
Sbjct: 78 LIMEFLPGGDLMTML---IKYDTFS-EDVTRFY--MAECVLAIEAVHKLGFIHRDIKPDN 131
Query: 646 VLLDKDMNPKISDFGLARMF 665
+L+D+ + K+SDFGL+ F
Sbjct: 132 ILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 50/167 (29%), Positives = 77/167 (46%), Gaps = 41/167 (24%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMMLIAE------ 565
E+F + +G G FG V R + ++V A+K LS K EM+ ++
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS----------KFEMIKRSDSAFFWE 92
Query: 566 ----LQHRN---LVRILGCCVEQGEKIL--ILEYMPNKSLDVYL---FDPIKKRLLDWEA 613
+ H N +V++ Q +K L ++EYMP L V L +D +K W A
Sbjct: 93 ERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEK----W-A 144
Query: 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660
R + + L +H IHRD+K N+LLDK + K++DFG
Sbjct: 145 RFYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 11/102 (10%)
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK-RLLDWEARIR-IIQGIAQGL 625
+ N +++ +LI++Y+ D LFD +KK L EA ++ II+ + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLS-EAEVKKIIRQLVEAL 122
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMFG 666
LH++ IIH D+K NVL D+ + + D+GL ++ G
Sbjct: 123 NDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161
|
Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 23/154 (14%)
Query: 521 LGEGGFGPVY------KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
+G GGFG VY G+++ + + KR+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYL-----FDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+ +K+ IL+ M L +L F + R E II G+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAE----IILGLE------ 111
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
H ++R +++RDLK +N+LLD+ + +ISD GLA
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 36/134 (26%), Positives = 60/134 (44%), Gaps = 27/134 (20%)
Query: 541 AVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE---YMPNKSLD 597
A R + Q +NE++ + L H N+++I E+IL E YM + D
Sbjct: 202 AGSRAAIQ-------LENEILALGRLNHENILKI--------EEILRSEANTYMITQKYD 246
Query: 598 VYLFDPIKKRLLDWEARI------RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD 651
L+ + DW+ R I++ + + Y+H ++IHRD+K N+ L+ D
Sbjct: 247 FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303
Query: 652 MNPKISDFGLARMF 665
+ DFG A F
Sbjct: 304 GKIVLGDFGTAMPF 317
|
Length = 501 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 23/154 (14%)
Query: 521 LGEGGFGPVY------KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
+G GGFG VY G+++ + + KR+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYL-----FDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+ +K+ IL+ M L +L F + R E II G+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATE----IILGLE------ 111
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
H ++R +++RDLK +N+LLD+ + +ISD GLA
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 44/172 (25%), Positives = 83/172 (48%), Gaps = 46/172 (26%)
Query: 521 LGEGGFGPVYKGRLFNGQE-VAVKRLSSQSGQGLKEFKN-EMMLIAELQHRNLVRILGC- 577
+G G FG VY+ + E VA+K++ ++KN E++++ L H N++ +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYY 128
Query: 578 ---CVEQGEKIL----ILEYMP-------------NKSLDVYLFDPIKKRLLDWEARIRI 617
C ++ EK + ++E++P N +L ++L +L ++
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV-----KLYSYQ----- 178
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLAR-MFGG 667
+ + L Y+H S+ I HRDLK N+L+D + + K+ DFG A+ + G
Sbjct: 179 ---LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224
|
Length = 440 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
I+ GL +LH R II+RDLK NV+LD + + KI+DFG+ +
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
I L YLH S +++RDLK N++LDKD + KI+DFGL +
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 16/156 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVA-------VKRLSSQSGQGLKEFKNEMMLIAE 565
E+F +G G FG V RL ++ +++ + + + E ++ E
Sbjct: 1 EDFESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE 57
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
+V++ ++ LI+E++P + L +KK L E I A+ +
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYI---AETV 111
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661
L + +L IHRD+K N+LLD + K+SDFGL
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAELQHRNLVRILG 576
LG+G FG V R +G+ A+K L + E + E ++ +H L +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGLLYLHQYSRLR 635
+ ++EY+ L F ++R+ E R R I L YLH +
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFS-EDRTRFYGAEIVSALDYLHSG---K 115
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLAR 663
I++RDLK N++LDKD + KI+DFGL +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 31/115 (26%), Positives = 52/115 (45%), Gaps = 7/115 (6%)
Query: 548 QSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR 607
++ G K E+ ++ + HR ++ ++ K + MP D++ +
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTYVDRSGP 181
Query: 608 LLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
L E I I + + + L YLH IIHRD+K N+ LD+ N + DFG A
Sbjct: 182 L-PLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 24/55 (43%), Positives = 31/55 (56%), Gaps = 3/55 (5%)
Query: 609 LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
LD + +R +AQG+ +L + IHRD+ A NVLL KI DFGLAR
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 12/150 (8%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILG 576
+G G FG V R + + A+K L K E ++AE + +V++
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWE-ARIRIIQGIAQGLLYLHQYSRLR 635
++ +++Y+P + L I+ + + + AR I + + + +H ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL---IRLGIFEEDLARFYIAE-LTCAIESVH---KMG 121
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMF 665
IHRD+K N+L+D+D + K++DFGL F
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
IA GL +LH II+RDLK NV+LD + + KI+DFG+ +
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 47/180 (26%), Positives = 85/180 (47%), Gaps = 19/180 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GRLFNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAELQHRN 570
++F +LG G G V+K +G +A K + + ++ + E+ ++ E
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDP--IKKRLLDWEARIRIIQGIAQGLLYL 628
+V G GE + +E+M SLD L I +++L ++ I + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL---GKVSI--AVIKGLTYL 119
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFG--------LARMFGGDELQGNTKRIVGT 680
+ + +I+HRD+K SN+L++ K+ DFG +A F G + +R+ GT
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 25/87 (28%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 562 LIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGI 621
L++++ H +L + G CV E I++ E++ + LDV L + + W +I + Q +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLL 648
A L YL + ++H ++ A N+LL
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 29/76 (38%), Positives = 40/76 (52%), Gaps = 6/76 (7%)
Query: 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645
LI+E++P + L +KK L EA I + +HQ L IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDN 131
Query: 646 VLLDKDMNPKISDFGL 661
+LLD + K+SDFGL
Sbjct: 132 LLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
I L YLH +++RD+K N++LDKD + KI+DFGL +
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 31/163 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMMLIAEL----Q 567
++F + +G G FG V ++ + + + A+K L+ K EM+ AE +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN----------KWEMLKRAETACFRE 50
Query: 568 HRNLVRILGCCV----------EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRI 617
RN V + G C ++ L+++Y L + L + RL + AR I
Sbjct: 51 ERN-VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYI 108
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660
A+ +L +H +L +HRD+K NVLLD + + +++DFG
Sbjct: 109 ----AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 27/104 (25%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 559 EMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII 618
E ++ + H +++++ G LIL P D+Y + K+ + + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDI-LAIE 188
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
+ + + + YLH+ RIIHRD+KA N+ ++ + + DFG A
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
I GL +LH II+RDLK NV+LD+D + KI+DFG+ +
Sbjct: 105 IVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
LV + C L++EY+ L +F ++R L E I L +LH+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
II+RDLK NVLLD D + K++D+G+ +
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
I GL +LH I++RDLK N+LLD D + KI+DFG+ +
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 28/78 (35%), Positives = 43/78 (55%), Gaps = 8/78 (10%)
Query: 521 LGEGGFGPVYKGRLFN-GQE-----VAVKRLSSQSGQGLKE-FKNEMMLIAEL-QHRNLV 572
LG G FG V + F G+E VAVK L + + +E +E+ +++ L QH+N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 573 RILGCCVEQGEKILILEY 590
+LG C G ++I EY
Sbjct: 106 NLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 16/40 (40%), Positives = 28/40 (70%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660
+A+ +L + +L +HRD+K NVLLDK+ + +++DFG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 6/96 (6%)
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H LV + C + ++EY+ L +F ++R L E I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
LH+ II+RDLK NVLLD + + K++D+G+ +
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 17/43 (39%), Positives = 28/43 (65%)
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
Q LL +H +IHRD+K++N+LL + K+ DFG ++M+
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY 193
|
Length = 496 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 18/40 (45%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664
L YLH Y I+HRDLK N+L+ + K++DFGL+++
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 19/156 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKE----FKNEMMLIAELQH 568
E++ + +G G FG V R + Q+V +L S+ + F E ++A
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 569 RNLVRILGCCVEQGEKIL--ILEYMPNKSLDVYL--FDPIKKRLLDWEARIRIIQGIAQG 624
+V++ C Q +K L ++EYMP L + +D +K + A +
Sbjct: 103 PWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEV--------- 151
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660
+L L + +IHRD+K N+LLDK + K++DFG
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 26/70 (37%), Positives = 36/70 (51%), Gaps = 6/70 (8%)
Query: 609 LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
LD E + +A+G+ +L + IHRDL A N+LL KI DFGLAR D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 669 E---LQGNTK 675
++GN +
Sbjct: 268 SNYVVKGNAR 277
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 22/155 (14%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILG 576
LG G FG V R + + + A+K L + + K E ++AE + +VR+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG------IAQGLLYLHQ 630
++ +++Y+P + L R+ I IA+ +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI------------RMGIFPEDLARFYIAELTCAVES 116
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
++ IHRD+K N+L+D+D + K++DFGL F
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWE-ARIRIIQGIAQGLL 626
H LV + C + ++E++ L +F ++R L E AR + I+ L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 110
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+LH+ II+RDLK NVLLD + + K++D+G+ +
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|224632 COG1718, RIO1, Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 36/156 (23%), Positives = 61/156 (39%), Gaps = 28/156 (17%)
Query: 529 VYKGRLFNGQEVAVK--RLSSQSGQGLKE-------FKNE----MMLI---AELQHRNLV 572
VY +G+ VAVK R S+ + ++ F+N L+ A + RNL
Sbjct: 64 VYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLK 123
Query: 573 RILGCCVEQGEKI------LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
R V E I L++E++ + L + L + E + + + + +
Sbjct: 124 RAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAE---GLYEDVVEYMR 180
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
L Y ++H DL N+L+ P I D A
Sbjct: 181 RL--YKEAGLVHGDLSEYNILVHDG-EPYIIDVSQA 213
|
Length = 268 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+A+G+ +L SR + IHRDL A N+LL ++ KI DFGLAR
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 31/140 (22%), Positives = 65/140 (46%), Gaps = 13/140 (9%)
Query: 529 VYKGRLFNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK- 584
+YKG FN +EV ++ + +NE+ + + N+++I G ++ +
Sbjct: 36 IYKGI-FNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 585 ---ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDL 641
LILEY L L K++ L ++ ++ + +GL L++Y+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149
Query: 642 KASNVLLDKDMNPKISDFGL 661
+ + L+ ++ KI GL
Sbjct: 150 TSVSFLVTENYKLKIICHGL 169
|
Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 33/160 (20%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMMLIAELQH----RN-LVRI 574
+G+G FG VY+ R + + + A+K LS K E++ E+ H RN LVR
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS----------KKEIVAKKEVAHTIGERNILVRT 50
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLF-DPIKKRLLDW---------EARIRI-IQGIAQ 623
L +++ I+ L++ D+YL D + L W E R + I +
Sbjct: 51 L---LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL 107
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
L +LH+Y I++RDLK N+LLD + + DFGL++
Sbjct: 108 ALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK 144
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+A+G+ +L SR + IHRDL A N+LL ++ KI DFGLAR
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 19/54 (35%), Positives = 30/54 (55%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
A+ L L + +I+RDLK N+LLD + + DFGL ++ D+ + NT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 38/151 (25%), Positives = 69/151 (45%), Gaps = 14/151 (9%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILG 576
LG G FG V + + A+K L + + + K E ++AE + +V++
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 577 CCVEQGEKILILEYMPNKSLDVYL--FDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
++ +++Y+P + L + + L AR I A+ L + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL----ARFYI----AELTLAIESVHKM 120
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
IHRD+K N+L+D D + K++DFGL F
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 680 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.96 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.96 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.95 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.95 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.94 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.94 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.94 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.94 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.94 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.94 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.94 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.94 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.94 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.93 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.93 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.93 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.93 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.93 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.93 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.93 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.92 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.92 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.92 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.92 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.92 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.91 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.91 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.91 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.91 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.9 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.9 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.9 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.9 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.9 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.9 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.9 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.9 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.9 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.9 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.9 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.9 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.89 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.89 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.89 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.89 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.89 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.89 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.89 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.89 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.89 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.89 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.89 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.89 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.89 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.89 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.89 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.89 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.89 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.89 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.88 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.88 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.88 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.88 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.88 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.88 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.88 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.88 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.88 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.88 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.88 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.88 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.88 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.88 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.88 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.88 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.88 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.88 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.88 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.88 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.88 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.88 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.88 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.88 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.88 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.88 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.88 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.87 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.87 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.87 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.87 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.87 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.87 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.87 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.87 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.87 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.87 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.87 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.87 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.87 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.87 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.87 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.87 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.87 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.87 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.87 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.87 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.87 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.87 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.87 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.87 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.87 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.87 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.86 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.86 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.86 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.86 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.86 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.86 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.86 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.86 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.86 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.86 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.86 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.86 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.86 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.86 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.86 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.86 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.86 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.86 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.86 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.86 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.86 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.86 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.86 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.86 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.86 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.86 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.86 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.86 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.85 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.85 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.85 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.85 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.85 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.85 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.85 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.85 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.85 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.85 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.85 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.85 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.85 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.85 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.85 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.85 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.85 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.84 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.84 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.84 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.84 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.84 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.84 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.84 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.84 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.84 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.84 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.84 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.84 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.84 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.84 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.84 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.84 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.84 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.84 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.84 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.84 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.84 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.84 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.84 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.84 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.84 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.84 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.83 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.83 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.83 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.83 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.83 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.83 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.83 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.83 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.83 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.83 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.83 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.83 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.83 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.83 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.83 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.83 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.82 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.82 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.82 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.82 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.82 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.82 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.82 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.82 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.82 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.82 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.82 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.82 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.82 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.82 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.82 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.82 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.82 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.82 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.81 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.81 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.81 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.81 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.81 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.81 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.81 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.81 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.81 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.81 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.81 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.81 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.81 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.81 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.81 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.81 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.81 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.8 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.8 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.8 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.8 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.8 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.8 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.8 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.8 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.79 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.79 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.79 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.79 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.79 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.79 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.79 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.79 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.79 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.79 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.79 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.79 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.79 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.78 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.78 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.78 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.78 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.78 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.78 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.77 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.77 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.77 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.76 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.76 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.76 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.76 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.76 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.72 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.72 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.7 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.68 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.65 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.64 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.63 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.62 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.6 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.59 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.28 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.2 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.99 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.97 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 98.91 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.67 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.66 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.57 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.49 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.49 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.43 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.42 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.39 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.34 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.32 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.3 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.24 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.19 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.18 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.17 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.16 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.06 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.03 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.03 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.02 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.01 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 97.98 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 97.98 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.86 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.62 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.58 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.55 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.53 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.44 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.38 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.35 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.18 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.15 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.05 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.9 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.89 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.83 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.57 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.57 | |
| PLN02236 | 344 | choline kinase | 96.54 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.37 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.31 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.12 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 95.88 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.7 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.37 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.36 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.3 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.16 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.8 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.62 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.36 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.84 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.48 Aligned_cols=168 Identities=52% Similarity=0.831 Sum_probs=154.2
Q ss_pred CCCcccHHHHHHhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEE
Q 005731 499 WLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578 (680)
Q Consensus 499 ~~~~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 578 (680)
....|++.++..+|++|...+.||+|+||.||+|.+.++..||||++.....+..++|.+|++++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999998865433156799999999999999999999999
Q ss_pred EeCC-eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEe
Q 005731 579 VEQG-EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (680)
Q Consensus 579 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 657 (680)
.+.+ +++||||||++|+|+++|+..... .++|..|++|+.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875444 88999999999999999999999998899999999999999999999999
Q ss_pred eeccceecCC
Q 005731 658 DFGLARMFGG 667 (680)
Q Consensus 658 DFGla~~~~~ 667 (680)
|||||+....
T Consensus 220 DFGLa~~~~~ 229 (361)
T KOG1187|consen 220 DFGLAKLGPE 229 (361)
T ss_pred CccCcccCCc
Confidence 9999976543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=268.44 Aligned_cols=159 Identities=32% Similarity=0.570 Sum_probs=138.8
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.+|.+.+.||+|+|+.||+|++ .++..||||.+.+. .....+.+..|+++|+.++|||||++++++..++..|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 5788888999999999999985 45889999999765 44456678899999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC------CCeEEeeeccce
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD------MNPKISDFGLAR 663 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~------~~~kl~DFGla~ 663 (680)
||.+|+|..|+. +.+.+++.....++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+||
T Consensus 90 yC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999994 4457899999999999999999999988 9999999999999864 458999999999
Q ss_pred ecCCCccccCccccccC
Q 005731 664 MFGGDELQGNTKRIVGT 680 (680)
Q Consensus 664 ~~~~~~~~~~~~~~~Gt 680 (680)
.+.... ...+++||
T Consensus 164 ~L~~~~---~a~tlcGS 177 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGS 177 (429)
T ss_pred hCCchh---HHHHhhCC
Confidence 987543 33346665
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=257.80 Aligned_cols=160 Identities=29% Similarity=0.483 Sum_probs=136.7
Q ss_pred cCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCcc-------cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 005731 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQ-------GLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 583 (680)
.+.|.+.+.||+|+||.|-+|. ..+++.||||++++.... .....++|+++|++++|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3568888999999999999996 677999999999764211 22345799999999999999999999999999
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC---CCeEEeeec
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD---MNPKISDFG 660 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFG 660 (680)
.|||||||+||+|.+++ ...+.+.+..-..+++|++.|+.|||+++ |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~v---v~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKV---VANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHH---HhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999998887 44556677777889999999999999998 9999999999999766 679999999
Q ss_pred cceecCCCccccCccccccC
Q 005731 661 LARMFGGDELQGNTKRIVGT 680 (680)
Q Consensus 661 la~~~~~~~~~~~~~~~~Gt 680 (680)
||+..+.. ..+.++|||
T Consensus 325 lAK~~g~~---sfm~TlCGT 341 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGT 341 (475)
T ss_pred hhhccccc---eehhhhcCC
Confidence 99988632 245568887
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=261.66 Aligned_cols=161 Identities=30% Similarity=0.470 Sum_probs=140.2
Q ss_pred cCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKIL 586 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 586 (680)
.+.|+.+++||+|.||.||+|+ ..+|+.||+|++... .+....-..+||.+|++|+||||++|.+..++. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3568888999999999999997 678999999998753 344556678999999999999999999999887 68999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|+|||++ +|.-++. ...-.++..++..++.|++.||+|||..+ |+|||||.+|||||.+|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999986 5655552 23446889999999999999999999998 9999999999999999999999999999998
Q ss_pred CCccccCccccc
Q 005731 667 GDELQGNTKRIV 678 (680)
Q Consensus 667 ~~~~~~~~~~~~ 678 (680)
.+.....|++++
T Consensus 270 ~~~~~~~T~rVv 281 (560)
T KOG0600|consen 270 PSGSAPYTSRVV 281 (560)
T ss_pred CCCCcccccceE
Confidence 888777787765
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=250.90 Aligned_cols=158 Identities=30% Similarity=0.408 Sum_probs=137.0
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-eEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-EKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey 590 (680)
+++..+.||+|..|+|||+.+ .+++.+|+|.+... .+...+++.+|++++++.+||+||.++|.|.... ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 344567999999999999986 46889999999543 4455789999999999999999999999999998 59999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCcc
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (680)
|++|||+.++.. .+.+++....+|+.+|++||.|||+. .+||||||||+|||++.+|++||+|||.++.+...
T Consensus 160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999843 35688999999999999999999973 25999999999999999999999999999988654
Q ss_pred ccCccccccC
Q 005731 671 QGNTKRIVGT 680 (680)
Q Consensus 671 ~~~~~~~~Gt 680 (680)
..++++||
T Consensus 233 --~a~tfvGT 240 (364)
T KOG0581|consen 233 --IANTFVGT 240 (364)
T ss_pred --hccccccc
Confidence 34457776
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=261.38 Aligned_cols=160 Identities=33% Similarity=0.481 Sum_probs=145.1
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
..|...+.||+|+|+.||+++. ..|+.||+|++.+. .....+...+||++.+.|+|||||+++++|.+.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999985 88999999999763 3345677899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|+|++++|..++. +.+.+++.++..+..||+.||.|||+.+ |||||||..|++|+++.++||+|||||..++.+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999998883 5578999999999999999999999987 999999999999999999999999999999877
Q ss_pred ccccCccccccC
Q 005731 669 ELQGNTKRIVGT 680 (680)
Q Consensus 669 ~~~~~~~~~~Gt 680 (680)
+.+..| +|||
T Consensus 172 ~Erk~T--lCGT 181 (592)
T KOG0575|consen 172 GERKKT--LCGT 181 (592)
T ss_pred ccccce--ecCC
Confidence 555444 8888
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=247.22 Aligned_cols=161 Identities=27% Similarity=0.419 Sum_probs=142.0
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|++.++||+|+||+||.++. ++++.+|+|++++.. ....+...+|..+|.+++||.||.++-.+++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46899999999999999999974 568899999998642 23466788999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+||+.||.|..+| .+++.+.++.+.-++..|+.||.|||+.+ ||||||||+|||||++|+++|+||||++.-..
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999998 55677888888888899999999999998 99999999999999999999999999996644
Q ss_pred CccccCccccccC
Q 005731 668 DELQGNTKRIVGT 680 (680)
Q Consensus 668 ~~~~~~~~~~~Gt 680 (680)
+. ..+.++|||
T Consensus 178 ~~--~~t~tfcGT 188 (357)
T KOG0598|consen 178 DG--DATRTFCGT 188 (357)
T ss_pred CC--CccccccCC
Confidence 43 345568998
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=257.11 Aligned_cols=150 Identities=41% Similarity=0.633 Sum_probs=132.1
Q ss_pred cceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-eEEEEEEcc
Q 005731 515 FSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-EKILILEYM 591 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~ 591 (680)
+...+.||+|+||+||+|.......||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. ...||||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344467999999999999976555599999986422 22669999999999999999999999999987 799999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC-CeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 667 (680)
++|+|..++++. ....+++..+++++.|||+||.|||++.+ ||||||||+|||++.++ ++||+|||+++....
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 999999999664 46789999999999999999999999763 99999999999999997 999999999997754
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=223.12 Aligned_cols=109 Identities=48% Similarity=0.756 Sum_probs=81.7
Q ss_pred CceEEecCCCCCCCC--CCceEEEeeCCeEEEEecCCCeeEee-cccCCC-CCceEEEccCCCEEEEeCCCCCcccccee
Q 005731 71 DTVVWVANRDRPISG--RNAVLTISNNGNLVLLSQTNGTIWST-NVSSDV-KNPVAQLRDDGNLVIRDNSSDSTAESYLW 146 (680)
Q Consensus 71 ~tvVW~anr~~pv~~--~~~~l~~~~~g~l~l~~~~~~~~w~~-~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~~~~~~W 146 (680)
+||||+|||++|+.. ...+|.|+.||+|+|++..++++|++ ++.+.. .+..|+|+|+|||||++.. +.++|
T Consensus 2 ~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~-----~~~lW 76 (114)
T PF01453_consen 2 RTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS-----GNVLW 76 (114)
T ss_dssp --------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT-----SEEEE
T ss_pred cccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec-----ceEEE
Confidence 689999999999954 34889999999999999999999999 555533 5889999999999999964 57999
Q ss_pred eecCCCcccccccccccceeecCCceeEEEeCCCCCCC
Q 005731 147 QSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPS 184 (680)
Q Consensus 147 qSFd~PtDTlLpgq~l~~~~~~g~~~~l~S~~s~~d~s 184 (680)
|||||||||+||+|+|+.+..+|....++||++.+|||
T Consensus 77 ~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 77 QSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp ESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred eecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999999988877777899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=256.21 Aligned_cols=153 Identities=38% Similarity=0.633 Sum_probs=137.6
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
+.+.+.+.||+|.||.|+.|.......||||.++.. ....+.|.+|+++|++|+|+|||+++|+|..++.++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 345566899999999999999888889999999864 4456889999999999999999999999999989999999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCcc
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (680)
.|+|.++|.+ .....+...+.+.++.|||+||+||+++. +|||||.++||||+++..+||+||||||.+.+++-
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 9999999965 34567888999999999999999999987 99999999999999999999999999997766553
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=227.77 Aligned_cols=151 Identities=35% Similarity=0.591 Sum_probs=133.1
Q ss_pred CCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCc-cc-HHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG-QG-LKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~-~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.+|...++||+|.||.||+|+ ..+|+.||||+++.... ++ ....++|++.|+.++|+||+.|++++.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467778999999999999998 56799999999985422 22 4567899999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
||+ -+|+..+++ +...+...++..++.++++||+|||.+. |+||||||.|+|++++|.+||+|||+|+.++...
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 996 488888854 3457888999999999999999999987 9999999999999999999999999999997543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=262.90 Aligned_cols=152 Identities=36% Similarity=0.583 Sum_probs=133.1
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 583 (680)
.+.+.+..+.||+|+||+||+|+.. +...||||.++..... ...+|++|+++++.++|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3455666799999999999999743 3467999999876544 67899999999999999999999999999999
Q ss_pred EEEEEEccCCCChhhHhcccc-------c----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC
Q 005731 584 KILILEYMPNKSLDVYLFDPI-------K----KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 652 (680)
++||+|||..|||.+||.... . ...+...+.+.||.|||.||+||-++. +|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 999999999999999996421 1 223788999999999999999999876 99999999999999999
Q ss_pred CeEEeeeccceec
Q 005731 653 NPKISDFGLARMF 665 (680)
Q Consensus 653 ~~kl~DFGla~~~ 665 (680)
.|||+||||+|-+
T Consensus 641 ~VKIsDfGLsRdi 653 (774)
T KOG1026|consen 641 VVKISDFGLSRDI 653 (774)
T ss_pred EEEecccccchhh
Confidence 9999999999843
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-27 Score=228.17 Aligned_cols=157 Identities=32% Similarity=0.464 Sum_probs=139.7
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|+..+.||.|+||.|.+++. .+|.-+|+|++++... ...+...+|-.+|+.+.||.+++|++.+.+....+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 5788889999999999999985 4588899999986533 23456778999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||++||.|.++| .+.+.+++....-++.||+.||+|||+.. |++|||||||||||.+|.+||+|||+|+...+
T Consensus 124 eyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 999999999999 34567889999999999999999999987 99999999999999999999999999998854
Q ss_pred ccccCccccccC
Q 005731 669 ELQGNTKRIVGT 680 (680)
Q Consensus 669 ~~~~~~~~~~Gt 680 (680)
.|-++|||
T Consensus 197 ----rT~TlCGT 204 (355)
T KOG0616|consen 197 ----RTWTLCGT 204 (355)
T ss_pred ----cEEEecCC
Confidence 36678887
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=234.31 Aligned_cols=149 Identities=27% Similarity=0.403 Sum_probs=129.8
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|+...++|+|+||.||+++. .+|+.||||++..... .-.+-.++|+++|+.++|+|+|.|+.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4677788999999999999985 5699999999975322 234557899999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|++..-|++.- .....++.+...+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+||.+.+
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99887665543 22345788889999999999999999988 99999999999999999999999999999863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=246.08 Aligned_cols=153 Identities=32% Similarity=0.459 Sum_probs=136.1
Q ss_pred hcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 585 (680)
..++|.+++.||+|+|++|++|+ ..+++++|||++.+. .+...+...+|-.+|.+| .||.|++|+-.|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34689999999999999999997 567899999999764 233445567788888888 8999999999999999999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+|+||.++|+|.++| .+.+.+++.....++.+|+.||+|||+.+ ||||||||+|||||+++++||+|||-|+++
T Consensus 151 FvLe~A~nGdll~~i---~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLI---KKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHH---HHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999 44567888888899999999999999988 999999999999999999999999999999
Q ss_pred CCCc
Q 005731 666 GGDE 669 (680)
Q Consensus 666 ~~~~ 669 (680)
.+.+
T Consensus 225 ~~~~ 228 (604)
T KOG0592|consen 225 SPSQ 228 (604)
T ss_pred Chhh
Confidence 7654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=239.86 Aligned_cols=159 Identities=26% Similarity=0.507 Sum_probs=142.0
Q ss_pred CCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
-+|++.+.||+|.||.|-++. ...|+.||||.+++. +++..-.+++|+++|..|+||||+.++.+|...+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 478889999999999999997 577999999999753 5566778999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||..+|.|.+++ ...+.+++.+..+++.||..|+.|+|.++ ++|||||.+|||||+++++||+||||+-++..+
T Consensus 133 EYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999 44567899999999999999999999887 999999999999999999999999999988654
Q ss_pred ccccCccccccC
Q 005731 669 ELQGNTKRIVGT 680 (680)
Q Consensus 669 ~~~~~~~~~~Gt 680 (680)
. ..+++||+
T Consensus 207 k---fLqTFCGS 215 (668)
T KOG0611|consen 207 K---FLQTFCGS 215 (668)
T ss_pred c---HHHHhcCC
Confidence 3 24456663
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=256.54 Aligned_cols=152 Identities=32% Similarity=0.556 Sum_probs=136.9
Q ss_pred CCcceeeeeccCCceeEEEEEEcC----CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
....+.++||.|.||.|++|+++- ...||||.|+... +...++|+.|+.||.+++||||++|.|+.......+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 456778999999999999998642 4579999999753 44577899999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
.|||++|+|+.||+.. .+.+.+.+.+.|.++||.||.||-+.+ +|||||.++|||++.+...|++||||+|.+++
T Consensus 709 TEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999653 356899999999999999999999877 99999999999999999999999999999876
Q ss_pred Cc
Q 005731 668 DE 669 (680)
Q Consensus 668 ~~ 669 (680)
+.
T Consensus 784 d~ 785 (996)
T KOG0196|consen 784 DP 785 (996)
T ss_pred CC
Confidence 65
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=247.05 Aligned_cols=152 Identities=32% Similarity=0.538 Sum_probs=134.0
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
.+.....+.++||+|-||+|.+++...+..||||+++..... ...+|.+|+++|.+++||||++|+|+|..++..++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 445667788999999999999999888899999999875433 4578999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|||++|+|..|+....... ++-+..++|+.||+.||+||.+.. +|||||.++|+|++.++++||+|||++|-+
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccc
Confidence 9999999999996543222 344556789999999999999776 999999999999999999999999999955
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-28 Score=233.66 Aligned_cols=166 Identities=27% Similarity=0.465 Sum_probs=139.5
Q ss_pred CCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEE-EEEeCCe-EEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILG-CCVEQGE-KILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV 587 (680)
.+|++.++||+|.||.||++. +.+|..||.|.+.-. +.........|+.+|+.|+|||||++++ .+.+..+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 358888999999999999997 788999999998732 3345567889999999999999999998 5555555 8899
Q ss_pred EEccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 588 LEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYS-RLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~-~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|||+.+|+|...+.+-. ..+.+++..+++++.|+++||.++|.+- +-.|+||||||.||+|+.+|.+||.||||+|.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999998886543 3457899999999999999999999832 123999999999999999999999999999999
Q ss_pred CCCccccCccccccC
Q 005731 666 GGDELQGNTKRIVGT 680 (680)
Q Consensus 666 ~~~~~~~~~~~~~Gt 680 (680)
..+.+ .+.+++||
T Consensus 179 ~s~~t--fA~S~VGT 191 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGT 191 (375)
T ss_pred cchhH--HHHhhcCC
Confidence 76554 34457887
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-27 Score=240.60 Aligned_cols=160 Identities=36% Similarity=0.549 Sum_probs=135.6
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHh--hcCCCceeeEEEEEEeCC----eEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIA--ELQHRNLVRILGCCVEQG----EKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~l 586 (680)
...++.++||+|.||.||||.+. ++.||||++.. +....|++|-.+.. .++|+||++++++-..+. +.+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34556689999999999999975 48999999964 34566777666655 568999999999987766 8899
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCceEeCCCCCCcEEEcCCCCeEEeeec
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS------RLRIIHRDLKASNVLLDKDMNPKISDFG 660 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~iiHrDlkp~NILl~~~~~~kl~DFG 660 (680)
|+||.+.|+|.++| +...++|.+..+|+..+++||+|||++- +++|+|||||++||||..+++..|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 4467899999999999999999999753 4579999999999999999999999999
Q ss_pred cceecCCCccccCccccccC
Q 005731 661 LARMFGGDELQGNTKRIVGT 680 (680)
Q Consensus 661 la~~~~~~~~~~~~~~~~Gt 680 (680)
||.++......+.+..-+||
T Consensus 362 LAl~~~p~~~~~d~~~qVGT 381 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGT 381 (534)
T ss_pred eeEEecCCCCCcchhhhhhh
Confidence 99999877766555555665
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=201.48 Aligned_cols=109 Identities=34% Similarity=0.769 Sum_probs=103.3
Q ss_pred EeeCCCCCceeeeee-cccceeEEEEEeeecCeEEEEEEeeCCCeEEEEEEccCCcEEEEEEcCCCCceEEEEeeccCCC
Q 005731 210 TCSGQWDGTGFVSAL-SYTNFIYKQFMTENKDEFVYWYEAYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYC 288 (680)
Q Consensus 210 ~~~g~w~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~~G~l~~~~~~~~~~~W~~~~~~~~~~C 288 (680)
||+|+|+|..|++.| +..+..+.+.|+.++++.++.|...+.+.++|++||++|++++|.|.+.++.|..+|++|.++|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 899999999999999 7777778888999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCcccCCCCCCCCcccCCcccCC
Q 005731 289 GKYGYCGANTICSLDQTPMCECLEGFKLKS 318 (680)
Q Consensus 289 ~~~g~CG~~giC~~~~~~~C~C~~GF~~~~ 318 (680)
|+|+.||+||+|+.+..+.|+|++||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 999999999999988888999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-27 Score=243.10 Aligned_cols=152 Identities=28% Similarity=0.425 Sum_probs=133.4
Q ss_pred cCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHH-HHHHHHHHHhhcC-CCceeeEEEEEEeCC-eEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAELQ-HRNLVRILGCCVEQG-EKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~-~f~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lV 587 (680)
.++|.+.++||.|.||.||+|+ ..+++.||||++++......+ .=++|+..|++|+ ||||++|.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4679999999999999999997 567899999999875433222 2368999999998 999999999999988 99999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||||+ .+|...+.++ .+.++++++..|+.||++||+|+|.+| +.|||+||||||+..+..+||+||||||.+..
T Consensus 89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 99995 5788888654 678999999999999999999999998 99999999999999999999999999998755
Q ss_pred Cc
Q 005731 668 DE 669 (680)
Q Consensus 668 ~~ 669 (680)
..
T Consensus 163 kp 164 (538)
T KOG0661|consen 163 KP 164 (538)
T ss_pred CC
Confidence 43
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=199.94 Aligned_cols=115 Identities=43% Similarity=0.709 Sum_probs=101.7
Q ss_pred ccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEecCCCeeEee
Q 005731 32 SFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWST 111 (680)
Q Consensus 32 ~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~~~~~w~~ 111 (680)
+.|.+|++|+|+++.|++|||.+......+++|||...+.++||.||++.|. ...++|.|+.||+|+|+|.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 5688899999999999999999876544899999987667899999999984 567899999999999999999999999
Q ss_pred cccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCC
Q 005731 112 NVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHP 152 (680)
Q Consensus 112 ~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~P 152 (680)
++.+..+..+|+|+|+|||||++.. +.++|||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC-----CCEEEcCCCCC
Confidence 9875345678999999999999976 46899999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=238.19 Aligned_cols=162 Identities=28% Similarity=0.496 Sum_probs=138.3
Q ss_pred hcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC----Cc-ccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCe
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ----SG-QGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGE 583 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~----~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~ 583 (680)
..++|.+.+.||+|+||.|++|. ..+++.||||.++.. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 45689999999999999999997 456899999977653 11 23456778999999998 9999999999999999
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC-CCeEEeeeccc
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLA 662 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla 662 (680)
.++||||+.+|+|.+++.+ .+.+.+.+...++.|++.|++|||..+ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999843 567788999999999999999999988 9999999999999999 99999999999
Q ss_pred eecCCCccccCccccccC
Q 005731 663 RMFGGDELQGNTKRIVGT 680 (680)
Q Consensus 663 ~~~~~~~~~~~~~~~~Gt 680 (680)
+.... ......+.+||
T Consensus 169 ~~~~~--~~~~l~t~cGs 184 (370)
T KOG0583|consen 169 AISPG--EDGLLKTFCGS 184 (370)
T ss_pred cccCC--CCCcccCCCCC
Confidence 98841 11233446665
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=220.04 Aligned_cols=161 Identities=32% Similarity=0.462 Sum_probs=138.3
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|++.+.||+|-||.||.|+. .++-.||+|++.+.. .+..+++++|+++-..|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 36799999999999999999984 557799999997532 23457899999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+||...|+|...|.+. +...+++.....++.|+|.||.|+|..+ +|||||||+|+|++.++.+||+|||-+..-..
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 9999999999998542 4456788888899999999999999877 99999999999999999999999999986532
Q ss_pred CccccCccccccC
Q 005731 668 DELQGNTKRIVGT 680 (680)
Q Consensus 668 ~~~~~~~~~~~Gt 680 (680)
+ ...+++||
T Consensus 177 ~----kR~tlcgt 185 (281)
T KOG0580|consen 177 N----KRKTLCGT 185 (281)
T ss_pred C----Cceeeecc
Confidence 1 22246776
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=234.88 Aligned_cols=150 Identities=27% Similarity=0.404 Sum_probs=135.9
Q ss_pred hcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
..++|+++.+||+|+||.||+++ ..+|+.+|+|++++.. ....+..+.|-.+|...++|.||+|+-.|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999998 5569999999998742 2345678889999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||++||++..+| .+...|++.....++.+++.|+.-||+.+ +|||||||+|+|||..|++||+||||++-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999 56678899988899999999999999988 9999999999999999999999999997553
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=241.39 Aligned_cols=148 Identities=40% Similarity=0.575 Sum_probs=130.1
Q ss_pred CCcceeeeeccCCceeEEEEEEcC--C---cEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN--G---QEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~--~---~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 584 (680)
++..+.++||+|+||.||+|++.. + ..||||..+.. ......+|.+|++++++++|||||+++|++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 455566899999999999998543 2 23899998852 345678999999999999999999999999999999
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++|||+|.||+|+++|.+. ...++..+++.++.+.|+||+|||++. +|||||.++|+|++.++.+||+||||++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 9999999999999999442 225899999999999999999999987 99999999999999999999999999875
Q ss_pred c
Q 005731 665 F 665 (680)
Q Consensus 665 ~ 665 (680)
-
T Consensus 312 ~ 312 (474)
T KOG0194|consen 312 G 312 (474)
T ss_pred C
Confidence 4
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=239.37 Aligned_cols=159 Identities=33% Similarity=0.510 Sum_probs=140.2
Q ss_pred CCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|.+.+.||+|+||.||||+ ..+.+.||+|.+.+. .+...+.+++|++++++++||||+.+++.+....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578888999999999999998 456889999999763 33456789999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
|+.+ +|..+| .....++++.+..|+.++..||.|||+.+ |+|||+||+||||+.++.+|++|||+||.+..+.
T Consensus 82 ~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9976 999998 34567899999999999999999999887 9999999999999999999999999999886644
Q ss_pred cccCccccccC
Q 005731 670 LQGNTKRIVGT 680 (680)
Q Consensus 670 ~~~~~~~~~Gt 680 (680)
. ..+++.||
T Consensus 155 ~--vltsikGt 163 (808)
T KOG0597|consen 155 S--VLTSIKGT 163 (808)
T ss_pred e--eeeeccCc
Confidence 3 44566776
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=227.64 Aligned_cols=150 Identities=31% Similarity=0.478 Sum_probs=131.2
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC--eEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG--EKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 589 (680)
.++...+.||+|+||.||++... +|+..|||.+........+.+.+|+.+|.+++|||||+++|.....+ ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777899999999999999854 48999999987653333677899999999999999999999855544 5889999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-CCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~ 667 (680)
|+++|+|.+++.+... .++++.+..+..||++||+|||+++ ||||||||+|||++. ++.+||+|||+|+....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999854322 6899999999999999999999988 999999999999999 79999999999998864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=228.19 Aligned_cols=178 Identities=31% Similarity=0.469 Sum_probs=142.6
Q ss_pred CCCCCCCCCCcccHHHHHHhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHh--hcCCC
Q 005731 492 KDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIA--ELQHR 569 (680)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~--~l~H~ 569 (680)
..+++.+.+|.+-...++ ++..+.+.||+|.||+||+|.. .|+.||||++...++ +.+.+|.++.. .|+|+
T Consensus 193 ~tSGSGSGlplLVQRTia---rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHE 265 (513)
T KOG2052|consen 193 ETSGSGSGLPLLVQRTIA---RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHE 265 (513)
T ss_pred ccCCCCCCchhHhHHhhh---heeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccc
Confidence 344556667765544444 5788999999999999999985 588999999976443 44555555555 56999
Q ss_pred ceeeEEEEEEeCC----eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCceEeCC
Q 005731 570 NLVRILGCCVEQG----EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-----YSRLRIIHRD 640 (680)
Q Consensus 570 niv~l~g~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~iiHrD 640 (680)
||+.+++.-..+. ++|||.+|.++|||.+||. ...++.+..++++..+|.||+|||. ++++.|.|||
T Consensus 266 NILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRD 341 (513)
T KOG2052|consen 266 NILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRD 341 (513)
T ss_pred hhhhhhhccccCCCceEEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccc
Confidence 9999998866543 7899999999999999993 3578999999999999999999995 5788999999
Q ss_pred CCCCcEEEcCCCCeEEeeeccceecCCCcc--ccCccccccC
Q 005731 641 LKASNVLLDKDMNPKISDFGLARMFGGDEL--QGNTKRIVGT 680 (680)
Q Consensus 641 lkp~NILl~~~~~~kl~DFGla~~~~~~~~--~~~~~~~~Gt 680 (680)
||+.|||+..++...|+|+|||.....+.. ....|.-+||
T Consensus 342 lKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGT 383 (513)
T KOG2052|consen 342 LKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGT 383 (513)
T ss_pred cccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccce
Confidence 999999999999999999999998865532 2334444555
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=222.62 Aligned_cols=151 Identities=30% Similarity=0.452 Sum_probs=128.6
Q ss_pred cCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCC-ccc-HHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQS-GQG-LKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKIL 586 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~-~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 586 (680)
.+.|+.++.|++|+||.||+|+ ..+++.||+|+++... ..+ --..++||.+|.+++|||||.+-.+.+.. +..||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 3568888999999999999998 4568899999998532 222 23468999999999999999999987754 57999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|||||++ +|.+.+..- .+.+...+...++.|+++|++|||..- |+||||||+|+|+++.|.+||+||||||.++
T Consensus 155 VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999975 788887432 256788888899999999999999876 9999999999999999999999999999997
Q ss_pred CC
Q 005731 667 GD 668 (680)
Q Consensus 667 ~~ 668 (680)
..
T Consensus 229 sp 230 (419)
T KOG0663|consen 229 SP 230 (419)
T ss_pred CC
Confidence 65
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=228.60 Aligned_cols=148 Identities=28% Similarity=0.493 Sum_probs=127.4
Q ss_pred hcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCc--------------ccHHHHHHHHHHHhhcCCCceeeEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG--------------QGLKEFKNEMMLIAELQHRNLVRIL 575 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~--------------~~~~~f~~E~~~l~~l~H~niv~l~ 575 (680)
..++|++.+.||+|.||.|-+|+ ..+++.||||++.+... ...+..++||.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 34789999999999999999998 45689999999965211 1245788999999999999999999
Q ss_pred EEEEe--CCeEEEEEEccCCCChhhHhcccccCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC
Q 005731 576 GCCVE--QGEKILILEYMPNKSLDVYLFDPIKKRL-LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (680)
Q Consensus 576 g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 652 (680)
.+.-+ .+.+|||+|||..|.+... ..... +...+..+++.++..||+|||.++ ||||||||+|+||+++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 99765 3579999999999988432 22333 888999999999999999999998 99999999999999999
Q ss_pred CeEEeeeccceec
Q 005731 653 NPKISDFGLARMF 665 (680)
Q Consensus 653 ~~kl~DFGla~~~ 665 (680)
++||+|||.+-.+
T Consensus 248 ~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 248 TVKISDFGVSNEF 260 (576)
T ss_pred cEEeeccceeeec
Confidence 9999999999877
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=224.92 Aligned_cols=165 Identities=26% Similarity=0.386 Sum_probs=141.4
Q ss_pred cCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.+.|++.++||.|..++||+|+ .+.++.||||++.-. .....+++++|+..+..++||||++++..|+.+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4689999999999999999997 667899999999753 23347899999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
||.+||+.+.++..... .+++..+..|.+++++||.|||.++ .||||||+.||||+.+|.|||+|||.+..+-...
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999998665444 4888899999999999999999998 9999999999999999999999999876653322
Q ss_pred cc--cCccccccC
Q 005731 670 LQ--GNTKRIVGT 680 (680)
Q Consensus 670 ~~--~~~~~~~Gt 680 (680)
.+ ...++++||
T Consensus 181 ~R~~~rf~tfvgt 193 (516)
T KOG0582|consen 181 DRQVTRFNTFVGT 193 (516)
T ss_pred ceeeEeeccccCc
Confidence 21 111456665
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=223.21 Aligned_cols=150 Identities=33% Similarity=0.509 Sum_probs=128.5
Q ss_pred CCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCc-cc-HHHHHHHHHHHhhcCCCc-eeeEEEEEEeCC------
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG-QG-LKEFKNEMMLIAELQHRN-LVRILGCCVEQG------ 582 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~-~~-~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~------ 582 (680)
..|+..++||+|+||.||+|+ ..+|+.||+|++....+ ++ .....+|+.++++++|+| |++|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 456777889999999999998 56789999999975433 22 345689999999999999 999999998877
Q ss_pred eEEEEEEccCCCChhhHhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKK-RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 661 (680)
..++|+||++ -+|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7889999995 5898888543322 45677888999999999999999988 99999999999999999999999999
Q ss_pred ceecC
Q 005731 662 ARMFG 666 (680)
Q Consensus 662 a~~~~ 666 (680)
|+.+.
T Consensus 167 Ara~~ 171 (323)
T KOG0594|consen 167 ARAFS 171 (323)
T ss_pred HHHhc
Confidence 99775
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=235.27 Aligned_cols=160 Identities=32% Similarity=0.505 Sum_probs=142.0
Q ss_pred cCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
...|...++||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||+++..+..++++|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3467777899999999999997 567899999999875545556678999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCcc
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (680)
|++|+|.+.+ ....+++.++..|+.+++.||+|||.++ |||||||.+|||++.++.+||+|||++..+..++.
T Consensus 352 m~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999998877 3456899999999999999999999998 99999999999999999999999999999987776
Q ss_pred ccCccccccC
Q 005731 671 QGNTKRIVGT 680 (680)
Q Consensus 671 ~~~~~~~~Gt 680 (680)
+. .+++||
T Consensus 425 KR--~TmVGT 432 (550)
T KOG0578|consen 425 KR--STMVGT 432 (550)
T ss_pred cc--ccccCC
Confidence 43 347887
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=229.14 Aligned_cols=154 Identities=31% Similarity=0.456 Sum_probs=129.6
Q ss_pred hcCCcceeeeeccCCceeEEEEEE------cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 582 (680)
..++|++.++||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++....
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346799999999999999999963 235689999997532 23356789999999999 8999999999987654
Q ss_pred -eEEEEEEccCCCChhhHhccccc--------------------------------------------------------
Q 005731 583 -EKILILEYMPNKSLDVYLFDPIK-------------------------------------------------------- 605 (680)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 605 (680)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999988854211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 606 ---KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 606 ---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
...+.+.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 134778888999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=189.42 Aligned_cols=113 Identities=43% Similarity=0.724 Sum_probs=99.6
Q ss_pred ccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEecCCCeeEee
Q 005731 32 SFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWST 111 (680)
Q Consensus 32 ~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~~~~~w~~ 111 (680)
+.|..|+.|+|+++.|++|||..... ..+++|||...+.++||.|||+.|+.+ ++.|.|+.||+|+|++.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 56888999999999999999998754 688999998765789999999999854 4899999999999999999999999
Q ss_pred cccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCC
Q 005731 112 NVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDH 151 (680)
Q Consensus 112 ~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (680)
++....+..+++|+|+|||||++.. +.++||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYDSD-----GNFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC-----CCEEeCCCCC
Confidence 9874356778999999999999875 5689999997
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=222.40 Aligned_cols=151 Identities=31% Similarity=0.544 Sum_probs=130.0
Q ss_pred CCcceeeeeccCCceeEEEEEEcC-----------------CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN-----------------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRI 574 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~-----------------~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l 574 (680)
++|++.++||+|+||.||++...+ +..||||.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999997432 3479999987542 3345679999999999999999999
Q ss_pred EEEEEeCCeEEEEEEccCCCChhhHhcccc----------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 005731 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPI----------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638 (680)
Q Consensus 575 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 638 (680)
++++.+.+..++||||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999998874321 1124677889999999999999999987 999
Q ss_pred CCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 639 RDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 639 rDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|||||+|||+++++.+||+|||+++.+.
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~ 189 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLY 189 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecc
Confidence 9999999999999999999999998663
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=246.80 Aligned_cols=153 Identities=35% Similarity=0.642 Sum_probs=135.0
Q ss_pred cCCcceeeeeccCCceeEEEEEEcC--Cc----EEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFN--GQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~--~~----~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 584 (680)
..+.++.+.||+|+||.||+|+..+ +. .||||.+++. +.+...+|++|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4567778999999999999998543 33 4999999864 456678999999999999999999999999999999
Q ss_pred EEEEEccCCCChhhHhcccc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeec
Q 005731 585 ILILEYMPNKSLDVYLFDPI----KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 660 (680)
+|++|||++|+|.+||++.. ....+...+.+.++.|||+|+.|||++. +|||||.++|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997642 2456888999999999999999999876 9999999999999999999999999
Q ss_pred cce-ecCC
Q 005731 661 LAR-MFGG 667 (680)
Q Consensus 661 la~-~~~~ 667 (680)
||| ++..
T Consensus 848 lArDiy~~ 855 (1025)
T KOG1095|consen 848 LARDIYDK 855 (1025)
T ss_pred hhHhhhhc
Confidence 999 4433
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=228.07 Aligned_cols=148 Identities=28% Similarity=0.381 Sum_probs=131.8
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+++. .+++.||||++.... ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999999974 458899999997532 233457889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||+++|+|.+++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 9999999999884 3456889999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=230.03 Aligned_cols=151 Identities=30% Similarity=0.468 Sum_probs=134.9
Q ss_pred CCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
.-|++++.||+|+-|.|-.|+ ..+|+.+|||++.+. .......+.+|+.+|+-+.|||+++|++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 357888999999999999997 567999999999764 2223456789999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++|.|.++| .+++.+.+.+..+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||||.+-.++
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999998 45677889999999999999999999876 999999999999999999999999999976554
Q ss_pred c
Q 005731 669 E 669 (680)
Q Consensus 669 ~ 669 (680)
.
T Consensus 166 k 166 (786)
T KOG0588|consen 166 K 166 (786)
T ss_pred c
Confidence 3
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=228.72 Aligned_cols=147 Identities=27% Similarity=0.373 Sum_probs=130.7
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||++.. .+++.||||++... .....+++.+|++++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4788999999999999999974 56889999998642 2234567889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999884 3356788888899999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=224.07 Aligned_cols=149 Identities=25% Similarity=0.409 Sum_probs=132.5
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999854 58899999987531 234567889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999983 3346788899999999999999999987 99999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-24 Score=227.92 Aligned_cols=162 Identities=27% Similarity=0.429 Sum_probs=138.4
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 584 (680)
...++|.+.++||+|+||.|+++... +++.+|||.+++.. ....+....|-+++.-. +||.|+.|+..++..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999854 57899999998753 34566777888877766 599999999999999999
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
|.||||+.||++ +..+....+++..+.-++..|+.||.|||+++ ||+||||.+|||||.+|.+||+||||++.
T Consensus 445 ~fvmey~~Ggdm----~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDL----MHHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcE----EEEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 999999999995 22345567899999999999999999999998 99999999999999999999999999996
Q ss_pred cCCCccccCccccccC
Q 005731 665 FGGDELQGNTKRIVGT 680 (680)
Q Consensus 665 ~~~~~~~~~~~~~~Gt 680 (680)
-.... ..|.++|||
T Consensus 518 ~m~~g--~~TsTfCGT 531 (694)
T KOG0694|consen 518 GMGQG--DRTSTFCGT 531 (694)
T ss_pred cCCCC--CccccccCC
Confidence 54333 256779998
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=227.84 Aligned_cols=149 Identities=26% Similarity=0.376 Sum_probs=132.7
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+++. .+++.||||++... .......+.+|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4789999999999999999985 46889999999743 2234566889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999998843 346889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=232.19 Aligned_cols=164 Identities=17% Similarity=0.229 Sum_probs=137.3
Q ss_pred CcceeeeeccCCceeEEEEEE-cC-CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~-~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.|.+.+.||+|+||.||++.. .+ ++.||+|.+..........+++|+++++.++||||+++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 488999999999999999974 33 6788999876544445567889999999999999999999999999999999999
Q ss_pred CCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCcc
Q 005731 592 PNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (680)
Q Consensus 592 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (680)
++|+|.+++.... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9999998875432 2346788899999999999999999987 99999999999999999999999999998755433
Q ss_pred ccCccccccC
Q 005731 671 QGNTKRIVGT 680 (680)
Q Consensus 671 ~~~~~~~~Gt 680 (680)
.....+.+||
T Consensus 225 ~~~~~~~~gt 234 (478)
T PTZ00267 225 LDVASSFCGT 234 (478)
T ss_pred cccccccCCC
Confidence 2223334444
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=226.19 Aligned_cols=151 Identities=24% Similarity=0.286 Sum_probs=132.5
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
...++|++.+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++..+...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999854 5789999998642 2223456889999999999999999999999999999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999998832 34788888999999999999999987 999999999999999999999999999987
Q ss_pred CC
Q 005731 666 GG 667 (680)
Q Consensus 666 ~~ 667 (680)
..
T Consensus 193 ~~ 194 (370)
T cd05621 193 DE 194 (370)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-24 Score=228.24 Aligned_cols=151 Identities=36% Similarity=0.622 Sum_probs=133.3
Q ss_pred HHHHHhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 005731 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (680)
Q Consensus 506 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 583 (680)
.+..+..+.+.+.+.||+|.||+||+|.+.. .||||.++.. .++..++|++|+.++++-+|.||+-+.|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4445555677888999999999999998653 6999999754 34568899999999999999999999999998876
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.||..+++|-+|..+|+-. +..++.-+.+.|++|||+||.|||.++ |||||||..||+|.+++.|||.|||||.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 9999999999999998643 456888899999999999999999988 9999999999999999999999999986
Q ss_pred e
Q 005731 664 M 664 (680)
Q Consensus 664 ~ 664 (680)
.
T Consensus 537 v 537 (678)
T KOG0193|consen 537 V 537 (678)
T ss_pred e
Confidence 4
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=227.36 Aligned_cols=146 Identities=24% Similarity=0.354 Sum_probs=129.9
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999974 568899999996532 2345678999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999998843 345788888889999999999999887 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=218.84 Aligned_cols=149 Identities=32% Similarity=0.459 Sum_probs=121.2
Q ss_pred CcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe-----EEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE-----KILI 587 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~lV 587 (680)
.|+..+++|.|+||.||+|.+. ++++||||+.-.... .--+|+++|++++|||||+|+-++....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5677799999999999999854 478999999854221 22468999999999999999988875432 3489
Q ss_pred EEccCCCChhhHhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC-CCeEEeeeccceec
Q 005731 588 LEYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLARMF 665 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~~ 665 (680)
||||+. +|...+++. ..+..++..++.-+..||.+||+|||+.+ |+||||||+|||+|.+ +.+||+|||-|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999975 787777532 12455777777889999999999999977 9999999999999976 99999999999999
Q ss_pred CCCcc
Q 005731 666 GGDEL 670 (680)
Q Consensus 666 ~~~~~ 670 (680)
..++.
T Consensus 177 ~~~ep 181 (364)
T KOG0658|consen 177 VKGEP 181 (364)
T ss_pred ccCCC
Confidence 76654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=222.61 Aligned_cols=149 Identities=26% Similarity=0.383 Sum_probs=132.6
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+++.. +++.||||.+... .....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999854 5889999998643 2234567899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++|+|.+++.+ ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999988843 346788888899999999999999987 99999999999999999999999999987744
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=222.77 Aligned_cols=149 Identities=27% Similarity=0.393 Sum_probs=131.6
Q ss_pred CCcceeeeeccCCceeEEEEEEcC--CcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN--GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~--~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++..++||||+++++++.+....++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 579999999999999999997433 368999998642 223456788999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++|+|.+++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 110 ~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999884 3346888999999999999999999987 99999999999999999999999999987643
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=226.61 Aligned_cols=146 Identities=25% Similarity=0.391 Sum_probs=129.5
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.|+..++||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999984 568899999987532 2345678899999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|+++|+|.+++.+ ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 9999999998843 345788888889999999999999987 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=225.39 Aligned_cols=147 Identities=24% Similarity=0.374 Sum_probs=130.0
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
.+|++.+.||+|+||.||+++. .+++.||||.+.... ......+.+|++++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3689999999999999999984 458899999986431 223566889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
||+++|+|.+++.. ...++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999843 346788888889999999999999987 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-24 Score=230.77 Aligned_cols=161 Identities=30% Similarity=0.462 Sum_probs=137.4
Q ss_pred CcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------CeEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------GEKI 585 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 585 (680)
.+...+.||+|+||.||+|+ ..+|+.||||.++... ....+..-+|++++++++|+|||++.++-.+. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 35556899999999999998 5679999999998643 34566778999999999999999999875543 3568
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC--C--CeEEeeecc
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD--M--NPKISDFGL 661 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~--~--~~kl~DFGl 661 (680)
+|||||.+|||...|.+......+++.+.+.+..++..||.|||+++ |+||||||.||++-.. + ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999988877788999999999999999999999988 9999999999999432 3 479999999
Q ss_pred ceecCCCccccCccccccC
Q 005731 662 ARMFGGDELQGNTKRIVGT 680 (680)
Q Consensus 662 a~~~~~~~~~~~~~~~~Gt 680 (680)
||-+.++. .-++++||
T Consensus 171 Arel~d~s---~~~S~vGT 186 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGT 186 (732)
T ss_pred cccCCCCC---eeeeecCc
Confidence 99886654 35568887
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=220.60 Aligned_cols=141 Identities=28% Similarity=0.340 Sum_probs=125.3
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCC
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 594 (680)
+.||+|+||.||+++. .+++.||||+++.. .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 56889999998753 2234457889999999999999999999999999999999999999
Q ss_pred ChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 9988883 3456889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=219.54 Aligned_cols=149 Identities=27% Similarity=0.374 Sum_probs=131.7
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999854 68899999986432 234567889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++++|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999998843 346788999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=233.81 Aligned_cols=152 Identities=30% Similarity=0.486 Sum_probs=133.8
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEcCC-cEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCceeeEEEEE-Ee------
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLFNG-QEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCC-VE------ 580 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~-~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~-~~------ 580 (680)
...-++++.+.|.+|||+.||.|....+ .++|+|++-..++..++...+||++|+.|. |+|||.+++.. ..
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3445788889999999999999997665 999999998778888999999999999997 99999999943 22
Q ss_pred CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeec
Q 005731 581 QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (680)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 660 (680)
.-+.+|.||||.+|+|-+++..+.. ..|.+.++++|+.++++|+++||.. +++|||||||.|||||+.++..||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 1367899999999999999865433 3499999999999999999999987 5899999999999999999999999999
Q ss_pred cce
Q 005731 661 LAR 663 (680)
Q Consensus 661 la~ 663 (680)
-|.
T Consensus 192 Sat 194 (738)
T KOG1989|consen 192 SAT 194 (738)
T ss_pred ccc
Confidence 875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-24 Score=194.65 Aligned_cols=148 Identities=31% Similarity=0.492 Sum_probs=127.0
Q ss_pred CcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+|...|+||+|.||+||+|+ ..+++.||+|+++-. ++.-....++|+.+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45667899999999999998 456889999988643 222345678999999999999999999999988999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+. .+|.++... -.+.++.+....++.|+++||.|+|++. +.|||+||+|+||+.+|++|++|||+||.++-
T Consensus 83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 95 578777532 3456888888899999999999999987 99999999999999999999999999998753
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=219.55 Aligned_cols=141 Identities=28% Similarity=0.343 Sum_probs=125.4
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCC
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 594 (680)
+.||+|+||.||++.. .+++.||||++... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 46899999999753 2234567889999999999999999999999999999999999999
Q ss_pred ChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+|..++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 9988873 3346889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-23 Score=213.38 Aligned_cols=150 Identities=27% Similarity=0.359 Sum_probs=130.8
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.|+..+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999984 578999999986432 2234568899999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+++|+|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999998877432 2345788999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=224.24 Aligned_cols=153 Identities=32% Similarity=0.450 Sum_probs=131.3
Q ss_pred cCCcceeeeeccCCceeEEEEEE------cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCe
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGE 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 583 (680)
.++|++.+.||+|+||.||+++. .++..||||+++... ....+.+.+|+.++..+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999963 235689999997532 23456788999999999 89999999999999999
Q ss_pred EEEEEEccCCCChhhHhccccc----------------------------------------------------------
Q 005731 584 KILILEYMPNKSLDVYLFDPIK---------------------------------------------------------- 605 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 605 (680)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999988853210
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 606 --------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 606 --------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 124788889999999999999999987 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-23 Score=221.08 Aligned_cols=148 Identities=28% Similarity=0.391 Sum_probs=131.4
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||++.. .+++.||||.+... .......+.+|+.++..++||||+++++.+...+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999985 46889999998642 2234567889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||+++|+|.+++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 9999999999884 3456888899999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=217.24 Aligned_cols=140 Identities=24% Similarity=0.300 Sum_probs=124.5
Q ss_pred eccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCCh
Q 005731 521 LGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (680)
Q Consensus 521 LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (680)
||+|+||.||+++.. +++.||+|.+... .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999854 5789999998642 233456788999999999999999999999999999999999999999
Q ss_pred hhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM 144 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence 988843 346889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=218.94 Aligned_cols=141 Identities=28% Similarity=0.340 Sum_probs=125.0
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCC
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 594 (680)
+.||+|+||.||+++. .+++.||+|.+... .......+.+|++++.+++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999984 56899999998753 2234556788999999999999999999999999999999999999
Q ss_pred ChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 9988873 3346889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=223.27 Aligned_cols=150 Identities=25% Similarity=0.299 Sum_probs=131.4
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
..++|++.+.||+|+||.||+++. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 346899999999999999999985 46889999998642 12334567889999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+++|+|..++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999988732 34778888889999999999999987 9999999999999999999999999998775
Q ss_pred C
Q 005731 667 G 667 (680)
Q Consensus 667 ~ 667 (680)
.
T Consensus 194 ~ 194 (370)
T cd05596 194 A 194 (370)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=211.34 Aligned_cols=150 Identities=29% Similarity=0.479 Sum_probs=129.3
Q ss_pred cCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccC--CCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe-----CCe
Q 005731 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE-----QGE 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~~ 583 (680)
...|...+.||+|+||.|..+. ..+++.||||++.. ......++..+|+++|+.++|+||+.+.+++.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3456667899999999999997 45689999999973 344567788999999999999999999999865 347
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.|+|+|+| .-+|...+. .++.+..+....++.|+++||.|+|+.+ |+||||||.|+|++.+..+||+||||||
T Consensus 101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 568888873 3344888888899999999999999988 9999999999999999999999999999
Q ss_pred ecCCC
Q 005731 664 MFGGD 668 (680)
Q Consensus 664 ~~~~~ 668 (680)
.+...
T Consensus 174 ~~~~~ 178 (359)
T KOG0660|consen 174 YLDKF 178 (359)
T ss_pred ecccc
Confidence 98543
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-23 Score=221.93 Aligned_cols=153 Identities=24% Similarity=0.275 Sum_probs=133.2
Q ss_pred HHHhcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 005731 508 VAAATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (680)
Q Consensus 508 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 583 (680)
.....++|++.+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+..+..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3445579999999999999999999854 5789999998642 12234567889999999999999999999999999
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.++||||+++|+|..++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999988732 34778888889999999999999987 9999999999999999999999999998
Q ss_pred ecCC
Q 005731 664 MFGG 667 (680)
Q Consensus 664 ~~~~ 667 (680)
.+..
T Consensus 191 ~~~~ 194 (371)
T cd05622 191 KMNK 194 (371)
T ss_pred EcCc
Confidence 7754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-23 Score=218.67 Aligned_cols=151 Identities=23% Similarity=0.345 Sum_probs=133.2
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||++.. .+++.||||+++.. .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4789999999999999999984 46889999999753 2234567889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999988432 246888999999999999999999987 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-23 Score=217.47 Aligned_cols=148 Identities=26% Similarity=0.366 Sum_probs=129.3
Q ss_pred CcceeeeeccCCceeEEEEEE----cCCcEEEEEEccCC----CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQ----SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~----~~~~~VAVK~l~~~----~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 584 (680)
+|++.+.||+|+||.||+++. .+++.||+|++... .....+.+..|+.++..+ +||||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999874 35789999998642 122345688899999999 599999999999999999
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999988843 346888999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 005731 665 FGG 667 (680)
Q Consensus 665 ~~~ 667 (680)
+..
T Consensus 155 ~~~ 157 (332)
T cd05614 155 FLS 157 (332)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=216.13 Aligned_cols=141 Identities=27% Similarity=0.330 Sum_probs=124.3
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCC
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 594 (680)
+.||+|+||.||++.. .+++.||+|.+... ......++.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999974 56889999998753 2234567788999999999999999999999999999999999999
Q ss_pred ChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+|..++. ....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 9988873 34468899999999999999999997 55 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=220.86 Aligned_cols=150 Identities=27% Similarity=0.430 Sum_probs=133.8
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999854 6899999998753 2234567899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++++|.+++.+ ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999843 356889999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=216.94 Aligned_cols=150 Identities=23% Similarity=0.317 Sum_probs=131.7
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+++. .+++.||||.+... .....+.|.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999985 45889999998642 2223456889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++|+|.+++.+ ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999998843 2345788889999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=216.68 Aligned_cols=151 Identities=21% Similarity=0.289 Sum_probs=131.9
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999854 5789999998642 1223456888999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++|+|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998432 346788888899999999999999887 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=214.78 Aligned_cols=155 Identities=29% Similarity=0.475 Sum_probs=128.8
Q ss_pred eeeeccCCceeEEEEE-EcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCC
Q 005731 518 QCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 594 (680)
.++||.|-||+||-|. .++|+.||||++.+. ......++++|+.+|.+++||.||.|...|...+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 3899999999999997 467999999999763 334557899999999999999999999999999999999999955
Q ss_pred ChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC---CCeEEeeeccceecCCCccc
Q 005731 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD---MNPKISDFGLARMFGGDELQ 671 (680)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~~~ 671 (680)
++.+.+.. ..++.+++.....++.||+.||.|||.++ |+|+||||+||||... -++||+|||+||+++....+
T Consensus 648 DMLEMILS-sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 648 DMLEMILS-SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hHHHHHHH-hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 55444433 23456777777778899999999999988 9999999999999754 36999999999999775543
Q ss_pred cCccccccC
Q 005731 672 GNTKRIVGT 680 (680)
Q Consensus 672 ~~~~~~~Gt 680 (680)
..++||
T Consensus 724 ---rsVVGT 729 (888)
T KOG4236|consen 724 ---RSVVGT 729 (888)
T ss_pred ---hhhcCC
Confidence 245665
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-23 Score=222.18 Aligned_cols=153 Identities=34% Similarity=0.504 Sum_probs=130.6
Q ss_pred cCCcceeeeeccCCceeEEEEEE------cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCe
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGE 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 583 (680)
.++|++.+.||+|+||.||++.. .+++.||||+++... ....+.+.+|+++++.+ +|+||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 35789999999999999999863 234579999997542 23356788999999999 89999999999999999
Q ss_pred EEEEEEccCCCChhhHhcccc-----------------------------------------------------------
Q 005731 584 KILILEYMPNKSLDVYLFDPI----------------------------------------------------------- 604 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 604 (680)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999998875321
Q ss_pred --------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 605 --------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 605 --------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
....+++.++.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 0124678889999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=211.62 Aligned_cols=148 Identities=30% Similarity=0.469 Sum_probs=128.8
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.++||+|+||.||+|+. .+++.||+|.++... ......+.+|+.++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5799999999999999999985 468899999987532 23345778999999999999999999999998999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 975 88887743 2335788899999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=220.79 Aligned_cols=154 Identities=31% Similarity=0.461 Sum_probs=131.1
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCC
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQG 582 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~ 582 (680)
..++|.+.+.||+|+||.||+|+.. .+..||||++.... ....+.|.+|++++.++. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4568999999999999999999742 13479999997532 233567999999999996 999999999999999
Q ss_pred eEEEEEEccCCCChhhHhccccc---------------------------------------------------------
Q 005731 583 EKILILEYMPNKSLDVYLFDPIK--------------------------------------------------------- 605 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 605 (680)
..+|||||+++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999988753210
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc
Q 005731 606 ------------------------------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (680)
Q Consensus 606 ------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 649 (680)
...+++.++..++.||++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124678888999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccceecCC
Q 005731 650 KDMNPKISDFGLARMFGG 667 (680)
Q Consensus 650 ~~~~~kl~DFGla~~~~~ 667 (680)
+++.+||+|||+++.+..
T Consensus 272 ~~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 272 QGKIVKICDFGLARDIMH 289 (400)
T ss_pred CCCEEEEEeCCcceeccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=214.54 Aligned_cols=151 Identities=26% Similarity=0.354 Sum_probs=132.7
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.++|++.+.||+|+||.||+++.. ++..+|+|.+... .....+++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 368999999999999999999854 5888999998754 22345679999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999998843 345788899999999999999999853 499999999999999999999999999986643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-24 Score=223.08 Aligned_cols=154 Identities=32% Similarity=0.527 Sum_probs=137.0
Q ss_pred cCCcceeeeeccCCceeEEEEEEcC-CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
..+..+..+||-|-||.||.|.++. .-.||||.++. +....++|+.|+.+|+.++|||+|+|+|+|......|||.||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3456677899999999999998644 56899999986 455789999999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCcc
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (680)
|..|+|.++|++..+ ..++.-..+.|+.||+.||+||..+. +|||||.++|+|+.++..+||+||||+|++.++.-
T Consensus 345 M~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred ccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 999999999976543 34566677899999999999999877 99999999999999999999999999999987753
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=220.63 Aligned_cols=162 Identities=27% Similarity=0.467 Sum_probs=139.9
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe-EEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE-KILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 588 (680)
++|...+++|+|+||.++..+. .+++.+++|.+... .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788889999999999998874 45778999998743 33345567899999999999999999999999988 99999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||++||+|.+.+.+. +...++++.+..++.|++.|+.|||++. |+|||||+.||+++.+..+||.|||+|+.++.+
T Consensus 84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999998654 3567889999999999999999999776 999999999999999999999999999999877
Q ss_pred ccccCccccccC
Q 005731 669 ELQGNTKRIVGT 680 (680)
Q Consensus 669 ~~~~~~~~~~Gt 680 (680)
.. ...+++||
T Consensus 160 ~~--~a~tvvGT 169 (426)
T KOG0589|consen 160 DS--LASTVVGT 169 (426)
T ss_pred hh--hhheecCC
Confidence 53 23346776
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=215.09 Aligned_cols=141 Identities=30% Similarity=0.426 Sum_probs=123.8
Q ss_pred eeeccCCceeEEEEEE----cCCcEEEEEEccCC----CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 519 CKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQ----SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~----~~~~~VAVK~l~~~----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+.||+|+||.||+++. ..++.||||.++.. .......+.+|+++++.++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999974 35789999998642 122345678999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+++++|.+++. +...+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 99999988883 3446778888889999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=219.76 Aligned_cols=145 Identities=28% Similarity=0.456 Sum_probs=126.1
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|+..++||+|+||.||+++. .+++.||||.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4566778999999999999985 468999999986532 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++++|.... ...+..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999985432 3456777889999999999999987 99999999999999999999999999987743
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=219.38 Aligned_cols=141 Identities=23% Similarity=0.324 Sum_probs=125.3
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.++|++.+.||+|+||.||++.. .+++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 46799999999999999999984 5688999997542 3567899999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+. ++|..++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 165 ~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 165 YK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred CC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 85 68877773 2346789999999999999999999987 999999999999999999999999999764
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=213.78 Aligned_cols=146 Identities=26% Similarity=0.357 Sum_probs=126.9
Q ss_pred CcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCC-ceeeEEEEEEeCCeEEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHR-NLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 588 (680)
+|++.+.||+|+||.||+|... +++.||||++... .....+.+..|++++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999854 5789999998753 233456788899999999765 5888999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
||+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999988873 3346788999999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=210.25 Aligned_cols=149 Identities=24% Similarity=0.399 Sum_probs=130.1
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999864 5789999998753 22345678899999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|++++.+..+. .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLE---EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 99998776554 12346888999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=213.70 Aligned_cols=143 Identities=31% Similarity=0.381 Sum_probs=125.6
Q ss_pred eeeccCCceeEEEEEE----cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 519 CKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~----~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
+.||+|+||.||+++. .+++.+|+|++.... ......+.+|++++.+++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999863 357899999987532 2234567789999999999999999999999999999999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+|+|.+++. +...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 999998883 3346889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=214.10 Aligned_cols=150 Identities=20% Similarity=0.281 Sum_probs=130.6
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.++||+|+||.||+++.. +++.+|+|.+.+. .......|..|+.++..++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999854 4778999998642 1223445888999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999998432 345788888999999999999999987 99999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=207.97 Aligned_cols=149 Identities=27% Similarity=0.460 Sum_probs=130.9
Q ss_pred cCCcceeeeeccCCceeEEEEEEc----CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
.++|++.+.||+|+||.||+|... .+..||+|.++... ....+.|.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357889999999999999999743 35689999998642 2334678999999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
||||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999988432 346789999999999999999999887 999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=226.14 Aligned_cols=156 Identities=20% Similarity=0.305 Sum_probs=133.0
Q ss_pred HhcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC----
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG---- 582 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~---- 582 (680)
...++|++.+.||+|+||.||+++ ..+++.||||.+... .......+.+|+.++..++|+|++++...+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345799999999999999999997 457899999998643 2344567889999999999999999988775432
Q ss_pred ----eEEEEEEccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEe
Q 005731 583 ----EKILILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (680)
Q Consensus 583 ----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 657 (680)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 3679999999999999885432 2356888999999999999999999887 9999999999999999999999
Q ss_pred eeccceecCCC
Q 005731 658 DFGLARMFGGD 668 (680)
Q Consensus 658 DFGla~~~~~~ 668 (680)
|||+++.+...
T Consensus 186 DFGls~~~~~~ 196 (496)
T PTZ00283 186 DFGFSKMYAAT 196 (496)
T ss_pred ecccCeecccc
Confidence 99999987544
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=210.80 Aligned_cols=149 Identities=32% Similarity=0.444 Sum_probs=129.1
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.++|++.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|+.++++++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999854 688999999875432 234567889999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|++ ++|.+++.. ....++++.+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 996 677777633 2345788899999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=215.48 Aligned_cols=160 Identities=29% Similarity=0.456 Sum_probs=138.1
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 585 (680)
....|++.+.||+|.||.||+++.. +|+.+|+|.+.+... ...+.+.+|+.+|+++. |||||.+.+.+......+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3467999999999999999999854 499999999976433 24568999999999998 999999999999999999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC----CCeEEeeecc
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD----MNPKISDFGL 661 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGl 661 (680)
+|||++.||.|.+.+... .+++.+...++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999998888543 3889999999999999999999987 9999999999999643 4799999999
Q ss_pred ceecCCCccccCccccccC
Q 005731 662 ARMFGGDELQGNTKRIVGT 680 (680)
Q Consensus 662 a~~~~~~~~~~~~~~~~Gt 680 (680)
|+.+... .....++||
T Consensus 186 a~~~~~~---~~~~~~~Gt 201 (382)
T KOG0032|consen 186 AKFIKPG---ERLHTIVGT 201 (382)
T ss_pred ceEccCC---ceEeeecCC
Confidence 9998772 234456665
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=212.44 Aligned_cols=147 Identities=26% Similarity=0.348 Sum_probs=127.0
Q ss_pred CcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 588 (680)
+|++.+.||+|+||.||+++.. +++.||||.+.... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999854 57899999987532 23345677788888777 6899999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||+++|+|..++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 9999999988873 3346888999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=213.84 Aligned_cols=144 Identities=27% Similarity=0.419 Sum_probs=124.1
Q ss_pred cceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHH---hhcCCCceeeEEEEEEeCCeEEEE
Q 005731 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLI---AELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
|++.+.||+|+||.||++.. .+++.||||.++... ....+.+.+|++++ .+++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 66789999999999999985 468899999997431 22345566666554 567899999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|||+++++|...+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 99999999987763 346899999999999999999999987 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=214.39 Aligned_cols=146 Identities=27% Similarity=0.421 Sum_probs=125.8
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----eEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-----EKI 585 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 585 (680)
+|++.++||+|+||.||+|.. .+++.||||++... ......++.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999984 46899999998742 2234567889999999999999999999886432 479
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+||||+. ++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68888773 3346889999999999999999999987 999999999999999999999999999865
Q ss_pred C
Q 005731 666 G 666 (680)
Q Consensus 666 ~ 666 (680)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=213.46 Aligned_cols=141 Identities=26% Similarity=0.378 Sum_probs=123.8
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|+||.||+++. .+++.+|+|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999985 45789999998753 223455678899888876 899999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 99988873 3356889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=207.98 Aligned_cols=152 Identities=35% Similarity=0.530 Sum_probs=131.2
Q ss_pred CCcceeeeeccCCceeEEEEEE-----cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
++|++.+.||+|+||.||+|.. ..++.||+|.+.... .+...+|.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999973 245789999997532 3345678999999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC
Q 005731 587 ILEYMPNKSLDVYLFDPI--------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 652 (680)
||||+++++|.+++.... ....+++.+...++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999884321 1234788889999999999999999987 99999999999999999
Q ss_pred CeEEeeeccceecCC
Q 005731 653 NPKISDFGLARMFGG 667 (680)
Q Consensus 653 ~~kl~DFGla~~~~~ 667 (680)
.+||+|||+++.+..
T Consensus 162 ~~kl~dfg~~~~~~~ 176 (283)
T cd05090 162 HVKISDLGLSREIYS 176 (283)
T ss_pred cEEeccccccccccC
Confidence 999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=204.29 Aligned_cols=151 Identities=33% Similarity=0.495 Sum_probs=135.2
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.++|++.+.||+|++|.||+|...+++.||||.++.. ....++|.+|+.++++++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 4578999999999999999998777889999998753 234678999999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999985432 346789999999999999999999887 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=213.38 Aligned_cols=150 Identities=25% Similarity=0.354 Sum_probs=131.6
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.++|++.++||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999854 5788999988753 22345678999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|+++++|.+++.. ...+++.....++.|+++||.|||+.. +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999843 345788888999999999999999742 39999999999999999999999999998663
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=204.40 Aligned_cols=148 Identities=30% Similarity=0.496 Sum_probs=132.1
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
++|++.+.||+|+||.||+++..++..+|+|.+... ....+.|.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 468888999999999999999878889999998643 3345688999999999999999999999999999999999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 99999887432 235789999999999999999999887 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=207.93 Aligned_cols=150 Identities=29% Similarity=0.370 Sum_probs=131.0
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
+|++.++||+|+||.||++.. .+++.||||.+.... ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999984 468899999986532 2234567889999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+++|+|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999887542 2345889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=212.62 Aligned_cols=141 Identities=26% Similarity=0.385 Sum_probs=123.4
Q ss_pred eeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|+||.||+|+.. +++.||||.+... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999854 5789999998753 223455678899988866 799999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
++|...+. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence 99988873 3346788999999999999999999987 999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=212.14 Aligned_cols=142 Identities=29% Similarity=0.357 Sum_probs=121.5
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhh-cCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAE-LQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|+||.||+|+. .+++.||||.++.. .....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999985 45789999998753 22334556667777765 4899999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|+|..++.. ...++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 999888733 346888899999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-24 Score=230.99 Aligned_cols=150 Identities=35% Similarity=0.553 Sum_probs=131.2
Q ss_pred ceeeeeccCCceeEEEEE-EcCCc----EEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 516 SMQCKLGEGGFGPVYKGR-LFNGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~-~~~~~----~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
...++||+|+||+||+|. .+.++ +||||++... ..+...+++.|+-+|++++||||+||+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 345799999999999997 44443 7899998754 4456789999999999999999999999998765 889999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
||+.|.|.++++. .+..+...+.+.+..|||+||.|||++. ++||||.++|||+..-..+||+|||+|+.+..+.
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999854 3456788999999999999999999887 9999999999999999999999999999997766
Q ss_pred cc
Q 005731 670 LQ 671 (680)
Q Consensus 670 ~~ 671 (680)
.+
T Consensus 853 ~e 854 (1177)
T KOG1025|consen 853 KE 854 (1177)
T ss_pred cc
Confidence 43
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=213.22 Aligned_cols=140 Identities=24% Similarity=0.369 Sum_probs=124.1
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|+||.||+++. .+++.||||.++.. .....+.+.+|..++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999985 46889999999753 223456688999999988 799999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
|+|..++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence 99988873 3356899999999999999999999987 99999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=212.00 Aligned_cols=150 Identities=35% Similarity=0.574 Sum_probs=129.0
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCc----EEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQ----EVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~----~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
.+|++.+.||+|+||.||+|... +++ .||||.++... ....++|.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56899999999999999999743 333 48999987532 34467899999999999999999999998764 5779
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999988532 345788899999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 005731 667 GD 668 (680)
Q Consensus 667 ~~ 668 (680)
..
T Consensus 161 ~~ 162 (316)
T cd05108 161 AD 162 (316)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=215.29 Aligned_cols=152 Identities=28% Similarity=0.464 Sum_probs=134.1
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
....|.+...||+|.|+.|..++. .++..||||.+++... ..+..+.+|+++|..++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 456799999999999999999984 5689999999986432 3345588999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||..+|.+.++|... +.+.......++.|+.+|++|||.++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999999443 44555777889999999999999998 99999999999999999999999999998864
Q ss_pred C
Q 005731 668 D 668 (680)
Q Consensus 668 ~ 668 (680)
.
T Consensus 208 ~ 208 (596)
T KOG0586|consen 208 G 208 (596)
T ss_pred c
Confidence 3
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=212.29 Aligned_cols=141 Identities=28% Similarity=0.370 Sum_probs=121.2
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHH-HHhhcCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMM-LIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|+||.||+++. .+++.+|||++... ......++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999984 56899999998643 1223445566655 56779999999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|+|..++. +...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 99988873 3456889999999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=212.09 Aligned_cols=146 Identities=25% Similarity=0.365 Sum_probs=126.6
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 588 (680)
+|+..+.||+|+||.||+++. .+++.||||.+... .....+.+..|..++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467789999999999999984 46889999998743 2234566788999988885 577888999999989999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
||+++|+|..++. +...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccccc
Confidence 9999999988873 3356889999999999999999999987 999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=204.31 Aligned_cols=150 Identities=35% Similarity=0.522 Sum_probs=134.4
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
++|++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++.+...+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 578999999999999999999878889999998753 3346789999999999999999999999999999999999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999988543 2345788899999999999999999887 99999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-24 Score=207.66 Aligned_cols=159 Identities=28% Similarity=0.499 Sum_probs=140.8
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
+-|.++++||+|+||.||++.+ ..|+.||||.+.. ...+.++..|+.++...+.|++|+++|.+.....+|+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 3477789999999999999974 5699999999874 456889999999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCccc
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (680)
..|+..+.++ .+++.+.+.++..++...++||+|||... -||||||+.||||+.+|.+||+|||.|..+.+.-.+
T Consensus 111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 9999999884 35668999999999999999999999865 899999999999999999999999999988665544
Q ss_pred cCccccccC
Q 005731 672 GNTKRIVGT 680 (680)
Q Consensus 672 ~~~~~~~Gt 680 (680)
. ++++||
T Consensus 186 R--NTVIGT 192 (502)
T KOG0574|consen 186 R--NTVIGT 192 (502)
T ss_pred h--CccccC
Confidence 3 347776
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=206.27 Aligned_cols=150 Identities=33% Similarity=0.581 Sum_probs=131.5
Q ss_pred CCcceeeeeccCCceeEEEEEE-----cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 585 (680)
++|++.+.||+|+||.||++.. .+++.||||++........+.|.+|++++.+++||||+++.+++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788899999999999999974 24789999999866555677899999999999999999999987543 4688
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+||||+++++|.+++.+. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999988432 245789999999999999999999987 999999999999999999999999999976
Q ss_pred CC
Q 005731 666 GG 667 (680)
Q Consensus 666 ~~ 667 (680)
..
T Consensus 159 ~~ 160 (284)
T cd05081 159 PQ 160 (284)
T ss_pred cC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=206.34 Aligned_cols=145 Identities=30% Similarity=0.393 Sum_probs=125.8
Q ss_pred eccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCCh
Q 005731 521 LGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (680)
Q Consensus 521 LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (680)
||+|+||.||++.. .+++.+|||.+.... ....+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999974 468899999986432 22346678899999999999999999999999999999999999999
Q ss_pred hhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 597 DVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 597 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 88774422 3346889999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=203.53 Aligned_cols=148 Identities=28% Similarity=0.476 Sum_probs=133.1
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++.+++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5789999999999999999984 568899999997654455667889999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
++++|.+++.. ...+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999988732 346788999999999999999999887 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=228.44 Aligned_cols=150 Identities=25% Similarity=0.367 Sum_probs=131.0
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.++||+|+||.||+|.. .+++.||||++.... ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999985 458899999987532 223567999999999999999999999999999999999
Q ss_pred EccCCCChhhHhccccc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeec
Q 005731 589 EYMPNKSLDVYLFDPIK--------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 660 (680)
||+++++|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998853211 123566778899999999999999987 9999999999999999999999999
Q ss_pred cceec
Q 005731 661 LARMF 665 (680)
Q Consensus 661 la~~~ 665 (680)
+|+..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99977
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=211.03 Aligned_cols=141 Identities=29% Similarity=0.416 Sum_probs=123.5
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|+||.||+++. .+++.||||++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999985 45889999998742 223456778888888876 699999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|+|..++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 99988873 3346889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-22 Score=202.43 Aligned_cols=149 Identities=31% Similarity=0.512 Sum_probs=132.5
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
++|++.+.||+|+||.||++...++..+|||.+... ....++|.+|+.++.+++||||+++++++.+....+++|||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 468888999999999999998777778999998753 3345779999999999999999999999999889999999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 99999988432 236889999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=211.05 Aligned_cols=141 Identities=28% Similarity=0.353 Sum_probs=120.1
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHH-HHhhcCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMM-LIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
++||+|+||.||+++. .+++.||+|.+.... .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999985 468899999986431 122344555554 67889999999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
++|...+. +...+....+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 99988773 3456788888899999999999999887 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=210.34 Aligned_cols=141 Identities=29% Similarity=0.371 Sum_probs=120.7
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHH-HHhhcCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMM-LIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|+||.||++.. .+++.||||++.... .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999985 468999999986431 222344555554 56789999999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|+|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 99988883 3456788889999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.4e-22 Score=218.31 Aligned_cols=145 Identities=27% Similarity=0.331 Sum_probs=126.8
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
...|.+.+.||+|+||.||++... .++.||||.... ..+.+|++++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999854 478899996432 3457899999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+. ++|..++.. ....+++.++..|+.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 95 688777743 2346899999999999999999999987 999999999999999999999999999987544
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-22 Score=202.66 Aligned_cols=149 Identities=32% Similarity=0.580 Sum_probs=131.8
Q ss_pred CCcceeeeeccCCceeEEEEEEc----CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
++|++.+.||+|+||.||+|... +...||||.++... .....+|.+|+.++++++||||+++++.+.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 57889999999999999999853 24579999987542 33456789999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998432 236889999999999999999999877 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=205.18 Aligned_cols=149 Identities=26% Similarity=0.335 Sum_probs=132.4
Q ss_pred CCcceeeeeccCCceeEEEEEEcC-CcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
+.|++.+.||.|.-|.||++++.+ +...|+|++.+.. .....+.+.|-+||+.++||.+..|++.+..++..+|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 467778999999999999999765 5899999998643 334567788999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|||+||+|...+.+ +..+.++++.+.-++..|+-||+|||..| ||.|||||+||||.++|++-|+||-|+...
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999887644 45667888888889999999999999888 999999999999999999999999998765
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-23 Score=219.14 Aligned_cols=156 Identities=33% Similarity=0.518 Sum_probs=133.0
Q ss_pred CCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
+-|+.++.||.|+||.||.++ ..+.+.||||++.-... .....++.|+..|.+++|||++.+-|++......||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 356777899999999999998 45678999999974333 34567899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|||- ||-.+.+. ..++++.+.++..|..+.+.||+|||+.+ .||||||+.||||++.|.|||+|||-|.++.+.
T Consensus 106 EYCl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 106 EYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9995 56666652 23567888999999999999999999987 999999999999999999999999999987553
Q ss_pred ccccCccccccC
Q 005731 669 ELQGNTKRIVGT 680 (680)
Q Consensus 669 ~~~~~~~~~~Gt 680 (680)
++|+||
T Consensus 180 ------nsFvGT 185 (948)
T KOG0577|consen 180 ------NSFVGT 185 (948)
T ss_pred ------hcccCC
Confidence 346776
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-22 Score=210.30 Aligned_cols=141 Identities=28% Similarity=0.376 Sum_probs=124.2
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|+||.||++.. .+++.||||+++.. .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999985 45789999999753 223456688999999888 699999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 99988773 3356899999999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-22 Score=202.94 Aligned_cols=146 Identities=41% Similarity=0.666 Sum_probs=126.6
Q ss_pred ceeeeeccCCceeEEEEEEc-----CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 516 SMQCKLGEGGFGPVYKGRLF-----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~-----~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++.+.||.|.||.||+|+.. .+..|+||.++.. .....++|.+|++.+.+++||||++++|++.+.+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35689999999999999876 2568999999653 33447899999999999999999999999998888999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|+++|+|.++|... ....+++..+..|+.||++||+|||+.+ ++|+||+++||++++++.+||+|||+++..
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 99999999999553 2356899999999999999999999987 999999999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=215.60 Aligned_cols=153 Identities=31% Similarity=0.471 Sum_probs=130.0
Q ss_pred cCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCe
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGE 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~ 583 (680)
.++|.+.+.||+|+||.||+|+.. .++.||||+++.... ...+.+.+|++++.++. ||||+++++++.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 356888899999999999999743 346899999975422 23457899999999997 9999999999999999
Q ss_pred EEEEEEccCCCChhhHhccccc----------------------------------------------------------
Q 005731 584 KILILEYMPNKSLDVYLFDPIK---------------------------------------------------------- 605 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 605 (680)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999998854211
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE
Q 005731 606 -------------------------------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648 (680)
Q Consensus 606 -------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 648 (680)
...+.+..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 123677788899999999999999876 9999999999999
Q ss_pred cCCCCeEEeeeccceecCC
Q 005731 649 DKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~ 667 (680)
++++.+||+|||+++.+..
T Consensus 273 ~~~~~~kL~DfGla~~~~~ 291 (401)
T cd05107 273 CEGKLVKICDFGLARDIMR 291 (401)
T ss_pred eCCCEEEEEecCcceeccc
Confidence 9999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=205.11 Aligned_cols=153 Identities=33% Similarity=0.559 Sum_probs=137.7
Q ss_pred hcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+..+|++.++||+|+||.||+|...+++.+|+|.+.........++.+|+.+++.++||||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34578889999999999999999877899999999876555677899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++++|.+++.+. ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++..+..
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999998553 3346789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.5e-22 Score=203.41 Aligned_cols=143 Identities=34% Similarity=0.497 Sum_probs=122.2
Q ss_pred eeccCCceeEEEEEEcC---CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCC
Q 005731 520 KLGEGGFGPVYKGRLFN---GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKS 595 (680)
Q Consensus 520 ~LG~G~fG~Vy~~~~~~---~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 595 (680)
+||+|+||.||+|...+ ...+++|.+.... .....+|.+|+++++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 69999999999997543 3578889876432 2335678899999999999999999999999999999999999999
Q ss_pred hhhHhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 596 LDVYLFDPIK--KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 596 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 9999855322 233467788899999999999999987 999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-22 Score=205.25 Aligned_cols=151 Identities=34% Similarity=0.565 Sum_probs=132.7
Q ss_pred CCcceeeeeccCCceeEEEEEE------cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
.+|.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5788889999999999999974 2345689999976555566789999999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccc----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEE
Q 005731 587 ILEYMPNKSLDVYLFDPI----------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 656 (680)
||||+++++|.+++.... +...+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999885321 2235899999999999999999999987 999999999999999999999
Q ss_pred eeeccceecC
Q 005731 657 SDFGLARMFG 666 (680)
Q Consensus 657 ~DFGla~~~~ 666 (680)
+|||+++.+.
T Consensus 162 ~dfg~~~~~~ 171 (288)
T cd05093 162 GDFGMSRDVY 171 (288)
T ss_pred ccCCcccccc
Confidence 9999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.7e-22 Score=204.92 Aligned_cols=143 Identities=21% Similarity=0.365 Sum_probs=124.4
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCccc---HHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeEEEEEEcc
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAELQHRNLVRILGCCVE----QGEKILILEYM 591 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~ 591 (680)
..|++|+++.||+|.. +++.||||+++...... .+.|.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999986 68899999997543222 5678899999999999999999999877 34688999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++|+|.+++.. ...+++.....++.+++.||+|||... .++||||||+|||+++++.+||+|||+++.+..
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 99999999843 346888999999999999999999742 378999999999999999999999999987543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.5e-22 Score=204.00 Aligned_cols=153 Identities=31% Similarity=0.502 Sum_probs=130.6
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 583 (680)
..++|++.+.||+|+||.||+|... .+..||||++.... .....+|.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998642 25679999986432 2345678999999999999999999999999999
Q ss_pred EEEEEEccCCCChhhHhccccc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEE
Q 005731 584 KILILEYMPNKSLDVYLFDPIK-------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 656 (680)
.++||||+++++|.+++.+... ...+.+..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999998854211 224577888999999999999999877 999999999999999999999
Q ss_pred eeeccceecC
Q 005731 657 SDFGLARMFG 666 (680)
Q Consensus 657 ~DFGla~~~~ 666 (680)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05062 161 GDFGMTRDIY 170 (277)
T ss_pred CCCCCccccC
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-22 Score=208.45 Aligned_cols=141 Identities=27% Similarity=0.374 Sum_probs=122.2
Q ss_pred eeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHHHhh-cCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAE-LQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|+||.||+|+.. +++.||||.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999854 57899999987531 2334556778888876 4999999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|+|..++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999988832 346788999999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=203.58 Aligned_cols=150 Identities=29% Similarity=0.495 Sum_probs=123.4
Q ss_pred CCcceeeeeccCCceeEEEEEE--cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhc---CCCceeeEEEEEEe-----
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL--FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAEL---QHRNLVRILGCCVE----- 580 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~--~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~----- 580 (680)
++|++.+.||+|+||.||+++. .+++.||||+++... ......+.+|+.++..+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4688999999999999999975 346889999886432 22234566777777665 69999999999863
Q ss_pred CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeec
Q 005731 581 QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (680)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 660 (680)
....++||||++ ++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999996 6888887432 2345789999999999999999999987 9999999999999999999999999
Q ss_pred cceecCC
Q 005731 661 LARMFGG 667 (680)
Q Consensus 661 la~~~~~ 667 (680)
+++.+..
T Consensus 156 ~~~~~~~ 162 (290)
T cd07862 156 LARIYSF 162 (290)
T ss_pred ceEeccC
Confidence 9987754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-22 Score=205.13 Aligned_cols=153 Identities=29% Similarity=0.489 Sum_probs=130.0
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 583 (680)
..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3568999999999999999998643 24589999987432 2234568899999999999999999999999999
Q ss_pred EEEEEEccCCCChhhHhccccc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEE
Q 005731 584 KILILEYMPNKSLDVYLFDPIK-------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 656 (680)
.++||||+++|+|.+++..... ...+.+..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999854211 234567788899999999999999887 999999999999999999999
Q ss_pred eeeccceecC
Q 005731 657 SDFGLARMFG 666 (680)
Q Consensus 657 ~DFGla~~~~ 666 (680)
+|||+++.+.
T Consensus 161 ~Dfg~~~~~~ 170 (288)
T cd05061 161 GDFGMTRDIY 170 (288)
T ss_pred CcCCcccccc
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-22 Score=208.86 Aligned_cols=141 Identities=29% Similarity=0.384 Sum_probs=122.2
Q ss_pred eeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|+||.||+++.. +++.||||.++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999854 58899999987531 23445677788887754 899999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|+|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999888733 346788899999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=226.50 Aligned_cols=149 Identities=28% Similarity=0.410 Sum_probs=132.5
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|.+.++||+|+||.||+|... +++.||||+++... ......+.+|+.++..++||||+++++.+......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67999999999999999999854 68899999987532 223467889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++++|.+++.. ...+++..+..|+.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++....
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 99999999998843 345788889999999999999999987 99999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-22 Score=213.76 Aligned_cols=148 Identities=28% Similarity=0.412 Sum_probs=128.1
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----eEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-----EKI 585 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 585 (680)
+|++.+.||+|+||.||++.. .+++.||||++... .....+++.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999985 56899999998653 2234567899999999999999999999998776 789
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+||||+. ++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57777763 3456889999999999999999999987 999999999999999999999999999876
Q ss_pred CCC
Q 005731 666 GGD 668 (680)
Q Consensus 666 ~~~ 668 (680)
...
T Consensus 154 ~~~ 156 (372)
T cd07853 154 EPD 156 (372)
T ss_pred ccC
Confidence 443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-22 Score=209.08 Aligned_cols=141 Identities=28% Similarity=0.346 Sum_probs=118.9
Q ss_pred eeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHH-HHHhhcCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEM-MLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|+||.||+++.. +++.||+|.+.... .....++..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999854 57889999986431 12233444444 456788999999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
++|..++.. ...+.......++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 999988843 345677888889999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-23 Score=198.01 Aligned_cols=160 Identities=30% Similarity=0.435 Sum_probs=136.2
Q ss_pred cCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC----C-c---ccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 005731 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ----S-G---QGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ 581 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~----~-~---~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 581 (680)
-++|...+.||+|..+.|.++. ..++++.|+|++... . + .-.++-+.|+.+|+++ -||+|+.+.+++...
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 4567777899999999998886 456889999998632 1 1 1234567899999998 699999999999999
Q ss_pred CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecc
Q 005731 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 661 (680)
...++|+|.|+.|.|.++| .+.-.+++++..+|+.|+.+|++|||... ||||||||+|||+|++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 9999999999999999999 44567888889999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCccccCccccccC
Q 005731 662 ARMFGGDELQGNTKRIVGT 680 (680)
Q Consensus 662 a~~~~~~~~~~~~~~~~Gt 680 (680)
|..+.+.+. ...+|||
T Consensus 170 a~~l~~Gek---LrelCGT 185 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGT 185 (411)
T ss_pred eeccCCchh---HHHhcCC
Confidence 999977653 3345666
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.7e-22 Score=201.47 Aligned_cols=149 Identities=33% Similarity=0.505 Sum_probs=131.7
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
.+|++.+.||+|+||.||++...++..+|+|.+... ....++|.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 357788999999999999998777778999998653 2344678899999999999999999999999999999999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 99999988432 236789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=205.94 Aligned_cols=148 Identities=30% Similarity=0.482 Sum_probs=128.3
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.++||+|+||.||+|+. .+++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5789999999999999999985 457889999987532 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 975 787776432 345788889999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-22 Score=211.54 Aligned_cols=151 Identities=32% Similarity=0.499 Sum_probs=127.5
Q ss_pred CCcceeeeeccCCceeEEEEEE------cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC-Ce
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ-GE 583 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~~ 583 (680)
++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5799999999999999999962 346899999997532 23456788999999999 789999999988654 46
Q ss_pred EEEEEEccCCCChhhHhccccc----------------------------------------------------------
Q 005731 584 KILILEYMPNKSLDVYLFDPIK---------------------------------------------------------- 605 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 605 (680)
.+++|||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999988753210
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 606 ------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 606 ------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 123678888999999999999999987 9999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.6e-22 Score=206.05 Aligned_cols=151 Identities=30% Similarity=0.492 Sum_probs=129.3
Q ss_pred CCcceeeeeccCCceeEEEEEEcC---------------CcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN---------------GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILG 576 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~---------------~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g 576 (680)
++|++.+.||+|+||.||+++... ...||||.+... .......|.+|++++.+++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999986432 235899998754 2334567999999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCChhhHhccccc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEE
Q 005731 577 CCVEQGEKILILEYMPNKSLDVYLFDPIK---------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647 (680)
Q Consensus 577 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 647 (680)
++......++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999998843211 124678889999999999999999987 999999999999
Q ss_pred EcCCCCeEEeeeccceecC
Q 005731 648 LDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 648 l~~~~~~kl~DFGla~~~~ 666 (680)
+++++.+||+|||+++.+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred EcCCCcEEecccccccccc
Confidence 9999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.8e-22 Score=203.61 Aligned_cols=151 Identities=33% Similarity=0.584 Sum_probs=132.1
Q ss_pred CCcceeeeeccCCceeEEEEEEcC------CcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
++|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.|.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468888999999999999997532 478999999764333 4578999999999999999999999999999999
Q ss_pred EEEEccCCCChhhHhcccc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCe
Q 005731 586 LILEYMPNKSLDVYLFDPI-----------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 654 (680)
+||||+++++|.+++.... ....+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999985421 1245788899999999999999999987 9999999999999999999
Q ss_pred EEeeeccceecC
Q 005731 655 KISDFGLARMFG 666 (680)
Q Consensus 655 kl~DFGla~~~~ 666 (680)
||+|||+++.+.
T Consensus 162 kl~d~g~~~~~~ 173 (280)
T cd05049 162 KIGDFGMSRDVY 173 (280)
T ss_pred EECCcccceecc
Confidence 999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-23 Score=211.50 Aligned_cols=160 Identities=28% Similarity=0.421 Sum_probs=140.1
Q ss_pred CCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
..|+..+.||+|+||.||+|. ...++.||+|++.-. .....+.++.|+.++..++|+||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 356777899999999999997 456889999999854 334567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCcc
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (680)
|.+|++.+.| .....+++..+.-|+.+++.||.|||.++ .+|||||+.|||+..+|.+||+|||++..+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999998888 33445577778888999999999999987 99999999999999999999999999999877665
Q ss_pred ccCccccccC
Q 005731 671 QGNTKRIVGT 680 (680)
Q Consensus 671 ~~~~~~~~Gt 680 (680)
+. .+++||
T Consensus 167 rr--~tfvGT 174 (467)
T KOG0201|consen 167 RR--KTFVGT 174 (467)
T ss_pred cc--cccccc
Confidence 54 568887
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=203.88 Aligned_cols=152 Identities=32% Similarity=0.546 Sum_probs=132.6
Q ss_pred CCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
++|.+.+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999732 355799999876555556789999999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC
Q 005731 587 ILEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN 653 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 653 (680)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985421 1235789999999999999999999987 999999999999999999
Q ss_pred eEEeeeccceecCC
Q 005731 654 PKISDFGLARMFGG 667 (680)
Q Consensus 654 ~kl~DFGla~~~~~ 667 (680)
+||+|||+++....
T Consensus 162 ~~l~dfg~a~~~~~ 175 (291)
T cd05094 162 VKIGDFGMSRDVYS 175 (291)
T ss_pred EEECCCCcccccCC
Confidence 99999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=204.22 Aligned_cols=149 Identities=26% Similarity=0.330 Sum_probs=130.4
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.+.||+|+||.||++.. .++..+|+|.+... .....+++.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688999999999999999984 45788999988653 223456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+++++|.+++.. ...+++..+..++.|+++||.|||+.. +++||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 999999999843 356788899999999999999999732 39999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=211.46 Aligned_cols=155 Identities=30% Similarity=0.529 Sum_probs=133.2
Q ss_pred HHhcCCcceeeeeccCCceeEEEEEEcC---C--cEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 005731 509 AAATENFSMQCKLGEGGFGPVYKGRLFN---G--QEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG 582 (680)
Q Consensus 509 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~---~--~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 582 (680)
+...+..++.++||.|-||.||+|...+ | -.||||..+.. .....+.|+.|..++++++||||++|+|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 3444556677899999999999997432 3 36899998864 445678899999999999999999999999874
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
..|||||.++-|.|..+|.. ++..++......++.||+.||+|||+.. +|||||..+|||+.....+||+||||+
T Consensus 464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence 79999999999999999943 3456888889999999999999999876 999999999999999999999999999
Q ss_pred eecCCCc
Q 005731 663 RMFGGDE 669 (680)
Q Consensus 663 ~~~~~~~ 669 (680)
|.+..+.
T Consensus 539 R~~ed~~ 545 (974)
T KOG4257|consen 539 RYLEDDA 545 (974)
T ss_pred hhccccc
Confidence 9886543
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=200.97 Aligned_cols=145 Identities=35% Similarity=0.451 Sum_probs=123.6
Q ss_pred eeeccCCceeEEEEEEcC---CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCC
Q 005731 519 CKLGEGGFGPVYKGRLFN---GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~---~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 594 (680)
+.||+|+||.||+|...+ +..+|+|.++... ......|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999997543 4579999987543 233457899999999999999999999999999999999999999
Q ss_pred ChhhHhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 595 SLDVYLFDPIK--KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 595 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+|.+++..... ....++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999854321 234567778889999999999999887 9999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=202.67 Aligned_cols=151 Identities=36% Similarity=0.602 Sum_probs=130.5
Q ss_pred CCcceeeeeccCCceeEEEEEEcC------CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
++|++.+.||+|+||.||+|.... ...||+|.+.... .....+|.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999997532 2579999987543 234567999999999999999999999999989999
Q ss_pred EEEEccCCCChhhHhccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC
Q 005731 586 LILEYMPNKSLDVYLFDPIK-------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 652 (680)
++|||+++++|.+++..... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998854311 145788899999999999999999987 99999999999999999
Q ss_pred CeEEeeeccceecC
Q 005731 653 NPKISDFGLARMFG 666 (680)
Q Consensus 653 ~~kl~DFGla~~~~ 666 (680)
.+||+|||+++...
T Consensus 162 ~~~L~dfg~~~~~~ 175 (283)
T cd05048 162 TVKISDFGLSRDIY 175 (283)
T ss_pred cEEECCCcceeecc
Confidence 99999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=204.11 Aligned_cols=152 Identities=30% Similarity=0.500 Sum_probs=130.4
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-----------------CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceee
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-----------------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVR 573 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-----------------~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~ 573 (680)
.++|++.+.||+|+||.||++... +...||+|.+... ......+|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998522 2346899999754 2334568999999999999999999
Q ss_pred EEEEEEeCCeEEEEEEccCCCChhhHhccccc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCc
Q 005731 574 ILGCCVEQGEKILILEYMPNKSLDVYLFDPIK--------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645 (680)
Q Consensus 574 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~N 645 (680)
+++++...+..++||||+++++|.+++..... ...+++.++..++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999998854221 124677889999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEeeeccceecC
Q 005731 646 VLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 646 ILl~~~~~~kl~DFGla~~~~ 666 (680)
||+++++.+||+|||+++.+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred EEEcCCCCEEeccCccccccc
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=200.91 Aligned_cols=150 Identities=30% Similarity=0.549 Sum_probs=131.0
Q ss_pred CCcceeeeeccCCceeEEEEEEc-C---CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-N---GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~---~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.+|++.+.||+|+||.||+|... + +..+|+|.++... ....+.|.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888899999999999999753 2 3479999987532 23456889999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998432 245788999999999999999999887 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.3e-23 Score=213.92 Aligned_cols=137 Identities=33% Similarity=0.511 Sum_probs=123.2
Q ss_pred eeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCChh
Q 005731 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLD 597 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 597 (680)
++-||.|+.|.||+|++. ++.||||+++... ..+|+-|++|+||||+.+.|+|....-.+||||||..|.|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 468999999999999974 6789999986432 35788899999999999999999999999999999999999
Q ss_pred hHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 598 VYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
..|. ....+.....+.+.++||.||.|||.+. |||||||.-||||+.+..+||+|||.++.+..-
T Consensus 201 ~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 201 EVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred HHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 9993 4567888999999999999999999886 999999999999999999999999999987543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-22 Score=212.80 Aligned_cols=147 Identities=30% Similarity=0.417 Sum_probs=129.2
Q ss_pred CcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-C-----CceeeEEEEEEeCCeEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-H-----RNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 586 (680)
+|++.+.||+|+||+|.++. ..+++.||||++++. ....++-..|+.+|..|+ | -|+|++++++..+++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 89999999999999999997 567999999999873 456777889999999997 4 379999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC--CCeEEeeecccee
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD--MNPKISDFGLARM 664 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DFGla~~ 664 (680)
|+|.+ .-+|.++|.. .+...++...+..|+.||+.||.+||+.+ |||+|||||||||.+- ..+||+|||.|..
T Consensus 266 VfELL-~~NLYellK~-n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKN-NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99988 5689999855 34456889999999999999999999887 9999999999999753 4799999999986
Q ss_pred cC
Q 005731 665 FG 666 (680)
Q Consensus 665 ~~ 666 (680)
..
T Consensus 341 ~~ 342 (586)
T KOG0667|consen 341 ES 342 (586)
T ss_pred cC
Confidence 53
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=203.59 Aligned_cols=152 Identities=31% Similarity=0.525 Sum_probs=131.7
Q ss_pred cCCcceeeeeccCCceeEEEEEEcC-----------------CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceee
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFN-----------------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVR 573 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----------------~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~ 573 (680)
.++|++.+.||+|+||.||++.... +..||+|.+.... ....+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578999999999999999987432 2468999987543 334678999999999999999999
Q ss_pred EEEEEEeCCeEEEEEEccCCCChhhHhcccc--------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCc
Q 005731 574 ILGCCVEQGEKILILEYMPNKSLDVYLFDPI--------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645 (680)
Q Consensus 574 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~N 645 (680)
+++++..+...+++|||+++++|..++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985432 1236789999999999999999999887 9999999999
Q ss_pred EEEcCCCCeEEeeeccceecC
Q 005731 646 VLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 646 ILl~~~~~~kl~DFGla~~~~ 666 (680)
|+++.++.+||+|||+++.+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred eeecCCCceEEccccceeecc
Confidence 999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-23 Score=199.98 Aligned_cols=150 Identities=28% Similarity=0.446 Sum_probs=128.7
Q ss_pred cCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++.|++-++||+|.|+.|++.. ..+|+.+|+|+++.. ...+.+++.+|+++-+.++||||++|.....+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4678888999999999999986 567999999988632 3447888999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC---CCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD---MNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla~~~ 665 (680)
|+|.|++|..-+-. +..+.+....++++||+++|.|+|.++ |||||+||+|+||..+ .-+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999655522 234566778899999999999999988 9999999999999643 35899999999988
Q ss_pred CC
Q 005731 666 GG 667 (680)
Q Consensus 666 ~~ 667 (680)
++
T Consensus 164 ~~ 165 (355)
T KOG0033|consen 164 ND 165 (355)
T ss_pred CC
Confidence 73
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=199.81 Aligned_cols=150 Identities=29% Similarity=0.526 Sum_probs=130.6
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.++|++.++||+|+||.||+|+..+...||+|.++.. ....++|.+|++++.+++||||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 3569999999999999999998777778999999753 234567899999999999999999999864 45689999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++++|.+++.+. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999998542 2345788999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=201.05 Aligned_cols=148 Identities=26% Similarity=0.489 Sum_probs=132.6
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
++|++.+.||+|+||.||++.. .+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4788889999999999999974 468899999987654455567889999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
++++|.+++. ....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 89 GGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 9999999873 3346889999999999999999999987 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=201.67 Aligned_cols=149 Identities=32% Similarity=0.497 Sum_probs=126.2
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCc----EEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQ----EVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~----~VAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
++|++.+.||+|+||.||+|.. .+++ .+++|.+..... ....++..|+.++++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 4678889999999999999985 3444 478888764322 33567888999999999999999999875 456789
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
++||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999843 2346889999999999999999999887 9999999999999999999999999998764
Q ss_pred C
Q 005731 667 G 667 (680)
Q Consensus 667 ~ 667 (680)
.
T Consensus 161 ~ 161 (279)
T cd05111 161 P 161 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.8e-22 Score=209.76 Aligned_cols=153 Identities=33% Similarity=0.520 Sum_probs=128.3
Q ss_pred cCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC-C
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ-G 582 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~ 582 (680)
.++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357899999999999999999632 34789999987532 22345678899999999 899999999988754 5
Q ss_pred eEEEEEEccCCCChhhHhccccc---------------------------------------------------------
Q 005731 583 EKILILEYMPNKSLDVYLFDPIK--------------------------------------------------------- 605 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 605 (680)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 68899999999999988743211
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 606 -KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 606 -~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 125789999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=199.61 Aligned_cols=150 Identities=31% Similarity=0.555 Sum_probs=127.8
Q ss_pred cceeeeeccCCceeEEEEEEcC----CcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe-----
Q 005731 515 FSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE----- 583 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----- 583 (680)
|.+.+.||+|+||.||+|.... +..||||+++.. .....+++.+|+++++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998532 367999998753 22345689999999999999999999999876554
Q ss_pred -EEEEEEccCCCChhhHhcccc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeee
Q 005731 584 -KILILEYMPNKSLDVYLFDPI---KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659 (680)
Q Consensus 584 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 659 (680)
.+++|||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999998885432 2346888999999999999999999987 999999999999999999999999
Q ss_pred ccceecCC
Q 005731 660 GLARMFGG 667 (680)
Q Consensus 660 Gla~~~~~ 667 (680)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05035 158 GLSKKIYS 165 (273)
T ss_pred cceeeccc
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=206.56 Aligned_cols=141 Identities=29% Similarity=0.393 Sum_probs=123.6
Q ss_pred eeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|+||.||+++.. +++.||||.+... .....+.+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999854 5789999998753 223456678899998888 799999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
++|..++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 99988873 3346899999999999999999999887 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=202.23 Aligned_cols=141 Identities=28% Similarity=0.403 Sum_probs=120.4
Q ss_pred eeccCCceeEEEEEEcC-------------------------CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeE
Q 005731 520 KLGEGGFGPVYKGRLFN-------------------------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574 (680)
Q Consensus 520 ~LG~G~fG~Vy~~~~~~-------------------------~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l 574 (680)
.||+|+||.||+|.... ...|++|.+.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13589999876544455678899999999999999999
Q ss_pred EEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC--
Q 005731 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-- 652 (680)
Q Consensus 575 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-- 652 (680)
++++.+....++||||+++|+|+.++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999988843 2346788999999999999999999887 99999999999998644
Q ss_pred -----CeEEeeeccceec
Q 005731 653 -----NPKISDFGLARMF 665 (680)
Q Consensus 653 -----~~kl~DFGla~~~ 665 (680)
.+|++|||+++..
T Consensus 157 ~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCccceeeecCCcccccc
Confidence 3799999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=202.33 Aligned_cols=150 Identities=35% Similarity=0.575 Sum_probs=128.7
Q ss_pred CcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
+|++.+.||+|+||.||+|... ....+++|.+.... ....+++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999742 23578999887543 2345679999999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccc---------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCc
Q 005731 587 ILEYMPNKSLDVYLFDPI---------------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~N 645 (680)
++||+.+++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1235788999999999999999999887 9999999999
Q ss_pred EEEcCCCCeEEeeeccceecC
Q 005731 646 VLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 646 ILl~~~~~~kl~DFGla~~~~ 666 (680)
||+++++.+||+|||+++.+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred EEEcCCCcEEecccccccccc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=207.69 Aligned_cols=139 Identities=27% Similarity=0.344 Sum_probs=119.1
Q ss_pred eccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhc---CCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 521 LGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAEL---QHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 521 LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
||+|+||.||+++. .+++.||||++.... ......+..|..++.+. +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999985 458999999986421 12233455666666665 699999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|+|..++. +...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 99988873 3456889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=200.20 Aligned_cols=149 Identities=32% Similarity=0.591 Sum_probs=124.7
Q ss_pred ceeeeeccCCceeEEEEEEcC-Cc--EEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------CeE
Q 005731 516 SMQCKLGEGGFGPVYKGRLFN-GQ--EVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------GEK 584 (680)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~~-~~--~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 584 (680)
.+.+.||+|+||.||+|.... ++ .+|||.++.. .....+.|.+|++++++++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456899999999999998644 32 6899988653 234467889999999999999999999988543 246
Q ss_pred EEEEEccCCCChhhHhcccc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecc
Q 005731 585 ILILEYMPNKSLDVYLFDPI---KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 661 (680)
+++|||+++|+|..++.... ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999988874221 2345789999999999999999999987 99999999999999999999999999
Q ss_pred ceecCC
Q 005731 662 ARMFGG 667 (680)
Q Consensus 662 a~~~~~ 667 (680)
++.+..
T Consensus 159 ~~~~~~ 164 (272)
T cd05075 159 SKKIYN 164 (272)
T ss_pred ccccCc
Confidence 997643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=203.36 Aligned_cols=154 Identities=31% Similarity=0.534 Sum_probs=132.8
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 582 (680)
..++|++.+.||+|+||.||++... ....+|+|.+... ......++.+|++++.++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4467899999999999999999753 2368999998753 233456788999999999 8999999999999999
Q ss_pred eEEEEEEccCCCChhhHhccc-------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc
Q 005731 583 EKILILEYMPNKSLDVYLFDP-------------IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 649 (680)
..+++|||+++|+|..++... .....+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998532 12346889999999999999999999887 99999999999999
Q ss_pred CCCCeEEeeeccceecCC
Q 005731 650 KDMNPKISDFGLARMFGG 667 (680)
Q Consensus 650 ~~~~~kl~DFGla~~~~~ 667 (680)
+++.+||+|||+++.+..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 167 EDHVMKIADFGLARDIHH 184 (293)
T ss_pred CCCeEEeCcccccccccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=199.67 Aligned_cols=150 Identities=31% Similarity=0.561 Sum_probs=131.1
Q ss_pred CCcceeeeeccCCceeEEEEEEcC-C---cEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN-G---QEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~-~---~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
..|++.+.||+|+||.||+|.... + ..||||.+... ......+|..|+.++++++||||+++.+++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998542 3 36999998754 333467899999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988432 345789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-21 Score=197.45 Aligned_cols=151 Identities=33% Similarity=0.548 Sum_probs=135.3
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.++|++.++||+|+||.||++...+++.+|||.+... ....+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4679999999999999999999877889999998753 334678999999999999999999999999888999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++++|.+++... ....+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 999999998542 2346889999999999999999999887 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=199.25 Aligned_cols=150 Identities=33% Similarity=0.552 Sum_probs=132.8
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.+|++.+.||+|+||.||+|.. ..++.||+|.+... ....+++.+|++++++++||||+++++++......+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4578889999999999999985 45889999998753 344678999999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999988442 2345789999999999999999999887 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=212.10 Aligned_cols=145 Identities=24% Similarity=0.387 Sum_probs=126.9
Q ss_pred cCCcceeeeeccCCceeEEEEEEc---CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
..+|++.+.||+|+||.||++... .++.||||.+... +.+.+|++++++++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999743 3578999988642 23568999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|++. ++|..++ .....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9985 6787777 23456899999999999999999999987 999999999999999999999999999877543
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=202.68 Aligned_cols=150 Identities=28% Similarity=0.436 Sum_probs=134.6
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.++|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36899999999999999999984 57899999999765555567789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+++++|.+++. ...+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999873 235788899999999999999999887 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=198.28 Aligned_cols=143 Identities=30% Similarity=0.506 Sum_probs=126.3
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCCh
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (680)
+.||+|+||.||+|+. .+++.+|+|.+.... ......|.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999985 468899999886532 33456799999999999999999999999999999999999999999
Q ss_pred hhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
.+++.. ....+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 998843 2345789999999999999999999887 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-21 Score=200.87 Aligned_cols=149 Identities=28% Similarity=0.357 Sum_probs=129.8
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.|+..+.||+|+||.||++.. .+++.+|+|.+.... ....+.+.+|++++.+++|+|++++.+.+..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367778999999999999985 468899999986532 2234567889999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 81 IMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred eccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999998887542 2346899999999999999999999887 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=199.62 Aligned_cols=145 Identities=37% Similarity=0.592 Sum_probs=128.7
Q ss_pred cceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCccc--HHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 515 FSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQG--LKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
|++.+.||+|+||.||++... +++.+|+|.+....... .....+|+.++.+++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999854 46789999998754332 223456999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
++++|.+++. ....+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.++|+|||++..+
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999984 4456799999999999999999999987 999999999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=203.62 Aligned_cols=153 Identities=31% Similarity=0.546 Sum_probs=131.5
Q ss_pred cCCcceeeeeccCCceeEEEEEEc--------CCcEEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ 581 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 581 (680)
..+|.+.+.||+|+||.||+++.. ++..||+|.+... .....+++.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 357888899999999999999631 2457999998753 234467899999999999 899999999999999
Q ss_pred CeEEEEEEccCCCChhhHhcccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE
Q 005731 582 GEKILILEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 648 (680)
...++||||+++++|.+++.... ....+++.++..++.||++||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 99999999999999999986432 1235788889999999999999999987 9999999999999
Q ss_pred cCCCCeEEeeeccceecCC
Q 005731 649 DKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~ 667 (680)
+.++.+||+|||+++.+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 171 TENNVMKIADFGLARDVNN 189 (304)
T ss_pred cCCCcEEECCCccceeccc
Confidence 9999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=201.18 Aligned_cols=150 Identities=31% Similarity=0.426 Sum_probs=132.8
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||++.. .+++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688999999999999999985 458999999986432 234567889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++++|.+++.. ...++...+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999998843 356889999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=200.21 Aligned_cols=153 Identities=29% Similarity=0.475 Sum_probs=131.9
Q ss_pred cCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 584 (680)
.++|++.+.||+|+||.||++... .+..||+|.+.... ......+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 367889999999999999999753 24689999987543 23356789999999999999999999999999999
Q ss_pred EEEEEccCCCChhhHhccccc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEe
Q 005731 585 ILILEYMPNKSLDVYLFDPIK-------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 657 (680)
++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999854321 234688899999999999999999887 9999999999999999999999
Q ss_pred eeccceecCC
Q 005731 658 DFGLARMFGG 667 (680)
Q Consensus 658 DFGla~~~~~ 667 (680)
|||+++.+..
T Consensus 162 dfg~~~~~~~ 171 (277)
T cd05032 162 DFGMTRDIYE 171 (277)
T ss_pred Ccccchhhcc
Confidence 9999986643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=201.19 Aligned_cols=154 Identities=27% Similarity=0.457 Sum_probs=132.9
Q ss_pred hcCCcceeeeeccCCceeEEEEEEcC-----CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEe-CCe
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLFN-----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVE-QGE 583 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~ 583 (680)
..++|++.+.||+|+||.||+|.... +..|++|++.... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34689999999999999999998654 6889999987542 3345678999999999999999999999876 467
Q ss_pred EEEEEEccCCCChhhHhcccccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEee
Q 005731 584 KILILEYMPNKSLDVYLFDPIKK-----RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISD 658 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 658 (680)
.++++||+++++|.+++...... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998543222 46889999999999999999999887 99999999999999999999999
Q ss_pred eccceecCC
Q 005731 659 FGLARMFGG 667 (680)
Q Consensus 659 FGla~~~~~ 667 (680)
||+++.+..
T Consensus 161 ~g~~~~~~~ 169 (280)
T cd05043 161 NALSRDLFP 169 (280)
T ss_pred CCCcccccC
Confidence 999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=202.27 Aligned_cols=150 Identities=28% Similarity=0.461 Sum_probs=134.5
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.++|++.+.||+|+||.||++.. .+++.+|+|.+........+.|.+|++++++++||||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 45788999999999999999985 46889999998765555667899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+++++|..++.+. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999987432 346889999999999999999999987 9999999999999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=199.57 Aligned_cols=149 Identities=36% Similarity=0.557 Sum_probs=130.3
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+|++.+.||+|++|.||+|+. .+++.||||++... .....+.+.+|+.++.+++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 478889999999999999985 46889999998643 223356788999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
++ ++|.+++........+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 688888754333456889999999999999999999887 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=197.72 Aligned_cols=148 Identities=33% Similarity=0.579 Sum_probs=132.8
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
++|++.+.||+|+||.||++.. .++.||||.+..... ..+++.+|+.++++++|+||+++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 5788889999999999999985 478999999986433 56789999999999999999999999998899999999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 84 KGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 99999998442 2236899999999999999999999987 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=201.99 Aligned_cols=149 Identities=28% Similarity=0.436 Sum_probs=133.7
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
..+|++.+.||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 36899999999999999999984 56889999999765555567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++++|.+++. ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 99 ~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred cCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 99999999873 235788999999999999999999987 99999999999999999999999999886643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=198.41 Aligned_cols=154 Identities=30% Similarity=0.436 Sum_probs=131.7
Q ss_pred HhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
.+++++.....||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3455666667999999999999984 457889999987665556778999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-CCCeEEeeeccceecC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFG 666 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~ 666 (680)
||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++..+.
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999998854322112277888889999999999999887 999999999999986 6799999999998764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=197.80 Aligned_cols=149 Identities=36% Similarity=0.547 Sum_probs=131.9
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.|.+|+.++++++|+||+++++++ ..+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 46788999999999999999998888999999987533 3457899999999999999999999986 456789999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
++++|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.+.
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 999999987442 2346788999999999999999999887 9999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=200.11 Aligned_cols=150 Identities=28% Similarity=0.364 Sum_probs=129.8
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.|+..+.||+|+||.||++.. .+++.+|||.+.... ....+.+.+|+.++++++|+|++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367778999999999999974 468899999986532 2234567889999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999999887432 2345888999999999999999999877 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=198.19 Aligned_cols=152 Identities=25% Similarity=0.447 Sum_probs=132.3
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+|+. .+++.||||.+... .......+.+|++++++++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999984 46899999987542 2233457899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++++|.+++.... ....++...+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988874322 2345788889999999999999999887 99999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=198.62 Aligned_cols=145 Identities=27% Similarity=0.405 Sum_probs=127.7
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.+.||+|+||.||++.. .+++.||+|.+... .....++|.+|+.++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999974 56889999998653 233456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999996542 3577888899999999999999987 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=202.61 Aligned_cols=151 Identities=35% Similarity=0.535 Sum_probs=129.4
Q ss_pred CcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
+|++.++||+|+||.||+|... .++.||||+++.... ...+.|.+|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667789999999999999753 247899999975432 234678999999999999999999999999999999
Q ss_pred EEEccCCCChhhHhccc-------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC
Q 005731 587 ILEYMPNKSLDVYLFDP-------------IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN 653 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 653 (680)
++||+.+++|..++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999987421 11235788889999999999999999887 999999999999999999
Q ss_pred eEEeeeccceecCC
Q 005731 654 PKISDFGLARMFGG 667 (680)
Q Consensus 654 ~kl~DFGla~~~~~ 667 (680)
+||+|||+++.+..
T Consensus 163 ~kl~Dfg~~~~~~~ 176 (283)
T cd05091 163 VKISDLGLFREVYA 176 (283)
T ss_pred eEeccccccccccc
Confidence 99999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=200.73 Aligned_cols=150 Identities=35% Similarity=0.581 Sum_probs=130.1
Q ss_pred CCcceeeeeccCCceeEEEEEE-----cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEK 584 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 584 (680)
+.|++.+.||+|+||.||+++. .+++.||+|.++... ....+.+.+|++++++++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578889999999999999973 357889999987542 33456799999999999999999999998875 568
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||||+++++|.+++.+. ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999988432 235789999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 005731 665 FGG 667 (680)
Q Consensus 665 ~~~ 667 (680)
+..
T Consensus 159 ~~~ 161 (284)
T cd05079 159 IET 161 (284)
T ss_pred ccc
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=206.95 Aligned_cols=144 Identities=26% Similarity=0.354 Sum_probs=125.2
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
....+|++.+.||+|+||.||+|+.. +++.||+|..... ....|+.++.+++||||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34568999999999999999999854 4678999975432 2356899999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
||+. ++|.+++.. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9995 678777743 2356889999999999999999999987 999999999999999999999999999854
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=200.55 Aligned_cols=151 Identities=32% Similarity=0.547 Sum_probs=132.1
Q ss_pred CCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
++|...++||+|+||.||++... ++..+|+|.+..........|.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56778899999999999999632 356899999886555567789999999999999999999999999999999
Q ss_pred EEEccCCCChhhHhccccc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCe
Q 005731 587 ILEYMPNKSLDVYLFDPIK------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 654 (680)
+|||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999854321 135788999999999999999999887 9999999999999999999
Q ss_pred EEeeeccceecC
Q 005731 655 KISDFGLARMFG 666 (680)
Q Consensus 655 kl~DFGla~~~~ 666 (680)
||+|||+++.+.
T Consensus 162 kL~dfg~~~~~~ 173 (280)
T cd05092 162 KIGDFGMSRDIY 173 (280)
T ss_pred EECCCCceeEcC
Confidence 999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-21 Score=198.41 Aligned_cols=143 Identities=29% Similarity=0.414 Sum_probs=123.5
Q ss_pred eccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCCh
Q 005731 521 LGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (680)
Q Consensus 521 LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (680)
||+|+||.||+++. .+++.+|+|.+.... ....+.+..|++++.+++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999984 468999999986421 12234566799999999999999999999999999999999999999
Q ss_pred hhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
..++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 8887442 2345788999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=198.76 Aligned_cols=147 Identities=29% Similarity=0.488 Sum_probs=131.1
Q ss_pred cceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 515 FSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
|++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++++......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 667789999999999999854 4778899998765555677899999999999999999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
++|..++.+ ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 999887743 2346889999999999999999999987 9999999999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-21 Score=195.81 Aligned_cols=149 Identities=30% Similarity=0.527 Sum_probs=129.8
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
++|++.+.||+|++|.||++....+..+|+|.+.... ...+.+.+|+.++++++|||++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4688889999999999999987777789999887532 34567899999999999999999998874 456899999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 99999988542 2345789999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=198.59 Aligned_cols=149 Identities=34% Similarity=0.520 Sum_probs=128.5
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCc----EEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~----~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
++|++.+.||+|+||.||+|+. .+++ .||+|.+... .....+++.+|+.++..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 5788889999999999999973 4444 4899998753 33345678999999999999999999999875 45789
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
++||+++|+|.+++.+. ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999999988532 346889999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 005731 667 G 667 (680)
Q Consensus 667 ~ 667 (680)
.
T Consensus 161 ~ 161 (279)
T cd05109 161 I 161 (279)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=199.33 Aligned_cols=151 Identities=31% Similarity=0.502 Sum_probs=130.6
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC------C
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ------G 582 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~------~ 582 (680)
+++.|++.+.||+|+||.||+|.. .+++.||+|.+... .....++.+|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 456788889999999999999985 45789999998753 34456788999999998 799999999998753 4
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
..+++|||+++++|.+++... ....+.+..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 689999999999999988542 3346889999999999999999999987 999999999999999999999999999
Q ss_pred eecC
Q 005731 663 RMFG 666 (680)
Q Consensus 663 ~~~~ 666 (680)
+.+.
T Consensus 159 ~~~~ 162 (272)
T cd06637 159 AQLD 162 (272)
T ss_pred eecc
Confidence 8764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=196.92 Aligned_cols=149 Identities=32% Similarity=0.541 Sum_probs=130.9
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
++|++.+.||+|+||.||++...++..+|+|.+.... ...+.|.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4688889999999999999988788889999987533 24567999999999999999999999874 456899999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++|.+++.+. ....+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 99999988542 2345789999999999999999999987 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-22 Score=190.37 Aligned_cols=155 Identities=27% Similarity=0.353 Sum_probs=137.4
Q ss_pred HhcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----e
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-----E 583 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~ 583 (680)
...++|.+.+.||+|||+.||.++ +.+++.+|+|++.....++.+..++|++..++++||||++++++...+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345789999999999999999998 6778999999998777778889999999999999999999998876543 5
Q ss_pred EEEEEEccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 584 KILILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
.||+++|...|+|.+.+.... ++..+++.+.+.|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.|||-+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999886543 3457899999999999999999999975 58999999999999999999999999988
Q ss_pred eec
Q 005731 663 RMF 665 (680)
Q Consensus 663 ~~~ 665 (680)
...
T Consensus 177 ~~a 179 (302)
T KOG2345|consen 177 TQA 179 (302)
T ss_pred ccc
Confidence 744
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-21 Score=198.39 Aligned_cols=150 Identities=30% Similarity=0.439 Sum_probs=131.3
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|+..+.||+|++|.||++... +++.||+|++.... ....+.+.+|+.++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999864 58899999886432 2234568899999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|++++.|..++. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999998887763 2345899999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=197.48 Aligned_cols=143 Identities=24% Similarity=0.401 Sum_probs=122.4
Q ss_pred eeeccCCceeEEEEEEcC-------------CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 519 CKLGEGGFGPVYKGRLFN-------------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~-------------~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
+.||+|+||.||+|.... ...|++|.+..........|..|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997432 2358999887654445567889999999999999999999999999999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC-------eEEee
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN-------PKISD 658 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-------~kl~D 658 (680)
+||||+++++|+.++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999888743 2345889999999999999999999887 999999999999987664 89999
Q ss_pred eccceecC
Q 005731 659 FGLARMFG 666 (680)
Q Consensus 659 FGla~~~~ 666 (680)
||++..+.
T Consensus 156 ~g~~~~~~ 163 (262)
T cd05077 156 PGIPITVL 163 (262)
T ss_pred CCCCcccc
Confidence 99997654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=202.20 Aligned_cols=151 Identities=34% Similarity=0.551 Sum_probs=130.8
Q ss_pred CCcceeeeeccCCceeEEEEEEc--------CCcEEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~--------~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 582 (680)
++|.+.+.||+|+||.||++... ....+|+|.+... ......++.+|++++.++ +||||+++++++....
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 57999999999999999999642 2357999999753 233456788999999999 7999999999999999
Q ss_pred eEEEEEEccCCCChhhHhccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIK-------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 649 (680)
..++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999864321 235788999999999999999999887 99999999999999
Q ss_pred CCCCeEEeeeccceecC
Q 005731 650 KDMNPKISDFGLARMFG 666 (680)
Q Consensus 650 ~~~~~kl~DFGla~~~~ 666 (680)
.++.+||+|||+++.+.
T Consensus 175 ~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 175 EDNVMKIADFGLARDIH 191 (307)
T ss_pred CCCcEEECCCccccccc
Confidence 99999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.8e-21 Score=194.15 Aligned_cols=151 Identities=25% Similarity=0.412 Sum_probs=132.8
Q ss_pred CcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+|+..+.||+|+||.||.++ ..+++.+++|.+... .....+++.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 57888999999999999987 456889999988643 334466789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+++++|.+++... ....+++.++..++.|++++|+|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999988543 2346788999999999999999999887 999999999999999999999999999877443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=199.15 Aligned_cols=142 Identities=29% Similarity=0.456 Sum_probs=120.2
Q ss_pred eeccCCceeEEEEEEcCC---cEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCC
Q 005731 520 KLGEGGFGPVYKGRLFNG---QEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKS 595 (680)
Q Consensus 520 ~LG~G~fG~Vy~~~~~~~---~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 595 (680)
.||+|+||.||+++..++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999975443 346677766432 2346789999999999999999999999999999999999999999
Q ss_pred hhhHhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 596 LDVYLFDPIK-KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 596 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
|.+++.+... ....+...+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 9999854322 234566777889999999999999887 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.6e-21 Score=195.93 Aligned_cols=149 Identities=31% Similarity=0.493 Sum_probs=130.8
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-----cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
++|++.+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|++++.+++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788899999999999999974 468999999886421 1234578899999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|+||+++++|.+.+.. ...++...+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999988743 345788888999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 005731 667 G 667 (680)
Q Consensus 667 ~ 667 (680)
.
T Consensus 156 ~ 156 (263)
T cd06625 156 T 156 (263)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=202.80 Aligned_cols=149 Identities=34% Similarity=0.605 Sum_probs=128.5
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCc--EEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~--~VAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 587 (680)
++|++.+.||+|+||.||+|... ++. .+|+|.+... .....++|.+|++++.++ +||||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888899999999999999853 343 5688877643 233456889999999999 899999999999999999999
Q ss_pred EEccCCCChhhHhcccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCe
Q 005731 588 LEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 654 (680)
|||+++++|.+++.... ....+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999985432 1235788999999999999999999887 9999999999999999999
Q ss_pred EEeeecccee
Q 005731 655 KISDFGLARM 664 (680)
Q Consensus 655 kl~DFGla~~ 664 (680)
||+|||+++.
T Consensus 164 kl~dfg~~~~ 173 (303)
T cd05088 164 KIADFGLSRG 173 (303)
T ss_pred EeCccccCcc
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-21 Score=199.46 Aligned_cols=148 Identities=32% Similarity=0.536 Sum_probs=133.0
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
+.|++.++||+|+||.||+|+.. +++.+++|.+........+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999854 58899999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
++++|..++.+. ...+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 999998876432 345889999999999999999999887 999999999999999999999999998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.2e-21 Score=195.05 Aligned_cols=152 Identities=28% Similarity=0.465 Sum_probs=133.8
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999865 7899999988632 2233568999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++++|.+++.+.. ....+++.++..++.++++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999998885432 2345788999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=200.91 Aligned_cols=152 Identities=25% Similarity=0.411 Sum_probs=132.1
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.+.||+|+||.||++... +++.||+|.+... ......++.+|+.++.+++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999854 6899999988653 233356789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+++++|..++........+++..+..++.|++.||.|||+.. +|+|+||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999988854333346899999999999999999999742 39999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=198.53 Aligned_cols=150 Identities=30% Similarity=0.448 Sum_probs=131.3
Q ss_pred CCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
++|++.+.||+|+||.||+++.. +.+.|++|.+...... ..+++.+|++++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999853 3467999998764433 4678999999999999999999999999988999
Q ss_pred EEEEccCCCChhhHhcccccC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeee
Q 005731 586 LILEYMPNKSLDVYLFDPIKK------RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 659 (680)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998543311 25889999999999999999999887 999999999999999999999999
Q ss_pred ccceec
Q 005731 660 GLARMF 665 (680)
Q Consensus 660 Gla~~~ 665 (680)
|+++..
T Consensus 162 ~~~~~~ 167 (275)
T cd05046 162 SLSKDV 167 (275)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-21 Score=198.82 Aligned_cols=146 Identities=41% Similarity=0.569 Sum_probs=126.4
Q ss_pred cceeeeeccCCceeEEEEE-----EcCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEE
Q 005731 515 FSMQCKLGEGGFGPVYKGR-----LFNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKIL 586 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~-----~~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 586 (680)
|+..+.||+|+||.||++. ..+++.||+|.+.... ....+.|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 3788999999999998764 2357789999987542 23456789999999999999999999988764 35789
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+|||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999998832 35899999999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 005731 667 G 667 (680)
Q Consensus 667 ~ 667 (680)
.
T Consensus 159 ~ 159 (283)
T cd05080 159 E 159 (283)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-21 Score=194.49 Aligned_cols=151 Identities=28% Similarity=0.448 Sum_probs=133.3
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+|++.+.||+|++|.||++.. .+++.|++|.+... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477889999999999999985 46889999998642 234567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999988543 2356888999999999999999999887 999999999999999999999999999977543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=201.95 Aligned_cols=151 Identities=33% Similarity=0.488 Sum_probs=131.0
Q ss_pred CCcceeeeeccCCceeEEEEEE------cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 584 (680)
++|++.+.||+|+||.||++.. ..+..||||.++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 5688899999999999999963 234589999987542 23456789999999999 799999999999999999
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
+++|||+.+|+|.+++... ....+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 9999999999999988532 2234799999999999999999999987 99999999999999999999999999986
Q ss_pred cCC
Q 005731 665 FGG 667 (680)
Q Consensus 665 ~~~ 667 (680)
+..
T Consensus 191 ~~~ 193 (302)
T cd05055 191 IMN 193 (302)
T ss_pred ccC
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=196.72 Aligned_cols=142 Identities=29% Similarity=0.474 Sum_probs=122.2
Q ss_pred eeeccCCceeEEEEEEcCCc-----------EEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 519 CKLGEGGFGPVYKGRLFNGQ-----------EVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~-----------~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
+.||+|+||.||+|...... .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999865432 5788877654332 6789999999999999999999999988 788999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC-------CeEEeeec
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-------NPKISDFG 660 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-------~~kl~DFG 660 (680)
|||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999998542 226789999999999999999999887 99999999999999887 79999999
Q ss_pred cceecCC
Q 005731 661 LARMFGG 667 (680)
Q Consensus 661 la~~~~~ 667 (680)
+++.+..
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=212.68 Aligned_cols=149 Identities=23% Similarity=0.397 Sum_probs=122.0
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--------
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-------- 581 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-------- 581 (680)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 356899999999999999999985 468899999886422 2345799999999999999999887532
Q ss_pred CeEEEEEEccCCCChhhHhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC-CeEEeee
Q 005731 582 GEKILILEYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDF 659 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DF 659 (680)
...++||||+++ +|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 146789999975 666655322 23456889999999999999999999987 99999999999998664 7999999
Q ss_pred ccceecCC
Q 005731 660 GLARMFGG 667 (680)
Q Consensus 660 Gla~~~~~ 667 (680)
|+|+.+..
T Consensus 216 Gla~~~~~ 223 (440)
T PTZ00036 216 GSAKNLLA 223 (440)
T ss_pred ccchhccC
Confidence 99987744
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.3e-22 Score=195.10 Aligned_cols=142 Identities=28% Similarity=0.409 Sum_probs=128.1
Q ss_pred eeeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEEccCCCCh
Q 005731 519 CKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILEYMPNKSL 596 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (680)
+.||+|+++.|--+. +.++.++|||++.+.......+..+|++++...+ |+||+.|++++.++...|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 789999999999886 7889999999999877777888999999999985 99999999999999999999999999999
Q ss_pred hhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC---eEEeeeccceecC
Q 005731 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN---PKISDFGLARMFG 666 (680)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGla~~~~ 666 (680)
.+++ .+.+.+.+.+..++.++|+.||.|||.++ |.||||||+|||-.+-.. +||+||.|+.-+.
T Consensus 164 LshI---~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 164 LSHI---QKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred HHHH---HHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccc
Confidence 9998 44567889999999999999999999998 999999999999976543 7999999986553
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-21 Score=194.28 Aligned_cols=143 Identities=31% Similarity=0.502 Sum_probs=126.9
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCChh
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLD 597 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 597 (680)
+.||+|+||.||+|...+++.+|+|.+..... .....|.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999988889999999876433 23457899999999999999999999999999999999999999999
Q ss_pred hHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 598 VYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+++... ...+++..+..++.|++.+|.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 887432 345789999999999999999999887 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-21 Score=195.24 Aligned_cols=142 Identities=32% Similarity=0.540 Sum_probs=122.6
Q ss_pred eeccCCceeEEEEEEc---CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCC
Q 005731 520 KLGEGGFGPVYKGRLF---NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKS 595 (680)
Q Consensus 520 ~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 595 (680)
.||+|+||.||+|... .+..||+|.+.... ....++|.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999743 35579999987543 233567999999999999999999999875 457899999999999
Q ss_pred hhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 596 LDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccC
Confidence 9998843 2346889999999999999999999987 99999999999999999999999999986644
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.4e-21 Score=196.25 Aligned_cols=150 Identities=33% Similarity=0.595 Sum_probs=131.2
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CC---cEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NG---QEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~---~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
++|+..+.||+|+||.||+|... ++ ..+|+|.+.... ....+++.+|++++++++|||++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46888899999999999999854 23 379999987542 33456799999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++++|..++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999998843 2346889999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-21 Score=200.99 Aligned_cols=150 Identities=31% Similarity=0.566 Sum_probs=128.5
Q ss_pred CCcceeeeeccCCceeEEEEEEcC-C--cEEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN-G--QEVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~-~--~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 587 (680)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.|.+|++++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998643 3 35788888742 333456789999999999 799999999999999999999
Q ss_pred EEccCCCChhhHhcccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCe
Q 005731 588 LEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 654 (680)
|||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985421 1135788999999999999999999887 9999999999999999999
Q ss_pred EEeeeccceec
Q 005731 655 KISDFGLARMF 665 (680)
Q Consensus 655 kl~DFGla~~~ 665 (680)
||+|||++...
T Consensus 159 kl~dfg~~~~~ 169 (297)
T cd05089 159 KIADFGLSRGE 169 (297)
T ss_pred EECCcCCCccc
Confidence 99999998643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.1e-21 Score=194.48 Aligned_cols=151 Identities=28% Similarity=0.499 Sum_probs=134.8
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.++|++.+.||+|+||.||++.. .+++.+++|.+........+.+.+|++++++++||||+++++++......+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 46799999999999999999985 45788999999865555678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++++|..++... ...++..++..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++..+..
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999887432 246888999999999999999999887 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.4e-21 Score=195.61 Aligned_cols=148 Identities=34% Similarity=0.553 Sum_probs=129.5
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcc---------cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQ---------GLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~---------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 583 (680)
+|.+.+.||+|++|.||+|.. .+++.+|+|.+...... ..+.+.+|+.++.+++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367778999999999999974 45789999988643221 23568899999999999999999999999999
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.+++|||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999833 346788889999999999999999887 9999999999999999999999999998
Q ss_pred ecCC
Q 005731 664 MFGG 667 (680)
Q Consensus 664 ~~~~ 667 (680)
.+..
T Consensus 155 ~~~~ 158 (267)
T cd06628 155 KLEA 158 (267)
T ss_pred cccc
Confidence 7753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.3e-21 Score=195.17 Aligned_cols=148 Identities=30% Similarity=0.479 Sum_probs=127.6
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-----cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEK 584 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 584 (680)
.+|++.+.||+|+||.||++.. .+++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5789999999999999999985 458899999875321 12346788999999999999999999988764 467
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
+++|||+++++|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999988843 245788888999999999999999887 99999999999999999999999999986
Q ss_pred cC
Q 005731 665 FG 666 (680)
Q Consensus 665 ~~ 666 (680)
+.
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-21 Score=201.11 Aligned_cols=151 Identities=33% Similarity=0.559 Sum_probs=130.4
Q ss_pred CCcceeeeeccCCceeEEEEEEc--------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~--------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 582 (680)
++|.+.+.||+|+||.||+++.. ....+|+|.+.... .....++.+|++++.++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57888999999999999999631 24579999987532 33456789999999999 6999999999999989
Q ss_pred eEEEEEEccCCCChhhHhcccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc
Q 005731 583 EKILILEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 649 (680)
..+++|||+++|+|.+++.... ....+.+.++..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999985421 1245888999999999999999999887 99999999999999
Q ss_pred CCCCeEEeeeccceecC
Q 005731 650 KDMNPKISDFGLARMFG 666 (680)
Q Consensus 650 ~~~~~kl~DFGla~~~~ 666 (680)
+++.+||+|||+++.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 169 EDNVMKIADFGLARGVH 185 (314)
T ss_pred CCCcEEEcccccccccc
Confidence 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-21 Score=197.21 Aligned_cols=153 Identities=31% Similarity=0.499 Sum_probs=131.0
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 583 (680)
..++|++.+.||+|++|.||+|... .+..||+|.+.... ......|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3467999999999999999999854 35689999886432 3334679999999999999999999999999999
Q ss_pred EEEEEEccCCCChhhHhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC---CeEE
Q 005731 584 KILILEYMPNKSLDVYLFDPIK----KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM---NPKI 656 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl 656 (680)
.++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999998854321 235889999999999999999999987 99999999999998754 5999
Q ss_pred eeeccceecC
Q 005731 657 SDFGLARMFG 666 (680)
Q Consensus 657 ~DFGla~~~~ 666 (680)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05036 161 ADFGMARDIY 170 (277)
T ss_pred ccCccccccC
Confidence 9999998763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.9e-21 Score=199.48 Aligned_cols=149 Identities=29% Similarity=0.477 Sum_probs=134.0
Q ss_pred CCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.+|++.+.||.|++|.||++. ..+++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 579999999999999999997 4578999999987655555678899999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
++++|..++. ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 9999998873 235789999999999999999999987 999999999999999999999999998876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.4e-21 Score=194.22 Aligned_cols=148 Identities=32% Similarity=0.497 Sum_probs=130.6
Q ss_pred CcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC-----cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+++.+|++++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999865 78999999886432 23456799999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999998843 345788999999999999999999887 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=199.03 Aligned_cols=152 Identities=32% Similarity=0.533 Sum_probs=131.8
Q ss_pred cCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 584 (680)
.++|++.+.||+|+||.||++... ++..||+|.+.... ....++|.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999753 46789999987542 33456799999999999999999999999999999
Q ss_pred EEEEEccCCCChhhHhcccc-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCc
Q 005731 585 ILILEYMPNKSLDVYLFDPI-------------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~N 645 (680)
+++|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 1124678889999999999999999887 9999999999
Q ss_pred EEEcCCCCeEEeeeccceecC
Q 005731 646 VLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 646 ILl~~~~~~kl~DFGla~~~~ 666 (680)
|++++++.+||+|||+++.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred eEecCCCceEECccccceecc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-21 Score=196.11 Aligned_cols=147 Identities=31% Similarity=0.461 Sum_probs=128.3
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc----------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG----------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQG 582 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~----------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 582 (680)
+|.+.+.||+|+||.||+|.. .+++.||+|.++.... ...+.+.+|+.++.+++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467789999999999999974 4688999998753110 12346888999999999999999999999999
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999988432 56888899999999999999999887 999999999999999999999999999
Q ss_pred eecC
Q 005731 663 RMFG 666 (680)
Q Consensus 663 ~~~~ 666 (680)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.2e-21 Score=202.59 Aligned_cols=141 Identities=23% Similarity=0.289 Sum_probs=114.4
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEc--CCcEEEEEEccCC-----CcccHHHHHHHHHHHhhcCCCceee-EEEEEEeC
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLF--NGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAELQHRNLVR-ILGCCVEQ 581 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~--~~~~VAVK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~-l~g~~~~~ 581 (680)
....+|++.+.||+|+||+||+|... +++.||||++... .....+.|.+|++++.+++|+|++. ++. .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence 34578999999999999999999754 5778899987532 1223567999999999999999985 443 2
Q ss_pred CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCC-CCCcEEEcCCCCeEEeeec
Q 005731 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDL-KASNVLLDKDMNPKISDFG 660 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kl~DFG 660 (680)
...+|||||+++++|.... .. . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4689999999999995221 11 1 1467889999999999987 999999 9999999999999999999
Q ss_pred cceecCC
Q 005731 661 LARMFGG 667 (680)
Q Consensus 661 la~~~~~ 667 (680)
+|+.+..
T Consensus 158 lA~~~~~ 164 (365)
T PRK09188 158 LASVFRR 164 (365)
T ss_pred cceeccc
Confidence 9998754
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.3e-21 Score=202.82 Aligned_cols=152 Identities=32% Similarity=0.540 Sum_probs=130.5
Q ss_pred CCcceeeeeccCCceeEEEEEEc--------CCcEEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~--------~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 582 (680)
.+|++.+.||+|+||.||+++.. ....||+|.+... .....+++.+|++++.++ +||||+++++++.+..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999632 1236899988753 233467899999999999 8999999999999999
Q ss_pred eEEEEEEccCCCChhhHhcccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc
Q 005731 583 EKILILEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 649 (680)
..+++|||+++|+|.+++.... ....+.+.+++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999985421 2235788999999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccceecCC
Q 005731 650 KDMNPKISDFGLARMFGG 667 (680)
Q Consensus 650 ~~~~~kl~DFGla~~~~~ 667 (680)
.++.+||+|||+++.+..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 169 EDNVMKIADFGLARDVHN 186 (334)
T ss_pred CCCcEEECCcccceeccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=193.94 Aligned_cols=150 Identities=31% Similarity=0.479 Sum_probs=132.2
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.++|++.+.||+|+||.||++...++..+|+|.+... ....+.|.+|++++++++|+||+++.+.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678999999999999999998777788999988753 3345688999999999999999999999887 7789999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999998543 2345788899999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7e-21 Score=199.26 Aligned_cols=148 Identities=33% Similarity=0.472 Sum_probs=130.0
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcc-----cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
+|++.+.||+|++|.||+|.. .+++.||||++...... ....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477889999999999999985 46889999999753221 245677899999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+ +++|.+++.... ..+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999884321 36899999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-21 Score=198.76 Aligned_cols=158 Identities=25% Similarity=0.358 Sum_probs=133.2
Q ss_pred HHHHHhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEe---
Q 005731 506 ASVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE--- 580 (680)
Q Consensus 506 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~--- 580 (680)
..+..+.++|++.+.||+|+||.||++.. .+++.+|+|.+... .....++.+|+.++.++ +||||+++++++..
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 44455678999999999999999999975 45789999988653 22346788999999999 69999999998853
Q ss_pred --CCeEEEEEEccCCCChhhHhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEe
Q 005731 581 --QGEKILILEYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (680)
Q Consensus 581 --~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 657 (680)
++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 35689999999999998887532 22346788889999999999999999887 9999999999999999999999
Q ss_pred eeccceecCC
Q 005731 658 DFGLARMFGG 667 (680)
Q Consensus 658 DFGla~~~~~ 667 (680)
|||+++.+..
T Consensus 167 dfg~~~~~~~ 176 (286)
T cd06638 167 DFGVSAQLTS 176 (286)
T ss_pred cCCceeeccc
Confidence 9999987643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=197.60 Aligned_cols=152 Identities=26% Similarity=0.468 Sum_probs=132.6
Q ss_pred CCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|++|.||++. ..+++.+|||.+... ......++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 467888999999999999998 457899999987642 2234567899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++++|.+++.... ....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999998875322 2346889999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=205.47 Aligned_cols=146 Identities=32% Similarity=0.422 Sum_probs=124.2
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------ 582 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 582 (680)
.++|++.+.||+|+||.||++.. .+++.||||++... ......++.+|+.++..++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 47899999999999999999974 46889999998643 2334567889999999999999999999986543
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
..++||||+++ +|...+. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999975 4555442 23678888899999999999999987 999999999999999999999999999
Q ss_pred eecC
Q 005731 663 RMFG 666 (680)
Q Consensus 663 ~~~~ 666 (680)
+...
T Consensus 171 ~~~~ 174 (359)
T cd07876 171 RTAC 174 (359)
T ss_pred cccc
Confidence 8653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.5e-21 Score=195.43 Aligned_cols=146 Identities=30% Similarity=0.520 Sum_probs=129.4
Q ss_pred CcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCC------cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS------GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
+|+..+.||+|+||.||+|...+++.+|||.+.... ....+.+.+|++++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467789999999999999988788999999886432 12235688999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999843 345788889999999999999999887 999999999999999999999999999865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.2e-21 Score=196.49 Aligned_cols=149 Identities=34% Similarity=0.557 Sum_probs=129.3
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCc----EEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQ----EVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~----~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
.+|++.+.||+|+||.||+|... +++ .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56888899999999999999853 333 68999887543 3345788999999999999999999999887 78999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999988542 335889999999999999999999977 9999999999999999999999999998775
Q ss_pred C
Q 005731 667 G 667 (680)
Q Consensus 667 ~ 667 (680)
.
T Consensus 161 ~ 161 (279)
T cd05057 161 V 161 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.4e-21 Score=198.80 Aligned_cols=148 Identities=31% Similarity=0.482 Sum_probs=128.8
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5789999999999999999985 457899999986432 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
++ ++|..++... ...+++..+..++.||++||+|||+.+ |+|+||||+||++++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 5888877432 345788899999999999999999887 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-20 Score=191.29 Aligned_cols=150 Identities=23% Similarity=0.416 Sum_probs=131.6
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
+|++.+.||+|+||.||++.. .+++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+..+...+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 478889999999999999984 46889999988642 2334677889999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++++|.+++.. .....++......++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 99999888743 23345788899999999999999999987 99999999999999999999999999987743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.7e-21 Score=199.14 Aligned_cols=146 Identities=24% Similarity=0.382 Sum_probs=129.4
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||++.. ..++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4688899999999999999985 457899999987532 233567889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999999833 346788888999999999999999887 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=192.75 Aligned_cols=147 Identities=42% Similarity=0.631 Sum_probs=130.0
Q ss_pred eeeccCCceeEEEEEEcC----CcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|+||.||++.... +..|++|.+...... ..+++.+|++++..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998543 789999999764333 367899999999999999999999999999999999999999
Q ss_pred CChhhHhccccc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 594 KSLDVYLFDPIK------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 594 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++|.+++..... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999855321 367899999999999999999999987 99999999999999999999999999998755
Q ss_pred C
Q 005731 668 D 668 (680)
Q Consensus 668 ~ 668 (680)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.1e-21 Score=194.04 Aligned_cols=142 Identities=32% Similarity=0.535 Sum_probs=123.3
Q ss_pred eeccCCceeEEEEEE---cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCC
Q 005731 520 KLGEGGFGPVYKGRL---FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (680)
Q Consensus 520 ~LG~G~fG~Vy~~~~---~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 594 (680)
+||+|+||.||+|.. .+++.+|+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 357899999986532 234678999999999999999999999875 45778999999999
Q ss_pred ChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 9999883 3346889999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=191.84 Aligned_cols=149 Identities=28% Similarity=0.543 Sum_probs=131.8
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
.+|++.+.||+|+||.||++...+++.+|+|.+... .....+|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 468888999999999999998767889999998753 2345678999999999999999999999999999999999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++|.+++... ...++++.+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 99999887432 245788999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=204.46 Aligned_cols=149 Identities=31% Similarity=0.415 Sum_probs=127.1
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------ 581 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 581 (680)
..++|++.+.||+|+||.||++.. .+++.||||++.... ....+++.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 357899999999999999999984 568899999987532 22345678999999999999999999987543
Q ss_pred CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecc
Q 005731 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 661 (680)
...++++|++ +++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3568999987 788877762 345889999999999999999999987 99999999999999999999999999
Q ss_pred ceecCC
Q 005731 662 ARMFGG 667 (680)
Q Consensus 662 a~~~~~ 667 (680)
++....
T Consensus 165 ~~~~~~ 170 (343)
T cd07878 165 ARQADD 170 (343)
T ss_pred ceecCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=192.00 Aligned_cols=148 Identities=32% Similarity=0.559 Sum_probs=128.5
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe-CCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE-QGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~ 591 (680)
++|++.+.||+|+||.||++.. .+..||+|.+... ...+.|.+|+.++++++|+|++++++++.. +...+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4788889999999999999975 4778999998643 235678999999999999999999998654 45789999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 999999988542 2335789999999999999999999887 99999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-20 Score=191.52 Aligned_cols=153 Identities=27% Similarity=0.445 Sum_probs=134.7
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.+.||.|+||.||+|.. .++..+|+|++... .....+.+.+|+++++.++|+|++++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4789999999999999999984 46789999998643 233567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+++++|.+++........+++.....++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999854333356889999999999999999999887 999999999999999999999999999877543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-22 Score=213.37 Aligned_cols=161 Identities=26% Similarity=0.455 Sum_probs=139.0
Q ss_pred CCcceeeeeccCCceeEEEEEEcC-CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
+.|+++..||.|+||.||++...+ +-..|.|++...++..++.|+-||+||+..+||+||+|++.+...+.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 457777899999999999998554 4455778888878888999999999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCccc
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (680)
.||-.+..+.+ -...+..+++.-+++|++.||.|||++. |||||||+.|||++.+|.++|+|||.+........+
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 99999988754 2457899999999999999999999987 999999999999999999999999998766443322
Q ss_pred cCccccccC
Q 005731 672 GNTKRIVGT 680 (680)
Q Consensus 672 ~~~~~~~Gt 680 (680)
...++||
T Consensus 187 --RDsFIGT 193 (1187)
T KOG0579|consen 187 --RDSFIGT 193 (1187)
T ss_pred --hccccCC
Confidence 2246776
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=195.43 Aligned_cols=151 Identities=28% Similarity=0.412 Sum_probs=126.0
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHH-HhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMML-IAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|++.+.||+|+||.||++.. .+++.||+|+++... .....++..|+.+ ++.++||||+++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4788999999999999999985 468999999987532 2233456666665 566789999999999999999999999
Q ss_pred ccCCCChhhHhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 590 YMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 590 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|++ ++|.+++... .....+++..+..++.||+.||+|||++. +++||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 996 6887776432 23356899999999999999999999862 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=195.14 Aligned_cols=149 Identities=34% Similarity=0.557 Sum_probs=130.7
Q ss_pred CCcceeeeeccCCceeEEEEEEc-----CCcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEe--CCeE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-----NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVE--QGEK 584 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~VAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 584 (680)
+.|++.+.||+|+||.||+++.. .++.+|||.+...... ..++|.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777799999999999999853 3678999999764332 46789999999999999999999999877 5578
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998432 235889999999999999999999887 99999999999999999999999999998
Q ss_pred cC
Q 005731 665 FG 666 (680)
Q Consensus 665 ~~ 666 (680)
+.
T Consensus 159 ~~ 160 (284)
T cd05038 159 LP 160 (284)
T ss_pred cc
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=196.42 Aligned_cols=149 Identities=32% Similarity=0.424 Sum_probs=127.8
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++++|.+.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.++++++|+||+++.+++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 357899999999999999999974 4688999999865432 23346788999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
||+. ++|.+++... ...+.+..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 9996 6776665332 235678888899999999999999887 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=196.41 Aligned_cols=147 Identities=33% Similarity=0.475 Sum_probs=128.2
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.+.||+|++|.||++... +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999854 688999999865322 2235577899999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+.+ +|.+++.+. ...+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 985 898887432 236788999999999999999999887 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=192.93 Aligned_cols=144 Identities=35% Similarity=0.466 Sum_probs=126.7
Q ss_pred eeeccCCceeEEEEEEcC--C--cEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRLFN--G--QEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~--~--~~VAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|++|.||+|.... + ..||||.+..... ...+.|.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998533 2 3699999986544 556789999999999999999999999988 889999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++|.+++.+... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999855322 46889999999999999999999987 99999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8e-21 Score=197.43 Aligned_cols=149 Identities=28% Similarity=0.417 Sum_probs=130.7
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|++.++||+|+||.||++... +++.||+|++..... ...+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999864 588999999864322 235678899999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+++++|..+.. ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 999999987663 2335889999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=193.91 Aligned_cols=149 Identities=30% Similarity=0.478 Sum_probs=128.7
Q ss_pred CCcceeeeeccCCceeEEEEEEcC----CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
++|.+.+.||+|+||.||+|...+ ...||||...... ....+.|.+|+.++++++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 568888999999999999997533 2468999887543 3456689999999999999999999998865 567899
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999998432 235789999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=194.47 Aligned_cols=148 Identities=30% Similarity=0.494 Sum_probs=129.4
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC------cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS------GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
+|+..+.||+|++|.||++.. .+++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999974 668899999986432 1135678999999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC-CeEEeeeccceec
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMF 665 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~ 665 (680)
||||+++++|.+++.+ ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||+++.+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998843 346788999999999999999999987 99999999999998775 5999999999877
Q ss_pred CC
Q 005731 666 GG 667 (680)
Q Consensus 666 ~~ 667 (680)
..
T Consensus 155 ~~ 156 (268)
T cd06630 155 AA 156 (268)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=195.79 Aligned_cols=159 Identities=30% Similarity=0.426 Sum_probs=134.8
Q ss_pred HHHHHHhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC-
Q 005731 505 LASVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ- 581 (680)
Q Consensus 505 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~- 581 (680)
..++..++++|++.+.||+|+||.||++.. .+++.+|+|.+... .....++.+|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 344555678999999999999999999985 56889999998653 22346778899999999 899999999998754
Q ss_pred ----CeEEEEEEccCCCChhhHhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEE
Q 005731 582 ----GEKILILEYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656 (680)
Q Consensus 582 ----~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 656 (680)
...++||||+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence 3589999999999999887432 23356889999999999999999999887 999999999999999999999
Q ss_pred eeeccceecCC
Q 005731 657 SDFGLARMFGG 667 (680)
Q Consensus 657 ~DFGla~~~~~ 667 (680)
+|||+++.+..
T Consensus 170 ~dfg~~~~~~~ 180 (291)
T cd06639 170 VDFGVSAQLTS 180 (291)
T ss_pred eecccchhccc
Confidence 99999987643
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=192.34 Aligned_cols=148 Identities=32% Similarity=0.505 Sum_probs=132.3
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+|++.+.||+|+||.||++.. .+++.|++|.+..... ...+++.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 478889999999999999985 4688999999876433 3577899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++++|.+++.. ...+++..+..++.++++||+|||+.+ |+|+||+|+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 999999998843 345788889999999999999999987 99999999999999999999999999987743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=200.05 Aligned_cols=153 Identities=28% Similarity=0.384 Sum_probs=132.9
Q ss_pred CCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.-|.+.+.||+|.|..|-+++ .-+|+.||||++.+.. ......+..|++.|+-++|||||+||.+.-....+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 347777899999999999997 5689999999998642 3345578899999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc-CCCCeEEeeeccceecCCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~ 668 (680)
.=++|+|.+|+.++. ..+.++...+++.||+.|+.|+|+.. +|||||||+|+.+- .-|-+||+|||++-.+.+.
T Consensus 98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999996543 45788888999999999999999765 99999999999885 5678999999999988776
Q ss_pred cc
Q 005731 669 EL 670 (680)
Q Consensus 669 ~~ 670 (680)
+.
T Consensus 173 ~k 174 (864)
T KOG4717|consen 173 KK 174 (864)
T ss_pred ch
Confidence 53
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=198.47 Aligned_cols=143 Identities=28% Similarity=0.463 Sum_probs=117.9
Q ss_pred eeeccCCceeEEEEEEc---CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe--CCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRLF---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE--QGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~ 593 (680)
++||+|+||.||+|+.. +++.+|+|.+.... ....+.+|++++++++||||+++++++.. ....+++|||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 68999999999999854 46789999987532 23567889999999999999999998864 356789999986
Q ss_pred CChhhHhccc------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE----cCCCCeEEeeeccce
Q 005731 594 KSLDVYLFDP------IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLAR 663 (680)
Q Consensus 594 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla~ 663 (680)
++|..++... .+...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +..+.+||+|||+|+
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 4776665321 11235788889999999999999999987 9999999999999 456789999999998
Q ss_pred ecCC
Q 005731 664 MFGG 667 (680)
Q Consensus 664 ~~~~ 667 (680)
.+..
T Consensus 161 ~~~~ 164 (317)
T cd07868 161 LFNS 164 (317)
T ss_pred ccCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=193.56 Aligned_cols=149 Identities=34% Similarity=0.548 Sum_probs=130.3
Q ss_pred CcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
+|+..+.||+|++|.||+|+.. +++.||||.+..... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999864 688999999875432 23567788999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
++ +|.+++........+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 85 88887754433456899999999999999999999887 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.8e-21 Score=203.58 Aligned_cols=148 Identities=30% Similarity=0.420 Sum_probs=125.0
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------ 581 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 581 (680)
..++|++.+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 347899999999999999999974 45889999999753 223356788999999999999999999988643
Q ss_pred CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecc
Q 005731 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 661 (680)
...++||||+++ +|...+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999975 5655542 24788888999999999999999987 99999999999999999999999999
Q ss_pred ceecCC
Q 005731 662 ARMFGG 667 (680)
Q Consensus 662 a~~~~~ 667 (680)
++....
T Consensus 166 ~~~~~~ 171 (355)
T cd07874 166 ARTAGT 171 (355)
T ss_pred cccCCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=195.28 Aligned_cols=148 Identities=27% Similarity=0.358 Sum_probs=129.3
Q ss_pred CcceeeeeccCCceeEEEEEE----cCCcEEEEEEccCCC----cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~----~~~~~VAVK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 584 (680)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+++.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999974 368899999987532 22356788999999999 699999999999998899
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998843 345788888899999999999999887 99999999999999999999999999987
Q ss_pred cCC
Q 005731 665 FGG 667 (680)
Q Consensus 665 ~~~ 667 (680)
+..
T Consensus 155 ~~~ 157 (290)
T cd05613 155 FHE 157 (290)
T ss_pred ccc
Confidence 644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=194.30 Aligned_cols=149 Identities=31% Similarity=0.508 Sum_probs=132.1
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+|++.+.||+|++|.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478889999999999999985 468999999987543 23356799999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+ +++|.+++... ...+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 99999887432 256899999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=196.45 Aligned_cols=148 Identities=26% Similarity=0.379 Sum_probs=130.1
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.+.||+|+||.||++.. .+++.||+|++.... ....+++.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 5688889999999999999984 468899999876432 34467899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+++++|..++.. .+.+++.....++.+++.+|.|||+.. +++||||||+||++++++.++|+|||+++.+
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 999999888733 346889999999999999999999732 3999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=191.78 Aligned_cols=148 Identities=30% Similarity=0.495 Sum_probs=127.7
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-----cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEK 584 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 584 (680)
.+|+..+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4788899999999999999975 468899999886421 12345688999999999999999999988753 567
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999988843 345788889999999999999999877 99999999999999999999999999986
Q ss_pred cC
Q 005731 665 FG 666 (680)
Q Consensus 665 ~~ 666 (680)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=195.22 Aligned_cols=148 Identities=29% Similarity=0.452 Sum_probs=132.4
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
++|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6789999999999999999974 467899999987544445677899999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++++|.+++.+ ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+..
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 99999988732 35788899999999999999999887 99999999999999999999999999886644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.1e-22 Score=193.46 Aligned_cols=151 Identities=29% Similarity=0.467 Sum_probs=123.8
Q ss_pred CCcceeeeeccCCceeEEEEEEc---C--CcEEEEEEccCCCc-cc-HHHHHHHHHHHhhcCCCceeeEEEEEEe-CCeE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF---N--GQEVAVKRLSSQSG-QG-LKEFKNEMMLIAELQHRNLVRILGCCVE-QGEK 584 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~---~--~~~VAVK~l~~~~~-~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 584 (680)
..|+....||+|.||.||+|... + .+++|||+++.... .+ .....+|+.+++.++||||+.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46888899999999999999532 2 34799999986422 12 2346789999999999999999999887 7789
Q ss_pred EEEEEccCCCChhhHhc-c-cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC----CCeEEee
Q 005731 585 ILILEYMPNKSLDVYLF-D-PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD----MNPKISD 658 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~-~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~D 658 (680)
+|++||.+.. |-..++ . ..+.+.++......|+.||+.|+.|||++= |+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 9999999874 544443 2 234467888888899999999999999875 9999999999999877 8999999
Q ss_pred eccceecCC
Q 005731 659 FGLARMFGG 667 (680)
Q Consensus 659 FGla~~~~~ 667 (680)
||+||++..
T Consensus 180 lGlaR~~~~ 188 (438)
T KOG0666|consen 180 LGLARLFNN 188 (438)
T ss_pred ccHHHHhhc
Confidence 999998854
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.1e-21 Score=198.97 Aligned_cols=146 Identities=26% Similarity=0.434 Sum_probs=128.7
Q ss_pred cceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
|.....||+|+||.||++.. .+++.||||.+........+.+.+|+.++++++||||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 33346799999999999985 46889999998765555567789999999999999999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++|.+++. ...+++.++..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+..
T Consensus 104 ~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 104 GALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred CcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 99988873 235788999999999999999999987 99999999999999999999999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-20 Score=195.71 Aligned_cols=150 Identities=27% Similarity=0.346 Sum_probs=132.4
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|++|.||++... +++.+|+|.+..... ...+.+..|++++.+++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999854 489999999975432 24567899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||+.+++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 99999999998743 23356888999999999999999999887 9999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-20 Score=189.23 Aligned_cols=143 Identities=35% Similarity=0.541 Sum_probs=127.3
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCChh
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLD 597 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 597 (680)
++||+|+||.||++...+++.||+|.+...... ..+.|.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999998766999999998754332 4568999999999999999999999999999999999999999999
Q ss_pred hHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 598 VYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+++... ...+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 988432 235788899999999999999999887 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=209.19 Aligned_cols=153 Identities=35% Similarity=0.488 Sum_probs=133.0
Q ss_pred CCcceeeeeccCCceeEEEEEEc--CCc--EEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF--NGQ--EVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~--~~~--~VAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
++..+.|+||+|+||.|++|.+. .|+ .||||.+...... ....|++|+.+|.+|+|||++||+|+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 44556689999999999999753 343 6899999865433 67899999999999999999999999877 678999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+|..+.|||.+.|++ ..+..+-......++.|||.||.||..+. +|||||..+|+||-....+||+||||.|.++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999976 44556777888899999999999999887 99999999999999999999999999999976
Q ss_pred Ccc
Q 005731 668 DEL 670 (680)
Q Consensus 668 ~~~ 670 (680)
++.
T Consensus 265 ned 267 (1039)
T KOG0199|consen 265 NED 267 (1039)
T ss_pred CCc
Confidence 653
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=198.78 Aligned_cols=145 Identities=21% Similarity=0.301 Sum_probs=124.8
Q ss_pred eeeeeccC--CceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 517 MQCKLGEG--GFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 517 ~~~~LG~G--~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
+.++||+| +|++||++.. .+++.||||+++... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999974 568999999997532 233456788999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+...
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 9999999884322 234789999999999999999999987 999999999999999999999999865443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=194.07 Aligned_cols=149 Identities=31% Similarity=0.511 Sum_probs=122.6
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhc---CCCceeeEEEEEEeC-----C
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAEL---QHRNLVRILGCCVEQ-----G 582 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~-----~ 582 (680)
+|++.+.||+|+||.||+++. .+++.||+|.++... ......+.+|++++.++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488889999999999999985 468899999987532 12234566777777665 799999999988642 4
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
..+++|||+. ++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999997 4888877432 2345889999999999999999999987 999999999999999999999999999
Q ss_pred eecCC
Q 005731 663 RMFGG 667 (680)
Q Consensus 663 ~~~~~ 667 (680)
+.+..
T Consensus 156 ~~~~~ 160 (288)
T cd07863 156 RIYSC 160 (288)
T ss_pred ccccC
Confidence 87753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=202.29 Aligned_cols=147 Identities=30% Similarity=0.419 Sum_probs=124.8
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------C
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------G 582 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 582 (680)
.++|++.+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999974 45889999999753 223456788999999999999999999987543 3
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
..++||||+++ +|...+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 57999999975 6666552 24778888999999999999999987 999999999999999999999999999
Q ss_pred eecCC
Q 005731 663 RMFGG 667 (680)
Q Consensus 663 ~~~~~ 667 (680)
+....
T Consensus 174 ~~~~~ 178 (364)
T cd07875 174 RTAGT 178 (364)
T ss_pred cccCC
Confidence 87644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=196.20 Aligned_cols=150 Identities=27% Similarity=0.447 Sum_probs=127.0
Q ss_pred CcceeeeeccCCceeEEEEEEc---CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF---NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKI 585 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 585 (680)
+|++.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999853 47899999997632 33456788999999999999999999999988 7899
Q ss_pred EEEEccCCCChhhHhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC----CCCeEEeee
Q 005731 586 LILEYMPNKSLDVYLFDPIK--KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK----DMNPKISDF 659 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kl~DF 659 (680)
+||||+++ +|...+..... ...++...+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 56555532221 236788899999999999999999887 999999999999999 899999999
Q ss_pred ccceecCC
Q 005731 660 GLARMFGG 667 (680)
Q Consensus 660 Gla~~~~~ 667 (680)
|+++.+..
T Consensus 157 g~~~~~~~ 164 (316)
T cd07842 157 GLARLFNA 164 (316)
T ss_pred ccccccCC
Confidence 99987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=192.35 Aligned_cols=143 Identities=34% Similarity=0.607 Sum_probs=122.7
Q ss_pred eeeccCCceeEEEEEEcC-Cc--EEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRLFN-GQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~-~~--~VAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998643 43 5788888743 234456789999999999 899999999999999999999999999
Q ss_pred CChhhHhcccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeec
Q 005731 594 KSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (680)
Q Consensus 594 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 660 (680)
++|.+++.... ....++++++..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985421 1234788999999999999999999887 9999999999999999999999999
Q ss_pred ccee
Q 005731 661 LARM 664 (680)
Q Consensus 661 la~~ 664 (680)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=196.46 Aligned_cols=149 Identities=36% Similarity=0.628 Sum_probs=126.3
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCc----EEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQ----EVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~----~VAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
++|+..+.||+|+||.||++.. .+++ .||+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 5678889999999999999974 3444 578898875432 3345789999999999999999999998754 5779
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999987432 335788899999999999999999987 9999999999999999999999999999775
Q ss_pred C
Q 005731 667 G 667 (680)
Q Consensus 667 ~ 667 (680)
.
T Consensus 161 ~ 161 (303)
T cd05110 161 G 161 (303)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=216.64 Aligned_cols=157 Identities=24% Similarity=0.384 Sum_probs=129.8
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKI 585 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 585 (680)
..++|++.+.||+|+||.||++.. ..++.+|+|.+... .......|..|+.++..++||||+++++++... ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 346899999999999999999985 45778999988643 233456789999999999999999999988654 4689
Q ss_pred EEEEccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceEeCCCCCCcEEEcC----------
Q 005731 586 LILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSR----LRIIHRDLKASNVLLDK---------- 650 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~iiHrDlkp~NILl~~---------- 650 (680)
|||||+++++|..+|.... ....+++..++.|+.||+.||+|||..+. .+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999885422 23468999999999999999999998431 34999999999999964
Q ss_pred -------CCCeEEeeeccceecCC
Q 005731 651 -------DMNPKISDFGLARMFGG 667 (680)
Q Consensus 651 -------~~~~kl~DFGla~~~~~ 667 (680)
...+||+|||+++.+..
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred cccccCCCCceEEccCCccccccc
Confidence 23489999999987643
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=190.71 Aligned_cols=146 Identities=33% Similarity=0.585 Sum_probs=127.5
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
++|++.+.||+|+||.||++. ..++.||+|.+... ...+.+.+|+.++.+++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~-~~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE-YTGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEecc-cCCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 468889999999999999997 46788999998643 2346789999999999999999999998654 5799999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 99999998543 2335788999999999999999999887 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=197.54 Aligned_cols=144 Identities=29% Similarity=0.451 Sum_probs=127.6
Q ss_pred eeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCC
Q 005731 517 MQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKS 595 (680)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 595 (680)
....||+|+||.||++.. .+++.||+|.+........+.+.+|+.++..++||||+++++.+..++..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 345799999999999985 4688999999875444456778899999999999999999999999999999999999999
Q ss_pred hhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 596 LDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|..++. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 105 L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 105 LTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred HHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 988762 245789999999999999999999887 99999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-21 Score=206.95 Aligned_cols=155 Identities=32% Similarity=0.477 Sum_probs=129.3
Q ss_pred eeeeccCCceeEEEEEE-cCCcEEEEEEcc----CCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe--EEEEEEc
Q 005731 518 QCKLGEGGFGPVYKGRL-FNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE--KILILEY 590 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~----~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~Ey 590 (680)
.++||+|+|-+||+|.. .+|-+||--.++ ...+..+++|..|+++|+.|+||||++++.++.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 37999999999999973 447777743332 1245567899999999999999999999999987665 7789999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-CCCeEEeeeccceecCCCc
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~ 669 (680)
|..|+|..|+.+ -+.+..+.+..+++||++||.|||++. +||||||||-+||+|+. -|.|||.|+|||+++....
T Consensus 125 ~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999843 356788899999999999999999985 79999999999999985 5899999999999986654
Q ss_pred cccCccccccC
Q 005731 670 LQGNTKRIVGT 680 (680)
Q Consensus 670 ~~~~~~~~~Gt 680 (680)
. .+++||
T Consensus 201 a----ksvIGT 207 (632)
T KOG0584|consen 201 A----KSVIGT 207 (632)
T ss_pred c----ceeccC
Confidence 3 246776
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=193.07 Aligned_cols=149 Identities=28% Similarity=0.376 Sum_probs=132.4
Q ss_pred CcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
+|++.+.||.|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999854 58899999987532 2346789999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|+++++|..++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999998843 246889999999999999999999887 999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-20 Score=189.51 Aligned_cols=150 Identities=30% Similarity=0.438 Sum_probs=134.5
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.+.||+|++|.||++... +++.|+||++..... ...+++.+|+.++.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999865 589999999876433 4467899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+++++|.+++.. ...+++..+..++.|+++||+|||+ .+ ++|+||+|+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999843 2568899999999999999999998 77 999999999999999999999999999977543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-20 Score=191.51 Aligned_cols=150 Identities=31% Similarity=0.545 Sum_probs=125.5
Q ss_pred cceeeeeccCCceeEEEEEEc----CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 005731 515 FSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------ 582 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 582 (680)
|++.+.||+|+||.||+|... .++.||||.+... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999743 3688999998753 2334667899999999999999999999887543
Q ss_pred eEEEEEEccCCCChhhHhcccc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeee
Q 005731 583 EKILILEYMPNKSLDVYLFDPI---KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 659 (680)
..++++||+++|+|..++.... ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988764321 1235788889999999999999999887 999999999999999999999999
Q ss_pred ccceecCC
Q 005731 660 GLARMFGG 667 (680)
Q Consensus 660 Gla~~~~~ 667 (680)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05074 158 GLSKKIYS 165 (273)
T ss_pred cccccccC
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=191.77 Aligned_cols=148 Identities=26% Similarity=0.481 Sum_probs=131.0
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcC---CCceeeEEEEEEeCCeEEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQ---HRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 588 (680)
.|+..+.||+|+||.||+|.. .+++.+|||.+... ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999985 56889999998653 3344567889999999997 999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++++|.+++.. ..+++.....++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988732 36889999999999999999999887 999999999999999999999999999887543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-20 Score=189.61 Aligned_cols=150 Identities=39% Similarity=0.630 Sum_probs=130.3
Q ss_pred cceeeeeccCCceeEEEEEEcC-----CcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 515 FSMQCKLGEGGFGPVYKGRLFN-----GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~~~-----~~~VAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
|++.+.||+|+||.||++.... +..||+|.+...... ..+.+..|++++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566899999999999998543 388999999764333 5678999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999884322 112899999999999999999999887 999999999999999999999999999877543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=189.76 Aligned_cols=149 Identities=30% Similarity=0.489 Sum_probs=133.6
Q ss_pred cCCcceeeeeccCCceeEEEEEEcC-CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.++|++.+.||+|+||.||++.... ++.+++|.+..... .+++.+|++++++++||||+++++.+......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678889999999999999998654 78999999875422 67899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+..
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 999999998843 2356899999999999999999999887 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-20 Score=188.41 Aligned_cols=150 Identities=25% Similarity=0.432 Sum_probs=131.4
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+|++.+.||+|+||.||++.. .+++.||+|.+... .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588899999999999999974 46889999998642 233456889999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++++|.+++... ....+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999998887432 2235788899999999999999999887 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-20 Score=190.30 Aligned_cols=148 Identities=32% Similarity=0.513 Sum_probs=128.3
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC-----CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEK 584 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 584 (680)
.+|++.+.||+|+||.||+++. .+++.||+|.+... ..+..+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5789999999999999999984 46889999987532 223456789999999999999999999998764 457
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999988732 345788889999999999999999887 99999999999999999999999999986
Q ss_pred cC
Q 005731 665 FG 666 (680)
Q Consensus 665 ~~ 666 (680)
+.
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 63
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=195.00 Aligned_cols=147 Identities=29% Similarity=0.453 Sum_probs=129.4
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++.+......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 466678899999999999974 457899999987432 334567899999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++++|.+++. ...+.+..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999988873 245788999999999999999999887 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-20 Score=193.03 Aligned_cols=150 Identities=28% Similarity=0.429 Sum_probs=131.1
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|++.+.||+|+||.||++... +++.||||+++.. .....+.+.+|++++++++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999854 5889999998753 23345788999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|++++.+..++. +...+++.++..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877766552 2345789999999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-21 Score=191.91 Aligned_cols=161 Identities=30% Similarity=0.339 Sum_probs=135.2
Q ss_pred cCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCcc---cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQ---GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|..+++||+|.||.|..++ ..+++.+|||++++.... ....-+.|-++|.+.+||.+..|--.++..++++.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3678888999999999999997 456899999999875332 334457799999999999999998888999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||..||.|.-+| .+...+.++....+-..|..||.|||+.+ ||.||||.+|+|||.+|++||+||||++.-..
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999998777 44566777766677888999999999987 99999999999999999999999999985332
Q ss_pred CccccCccccccC
Q 005731 668 DELQGNTKRIVGT 680 (680)
Q Consensus 668 ~~~~~~~~~~~Gt 680 (680)
. .+.+.++|||
T Consensus 321 ~--g~t~kTFCGT 331 (516)
T KOG0690|consen 321 Y--GDTTKTFCGT 331 (516)
T ss_pred c--cceeccccCC
Confidence 2 2345568887
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-20 Score=188.75 Aligned_cols=142 Identities=38% Similarity=0.599 Sum_probs=122.9
Q ss_pred eeeccCCceeEEEEEEc-C---CcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRLF-N---GQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~-~---~~~VAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
++||+|+||.||+|... . +..+|+|.+..... ...+++.+|+.+++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999632 2 26899999875433 24567999999999999999999999875 5578999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeec
Confidence 999999843 236789999999999999999999887 99999999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=184.14 Aligned_cols=142 Identities=18% Similarity=0.182 Sum_probs=109.0
Q ss_pred eeeeccCCceeEEEEEEcCCcEEEEEEccCCCcc--c-------HHHH-----------------HHHHHHHhhcCCCce
Q 005731 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ--G-------LKEF-----------------KNEMMLIAELQHRNL 571 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~--~-------~~~f-----------------~~E~~~l~~l~H~ni 571 (680)
.+.||+|+||.||+|...+|+.||||+++..... . ...| ..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3689999999999999778999999999753211 1 1122 349999999987776
Q ss_pred eeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEeCCCCCCcEEEcC
Q 005731 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL-HQYSRLRIIHRDLKASNVLLDK 650 (680)
Q Consensus 572 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHrDlkp~NILl~~ 650 (680)
.....+.. ...+|||||++++++..... ....++.++...++.|++.+|.|+ |..+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 43332222 23489999999887754431 234678889999999999999999 6777 99999999999998
Q ss_pred CCCeEEeeeccceecCCC
Q 005731 651 DMNPKISDFGLARMFGGD 668 (680)
Q Consensus 651 ~~~~kl~DFGla~~~~~~ 668 (680)
++.++|+|||+|...+..
T Consensus 153 ~~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 153 DGKLYIIDVSQSVEHDHP 170 (190)
T ss_pred CCcEEEEEccccccCCCc
Confidence 478999999999866443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-20 Score=193.24 Aligned_cols=150 Identities=29% Similarity=0.417 Sum_probs=127.1
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCe-----
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGE----- 583 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~----- 583 (680)
++|++.+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688999999999999999985 468899999876432 22346788999999999 56999999999987665
Q ss_pred EEEEEEccCCCChhhHhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-CCCeEEeeec
Q 005731 584 KILILEYMPNKSLDVYLFDPIK--KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFG 660 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFG 660 (680)
.++||||+++ +|..++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 78887754322 346789999999999999999999887 999999999999998 8899999999
Q ss_pred cceecC
Q 005731 661 LARMFG 666 (680)
Q Consensus 661 la~~~~ 666 (680)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.6e-20 Score=187.27 Aligned_cols=150 Identities=28% Similarity=0.434 Sum_probs=129.3
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-CeEEEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-GEKILILE 589 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E 589 (680)
+|++.+.||+|++|.||++.. .+++.+|+|++... .....+.+.+|++++++++|+|++++.+.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488899999999999999984 45789999998643 223456789999999999999999999887643 46789999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+++++|.+++... ....+++.++..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999888542 3346899999999999999999999987 99999999999999999999999999987743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=191.48 Aligned_cols=149 Identities=28% Similarity=0.432 Sum_probs=132.7
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.+.||.|++|.||+|.. .+++.||+|.+.... ......+.+|+++++.++|+|++++.+++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3678889999999999999985 468899999987542 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999988743 26889999999999999999999887 999999999999999999999999999887543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.7e-20 Score=190.39 Aligned_cols=147 Identities=29% Similarity=0.449 Sum_probs=129.7
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
-|+..+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.++.+++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 366778999999999999975 468899999886432 234567899999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++++|..++. ...+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 9999998873 245789999999999999999999887 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.5e-20 Score=194.27 Aligned_cols=144 Identities=28% Similarity=0.461 Sum_probs=117.9
Q ss_pred eeeccCCceeEEEEEEc---CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe--CCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRLF---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE--QGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~ 593 (680)
.+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 58999999999999854 35789999987532 23567899999999999999999999864 4578999999875
Q ss_pred CChhhHhccc------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE----cCCCCeEEeeeccce
Q 005731 594 KSLDVYLFDP------IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLAR 663 (680)
Q Consensus 594 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla~ 663 (680)
+|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 666655321 12235788889999999999999999987 9999999999999 566789999999999
Q ss_pred ecCCC
Q 005731 664 MFGGD 668 (680)
Q Consensus 664 ~~~~~ 668 (680)
.+...
T Consensus 161 ~~~~~ 165 (317)
T cd07867 161 LFNSP 165 (317)
T ss_pred ccCCC
Confidence 77543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-20 Score=203.87 Aligned_cols=169 Identities=28% Similarity=0.470 Sum_probs=144.4
Q ss_pred HHHHHHhcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEe--
Q 005731 505 LASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE-- 580 (680)
Q Consensus 505 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~-- 580 (680)
+..+...++.|++.++||.|.+|.||+++ .++++.+|||++... ....++...|..+++.. +|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34445567889999999999999999997 567899999998763 34456778888888887 79999999999875
Q ss_pred ---CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEe
Q 005731 581 ---QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (680)
Q Consensus 581 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 657 (680)
++++|||||||.+||..+++.... ...+.|+.+..|+..+++||.+||... +||||||-.||||+.++.|||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 468999999999999999886544 667899999999999999999999876 9999999999999999999999
Q ss_pred eeccceecCCCccccCccccccC
Q 005731 658 DFGLARMFGGDELQGNTKRIVGT 680 (680)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~Gt 680 (680)
|||+++.++.. ....++.+||
T Consensus 166 DFGvSaQldsT--~grRnT~iGt 186 (953)
T KOG0587|consen 166 DFGVSAQLDST--VGRRNTFIGT 186 (953)
T ss_pred eeeeeeeeecc--cccccCcCCC
Confidence 99999987554 3455667887
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=189.80 Aligned_cols=143 Identities=31% Similarity=0.547 Sum_probs=120.8
Q ss_pred eeeccCCceeEEEEEEc----CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe-CCeEEEEEEccC
Q 005731 519 CKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE-QGEKILILEYMP 592 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~~ 592 (680)
+.||+|+||.||+|... ....||+|++... .....+.+.+|+.+++.++||||+++++++.. +...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999743 2357999998643 23446788999999999999999999998764 456889999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+++|.+++... .....+..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999998432 234577788899999999999999887 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-21 Score=195.98 Aligned_cols=154 Identities=27% Similarity=0.346 Sum_probs=135.9
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
+.|+.-++||+|+||.||-+.. .+|+.+|.|++.+. ..++....++|-.+|.+++.+.||.|--.+...+.+++||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 5688889999999999999874 56999999988653 2345566789999999999999999988889999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
..|.||+|.-+|+.... ..+++..++-++.+|+.||++||.+. ||.|||||+|||||+.|+++|+|.|||.-+...
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999988866433 57899999999999999999999887 999999999999999999999999999998766
Q ss_pred cc
Q 005731 669 EL 670 (680)
Q Consensus 669 ~~ 670 (680)
+.
T Consensus 341 ~~ 342 (591)
T KOG0986|consen 341 KP 342 (591)
T ss_pred Cc
Confidence 54
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=190.65 Aligned_cols=148 Identities=28% Similarity=0.441 Sum_probs=130.8
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
..|+..+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+++++++.||||+++++++......++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3567778999999999999985 458899999987532 34467789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++++|.+++. ...+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999998873 235788889999999999999999887 99999999999999999999999999987754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=193.37 Aligned_cols=144 Identities=29% Similarity=0.437 Sum_probs=123.0
Q ss_pred eeeccCCceeEEEEEEcC--------CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 519 CKLGEGGFGPVYKGRLFN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~--------~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+.||+|+||.||+|.... ..++|+|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997432 235888888765445567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC--------eEEeeeccc
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN--------PKISDFGLA 662 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~kl~DFGla 662 (680)
+++|+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998542 235788999999999999999999887 999999999999987765 699999998
Q ss_pred eecCC
Q 005731 663 RMFGG 667 (680)
Q Consensus 663 ~~~~~ 667 (680)
.....
T Consensus 156 ~~~~~ 160 (258)
T cd05078 156 ITVLP 160 (258)
T ss_pred cccCC
Confidence 76543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-20 Score=208.66 Aligned_cols=152 Identities=22% Similarity=0.377 Sum_probs=119.1
Q ss_pred cCCcceeeeeccCCceeEEEEEEcC--CcEEEEE------------------EccCCCcccHHHHHHHHHHHhhcCCCce
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFN--GQEVAVK------------------RLSSQSGQGLKEFKNEMMLIAELQHRNL 571 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~--~~~VAVK------------------~l~~~~~~~~~~f~~E~~~l~~l~H~ni 571 (680)
.++|++.++||+|+||.||++.... +...++| .+.. .......+.+|++++.+++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCc
Confidence 4689999999999999999986432 2222222 1111 12235578899999999999999
Q ss_pred eeEEEEEEeCCeEEEEEEccCCCChhhHhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc
Q 005731 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIK--KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (680)
Q Consensus 572 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 649 (680)
+++++++...+..++|+|++. ++|..++..... ...........|+.||+.||+|||+.+ ||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999985 566666543211 122335567789999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccceecCCC
Q 005731 650 KDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 650 ~~~~~kl~DFGla~~~~~~ 668 (680)
.++.+||+|||+++.+...
T Consensus 302 ~~~~vkL~DFGla~~~~~~ 320 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKE 320 (501)
T ss_pred CCCCEEEEeCCCceecCcc
Confidence 9999999999999987543
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.2e-20 Score=185.51 Aligned_cols=149 Identities=34% Similarity=0.516 Sum_probs=132.9
Q ss_pred CcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+|++.+.||+|++|.||++... +++.+++|.+..... ...+.+.+|++++.+++|||++++++++..+...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999754 578999999976433 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999998833 356899999999999999999999887 999999999999999999999999999977543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=192.33 Aligned_cols=148 Identities=31% Similarity=0.525 Sum_probs=129.0
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+|+..+.||+|++|.||+|+. .+++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478889999999999999985 468899999986432 22346789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+. ++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 96 6888887432 3356889999999999999999999887 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-20 Score=225.75 Aligned_cols=142 Identities=27% Similarity=0.498 Sum_probs=122.0
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
..|...+.||+|+||.||+|+. .+++.||||+++..... ...|++++++++||||++++|+|.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4567778999999999999985 57899999998753321 134688999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
++|+|.+++. .++|.++.+|+.||++||+|||..+..+|+||||||+||+++.++.+++. ||++...
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 9999999983 37899999999999999999997656679999999999999999988876 7766543
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=202.02 Aligned_cols=154 Identities=33% Similarity=0.517 Sum_probs=132.1
Q ss_pred eeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCChhh
Q 005731 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDV 598 (680)
Q Consensus 520 ~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 598 (680)
+||+|.||+||-|+ +.+...+|||.+.....+...-+..|+.+-+.++|.|||+++|.+.+++..-|.||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999998 45566899999987766677778899999999999999999999999999999999999999999
Q ss_pred HhcccccCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc-CCCCeEEeeeccceecCCCccccCcc
Q 005731 599 YLFDPIKKRLL--DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMFGGDELQGNTK 675 (680)
Q Consensus 599 ~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~ 675 (680)
.|.. +-+++ .+.++-.+-+||++||.|||++. |||||||-+|+|++ -.|.+||+|||-++.+.+=. ..|.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--cccc
Confidence 9843 44555 56677788999999999999987 99999999999997 57899999999999885432 2344
Q ss_pred ccccC
Q 005731 676 RIVGT 680 (680)
Q Consensus 676 ~~~Gt 680 (680)
++.||
T Consensus 735 TFTGT 739 (1226)
T KOG4279|consen 735 TFTGT 739 (1226)
T ss_pred ccccc
Confidence 56665
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=193.72 Aligned_cols=148 Identities=31% Similarity=0.496 Sum_probs=127.9
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+|++.+.||+|+||.||+++. .+|+.+|+|++.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999985 468899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++ ++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 97 5777766332 345899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=192.56 Aligned_cols=150 Identities=29% Similarity=0.436 Sum_probs=128.9
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 587 (680)
++|++.+.||+|+||.||+|... +++.+|+|.++... ......+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999854 58899999987432 22334677899999999999999999999877 889999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+. ++|.+.+... ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 4888877432 236899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 005731 668 D 668 (680)
Q Consensus 668 ~ 668 (680)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.1e-20 Score=191.91 Aligned_cols=149 Identities=32% Similarity=0.483 Sum_probs=128.2
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.+.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+++.+|++++++++||||+++.+++...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35688889999999999999985 468899999886432 23345788999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|||++ |++.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++...
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99997 566665532 2345889999999999999999999887 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-20 Score=190.69 Aligned_cols=156 Identities=28% Similarity=0.460 Sum_probs=131.6
Q ss_pred HHHHHhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEe---
Q 005731 506 ASVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE--- 580 (680)
Q Consensus 506 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~--- 580 (680)
.++..+.+.|++.+.||+|+||.||+|.. .+++.+|+|.+... .....++..|+.++.++ +||||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 34444567899999999999999999985 56889999998653 23456788999999998 79999999999863
Q ss_pred ---CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEe
Q 005731 581 ---QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (680)
Q Consensus 581 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 657 (680)
....+++|||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence 45789999999999999888442 2345778888899999999999999987 9999999999999999999999
Q ss_pred eeccceecC
Q 005731 658 DFGLARMFG 666 (680)
Q Consensus 658 DFGla~~~~ 666 (680)
|||+++...
T Consensus 164 dfg~~~~~~ 172 (282)
T cd06636 164 DFGVSAQLD 172 (282)
T ss_pred eCcchhhhh
Confidence 999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.8e-20 Score=186.15 Aligned_cols=150 Identities=28% Similarity=0.455 Sum_probs=130.4
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+|+..+.||+|++|.||++.. .+++.+|||.+... .....+++.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 578889999999999999974 56889999998653 233467899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC-CCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~~~~ 667 (680)
+++++|.+++... ....+++..+..++.+++++|+|||+.+ ++|+||||+||+++++ ..+||+|||+++.+..
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999998542 2345788999999999999999999987 9999999999999855 4689999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-21 Score=217.26 Aligned_cols=168 Identities=26% Similarity=0.289 Sum_probs=140.1
Q ss_pred HHHHHhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC
Q 005731 506 ASVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ 581 (680)
Q Consensus 506 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 581 (680)
.++.-..++|.+.++||+|+||.|..+++ .+++.+|+|++++. .......|..|-.+|..-+.+=|+.|.-.|++.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 34455568999999999999999999986 45788999999863 223345688888899888888899999999999
Q ss_pred CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecc
Q 005731 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 661 (680)
.++|+|||||+||+|-..|.+ ...++++-...++..|..||.-||+.+ +|||||||+|||||..|++||||||-
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999998833 336788877788889999999999877 99999999999999999999999999
Q ss_pred ceecCCCccccCccccccC
Q 005731 662 ARMFGGDELQGNTKRIVGT 680 (680)
Q Consensus 662 a~~~~~~~~~~~~~~~~Gt 680 (680)
+-.+..+.... ....+||
T Consensus 222 Clkm~~dG~V~-s~~aVGT 239 (1317)
T KOG0612|consen 222 CLKMDADGTVR-SSVAVGT 239 (1317)
T ss_pred HHhcCCCCcEE-eccccCC
Confidence 98887665432 2235666
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.9e-20 Score=189.27 Aligned_cols=152 Identities=30% Similarity=0.471 Sum_probs=131.8
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC------
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG------ 582 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~------ 582 (680)
++++|++.+.||+|++|.||+|... +++.+++|.+.... ...+++.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5678999999999999999999864 57899999987543 3456799999999999 7999999999997644
Q ss_pred eEEEEEEccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecc
Q 005731 583 EKILILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 661 (680)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999998875422 2456889999999999999999999887 99999999999999999999999999
Q ss_pred ceecC
Q 005731 662 ARMFG 666 (680)
Q Consensus 662 a~~~~ 666 (680)
+....
T Consensus 160 ~~~~~ 164 (275)
T cd06608 160 SAQLD 164 (275)
T ss_pred ceecc
Confidence 98654
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.3e-20 Score=178.29 Aligned_cols=143 Identities=20% Similarity=0.238 Sum_probs=112.4
Q ss_pred eeeeccCCceeEEEEEEcCCcEEEEEEccCCCcc--c------------------------HHHHHHHHHHHhhcCCCce
Q 005731 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ--G------------------------LKEFKNEMMLIAELQHRNL 571 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~--~------------------------~~~f~~E~~~l~~l~H~ni 571 (680)
.+.||+|++|+||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998753211 0 1224678999999999987
Q ss_pred eeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCcEEEcC
Q 005731 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDK 650 (680)
Q Consensus 572 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~ 650 (680)
.....+... ..+|||||++++++.... .....++..+...++.|++.+|.++|. .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~---l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPR---LKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhh---hhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443332 348999999988654332 122456778889999999999999999 77 99999999999998
Q ss_pred CCCeEEeeeccceecCCCc
Q 005731 651 DMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 651 ~~~~kl~DFGla~~~~~~~ 669 (680)
++.++|+|||+|+.+....
T Consensus 153 ~~~~~liDFG~a~~~~~~~ 171 (190)
T cd05145 153 DGKPYIIDVSQAVELDHPN 171 (190)
T ss_pred CCCEEEEEcccceecCCCC
Confidence 8899999999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5e-20 Score=203.37 Aligned_cols=153 Identities=25% Similarity=0.401 Sum_probs=120.3
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-----------------cCCcEEEEEEccCCCcccHHH--------------HHHH
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-----------------FNGQEVAVKRLSSQSGQGLKE--------------FKNE 559 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-----------------~~~~~VAVK~l~~~~~~~~~~--------------f~~E 559 (680)
..++|++.++||+|+||.||+|.. ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999963 235689999987533222223 3457
Q ss_pred HHHHhhcCCCce-----eeEEEEEEe--------CCeEEEEEEccCCCChhhHhcccc---------------------c
Q 005731 560 MMLIAELQHRNL-----VRILGCCVE--------QGEKILILEYMPNKSLDVYLFDPI---------------------K 605 (680)
Q Consensus 560 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~ 605 (680)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788876654 677787753 356899999999999999886321 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 606 KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 606 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 123467788899999999999999887 9999999999999999999999999997653
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.6e-20 Score=204.00 Aligned_cols=151 Identities=21% Similarity=0.311 Sum_probs=121.3
Q ss_pred HHHHhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCC------CceeeEEEEEE
Q 005731 507 SVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH------RNLVRILGCCV 579 (680)
Q Consensus 507 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H------~niv~l~g~~~ 579 (680)
++...+++|++.++||+|+||.||++.. ..++.||||+++.. ....+++..|++++..++| ++++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3445568899999999999999999985 45789999999653 2234556677777777655 45888988887
Q ss_pred eC-CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeCCCCCCcEEEcCCC-----
Q 005731 580 EQ-GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDM----- 652 (680)
Q Consensus 580 ~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~----- 652 (680)
.. .+.++|||++ +++|.+++.+ ...+.+..+..|+.||+.||+|||.+ + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 64 4788999987 6788777743 34688999999999999999999974 5 99999999999998765
Q ss_pred -----------CeEEeeeccceec
Q 005731 653 -----------NPKISDFGLARMF 665 (680)
Q Consensus 653 -----------~~kl~DFGla~~~ 665 (680)
.+||+|||++...
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred ccccccCCCCceEEECCCCccccC
Confidence 4999999988643
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-19 Score=182.30 Aligned_cols=150 Identities=33% Similarity=0.555 Sum_probs=134.3
Q ss_pred CcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777899999999999999864 688999999986544567789999999999999999999999999999999999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999887432 246899999999999999999999877 999999999999999999999999999887554
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=189.45 Aligned_cols=151 Identities=28% Similarity=0.397 Sum_probs=129.5
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 588 (680)
++|+..+.||.|++|.||++.. .+++.+|+|.+.... ....+++.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3688889999999999999986 458899999987532 23467799999999999999999999998654 3689999
Q ss_pred EccCCCChhhHhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 589 EYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||+++++|.+++... .....++...+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999998876432 22345788889999999999999999987 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-20 Score=213.90 Aligned_cols=150 Identities=34% Similarity=0.508 Sum_probs=121.8
Q ss_pred HHhcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-----
Q 005731 509 AAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ----- 581 (680)
Q Consensus 509 ~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~----- 581 (680)
.+...+|+..+.||+||||.||+++ .-||+.+|||++... .......+.+|+.++++|+|||||+++..+++.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4456789999999999999999998 458999999999754 334466788999999999999999987654320
Q ss_pred --------------------------------------------------------------------------------
Q 005731 582 -------------------------------------------------------------------------------- 581 (680)
Q Consensus 582 -------------------------------------------------------------------------------- 581 (680)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEEccCCCChhhHhcccccCCCC-CHHHHHHHHHHHHHHHH
Q 005731 582 ----------------------------------GEKILILEYMPNKSLDVYLFDPIKKRLL-DWEARIRIIQGIAQGLL 626 (680)
Q Consensus 582 ----------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l-~~~~~~~i~~~ia~~L~ 626 (680)
..+||=||||+...|+.++.+. ... .....++++.+|+.||+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHH
Confidence 0135667888777777666332 111 35677899999999999
Q ss_pred HHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 627 yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
|+|+.+ ||||||||.||+||++..|||.|||+|.-
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 999998 99999999999999999999999999987
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=187.31 Aligned_cols=153 Identities=29% Similarity=0.469 Sum_probs=128.0
Q ss_pred CcceeeeeccCCceeEEEEEEcC--CcEEEEEEccCC----------CcccHHHHHHHHHHHhh-cCCCceeeEEEEEEe
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLFN--GQEVAVKRLSSQ----------SGQGLKEFKNEMMLIAE-LQHRNLVRILGCCVE 580 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~~--~~~VAVK~l~~~----------~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~ 580 (680)
+|++.+.||+|+||.||++.... ++.+|||.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778999999999999998654 688999987532 12234567789988875 799999999999999
Q ss_pred CCeEEEEEEccCCCChhhHhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeee
Q 005731 581 QGEKILILEYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659 (680)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 659 (680)
.+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+.. +++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999998887432 23346888999999999999999999632 3999999999999999999999999
Q ss_pred ccceecCCC
Q 005731 660 GLARMFGGD 668 (680)
Q Consensus 660 Gla~~~~~~ 668 (680)
|++......
T Consensus 159 g~~~~~~~~ 167 (269)
T cd08528 159 GLAKQKQPE 167 (269)
T ss_pred cceeecccc
Confidence 999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-19 Score=183.04 Aligned_cols=150 Identities=33% Similarity=0.498 Sum_probs=133.5
Q ss_pred CcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKILIL 588 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 588 (680)
+|+..+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999865 688999999875432 4567899999999999999999999999988 8899999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999998843 237899999999999999999999977 999999999999999999999999999987554
Q ss_pred c
Q 005731 669 E 669 (680)
Q Consensus 669 ~ 669 (680)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.7e-20 Score=186.43 Aligned_cols=156 Identities=27% Similarity=0.470 Sum_probs=130.3
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe--CCeEEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE--QGEKILIL 588 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 588 (680)
+|++.+.||.|+||.||++.. .+++.+|+|.+... .....+++.+|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999974 56789999998643 23345678899999999999999999998764 34679999
Q ss_pred EccCCCChhhHhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYS--RLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
||+++++|.+++... .....+++..++.++.|++.||+|||..+ ..+++|+||||+||+++.++.+||+|||+++.+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999988543 22456899999999999999999999332 234999999999999999999999999999987
Q ss_pred CCCc
Q 005731 666 GGDE 669 (680)
Q Consensus 666 ~~~~ 669 (680)
....
T Consensus 161 ~~~~ 164 (265)
T cd08217 161 GHDS 164 (265)
T ss_pred cCCc
Confidence 5443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=188.11 Aligned_cols=141 Identities=29% Similarity=0.357 Sum_probs=117.6
Q ss_pred eeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHh---hcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 520 KLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIA---ELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 520 ~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~---~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
.||+|+||.||++.. .+++.+|||.+.... ......+.+|..++. ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999985 458899999886432 122233445544433 3479999999999999999999999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++..+.
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 999998874 3346899999999999999999999987 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.4e-20 Score=188.81 Aligned_cols=149 Identities=28% Similarity=0.382 Sum_probs=131.3
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|+..+.||+|++|.||++... +++.+|+|.+.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999864 58899999987643 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+++++|.+++.... ..++...+..++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||++..+.
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999884322 567888999999999999999998 66 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-20 Score=188.19 Aligned_cols=140 Identities=27% Similarity=0.425 Sum_probs=124.9
Q ss_pred eccCCceeEEEEEEc-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCCh
Q 005731 521 LGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (680)
Q Consensus 521 LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (680)
||+|+||.||+++.. +++.+++|.+..... ...+.+.+|++++.+++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999865 489999999875432 3466789999999999999999999999999999999999999999
Q ss_pred hhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
.+++.+ ...+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~ 144 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGL 144 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence 998843 236889999999999999999999887 9999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=187.54 Aligned_cols=148 Identities=32% Similarity=0.521 Sum_probs=129.0
Q ss_pred cceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEEEEE
Q 005731 515 FSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKILILE 589 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 589 (680)
|++.+.||+|++|.||++... +++.+|+|++.... ....+.+.+|++++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567899999999999999854 58899999997642 33456788999999999999999999999988 78999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|+++ +|.+++... ...+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 888877432 246889999999999999999999987 999999999999999999999999999977554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=188.46 Aligned_cols=142 Identities=30% Similarity=0.395 Sum_probs=123.9
Q ss_pred eccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCCh
Q 005731 521 LGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (680)
Q Consensus 521 LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (680)
||+|+||.||++.. .+++.+|+|.+.... ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999974 468899999986432 22345678899999999999999999999999999999999999999
Q ss_pred hhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
.+++.... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 99885432 236788999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.2e-20 Score=191.09 Aligned_cols=152 Identities=29% Similarity=0.482 Sum_probs=128.8
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC----
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG---- 582 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~---- 582 (680)
...++|++.+.||+|+||.||+|... +++.||||+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999864 58899999986432 223456788999999999999999999987654
Q ss_pred ------eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEE
Q 005731 583 ------EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656 (680)
Q Consensus 583 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 656 (680)
..++|+||+++ ++...+.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 66666532 2346889999999999999999999987 999999999999999999999
Q ss_pred eeeccceecCC
Q 005731 657 SDFGLARMFGG 667 (680)
Q Consensus 657 ~DFGla~~~~~ 667 (680)
+|||+++.+..
T Consensus 158 ~dfg~~~~~~~ 168 (302)
T cd07864 158 ADFGLARLYNS 168 (302)
T ss_pred CcccccccccC
Confidence 99999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=187.71 Aligned_cols=146 Identities=26% Similarity=0.423 Sum_probs=129.0
Q ss_pred cceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44447999999999999984 56889999998754444566789999999999999999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||+++....
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 999988743 45788999999999999999999987 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.6e-20 Score=188.71 Aligned_cols=145 Identities=39% Similarity=0.571 Sum_probs=124.1
Q ss_pred eeeccCCceeEEEEEEcC-------CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 519 CKLGEGGFGPVYKGRLFN-------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~-------~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+.||+|+||.||+|+..+ ++.+|||.+.... .....+|.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997532 2579999886532 23466889999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC-----CeEEeeecc
Q 005731 591 MPNKSLDVYLFDPI----KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-----NPKISDFGL 661 (680)
Q Consensus 591 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~kl~DFGl 661 (680)
+++++|.+++.+.. ....+.+.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999985432 2234788999999999999999999877 99999999999999877 899999999
Q ss_pred ceecC
Q 005731 662 ARMFG 666 (680)
Q Consensus 662 a~~~~ 666 (680)
++.+.
T Consensus 158 ~~~~~ 162 (269)
T cd05044 158 ARDIY 162 (269)
T ss_pred ccccc
Confidence 98653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=185.63 Aligned_cols=141 Identities=28% Similarity=0.379 Sum_probs=125.1
Q ss_pred eccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCCh
Q 005731 521 LGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (680)
Q Consensus 521 LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (680)
||.|++|.||+++.. +++.+|+|.+.... ....+.+.+|+.++++++||||+++++.+.++...+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999854 48899999986532 23456799999999999999999999999999999999999999999
Q ss_pred hhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
.+++.+ ...++...+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 999843 345788999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-19 Score=187.36 Aligned_cols=149 Identities=30% Similarity=0.483 Sum_probs=125.9
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|++.+.||+|++|.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5789999999999999999985 468899999986432 2334678899999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-CCCeEEeeeccceecC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFG 666 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~ 666 (680)
|++ ++|.+++... ....+++.....++.||+.||+|||+.+ ++|+||+|+||++++ ++.+||+|||+++.+.
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 5777776332 2233577888899999999999999887 999999999999985 5679999999998664
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-20 Score=189.85 Aligned_cols=150 Identities=33% Similarity=0.489 Sum_probs=132.9
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 587 (680)
++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999854 6899999998652 2233567889999999998 99999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999998843 346899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 005731 668 D 668 (680)
Q Consensus 668 ~ 668 (680)
.
T Consensus 155 ~ 155 (280)
T cd05581 155 N 155 (280)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=193.96 Aligned_cols=148 Identities=28% Similarity=0.451 Sum_probs=126.6
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----eE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-----EK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 584 (680)
.++|++.+.||+|+||.||+|.. .+++.||||.+... .......+.+|+.++.+++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999974 56899999998643 2334567889999999999999999999876543 57
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++++||+.+ +|...+ ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999974 776665 2346889999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 005731 665 FGG 667 (680)
Q Consensus 665 ~~~ 667 (680)
...
T Consensus 156 ~~~ 158 (336)
T cd07849 156 ADP 158 (336)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=187.63 Aligned_cols=151 Identities=30% Similarity=0.478 Sum_probs=134.3
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.++.|+..+.||+|++|.||++... +++.+++|.+..... ..+.+.+|++++++++|+|++++++.+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999865 688999999976433 56788999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999984422 37899999999999999999999877 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=193.55 Aligned_cols=149 Identities=28% Similarity=0.434 Sum_probs=127.8
Q ss_pred hcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG----- 582 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----- 582 (680)
..++|++.+.||+|+||.||++. ..+++.||||++... .....+.+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 45789999999999999999997 456899999998643 2223456889999999999999999999987553
Q ss_pred -eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecc
Q 005731 583 -EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (680)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 661 (680)
..++||||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 458999998 778887763 246889999999999999999999887 99999999999999999999999999
Q ss_pred ceecCC
Q 005731 662 ARMFGG 667 (680)
Q Consensus 662 a~~~~~ 667 (680)
++....
T Consensus 165 ~~~~~~ 170 (343)
T cd07880 165 ARQTDS 170 (343)
T ss_pred cccccc
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=188.84 Aligned_cols=142 Identities=27% Similarity=0.429 Sum_probs=126.7
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCChh
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLD 597 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 597 (680)
.+||+|+||.||++.. .+++.||||++........+.+.+|+.++++++|+|++++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999985 568999999986544445667899999999999999999999999999999999999999998
Q ss_pred hHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 598 VYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++. ...+++.....++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++..+..
T Consensus 106 ~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 106 DIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 8763 235788999999999999999999987 99999999999999999999999999876643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=189.44 Aligned_cols=149 Identities=30% Similarity=0.503 Sum_probs=125.5
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-------
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------- 582 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------- 582 (680)
++|++.++||+|+||.||++.. .+++.||||.+.... ......+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 5799999999999999999985 468899999886432 223345678999999999999999999987654
Q ss_pred -eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecc
Q 005731 583 -EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (680)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 661 (680)
..++||||+.+ +|...+.. ....+++.++..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 35999999964 77777632 2235789999999999999999999987 99999999999999999999999999
Q ss_pred ceecCC
Q 005731 662 ARMFGG 667 (680)
Q Consensus 662 a~~~~~ 667 (680)
+..+..
T Consensus 166 ~~~~~~ 171 (310)
T cd07865 166 ARAFSL 171 (310)
T ss_pred cccccC
Confidence 987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=194.09 Aligned_cols=148 Identities=31% Similarity=0.523 Sum_probs=126.4
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC--CeEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ--GEKI 585 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~ 585 (680)
.++|++.+.||+|+||.||+|... +++.+|||++... .......+.+|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888999999999999999854 5889999988542 223445678899999999 999999999998654 3689
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 588887732 26788889999999999999999987 999999999999999999999999999876
Q ss_pred CC
Q 005731 666 GG 667 (680)
Q Consensus 666 ~~ 667 (680)
..
T Consensus 158 ~~ 159 (337)
T cd07852 158 SE 159 (337)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=188.40 Aligned_cols=148 Identities=28% Similarity=0.372 Sum_probs=128.1
Q ss_pred CcceeeeeccCCceeEEEEEE----cCCcEEEEEEccCCC----cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~----~~~~~VAVK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 584 (680)
+|++.+.||+|++|.||+++. .+++.||||.++... ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999873 356889999986421 22345788999999999 699999999999999999
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||||+++++|.+++.. ...+++..+..++.|++++|.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999988843 345788889999999999999999877 99999999999999999999999999987
Q ss_pred cCC
Q 005731 665 FGG 667 (680)
Q Consensus 665 ~~~ 667 (680)
+..
T Consensus 155 ~~~ 157 (288)
T cd05583 155 FLA 157 (288)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=189.58 Aligned_cols=150 Identities=33% Similarity=0.482 Sum_probs=127.7
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKIL 586 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 586 (680)
.++|++.+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46799999999999999999985 458999999986432 22234567899999999999999999998765 46899
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+.+ +|.+++... ...+++.++..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999974 787777432 256889999999999999999999987 9999999999999999999999999998775
Q ss_pred C
Q 005731 667 G 667 (680)
Q Consensus 667 ~ 667 (680)
.
T Consensus 160 ~ 160 (309)
T cd07845 160 L 160 (309)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.2e-20 Score=194.35 Aligned_cols=148 Identities=25% Similarity=0.421 Sum_probs=127.5
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVE----QGEKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 585 (680)
++|++.+.||+|++|.||++.. .+++.||+|++.... ......+.+|+.++.+++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6899999999999999999984 468999999987532 2345678889999999999999999988753 34689
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+||||+. ++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 85 lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 68888873 3345899999999999999999999987 999999999999999999999999999876
Q ss_pred CC
Q 005731 666 GG 667 (680)
Q Consensus 666 ~~ 667 (680)
..
T Consensus 158 ~~ 159 (334)
T cd07855 158 SS 159 (334)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=193.01 Aligned_cols=147 Identities=32% Similarity=0.436 Sum_probs=125.6
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------C
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------G 582 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 582 (680)
.++|+..+.||+|+||.||++.. .+++.||||.+... ......++.+|+.++.+++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 47899999999999999999984 46899999998642 233456778899999999999999999988643 3
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
..++||||+. ++|...+.. .++...+..++.|++.||+|||..+ |+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 5799999996 477776622 2788888999999999999999987 999999999999999999999999999
Q ss_pred eecCC
Q 005731 663 RMFGG 667 (680)
Q Consensus 663 ~~~~~ 667 (680)
+....
T Consensus 166 ~~~~~ 170 (353)
T cd07850 166 RTAGT 170 (353)
T ss_pred eeCCC
Confidence 87654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=185.21 Aligned_cols=141 Identities=30% Similarity=0.346 Sum_probs=117.7
Q ss_pred eeccCCceeEEEEEE-cCCcEEEEEEccCCCc---ccHHHHHHHHH---HHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 520 KLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG---QGLKEFKNEMM---LIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 520 ~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~---~~~~~f~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
.||+|+||.||++.. .+++.||+|.+..... .....+..|.. ++...+||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999974 4588999999865321 22223444443 4444579999999999999999999999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+++|..++. +...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999988873 3456899999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-20 Score=173.90 Aligned_cols=155 Identities=28% Similarity=0.426 Sum_probs=127.7
Q ss_pred hcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 587 (680)
..+.....+.||+|++|.|-+-+ ..+|..+|||++... ..+..++.++|+.+..+. ..|.+|+++|........++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 33455556789999999998776 467999999999854 334456778888876665 799999999999999999999
Q ss_pred EEccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 588 LEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||.|+ -||+.+-.+.. +...+++.-+-+|+..|.+||.|||++ +.+||||+||+||||+.+|++||+|||++-.+.
T Consensus 124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 99995 58877754332 345677777789999999999999984 579999999999999999999999999998876
Q ss_pred CC
Q 005731 667 GD 668 (680)
Q Consensus 667 ~~ 668 (680)
+.
T Consensus 201 dS 202 (282)
T KOG0984|consen 201 DS 202 (282)
T ss_pred hh
Confidence 54
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.6e-20 Score=195.87 Aligned_cols=145 Identities=25% Similarity=0.400 Sum_probs=127.2
Q ss_pred CCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
.-|..++.||-|+||+|.+++ .++...+|+|.|++.+. ......+.|-.||+..+.+=||+|+-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 357778999999999999997 45567889999986432 33456788999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
||++||++-++| ++.+.++++....++..+..|+++.|.-+ +|||||||+|||||.+|.+||+||||+.
T Consensus 709 dYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 709 DYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred eccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccc
Confidence 999999998888 55667777777778888999999999777 9999999999999999999999999986
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.1e-20 Score=194.22 Aligned_cols=151 Identities=26% Similarity=0.345 Sum_probs=128.2
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc--------ccHHHHHHHHHHHhhcC---CCceeeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAELQ---HRNLVRILGCCV 579 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--------~~~~~f~~E~~~l~~l~---H~niv~l~g~~~ 579 (680)
..+|+..+.+|.|+||.|+.+..+ +..+|+||.+.+... ..+-..-.|+++|+.++ |+||++++++|.
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346899999999999999999854 467899998875321 11223456999999997 999999999999
Q ss_pred eCCeEEEEEEcc-CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEee
Q 005731 580 EQGEKILILEYM-PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISD 658 (680)
Q Consensus 580 ~~~~~~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 658 (680)
+.+..||+||-. ++.+|.+++ ..+..+++.+...|++||+.|+++||+++ |||||||-+|+.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 999999999965 466777777 34567899999999999999999999998 99999999999999999999999
Q ss_pred eccceecCCC
Q 005731 659 FGLARMFGGD 668 (680)
Q Consensus 659 FGla~~~~~~ 668 (680)
||-|......
T Consensus 714 fgsaa~~ksg 723 (772)
T KOG1152|consen 714 FGSAAYTKSG 723 (772)
T ss_pred ccchhhhcCC
Confidence 9999877554
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.2e-19 Score=191.11 Aligned_cols=155 Identities=30% Similarity=0.394 Sum_probs=130.4
Q ss_pred cHHHHHHhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 005731 504 SLASVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVE 580 (680)
Q Consensus 504 ~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 580 (680)
...++...+++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3455666789999999999999999999974 568899999987532 2235678899999999999999999998864
Q ss_pred C------CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCe
Q 005731 581 Q------GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (680)
Q Consensus 581 ~------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 654 (680)
. ...++++|++ +++|..++. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3 2467888876 788977763 235889999999999999999999987 9999999999999999999
Q ss_pred EEeeeccceecC
Q 005731 655 KISDFGLARMFG 666 (680)
Q Consensus 655 kl~DFGla~~~~ 666 (680)
||+|||+++...
T Consensus 160 kl~dfg~~~~~~ 171 (345)
T cd07877 160 KILDFGLARHTD 171 (345)
T ss_pred EEeccccccccc
Confidence 999999998654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=183.90 Aligned_cols=150 Identities=26% Similarity=0.490 Sum_probs=130.0
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+|++.+.||+|+||.||++.. .++..+|+|.+... .....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 578889999999999999985 45889999998643 223456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC-CeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 667 (680)
+++++|.+++.+. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++ .+||+|||++..+..
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999988542 2335789999999999999999999887 99999999999999875 569999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.8e-19 Score=181.11 Aligned_cols=152 Identities=23% Similarity=0.435 Sum_probs=134.0
Q ss_pred CcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+|++.+.||+|++|.||++... +++.+++|++..... ...+++.+|+++++.++|||++++.+.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999854 588999999875432 4567789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+++++|.+++.... ....+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999885432 1357899999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=186.44 Aligned_cols=147 Identities=33% Similarity=0.545 Sum_probs=127.7
Q ss_pred cceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
|++.+.||.|++|.||+|.. .+++.||||++.... ....+.+.+|++++++++|||++++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56678999999999999985 468999999987432 223467889999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+ ++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 6898887432 2236899999999999999999999887 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.1e-19 Score=187.90 Aligned_cols=149 Identities=31% Similarity=0.483 Sum_probs=127.5
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
+.|+..+.||+|+||.||++.. .+++.+|+|.+.... .....++.+|++++++++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3477778999999999999984 468899999986432 223457889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+. |+|.+.+.. ....+++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9997 477666532 2345889999999999999999999987 99999999999999999999999999876643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.3e-21 Score=216.43 Aligned_cols=165 Identities=32% Similarity=0.464 Sum_probs=136.5
Q ss_pred HhcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
..+-++.....||.|.||.||-+. ..+|+..|||-++-. .........+|+.++..++|||+|+++|+-++++..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 345567777899999999999997 677999999988643 33456678899999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
.||||++|+|.+.+.. .+-.++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|+.|||-|+.+.
T Consensus 1312 FMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 9999999999998833 233444444567889999999999998 9999999999999999999999999999886
Q ss_pred CCc--cccCccccccC
Q 005731 667 GDE--LQGNTKRIVGT 680 (680)
Q Consensus 667 ~~~--~~~~~~~~~Gt 680 (680)
..- .....+.++||
T Consensus 1386 ~~~~~~~~el~~~~GT 1401 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGT 1401 (1509)
T ss_pred CchhcCCHHHHhhcCC
Confidence 542 12334456665
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=191.88 Aligned_cols=149 Identities=26% Similarity=0.429 Sum_probs=127.4
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-----Ce
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-----GE 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 583 (680)
.++|++.+.||+|+||.||+++. .+++.||||.+... ......++.+|+.++..++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35799999999999999999984 56899999998753 233455678899999999999999999987654 34
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.++||||+. ++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 68887773 3356889999999999999999999887 9999999999999999999999999998
Q ss_pred ecCC
Q 005731 664 MFGG 667 (680)
Q Consensus 664 ~~~~ 667 (680)
....
T Consensus 157 ~~~~ 160 (337)
T cd07858 157 TTSE 160 (337)
T ss_pred ccCC
Confidence 7643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.5e-19 Score=181.67 Aligned_cols=142 Identities=25% Similarity=0.337 Sum_probs=119.6
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCCCc---ccHHHHHHHHHHH-hhcCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG---QGLKEFKNEMMLI-AELQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~---~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+|+||.||+|.. .+++.||||.+..... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999985 4588999999865321 2233445555444 455899999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 999998832 346788999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.6e-19 Score=181.12 Aligned_cols=149 Identities=23% Similarity=0.321 Sum_probs=121.2
Q ss_pred HHhcCCcceeeee--ccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhh-cCCCceeeEEEEEEeCCeE
Q 005731 509 AAATENFSMQCKL--GEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAE-LQHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 509 ~~~~~~f~~~~~L--G~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~ 584 (680)
....++|++.+.+ |+|+||.||++.. .+++.+|+|.+........ |+..... .+||||+++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3344667776766 9999999999984 4678899999865321111 2222221 2799999999999999999
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC-CeEEeeeccce
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLAR 663 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~ 663 (680)
++||||+++++|.+++.. ...++++++..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+++
T Consensus 85 ~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 999999999999998843 337899999999999999999999987 99999999999999988 99999999998
Q ss_pred ecCCC
Q 005731 664 MFGGD 668 (680)
Q Consensus 664 ~~~~~ 668 (680)
.+...
T Consensus 159 ~~~~~ 163 (267)
T PHA03390 159 IIGTP 163 (267)
T ss_pred ecCCC
Confidence 77543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-21 Score=186.47 Aligned_cols=149 Identities=31% Similarity=0.562 Sum_probs=121.5
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccC-CCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeC--------
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSS-QSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQ-------- 581 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~-~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-------- 581 (680)
..|+...+||+|.||.||+|+. .+++.||+|++-. .... .-...++|+.+|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4566667999999999999984 5578899987632 2222 234457899999999999999999888643
Q ss_pred CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecc
Q 005731 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 661 (680)
...|||++++++ +|.-.|.+ ....+...++.+++.++..||.|+|... |+|||+||+|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347999999975 67666632 3356889999999999999999999766 99999999999999999999999999
Q ss_pred ceecCC
Q 005731 662 ARMFGG 667 (680)
Q Consensus 662 a~~~~~ 667 (680)
||.+..
T Consensus 171 ar~fs~ 176 (376)
T KOG0669|consen 171 ARAFST 176 (376)
T ss_pred ccceec
Confidence 987743
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-19 Score=190.68 Aligned_cols=147 Identities=29% Similarity=0.437 Sum_probs=125.8
Q ss_pred CCcc-eeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCccc--------------HHHHHHHHHHHhhcCCCceeeEEE
Q 005731 513 ENFS-MQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQG--------------LKEFKNEMMLIAELQHRNLVRILG 576 (680)
Q Consensus 513 ~~f~-~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~--------------~~~f~~E~~~l~~l~H~niv~l~g 576 (680)
++|. +.+.||+|+||.||++.. .+++.||||.+....... ...+.+|++++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 347799999999999984 468999999886432111 125788999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEE
Q 005731 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656 (680)
Q Consensus 577 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 656 (680)
++...+..++||||+. ++|.+++. ....+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 68888873 3345788999999999999999999887 999999999999999999999
Q ss_pred eeeccceecC
Q 005731 657 SDFGLARMFG 666 (680)
Q Consensus 657 ~DFGla~~~~ 666 (680)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (335)
T PTZ00024 161 ADFGLARRYG 170 (335)
T ss_pred CCccceeecc
Confidence 9999998775
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.5e-19 Score=183.73 Aligned_cols=146 Identities=25% Similarity=0.375 Sum_probs=123.1
Q ss_pred cceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcC-CCceeeEEEEEEeC--CeEEEEEE
Q 005731 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQ--GEKILILE 589 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 589 (680)
|++.+.||+|+||.||++.. .+++.+|+|+++... ........+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999984 468899999987532 222234457888999885 99999999999987 88999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|++ ++|.+.+.. ....+++.++..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 577777633 2346899999999999999999999987 999999999999999 9999999999987643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=5e-19 Score=188.53 Aligned_cols=146 Identities=29% Similarity=0.422 Sum_probs=123.0
Q ss_pred CcceeeeeccCCceeEEEEEEc-C--CcEEEEEEccCC--CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC----Ce
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF-N--GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ----GE 583 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~-~--~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 583 (680)
+|++.+.||+|+||.||++... . ++.||||++... .....+.+.+|++++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999853 3 678999998743 222356788999999999 599999999876543 35
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.++++||+. ++|.+.+. ....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788889886 68888873 3456889999999999999999999987 9999999999999999999999999998
Q ss_pred ecC
Q 005731 664 MFG 666 (680)
Q Consensus 664 ~~~ 666 (680)
.+.
T Consensus 154 ~~~ 156 (332)
T cd07857 154 GFS 156 (332)
T ss_pred ecc
Confidence 764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.1e-20 Score=188.98 Aligned_cols=153 Identities=32% Similarity=0.451 Sum_probs=127.8
Q ss_pred CCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCC-------cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-Ce
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQS-------GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-GE 583 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~-------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~ 583 (680)
++|-++..||+|+|+.||++- +...+-||||+-.... ..-.+...+|-++-+.|+||.||++++++.-+ +.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 467778899999999999996 6667889999753211 11233466788999999999999999998755 56
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC---CCCeEEeeec
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFG 660 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFG 660 (680)
.+-|+||++|.+|+-+|. ..+.+.+++...|++||+.||.||.+. +++|||-||||.||||-. -|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 789999999999999993 345788999999999999999999987 589999999999999954 4789999999
Q ss_pred cceecCCCc
Q 005731 661 LARMFGGDE 669 (680)
Q Consensus 661 la~~~~~~~ 669 (680)
|++++.++.
T Consensus 619 LSKIMdddS 627 (775)
T KOG1151|consen 619 LSKIMDDDS 627 (775)
T ss_pred hhhhccCCc
Confidence 999997654
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=182.63 Aligned_cols=152 Identities=28% Similarity=0.467 Sum_probs=132.3
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+|++.+.||+|++|.||++.. .+++.+++|.+... ......++.+|++++++++|+||+++.+++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999974 46789999998753 223456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+++++|.+++.+.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999875422 2356788999999999999999999887 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-19 Score=188.33 Aligned_cols=149 Identities=30% Similarity=0.479 Sum_probs=127.4
Q ss_pred HhcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe-CCeEE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE-QGEKI 585 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 585 (680)
..+++|++.+.||+|+||.||++. ..+++.||||++... .....+.+.+|++++..++||||+++.+++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 356789999999999999999997 447899999988642 22345678899999999999999999999876 45789
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+++||+ +++|..++. ...++......++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||+++..
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 568887763 235778888889999999999999987 999999999999999999999999999865
Q ss_pred C
Q 005731 666 G 666 (680)
Q Consensus 666 ~ 666 (680)
.
T Consensus 159 ~ 159 (328)
T cd07856 159 D 159 (328)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.4e-19 Score=187.18 Aligned_cols=145 Identities=23% Similarity=0.228 Sum_probs=123.5
Q ss_pred eeeeeccCCceeEEEEEEcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCC
Q 005731 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (680)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 594 (680)
+.+.+|.|+++.|+++.. +++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 345566666666666654 7899999998753 3445678999999999999999999999999999999999999999
Q ss_pred ChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+|.+++... ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+..+.
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence 999988543 2235788888999999999999999987 9999999999999999999999999987653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=189.33 Aligned_cols=148 Identities=30% Similarity=0.458 Sum_probs=129.3
Q ss_pred CcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----eEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-----EKI 585 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 585 (680)
+|++.+.||+|++|.||++... +++.+|||++.... ....+.+.+|+++++.++|+||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999854 48899999987643 344567899999999999999999999988775 789
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
++|||++ ++|..++.+ ...+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 578877732 337889999999999999999999987 999999999999999999999999999987
Q ss_pred CCC
Q 005731 666 GGD 668 (680)
Q Consensus 666 ~~~ 668 (680)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.1e-19 Score=188.10 Aligned_cols=142 Identities=25% Similarity=0.300 Sum_probs=122.2
Q ss_pred eeeccC--CceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEG--GFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G--~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.||+| +||+||++.. .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 8999999985 578999999987432 22356788999999999999999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+..
T Consensus 84 ~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 84 GSANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred CCHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 9999887543 2235788888999999999999999887 99999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.7e-19 Score=187.90 Aligned_cols=146 Identities=31% Similarity=0.472 Sum_probs=124.2
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------ 582 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 582 (680)
.++|...+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36899999999999999999984 56899999998653 2233456889999999999999999999987542
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
..++|+||+.. +|..++ ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 676554 235788999999999999999999987 999999999999999999999999999
Q ss_pred eecC
Q 005731 663 RMFG 666 (680)
Q Consensus 663 ~~~~ 666 (680)
+...
T Consensus 165 ~~~~ 168 (342)
T cd07879 165 RHAD 168 (342)
T ss_pred cCCC
Confidence 8653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.9e-19 Score=183.74 Aligned_cols=150 Identities=25% Similarity=0.404 Sum_probs=125.2
Q ss_pred CCcceeeeeccCCceeEEEEEEcC-CcEEEEEEccCCC-cccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|++.+.||+|++|.||++.... ++.||||.++... .....++..|+.++.+.+ ||||+++++++......+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 578888999999999999998654 8899999997532 233456777887777775 9999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+. ++|...+.. ....+++..+..++.|+++||+|||+.. +|+||||+|+||++++++.+||+|||++..+..
T Consensus 95 ~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 95 LMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 985 467666532 1246889999999999999999999731 399999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.3e-19 Score=183.39 Aligned_cols=148 Identities=31% Similarity=0.420 Sum_probs=127.0
Q ss_pred cceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEEcc
Q 005731 515 FSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
|++.+.||+|++|.||+|... +++.|+||++..... .......+|+..+.+++ |||++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999864 578999999875322 22234567999999999 999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 889988874322 246799999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.1e-19 Score=186.07 Aligned_cols=150 Identities=33% Similarity=0.510 Sum_probs=125.6
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------ 582 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 582 (680)
.++|++.++||+|+||.||++.. .+++.+|||++.... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999985 468899999886432 222346788999999999999999999876543
Q ss_pred --eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeec
Q 005731 583 --EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (680)
Q Consensus 583 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 660 (680)
..++||||+.. +|...+.. ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 56665533 2346899999999999999999999987 9999999999999999999999999
Q ss_pred cceecCC
Q 005731 661 LARMFGG 667 (680)
Q Consensus 661 la~~~~~ 667 (680)
+++....
T Consensus 161 ~~~~~~~ 167 (311)
T cd07866 161 LARPYDG 167 (311)
T ss_pred cchhccC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-18 Score=181.38 Aligned_cols=149 Identities=19% Similarity=0.301 Sum_probs=110.3
Q ss_pred cCCcceeeeeccCCceeEEEEEEcC----CcEEEEEEccCCCcccH-----------HHHHHHHHHHhhcCCCceeeEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQSGQGL-----------KEFKNEMMLIAELQHRNLVRILG 576 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~~~~~~-----------~~f~~E~~~l~~l~H~niv~l~g 576 (680)
.++|++.++||+|+||.||+|...+ +..+|+|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3689999999999999999998544 34566665432221111 11223344556678999999999
Q ss_pred EEEeCC----eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC
Q 005731 577 CCVEQG----EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (680)
Q Consensus 577 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 652 (680)
.+.... ..++++|++. .++.+.+.. ....++..+..++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 776543 4467888764 355555421 223567788899999999999999887 99999999999999999
Q ss_pred CeEEeeeccceecCC
Q 005731 653 NPKISDFGLARMFGG 667 (680)
Q Consensus 653 ~~kl~DFGla~~~~~ 667 (680)
.+||+|||+|+.+..
T Consensus 164 ~~~l~DFGla~~~~~ 178 (294)
T PHA02882 164 RGYIIDYGIASHFII 178 (294)
T ss_pred cEEEEEcCCceeecc
Confidence 999999999987743
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.9e-18 Score=179.48 Aligned_cols=149 Identities=33% Similarity=0.532 Sum_probs=124.4
Q ss_pred cceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhc---CCCceeeEEEEEEeCCe-----
Q 005731 515 FSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAEL---QHRNLVRILGCCVEQGE----- 583 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 583 (680)
|++.+.||+|+||.||+++.. +++.+|+|++..... .....+.+|+.++.++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567899999999999999865 489999999974322 2234566788777665 69999999999988776
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.+++|||+. ++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 4788877432 2235899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCC
Q 005731 664 MFGGD 668 (680)
Q Consensus 664 ~~~~~ 668 (680)
.+...
T Consensus 156 ~~~~~ 160 (287)
T cd07838 156 IYSFE 160 (287)
T ss_pred eccCC
Confidence 87543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.2e-18 Score=181.98 Aligned_cols=145 Identities=32% Similarity=0.496 Sum_probs=124.5
Q ss_pred cceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
|...++||+|+||.||+|.. .+++.|++|++.... ....+.+.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56668899999999999985 468899999986432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+. ++|.+++.. ....+++.++..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 96 567666532 2346889999999999999999999887 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.5e-20 Score=173.83 Aligned_cols=147 Identities=24% Similarity=0.459 Sum_probs=126.2
Q ss_pred hcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCC--eEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQG--EKIL 586 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~l 586 (680)
..++|++.+++|+|.+++||.|. ..+.+.++||.++. ...+.+.+|+.+|..+. ||||++|+++..+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45789999999999999999997 56788999999975 34567889999999997 999999999987653 5679
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC-CCeEEeeeccceec
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLARMF 665 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~~ 665 (680)
|+||+.+.+....- ..++..++..++.++++||.|+|+.| |+|||+||.|++||.. -.++|+|+|||..+
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998876543 34666778889999999999999988 9999999999999965 56999999999988
Q ss_pred CCCc
Q 005731 666 GGDE 669 (680)
Q Consensus 666 ~~~~ 669 (680)
-+.+
T Consensus 184 Hp~~ 187 (338)
T KOG0668|consen 184 HPGK 187 (338)
T ss_pred CCCc
Confidence 6554
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.1e-19 Score=183.61 Aligned_cols=151 Identities=28% Similarity=0.410 Sum_probs=123.8
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+|+..++||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.++.++. ||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455668899999999999984 458899999987532 234567899999999996 99999999999999999999999
Q ss_pred cCCCChhhHhcc--cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFD--PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+. +++.++... ......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 86 455443211 112356889999999999999999999742 399999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=183.89 Aligned_cols=149 Identities=33% Similarity=0.499 Sum_probs=126.8
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
+.|+..+.||+|+||.||+|.. .+++.+|+|.+... .....+++.+|++++++++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3476678999999999999985 45789999988632 2233457889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+. |+|...+.. ....+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+..
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 577666532 2345788999999999999999999887 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.6e-19 Score=188.39 Aligned_cols=146 Identities=30% Similarity=0.439 Sum_probs=125.3
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC----------
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ---------- 581 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~---------- 581 (680)
.+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 6899999999999999999985 46889999998765555667889999999999999999999776543
Q ss_pred ----CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc-CCCCeEE
Q 005731 582 ----GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKI 656 (680)
Q Consensus 582 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl 656 (680)
...++||||++ ++|.+++. ...+++.....++.||+.||.|||+.+ |+||||||+||+++ ++..+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 58877763 235788999999999999999999887 99999999999997 4567899
Q ss_pred eeeccceecC
Q 005731 657 SDFGLARMFG 666 (680)
Q Consensus 657 ~DFGla~~~~ 666 (680)
+|||+++.+.
T Consensus 157 ~dfg~~~~~~ 166 (342)
T cd07854 157 GDFGLARIVD 166 (342)
T ss_pred CCcccceecC
Confidence 9999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.2e-19 Score=181.39 Aligned_cols=148 Identities=34% Similarity=0.539 Sum_probs=128.5
Q ss_pred cceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
|+..+.||+|++|.||++.. .+++.+++|++..... .....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45678999999999999985 4688999999875422 24567889999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
++ +|..++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||.+..+...
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 75 887777432 246889999999999999999999987 999999999999999999999999999877554
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5e-19 Score=186.30 Aligned_cols=163 Identities=26% Similarity=0.361 Sum_probs=136.2
Q ss_pred hcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccC--CCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~--~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 587 (680)
....|+++++||+||.+.||++...+.+.+|+|++.. .+.+...-|++|+.+|.+++ |.+|++|++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3456899999999999999999988888999998753 35567889999999999994 99999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||= ..+|..+|... ......| .+..+..|++.++.++|+++ |||.||||.|+|+ -.|.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcccCc
Confidence 9984 67898888432 1222234 56678899999999999998 9999999999999 677999999999999988
Q ss_pred CccccCccccccC
Q 005731 668 DELQGNTKRIVGT 680 (680)
Q Consensus 668 ~~~~~~~~~~~Gt 680 (680)
+........-+||
T Consensus 512 DTTsI~kdsQvGT 524 (677)
T KOG0596|consen 512 DTTSIVKDSQVGT 524 (677)
T ss_pred cccceeeccccCc
Confidence 7765544455665
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.9e-19 Score=181.42 Aligned_cols=147 Identities=35% Similarity=0.516 Sum_probs=128.6
Q ss_pred cceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 515 FSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
|+..+.||+|.+|.||+|... +++.+|+|.+.... ....+.+.+|+.++++++|+|++++++++......++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999854 58999999987642 334567889999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||+++....
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 8 58988884321 46889999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-20 Score=181.80 Aligned_cols=155 Identities=26% Similarity=0.421 Sum_probs=127.5
Q ss_pred CcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----eEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-----EKI 585 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 585 (680)
+.+-.+-||-|+||.||..+ -++|+.||.|++..-. -...+++.+|+++|..++|.|++..++...-.. +.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 34445789999999999997 4679999999987532 234567889999999999999999988765442 567
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
++.|.| ..+|.+.+ .+...++.+.+.-+..||++||.|||+.+ |.||||||.|+|++.+..+||+||||||..
T Consensus 134 V~TELm-QSDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELM-QSDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHH-Hhhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 888888 45777776 34456777888888999999999999987 999999999999999999999999999998
Q ss_pred CCCccccCcc
Q 005731 666 GGDELQGNTK 675 (680)
Q Consensus 666 ~~~~~~~~~~ 675 (680)
+.++.+.+|.
T Consensus 207 e~d~~~hMTq 216 (449)
T KOG0664|consen 207 DQRDRLNMTH 216 (449)
T ss_pred chhhhhhhHH
Confidence 8777665554
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=175.96 Aligned_cols=141 Identities=31% Similarity=0.412 Sum_probs=125.1
Q ss_pred eccCCceeEEEEEEc-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCCh
Q 005731 521 LGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (680)
Q Consensus 521 LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (680)
||+|+||.||++... +++.+|+|.+..... ...+.+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999854 588999999875422 2456889999999999999999999999999999999999999999
Q ss_pred hhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 998833 336789999999999999999999977 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-19 Score=177.00 Aligned_cols=148 Identities=26% Similarity=0.335 Sum_probs=120.6
Q ss_pred hcCCccee-eeeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEe----CCe
Q 005731 511 ATENFSMQ-CKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE----QGE 583 (680)
Q Consensus 511 ~~~~f~~~-~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~ 583 (680)
.+++|++. ++||-|-.|.|..+. ..+++.+|+|++... ...++|+++--+. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666654 689999999999987 456889999998652 3346777765444 69999999998864 346
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC---CCCeEEeeec
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFG 660 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFG 660 (680)
+++|||.|+||.|.+.+.+ .....+++.+...|+.||+.|+.|||+.. |.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999888744 34456899999999999999999999877 999999999999974 5579999999
Q ss_pred cceecCC
Q 005731 661 LARMFGG 667 (680)
Q Consensus 661 la~~~~~ 667 (680)
+|+.-..
T Consensus 210 FAK~t~~ 216 (400)
T KOG0604|consen 210 FAKETQE 216 (400)
T ss_pred cccccCC
Confidence 9997643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.3e-19 Score=199.79 Aligned_cols=156 Identities=36% Similarity=0.522 Sum_probs=132.7
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEc--------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCV 579 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~--------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~ 579 (680)
...++..+.+.||+|.||+|++|... ....||||.++... ....+.+..|++++..+ +|+||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 34455566679999999999999743 14579999998643 34567899999999998 6999999999999
Q ss_pred eCCeEEEEEEccCCCChhhHhcccc-----c------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcE
Q 005731 580 EQGEKILILEYMPNKSLDVYLFDPI-----K------K--RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNV 646 (680)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NI 646 (680)
+++..++|+||++.|+|.++|+... . . ..+...+.+.++.|||.||+||++.. +|||||.++||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhE
Confidence 9999999999999999999996543 0 0 13788999999999999999999876 99999999999
Q ss_pred EEcCCCCeEEeeeccceecCCC
Q 005731 647 LLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 647 Ll~~~~~~kl~DFGla~~~~~~ 668 (680)
|+.++..+||+|||+||.....
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~ 471 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNK 471 (609)
T ss_pred EecCCCEEEEccccceeccCCC
Confidence 9999999999999999965443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=178.97 Aligned_cols=150 Identities=29% Similarity=0.441 Sum_probs=123.9
Q ss_pred CcceeeeeccCCceeEEEEEEcC-CcEEEEEEccCC-----CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
+|.+.+.||+|+||.||++.... +..+++|.++.. ......++.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999997433 444555555421 222344677899999999999999999999998999999
Q ss_pred EEccCCCChhhHhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 588 LEYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|||+++++|...+... .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++ +.+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887542 23356899999999999999999999887 999999999999975 569999999998774
Q ss_pred C
Q 005731 667 G 667 (680)
Q Consensus 667 ~ 667 (680)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.8e-20 Score=178.66 Aligned_cols=150 Identities=29% Similarity=0.402 Sum_probs=121.6
Q ss_pred cceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.+.+..||.|+||+|+|-.+ +.|+.+|||+++... +....+++.|.++..+- +.||||+++|.+...+..||.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 34457899999999999864 569999999998643 34567888999866555 7899999999999999999999999
Q ss_pred CCCChhhHhccc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDP--IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+ .||+.+-..- ..+..+++.-.-+|.....+||.||-++ +.|||||+||+||||+..|.+||+|||++-.+.+
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 4 5776653211 2344567776778888899999999874 4799999999999999999999999999876644
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-18 Score=186.31 Aligned_cols=148 Identities=30% Similarity=0.446 Sum_probs=127.4
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe-----
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE----- 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----- 583 (680)
.++|++.+.||+|++|.||+|... +++.||||++... .....+.+.+|+.++++++|||++++.+++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 468999999999999999999854 5789999998643 22234667889999999999999999988766554
Q ss_pred -EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 584 -KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 584 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 6789887732 46899999999999999999999887 999999999999999999999999999
Q ss_pred eecCC
Q 005731 663 RMFGG 667 (680)
Q Consensus 663 ~~~~~ 667 (680)
..+..
T Consensus 166 ~~~~~ 170 (343)
T cd07851 166 RHTDD 170 (343)
T ss_pred ccccc
Confidence 87643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.9e-19 Score=173.96 Aligned_cols=161 Identities=25% Similarity=0.371 Sum_probs=136.4
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 586 (680)
-++|.++++||+|+|..|..+++ .+.+.+|+|++++. +.+..+..+.|-.+.... +||.+|-|..+++....++.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 36899999999999999999985 56788999999763 345566677777777665 79999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|.||+++|+|--++ +++..++++....+...|..||.|||+.+ ||.||||..|+|||..|.+||+|+|+++.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999995444 55667888888888999999999999998 9999999999999999999999999998542
Q ss_pred CCccccCccccccC
Q 005731 667 GDELQGNTKRIVGT 680 (680)
Q Consensus 667 ~~~~~~~~~~~~Gt 680 (680)
.+ .+.|.+++||
T Consensus 403 ~~--gd~tstfcgt 414 (593)
T KOG0695|consen 403 GP--GDTTSTFCGT 414 (593)
T ss_pred CC--CcccccccCC
Confidence 22 3456678887
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.3e-18 Score=166.32 Aligned_cols=137 Identities=21% Similarity=0.330 Sum_probs=105.9
Q ss_pred eeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-----CCCceeeEEEEEEeCC---eEE-EE
Q 005731 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-----QHRNLVRILGCCVEQG---EKI-LI 587 (680)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-----~H~niv~l~g~~~~~~---~~~-lV 587 (680)
-.+.||+|+||.||. ...++.. +||++........+++.+|+.++..+ .||||++++|++.++. ..+ +|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 347899999999996 3233444 79988764444567899999999999 5799999999998864 334 78
Q ss_pred EEc--cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEeCCCCCCcEEEcCC----CCeEEee-e
Q 005731 588 LEY--MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL-LYLHQYSRLRIIHRDLKASNVLLDKD----MNPKISD-F 659 (680)
Q Consensus 588 ~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~D-F 659 (680)
+|| +.+++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++.. ..++|+| |
T Consensus 84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 557999999833 234444 35677788777 9999988 9999999999999743 3799999 5
Q ss_pred cccee
Q 005731 660 GLARM 664 (680)
Q Consensus 660 Gla~~ 664 (680)
|.+..
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 55444
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.6e-19 Score=180.77 Aligned_cols=161 Identities=27% Similarity=0.341 Sum_probs=130.8
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc---ccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 586 (680)
..+|..+.+||+|+||.|.+++.+ +.+.+|||++++... ...+--..|-++|+-. +-|.++.|...++..+++|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457888999999999999999754 467899999986422 2233345566677665 46789999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+.||+|--++ +.-+.+.+..++-++..||-||-|||+++ ||.||||.+|||||.+|.+||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999997666 34456777888899999999999999998 9999999999999999999999999998542
Q ss_pred CCccccCccccccC
Q 005731 667 GDELQGNTKRIVGT 680 (680)
Q Consensus 667 ~~~~~~~~~~~~Gt 680 (680)
-+. ..|.+++||
T Consensus 502 ~~~--~TTkTFCGT 513 (683)
T KOG0696|consen 502 FDG--VTTKTFCGT 513 (683)
T ss_pred cCC--cceeeecCC
Confidence 222 345568887
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-17 Score=166.36 Aligned_cols=148 Identities=37% Similarity=0.549 Sum_probs=131.6
Q ss_pred cceeeeeccCCceeEEEEEEcC-CcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 515 FSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
|++.+.||+|++|.||++.... ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999998654 889999999865444 57789999999999999999999999999899999999999
Q ss_pred CCChhhHhcccccCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 593 NKSLDVYLFDPIKKRL-LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+++|.+++... .. +++.....++.+++++|.|||+.+ ++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 99999988432 22 788999999999999999999986 999999999999999999999999999987554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.6e-18 Score=172.01 Aligned_cols=133 Identities=22% Similarity=0.166 Sum_probs=114.4
Q ss_pred CCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCChhhHhcc
Q 005731 524 GGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD 602 (680)
Q Consensus 524 G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 602 (680)
|.+|.||++.. .+++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999984 568899999997532 234455556666799999999999999999999999999999988843
Q ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 603 PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 603 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+|++|||++..+..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~ 137 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED 137 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence 335889999999999999999999887 99999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-19 Score=193.55 Aligned_cols=163 Identities=26% Similarity=0.461 Sum_probs=141.7
Q ss_pred HhcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
...++|++.+.+|.|.+|.|||++ ...++..|||.++........-...|+-+++..+||||+.++|.+...+..+++|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 345789999999999999999998 5678999999998766667777889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+.+|+|++.-+ ....+.+.++..+.+..++||+|||+.+ -+|||||-.|||+++.+.+|++|||.+..++..
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999987653 3456788888899999999999999988 799999999999999999999999999888654
Q ss_pred ccccCccccccC
Q 005731 669 ELQGNTKRIVGT 680 (680)
Q Consensus 669 ~~~~~~~~~~Gt 680 (680)
-.+ ...++||
T Consensus 166 i~K--rksfiGt 175 (829)
T KOG0576|consen 166 IAK--RKSFIGT 175 (829)
T ss_pred hhh--hhcccCC
Confidence 332 2346665
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.4e-19 Score=169.91 Aligned_cols=153 Identities=24% Similarity=0.373 Sum_probs=123.1
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 589 (680)
++.+.+..||.|+.|+|++.+. .+|..+|||.+... ..+..++++..+.++.+-+ .|.||+.+|+|......++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3445567899999999999985 45899999999764 3445677888888777665 8999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
.|... ++..|.+ -.+++++.-+-++...+.+||.||-++. .|||||+||+|||+|+.|++||+|||++-.+.+..
T Consensus 172 lMs~C-~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMSTC-AEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHH-HHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 98532 3444422 2345666666688899999999998744 69999999999999999999999999998876554
Q ss_pred c
Q 005731 670 L 670 (680)
Q Consensus 670 ~ 670 (680)
.
T Consensus 247 A 247 (391)
T KOG0983|consen 247 A 247 (391)
T ss_pred c
Confidence 3
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.2e-18 Score=191.81 Aligned_cols=149 Identities=23% Similarity=0.304 Sum_probs=105.2
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc-C----CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEE------EE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF-N----GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGC------CV 579 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~----~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~------~~ 579 (680)
..++|++.+.||+|+||.||+|+.. + +..||||++..... .+.+..| .+....+.++..+... +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999864 4 68999999864321 1111111 1122222222222111 24
Q ss_pred eCCeEEEEEEccCCCChhhHhcccccC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCC
Q 005731 580 EQGEKILILEYMPNKSLDVYLFDPIKK-----------------RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642 (680)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 642 (680)
.....++||||+++++|.+++...... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556899999999999998887532100 01112335578999999999999987 9999999
Q ss_pred CCcEEEcC-CCCeEEeeeccceecC
Q 005731 643 ASNVLLDK-DMNPKISDFGLARMFG 666 (680)
Q Consensus 643 p~NILl~~-~~~~kl~DFGla~~~~ 666 (680)
|+|||+++ ++.+||+|||+|+.+.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~ 307 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLR 307 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccc
Confidence 99999986 5799999999998664
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-17 Score=165.32 Aligned_cols=147 Identities=17% Similarity=0.158 Sum_probs=113.0
Q ss_pred CCcceeeeeccCCceeEEEEE--EcCCcEEEEEEccCCCcc------------------------cHHHHHHHHHHHhhc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR--LFNGQEVAVKRLSSQSGQ------------------------GLKEFKNEMMLIAEL 566 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~--~~~~~~VAVK~l~~~~~~------------------------~~~~f~~E~~~l~~l 566 (680)
.-|++.+.||+|++|.||+|. ..+|+.||||.++..... ....+.+|++++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358888999999999999998 568999999998743210 012356899999999
Q ss_pred CCCc--eeeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCC
Q 005731 567 QHRN--LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKAS 644 (680)
Q Consensus 567 ~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~ 644 (680)
.|.. +.+.++. ...++||||+++.+|..... ....+...+...++.|++.+|++||..+ .|+||||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 7532 3444442 24589999999988865441 2233455567789999999999999875 4999999999
Q ss_pred cEEEcCCCCeEEeeeccceecCCCc
Q 005731 645 NVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 645 NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
||+++ ++.++|+|||+|...+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCCcc
Confidence 99999 8899999999999765543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.2e-17 Score=156.47 Aligned_cols=152 Identities=24% Similarity=0.369 Sum_probs=124.9
Q ss_pred hcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCC-CceeeEEEEEEeCCeEEEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH-RNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 588 (680)
...+|.++++||.|+||.+|.|. +.+|++||||.-.... ...++.-|..+...++| ..|.++..+..++..-.|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34689999999999999999997 6789999999865432 23466778888888875 56777778888888999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC---CCCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~~ 665 (680)
|.+ |.||++.+.- -...++.++.+-++-|++.-++|+|..+ +|||||||+|+|+.- ...+.++|||||+.+
T Consensus 91 dLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 987 8899877521 1235778889999999999999999988 999999999999964 456899999999988
Q ss_pred CCCcc
Q 005731 666 GGDEL 670 (680)
Q Consensus 666 ~~~~~ 670 (680)
-+-.+
T Consensus 165 ~d~~t 169 (341)
T KOG1163|consen 165 RDIRT 169 (341)
T ss_pred ccccc
Confidence 65443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-16 Score=155.50 Aligned_cols=143 Identities=38% Similarity=0.635 Sum_probs=125.9
Q ss_pred eccCCceeEEEEEEcC-CcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCChhh
Q 005731 521 LGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDV 598 (680)
Q Consensus 521 LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 598 (680)
||+|.+|.||++.... ++.+++|++...... ..+.+.+|++.++++.|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998654 899999999864332 35789999999999999999999999999999999999999999999
Q ss_pred HhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-CCCeEEeeeccceecCCC
Q 005731 599 YLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFGGD 668 (680)
Q Consensus 599 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~ 668 (680)
++.... ..+++..+..++.+++++|.|||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 884321 35788999999999999999999987 999999999999999 899999999999877543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.9e-19 Score=183.10 Aligned_cols=159 Identities=26% Similarity=0.332 Sum_probs=135.2
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCc-EEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQ-EVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~-~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
.+++.+-.||-|+||.|-++...... .+|+|.+++.. ....+....|-.+|...+.|.||+|+-.+.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555678999999999998765433 47888887642 233456778999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|-|-||.|=..|++ ++.++..+...++..+.+|++|||.++ ||.|||||+|++|+.+|-+||.|||+|+.++..
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999988843 456788888888899999999999988 999999999999999999999999999999765
Q ss_pred ccccCccccccC
Q 005731 669 ELQGNTKRIVGT 680 (680)
Q Consensus 669 ~~~~~~~~~~Gt 680 (680)
+ .|.+++||
T Consensus 574 ~---KTwTFcGT 582 (732)
T KOG0614|consen 574 R---KTWTFCGT 582 (732)
T ss_pred C---ceeeecCC
Confidence 4 47779998
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.3e-17 Score=155.62 Aligned_cols=132 Identities=20% Similarity=0.234 Sum_probs=105.6
Q ss_pred eeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcc----cHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEEcc
Q 005731 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ----GLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~----~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
....|++|+||+||.+.. .+.+++.+.+.....- ....|.+|+++|++++ |+++.+++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999998764 6778888877653221 1225889999999995 5789999886 4579999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCC-CCCcEEEcCCCCeEEeeeccceecC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDL-KASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+|.+|...+. . ....++.|++++|.++|..+ |+|||| ||+|||++.++.++|+|||+|....
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9999854331 0 12357789999999999988 999999 7999999999999999999998654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.5e-17 Score=160.20 Aligned_cols=143 Identities=14% Similarity=0.119 Sum_probs=115.8
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccH---HH------HHHHHHHHhhcCCCceeeEEEEEEe
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGL---KE------FKNEMMLIAELQHRNLVRILGCCVE 580 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~---~~------f~~E~~~l~~l~H~niv~l~g~~~~ 580 (680)
...++|+..++||.|+||.||.... ++..+|||.+........ .. |.+|+..+.+++||+|.....++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468999999999999999999765 577899999975432222 22 6899999999999999999888654
Q ss_pred C--------CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC
Q 005731 581 Q--------GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (680)
Q Consensus 581 ~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 652 (680)
. ...+|+|||++|.+|.+.. .++. ....+++.+|..+|..+ ++|||+||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 3578999999999997763 1222 24568999999999988 99999999999999988
Q ss_pred CeEEeeeccceecCCC
Q 005731 653 NPKISDFGLARMFGGD 668 (680)
Q Consensus 653 ~~kl~DFGla~~~~~~ 668 (680)
++|+|||..+....+
T Consensus 173 -i~liDfg~~~~~~e~ 187 (232)
T PRK10359 173 -LRIIDLSGKRCTAQR 187 (232)
T ss_pred -EEEEECCCcccccch
Confidence 999999999877443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-17 Score=183.76 Aligned_cols=149 Identities=34% Similarity=0.462 Sum_probs=118.2
Q ss_pred cceeeeeccCCcee-EEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 515 FSMQCKLGEGGFGP-VYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 515 f~~~~~LG~G~fG~-Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
|.-.+.+|.|+.|+ ||+|.. ++++||||++-. ....-..+|+..|..- +||||||+++.-.++...||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44457889998875 688875 688999999864 2345567899998887 6999999999999999999999998
Q ss_pred CCChhhHhcccccCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC---C--CCeEEeeeccceecC
Q 005731 593 NKSLDVYLFDPIKKRLL-DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---D--MNPKISDFGLARMFG 666 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l-~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~--~~~kl~DFGla~~~~ 666 (680)
..+|++++......... .-...+.+..|+++||++||+.+ ||||||||+||||+. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 57999998543111111 11344667899999999999866 999999999999976 2 468999999999998
Q ss_pred CCccc
Q 005731 667 GDELQ 671 (680)
Q Consensus 667 ~~~~~ 671 (680)
.+++.
T Consensus 663 ~~~sS 667 (903)
T KOG1027|consen 663 GGKSS 667 (903)
T ss_pred CCcch
Confidence 87753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.3e-17 Score=159.43 Aligned_cols=136 Identities=20% Similarity=0.270 Sum_probs=113.7
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCc--------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
+.||+|++|.||+|.. .+..|+||+...... .....+.+|++++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999986 677899998653221 1124678899999999999988877777777888999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+++++|.+.+... .+ .+..++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||+++...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999887321 12 77889999999999999987 99999999999999 7899999999998643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.3e-17 Score=157.91 Aligned_cols=147 Identities=18% Similarity=0.186 Sum_probs=113.2
Q ss_pred HHHHhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcc----------------------cHHHHHHHHHHHh
Q 005731 507 SVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ----------------------GLKEFKNEMMLIA 564 (680)
Q Consensus 507 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~----------------------~~~~f~~E~~~l~ 564 (680)
++......|.+.+.||+|+||.||++...+++.||||++...... ....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 333444457788999999999999998878999999987542100 1123677888999
Q ss_pred hcCCCc--eeeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCC
Q 005731 565 ELQHRN--LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642 (680)
Q Consensus 565 ~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 642 (680)
.+.|++ +.+.++ ....++||||+++++|..... ......++.+++.++.++|+.+ |+|||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 998874 444443 245689999999999865431 0234578889999999999977 9999999
Q ss_pred CCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 643 ASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
|+||++++++.++|+|||++.....+.
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~~~ 179 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDHPN 179 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCCcc
Confidence 999999999999999999998775543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=160.12 Aligned_cols=138 Identities=33% Similarity=0.470 Sum_probs=122.7
Q ss_pred CceeEEEEEEc-CCcEEEEEEccCCCccc-HHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCChhhHhcc
Q 005731 525 GFGPVYKGRLF-NGQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD 602 (680)
Q Consensus 525 ~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 602 (680)
+||.||++... +++.+|+|++....... .+.+.+|++.+++++|+|++++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999865 48999999997654444 68899999999999999999999999999999999999999999998843
Q ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 603 PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 603 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
. ..+++..+..++.+++++|.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 2 23788999999999999999999987 999999999999999999999999999987553
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.7e-17 Score=166.54 Aligned_cols=158 Identities=26% Similarity=0.422 Sum_probs=135.1
Q ss_pred HHHHHHhcCCcceeeeeccCCceeEEEEEE------cCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEE
Q 005731 505 LASVAAATENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGC 577 (680)
Q Consensus 505 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~ 577 (680)
..++.....++++...+-+|.||.||+|.+ .+.+.|-||.++.. ++.....++.|..++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 345666677888888999999999999953 34567888988765 44457789999999999999999999999
Q ss_pred EEeC-CeEEEEEEccCCCChhhHhc-----ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC
Q 005731 578 CVEQ-GEKILILEYMPNKSLDVYLF-----DPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD 651 (680)
Q Consensus 578 ~~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~ 651 (680)
+.+. ...+++|.++.-|+|..||. +....+.+.-.+.+.++.|++.|++|||.++ +||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 9876 46788899999999999997 4444456777888999999999999999988 9999999999999999
Q ss_pred CCeEEeeeccceec
Q 005731 652 MNPKISDFGLARMF 665 (680)
Q Consensus 652 ~~~kl~DFGla~~~ 665 (680)
.++||+|=.|+|-+
T Consensus 433 LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 433 LQVKLTDSALSRDL 446 (563)
T ss_pred eeEEeccchhcccc
Confidence 99999999999855
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-16 Score=155.71 Aligned_cols=132 Identities=23% Similarity=0.364 Sum_probs=107.4
Q ss_pred eeccCCceeEEEEEEcCCcEEEEEEccCCC---c-----ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQS---G-----QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 520 ~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~---~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.||+|+||.||+|. .++..|++|...... . ...+++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 48999999999998 467889999865321 1 12356788999999999887666555666677789999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
++++|.+.+... . . .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||+++...
T Consensus 80 ~g~~l~~~~~~~---~------~-~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEG---N------D-ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhc---H------H-HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999998876321 0 0 78899999999999987 99999999999999 8899999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=180.31 Aligned_cols=139 Identities=21% Similarity=0.308 Sum_probs=112.6
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEE-ccCCC-------cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKR-LSSQS-------GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~-l~~~~-------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 584 (680)
..|...+.||+|+||.||++...... +++|+ +.+.. ....+++.+|++++.+++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34556789999999999999865443 44443 22111 11235688999999999999999888888887788
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+|+.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999988772 35678999999999999987 9999999999999 678999999999987
Q ss_pred cCC
Q 005731 665 FGG 667 (680)
Q Consensus 665 ~~~ 667 (680)
...
T Consensus 477 ~~~ 479 (535)
T PRK09605 477 SDL 479 (535)
T ss_pred CCc
Confidence 643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.3e-17 Score=157.43 Aligned_cols=147 Identities=20% Similarity=0.389 Sum_probs=118.0
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEE-EEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGC-CVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E 589 (680)
+.|.+.+.||+|.||.+-+++++ ..+.+++|-+... ....++|.+|..---.| .|.||+.-+++ ++..+..+.++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 57888899999999999999865 4678899988753 33567888888644444 68999987765 455566778999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc--CCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD--KDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGla~~~~~ 667 (680)
|++.|+|.+-+ ....+.+....+++.|++.||.|+|++. +||||||.+||||= +.-.+||+|||+.+..+.
T Consensus 103 ~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999997766 2344666677789999999999999988 99999999999993 334799999999987653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.8e-17 Score=172.93 Aligned_cols=146 Identities=25% Similarity=0.339 Sum_probs=121.7
Q ss_pred cCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++.|++...+|.|+|+.|-++. ..+++..+||++.+.. .+-.+|+.++.+. +||||+++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 5778888999999999999987 4568899999997642 2224566555554 79999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE-cCCCCeEEeeeccceecCCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL-DKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~ 668 (680)
.+.++.+...+.. . .....++..|+.+|+.|+.|||+++ +|||||||+|||+ +..++++|+|||.++...++
T Consensus 397 ~l~g~ell~ri~~---~-~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRS---K-PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHh---c-chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999988766632 2 2233677789999999999999988 9999999999999 58999999999999987665
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.1e-16 Score=154.67 Aligned_cols=150 Identities=23% Similarity=0.379 Sum_probs=123.6
Q ss_pred CCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
-+|.+.++||+|+||.++.|+ +.+++.||||.=... ....+++.|-+..+.| ..+.|...+-+-.++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 479999999999999999997 778999999975432 2334566677776666 468888888888888889999998
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-----CCCeEEeeeccceec
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-----DMNPKISDFGLARMF 665 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DFGla~~~ 665 (680)
+ |-||++...- -.+.++.++.+.+|.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||||+.+
T Consensus 106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 7 8899887532 2346889999999999999999999988 999999999999974 345899999999998
Q ss_pred CCCcc
Q 005731 666 GGDEL 670 (680)
Q Consensus 666 ~~~~~ 670 (680)
.+..+
T Consensus 180 rDp~T 184 (449)
T KOG1165|consen 180 RDPKT 184 (449)
T ss_pred cCccc
Confidence 66544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=162.20 Aligned_cols=145 Identities=25% Similarity=0.359 Sum_probs=119.5
Q ss_pred CcceeeeeccCCceeEEEEEEcCC--cEEEEEEccCCCcccHHHHHHHHHHHhhcCC----CceeeEEEEE-EeCCeEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLFNG--QEVAVKRLSSQSGQGLKEFKNEMMLIAELQH----RNLVRILGCC-VEQGEKIL 586 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~~~--~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 586 (680)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999985443 4788887765433333377889998888873 5788888888 46778899
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC-----CCeEEeeecc
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-----MNPKISDFGL 661 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~kl~DFGl 661 (680)
||+.+ |.+|.++.... ..+.++..+.++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~-~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRN-PPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhC-CCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99976 88998865333 2567899999999999999999999988 9999999999999865 4699999999
Q ss_pred ce
Q 005731 662 AR 663 (680)
Q Consensus 662 a~ 663 (680)
|+
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 99
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.4e-16 Score=158.15 Aligned_cols=153 Identities=20% Similarity=0.247 Sum_probs=126.1
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCC--Cc----eeeEEEEEEeCCe
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH--RN----LVRILGCCVEQGE 583 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H--~n----iv~l~g~~~~~~~ 583 (680)
.+++|.+...+|+|.||.|.++.. ..+..||||+++.. ..-.+..+-|++++.++.+ |+ +|.+.+++.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 368899999999999999999963 34789999999863 3345667889999999942 33 7788888888899
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-------------
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK------------- 650 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~------------- 650 (680)
.+||+|.| |-|+.++|.. ++..+++..++..|+.|++++++|||+.. ++|-||||+|||+-+
T Consensus 166 iCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999988 5689999854 34567899999999999999999999877 999999999999931
Q ss_pred -------CCCeEEeeeccceecCCCc
Q 005731 651 -------DMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 651 -------~~~~kl~DFGla~~~~~~~ 669 (680)
+..+||+|||-|+.-...+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h 266 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH 266 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc
Confidence 2358999999999765544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.6e-15 Score=157.95 Aligned_cols=135 Identities=27% Similarity=0.325 Sum_probs=112.4
Q ss_pred cCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-----CC---ceeeEEEEEEeC-
Q 005731 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-----HR---NLVRILGCCVEQ- 581 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-----H~---niv~l~g~~~~~- 581 (680)
..+|.+.++||-|.|++||++. ....+-||+|+.+. ...-.+..+.||++|.+++ |+ .||+|++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 4689999999999999999997 45678999999986 3345667789999999883 43 599999999764
Q ss_pred ---CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC
Q 005731 582 ---GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD 651 (680)
Q Consensus 582 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~ 651 (680)
.+++||+|++ |.+|..++.. ..-+.++...+.+|++||+.||.|||.++ +|||-||||+||||..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 5899999998 6677777643 23456888999999999999999999987 79999999999999644
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.8e-16 Score=158.83 Aligned_cols=149 Identities=26% Similarity=0.466 Sum_probs=127.6
Q ss_pred HHHhcCCcceeeeeccCCceeEEEEEEc----CCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 005731 508 VAAATENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (680)
Q Consensus 508 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 582 (680)
.....+.|..+++||+|.|+.||++... ..+.||+|.+...+ ...+..+|+++|..+ -|.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445577899999999999999999743 46789999997543 346688999999999 4899999999999999
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC-CCeEEeeecc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGL 661 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGl 661 (680)
...+|+||+++....++.+ .+...++..++..+.+||+++|.++ ||||||||.|+|.+.. +.-.|.||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999999988873 3567888899999999999999998 9999999999999854 5679999999
Q ss_pred ceecCC
Q 005731 662 ARMFGG 667 (680)
Q Consensus 662 a~~~~~ 667 (680)
|..++.
T Consensus 180 A~~~d~ 185 (418)
T KOG1167|consen 180 AQRYDG 185 (418)
T ss_pred HHHHHh
Confidence 985443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=5e-16 Score=154.26 Aligned_cols=146 Identities=32% Similarity=0.429 Sum_probs=118.2
Q ss_pred CCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------e
Q 005731 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------E 583 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~ 583 (680)
.+|.-...++.|.- .|..+- .-.+++||+|++... .....++..+|..++..++|+|+++++.++.-.. +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888887 555553 335789999988643 2334567789999999999999999999987543 6
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.|+|||||. .+|...+. ..++.+++..|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 799999995 57766653 34677888899999999999999887 9999999999999999999999999999
Q ss_pred ecCCC
Q 005731 664 MFGGD 668 (680)
Q Consensus 664 ~~~~~ 668 (680)
.-+.+
T Consensus 167 ~e~~~ 171 (369)
T KOG0665|consen 167 TEDTD 171 (369)
T ss_pred ccCcc
Confidence 65444
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.7e-15 Score=145.88 Aligned_cols=139 Identities=20% Similarity=0.243 Sum_probs=99.1
Q ss_pred eeeeccCCceeEEEEEEcCCcEEEEEEccCCCcc--cHHHH----------------------HHHHHHHhhcCCCc--e
Q 005731 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ--GLKEF----------------------KNEMMLIAELQHRN--L 571 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~--~~~~f----------------------~~E~~~l~~l~H~n--i 571 (680)
.+.||+|+||.||+|...++++||||++...... ....+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999778999999988653211 11111 34555666654432 4
Q ss_pred eeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCcEEEcC
Q 005731 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDK 650 (680)
Q Consensus 572 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~ 650 (680)
.+.++. ...++||||++++.+........ ... .+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 24689999999955422111110 011 5567899999999999998 66 99999999999999
Q ss_pred CCCeEEeeeccceecCCC
Q 005731 651 DMNPKISDFGLARMFGGD 668 (680)
Q Consensus 651 ~~~~kl~DFGla~~~~~~ 668 (680)
++.++|+|||.|......
T Consensus 150 ~~~~~liDfg~a~~~~~~ 167 (187)
T cd05119 150 DGKVYIIDVPQAVEIDHP 167 (187)
T ss_pred CCcEEEEECcccccccCc
Confidence 899999999999877553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.8e-15 Score=136.77 Aligned_cols=137 Identities=23% Similarity=0.230 Sum_probs=115.0
Q ss_pred eeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCC--CceeeEEEEEEeCCeEEEEEEccCCC
Q 005731 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH--RNLVRILGCCVEQGEKILILEYMPNK 594 (680)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~g 594 (680)
+.+.|++|.++.||++...+ ..++||....... ...+.+|+.++..++| +.+.+++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999654 7899999875432 5678999999999976 58899998888778899999999988
Q ss_pred ChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||+++...
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 77432 456667789999999999998644569999999999999998999999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.6e-16 Score=121.39 Aligned_cols=66 Identities=53% Similarity=1.104 Sum_probs=57.7
Q ss_pred CCCCCceeEeeccCCCCccceeeccCCCHHHHHHHHhcCCccccccccccCCCceeEEEcCCcccc
Q 005731 336 CTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEGSGCLMWYGDLLDS 401 (680)
Q Consensus 336 C~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~~~~~g~~C~~w~~~l~~~ 401 (680)
|+.++.|+++++|++|++....++.+.++++|++.||+||||+||+|.+..++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 545789999999999999777666679999999999999999999998655578899999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.3e-15 Score=157.54 Aligned_cols=154 Identities=23% Similarity=0.295 Sum_probs=130.4
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC------CCceeeEEEEEEeCCe
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ------HRNLVRILGCCVEQGE 583 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~------H~niv~l~g~~~~~~~ 583 (680)
.-.+|.+....|+|-|++|.+|.. ..++.||||+|.... ...+.=+.|+++|.+|+ .-|+++|+-.|....+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 346899889999999999999974 447899999998743 33455578999999995 3479999999999999
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC-CCeEEeeeccc
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLA 662 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla 662 (680)
++||+|-+ ..+|.+.|......-.|....+..++.|+.-||..|-..+ |+|.||||.|||+++. ..+||+|||-|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999987 5689999877666677888899999999999999999877 9999999999999975 56899999999
Q ss_pred eecCCCc
Q 005731 663 RMFGGDE 669 (680)
Q Consensus 663 ~~~~~~~ 669 (680)
-....++
T Consensus 585 ~~~~ene 591 (752)
T KOG0670|consen 585 SFASENE 591 (752)
T ss_pred ccccccc
Confidence 8776554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.9e-14 Score=145.67 Aligned_cols=150 Identities=35% Similarity=0.544 Sum_probs=127.1
Q ss_pred cceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcc---cHHHHHHHHHHHhhcCCC-ceeeEEEEEEeCCeEEEEEEc
Q 005731 515 FSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ---GLKEFKNEMMLIAELQHR-NLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~---~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~Ey 590 (680)
|.+.+.||.|+|+.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999865 78999998764332 367899999999999988 799999999777778999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC-CeEEeeeccceecCCCc
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMFGGDE 669 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 669 (680)
+.++++..++........+.......++.|++.++.|+|..+ ++|||+||+||+++... .+|++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999866532211126788889999999999999999988 99999999999999988 79999999999765543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=5e-14 Score=142.25 Aligned_cols=136 Identities=24% Similarity=0.263 Sum_probs=104.0
Q ss_pred eeec-cCCceeEEEEEEcCCcEEEEEEccCCC-------------cccHHHHHHHHHHHhhcCCCce--eeEEEEEEeCC
Q 005731 519 CKLG-EGGFGPVYKGRLFNGQEVAVKRLSSQS-------------GQGLKEFKNEMMLIAELQHRNL--VRILGCCVEQG 582 (680)
Q Consensus 519 ~~LG-~G~fG~Vy~~~~~~~~~VAVK~l~~~~-------------~~~~~~f~~E~~~l~~l~H~ni--v~l~g~~~~~~ 582 (680)
..|| .|+.|+||+.... +..++||++.... ......+.+|++++.+++|+++ .+.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4576 7888888888764 6788998875311 1223567889999999998875 67777654432
Q ss_pred ----eEEEEEEccCC-CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEe
Q 005731 583 ----EKILILEYMPN-KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (680)
Q Consensus 583 ----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 657 (680)
..++|||++++ .+|.+++.+ ..++.. .+.+|+.+|.+||+.+ |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 688887732 233433 3568999999999988 9999999999999998999999
Q ss_pred eeccceecC
Q 005731 658 DFGLARMFG 666 (680)
Q Consensus 658 DFGla~~~~ 666 (680)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999998764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.6e-13 Score=147.64 Aligned_cols=142 Identities=23% Similarity=0.297 Sum_probs=99.7
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCcccH------------------------------H----------HHHH
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGL------------------------------K----------EFKN 558 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~------------------------------~----------~f~~ 558 (680)
+.||.|++|+||+|++.+|+.||||+.+....... + .|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999865311100 0 2445
Q ss_pred HHHHHhhc----CCCceeeEEEEEE-eCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 005731 559 EMMLIAEL----QHRNLVRILGCCV-EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ-GLLYLHQYS 632 (680)
Q Consensus 559 E~~~l~~l----~H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~~ 632 (680)
|++.+.++ +|.+-+.+-.++. .....+|||||++|++|.+..... .... .+..++.++++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~--~~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD--EAGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH--hcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 55555554 2322233322322 234679999999999998765321 1112 23456666666 467889877
Q ss_pred CCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 633 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
++|+|++|.||++++++.++++|||++..+..+
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 999999999999999999999999999988643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=5e-13 Score=154.23 Aligned_cols=147 Identities=26% Similarity=0.352 Sum_probs=113.4
Q ss_pred HHhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC---CCceeeEEEEEEeCCeEE
Q 005731 509 AAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ---HRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 509 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~ 585 (680)
......|.+.+.||+|+||.||+|...+++.||+|+-+....- +|---.+++.||+ -+-|+++.....-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3445689999999999999999999878999999987654321 1111122333333 123444444455566788
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-------CCCeEEee
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-------DMNPKISD 658 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-------~~~~kl~D 658 (680)
||+||.+.|+|.+++ +..+.+++...+.++.|+++-++.||..+ |||+||||+|+||.. ...++|+|
T Consensus 771 lv~ey~~~Gtlld~~---N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLI---NTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhh---ccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 999999999999998 45678899999999999999999999887 999999999999953 34689999
Q ss_pred ecccee
Q 005731 659 FGLARM 664 (680)
Q Consensus 659 FGla~~ 664 (680)
||-+-=
T Consensus 845 fG~siD 850 (974)
T KOG1166|consen 845 FGRSID 850 (974)
T ss_pred ccccee
Confidence 998853
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-11 Score=117.78 Aligned_cols=131 Identities=21% Similarity=0.157 Sum_probs=97.2
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCcee-eEEEEEEeCCeEEEEEEccCCCChh
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV-RILGCCVEQGEKILILEYMPNKSLD 597 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gsL~ 597 (680)
+.|+.|.++.||+++.. ++.+++|....... ....+.+|++++..+.+.+++ +++... ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 67899999999999854 77899998765322 233567899999888665544 444432 33468999999998874
Q ss_pred hHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 598 VYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS--RLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
... . ....++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.|..-
T Consensus 80 ~~~-------~----~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 80 TED-------F----SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred ccc-------c----cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 320 0 11235678999999999875 23469999999999998 668999999999853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.1e-12 Score=105.33 Aligned_cols=80 Identities=38% Similarity=0.755 Sum_probs=63.2
Q ss_pred CCCCCCC---CceeEeeccCCCCccceeeccCCCHHHHHHHHhcCCccccccccccCCCceeEEEcCCcccccCCccccC
Q 005731 333 SSECTRG---TQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEGSGCLMWYGDLLDSRRPIRNFT 409 (680)
Q Consensus 333 ~~~C~~~---~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~~~~~g~~C~~w~~~l~~~~~~~~~~~ 409 (680)
+++|... +.|.++.++++|++.... .+.++++|++.|++||+|.||+|.+. +++|++|...+.+.+.... .
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~~--~~~C~~~~~~~~~~~~~~~--~ 75 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNNG--SGGCLLWNGLLNNLRSLSS--G 75 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecCC--CCeEEEEeceecceEeecC--C
Confidence 3457543 689999999999886543 56799999999999999999999852 4679999999888765432 3
Q ss_pred Cceeeeecc
Q 005731 410 GQSVYLQVP 418 (680)
Q Consensus 410 ~~~lyvrl~ 418 (680)
+.++|||++
T Consensus 76 ~~~~yiKv~ 84 (84)
T cd01098 76 GGTLYLRLA 84 (84)
T ss_pred CcEEEEEeC
Confidence 578999875
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.1e-12 Score=103.32 Aligned_cols=71 Identities=20% Similarity=0.330 Sum_probs=59.3
Q ss_pred CCCCCceeEeeccCCCCccceeeccCCCHHHHHHHHhc---CCccccccccccCCCceeEEEcCCc-ccccCCccccCCc
Q 005731 336 CTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLK---NCTCKAYANSNVTEGSGCLMWYGDL-LDSRRPIRNFTGQ 411 (680)
Q Consensus 336 C~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~A~~~~~~~~g~~C~~w~~~l-~~~~~~~~~~~~~ 411 (680)
|...+.|+++.++++|++.. .++++|++.|++ ||||.||+|.+. +.||++|++++ .++++... .+.
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~--~~gC~~W~~~l~~d~~~~~~--~g~ 74 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA--RKQCLWFPFNSMSGVRKEFS--HGF 74 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC--CCCeEEecCcchhhHHhccC--CCc
Confidence 44567899999999998754 589999999999 999999999753 46899999999 88877544 578
Q ss_pred eeeee
Q 005731 412 SVYLQ 416 (680)
Q Consensus 412 ~lyvr 416 (680)
++|+|
T Consensus 75 ~Ly~r 79 (80)
T cd00129 75 DLYEN 79 (80)
T ss_pred eeEeE
Confidence 89987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.6e-11 Score=136.29 Aligned_cols=148 Identities=17% Similarity=0.218 Sum_probs=93.8
Q ss_pred cCCcceeeeeccCCceeEEEEEEcC-CcEEEEEEccCCCcc----------------------------------cHH--
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQ----------------------------------GLK-- 554 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~----------------------------------~~~-- 554 (680)
...|+. +.||.|++|+||+|++.+ |+.||||++++.-.. ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345765 789999999999999877 999999999753110 001
Q ss_pred ----HHHHHHHHHhhc----CCCceeeEEEEEEe-CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHH-
Q 005731 555 ----EFKNEMMLIAEL----QHRNLVRILGCCVE-QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG- 624 (680)
Q Consensus 555 ----~f~~E~~~l~~l----~H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~- 624 (680)
.|.+|+.-+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.+...- .....+... ++...++.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l--~~~g~d~~~---la~~~v~~~ 272 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL--RAAGTDMKL---LAERGVEVF 272 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH--HhcCCCHHH---HHHHHHHHH
Confidence 134444444444 24444443333332 3467899999999999764211 111122111 11111111
Q ss_pred HHHHHhCCCCceEeCCCCCCcEEEcCCC----CeEEeeeccceecCCC
Q 005731 625 LLYLHQYSRLRIIHRDLKASNVLLDKDM----NPKISDFGLARMFGGD 668 (680)
Q Consensus 625 L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGla~~~~~~ 668 (680)
+.-++..+ ++|+|+||.||+++.++ .+++.|||++..+..+
T Consensus 273 ~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 273 FTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 22223445 99999999999999888 9999999999988554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=8e-12 Score=141.45 Aligned_cols=143 Identities=25% Similarity=0.344 Sum_probs=109.6
Q ss_pred eeeeeccCCceeEEEEEE-cCCcEEEEEEcc----C-CCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 517 MQCKLGEGGFGPVYKGRL-FNGQEVAVKRLS----S-QSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~----~-~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
..+.+|.|++|.|+.... ...+..+.|... . .... ....+..|+.+-..++|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 347899999997777653 223333333222 1 1111 12226678888888999999888777777766666699
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|+++ +|..++.+ ...+...++..+++|+.+|+.|||+.+ |.|||+|++|++++.++.+||+|||.+..+.
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence 9999 99888733 346778888899999999999999988 9999999999999999999999999998774
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.4e-11 Score=144.32 Aligned_cols=85 Identities=19% Similarity=0.262 Sum_probs=66.0
Q ss_pred hcCC-CceeeEEEEE-------EeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 005731 565 ELQH-RNLVRILGCC-------VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636 (680)
Q Consensus 565 ~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 636 (680)
.++| +||+++++++ .+.+..++++||+ +++|.++|... ...+++.++..++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3445 5777788876 2334567788987 56999998532 345899999999999999999999987 9
Q ss_pred EeCCCCCCcEEEcCCCCeE
Q 005731 637 IHRDLKASNVLLDKDMNPK 655 (680)
Q Consensus 637 iHrDlkp~NILl~~~~~~k 655 (680)
+||||||+||||+..+.+|
T Consensus 102 vHrDlKP~NiLl~~~~~~k 120 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVS 120 (793)
T ss_pred eeccCCchhEEEcccCcEE
Confidence 9999999999996533333
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.1e-10 Score=107.01 Aligned_cols=140 Identities=15% Similarity=0.127 Sum_probs=99.3
Q ss_pred eeeccCCceeEEEEEEcC-------CcEEEEEEccCC-------------C---------cccHHHHH----HHHHHHhh
Q 005731 519 CKLGEGGFGPVYKGRLFN-------GQEVAVKRLSSQ-------------S---------GQGLKEFK----NEMMLIAE 565 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~-------~~~VAVK~l~~~-------------~---------~~~~~~f~----~E~~~l~~ 565 (680)
..||.|--+.||.|.-.+ +..+|||..+.. . ....+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999997443 479999976421 0 00122333 79999988
Q ss_pred cCC--CceeeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEeCCCC
Q 005731 566 LQH--RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL-HQYSRLRIIHRDLK 642 (680)
Q Consensus 566 l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHrDlk 642 (680)
+.. .++.+.+++ ...+|||||+.+..+.... .+...++.++...+..+++.+|..| |..+ |||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~---Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK---LKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh---hhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 853 455566654 4678999999775442211 1122344455667889999999999 7776 9999999
Q ss_pred CCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 643 ASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
+.|||++ ++.+.|+|||.|.......
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~hp~ 178 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPTHPH 178 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCCCCC
Confidence 9999996 4689999999998775443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.5e-10 Score=110.34 Aligned_cols=143 Identities=20% Similarity=0.276 Sum_probs=110.2
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCC--CceeeEEEEEEeCC---eEEEEEEccC
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQH--RNLVRILGCCVEQG---EKILILEYMP 592 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~-~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~Ey~~ 592 (680)
+.|+.|..+.||+++..+|+.+++|....... ....++..|++++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999876678899999765322 245678899999999976 44566777766542 5689999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS---------------------------------------- 632 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------- 632 (680)
+.++...+. ...++..++..++.++++.|..||+..
T Consensus 84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 988865441 134667777788888888888888521
Q ss_pred -------------CCceEeCCCCCCcEEEcC--CCCeEEeeeccceec
Q 005731 633 -------------RLRIIHRDLKASNVLLDK--DMNPKISDFGLARMF 665 (680)
Q Consensus 633 -------------~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~ 665 (680)
...++|+|+.|.||+++. ++.+.|+||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245799999999999998 667899999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.3e-11 Score=131.81 Aligned_cols=144 Identities=28% Similarity=0.324 Sum_probs=115.9
Q ss_pred eeccCCceeEEEEE----EcCCcEEEEEEccCCCc-cc-HHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEEccC
Q 005731 520 KLGEGGFGPVYKGR----LFNGQEVAVKRLSSQSG-QG-LKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 520 ~LG~G~fG~Vy~~~----~~~~~~VAVK~l~~~~~-~~-~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
++|+|+||.|+.++ .+.+..+|+|.+++... .. ......|..++..++ ||.++++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999864 34467788888865321 11 124566788888887 9999999999999999999999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
+|+|...+ .....++......+...++-+++++|+.+ |+|||+|++||+++.+|.+|+.|||+++..-..+
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 99997766 33344556666667778999999999887 9999999999999999999999999999775443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.7e-09 Score=99.07 Aligned_cols=136 Identities=19% Similarity=0.288 Sum_probs=100.3
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEE-ccCC--Cc-----ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKR-LSSQ--SG-----QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~-l~~~--~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
..+++|+-+.+|.+...+ .++++|. +++. .+ ...++-.+|+.++.+++--.|..-.=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 357899999999997543 3455553 3332 11 1234567899999998755554444556677788999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
+++..|.+.+... ...++..|-+-+.-||..+ |+|+||.++||++..+. +.++||||+..-...+
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~E 145 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEVE 145 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccHH
Confidence 9999998887332 2556777888899999988 99999999999996654 9999999998654433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.5e-09 Score=109.17 Aligned_cols=151 Identities=23% Similarity=0.324 Sum_probs=98.6
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCC----------CceeeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQH----------RNLVRILGCC 578 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H----------~niv~l~g~~ 578 (680)
..+...+.||.|+++.||.++.. +++++|||..... .....+++++|.-.+..+.+ -.++--++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 35667789999999999999864 4899999987532 23456778888776666443 1122222221
Q ss_pred E---------eC--C------eEEEEEEccCCCChhhHhc---ccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 005731 579 V---------EQ--G------EKILILEYMPNKSLDVYLF---DPIKK-RLLDWEARIRIIQGIAQGLLYLHQYSRLRII 637 (680)
Q Consensus 579 ~---------~~--~------~~~lV~Ey~~~gsL~~~l~---~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 637 (680)
. .. . ..+++|+-+ .++|..++. ..... ..+....++.+..|+.+.+++||..+ ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 1 11 1 235677766 578877742 21111 12334455667789999999999998 99
Q ss_pred eCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 638 HRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 638 HrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+||||+|++++++|.++|.||+.....+.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~ 197 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGT 197 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCc
Confidence 999999999999999999999998887654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.4e-08 Score=94.77 Aligned_cols=150 Identities=21% Similarity=0.290 Sum_probs=105.7
Q ss_pred eeeeeccCCceeEEEEEEcCCcEEEEEE-ccCC--C-----cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKR-LSSQ--S-----GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~-l~~~--~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
..+.|-+|+-+.|+++.. .|+...||. ..+. . .....+.++|++++.+++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 357899999999999985 466666663 3321 1 123456788999999986555444444556666778999
Q ss_pred EccCC-CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC---CeEEeeecccee
Q 005731 589 EYMPN-KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM---NPKISDFGLARM 664 (680)
Q Consensus 589 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DFGla~~ 664 (680)
||+++ -++.+++........ ..+....++..|-+.+.-||..+ |||+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 466777644322222 22233678889999999999988 99999999999997654 358999999876
Q ss_pred cCCCccc
Q 005731 665 FGGDELQ 671 (680)
Q Consensus 665 ~~~~~~~ 671 (680)
-...+.+
T Consensus 166 s~~~EDK 172 (229)
T KOG3087|consen 166 SRLPEDK 172 (229)
T ss_pred ccCcccc
Confidence 5444433
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.7e-10 Score=111.02 Aligned_cols=138 Identities=27% Similarity=0.511 Sum_probs=113.2
Q ss_pred ceeeeeccCCceeEEEEEEcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 516 SMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
.+..+|.+...|+.|+|+.. |..+++|++... .....+.|..|.-.|+-+.||||+.++|.|....+..++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34467888899999999965 456677877643 233456788999999999999999999999999999999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe-CCCCCCcEEEcCCCCeEEe
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH-RDLKASNVLLDKDMNPKIS 657 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH-rDlkp~NILl~~~~~~kl~ 657 (680)
|||...|++. ..-..+..+.++++.+||+|++|||+.. +++- --|.+..+++|++.++||+
T Consensus 272 gslynvlhe~-t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 272 GSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred hHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee
Confidence 9999999664 3345677889999999999999999875 3443 3688999999999988874
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=2e-07 Score=95.39 Aligned_cols=140 Identities=19% Similarity=0.124 Sum_probs=98.5
Q ss_pred eeccCCceeEEEEEEcCCcEEEEEEccCCCc-----------ccHHHHHHHHHHHhhcCCCc--eeeEEEEEEe-----C
Q 005731 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG-----------QGLKEFKNEMMLIAELQHRN--LVRILGCCVE-----Q 581 (680)
Q Consensus 520 ~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~-----------~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~-----~ 581 (680)
.+-+-....|++.+. +|+.+.||+...... .....+.+|...+.++...+ ..+.+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 343333444667654 677899997743221 11124778999888884333 3445555543 2
Q ss_pred CeEEEEEEccCCC-ChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-------CCC
Q 005731 582 GEKILILEYMPNK-SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-------DMN 653 (680)
Q Consensus 582 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-------~~~ 653 (680)
...+||+|++++- +|.+++.+-. ....+...+..++.+++..+.-||..+ |+|+|+++.|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3578999999986 7888873211 233455667789999999999999998 999999999999975 467
Q ss_pred eEEeeecccee
Q 005731 654 PKISDFGLARM 664 (680)
Q Consensus 654 ~kl~DFGla~~ 664 (680)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999999865
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.6e-09 Score=123.57 Aligned_cols=142 Identities=22% Similarity=0.246 Sum_probs=108.7
Q ss_pred CcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCC-cccHHHHHHHHHHH--hhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS-GQGLKEFKNEMMLI--AELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l--~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.+...+.||.+.|=.|.+++.+.|. |+||++-+.. ...++.|.++++-+ .-++|||.+.+.-+-....-.|||=+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4666789999999999999988887 8999987654 34566666655544 445899999887665555556677677
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.. -+|.+.| ..+..+..-+..-|+.|++.||.-+|..+ |+|+|||.|||||+.=.=+.|+||.--|
T Consensus 103 vk-hnLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 103 VK-HNLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred Hh-hhhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 64 3564444 22334566677789999999999999887 9999999999999998889999998655
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.1e-08 Score=102.97 Aligned_cols=89 Identities=27% Similarity=0.481 Sum_probs=67.0
Q ss_pred CCCceeeEEEEEEe---------------------------CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHH
Q 005731 567 QHRNLVRILGCCVE---------------------------QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQ 619 (680)
Q Consensus 567 ~H~niv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 619 (680)
+|||||++.++|.+ ...+|+||.-.+ .+|..++..+ ........-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence 58999988887753 235688887664 5787777322 233445566788
Q ss_pred HHHHHHHHHHhCCCCceEeCCCCCCcEEEc--CCC--CeEEeeeccce
Q 005731 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLD--KDM--NPKISDFGLAR 663 (680)
Q Consensus 620 ~ia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~--~~kl~DFGla~ 663 (680)
|+++|+.|||.++ |.|||+|++||||. ++. .+.|+|||.+-
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence 9999999999988 99999999999994 343 46889999764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.1e-09 Score=120.58 Aligned_cols=151 Identities=26% Similarity=0.368 Sum_probs=118.8
Q ss_pred CCcceeeeeccCCceeEEEEEEc--CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF--NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~--~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 587 (680)
..|.+.+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45777788999999999887643 34466777665432 233444555777777776 99999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEeCCCCCCcEEEcCCC-CeEEeeeccceec
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH-QYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMF 665 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~ 665 (680)
+||..++++.+.+... .....+......++.|+..++.|+| +.+ +.||||||+|.+++..+ ..|++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999996655211 1113455667788999999999999 776 99999999999999999 9999999999988
Q ss_pred CC
Q 005731 666 GG 667 (680)
Q Consensus 666 ~~ 667 (680)
..
T Consensus 176 ~~ 177 (601)
T KOG0590|consen 176 RN 177 (601)
T ss_pred cc
Confidence 65
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.1e-07 Score=91.79 Aligned_cols=128 Identities=25% Similarity=0.286 Sum_probs=82.4
Q ss_pred eEEEEEEcCCcEEEEEEccCCC---------------------c-----ccHHHHHHHHHHHhhcCCC--ceeeEEEEEE
Q 005731 528 PVYKGRLFNGQEVAVKRLSSQS---------------------G-----QGLKEFKNEMMLIAELQHR--NLVRILGCCV 579 (680)
Q Consensus 528 ~Vy~~~~~~~~~VAVK~l~~~~---------------------~-----~~~~~f~~E~~~l~~l~H~--niv~l~g~~~ 579 (680)
.||.|...++..+|||..+... . ......++|.+.|.++..- ++.+.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998889999999754210 0 0123467899999999765 455665442
Q ss_pred eCCeEEEEEEccC--CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCceEeCCCCCCcEEEcCCCCeEE
Q 005731 580 EQGEKILILEYMP--NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY-LHQYSRLRIIHRDLKASNVLLDKDMNPKI 656 (680)
Q Consensus 580 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~iiHrDlkp~NILl~~~~~~kl 656 (680)
...|||||++ +..+.... +. .+..+....++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DV----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HC----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHH-hc----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4579999998 55553322 11 11123445667777776665 46666 9999999999999888 9999
Q ss_pred eeeccceecCCC
Q 005731 657 SDFGLARMFGGD 668 (680)
Q Consensus 657 ~DFGla~~~~~~ 668 (680)
+|||.|......
T Consensus 148 IDf~qav~~~~p 159 (188)
T PF01163_consen 148 IDFGQAVDSSHP 159 (188)
T ss_dssp --GTTEEETTST
T ss_pred EecCcceecCCc
Confidence 999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.5e-08 Score=107.26 Aligned_cols=100 Identities=35% Similarity=0.513 Sum_probs=88.8
Q ss_pred HhhcCCCceeeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCC
Q 005731 563 IAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642 (680)
Q Consensus 563 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 642 (680)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ....+++.-...++++|++||+|||.-. -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3567899999999999999999999999999999999854 3456788888889999999999999743 23999999
Q ss_pred CCcEEEcCCCCeEEeeeccceecC
Q 005731 643 ASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~~~~ 666 (680)
+.|+++|....+||+|||+..+..
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cccceeeeeEEEEechhhhccccc
Confidence 999999999999999999998774
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.4e-07 Score=82.28 Aligned_cols=88 Identities=25% Similarity=0.321 Sum_probs=63.4
Q ss_pred eEEEeeCCeEEEEecC-CCeeEeecccCCC-CCceEEEccCCCEEEEeCCCCCccccceeeecCCCccccccccccccee
Q 005731 89 VLTISNNGNLVLLSQT-NGTIWSTNVSSDV-KNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (680)
Q Consensus 89 ~l~~~~~g~l~l~~~~-~~~~w~~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~l~~~~ 166 (680)
++.++.||+||+++.. +.++|++++.... ....+.|+++|||||++.+ +.++|+| +|-
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S-----~t~---------- 82 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD-----GRVVWSS-----NTT---------- 82 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC-----CCEEEEe-----ccc----------
Confidence 4566789999999865 5899999986432 2367899999999999876 4579996 111
Q ss_pred ecCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeC
Q 005731 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSG 213 (680)
Q Consensus 167 ~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g 213 (680)
...+.|.+.|+++|+.+++-.. ..+.|.+.
T Consensus 83 ----------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf 112 (114)
T smart00108 83 ----------------GANGNYVLVLLDDGNLVIYDSD-GNFLWQSF 112 (114)
T ss_pred ----------------CCCCceEEEEeCCCCEEEECCC-CCEEeCCC
Confidence 1345678889999997665333 34667653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.5e-07 Score=99.80 Aligned_cols=122 Identities=20% Similarity=0.242 Sum_probs=99.9
Q ss_pred EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHH
Q 005731 534 LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEA 613 (680)
Q Consensus 534 ~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~ 613 (680)
..++.+|.|...+...+.......+-++.++.++||||++++....+.+..|||+|-+. .|..++.+ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 45688899988876554445566778889999999999999999999999999999873 46666632 22344
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 614 ~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
....+.||+.||.|||+.+ .++|++|.-..|++++.|+.||.+|-++...
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 5566889999999999877 5999999999999999999999999988654
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.2e-07 Score=80.98 Aligned_cols=88 Identities=24% Similarity=0.270 Sum_probs=63.8
Q ss_pred EEEee-CCeEEEEecC-CCeeEeecccCC-CCCceEEEccCCCEEEEeCCCCCccccceeeecCCCccccccccccccee
Q 005731 90 LTISN-NGNLVLLSQT-NGTIWSTNVSSD-VKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (680)
Q Consensus 90 l~~~~-~g~l~l~~~~-~~~~w~~~~~~~-~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~l~~~~ 166 (680)
+.++. ||+||+++.. +.++|++++... .....+.|+++|||||++.+ +.++|+|=-.
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S~~~--------------- 83 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS-----GTVVWSSNTT--------------- 83 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC-----CcEEEEeccc---------------
Confidence 44565 9999999865 589999998652 34567899999999999876 4689996110
Q ss_pred ecCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeCC
Q 005731 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQ 214 (680)
Q Consensus 167 ~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 214 (680)
...+.+.+.|+++|+..++-.+ ..+.|.+..
T Consensus 84 ----------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~ 114 (116)
T cd00028 84 ----------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114 (116)
T ss_pred ----------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence 0246678889999997766433 356777654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.4e-06 Score=84.42 Aligned_cols=108 Identities=24% Similarity=0.244 Sum_probs=84.1
Q ss_pred HHHHHHHHHHHhhcCC--CceeeEEEEEEeCC----eEEEEEEccCC-CChhhHhcccccCCCCCHHHHHHHHHHHHHHH
Q 005731 553 LKEFKNEMMLIAELQH--RNLVRILGCCVEQG----EKILILEYMPN-KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625 (680)
Q Consensus 553 ~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L 625 (680)
.....+|...+.++.. -.+.+.+++..... ..+||+|++++ .+|.+++... ...+......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 3467788887777743 34556666665532 45899999987 4788887331 1255667788999999999
Q ss_pred HHHHhCCCCceEeCCCCCCcEEEcCCC---CeEEeeeccceecC
Q 005731 626 LYLHQYSRLRIIHRDLKASNVLLDKDM---NPKISDFGLARMFG 666 (680)
Q Consensus 626 ~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DFGla~~~~ 666 (680)
+-||+.+ |+|+|+++.|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999998 99999999999999887 89999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.8e-06 Score=92.29 Aligned_cols=141 Identities=19% Similarity=0.257 Sum_probs=109.9
Q ss_pred ceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeEEEEEEccCC-CChhhH
Q 005731 526 FGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE----QGEKILILEYMPN-KSLDVY 599 (680)
Q Consensus 526 fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~ 599 (680)
-.+.||+. ..+|..++.|+++....+....--.-+++++++.|+|+|++..++.. +..+++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35678887 46799999999954333332223345778899999999999998873 3467899999985 666555
Q ss_pred hccc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 600 LFDP------------IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 600 l~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
.+.. ......++..++.++.|+..||.++|+.| +..+-|.|.+||++.+.+++|+.-|+..++..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4432 12235677889999999999999999988 88899999999999999999999999888866
Q ss_pred Cc
Q 005731 668 DE 669 (680)
Q Consensus 668 ~~ 669 (680)
+.
T Consensus 446 d~ 447 (655)
T KOG3741|consen 446 DP 447 (655)
T ss_pred CC
Confidence 55
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.7e-06 Score=84.75 Aligned_cols=139 Identities=19% Similarity=0.177 Sum_probs=95.7
Q ss_pred cceeeeeccCCceeEEEEEEcCCcEEEEEEccCC--------------------C--cccHHHHHHHHHHHhhcCCC--c
Q 005731 515 FSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--------------------S--GQGLKEFKNEMMLIAELQHR--N 570 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--------------------~--~~~~~~f~~E~~~l~~l~H~--n 570 (680)
..+.++||-|--+.||.|..+.|.++|||.=+.. + .......++|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4566899999999999999888999999953210 0 01223467889999988644 5
Q ss_pred eeeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC
Q 005731 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK 650 (680)
Q Consensus 571 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~ 650 (680)
+.+-+++ +...+||||+++-.|...- -..-..++++ ..|++-+.-+-..+ |||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il---~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEIL---DKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHH---HHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 5555544 5678999999987763221 0122333333 33334333333444 999999999999999
Q ss_pred CCCeEEeeeccceecCCC
Q 005731 651 DMNPKISDFGLARMFGGD 668 (680)
Q Consensus 651 ~~~~kl~DFGla~~~~~~ 668 (680)
+|.+.++||--+......
T Consensus 238 dg~~~vIDwPQ~v~~~hp 255 (304)
T COG0478 238 DGDIVVIDWPQAVPISHP 255 (304)
T ss_pred CCCEEEEeCcccccCCCC
Confidence 999999999988765443
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.9e-06 Score=73.63 Aligned_cols=100 Identities=27% Similarity=0.439 Sum_probs=68.4
Q ss_pred CEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEec-CCCCCCCCCCceEEEeeCCeEEEEecCCCeeEeecccCC
Q 005731 38 EKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVA-NRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSD 116 (680)
Q Consensus 38 ~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~a-nr~~pv~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~ 116 (680)
+.+.+.+|.+.|-|..+|+ |.|... ..++||.. +...+.. ..+.+.|+.||||||+|..+.++|+|...
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~~~--~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~-- 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLYDS--NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDY-- 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEEET--TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTS--
T ss_pred cccccccccccceECCCCe-----EEEEcC--CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCC--
Confidence 4565656899999999886 434322 25779999 4333331 46899999999999999999999999432
Q ss_pred CCCceEEEcc--CCCEEEEeCCCCCccccceeeecCCCc
Q 005731 117 VKNPVAQLRD--DGNLVIRDNSSDSTAESYLWQSFDHPS 153 (680)
Q Consensus 117 ~~~~~~~l~d--~GNlvl~~~~~~~~~~~~~WqSFd~Pt 153 (680)
...+.+..++ .||++ +... ..+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~~-----~~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKND-----SLTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EEST-----SSEEEESS----
T ss_pred CccEEEeccCcccCCCc-cccc-----eEEeECCCCCCC
Confidence 4567788888 89999 6543 357999876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.1e-07 Score=100.14 Aligned_cols=150 Identities=24% Similarity=0.300 Sum_probs=118.9
Q ss_pred HhcCCcceeeeeccCCceeEEEEEE--cCCcEEEEEEccCCCcccHH--HHHHHHHHHhhc-CCCceeeEEEEEEeCCeE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRL--FNGQEVAVKRLSSQSGQGLK--EFKNEMMLIAEL-QHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~--~~~~~VAVK~l~~~~~~~~~--~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 584 (680)
....+|.++..||.|.|+.|++... .++..+++|.+.+....... .-..|+.+...+ .|.+++++...+.+-.+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788899999999999999863 45778999988654332222 224566666655 588899988888888888
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC-CCeEEeeeccce
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLAR 663 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~ 663 (680)
|+-.||++++++.... .-...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 9999999999987655 23345778888999999999999999876 9999999999999876 788999999986
Q ss_pred ec
Q 005731 664 MF 665 (680)
Q Consensus 664 ~~ 665 (680)
.+
T Consensus 416 ~~ 417 (524)
T KOG0601|consen 416 RL 417 (524)
T ss_pred cc
Confidence 43
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=3e-06 Score=93.91 Aligned_cols=143 Identities=18% Similarity=0.210 Sum_probs=91.7
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCcc------------------------------cHHH----------HHH
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ------------------------------GLKE----------FKN 558 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~------------------------------~~~~----------f~~ 558 (680)
+-|+.++-|+||+|++.+|+.||||+.+..-.. ..++ |.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 678899999999999999999999997642110 0011 233
Q ss_pred HHHHHhhc----CCCceeeEEEEEEe-CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 005731 559 EMMLIAEL----QHRNLVRILGCCVE-QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG-LLYLHQYS 632 (680)
Q Consensus 559 E~~~l~~l----~H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~-L~yLH~~~ 632 (680)
|..-+.++ ++..-+++=.++.+ .....|+|||++|-.+.+...- +...++.+.+ +..++++ +.-+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l--~~~g~d~k~i---a~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL--KSAGIDRKEL---AELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH--HhcCCCHHHH---HHHHHHHHHHHHHhcC
Confidence 44333333 22222233333332 4578899999999998777422 1233443333 3323332 22222234
Q ss_pred CCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 633 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
++|.|..|.||+++.++.+-+.|||+...+.+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~ 319 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKF 319 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHHH
Confidence 9999999999999999999999999998876543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=5.4e-07 Score=103.35 Aligned_cols=111 Identities=28% Similarity=0.393 Sum_probs=76.0
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
..+|..++.|..|++|.||..++. ..+.+|+|.-+... ..+ + ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l--ilR---n---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL--ILR---N---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch--hhh---c---cccccCCccee------------------
Confidence 467999999999999999999854 36678884332211 011 1 22222333333
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|+-...+.. .+.++.+ ++.+++|||..+ |+|||+||+|.||+.-|.+|+.|||+.++.
T Consensus 136 ---gDc~tllk~---~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ---GDCATLLKN---IGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ---chhhhhccc---CCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 444444421 1222222 278899999887 999999999999999999999999999854
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.24 E-value=3e-05 Score=75.54 Aligned_cols=139 Identities=17% Similarity=0.156 Sum_probs=101.2
Q ss_pred eccCCceeEEEEEEcCCcEEEEEEccCC------CcccHHHHHHHHHHHhhcCCC--ceeeEEEEEEeC----CeEEEEE
Q 005731 521 LGEGGFGPVYKGRLFNGQEVAVKRLSSQ------SGQGLKEFKNEMMLIAELQHR--NLVRILGCCVEQ----GEKILIL 588 (680)
Q Consensus 521 LG~G~fG~Vy~~~~~~~~~VAVK~l~~~------~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~~----~~~~lV~ 588 (680)
-|+||-+.|++-.+. |+.+-+|+-... .+.+...|.+|+..|.++... .+.+........ -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 456888889987754 446888987521 144677899999999998543 344444222221 2468999
Q ss_pred EccC-CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC--eEEeeecccee
Q 005731 589 EYMP-NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN--PKISDFGLARM 664 (680)
Q Consensus 589 Ey~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DFGla~~ 664 (680)
|-++ --+|.+++.+. .....+...+..+..++++.+.-||..+ +.|+|+-+.||+++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9775 36888777332 2234566777889999999999999988 999999999999986666 99999987764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.1e-05 Score=77.53 Aligned_cols=140 Identities=16% Similarity=0.171 Sum_probs=84.6
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCc--eeeEEEEEEeCCeEEEEEEccCCCC-
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN--LVRILGCCVEQGEKILILEYMPNKS- 595 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gs- 595 (680)
+.||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 24467788876422 3345688999998886433 4566777777777789999999863
Q ss_pred hhhHhcc--------------------cccCCCCCHHHHH-HHHH----------HHHH-HHHHHHh-CCCCceEeCCCC
Q 005731 596 LDVYLFD--------------------PIKKRLLDWEARI-RIIQ----------GIAQ-GLLYLHQ-YSRLRIIHRDLK 642 (680)
Q Consensus 596 L~~~l~~--------------------~~~~~~l~~~~~~-~i~~----------~ia~-~L~yLH~-~~~~~iiHrDlk 642 (680)
+...+.. ............. .+.. .+.+ ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2111100 0000011111100 0100 0111 1222221 123357899999
Q ss_pred CCcEEEcCCCCeEEeeecccee
Q 005731 643 ASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~~ 664 (680)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.18 E-value=3.9e-06 Score=68.66 Aligned_cols=60 Identities=38% Similarity=0.866 Sum_probs=47.4
Q ss_pred CceeEeeccCCCCccceeeccCCCHHHHHHHHhc-CCccccccccccCCCceeEEEc-CCccccc
Q 005731 340 TQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLK-NCTCKAYANSNVTEGSGCLMWY-GDLLDSR 402 (680)
Q Consensus 340 ~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~A~~~~~~~~g~~C~~w~-~~l~~~~ 402 (680)
..|.+++++.+++..... ....++++|++.|++ +|+|.||.|.. ++.+|.+|. +.+.+..
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~--~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN--GTKGCLLWSESSLGDAR 65 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC--CCCEEEEeeCCccccce
Confidence 568899999988654432 345799999999999 99999999975 346799999 6666654
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.6e-06 Score=80.56 Aligned_cols=62 Identities=26% Similarity=0.149 Sum_probs=53.4
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|+|.+++.+ ....+++.++..++.||++||+|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence 688888843 2346899999999999999999999864 999999999999999 9999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.6e-05 Score=77.08 Aligned_cols=156 Identities=19% Similarity=0.223 Sum_probs=98.5
Q ss_pred ccHHHHHHhcCCcceee---eeccCCceeEEEEEEcCCcEEEEEEccCCCcc---------cHH---------------H
Q 005731 503 FSLASVAAATENFSMQC---KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ---------GLK---------------E 555 (680)
Q Consensus 503 ~~~~~~~~~~~~f~~~~---~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~---------~~~---------------~ 555 (680)
.++..+....++..+.+ .|..|--+.||+|...++..+|||+.+..... +.. .
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34455555555555544 45567778999998878999999997642111 111 1
Q ss_pred HHHHHHHHhhcC--CCceeeEEEEEEeCCeEEEEEEccCCCCh-hhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 005731 556 FKNEMMLIAELQ--HRNLVRILGCCVEQGEKILILEYMPNKSL-DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632 (680)
Q Consensus 556 f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~ 632 (680)
...|..-|.++. +-.+.+-+++ .+..|||||+..... .-.| +.-.++.++...+..++++.+.-|-..+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 223444444442 2222233322 245699999965422 1111 2223344456677788888888887633
Q ss_pred CCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 633 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
++||+||..-|||+. ++.+.|+|||-|.......
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp~ 220 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHPN 220 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccCCCc
Confidence 499999999999998 8899999999998776443
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.8e-05 Score=87.53 Aligned_cols=142 Identities=19% Similarity=0.253 Sum_probs=90.7
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCccc---------------------------HH----------HHHHHHH
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQG---------------------------LK----------EFKNEMM 561 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~---------------------------~~----------~f~~E~~ 561 (680)
+.|+..+.|+||+|++++|+.||||+-++.-... .+ .|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999865421100 00 1334444
Q ss_pred HHhh----cCCCce---eeEEEEEEe-CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 005731 562 LIAE----LQHRNL---VRILGCCVE-QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633 (680)
Q Consensus 562 ~l~~----l~H~ni---v~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 633 (680)
-..+ +.|-++ |+.=.++.+ ...+.|+||||+|..+.+... .....++...+..-+.+...-+-+-| |
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~~qIf~~--G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYLEQIFKT--G- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHHHHHHhc--C-
Confidence 3222 334441 112222222 246899999999988866532 23344555554443333332232333 3
Q ss_pred CceEeCCCCCCcEEEcC----CCCeEEeeeccceecCC
Q 005731 634 LRIIHRDLKASNVLLDK----DMNPKISDFGLARMFGG 667 (680)
Q Consensus 634 ~~iiHrDlkp~NILl~~----~~~~kl~DFGla~~~~~ 667 (680)
++|+|-.|-||+++. +..+.+.|||+.+.+..
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999984 67899999999987644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.06 E-value=3e-06 Score=92.59 Aligned_cols=150 Identities=25% Similarity=0.320 Sum_probs=115.3
Q ss_pred Ccceeeeecc--CCceeEEEEEE---cCCcEEEEEEccC--CCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEE
Q 005731 514 NFSMQCKLGE--GGFGPVYKGRL---FNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 514 ~f~~~~~LG~--G~fG~Vy~~~~---~~~~~VAVK~l~~--~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 585 (680)
.|.....+|. |.+|.||.+.. .++..+|+|+-+. ..++....=.+|+...+++ .|+|.++....+..++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4555678999 99999999875 4578899998442 2222223335667666677 4999999888888889999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEeCCCCCCcEEEcCC-CCeEEeeec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ----GLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFG 660 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFG 660 (680)
+-+|++. .+|.++-.. ....++......+..+... ||.++|... ++|-|+||.||++..+ ...++.|||
T Consensus 195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999875 777776533 2233566666777777777 999999887 9999999999999999 889999999
Q ss_pred cceecCCCc
Q 005731 661 LARMFGGDE 669 (680)
Q Consensus 661 la~~~~~~~ 669 (680)
+...+....
T Consensus 269 ~v~~i~~~~ 277 (524)
T KOG0601|consen 269 LVSKISDGN 277 (524)
T ss_pred eeEEccCCc
Confidence 999886654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.1e-05 Score=76.27 Aligned_cols=105 Identities=22% Similarity=0.212 Sum_probs=82.0
Q ss_pred HHHHHHHhhcCC-CceeeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 005731 557 KNEMMLIAELQH-RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635 (680)
Q Consensus 557 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 635 (680)
..|..++..+++ +++.+++|+|- .+++.||...+++...-..-..-...+|..|.+|+.++++.+++|+....-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357788888876 69999999993 4678999987766321000011224689999999999999999999754445
Q ss_pred eEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 636 IIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 636 iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+..+|++|+|+-+++++++|++|...+-..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.03 E-value=6.4e-05 Score=76.24 Aligned_cols=142 Identities=15% Similarity=0.151 Sum_probs=86.3
Q ss_pred eeccCCc-eeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEEccCCCChh
Q 005731 520 KLGEGGF-GPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILEYMPNKSLD 597 (680)
Q Consensus 520 ~LG~G~f-G~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 597 (680)
.|..|.. ..||+.... +..+.||+..... ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 788998754 4678888876532 345677888888773 344556777776666789999999998876
Q ss_pred hHhc------------------cccc--CCCCC--HHHHHHH-HH-------------------HHHHHHHHHHh----C
Q 005731 598 VYLF------------------DPIK--KRLLD--WEARIRI-IQ-------------------GIAQGLLYLHQ----Y 631 (680)
Q Consensus 598 ~~l~------------------~~~~--~~~l~--~~~~~~i-~~-------------------~ia~~L~yLH~----~ 631 (680)
.... +... ...+. ....... .. .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 0000 00110 0011100 00 01111222211 1
Q ss_pred CCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 632 ~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
..+.++|+|+.|.|||++.+..+.|+||+.|..-
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 2345899999999999999878899999998743
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00015 Score=71.03 Aligned_cols=140 Identities=14% Similarity=0.182 Sum_probs=91.4
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHH---------HHHHHHHHhhcCCC---ceeeEEEE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKE---------FKNEMMLIAELQHR---NLVRILGC 577 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~---------f~~E~~~l~~l~H~---niv~l~g~ 577 (680)
...++|...+++.......|.+-+. +++.+.+|..+.......+. ..+++..+.+++.. ....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3457788888888777777776664 56788899876543222222 22344444444322 22232222
Q ss_pred EEe-----CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC
Q 005731 578 CVE-----QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (680)
Q Consensus 578 ~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 652 (680)
... ....+|+|||++|..|.+.. .++. .++..+..++.-||..| +.|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence 221 13456899999998885543 1222 24456778899999988 9999999999999855
Q ss_pred CeEEeeeccceec
Q 005731 653 NPKISDFGLARMF 665 (680)
Q Consensus 653 ~~kl~DFGla~~~ 665 (680)
.++++||+..+..
T Consensus 172 ~i~iID~~~k~~~ 184 (229)
T PF06176_consen 172 GIRIIDTQGKRMS 184 (229)
T ss_pred cEEEEECcccccc
Confidence 5999999988754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.01 E-value=9e-05 Score=74.07 Aligned_cols=145 Identities=21% Similarity=0.203 Sum_probs=85.8
Q ss_pred eeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCC--ceeeEEEEEEe---CCeEEEEEEccC
Q 005731 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHR--NLVRILGCCVE---QGEKILILEYMP 592 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~---~~~~~lV~Ey~~ 592 (680)
++.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++..... ....+++||+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3679999999999999776 68999997653 4556778888888887433 34566664433 235789999999
Q ss_pred CCChhh----------------Hhc---cc-ccCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 005731 593 NKSLDV----------------YLF---DP-IKKRLLDWEA---------RIRI------------IQGIAQ-GLLYLHQ 630 (680)
Q Consensus 593 ~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH~ 630 (680)
+..+.. .+. .. .......... .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 110 00 0001111100 0000 011222 2333332
Q ss_pred ----CCCCceEeCCCCCCcEEEc-CCCCeEEeeeccceec
Q 005731 631 ----YSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMF 665 (680)
Q Consensus 631 ----~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~ 665 (680)
.....++|+|+.|.|||++ +++.+.|+||+.+..-
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 1345699999999999999 5666689999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.6e-06 Score=84.31 Aligned_cols=95 Identities=28% Similarity=0.372 Sum_probs=78.5
Q ss_pred HHhhcCCCceeeEEEEEEeC-----CeEEEEEEccCCCChhhHhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 005731 562 LIAELQHRNLVRILGCCVEQ-----GEKILILEYMPNKSLDVYLFDPIK-KRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635 (680)
Q Consensus 562 ~l~~l~H~niv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 635 (680)
-|-.+.|.|||++..|+.+. .+...+.|||+.|+|..+|.+..+ ...+....-.+++.||..||.|||+. .++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 34456799999999988654 357789999999999999976433 34566667778999999999999996 588
Q ss_pred eEeCCCCCCcEEEcCCCCeEEe
Q 005731 636 IIHRDLKASNVLLDKDMNPKIS 657 (680)
Q Consensus 636 iiHrDlkp~NILl~~~~~~kl~ 657 (680)
|+|+++..+-|++..++-+||.
T Consensus 199 iihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred cccCCcchhheeecCCceEEec
Confidence 9999999999999999988874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.4e-06 Score=93.44 Aligned_cols=81 Identities=28% Similarity=0.391 Sum_probs=71.0
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
..|+.|+.+...+|.++|.++......++.....++.|++.|++| ++ .+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999765555566788889999999999999 55 899999999999999999999999999
Q ss_pred eecCCCc
Q 005731 663 RMFGGDE 669 (680)
Q Consensus 663 ~~~~~~~ 669 (680)
..+....
T Consensus 404 ts~~~~~ 410 (516)
T KOG1033|consen 404 TSQDKDE 410 (516)
T ss_pred eecccCC
Confidence 8775544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00023 Score=85.05 Aligned_cols=79 Identities=18% Similarity=0.407 Sum_probs=57.8
Q ss_pred eeeeccCCceeEEEEEEcCC---cEEEEEEccCCC-cccHHHHHHHHHHHhhcC-CCce--eeEEEEEEeC---CeEEEE
Q 005731 518 QCKLGEGGFGPVYKGRLFNG---QEVAVKRLSSQS-GQGLKEFKNEMMLIAELQ-HRNL--VRILGCCVEQ---GEKILI 587 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~~---~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 587 (680)
.+.++.|.+..+|+.+..++ ..+++|+..... ......+.+|.+++..+. |.++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 47789999999999876553 467777765422 223457889999999995 6664 7788887654 357899
Q ss_pred EEccCCCCh
Q 005731 588 LEYMPNKSL 596 (680)
Q Consensus 588 ~Ey~~~gsL 596 (680)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.001 Score=69.60 Aligned_cols=78 Identities=15% Similarity=0.114 Sum_probs=56.7
Q ss_pred ceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCC---CceeeEEEEEEe---CCeEEEEEE
Q 005731 516 SMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH---RNLVRILGCCVE---QGEKILILE 589 (680)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~---~~~~~lV~E 589 (680)
.-.+.||.|..+.||+....+++ +.+|..+. ......|.+|.+.++.+.. ..+.++++++.. .+..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 34478999999999998765554 56666432 1134688899999988853 357778887754 356899999
Q ss_pred ccCCCCh
Q 005731 590 YMPNKSL 596 (680)
Q Consensus 590 y~~~gsL 596 (680)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00053 Score=69.15 Aligned_cols=73 Identities=12% Similarity=0.172 Sum_probs=44.5
Q ss_pred eeeccCCce-eEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCC---ceeeEEEEEEeC---CeEEEEEEcc
Q 005731 519 CKLGEGGFG-PVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHR---NLVRILGCCVEQ---GEKILILEYM 591 (680)
Q Consensus 519 ~~LG~G~fG-~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lV~Ey~ 591 (680)
+.|+.|+.. .||+. +..+++|.... ......+.+|.+++..+... .+.+.++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567766665 58875 23466776543 22345788899988877532 233344433221 2348899999
Q ss_pred CCCChh
Q 005731 592 PNKSLD 597 (680)
Q Consensus 592 ~~gsL~ 597 (680)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0009 Score=65.27 Aligned_cols=134 Identities=19% Similarity=0.288 Sum_probs=90.6
Q ss_pred eeeeccCCceeEEEEEEcCCcEEEEEEccCCC----------------cccHHHHHHHHHHHhhcC------CCceeeEE
Q 005731 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS----------------GQGLKEFKNEMMLIAELQ------HRNLVRIL 575 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~----------------~~~~~~f~~E~~~l~~l~------H~niv~l~ 575 (680)
...||+|+.=.||.- ++.....||++.... ....+++++|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 357999999888854 455667888886543 123567777777666555 78899999
Q ss_pred EEEEeCCeEEEEEEccCC------CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc
Q 005731 576 GCCVEQGEKILILEYMPN------KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (680)
Q Consensus 576 g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 649 (680)
|+.......-+|+|.+.+ -+|.+++ ....++. . +...+-+-..||-+.. |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999998888888887642 3455555 2233444 2 2333344455666555 99999999999996
Q ss_pred CCC----CeEEee-ecccee
Q 005731 650 KDM----NPKISD-FGLARM 664 (680)
Q Consensus 650 ~~~----~~kl~D-FGla~~ 664 (680)
... .+.|+| ||-...
T Consensus 153 ~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred ecCCCceEEEEEeCCCCccc
Confidence 432 467777 565443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0011 Score=64.18 Aligned_cols=125 Identities=25% Similarity=0.401 Sum_probs=88.7
Q ss_pred CCcceeeeeccCCc-eeEEEEEEcCCcEEEEEEccC---CC--------c----------ccHHHHHHHHHHHhhcC---
Q 005731 513 ENFSMQCKLGEGGF-GPVYKGRLFNGQEVAVKRLSS---QS--------G----------QGLKEFKNEMMLIAELQ--- 567 (680)
Q Consensus 513 ~~f~~~~~LG~G~f-G~Vy~~~~~~~~~VAVK~l~~---~~--------~----------~~~~~f~~E~~~l~~l~--- 567 (680)
.+++..+.||.|.- |.||++++ +|+.+|+|.... .. . ....-|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 68889999999999 99999997 567999999321 00 0 11235888999888885
Q ss_pred CCce--eeEEEEEEeCC------------------eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHH
Q 005731 568 HRNL--VRILGCCVEQG------------------EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627 (680)
Q Consensus 568 H~ni--v~l~g~~~~~~------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y 627 (680)
+.++ |+.+|+..-.. ..-||.||++... .+. ..-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 3456 89999874321 1246667654332 111 2235567888889
Q ss_pred HHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 628 LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
+|..+ |+-+|+|++|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99877 999999999976 4589999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0017 Score=65.35 Aligned_cols=142 Identities=16% Similarity=0.214 Sum_probs=80.8
Q ss_pred eeeccCCceeEEEEEEcC--CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCce-eeEEEEEEeCCeEEEEEEccCCCC
Q 005731 519 CKLGEGGFGPVYKGRLFN--GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-VRILGCCVEQGEKILILEYMPNKS 595 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~--~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gs 595 (680)
+.|..|-...+|+....+ ++.+++|........ ...-.+|+.++..+....+ .++++... ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567788888999987654 678888876543221 1222468888887743333 34444322 247999999877
Q ss_pred hhhHh-----------------cccccC--------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 005731 596 LDVYL-----------------FDPIKK--------RLLD-WEARIRIIQ----------------------GIAQGLLY 627 (680)
Q Consensus 596 L~~~l-----------------~~~~~~--------~~l~-~~~~~~i~~----------------------~ia~~L~y 627 (680)
+.... +..... .... ++.+..+.. .+.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 63210 000000 0111 122111111 11111112
Q ss_pred H----HhC-CCCceEeCCCCCCcEEEcC-CCCeEEeeeccceec
Q 005731 628 L----HQY-SRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMF 665 (680)
Q Consensus 628 L----H~~-~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~ 665 (680)
| ... .+..++|+|+.+.|||++. ++.+.|+||-.|..-
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 2 111 2346999999999999998 578999999988743
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00097 Score=68.18 Aligned_cols=139 Identities=16% Similarity=0.115 Sum_probs=78.0
Q ss_pred eeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCce-eeEEEEEEeCCeEEEEEEccCCCChhh
Q 005731 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-VRILGCCVEQGEKILILEYMPNKSLDV 598 (680)
Q Consensus 520 ~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL~~ 598 (680)
.+..|-...+|+.. .+++.+++|..........-...+|.++++.+....+ .+++... ..++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 35567778899887 4566788887654322211134678888888754333 2334332 1368999999876642
Q ss_pred H-----------------hcccc-cCCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCceEeCCCCCCc
Q 005731 599 Y-----------------LFDPI-KKRLLDWEAR-IRIIQG---------IAQGLLYLHQY-----SRLRIIHRDLKASN 645 (680)
Q Consensus 599 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------ia~~L~yLH~~-----~~~~iiHrDlkp~N 645 (680)
. |+... ....++...+ ..+..+ +.+.+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11100 1111222211 111111 11112222111 12358999999999
Q ss_pred EEEcCCCCeEEeeecccee
Q 005731 646 VLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 646 ILl~~~~~~kl~DFGla~~ 664 (680)
|++++++ ++|+||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0033 Score=67.92 Aligned_cols=74 Identities=14% Similarity=0.206 Sum_probs=53.7
Q ss_pred eeeccCCceeEEEEEEcCC-cEEEEEEccCC-----C--cccHHHHHHHHHHHhhcC---CCceeeEEEEEEeCCeEEEE
Q 005731 519 CKLGEGGFGPVYKGRLFNG-QEVAVKRLSSQ-----S--GQGLKEFKNEMMLIAELQ---HRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~-~~VAVK~l~~~-----~--~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 587 (680)
+.||.|.+..||+....+| +.|+||.-... . +...+++..|.+.|..+. -..+.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6799999999999998776 58999985421 1 234567788888888762 2356667766 33557899
Q ss_pred EEccCCC
Q 005731 588 LEYMPNK 594 (680)
Q Consensus 588 ~Ey~~~g 594 (680)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0024 Score=66.55 Aligned_cols=144 Identities=18% Similarity=0.165 Sum_probs=97.7
Q ss_pred eeeeeccCCceeEEEEEEcCCcEEEEEEccCCC---------cc-------------c----HHHHHHHHHHHhhcCCCc
Q 005731 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS---------GQ-------------G----LKEFKNEMMLIAELQHRN 570 (680)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~---------~~-------------~----~~~f~~E~~~l~~l~H~n 570 (680)
+...|..|--+.||.++-.+|..+|||+.+..- .. . .-....|++-|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 346788899999999998899999999865310 00 0 112345777777765433
Q ss_pred eeeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC
Q 005731 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK 650 (680)
Q Consensus 571 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~ 650 (680)
|.----+.. ....|||+|+.......-. .+.-.+....+..+..++++-|.-|...| ++||.||.--|+|+ .
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPk---LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-h 299 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPK---LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-H 299 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCcc---cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-E
Confidence 221110111 2356999999644432221 23345666778888889999999998877 69999999999999 6
Q ss_pred CCCeEEeeeccceecCCC
Q 005731 651 DMNPKISDFGLARMFGGD 668 (680)
Q Consensus 651 ~~~~kl~DFGla~~~~~~ 668 (680)
+|.+.|+|.+-+.-....
T Consensus 300 dG~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHDHP 317 (520)
T ss_pred CCEEEEEEccccccCCCh
Confidence 789999999887655443
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0027 Score=66.37 Aligned_cols=143 Identities=19% Similarity=0.151 Sum_probs=85.4
Q ss_pred eeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCc--eeeEEEE------EEeCCeEEEEEE
Q 005731 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN--LVRILGC------CVEQGEKILILE 589 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E 589 (680)
.+.|..|....+|+....+ ..+++|+... ....+...|++++..+++.. +.+.+.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778778999987544 4688888764 23455667777777774332 3444331 123446789999
Q ss_pred ccCCCChhh----Hh----------cccc---c-----CCCCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 005731 590 YMPNKSLDV----YL----------FDPI---K-----KRLLDWEARI----------RIIQGIAQGLLYLHQ----YSR 633 (680)
Q Consensus 590 y~~~gsL~~----~l----------~~~~---~-----~~~l~~~~~~----------~i~~~ia~~L~yLH~----~~~ 633 (680)
|++|..+.. .. +... . .....|.... .....+.+++.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 00 0000 0 0111221111 011223444555543 122
Q ss_pred CceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 634 ~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
..++|+|+.|.|||++++..+.|+||..+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999987789999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0036 Score=58.91 Aligned_cols=128 Identities=23% Similarity=0.327 Sum_probs=84.3
Q ss_pred eeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCcee-eEEEEEEeCCeEEEEEEccCCCC
Q 005731 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV-RILGCCVEQGEKILILEYMPNKS 595 (680)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gs 595 (680)
..+.|++|.+|.||++.. .+.++|+|+-.. +.....+..|++++..+.-.++. +++.|. +.++.|||++|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeec-cCceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 346899999999999985 455889998764 34567889999999988766653 344442 3345699999988
Q ss_pred hhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCC-C-CcEEEcCCCCeEEeeeccceec
Q 005731 596 LDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK-A-SNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk-p-~NILl~~~~~~kl~DFGla~~~ 665 (680)
|.+.-.. .+.++...+ ++.---|-.. +|-|..|. | .||++ .+..+.|+||--|++-
T Consensus 99 L~~~~~~------~~rk~l~~v----lE~a~~LD~~---GI~H~El~~~~k~vlv-~~~~~~iIDFd~At~k 156 (201)
T COG2112 99 LGKLEIG------GDRKHLLRV----LEKAYKLDRL---GIEHGELSRPWKNVLV-NDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhc------ccHHHHHHH----HHHHHHHHHh---ccchhhhcCCceeEEe-cCCcEEEEEccchhhc
Confidence 8665411 123333333 3332222222 37777775 3 35555 4449999999999843
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0079 Score=63.02 Aligned_cols=142 Identities=24% Similarity=0.314 Sum_probs=82.5
Q ss_pred eeeccCCceeEEEEEEcC-------CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCce-eeEEEEEEeCCeEEEEEEc
Q 005731 519 CKLGEGGFGPVYKGRLFN-------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-VRILGCCVEQGEKILILEY 590 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~-------~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey 590 (680)
+.|..|-...+|+.+..+ ++.+++|...... .......+|.+++..+....+ .++++.+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777899887654 4788899865432 222344677777777743333 344554432 368999
Q ss_pred cCCCChhhHh-----------------cccccC--C----CC--CHHHHHH--------------------------HHH
Q 005731 591 MPNKSLDVYL-----------------FDPIKK--R----LL--DWEARIR--------------------------IIQ 619 (680)
Q Consensus 591 ~~~gsL~~~l-----------------~~~~~~--~----~l--~~~~~~~--------------------------i~~ 619 (680)
++|..+.... +..... . .. -+..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9887764311 110000 0 00 0111100 111
Q ss_pred HHHHHHHHHHh------CCCCceEeCCCCCCcEEEcCC----CCeEEeeeccceec
Q 005731 620 GIAQGLLYLHQ------YSRLRIIHRDLKASNVLLDKD----MNPKISDFGLARMF 665 (680)
Q Consensus 620 ~ia~~L~yLH~------~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~~ 665 (680)
.+.+-+..|.. ..+..++|+|+.|.|||++++ +.++|+||..|..-
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 22233334432 134568999999999999975 88999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.00083 Score=54.29 Aligned_cols=49 Identities=20% Similarity=0.336 Sum_probs=34.6
Q ss_pred eccCCCCccceeeccCCCHHHHHHHHhcCCccccccccccCCCceeEEEcCC
Q 005731 346 DNVKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEGSGCLMWYGD 397 (680)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~~~~~~~g~~C~~w~~~ 397 (680)
+++.++.+..... ...+.++|++.|+.+|+|.||.|... ...|+++...
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~~--~~~C~lk~~~ 58 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNTK--SKKCFLKSSE 58 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEECC--CCeEEcccCC
Confidence 4555555444322 24689999999999999999999742 3459987554
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.019 Score=60.74 Aligned_cols=141 Identities=20% Similarity=0.203 Sum_probs=74.8
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCC--ceeeEEE------EEEeCCeEEEEEEc
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHR--NLVRILG------CCVEQGEKILILEY 590 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g------~~~~~~~~~lV~Ey 590 (680)
+.|..|....+|+.+..++ .+++|+..... .+....|+.++..+... .+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777788999876555 67888875212 23333444444444211 1223222 11234567899999
Q ss_pred cCCCChhh-----------Hh---ccccc--------CCCCCH-HHHHH------------HH-HHHHHHHHHHHhC---
Q 005731 591 MPNKSLDV-----------YL---FDPIK--------KRLLDW-EARIR------------II-QGIAQGLLYLHQY--- 631 (680)
Q Consensus 591 ~~~gsL~~-----------~l---~~~~~--------~~~l~~-~~~~~------------i~-~~ia~~L~yLH~~--- 631 (680)
++|..+.. .| +.... ...+.| ..... .. ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 11 11000 001111 11111 11 1111222333211
Q ss_pred -CCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 632 -SRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 632 -~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
-+..++|+|+.|.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999877666899999885
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.021 Score=58.96 Aligned_cols=32 Identities=25% Similarity=0.468 Sum_probs=26.7
Q ss_pred CceEeCCCCCCcEEEcCCCC-eEEeeeccceec
Q 005731 634 LRIIHRDLKASNVLLDKDMN-PKISDFGLARMF 665 (680)
Q Consensus 634 ~~iiHrDlkp~NILl~~~~~-~kl~DFGla~~~ 665 (680)
..++|+|+.|.|||+++++. .-|+||+.|.+-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 35899999999999997554 579999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.044 Score=57.62 Aligned_cols=142 Identities=20% Similarity=0.210 Sum_probs=80.7
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCC--ceeeEEEE------EEeCCeEEEEEEc
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHR--NLVRILGC------CVEQGEKILILEY 590 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~------~~~~~~~~lV~Ey 590 (680)
+.++.|....+|+....++ .+++|+..... ..++...|++++..|... .+.+.+.. ....+..++++||
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 5567777788999875555 56778765421 234455666666666322 23333331 1123567899999
Q ss_pred cCCCChhhH--------------hcccccC---------CCCCHHHHH------------HHHHHHHHHHHHHHh----C
Q 005731 591 MPNKSLDVY--------------LFDPIKK---------RLLDWEARI------------RIIQGIAQGLLYLHQ----Y 631 (680)
Q Consensus 591 ~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~ia~~L~yLH~----~ 631 (680)
++|..+... ++..... ..-.|.... .....+.+.++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 988654210 1110000 001111110 011223445555542 2
Q ss_pred CCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 632 ~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.+..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 23569999999999999988877999999985
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.031 Score=59.72 Aligned_cols=142 Identities=16% Similarity=0.232 Sum_probs=81.2
Q ss_pred eeeccCCceeEEEEEEcC-----CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCcee-eEEEEEEeCCeEEEEEEccC
Q 005731 519 CKLGEGGFGPVYKGRLFN-----GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV-RILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~-----~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~ 592 (680)
+.|..|-.-.+|+....+ ++.+++|...........+ .+|..++..+...++. ++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456557778899986432 3678888876543333333 6788888877544443 455554332 5899998
Q ss_pred CCChhhH-h----------------cccc-cC-C-CCCHHHHHHHHHH-----------------HHHHHHHH----Hh-
Q 005731 593 NKSLDVY-L----------------FDPI-KK-R-LLDWEARIRIIQG-----------------IAQGLLYL----HQ- 630 (680)
Q Consensus 593 ~gsL~~~-l----------------~~~~-~~-~-~l~~~~~~~i~~~-----------------ia~~L~yL----H~- 630 (680)
+.+|... + +... .. . ...++++.++..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776422 0 1100 00 1 1112222222211 11112222 21
Q ss_pred CCCCceEeCCCCCCcEEEcC-CCCeEEeeeccceec
Q 005731 631 YSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMF 665 (680)
Q Consensus 631 ~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~ 665 (680)
..+..++|+|+++.|||+++ ++.++|+||..|..-
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 22346899999999999986 468999999998753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.037 Score=57.93 Aligned_cols=146 Identities=18% Similarity=0.256 Sum_probs=81.7
Q ss_pred eeeeccCCceeEEEEEEcCCcEEEEEEccC--CCcccHHHHHHHHHHHhhcCC--CceeeEEEEEEeCC--eEEEEEEcc
Q 005731 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQH--RNLVRILGCCVEQG--EKILILEYM 591 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~--~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~Ey~ 591 (680)
.+.+..|-.-.+|.... +++++++. ... ..........+|.++|+.+.- .-+-+.++.|.++. ..+.||||+
T Consensus 30 v~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 34454443334444432 26777777 331 122334555678888887643 23445567777665 679999999
Q ss_pred CCCChhhHhcccc-----------------------------------cCCCCCHHHHHHH--------HHHHHHHHHHH
Q 005731 592 PNKSLDVYLFDPI-----------------------------------KKRLLDWEARIRI--------IQGIAQGLLYL 628 (680)
Q Consensus 592 ~~gsL~~~l~~~~-----------------------------------~~~~l~~~~~~~i--------~~~ia~~L~yL 628 (680)
+|....+.+.... ..+...|....+. .-...+-..+|
T Consensus 108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 8743322211000 0000111111110 01122334455
Q ss_pred HhC-----CCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 629 HQY-----SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 629 H~~-----~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+.. .+..++|+|+.+.||+++.+..+-|.||+++..=
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 432 2346999999999999999888999999999853
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.039 Score=57.19 Aligned_cols=76 Identities=17% Similarity=0.232 Sum_probs=48.6
Q ss_pred cceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC---CCceeeEEEEEEeCCeEEEEEEcc
Q 005731 515 FSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ---HRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.+..+.|+.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. -..+.+.+++....+..+|||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3444678989999999987 6778899998762 33467788888887773 345778888887777789999999
Q ss_pred CCC
Q 005731 592 PNK 594 (680)
Q Consensus 592 ~~g 594 (680)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.00088 Score=74.00 Aligned_cols=140 Identities=16% Similarity=0.095 Sum_probs=96.2
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCc-eeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN-LVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~ 591 (680)
+.+.....+++++.+.++|.+-...+.+..+.+... ....-++++|.+++||| .++.++-+..+...+++++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 334444678899999999987433444445554332 44567889999999999 788888877778889999999
Q ss_pred CCC--ChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 592 PNK--SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 592 ~~g--sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
..+ +..... .....+...+...+...-++++++||+.- =+||| ||+..+ ...|..||+.+..+.+.
T Consensus 317 s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 317 STGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred cCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 877 221111 11112333334455666788999999753 48998 777755 68899999998877554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.001 Score=77.19 Aligned_cols=149 Identities=18% Similarity=0.192 Sum_probs=98.8
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
..+.+.+.+-+-+|.++.++.+.-. .+...++|..... .....+..+.+-.++-..+||-+++..--+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4467777788889999999887522 2333333332211 11222333333333333456777766555556678899
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+++|..+++|...|+... ..+.+-....+..+..+++|||... ++|||++|.|+|+..++..+++|||+....
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 999999999988874422 2332323334455888999999764 899999999999999999999999965543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.01 Score=61.11 Aligned_cols=134 Identities=16% Similarity=0.168 Sum_probs=87.7
Q ss_pred CcceeeeeccCCceeEEEEEEcCCcEEEEEEccC----------C--------Cc--c--cHHHHHHHHHHHhhcCC-C-
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSS----------Q--------SG--Q--GLKEFKNEMMLIAELQH-R- 569 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~----------~--------~~--~--~~~~f~~E~~~l~~l~H-~- 569 (680)
-+++.++||-|--+-||.+-...|++.++|.=+. . .. . ..-...+|...|..+.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3677899999999999999888888888874210 0 00 0 11124467777777742 1
Q ss_pred ceeeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc
Q 005731 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (680)
Q Consensus 570 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 649 (680)
-+.+.+++ +..++|||++.+-.|...- ...+..++.. .+..-+--|-..+ +||+|..--||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~---~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYD---DLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHH---HHHHHHHHHHHcC---ceecccchheeEEe
Confidence 13333333 4678999999887774321 1223333333 2333344455556 99999999999999
Q ss_pred CCCCeEEeeeccce
Q 005731 650 KDMNPKISDFGLAR 663 (680)
Q Consensus 650 ~~~~~kl~DFGla~ 663 (680)
++..++++||--..
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999997544
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.27 Score=53.26 Aligned_cols=73 Identities=11% Similarity=0.085 Sum_probs=48.5
Q ss_pred eeeeccCCceeEEEEEEcCCcEEEEEEccCC----Cc---ccHHHHHHHHHHHhhcC---CCceeeEEEEEEeCCeEEEE
Q 005731 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ----SG---QGLKEFKNEMMLIAELQ---HRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~----~~---~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 587 (680)
.+.||.|....||+... .++.++||+-... .. ....+-..|.+.|..+. ...+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 47899999999999875 4556889976521 11 12333344566665543 246777888776 456788
Q ss_pred EEccCC
Q 005731 588 LEYMPN 593 (680)
Q Consensus 588 ~Ey~~~ 593 (680)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.059 Score=56.45 Aligned_cols=73 Identities=21% Similarity=0.229 Sum_probs=56.6
Q ss_pred CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecc
Q 005731 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 661 (680)
...|++|++. ++++. ..+...+++.+.++.+.+.-++-+.. +.+.=|||+.-.||||+ +|++-|+||-+
T Consensus 299 ~y~yl~~kdh-gt~is-------~ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 299 LYLYLHFKDH-GTPIS-------IIKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred eEEEEEEecC-Cceee-------eeecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeee
Confidence 3556777764 44442 12345788899999988887777765 45799999999999999 99999999999
Q ss_pred ceec
Q 005731 662 ARMF 665 (680)
Q Consensus 662 a~~~ 665 (680)
+|.-
T Consensus 368 sRl~ 371 (488)
T COG5072 368 SRLS 371 (488)
T ss_pred eecc
Confidence 9943
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.16 Score=54.02 Aligned_cols=72 Identities=15% Similarity=0.186 Sum_probs=46.7
Q ss_pred eeccCCceeEEEEEEcCC-cEEEEEEccC-------CCcccHHHHHHHHHHHhhcC--CC-ceeeEEEEEEeCCeEEEEE
Q 005731 520 KLGEGGFGPVYKGRLFNG-QEVAVKRLSS-------QSGQGLKEFKNEMMLIAELQ--HR-NLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 520 ~LG~G~fG~Vy~~~~~~~-~~VAVK~l~~-------~~~~~~~~f~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 588 (680)
.||.|....||++...++ +.|+||.-.. .-+...++...|.+.|.... -| .+.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999987654 6899997431 11334555566777776542 23 34445443 445567999
Q ss_pred EccCC
Q 005731 589 EYMPN 593 (680)
Q Consensus 589 Ey~~~ 593 (680)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.23 Score=52.73 Aligned_cols=142 Identities=15% Similarity=0.225 Sum_probs=78.5
Q ss_pred eeeccCCceeEEEEEEcC----CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCcee-eEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV-RILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
+.|..|=...+|+....+ +..|++|........... -.+|..++..+...++. ++++++.. . +|.||+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVID-RERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEec-hHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence 455556677788886443 237888877543332222 25788888887655543 45555532 2 58999987
Q ss_pred CChhhH-------h----------cccc-c--CCCCCHHHHHHHHHHH----------------------HHHHHHHH--
Q 005731 594 KSLDVY-------L----------FDPI-K--KRLLDWEARIRIIQGI----------------------AQGLLYLH-- 629 (680)
Q Consensus 594 gsL~~~-------l----------~~~~-~--~~~l~~~~~~~i~~~i----------------------a~~L~yLH-- 629 (680)
..|... + +... . ....-|..+.++..++ .+-+..+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665321 0 1100 0 0011222222222111 11121111
Q ss_pred --h-CCCCceEeCCCCCCcEEEcC-CCCeEEeeeccceec
Q 005731 630 --Q-YSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMF 665 (680)
Q Consensus 630 --~-~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~ 665 (680)
. ..+..+.|.|+-+.|||+++ ++.++++||..|..-
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 1 12234799999999999975 578999999988743
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.6 Score=48.92 Aligned_cols=29 Identities=24% Similarity=0.349 Sum_probs=25.4
Q ss_pred CceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 634 LRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 634 ~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 46899999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.36 Score=47.70 Aligned_cols=75 Identities=20% Similarity=0.294 Sum_probs=52.7
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhc---CCCceeeEEEEEEeCCeEEEEEEccCCCC
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL---QHRNLVRILGCCVEQGEKILILEYMPNKS 595 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 595 (680)
+.+.-|..-+.|+.. .+..++-||.-. ......|..|+.-|..+ +..++.+.+.+-....+.|+||||++-+.
T Consensus 22 ~~v~gG~inea~~v~-dg~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLR-DGTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEee-cCCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 445555555555544 345678888753 33456788888766655 44567788888888899999999999877
Q ss_pred hh
Q 005731 596 LD 597 (680)
Q Consensus 596 L~ 597 (680)
++
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 75
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.36 E-value=0.1 Score=51.55 Aligned_cols=30 Identities=37% Similarity=0.557 Sum_probs=21.6
Q ss_pred ceEeCCCCCCcEEE-cCCCCeEEeeecccee
Q 005731 635 RIIHRDLKASNVLL-DKDMNPKISDFGLARM 664 (680)
Q Consensus 635 ~iiHrDlkp~NILl-~~~~~~kl~DFGla~~ 664 (680)
.+.|.|+.|.|||+ +.++.++|+||-.|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 8899999999998874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.84 E-value=0.58 Score=49.52 Aligned_cols=136 Identities=24% Similarity=0.295 Sum_probs=78.2
Q ss_pred CceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCc------eeeEEEEE--EeC--CeEEEEEEccCCC
Q 005731 525 GFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN------LVRILGCC--VEQ--GEKILILEYMPNK 594 (680)
Q Consensus 525 ~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~--~~~--~~~~lV~Ey~~~g 594 (680)
.-..+|+....+++. ++|..+.. ....+..-|+..+..+.-.. |.++-|-. .-. ...+-++||++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 345678887767766 78887764 34455566666666552111 22222211 112 3678899999998
Q ss_pred Chhh-Hh--------------c---------ccccCCCCCHHH-------------HHHHHHHHHHHHHHHHhCC----C
Q 005731 595 SLDV-YL--------------F---------DPIKKRLLDWEA-------------RIRIIQGIAQGLLYLHQYS----R 633 (680)
Q Consensus 595 sL~~-~l--------------~---------~~~~~~~l~~~~-------------~~~i~~~ia~~L~yLH~~~----~ 633 (680)
.+.. .. + +........|.. ......++...+..+++.- +
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8862 10 0 000111233330 0112234444555554321 1
Q ss_pred ---CceEeCCCCCCcEEEcCCCC-eEEeeeccce
Q 005731 634 ---LRIIHRDLKASNVLLDKDMN-PKISDFGLAR 663 (680)
Q Consensus 634 ---~~iiHrDlkp~NILl~~~~~-~kl~DFGla~ 663 (680)
..+||+|+-|.||+++.+.. +.++||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 22999999999999998875 8999999876
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 680 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-33 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-32 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-04 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 8e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 7e-90
Identities = 75/197 (38%), Positives = 105/197 (53%), Gaps = 14/197 (7%)
Query: 494 KGKDSWLPLFSLASVAAATENFSMQC------KLGEGGFGPVYKGRLFNGQEVAVKRLSS 547
+ D+ FS + T NF + K+GEGGFG VYKG + N VAVK+L++
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 548 ----QSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDP 603
+ + ++F E+ ++A+ QH NLV +LG + + L+ YMPN SL L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 604 IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
L W R +I QG A G+ +LH+ IHRD+K++N+LLD+ KISDFGLAR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 664 MFGGDELQGNTKRIVGT 680
T RIVGT
Sbjct: 182 ASEKFAQTVMTSRIVGT 198
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 1e-87
Identities = 80/199 (40%), Positives = 118/199 (59%), Gaps = 3/199 (1%)
Query: 484 FGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVK 543
F +V + + L FSL + A++NFS + LG GGFG VYKGRL +G VAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 544 RLSSQSGQGLK-EFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD 602
RL + QG + +F+ E+ +I+ HRNL+R+ G C+ E++L+ YM N S+ L +
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 603 PIKKRL-LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661
+ + LDW R RI G A+GL YLH + +IIHRD+KA+N+LLD++ + DFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 662 ARMFGGDELQGNTKRIVGT 680
A++ + T + GT
Sbjct: 181 AKLMDYKDTHVTT-AVRGT 198
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 2e-79
Identities = 69/179 (38%), Positives = 109/179 (60%), Gaps = 4/179 (2%)
Query: 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMML 562
L + AT NF + +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 563 IAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRL-LDWEARIRIIQGI 621
++ +H +LV ++G C E+ E ILI +YM N +L +L+ + + WE R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
A+GL YLH + IIHRD+K+ N+LLD++ PKI+DFG+++ + + + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-64
Identities = 50/189 (26%), Positives = 84/189 (44%), Gaps = 17/189 (8%)
Query: 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMML 562
++ + + G FG V+K + + VAVK Q Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 563 IAELQHRNLVRILGCCVE----QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII 618
+ ++H N+++ +G + LI + SL +L K ++ W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 619 QGIAQGLLYLHQ-------YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671
+ +A+GL YLH+ + I HRD+K+ NVLL ++ I+DFGLA F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 672 GNTKRIVGT 680
G+T VGT
Sbjct: 188 GDTHGQVGT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 5e-56
Identities = 57/195 (29%), Positives = 86/195 (44%), Gaps = 23/195 (11%)
Query: 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMML 562
+ + + +N + +G G +G VYKG L + + VAVK S + Q K +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60
Query: 563 IAELQHRNLVRILGCCVE-----QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRI 617
+ ++H N+ R + + E +L++EY PN SL YL DW + R+
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRL 116
Query: 618 IQGIAQGLLYLHQ------YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG---- 667
+ +GL YLH + + I HRDL + NVL+ D ISDFGL+ G
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 668 --DELQGNTKRIVGT 680
E VGT
Sbjct: 177 RPGEEDNAAISEVGT 191
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-49
Identities = 53/170 (31%), Positives = 90/170 (52%), Gaps = 6/170 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRN 570
+ +++ K+G G FG V++ ++G +VAVK L Q + + EF E+ ++ L+H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+V +G + ++ EY+ SL L + LD R+ + +A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I+HR+LK+ N+L+DK K+ DFGL+R+ L +K GT
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGT 202
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 11/169 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
+ ++ +G G FG V K + + ++VA+K++ S+S K F E+ ++ + H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAK-WRAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ G C+ L++EY SL L + +QG+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 633 RLRIIHRDLKASNVLLDKDMN-PKISDFGLARMFGGDELQGNTKRIVGT 680
+IHRDLK N+LL KI DFG A ++Q + G+
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGS 166
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-45
Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 7/157 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRN 570
+ + KL E G ++KGR + G ++ VK L + S + ++F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 571 LVRILGCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
++ +LG C I +MP SL L + ++D ++ +A+G+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFL 127
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
H L I L + +V++D+DM +IS + F
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 6/158 (3%)
Query: 520 KLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
LG+G FG K G+ + +K L + + F E+ ++ L+H N+++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
+ I EY+ +L + W R+ + IA G+ YLH + IIH
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 639 RDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR 676
RDL + N L+ ++ N ++DFGLAR+ ++ Q R
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRL----SSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
+G GGFG VY+ + G EVAVK Q ++ + E L A L+H N++ +
Sbjct: 14 IIGIGGFGKVYRAF-WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
G C+++ L++E+ L+ L + + + + IA+G+ YLH + +
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 636 IIHRDLKASNVLLDKDMNP--------KISDFGLARMFGGDELQGNT 674
IIHRDLK+SN+L+ + + KI+DFGLAR +
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-44
Identities = 48/181 (26%), Positives = 90/181 (49%), Gaps = 23/181 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQG-------LKEFKNEMMLIA 564
+ ++G+GGFG V+KGRL + VA+K L +G +EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
L H N+V++ G +++E++P L L D K + W ++R++ IA G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDK-----DMNPKISDFGLARMFGGDELQGNTKRIVG 679
+ Y+ I+HRDL++ N+ L + K++DFGL++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 680 T 680
Sbjct: 189 N 189
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 10/170 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRN 570
++ ++G G FG VYKG+ ++G +VAVK L+ + Q L+ FKNE+ ++ + +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGK-WHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
++ +G I + ++ SL +L + + + I I + A+G+ YLH
Sbjct: 82 ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA 138
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
IIHRDLK++N+ L +D KI DFGLA +++ G+
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 21/182 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNE--MMLIAELQHR 569
+ ++ +G+G +G V++G + G+ VAVK SS+ K + E + L+H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGS-WQGENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62
Query: 570 NLVRILGCCVEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
N++ + + LI Y SL +D ++ LD + +RI+ IA GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGL 118
Query: 626 LYLH-----QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF--GGDELQGNTKRIV 678
+LH + I HRDLK+ N+L+ K+ I+D GLA M ++L V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 679 GT 680
GT
Sbjct: 179 GT 180
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-41
Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 21/181 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNE--MMLIAELQHRN 570
+ M ++G+G +G V+ G+ + G++VAVK + + E + ++H N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGK-WRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 571 LVRILGCCVEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
++ + ++ LI +Y N SL +D +K LD ++ +++ GL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLC 148
Query: 627 YLH-----QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF--GGDELQGNTKRIVG 679
+LH + I HRDLK+ N+L+ K+ I+D GLA F +E+ VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 680 T 680
T
Sbjct: 209 T 209
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 50/159 (31%), Positives = 81/159 (50%), Gaps = 10/159 (6%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGC 577
+G+G FG VY GR ++G EVA++ + + + LK FK E+M + +H N+V +G
Sbjct: 40 LIGKGRFGQVYHGR-WHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRII 637
C+ +I ++L + D K +LD +I Q I +G+ YLH I+
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 638 HRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR 676
H+DLK+ NV D + I+DFGL + G + +
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDK 190
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-40
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 490 DGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS 549
D G S LPL ++A +Q +G+G FG V++G+ + G+EVAVK SS+
Sbjct: 22 DMTTSGSGSGLPLLVQRTIA---RTIVLQESIGKGRFGEVWRGK-WRGEEVAVKIFSSRE 77
Query: 550 GQGLKEFKNE--MMLIAELQHRNLVRILGCCVEQGEKI----LILEYMPNKSLDVYLFDP 603
+ + E + L+H N++ + + L+ +Y + SL FD
Sbjct: 78 ---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDY 130
Query: 604 IKKRLLDWEARIRIIQGIAQGLLYLHQ-----YSRLRIIHRDLKASNVLLDKDMNPKISD 658
+ + + E I++ A GL +LH + I HRDLK+ N+L+ K+ I+D
Sbjct: 131 LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190
Query: 659 FGLARMF--GGDELQGNTKRIVGT 680
GLA D + VGT
Sbjct: 191 LGLAVRHDSATDTIDIAPNHRVGT 214
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 56/165 (33%), Positives = 77/165 (46%), Gaps = 15/165 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN-----GQEVAVKRLSSQSG-QGLKEFKNEMMLIAEL 566
LGEG FG V G+ VAVK L + +G Q +K E+ ++ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 567 QHRNLVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
H ++++ GCC + G L++EY+P SL YL + + + Q I +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ YLH IHRDL A NVLLD D KI DFGLA+
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 12/164 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ 567
+ +LG+G FG V R G+ VAVK+L + + L++F+ E+ ++ LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 568 HRNLVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
H N+V+ G C G + LI+EY+P SL YL K +D ++ I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
YL R IHRDL N+L++ + KI DFGL ++ D+
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 12/164 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ 567
+ +LG+G FG V R G+ VAVK+L + + L++F+ E+ ++ LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 568 HRNLVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
H N+V+ G C G + LI+EY+P SL YL K +D ++ I +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
YL R IHRDL N+L++ + KI DFGL ++ D+
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 7/159 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAELQHRN 570
E+ + ++G G FG V+ GRL + VAVK + +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+VR++G C ++ +++E + +L + L + ++++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
IHRDL A N L+ + KISDFG++R
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 55/165 (33%), Positives = 84/165 (50%), Gaps = 13/165 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF-----NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAEL 566
LGEG FG V R G++VAVK L +SG + + K E+ ++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 567 QHRNLVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
H N+V+ G C E G LI+E++P+ SL YL P K ++ + +++ I +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ YL + +HRDL A NVL++ + KI DFGL + D+
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ 567
+ +LG+G FG V R G VAVK+L ++F+ E+ ++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 568 HRNLVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
+V+ G G + L++EY+P+ L +L + LD + I +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
YL R +HRDL A N+L++ + + KI+DFGLA++ D+
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 8/152 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 573 RILGCCVEQGEKILI-LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
++LG VE+ + I EYM SL YL + +L + ++ + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+HRDL A NVL+ +D K+SDFGL +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE------VAVKRLSSQSGQGLKEFKNEMMLIAEL 566
+ ++ +LGEG FG V+ N VAVK L S ++F+ E L+ L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL------------FDPIKKRLLDWEAR 614
QH+++VR G C E +++ EYM + L+ +L + + L
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 615 IRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ + +A G++YL + L +HRDL N L+ + + KI DFG++R
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-35
Identities = 47/152 (30%), Positives = 80/152 (52%), Gaps = 8/152 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
+ + +G+G FG V G + G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 573 RILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
++LG VE+ + ++ EYM SL YL + +L + ++ + + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+HRDL A NVL+ +D K+SDFGL +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 22/170 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG------QEVAVKRLSSQSGQGLKEFKNEMMLIAEL 566
+ ++ +LGEG FG V+ +N VAVK L + K+F+ E L+ L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------------FDPIKKRLLDWEA 613
QH ++V+ G C + I++ EYM + L+ +L K L
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ I IA G++YL + +HRDL N L+ ++ KI DFG++R
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 53/163 (32%), Positives = 83/163 (50%), Gaps = 12/163 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAEL 566
F LG G FG VYKG E VA+K L + S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
+ ++ R+LG C+ ++ I + MP L Y+ + K + + + IA+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
YL R++HRDL A NVL+ + KI+DFGLA++ G +E
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 17/161 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
+++ KLGEGGF V L +G A+KR+ Q +E + E + H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 572 VRILGCCVEQGEK----ILILEYMPNKSLDVYLFDPIKKRLLDW----EARI-RIIQGIA 622
+R++ C+ + L+L + +L ++ I++ E +I ++ GI
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTL----WNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+GL +H HRDLK +N+LL + P + D G
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 57/171 (33%), Positives = 78/171 (45%), Gaps = 23/171 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAE 565
+LGE FG VYKG LF Q VA+K L G +EF++E ML A
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------------FDPIKKRLLDWE 612
LQH N+V +LG + +I Y + L +L D K L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 613 ARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ ++ IA G+ YL S ++H+DL NVL+ +N KISD GL R
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 6/157 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
+ ++G G FG V+ G N +VA+K + + ++F E ++ +L H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 66
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ G C+EQ L+ E+M + L YL ++ L E + + + +G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+IHRDL A N L+ ++ K+SDFG+ R D+
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 21/169 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAEL-Q 567
+ Q +GEG FG V K R+ A+KR+ S ++F E+ ++ +L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------FDPIKKRLLDWEARIRIIQ- 619
H N++ +LG C +G L +EY P+ +L +L DP + + Q
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 620 -----GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+A+G+ YL S+ + IHRDL A N+L+ ++ KI+DFGL+R
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 12/163 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAEL 566
LG G FG V+KG E V +K + +SG Q + + M+ I L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
H ++VR+LG C ++ + +Y+P SL ++ + L + + IA+G+
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMY 129
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
YL ++HR+L A NVLL +++DFG+A + D+
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 17/165 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAE 565
E +M +LG+G FG VY+G + VA+K + + S + EF NE ++ E
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------FDPIKKRLLDWEARIRII 618
++VR+LG + ++I+E M L YL + I++
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
IA G+ YL + + +HRDL A N ++ +D KI DFG+ R
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E ++ +LG G FG V G+ +VAVK + S EF E + +L H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLV 66
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
+ G C ++ ++ EY+ N L YL + L+ + + + +G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ IHRDL A N L+D+D+ K+SDFG+ R D+
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 50/159 (31%), Positives = 85/159 (53%), Gaps = 8/159 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE--VAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ +M+ KLG G +G VY+G VAVK L + + ++EF E ++ E++H N
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVW-KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 70
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
LV++LG C + +I E+M +L YL + ++ + + + I+ + YL
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL-- 127
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ IHRDL A N L+ ++ K++DFGL+R+ GD
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 6/157 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
++ + +LG G FG V G+ +VA+K + S EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 82
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ G C +Q +I EYM N L YL + + + + + + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ +HRDL A N L++ K+SDFGL+R DE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE----VAVKRL--SSQSGQGLKEFKNEMMLIAEL 566
+ LGEG FG V +G L VAVK + + S + ++EF +E + +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 567 QHRNLVRILGCCVEQG-----EKILILEYMPNKSLDVYL---FDPIKKRLLDWEARIRII 618
H N++R+LG C+E + ++IL +M L YL + + + ++ +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
IA G+ YL S +HRDL A N +L DM ++DFGL++
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 16/164 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKE-FKNEMMLIAELQH 568
+ LG+GGF ++ + A K + S +E E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIK--KRLLDWEARIRIIQGIAQGL 625
+++V G E + + ++LE +SL + K K L + EAR ++ I G
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGC 154
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
YLH+ R+IHRDLK N+ L++D+ KI DFGLA D
Sbjct: 155 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ ++ KLG G FG V+ +VAVK + ++ F E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ ++ I I E+M SL +L + I IA+G+ ++
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ IHRDL+A+N+L+ + KI+DFGLAR+ +E
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKE-FKNEMMLIAELQHRNLVRILG 576
LG+GGF ++ + A K + S +E E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 577 CCVEQGEKI-LILEYMPNKSLDVYLFDPIK--KRLLDWEARIRIIQGIAQGLLYLHQYSR 633
E + + ++LE +SL + K K L + EAR ++ I G YLH R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---R 133
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
R+IHRDLK N+ L++D+ KI DFGLA D
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 54/157 (34%), Positives = 80/157 (50%), Gaps = 6/157 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E + +LG G FG V+ G +VAVK L S F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
R+ ++ I I EYM N SL +L P L + + IA+G+ ++
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
IHRDL+A+N+L+ ++ KI+DFGLAR+ +E
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 24/170 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+F LG+G FG V K R + + A+K++ + L +E+ML+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 571 LVRILGCCVEQGEKI-------------LILEYMPNKSLDVYLFDPIKKR--LLDWEARI 615
+VR +E+ + + +EY N +L +D I +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 616 RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
R+ + I + L Y+H IIHRDLK N+ +D+ N KI DFGLA+
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 17/175 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHR 569
E + K+GEG FG + +G++ +K +S S + +E + E+ ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR---LLDWEARI-RIIQGIAQGL 625
N+V+ E G ++++Y L F I + L E +I I L
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDL----FKRINAQKGVLFQ-EDQILDWFVQICLAL 138
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
++H +I+HRD+K+ N+ L KD ++ DFG+AR+ +GT
Sbjct: 139 KHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 51/179 (28%), Positives = 76/179 (42%), Gaps = 31/179 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAE 565
N +GEG FG V++ R VAVK L S +F+ E L+AE
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL---------------------FDPI 604
+ N+V++LG C L+ EYM L+ +L
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 605 KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
L ++ I + +A G+ YL S + +HRDL N L+ ++M KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRL-SSQSGQGLKEFKNEMMLIAELQ 567
++ +G G G V GRL VA+K L + + + ++F +E ++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H N++R+ G +++ EYM N SLD +L + +++G+ G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRY 166
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
L S L +HRDL A NVL+D ++ K+SDFGL+R+ D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 53/163 (32%), Positives = 83/163 (50%), Gaps = 12/163 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAEL 566
F LG G FG VYKG E VA+K L + S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
+ ++ R+LG C+ ++ I + MP L Y+ + K + + + IA+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
YL R++HRDL A NVL+ + KI+DFGLA++ G +E
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-33
Identities = 49/158 (31%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
+ +M+ KLG G +G VY+G VAVK L + + ++EF E ++ E++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 278
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
V++LG C + +I E+M +L YL + ++ + + + I+ + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ IHR+L A N L+ ++ K++DFGL+R+ GD
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 18/166 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG----QEVAVKRL--SSQSGQGLKEFKNEMMLIAEL 566
+ F++ LG+G FG V + +L +VAVK L + ++EF E + E
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 567 QHRNLVRILGCCVEQGEKI------LILEYMPNKSLDVYLFD---PIKKRLLDWEARIRI 617
H ++ +++G + K +IL +M + L +L L + +R
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ IA G+ YL S IHRDL A N +L +DM ++DFGL+R
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 14/156 (8%)
Query: 520 KLGEGGFGPVYKGRLFNG---QEVAVKRL--SSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
+LG G FG V KG + VAVK L + E E ++ +L + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
+G C + E L++E L+ YL + R + + I ++ ++ G+ YL
Sbjct: 84 IGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EE 135
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+HRDL A NVLL KISDFGL++ DE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 41/173 (23%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL--------FNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 564
E+ LG+G F ++KG + EV +K L + F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
+L H++LV G CV E IL+ E++ SLD YL K ++ ++ + + +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAA 125
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNP--------KISDFGLARMFGGDE 669
+ +L +IH ++ A N+LL ++ + K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 12/158 (7%)
Query: 517 MQCKLGEGGFGPVYKGRLFNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLV 572
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 573 RILGCCVEQGEKILI-LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
R++G C Q E +++ +E L +L K+ + ++ ++ G+ YL
Sbjct: 74 RLIGVC--QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL--- 126
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+HRDL A NVLL KISDFGL++ G D+
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 9e-33
Identities = 50/164 (30%), Positives = 72/164 (43%), Gaps = 13/164 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL----FNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAE 565
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
L HRNL+R+ G + K+ + E P SL L + R +A+G+
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGM 134
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
YL R IHRDL A N+LL KI DFGL R ++
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 48/174 (27%), Positives = 83/174 (47%), Gaps = 26/174 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRL-SSQSGQGLKEFKNEMMLI 563
+ ++ LGEG FG V VAVK L + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 564 AEL-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------------FDPIKKRLL 609
+ +H+N++ +LG C + G +I+EY +L YL + + + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
++ + +A+G+ YL + + IHRDL A NVL+ ++ KI+DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRL-SSQSGQGLKEFKNEMMLIAE 565
+ + LG G FG V + F + VAVK L + + +E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 566 L-QHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYL-------------FDPIKKRLLD 610
+ H N+V +LG C + G + +I+E+ +L YL + + K L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 611 WEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
E I +A+G+ +L + + IHRDL A N+LL + KI DFGLAR
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 11/150 (7%)
Query: 520 KLGEGGFGPVYKGRLFNG----QEVAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
+G G FG VY G L + AVK L + +F E +++ + H N++ +
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 575 LGCCVEQGEKIL-ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
LG C+ L +L YM + L ++ + + I +A+G+ YL +
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ +HRDL A N +LD+ K++DFGLAR
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 56/164 (34%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV 579
LG+G +G VY GR L N +A+K + + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 580 EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII--QGIAQGLLYLHQYSRLRII 637
E G + +E +P SL L L D E I Q I +GL YLH +I+
Sbjct: 90 ENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQ-ILEGLKYLHDN---QIV 144
Query: 638 HRDLKASNVLLD-KDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
HRD+K NVL++ KISDFG ++ G + T+ GT
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGT 186
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAELQ 567
+G+G FG VY G + + A+K L Q ++ F E +L+ L
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 568 HRNLVRILGCCVEQGEKILI-LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
H N++ ++G + + L YM + L ++ P +R + I +A+G+
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGME 138
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
YL + + +HRDL A N +LD+ K++DFGLAR
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 48/174 (27%), Positives = 83/174 (47%), Gaps = 26/174 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRL-SSQSGQGLKEFKNEMMLI 563
+ ++ LGEG FG V VAVK L + + L + +EM ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 564 AEL-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------------FDPIKKRLL 609
+ +H+N++ +LG C + G +I+EY +L YL + + + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
++ + +A+G+ YL + + IHRDL A NVL+ ++ KI+DFGLAR
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 17/165 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAE 565
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I++
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL----FDPIKKRLLDWEARIRIIQGI 621
H+N+VR +G ++ + +++E M L +L P + L + + + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLAR 663
A G YL IHRD+ A N LL KI DFG+AR
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 51/165 (30%), Positives = 78/165 (47%), Gaps = 17/165 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAE 565
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I++
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL----FDPIKKRLLDWEARIRIIQGI 621
H+N+VR +G ++ + ++LE M L +L P + L + + + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLAR 663
A G YL IHRD+ A N LL KI DFG+AR
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 47/185 (25%), Positives = 79/185 (42%), Gaps = 28/185 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
+F +G GGFG V+K + +G+ +KR+ + ++ + E+ +A+L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 572 VRILGCCVEQGEKI----------------LILEYMPNKSLDVYLFDPIKKRLLDWEARI 615
V GC + +E+ +L+ ++ ++L A
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 616 RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK 675
Q I +G+ Y+H ++I+RDLK SN+ L KI DFGL D G
Sbjct: 127 LFEQ-ITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 676 RIVGT 680
R GT
Sbjct: 180 RSKGT 184
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 53/179 (29%), Positives = 85/179 (47%), Gaps = 31/179 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAE 565
+N + LGEG FG V K F+ VAVK L + S L++ +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL---------------------FDPI 604
+ H +++++ G C + G +LI+EY SL +L D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 605 KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+R L I I+QG+ YL + ++++HRDL A N+L+ + KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 10/173 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAELQH 568
NF ++ K+G G F VY+ L +G VA+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI-RIIQGIAQGLLY 627
N+++ +E E ++LE L + K++ L E + + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+H R++HRD+K +NV + K+ D GL R F ++ +VGT
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 11/150 (7%)
Query: 520 KLGEGGFGPVYKGRLFNG----QEVAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
+G G FG VY G L + AVK L + +F E +++ + H N++ +
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 575 LGCCVEQGEKIL-ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
LG C+ L +L YM + L ++ + + I +A+G+ +L +
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ +HRDL A N +LD+ K++DFGLAR
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 50/163 (30%), Positives = 85/163 (52%), Gaps = 11/163 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAEL 566
+ Q +G G FG VYKG L VA+K L + + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
H N++R+ G + ++I EYM N +LD +L + K + +++GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 161
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
YL + + +HRDL A N+L++ ++ K+SDFGL+R+ D
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 42/172 (24%), Positives = 76/172 (44%), Gaps = 12/172 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAELQHRN 570
+S+ ++G GG V++ Q A+K L Q L ++NE+ + +LQ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 571 L--VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+R+ + +++E N L+ +L KK + WE + + + + + +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK--KKSIDPWERK-SYWKNMLEAVHTI 143
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
HQ+ I+H DLK +N L+ K+ DFG+A D VGT
Sbjct: 144 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 50/162 (30%), Positives = 83/162 (51%), Gaps = 10/162 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAELQ 567
N S+ +G G FG V GRL + VA+K L + + ++F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H N++R+ G + +++ EYM N SLD +L + +++GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKY 162
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
L S + +HRDL A N+L++ ++ K+SDFGL R+ D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 11/162 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAELQ 567
E + +GEG FG V++G + + VA+K + S ++F E + + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H ++V+++G E I I+E L +L +K LD + I ++ L Y
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 131
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
L R +HRD+ A NVL+ + K+ DFGL+R
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-31
Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ +L+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 242
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ E+ I + EYM SL +L + L + + IA G+ Y+
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
R+ +HRDL+A+N+L+ +++ K++DFGLAR+ +E
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 39/176 (22%), Positives = 72/176 (40%), Gaps = 17/176 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRN 570
+F LG GGFG V++ + + A+KR+ ++ E+ +A+L+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 571 LVRILGCCVEQGEKI------------LILEYMPNKSLDVYLFDPIKKRLLDWEARIRII 618
+VR +E+ + ++ ++L ++ + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
IA+ + +LH ++HRDLK SN+ D K+ DFGL DE +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 51/170 (30%), Positives = 71/170 (41%), Gaps = 22/170 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAE 565
N LG G FG V + F + VAVK L S+ + +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 566 L-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-----------FDPIKKRLLDWEA 613
L QH N+V +LG C G ++I EY L +L I
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ +AQG+ +L + IHRD+ A NVLL KI DFGLAR
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 42/172 (24%), Positives = 76/172 (44%), Gaps = 12/172 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAELQHRN 570
+S+ ++G GG V++ Q A+K L Q L ++NE+ + +LQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 571 L--VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+R+ + +++E N L+ +L KK + WE + + + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERK-SYWKNMLEAVHTI 124
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
HQ+ I+H DLK +N L+ K+ DFG+A D VGT
Sbjct: 125 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 11/162 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAELQ 567
E+ + LGEG FG VY+G N + VAVK + ++F +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H ++V+++G E+ I I+E P L YL K L + I + + Y
Sbjct: 72 HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAY 128
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
L + +HRD+ N+L+ K+ DFGL+R ++
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 50/174 (28%), Positives = 72/174 (41%), Gaps = 26/174 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAE 565
S LG G FG V + + + VAVK L S + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 566 L-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL---------------FDPIKKRLL 609
L H N+V +LG C G ++I EY L +L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
D E + +A+G+ +L + IHRDL A N+LL KI DFGLAR
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 12/165 (7%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAELQHRNL--VRIL 575
++G GG V++ Q A+K L Q L ++NE+ + +LQ + +R+
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
+ +++E N L+ +L KK + WE + + + + + +HQ+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERK-SYWKNMLEAVHTIHQH---G 175
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I+H DLK +N L+ D K+ DFG+A D VG
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ +L+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 325
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ E+ I + EYM SL +L + L + + IA G+ Y+
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
R+ +HRDL+A+N+L+ +++ K++DFGLAR+ +E
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN--------GQEVAVKRL-SSQSGQGLKEFKNEMMLI 563
+ + LGEG FG V +VAVK L S + + L + +EM ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 564 AEL-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------------FDPIKKRLL 609
+ +H+N++ +LG C + G +I+EY +L YL + L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ + +A+G+ YL + + IHRDL A NVL+ +D KI+DFGLAR
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 52/158 (32%), Positives = 84/158 (53%), Gaps = 17/158 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKE-FKNEMMLIAELQH 568
E+F + LG+G F VY+ + G EVA+K + + G+ + +NE+ + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIK---KRLLDWEARIRIIQGIAQG 624
+++ + E + L+LE N + +K K + EAR + I G
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEAR-HFMHQIITG 124
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
+LYLH + I+HRDL SN+LL ++MN KI+DFGLA
Sbjct: 125 MLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 4e-31
Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 10/157 (6%)
Query: 517 MQCKLGEGGFGPVYKGRLFNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLV 572
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
R++G C + + ++E L +L K+ + ++ ++ G+ YL
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+HR+L A NVLL KISDFGL++ G D+
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 48/171 (28%), Positives = 92/171 (53%), Gaps = 12/171 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ ++ K+G+G G VY + GQEVA+++++ Q + NE++++ E ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLLYLH 629
+V L + E +++EY+ SL D + + +D E +I + + Q L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMD-EGQIAAVCRECLQALEFLH 133
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 10/176 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHR 569
E++ + +G G +G K R +G+ + K S + + +E+ L+ EL+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 570 NLVRILGCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKKRLLDWEARI-RIIQGIAQGLL 626
N+VR +++ L ++EY L + K+R E + R++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 627 YLHQ--YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H+ ++HRDLK +NV LD N K+ DFGLAR+ D T VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 16/169 (9%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
++G G F VYKG EVA + + + FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 577 CCVEQGEK----ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
+ +L+ E M + +L YL + +++ + + I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148
Query: 633 RLRIIHRDLKASNVLLD-KDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
IIHRDLK N+ + + KI D GLA + K ++GT
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 193
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 48/172 (27%), Positives = 94/172 (54%), Gaps = 12/172 (6%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
E + + +LG+G FG VYK + G A K + ++S + L+++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 571 LVRILGCCVEQGEKILILEYMPNKSL-DVYLFDPIKKRLLDWEARIRII-QGIAQGLLYL 628
+V++LG G+ +++E+ P ++ + L R L E +I+++ + + + L +L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIML---ELDRGLT-EPQIQVVCRQMLEALNFL 133
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H RIIHRDLKA NVL+ + + +++DFG++ + ++ +GT
Sbjct: 134 HS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGT 180
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 12/171 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
K+GEG G V R +G++VAVK + + Q + NE++++ + QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLLYLH 629
+V + + E +++E++ +L D + + L+ E +I + + + Q L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLN-EEQIATVCEAVLQALAYLH 158
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+IHRD+K+ ++LL D K+SDFG D + + +VGT
Sbjct: 159 A---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGT 204
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-30
Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 11/162 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAELQ 567
E + +GEG FG V++G + + VA+K + S ++F E + + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H ++V+++G E I I+E L +L +K LD + I ++ L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAY 506
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
L R +HRD+ A NVL+ + K+ DFGL+R
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 50/179 (27%), Positives = 70/179 (39%), Gaps = 31/179 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAE 565
EN LG G FG V + + VAVK L + +E+ ++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 566 L-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL--------------------FDPI 604
L H N+V +LG C G LI EY L YL +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 605 KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+L +E + +A+G+ +L +HRDL A NVL+ KI DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 48/181 (26%), Positives = 74/181 (40%), Gaps = 18/181 (9%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 564
+ Q ++G G FG V++ + G + AVK++ + + E++ A
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACA 105
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQ 623
L +V + G E + +E + SL + + L E R G +
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP-EDRALYYLGQALE 161
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMFGGDELQGNTKR---IVG 679
GL YLH RI+H D+KA NVLL D + + DFG A D L + I G
Sbjct: 162 GLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 680 T 680
T
Sbjct: 219 T 219
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 42/156 (26%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGC 577
L EGGF VY+ + + +G+E A+KRL S + + E+ + +L H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 578 CVEQGEK-------ILILEYMPNKSLDVYLFDPIKKRLLDWEARI-RIIQGIAQGLLYLH 629
E+ L+L + L +L + L + +I + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLS-CDTVLKIFYQTCRAVQHMH 153
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
+ IIHRDLK N+LL K+ DFG A
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 51/156 (32%), Positives = 82/156 (52%), Gaps = 12/156 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQ 567
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + +L+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLL 626
H N ++ GC + + L++EY + D+ + K+ L E I + G QGL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQ-EVEIAAVTHGALQGLA 168
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
YLH +IHRD+KA N+LL + K+ DFG A
Sbjct: 169 YLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 51/172 (29%), Positives = 92/172 (53%), Gaps = 13/172 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQHR 569
E F+ K+G+G FG V+KG + VA+K + + + +++ + E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLLYL 628
+ + G ++ + +I+EY+ S D ++ LD E +I I + I +GL YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLD-ETQIATILREILKGLDYL 135
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H + IHRD+KA+NVLL + K++DFG+A +++ NT VGT
Sbjct: 136 H---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 182
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 40/166 (24%), Positives = 75/166 (45%), Gaps = 11/166 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRN 570
+ + LG+G V++GR G A+K + + + E ++ +L H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 571 LVRILGC--CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+V++ K+LI+E+ P SL L +P L + +++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 629 HQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARMFGGDEL 670
+ I+HR++K N++ D K++DFG AR DE
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 18/178 (10%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG-----LKEFKNEMMLI 563
+++ F KLG G + VYKG G VA+K + S +G ++E L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPN---KSLDVYLFDPIKKRLLDWEARIRIIQG 620
EL+H N+VR+ + + L+ E+M N K +D + L + Q
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ- 116
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ QGL + H+ +I+HRDLK N+L++K K+ DFGLAR F G + + +V
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV 170
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 54/172 (31%), Positives = 91/172 (52%), Gaps = 14/172 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
E F + KLGEG +G VYK GQ VA+K++ + L+E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 571 LVRILGCCVEQGEKILILEYMPNKSL-DVYLFDPIKKRLLDWEARIRII-QGIAQGLLYL 628
+V+ G + + +++EY S+ D+ ++ + L E I I Q +GL YL
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLT-EDEIATILQSTLKGLEYL 141
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H +R IHRD+KA N+LL+ + + K++DFG+A + NT ++GT
Sbjct: 142 HF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGT 188
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 52/175 (29%), Positives = 88/175 (50%), Gaps = 21/175 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 563
ENF K+GEG +G VYK R G+ VA+K++ L E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
EL H N+V++L + + L+ E++ + L ++ + + + Q + Q
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQ-LLQ 114
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
GL + H + R++HRDLK N+L++ + K++DFGLAR F G ++ T +V
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV 165
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 58/174 (33%), Positives = 90/174 (51%), Gaps = 21/174 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKN--------EMMLIA 564
E + K+GEG +G VYK + G+ VA+KR+ L E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
EL H N+V ++ + L+ E+M K L L D K L D + +I + Q + +G
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL-DENKTGLQDSQIKIYLYQ-LLRG 131
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ + HQ+ RI+HRDLK N+L++ D K++DFGLAR F G ++ T +V
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 49/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRN 570
+++ +Q +G G V ++VA+KR++ + + E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 571 LVRILGCCVEQGEKILILEYMPNKSL-----DVYLFDPIKKRLLDWEARIRII-QGIAQG 624
+V V + E L+++ + S+ + K +LD E+ I I + + +G
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREVLEG 133
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL-ARMFGGDELQGNTKR--IVGT 680
L YLH + IHRD+KA N+LL +D + +I+DFG+ A + G ++ N R VGT
Sbjct: 134 LEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 16/157 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAELQ 567
E+F + LG+G FG VY R + +A+K L ++G + + E+ + + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK--RLLDWEARIRIIQGIAQGL 625
H N++R+ G + LILEY P ++ + ++K + + I +A L
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTA-TYITELANAL 122
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
Y H R+IHRD+K N+LL KI+DFG +
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 40/166 (24%), Positives = 75/166 (45%), Gaps = 11/166 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRN 570
+ + LG+G V++GR G A+K + + + E ++ +L H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 571 LVRILGC--CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+V++ K+LI+E+ P SL L +P L + +++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 629 HQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARMFGGDEL 670
+ I+HR++K N++ D K++DFG AR DE
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
LGEG +G V + AVK L + G K E+ L+ L+H+N+++++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 576 G-CCVEQGEKI-LILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYS 632
E+ +K+ +++EY + + D + +KR +A + GL YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAH-GYFCQLIDGLEYLH--- 126
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
I+H+D+K N+LL KIS G+A
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 22/175 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 563
+ + K+GEG +G V+K + + VA+KR+ L + E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
EL+H+N+VR+ + L+ E+ + L Y D L + + Q + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF-DSCNGDLDPEIVKSFLFQ-LLK 112
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
GL + H ++HRDLK N+L++++ K+++FGLAR F G ++ + +V
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 51/174 (29%), Positives = 90/174 (51%), Gaps = 21/174 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKN--------EMMLIA 564
E + K+GEG +G VYK + G+ A+K++ L++ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
EL+H N+V++ + +L+ E++ + L L D + L A+ ++Q + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLL-DVCEGGLESVTAKSFLLQ-LLNG 112
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ Y H R++HRDLK N+L++++ KI+DFGLAR F G ++ T IV
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 43/194 (22%), Positives = 71/194 (36%), Gaps = 35/194 (18%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAEL-Q 567
T F K+G G FG V+K +G A+KR + E+ A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII--QGIAQGL 625
H ++VR E ++ EY SL + + + EA ++ + Q + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ-VGRGL 128
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNP-------------------KISDFGLARMFG 666
Y+H + ++H D+K SN+ + + P KI D G
Sbjct: 129 RYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI- 184
Query: 667 GDELQGNTKRIVGT 680
+ + G
Sbjct: 185 -----SSPQVEEGD 193
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 40/175 (22%), Positives = 66/175 (37%), Gaps = 19/175 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAEL-QH 568
++F +LG G +G V+K R +G+ AVK + + E+ ++ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK--RLLDWEARIR-IIQGIAQGL 625
VR+ E G L E L + L EA++ ++ L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-----GPSLQQHCEAWGASLP-EAQVWGYLRDTLLAL 170
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+LH ++H D+K +N+ L K+ DFGL G + G
Sbjct: 171 AHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGD 219
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-27
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 26/179 (14%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLV 572
+F + LG G G + +F+ ++VAVKR+ + E+ L+ E +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 573 RILGCCVEQGEKI--LILEYMPNKSLDVYLFDPIKKR---LLDWEARIRIIQGIAQGLLY 627
R C E+ + + +E L + ++++ L E ++Q GL +
Sbjct: 82 RYF--CTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPI-TLLQQTTSGLAH 133
Query: 628 LHQYSRLRIIHRDLKASNVLL-----DKDMNPKISDFGLARMFGGDEL-QGNTKRIVGT 680
LH L I+HRDLK N+L+ + ISDFGL + + GT
Sbjct: 134 LHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 9e-27
Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 16/169 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNL 571
+ M+ +LG GGFG V + G++VA+K+ + +E + E+ ++ +L H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 572 VRIL------GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLD-WEARIRIIQGIAQG 624
V +L +EY L YL L R ++ I+
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSA 133
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLD---KDMNPKISDFGLARMFGGDEL 670
L YLH+ RIIHRDLK N++L + + KI D G A+ EL
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHR 569
F + +G G +G VYKGR + GQ A+K + +G +E K E+ ++ + HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 570 NLVRILGCCVEQGEKI------LILEYMPNKSL-DVYLFDPIKKRLLDWEARIRII-QGI 621
N+ G +++ L++E+ S+ D+ K L E I I + I
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLK-EEWIAYICREI 138
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+GL +LHQ ++IHRD+K NVLL ++ K+ DFG++ + NT +GT
Sbjct: 139 LRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGT 192
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 52/160 (32%), Positives = 81/160 (50%), Gaps = 12/160 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-FKN----EMMLIAEL 566
+ + LGEG F VYK R Q VA+K++ K+ E+ L+ EL
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
H N++ +L + L+ ++M L+V + D L + ++ QGL
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDN-SLVLTPSHIKAYMLM-TLQGLE 126
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
YLHQ+ I+HRDLK +N+LLD++ K++DFGLA+ FG
Sbjct: 127 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 16/160 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG-----LKEFKNEMMLIAEL 566
E + KLGEG + VYKG+ VA+K + + +G ++E L+ +L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
+H N+V + + L+ EY+ +K L YL D + ++ + Q + +GL
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNIINMHNVKLFLFQ-LLRGLA 114
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
Y H+ +++HRDLK N+L+++ K++DFGLAR
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 37/182 (20%), Positives = 72/182 (39%), Gaps = 27/182 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLS-----------------SQSGQGLKE 555
++ + L +G F + + + A+K+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 556 FKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL------FDPIKKRLL 609
FKNE+ +I ++++ + G E +I EYM N S+ + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ II+ + Y+H + I HRD+K SN+L+DK+ K+SDFG + +
Sbjct: 150 IQVIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 670 LQ 671
++
Sbjct: 207 IK 208
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 16/166 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAELQ 567
++F + LG+G FG VY R N +A+K L + G + + E+ + + L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLR 72
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK--RLLDWEARIRIIQGIAQGL 625
H N++R+ ++ L+LE+ P L + ++K R + + ++ +A L
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSA-TFMEELADAL 127
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671
Y H ++IHRD+K N+L+ KI+DFG + +
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 39/190 (20%), Positives = 70/190 (36%), Gaps = 20/190 (10%)
Query: 504 SLASVAAATENFSMQCKLGEG--GFGPVYKGR-LFNGQEVAVKR--LSSQSGQGLKEFKN 558
++S + + +G+G V R G+ V V+R L + S + + +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 559 EMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDW--EARIR 616
E+ + H N+V + E ++ +M S D I +D E I
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA----KDLICTHFMDGMNELAIA 131
Query: 617 II-QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT- 674
I QG+ + L Y+H + +HR +KAS++L+ D +S +
Sbjct: 132 YILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 675 ----KRIVGT 680
K V
Sbjct: 189 HDFPKYSVKV 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 44/164 (26%), Positives = 72/164 (43%), Gaps = 23/164 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 563
E + K+GEG +G V+K R GQ VA+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVY-LFDPIKKRLLDWEARIRIIQGIA 622
+L+H NLV +L + L+ EY V D ++ + + + Q
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSITWQ-TL 112
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
Q + + H++ IHRD+K N+L+ K K+ DFG AR+
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 26/179 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAELQHRN 570
++ +G G FG V++ +L EVA+K++ K FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 571 LVRILGCCVEQGEKI------LILEYMPNKSLDVY----LFDPIKKRLLDWEARIRIIQG 620
+V + G+K L+LEY+P VY + +K+ + ++ + Q
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVYRASRHYAKLKQTMPMLLIKLYMYQ- 149
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMFGGDELQGNTKRIV 678
+ + L Y+H + I HRD+K N+LLD K+ DFG A++ + N I
Sbjct: 150 LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYIC 203
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-26
Identities = 49/184 (26%), Positives = 76/184 (41%), Gaps = 33/184 (17%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEM-MLIAELQHRNLVRILGCC 578
LG G G V F G+ VAVKR+ E+ +L H N++R C
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY--C 76
Query: 579 VEQGEK--ILILEYMPNKSLDVYL-----FDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
E ++ + LE N +L + D K ++ +++ IA G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLHS- 133
Query: 632 SRLRIIHRDLKASNVLLD-------------KDMNPKISDFGLARMFGGDE--LQGNTKR 676
L+IIHRDLK N+L+ +++ ISDFGL + + + N
Sbjct: 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 677 IVGT 680
GT
Sbjct: 192 PSGT 195
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 23/164 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMM---------L 562
E + +GEG +G V K R G+ VA+K+ L+ ++M+ L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKL 77
Query: 563 IAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIA 622
+ +L+H NLV +L C ++ L+ E++ + ++ L + L + + Q I
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL-ELFPNGLDYQVVQKYLFQ-II 134
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
G+ + H + IIHRD+K N+L+ + K+ DFG AR
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 54/165 (32%), Positives = 79/165 (47%), Gaps = 14/165 (8%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVRILGCC 578
LGEG +G V + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 579 VEQGEKI-LILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
+G L LEY L FD I + + +A+ R + G++YLH +
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIG 125
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I HRD+K N+LLD+ N KISDFGLA +F + + ++ GT
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG-QGLKEFKNEM-MLIAELQHR 569
++ +LG G +G V K R + +GQ +AVKR+ + Q K ++ + + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLLYL 628
V G +G+ + +E M Y K + + E + I I + L +L
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIP-EDILGKIAVSIVKALEHL 125
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H S+L +IHRD+K SNVL++ K+ DFG++ D++ + G
Sbjct: 126 H--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AGC 172
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 18/168 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQS---GQGLKEFKNEMMLIA 564
+S LG G FG V+ +EV VK ++ L + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIA 622
++H N++++L QG L++E + LD LF I RL + A I + +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGS-GLD--LFAFIDRHPRLDEPLAS-YIFRQLV 140
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670
+ YL IIHRD+K N+++ +D K+ DFG A +L
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 52/171 (30%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKN-EMMLIAELQHR 569
+++ +G G FG VY+ +L +G+ VA+K++ K FKN E+ ++ +L H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 570 NLVRILGCCVEQGEKI------LILEYMPNKSLDVY----LFDPIKKRLLDWEARIRIIQ 619
N+VR+ GEK L+L+Y+P VY + K+ L ++ + Q
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMFGGDE 669
+ + L Y+H I HRD+K N+LLD D K+ DFG A+ E
Sbjct: 165 -LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 11/165 (6%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAELQHRNLVRIL 575
KLG GG VY +VA+K + + LK F+ E+ ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
E L++EY+ +L Y+ L + I I G+ + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I+HRD+K N+L+D + KI DFG+A+ L T ++GT
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGT 175
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 51/156 (32%), Positives = 82/156 (52%), Gaps = 15/156 (9%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQHRNLVRILGC 577
+G+G F V R + G+EVA+K + + + L++ E+ ++ L H N+V++
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 578 CVEQGEKI-LILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+E + + LI+EY + FD + R+ + EAR + I + Y H +
Sbjct: 83 -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEAR-SKFRQIVSAVQYCH---QK 133
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670
RI+HRDLKA N+LLD DMN KI+DFG + F
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 54/164 (32%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVRILGCC 578
LGEG +G V + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
E + L LEY L FD I + + +A+ R + G++YLH + I
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGI 126
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
HRD+K N+LLD+ N KISDFGLA +F + + ++ GT
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 52/180 (28%), Positives = 77/180 (42%), Gaps = 28/180 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 563
+ + KLGEG +G VYK + VA+KR+ L+ + E+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
ELQHRN++ + LI EY L Y+ + + + Q +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDK--NPDVSMRVIKSFLYQ-LIN 143
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNP-----KISDFGLARMFGGDELQGNTKRIV 678
G+ + H R +HRDLK N+LL KI DFGLAR F G ++ T I+
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII 199
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 8/153 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG-QGLKEFKNEM-MLIAELQHR 569
E+ ++G G +G V K +GQ +AVKR+ S + K+ ++ +++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVY-LFDPIKKRLLDWEARIRII-QGIAQGLLY 627
+V+ G +G+ + +E M Y + ++ E + I + L +
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP-EEILGKITLATVKALNH 140
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660
L L+IIHRD+K SN+LLD+ N K+ DFG
Sbjct: 141 LK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 19/177 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQH 568
E +++ C LG+G FG V K + QE AVK + +S + E+ L+ +L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLL 626
N++++ + ++ E L FD I +KR + +A RII+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 627 YLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
Y+H+ I+HRDLK N+LL +KD + KI DFGL+ F + K +GT
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 53/157 (33%), Positives = 78/157 (49%), Gaps = 16/157 (10%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVK---RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
LG G FG V G G +VAVK R +S + + K E+ + +H +++++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 577 CCVEQGEKI-LILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
+ +++EY+ L FD I R+ + EAR R+ Q I + Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEAR-RLFQQILSAVDYCH---R 129
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670
++HRDLK NVLLD MN KI+DFGL+ M E
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 42/183 (22%), Positives = 78/183 (42%), Gaps = 9/183 (4%)
Query: 483 EFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVA 541
+ E+ D + + + ++F +LG G G V+K +G +A
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62
Query: 542 VKRLSSQSGQG-LKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL 600
K + + + E+ ++ E +V G GE + +E+M SLD
Sbjct: 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD--- 119
Query: 601 FDPIKKRLLDWEARIRII-QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659
+KK E + + + +GL YL + +I+HRD+K SN+L++ K+ DF
Sbjct: 120 -QVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDF 176
Query: 660 GLA 662
G++
Sbjct: 177 GVS 179
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 23/172 (13%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKN----EMMLI 563
AT + ++G G +G VYK R +G VA+K R+ + G G E+ L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVALL 65
Query: 564 AELQ---HRNLVRILGCCVEQGEKI-----LILEYMPNKSLDVYLFDPIKKRLLDWEARI 615
L+ H N+VR++ C L+ E++ ++ L YL D L I
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLP-AETI 122
Query: 616 R-IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
+ +++ +GL +LH I+HRDLK N+L+ K++DFGLAR++
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 42/175 (24%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ ++++ +G G +G V A K++ + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYL 628
++R+ + + L++E LF+ + K+ + +A RI++ + + Y
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122
Query: 629 HQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H+ L + HRDLK N L D K+ DFGLA F ++ + VGT
Sbjct: 123 HK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGT 171
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 41/175 (23%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKN----EMMLIAEL 566
+ F ++ G+G FG V G+ G VA+K++ F+N M +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLAVL 76
Query: 567 QHRNLVRILGCCVEQGEK-------ILILEYMPNKSLDVY----LFDPIKKRLLDWEARI 615
H N+V++ GE+ +++EY+P ++ + + ++
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPPILIKV 133
Query: 616 RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMFGGDE 669
+ Q + + + LH S + + HRD+K NVL+++ K+ DFG A+ E
Sbjct: 134 FLFQ-LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 41/180 (22%), Positives = 73/180 (40%), Gaps = 22/180 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHR 569
+ F + KLG G FG V+ +G E +K ++ +S +++ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDW------EARIRIIQGIAQ 623
N+++I + +++E L + I +++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVA-ELMKQMMN 135
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
L Y H ++H+DLK N+L KI DFGLA +F DE GT
Sbjct: 136 ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 40/166 (24%), Positives = 77/166 (46%), Gaps = 27/166 (16%)
Query: 519 CKLGEGGFGPVYKGR---LFNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAELQHRNL 571
CK+G G +G VYK + + ++ A+K++ S S E+ L+ EL+H N+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNV 80
Query: 572 VRILGCCVEQGEKI--LILEYMPN---KSLDVYLFDPIKKRLLDWEARIR--IIQGIAQG 624
+ + + ++ L+ +Y + + + K+ + + ++ I G
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNP----KISDFGLARMFG 666
+ YLH ++HRDLK +N+L+ + KI+D G AR+F
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 17/173 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
S LG G FG V+K G ++A K + ++ + +E KNE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR---LLDWEARIRIIQGIAQGLLYLH 629
++ + + +L++EY+ LFD I L + + I ++ I +G+ ++H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDT-ILFMKQICEGIRHMH 204
Query: 630 QYSRLRIIHRDLKASNVLL-DKDMNP-KISDFGLARMFGGDELQGNTKRIVGT 680
Q + I+H DLK N+L ++D KI DFGLAR + E K GT
Sbjct: 205 Q---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGT 251
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 41/184 (22%), Positives = 74/184 (40%), Gaps = 18/184 (9%)
Query: 485 GEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK 543
G GK G + A + ++G G G V+K R G +AVK
Sbjct: 1 GSSGSSGKQTGYLT----IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56
Query: 544 RLSSQSG-QGLKEFKNEM-MLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL- 600
++ + K ++ +++ +V+ G + + + +E M + +
Sbjct: 57 QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKR 116
Query: 601 -FDPIKKRLLDWEARIRII-QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISD 658
PI E + + I + L YL + +IHRD+K SN+LLD+ K+ D
Sbjct: 117 MQGPIP------ERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCD 168
Query: 659 FGLA 662
FG++
Sbjct: 169 FGIS 172
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 6e-24
Identities = 36/169 (21%), Positives = 62/169 (36%), Gaps = 23/169 (13%)
Query: 520 KLGEGGFGPVYKGR--LFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVRILG 576
+ GG G +Y NG+ V +K L + E +AE+ H ++V+I
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 577 CCVEQGEKI-----LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
+++EY+ +SL L I + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ +++ DLK N++L ++ K+ D G + GT
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGT 240
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-24
Identities = 55/157 (35%), Positives = 82/157 (52%), Gaps = 16/157 (10%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILG 576
LG G FG V G+ G +VAVK L+ Q S + + + E+ + +H +++++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 577 CCVEQGEKI-LILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
+ I +++EY+ L FD I RL + E+R R+ Q I G+ Y H R
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESR-RLFQQILSGVDYCH---R 134
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670
++HRDLK NVLLD MN KI+DFGL+ M E
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 26/198 (13%)
Query: 496 KDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--------RLS 546
+D+ LP S EN+ + LG G V + +E AVK S
Sbjct: 2 RDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59
Query: 547 SQSGQGLKE-FKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI 604
++ Q L+E E+ ++ ++ H N++++ L+ + M L FD +
Sbjct: 60 AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYL 115
Query: 605 --KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
K L + E R +I++ + + + LH+ L I+HRDLK N+LLD DMN K++DFG +
Sbjct: 116 TEKVTLSEKETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 663 RMFGGDELQGNTKRIVGT 680
E + + GT
Sbjct: 172 CQLDPGEK---LREVCGT 186
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 46/184 (25%), Positives = 72/184 (39%), Gaps = 25/184 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQSGQGLKEFKNEMMLIAE 565
+ + + +G+G F V + GQ+ AVK + +S G ++ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDW------EARIRIIQ 619
L+H ++V +L G ++ E+M L I KR A ++
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVAS-HYMR 137
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKR 676
I + L Y H IIHRD+K VLL + K+ FG+A G
Sbjct: 138 QILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGG 192
Query: 677 IVGT 680
VGT
Sbjct: 193 RVGT 196
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 26/194 (13%), Positives = 56/194 (28%), Gaps = 38/194 (19%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQH-------- 568
LG+ + G+ V +K+ K E++ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 569 --------RNLVRILGCC-----VEQGEKILILEY---MPNKSLDV-----YLFDPIKK- 606
+LV+ + +L P ++ L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 607 RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
+ L AR+++ + + L LH ++H L+ +++LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 667 GDELQGNTKRIVGT 680
G R
Sbjct: 262 GASAVSPIGRGFAP 275
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 47/183 (25%), Positives = 80/183 (43%), Gaps = 26/183 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQSGQGLKE---FKNEMML 562
+ + M LG G G V ++VA+K + + S + + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 563 IAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQG 620
+ +L H +++I + + ++LE M L FD + KRL + +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 122
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRI 677
+ + YLH IIHRDLK NVLL ++D KI+DFG +++ G L + +
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 176
Query: 678 VGT 680
GT
Sbjct: 177 CGT 179
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 41/177 (23%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 563
+ K+G+G FG V+K R GQ+VA+K++ ++ K E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 564 AELQHRNLVRILGCCVEQGEKI--------LILEYMPN------KSLDVYLFDPIKKRLL 609
L+H N+V ++ C + L+ ++ + ++ V KR++
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
+ GL Y+H+ +I+HRD+KA+NVL+ +D K++DFGLAR F
Sbjct: 131 --------QM-LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 175
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 17/157 (10%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKE-FKNEMMLIAELQHRNLVRILG 576
LGEG FG V Q+VA+K +S Q + + E+ + L+H +++++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 577 CCVEQGEKI-LILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
+ I +++EY + LFD I KKR+ + E R R Q I + Y H R
Sbjct: 77 V-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---R 126
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670
+I+HRDLK N+LLD ++N KI+DFGL+ +
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 46/183 (25%), Positives = 81/183 (44%), Gaps = 26/183 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS--------SQSGQGLKEFKNEMML 562
+ + M LG G G V ++VA++ +S ++ + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 563 IAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQG 620
+ +L H +++I + + ++LE M L FD + KRL + +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 247
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRI 677
+ + YLH+ IIHRDLK NVLL ++D KI+DFG +++ G L + +
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301
Query: 678 VGT 680
GT
Sbjct: 302 CGT 304
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 44/181 (24%), Positives = 81/181 (44%), Gaps = 23/181 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-------RLSSQSGQGLKE-FKNEMML 562
+ + + +G G V + G E AVK RLS + + ++E + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 563 IAEL-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQ 619
+ ++ H +++ ++ L+ + M L FD + K L + E R I++
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMR 207
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVG 679
+ + + +LH I+HRDLK N+LLD +M ++SDFG + E + + G
Sbjct: 208 SLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCG 261
Query: 680 T 680
T
Sbjct: 262 T 262
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 46/172 (26%), Positives = 89/172 (51%), Gaps = 29/172 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR--LFNGQEVAVKRLSSQSGQGLKEFKN--------EMML 562
+ + ++GEG +G V+K R G+ VA+KR+ ++ + E+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 563 IAELQ---HRNLVRILGCCV----EQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEAR 614
+ L+ H N+VR+ C ++ K+ L+ E++ ++ L YL D + + + E
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122
Query: 615 IRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
++ + +GL +LH + R++HRDLK N+L+ K++DFGLAR++
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 19/199 (9%), Positives = 44/199 (22%), Gaps = 36/199 (18%)
Query: 501 PLFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL---SSQSGQGLKEF 556
+ ++ + L G V+ R + ++ A+K + S L+
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 557 KNEMMLIAELQHRNLVRILGCC--------------------------VEQGEKILILEY 590
A L + +L++
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 591 MP---NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647
F + + A + + + L ++H N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLF 226
Query: 648 LDKDMNPKISDFGLARMFG 666
+ D + D G
Sbjct: 227 IMPDGRLMLGDVSALWKVG 245
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 54/182 (29%), Positives = 85/182 (46%), Gaps = 24/182 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 564
+++ M +LG G F V K R G+E A K RLSS +E + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIA 622
E++H N++ + + + +LILE + LFD + K+ L + EA + ++ I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEAT-QFLKQIL 118
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARMFGGDELQGNTKRIV 678
G+ YLH RI H DLK N++L + K+ DFG+A K I
Sbjct: 119 DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIF 172
Query: 679 GT 680
GT
Sbjct: 173 GT 174
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ + + +LG G FG V++ G+ K +++ KNE+ ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR--LLDWEARIRIIQGIAQGLLYL 628
L+ + ++ E +LILE++ LFD I + I ++ +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 629 HQYSRLRIIHRDLKASNVLL-DKDMNP-KISDFGLARMFGGDELQGNTKRIVGT 680
H+ I+H D+K N++ K + KI DFGLA DE K T
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTAT 213
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 19/177 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQH 568
++N+ ++ +LG+G F V + G E A K + S + ++ + E + +LQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLL 626
N+VR+ E+ L+ + + L F+ I ++ + +A IQ I + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 119
Query: 627 YLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
Y H I+HR+LK N+LL K K++DFGLA E GT
Sbjct: 120 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 21/164 (12%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLS----------SQSGQGLKEFKNEMMLIAELQHR 569
LG+GGFG V+ G L + +VA+K + S S E + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLY 627
++R+L Q +L+LE P + D LFD I K L + +R + + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSR-CFFGQVVAAIQH 154
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMFGGDEL 670
H ++HRD+K N+L+D K+ DFG + +
Sbjct: 155 CH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY 195
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 15/170 (8%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAELQHRNLVRIL 575
LG GG V+ R L + ++VAVK L + + F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 576 --GCCVEQGEKI--LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
G + +++EY+ +L + + + + I +I Q L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG-NTKRIVGT 680
+ IIHRD+K +N+++ K+ DFG+AR T ++GT
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 7e-23
Identities = 28/175 (16%), Positives = 53/175 (30%), Gaps = 30/175 (17%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR------LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAE 565
++ + LGEG F VY+ N Q+ +K + M +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK------RLLDWEARIRIIQ 619
++ + Q +L+ E + L + I +++ I
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGT----LLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLL-----------DKDMNPKISDFGLAR 663
+ + +H IIH D+K N +L D + D G +
Sbjct: 180 RMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 24/182 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 564
+ + + +LG G F V K R G E A K + + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIA 622
++ H N++ + + + +LILE + LFD + K+ L + EA I+ I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEA-TSFIKQIL 125
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLL-DKDMNP---KISDFGLARMFGGDELQGNTKRIV 678
G+ YLH +I H DLK N++L DK++ K+ DFGLA K I
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIF 179
Query: 679 GT 680
GT
Sbjct: 180 GT 181
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 49/182 (26%), Positives = 79/182 (43%), Gaps = 24/182 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 564
+ + + +LG G F V K R G E A K + + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIA 622
++ H N++ + + + +LILE + LFD + K+ L + EA I+ I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEA-TSFIKQIL 125
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARMFGGDELQGNTKRIV 678
G+ YLH +I H DLK N++L + K+ DFGLA K I
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIF 179
Query: 679 GT 680
GT
Sbjct: 180 GT 181
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 19/177 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQH 568
E +++ C LG+G FG V K + QE AVK + +S + E+ L+ +L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLL 626
N++++ + ++ E L FD I +KR + +A RII+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 627 YLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
Y+H+ I+HRDLK N+LL +KD + KI DFGL+ F + K +GT
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGT 186
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 54/182 (29%), Positives = 79/182 (43%), Gaps = 24/182 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 564
+ + +LG G F V K R G + A K R S +E + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIA 622
E+QH N++ + + + ILILE + LFD + K+ L + EA ++ I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEA-TEFLKQIL 124
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARMFGGDELQGNTKRIV 678
G+ YLH L+I H DLK N++L KI DFGLA K I
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 679 GT 680
GT
Sbjct: 179 GT 180
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 44/182 (24%), Positives = 79/182 (43%), Gaps = 41/182 (22%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLS-------------------SQSGQGLKEFKNEM 560
+G+G +G V + A+K LS + G + + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 561 MLIAE-------LQHRNLVRILGCCVEQGEK---ILILEYMPNKSLDVYLFD-PIKKRLL 609
+ + L H N+V+ L ++ + ++ E + + + P K L
Sbjct: 81 EQVYQEIAILKKLDHPNVVK-LVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF-GGD 668
+ +AR Q + +G+ YLH +IIHRD+K SN+L+ +D + KI+DFG++ F G D
Sbjct: 136 EDQAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 669 EL 670
L
Sbjct: 192 AL 193
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 53/324 (16%), Positives = 102/324 (31%), Gaps = 49/324 (15%)
Query: 383 SNVTEGSGCLMWYGDLLDSRRPIRNFTGQSVYLQVPTSESGNKKLLWILVVLVLPLVLLP 442
N+ + + L W LD + N+T + E+ W
Sbjct: 19 ENILDEAVILSWKPPALDGGSLVTNYT-------IEKREAMGGS--WSPCAKSRYTYTTI 69
Query: 443 SF------YIFCRR---------------RRKCKEKETENTETNQDLLAFDINMGITTRT 481
Y F E + D I
Sbjct: 70 EGLRAGKQYEFRIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDV----DEQGKIVRGK 125
Query: 482 NEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEV 540
+ + P +++ + +LG G FG V++ G
Sbjct: 126 GTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNF 185
Query: 541 AVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL 600
A K + + + + E+ ++ L+H LV + + E ++I E+M L
Sbjct: 186 AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS----GGEL 241
Query: 601 FDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL-DKDMNP-KI 656
F+ + + + + + ++ + +GL ++H+ +H DLK N++ K N K+
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKL 298
Query: 657 SDFGLARMFGGDELQGNTKRIVGT 680
DFGL + + K GT
Sbjct: 299 IDFGLTAHLDPKQ---SVKVTTGT 319
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 19/170 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL------SSQSGQGLKEFKNEMMLIAEL 566
+ + LG GGFG VY G + + VA+K + E++L+ ++
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 567 QHR--NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIA 622
++R+L +LILE P D LFD I + L + AR +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELAR-SFFWQVL 159
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLARMFGGDELQ 671
+ + + H ++HRD+K N+L+D + K+ DFG +
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT 206
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 3e-22
Identities = 24/180 (13%), Positives = 56/180 (31%), Gaps = 37/180 (20%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSS---QSGQGLKEFKNEMMLIAELQ--------- 567
LG+ + G+ V +K+ K E++ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 568 ----------------HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI-----KK 606
+ ++R+ + Y +S + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 607 RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
+ L AR+++ + + L LH Y ++H L+ +++LD+ ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 41/175 (23%), Positives = 76/175 (43%), Gaps = 18/175 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ F LG G F V+ + G+ A+K + +NE+ ++ +++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYL 628
+V + L+++ + LFD I + + +A +IQ + + YL
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDAS-LVIQQVLSAVKYL 122
Query: 629 HQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H+ I+HRDLK N+L +++ I+DFGL++M + GT
Sbjct: 123 HE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGT 170
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 4e-22
Identities = 45/237 (18%), Positives = 76/237 (32%), Gaps = 72/237 (30%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRN 570
+F +G GGFG V++ + + A+KR+ ++ E+ +A+L+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 571 LVRILGCCV-----------------------------------------EQGEKILILE 589
+VR + + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 590 YMPNKSLDVYLF------------DPIKKRLLDWEARI----RIIQGIAQGLLYLHQYSR 633
+ S VYL+ D + +R + I IA+ + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK----------RIVGT 680
++HRDLK SN+ D K+ DFGL DE + VGT
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 19/177 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQH 568
++N+ ++ +LG+G F V + G E A K + S + ++ + E + +LQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLL 626
N+VR+ E+ L+ + + L F+ I ++ + +A IQ I + +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 142
Query: 627 YLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
Y H I+HR+LK N+LL K K++DFGLA E GT
Sbjct: 143 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 193
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 39/166 (23%), Positives = 63/166 (37%), Gaps = 13/166 (7%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAELQHRNLVRIL 575
+G GG G VY+ + VA+K +S + E LQ ++V I
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
G+ + + + L L ++ L + I++ I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL-QGNTKRIVGT 680
HRD+K N+L+ D + DFG+A ++L Q VGT
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--TVGT 198
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 40/220 (18%), Positives = 73/220 (33%), Gaps = 58/220 (26%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQSGQGLKEFKNEMMLIAE 565
+ + ++ +G+G +G V A+K ++ + + ++ K E+ L+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI---------- 615
L H N+ R+ ++ L++E L D + + D +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHL----LDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 616 -------------------------------RIIQGIAQGLLYLHQYSRLRIIHRDLKAS 644
I++ I L YLH I HRD+K
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPE 197
Query: 645 NVLL--DKDMNPKISDFGLARMFGGDELQGNT--KRIVGT 680
N L +K K+ DFGL++ F GT
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-22
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 19/177 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQH 568
+E + KLG G +G V R E A+K + +S S + E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLL 626
N++++ ++ L++E L FD I + + + +A II+ + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAA-VIIKQVLSGVT 150
Query: 627 YLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
YLH+ I+HRDLK N+LL +KD KI DFGL+ +F + K +GT
Sbjct: 151 YLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGT 201
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-21
Identities = 56/178 (31%), Positives = 89/178 (50%), Gaps = 20/178 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQ 567
++ + Q LG+G FG V + GQE AVK +S + + E+ L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGL 625
H N++++ ++G L+ E L FD I +KR + +A RII+ + G+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RIIRQVLSGI 139
Query: 626 LYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
Y+H+ +I+HRDLK N+LL KD N +I DFGL+ F + K +GT
Sbjct: 140 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGT 191
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 33/175 (18%), Positives = 68/175 (38%), Gaps = 18/175 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
E + + LG G FG V++ + + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDW---EARIRIIQGIAQGLLY 627
++ + E ++I E++ +F+ I + E + + + + L +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREI-VSYVHQVCEALQF 117
Query: 628 LHQYSRLRIIHRDLKASNVLL--DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
LH I H D++ N++ + KI +FG AR + + +
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTA 166
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 47/172 (27%), Positives = 73/172 (42%), Gaps = 22/172 (12%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHR-NLVRIL 575
+LG G F V + GQE A K + + E +E+ ++ + ++ +
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDW----EARIRIIQGIAQGLLYLHQY 631
E ILILEY + F L + + R+I+ I +G+ YLHQ
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVI-RLIKQILEGVYYLHQ- 149
Query: 632 SRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I+H DLK N+LL + KI DFG++R G + I+GT
Sbjct: 150 --NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGT 196
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 47/172 (27%), Positives = 68/172 (39%), Gaps = 20/172 (11%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCC 578
LGEG V L QE AVK + Q G E+ ++ + Q HRN++ ++
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKR--LLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
E+ L+ E M S+ I KR + EA ++Q +A L +LH I
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEAS-VVVQDVASALDFLHN---KGI 132
Query: 637 IHRDLKASNVLL---DKDMNPKISDFGLARMF-----GGDELQGNTKRIVGT 680
HRDLK N+L ++ KI DF L G+
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-20
Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 18/177 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQH 568
TE + + +LG+G F V + + GQE A + S + ++ + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLL 626
N+VR+ E+G LI + + L F+ I ++ + +A IQ I + +L
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADAS-HCIQQILEAVL 124
Query: 627 YLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ HQ + ++HR+LK N+LL K K++DFGLA G+ Q GT
Sbjct: 125 HCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGT 176
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 16/156 (10%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVRILGCC 578
+G G FG R + VAVK + G + E + E++ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
+ +I+EY L ++ I R + EAR Q + G+ Y H ++I
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEAR-FFFQQLLSGVSYCH---SMQI 137
Query: 637 IHRDLKASNVLLDKD--MNPKISDFGLARMFGGDEL 670
HRDLK N LLD KI DFG ++
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 22/150 (14%), Positives = 50/150 (33%), Gaps = 16/150 (10%)
Query: 520 KLGEGGFGPVYKG---RLFNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHRNLVR 573
G ++ L ++VA+ + Q L+E + + ++ + + R
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
+L + +++ E++ SL + A IR +Q +A H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQ----EVADTSPSPVGA-IRAMQSLAAAADAAH---R 147
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ S V + D + ++
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 30/188 (15%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-------------SQSGQGLKEFK 557
E++ KLG G +G V + E A+K + + +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 558 NEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARI 615
NE+ L+ L H N++++ ++ L+ E+ L F+ I + + + +A
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA- 149
Query: 616 RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQG 672
I++ I G+ YLH+ I+HRD+K N+LL + +N KI DFGL+ F D
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 673 NTKRIVGT 680
+ +GT
Sbjct: 206 --RDRLGT 211
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 42/176 (23%), Positives = 72/176 (40%), Gaps = 20/176 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
T+ + ++ +G G + + E AVK + +E +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYL 628
++ + + ++ E M L D I +K + EA ++ I + + YL
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVLFTITKTVEYL 132
Query: 629 HQYSRLRIIHRDLKASNVLL-DKDMNP---KISDFGLARMFGGDELQGNTKRIVGT 680
H ++HRDLK SN+L D+ NP +I DFG A+ + G T
Sbjct: 133 HA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYT 183
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 44/174 (25%), Positives = 66/174 (37%), Gaps = 30/174 (17%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNE-MMLIAELQHRNLVRILGC 577
LG G G V + GQ+ A+K L + + E ++V IL
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90
Query: 578 CVEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDW----EARIRIIQGIAQGLLYLH 629
+I+E M L F I++R EA I++ I + +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAA-EIMRDIGTAIQFLH 145
Query: 630 QYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I HRD+K N+L +KD K++DFG A+ + LQ T
Sbjct: 146 S---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYT 192
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 42/203 (20%), Positives = 81/203 (39%), Gaps = 57/203 (28%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKN-EMMLIAELQHR 569
++ +S+ LG G FG V + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 570 NLVRILGCCVEQGEKI--------------------------------------LILEYM 591
N+++++ G++ +I+EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 592 PNKSLDVY----LFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647
P ++ F + + I I Q + + + ++H L I HRD+K N+L
Sbjct: 121 P---DTLHKVLKSFIRSGRSIPMNLISIYIYQ-LFRAVGFIHS---LGICHRDIKPQNLL 173
Query: 648 LD-KDMNPKISDFGLARMFGGDE 669
++ KD K+ DFG A+ E
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSE 196
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
++ F ++ +LG G VY+ + + A+K L + K + E+ ++ L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYL 628
++++ E L+LE + L FD I K + +A ++ I + + YL
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAA-DAVKQILEAVAYL 164
Query: 629 HQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H+ I+HRDLK N+L D KI+DFGL+++ L K + GT
Sbjct: 165 HE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGT 213
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 52/176 (29%), Positives = 76/176 (43%), Gaps = 18/176 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEF---KNEMMLIAELQH 568
E+F LGEG F V R +E A+K L + + E +++ L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 569 RNLVRILGCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKK--RLLDWEARIRIIQGIAQG 624
V++ Q ++ L L Y N L I+K + R + I
Sbjct: 90 PFFVKLYFTF--QDDEKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTAE-IVSA 142
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
L YLH IIHRDLK N+LL++DM+ +I+DFG A++ + Q VGT
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-18
Identities = 43/179 (24%), Positives = 85/179 (47%), Gaps = 41/179 (22%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+ + ++ +G G +G V + + VA+K++ + F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 562 LIAELQHRNLVRILGCCV----EQGEKI-LILEYMPN------KSLDVYLFDPIKKRLLD 610
++ L H ++V++L + E+ +++ ++LE + ++ VYL + K LL
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLL- 162
Query: 611 WEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ G+ Y+H S I+HRDLK +N L+++D + K+ DFGLAR E
Sbjct: 163 -------YN-LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 20/168 (11%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGC 577
LGEG F K + Q AVK +S + + E+ + + H N+V++
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKR--LLDWEARIRIIQGIAQGLLYLHQYSRLR 635
+Q L++E + L F+ IKK+ + EA I++ + + ++H +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEAS-YIMRKLVSAVSHMHD---VG 126
Query: 636 IIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
++HRDLK N+L + ++ KI DFG AR+ D K T
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFT 172
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 40/173 (23%), Positives = 79/173 (45%), Gaps = 32/173 (18%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+ + +G G +G V +G++VA+K+LS + F++ E++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 562 LIAELQHRNLVRIL-----GCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARI 615
L+ +QH N++ +L + L++ +M L + + + + +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQY 130
Query: 616 RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
+ Q + +GL Y+H ++HRDLK N+ +++D KI DFGLAR +
Sbjct: 131 LVYQ-MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 38/174 (21%), Positives = 65/174 (37%), Gaps = 29/174 (16%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGC 577
LG G G V + ++ A+K L + + E+ L ++VRI+
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 123
Query: 578 CVEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDW----EARIRIIQGIAQGLLYLH 629
+++E + L F I+ R EA I++ I + + YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 178
Query: 630 QYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ I HRD+K N+L + K++DFG A+ + T
Sbjct: 179 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYT 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 18/171 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ LG GG G V+ + VA+K++ Q +K E+ +I L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDP---------IKKRLLDWEARIR--IIQ 619
+V++ G ++ + VY+ +++ L E R + Q
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL-EEHARLFMYQ 128
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMFGGDE 669
+ +GL Y+H + ++HRDLK +N+ ++ +D+ KI DFGLAR+
Sbjct: 129 -LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 38/157 (24%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HR 569
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 570 NLVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
N++ + + + L+ E++ N + L D++ R + + I + L Y
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE-ILKALDY 145
Query: 628 LHQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLAR 663
H S I+HRD+K NV++D + ++ D+GLA
Sbjct: 146 CH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 5e-17
Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 32/174 (18%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+ + +G G G V + VA+K+LS + F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 562 LIAELQHRNLVRIL------GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI 615
L+ + H+N++ +L E + L++E M D L I+ L
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSY 168
Query: 616 RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ Q + G+ +LH IIHRDLK SN+++ D KI DFGLAR G
Sbjct: 169 LLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 46/175 (26%), Positives = 78/175 (44%), Gaps = 32/175 (18%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+ + +G G G V + VA+K+LS + F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 562 LIAELQHRNLVRIL-----GCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARI 615
L+ + H+N++ +L +E+ + + +++E M D L I+ L
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSY 131
Query: 616 RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670
+ Q + G+ +LH IIHRDLK SN+++ D KI DFGLAR G +
Sbjct: 132 LLYQ-MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 37/156 (23%), Positives = 62/156 (39%), Gaps = 26/156 (16%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNE-MMLIAELQHRNLVRILGC 577
LG G G V + ++ A+K L + + E + Q ++VRI+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 578 CVEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDW----EARIRIIQGIAQGLLYLH 629
+++E + L F I+ R EA I++ I + + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 134
Query: 630 QYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLA 662
+ I HRD+K N+L + K++DFG A
Sbjct: 135 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 79.5 bits (195), Expect = 4e-16
Identities = 37/203 (18%), Positives = 63/203 (31%), Gaps = 46/203 (22%)
Query: 507 SVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRL--------SSQSGQGLKEFKN 558
S TE K+GEG FG V++ + VA+K + + + +E
Sbjct: 14 SHCLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 559 EMMLIAELQ---------HRNLVRILGCCVEQGE--KILILEYM--------PNKSLDVY 599
E+++ EL + + QG +L+ + N D +
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 600 ----------------LFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKA 643
+ ++ +L I+ + L LR HRDL
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 644 SNVLLDKDMNPKISDFGLARMFG 666
NVLL K K+ +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSST 213
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 38/181 (20%), Positives = 66/181 (36%), Gaps = 36/181 (19%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKE--FKN---------EM 560
+++Q + G +G V G G VA+KR+ + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 561 MLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDP---------IKKRLLDW 611
L+ H N++ + + + + +YL I + +
Sbjct: 81 RLLNHFHHPNILGLRD---------IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI 131
Query: 612 -EARIR--IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
I+ + I GL LH+ ++HRDL N+LL + + I DF LAR D
Sbjct: 132 SPQHIQYFMYH-ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 669 E 669
Sbjct: 188 A 188
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 35/175 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
++ +GEG +G V N VA+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 562 LIAELQHRNLVRILGC----CVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIR 616
++ +H N++ I +EQ + + ++ + M + L+ +K + L I
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLS-NDHIC 131
Query: 617 --IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ Q I +GL Y+H S ++HRDLK SN+LL+ + KI DFGLAR+ D
Sbjct: 132 YFLYQ-ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 18/177 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMMLIAE------ 565
+ F LG GGFG V+ ++ ++ A K+L+ + LK+ K + E
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR---LKKRKGYQGAMVEKKILAK 241
Query: 566 LQHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQ 623
+ R +V L E + L++ M + ++++ + E R I
Sbjct: 242 VHSRFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
GL +LHQ II+RDLK NVLLD D N +ISD GLA + TK GT
Sbjct: 301 GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGT 352
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 42/176 (23%), Positives = 73/176 (41%), Gaps = 37/176 (21%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+ +G G +G V G +VA+K+L + F++ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76
Query: 562 LIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDP---------IKKRLLDWE 612
L+ ++H N++ +L + + + D YL P +K L +
Sbjct: 77 LLKHMRHENVIGLL--------DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 128
Query: 613 ARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
++ + +GL Y+H IIHRDLK N+ +++D KI DFGLAR +
Sbjct: 129 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 3e-15
Identities = 48/180 (26%), Positives = 80/180 (44%), Gaps = 27/180 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMMLIAE------ 565
+FS+ +G GGFG VY R + ++ A+K L + +K + E + + E
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSL 245
Query: 566 ---LQHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQG 620
+V + +K+ IL+ M L +L + + EA +R
Sbjct: 246 VSTGDCPFIVC-MSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFS-EADMRFYAAE 300
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I GL ++H +++RDLK +N+LLD+ + +ISD GLA F + VGT
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 40/175 (22%), Positives = 77/175 (44%), Gaps = 33/175 (18%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+N+ ++ +G G +G VY + VA+K+++ + F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77
Query: 562 LIAELQHRNLVRILGCCVEQGEKI-----LILEYMPNKSLDVYLFDPIKKRLLDWEARIR 616
++ L+ ++R+ + ++LE D L K + E I+
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTEEHIK 132
Query: 617 --IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ + G ++H IIHRDLK +N LL++D + K+ DFGLAR ++
Sbjct: 133 TILYN-LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 35/171 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+ +F ++ LGEG +G V G+ VA+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 562 LIAELQHRNLVRILGC----CVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIR 616
++ +H N++ I E ++ +I E M L I ++L + I+
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLS-DDHIQ 115
Query: 617 --IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
I Q + + LH + +IHRDLK SN+L++ + + K+ DFGLAR+
Sbjct: 116 YFIYQ-TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 1e-14
Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 13/173 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQ---SGQGLKEFKNEMMLIAELQH 568
F LG+GGFG V ++ ++ A K+L + +G NE ++ ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
R +V L E + + L+L M L +++ + + A + I GL
Sbjct: 244 RFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLED 301
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
LH R RI++RDLK N+LLD + +ISD GLA + K VGT
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 49/180 (27%), Positives = 86/180 (47%), Gaps = 32/180 (17%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+ + KLG+G +G V+K G+ VAVK++ F+N E+M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 562 LIAELQ-HRNLVRILGCCV-EQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIR-- 616
++ EL H N+V +L + + L+ +YM + L I+ +L+ +
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILE-PVHKQYV 114
Query: 617 IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR 676
+ Q + + + YLH S ++HRD+K SN+LL+ + + K++DFGL+R F N
Sbjct: 115 VYQ-LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 39/172 (22%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
E + +G G +G V G VAVK+LS + F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 562 LIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDP---------IKKRLLDWE 612
L+ ++H N++ +L + + DVYL +K + L +
Sbjct: 81 LLKHMKHENVIGLL--------DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-D 131
Query: 613 ARIR-IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
++ +I I +GL Y+H S IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 132 DHVQFLIYQILRGLKYIH--SA-DIIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 45/172 (26%), Positives = 75/172 (43%), Gaps = 15/172 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEF---KNEMMLIAELQH 568
+ F LG G FG V + +G A+K L Q LK+ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
LV++ + +++EY+ + +L R + AR Q I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQ-IVLTFEYL 157
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H +I+RDLK N+L+D+ +++DFG A+ ++G T + GT
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 42/173 (24%), Positives = 77/173 (44%), Gaps = 12/173 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAELQH 568
E+F + +G G FG V +L N +V A+K L+ E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
+ + L + + L+++Y L + L + RL + AR + + + +
Sbjct: 134 KWITT-LHYAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDS 190
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+HQ L +HRD+K N+L+D + + +++DFG D + VGT
Sbjct: 191 VHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGT 239
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-13
Identities = 21/126 (16%), Positives = 46/126 (36%), Gaps = 19/126 (15%)
Query: 26 DTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISG 85
+ +T + G+ L + L ++ T VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVE--PYHFIMQEDCN-----LVLYDH---STSVWASNTGIL-GK 50
Query: 86 RNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYL 145
+ + ++GN V+ ++W+++ N V L++DGN+VI + +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------I 102
Query: 146 WQSFDH 151
W + +
Sbjct: 103 WSTGTY 108
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 33/160 (20%), Positives = 59/160 (36%), Gaps = 19/160 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQG-LKEFKNEMMLIAE 565
+ + LG G FG V + F + VAVK L + + +E+ ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 566 L-QHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
+ H N+V +LG C + G + +I+E+ +L YL R + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
G + + I DLK + + S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 9e-13
Identities = 28/128 (21%), Positives = 49/128 (38%), Gaps = 19/128 (14%)
Query: 26 DTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISG 85
+++++ + + G L + L ++ VW +N G
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCN-----FVLYDS---GKPVWASNTGGL--G 50
Query: 86 RNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYL 145
LT+ NNGNLV+ Q+N IW T + + V L+ D N+VI +
Sbjct: 51 SGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV--------V 102
Query: 146 WQSFDHPS 153
W + P+
Sbjct: 103 WATGSGPA 110
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 14/173 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAELQH 568
E++ + +G G FG V R + ++V A+K LS + F E ++A
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
+V+ L + + +++EYMP L + + + AR + + L
Sbjct: 129 PWVVQ-LFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAE-VVLALDA 183
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+H + IHRD+K N+LLDK + K++DFG + + VGT
Sbjct: 184 IHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGT 232
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 39/173 (22%), Positives = 75/173 (43%), Gaps = 12/173 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAELQH 568
++F + +G G F V ++ +V A+K ++ E F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
R + + L + + L++EY L + L +R+ AR + + I +
Sbjct: 121 RWITQ-LHFAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAE-IVMAIDS 177
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+H+ L +HRD+K N+LLD+ + +++DFG D + VGT
Sbjct: 178 VHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGT 226
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 6e-12
Identities = 27/124 (21%), Positives = 52/124 (41%), Gaps = 18/124 (14%)
Query: 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPIS 84
+D + + + G L + + L ++ + VW + +
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN---NRAVWASGTNGK-- 48
Query: 85 GRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESY 144
VL + N+GNLV+ S + IW++N + N L+ D N+VI DNS+++
Sbjct: 49 ASGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNA----- 102
Query: 145 LWQS 148
+W +
Sbjct: 103 IWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 7e-05
Identities = 18/69 (26%), Positives = 34/69 (49%), Gaps = 1/69 (1%)
Query: 83 ISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAE 142
++ + I N+ NLVL N +W++ + V ++++DGNLVI S A
Sbjct: 16 LAEGGYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWAS 74
Query: 143 SYLWQSFDH 151
+ Q+ ++
Sbjct: 75 NTNRQNGNY 83
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 9e-12
Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 15/172 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEF---KNEMMLIAELQH 568
++F + LG G FG V+ R NG+ A+K L + LK+ +E ++++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
++R+ G + + +I++Y+ L L +R + A+ + + L YL
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAE-VCLALEYL 122
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H II+RDLK N+LLDK+ + KI+DFG A+ + T + GT
Sbjct: 123 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGT 166
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 1e-11
Identities = 24/123 (19%), Positives = 41/123 (33%), Gaps = 20/123 (16%)
Query: 26 DTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISG 85
+ + + + L + + L + L + +W +N DR G
Sbjct: 3 NVLLSGQTLHADHSLQAG--AYTLTIQNKCN-----LVKYQN---GRQIWASNTDR--RG 50
Query: 86 RNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYL 145
LT+ ++GNLV+ N +W + D L+ DG VI L
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV--------L 102
Query: 146 WQS 148
W
Sbjct: 103 WSL 105
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAELQH 568
++F + +G+G FG V + + A+K ++ Q E +N E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQGLL 626
LV L + E + ++++ + L +L + E +++ I + L
Sbjct: 75 PFLVN-LWYSFQDEEDMFMVVDLLLGGDLRYHLQ---QNVHFK-EETVKLFICELVMALD 129
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670
YL RIIHRD+K N+LLD+ + I+DF +A M +
Sbjct: 130 YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-11
Identities = 18/78 (23%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 71 DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNL 130
+ +W N G + +G LV+++ N T+W + V+ + V L+ D N+
Sbjct: 48 NNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNV 105
Query: 131 VIRDNSSDSTAESYLWQS 148
VI ++ LW +
Sbjct: 106 VIYGDA--------LWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-08
Identities = 20/88 (22%), Positives = 31/88 (35%), Gaps = 6/88 (6%)
Query: 61 YLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNP 120
+ P + + + + + NLVL N IW+TN
Sbjct: 5 FSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVL-YDNNNPIWATNTGGLGNGC 63
Query: 121 VAQLRDDGNLVIRDNSSDSTAESYLWQS 148
A L+ DG LV+ N + +WQS
Sbjct: 64 RAVLQPDGVLVVITNEN-----VTVWQS 86
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 3e-11
Identities = 27/123 (21%), Positives = 48/123 (39%), Gaps = 20/123 (16%)
Query: 26 DTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISG 85
+ + + + GE L + R+ L ++ D +W N
Sbjct: 2 NILYSGETLSPGEFLNN--GRYVFIMQEDCN-----LVLYDV---DKPIWATNTGGL--D 49
Query: 86 RNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYL 145
R L++ ++GNLV+ S N IW++N + N V L+ D N+VI +
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA--------R 101
Query: 146 WQS 148
W +
Sbjct: 102 WAT 104
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 17/160 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQH- 568
+ + K+G G FG +Y G + G+EVA+K + ++ Q E K + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK----IYKMMQGG 64
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+ I C E ++++E + SL+ LF+ R + + + + + Y+
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSLE-DLFN-FCSRKFSLKTVLLLADQMISRIEYI 121
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPK---ISDFGLARMF 665
H + IHRD+K N L+ I DFGLA+ +
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 27/176 (15%), Positives = 66/176 (37%), Gaps = 29/176 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR---------LFNGQEVAVKRLSSQSGQGLKEFK------ 557
+ ++ G +Y+ Q+ ++K L ++ G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 558 -----NEMMLIAELQHRNLVRILGCCVEQGE-KILILEYMPNKSLDVYLFDPIKKRLLDW 611
N+ + + +G V Q + + L+L + +SL D K +L
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ-SALDVSPKHVLSE 158
Query: 612 EARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI--SDFGLARMF 665
+ +++ + L +LH+ +H ++ A N+ +D + ++ + +G A +
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 36/158 (22%), Positives = 66/158 (41%), Gaps = 13/158 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
NF + K+G G FG + G+ L+ + VA+K +S + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ ++LE + SL+ LFD + R + + I + + Y+H +
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLE-DLFD-LCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 633 RLRIIHRDLKASNVLLDKDMNPK-----ISDFGLARMF 665
+I+RD+K N L+ + N I DF LA+ +
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 33/161 (20%), Positives = 73/161 (45%), Gaps = 17/161 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHR 569
++ + ++GEG FG +++G L N Q+VA+K S + Q E++ +L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
+ + E +L+++ + SL+ L D + R + + + + +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLG-PSLE-DLLD-LCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPK-----ISDFGLARMF 665
+ S +++RD+K N L+ + + + DFG+ + +
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 4e-10
Identities = 24/118 (20%), Positives = 42/118 (35%), Gaps = 15/118 (12%)
Query: 23 LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRP 82
L + + + + L + F+L Y G W +
Sbjct: 1 LGTNYLLSGQTLDTEGHLKNG--DFDLVMQDDCNL-VLYNGNW-----QSNTAN------ 46
Query: 83 ISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDST 140
+GR+ LT+++ G LV+ + T+W + S N A + DG LV+ S
Sbjct: 47 -NGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPSVFKI 103
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 45/168 (26%), Positives = 69/168 (41%), Gaps = 13/168 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEF---KNEMMLIAELQH 568
F LG+G FG V + A+K L + E E ++ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQGLL 626
L L + +++ ++EY L F + + + E R R I L
Sbjct: 208 PFLTA-LKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVSALD 262
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
YLH S +++RDLK N++LDKD + KI+DFGL + D T
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAELQ 567
+F +G+G FG V R + AVK L ++ KE K+ M L+ ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 568 HRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQGL 625
H LV L + +K+ +L+Y+ L F +++ E R R IA L
Sbjct: 98 HPFLVG-LHFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASAL 152
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGD 668
YLH L I++RDLK N+LLD + ++DFGL + +
Sbjct: 153 GYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 32/173 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV----AVKRLSSQSGQGLKEF---KNEMMLIAE 565
F + LG+G FG V+ + +G + A+K L K ++ + E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKME 76
Query: 566 ---LQHRN---LVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI- 617
L N +V+ L + K+ LIL+++ L F + K ++ E ++
Sbjct: 77 RDILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY 131
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGD 668
+ +A L +LH L II+RDLK N+LLD++ + K++DFGL++ +
Sbjct: 132 LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 39/153 (25%), Positives = 71/153 (46%), Gaps = 17/153 (11%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLV-RIL 575
K+G G FG +Y G + +EVA+K + ++ Q L E K + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGGTGIPNVR 69
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
VE +L+++ + SL+ LF+ ++ L + + + + + ++H S
Sbjct: 70 WFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS--- 123
Query: 636 IIHRDLKASNVLLDKDMNPK---ISDFGLARMF 665
+HRD+K N L+ I DFGLA+ +
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 8e-10
Identities = 23/110 (20%), Positives = 43/110 (39%), Gaps = 13/110 (11%)
Query: 23 LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRP 82
+ + + + +LT+ + +L L ++ W +N
Sbjct: 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVLY----GGKYGWQSNTHG- 51
Query: 83 ISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVI 132
+G + L +++ G L++ TIWS+ SS V L+DDG VI
Sbjct: 52 -NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-07
Identities = 16/71 (22%), Positives = 31/71 (43%), Gaps = 7/71 (9%)
Query: 78 NRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSS 137
D ++ +N L + + NLVL W +N + ++ +L G L+I+D+
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYGGK--YGWQSNTHGNGEHCFLRLNHKGELIIKDDDF 73
Query: 138 DSTAESYLWQS 148
+ +W S
Sbjct: 74 KT-----IWSS 79
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 16/164 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEF---KNEMMLIAELQH 568
+F LG+G FG V R A+K L + E E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQGLL 626
L L + +++ ++EY L F ++R+ E R R I L
Sbjct: 65 PFLTA-LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALE 119
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGD 668
YLH +++RD+K N++LDKD + KI+DFGL + + G
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 1e-09
Identities = 15/125 (12%), Positives = 45/125 (36%), Gaps = 18/125 (14%)
Query: 24 AADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPI 83
+ + ++ + D +L + + + L + + +VW +
Sbjct: 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKGSKTNIVWESGTSG-- 54
Query: 84 SGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAES 143
G++ + + ++G L + T++ +N + V L+ +G V+ +
Sbjct: 55 RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGPA------- 107
Query: 144 YLWQS 148
+W +
Sbjct: 108 -VWST 111
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 17/165 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAELQ 567
+F+ LG+G FG V E+ AVK L + + M+ L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 568 HRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGL 625
L + L C + +++ ++EY+ L I++ E IA GL
Sbjct: 401 PPFLTQ-LHSCFQTMDRLYFVMEYVNGG----DLMYHIQQVGRFKEPHAVFYAAEIAIGL 455
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGD 668
+L II+RDLK NV+LD + + KI+DFG+ + ++ G
Sbjct: 456 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 17/165 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAELQ 567
++F + +G G + V RL + A+K + + ++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 568 HRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGL 625
H LV L C + ++ ++EY+ L ++ ++R L E R I+ L
Sbjct: 69 HPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP-EEHARFYSAEISLAL 123
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGD 668
YLH+ II+RDLK NVLLD + + K++D+G+ + + GD
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 17/165 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEM----MLIAELQ 567
E+F + LG+G FG V+ + A+K L + + M +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 568 HRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGL 625
H L + C + E + ++EY+ L ++ D +R I GL
Sbjct: 77 HPFLTH-MFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFD-LSRATFYAAEIILGL 131
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGD 668
+LH I++RDLK N+LLDKD + KI+DFG+ + M G
Sbjct: 132 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 17/165 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAELQ 567
+F+ LG+G FG V E+ AVK L + + M+ L +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 568 HRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGL 625
L + L C + +++ ++EY+ L I++ E IA GL
Sbjct: 80 PPFLTQ-LHSCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGL 134
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGD 668
+L II+RDLK NV+LD + + KI+DFG+ + ++ G
Sbjct: 135 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 35/173 (20%), Positives = 68/173 (39%), Gaps = 37/173 (21%)
Query: 520 KLGEGGFGPVYKGRLFNGQ------EVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVR 573
+G+GGFG +Y + + + VK S +G E K Q + +R
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 574 IL-------------GCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII 618
G + G+ +I++ L +++ KR + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ-KIYEANAKRF-----SRKTV 154
Query: 619 QGIAQGLL----YLHQYSRLRIIHRDLKASNVLLDKDMNPKI--SDFGLARMF 665
++ +L Y+H++ +H D+KASN+LL+ ++ D+GLA +
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 3e-09
Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 30/173 (17%)
Query: 513 ENFSMQCKLGEGGFGPVY---------KGRLFNGQEVAVKRLSSQS-GQGLKEF---KNE 559
E F + LG+GG+G V+ G++F A+K L + K+ K E
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIF-----AMKVLKKAMIVRNAKDTAHTKAE 71
Query: 560 MMLIAELQHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI- 617
++ E++H +V L + G K+ LILEY+ L F +++ + E
Sbjct: 72 RNILEEVKHPFIVD-LIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFY 126
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGD 668
+ I+ L +LHQ II+RDLK N++L+ + K++DFGL + + G
Sbjct: 127 LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 17/165 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAELQ 567
++F + +G G + V RL + A++ + + ++
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 568 HRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGL 625
H LV L C + ++ ++EY+ L ++ ++R L E R I+ L
Sbjct: 112 HPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP-EEHARFYSAEISLAL 166
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGD 668
YLH+ II+RDLK NVLLD + + K++D+G+ + + GD
Sbjct: 167 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 6e-09
Identities = 48/165 (29%), Positives = 74/165 (44%), Gaps = 17/165 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAELQ 567
+NF LG+G FG V R+ ++ AVK L + + M L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 568 HRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGL 625
H L + L CC + +++ ++E++ L I+K EAR R I L
Sbjct: 83 HPFLTQ-LFCCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFYAAEIISAL 137
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA--RMFGGD 668
++LH II+RDLK NVLLD + + K++DFG+ + G
Sbjct: 138 MFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 2e-08
Identities = 19/79 (24%), Positives = 29/79 (36%), Gaps = 10/79 (12%)
Query: 70 PDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGN 129
D VW N G + NG + +L+ N +W++ S V L+ D N
Sbjct: 167 RDDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 224
Query: 130 LVIRDNSSDSTAESYLWQS 148
L I + LW +
Sbjct: 225 LAIYGGA--------LWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 3e-05
Identities = 17/90 (18%), Positives = 36/90 (40%), Gaps = 6/90 (6%)
Query: 65 WFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQL 124
+ + D + + + L++ + NLVL + +WSTN + A L
Sbjct: 129 YSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVL-FDRDDRVWSTNTAGKGTGCRAVL 187
Query: 125 RDDGNLVIRDNSSDSTAESYLWQSFDHPSD 154
+ +G + + N + + +W S + S
Sbjct: 188 QPNGRMDVLTNQNIA-----VWTSGNSRSA 212
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 5e-04
Identities = 19/123 (15%), Positives = 37/123 (30%), Gaps = 9/123 (7%)
Query: 71 DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNL 130
D VW +N + ++G LV+L+ N WS+ + N V L+ D +
Sbjct: 44 DVRVWASNTAG---ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTV 100
Query: 131 VIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTY 190
I + S + G + + + + Y
Sbjct: 101 TIYGPGLWDSGTSNKGSVVVA------NNGNSILYSTQGNDNHPQTLHATQSLQLSPYRL 154
Query: 191 GLD 193
++
Sbjct: 155 SME 157
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 33/174 (18%), Positives = 65/174 (37%), Gaps = 42/174 (24%)
Query: 520 KLGEGGFGPVYKG-RLFNGQEVA---VKRLSSQSGQGLKEFKNEMML-----IAELQHRN 570
K+G GGFG +Y ++ A VK ++G E K + I + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 571 LVRILG----------CCVEQGEKILILEYMPNKSLDVYLFDPIKK-------RLLDWEA 613
+ LG + + +++E + L + +L
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISGQNGTFKKSTVLQLGI--- 158
Query: 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI--SDFGLARMF 665
R++ + Y+H+ +H D+KA+N+LL ++ +D+GL+ +
Sbjct: 159 --RMLDVLE----YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 42/179 (23%), Positives = 71/179 (39%), Gaps = 40/179 (22%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG---QGLKEFK-------NEMMLIAELQH 568
KLG G F V+ + + N VA+K + E K + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 569 RNLVRILGCCVEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDWEAR---IRIIQGI 621
+++++L +G ++ E L L IKK +E R + ++ I
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKK----YEHRGIPLIYVKQI 136
Query: 622 AQ----GLLYLHQYSRLRIIHRDLKASNVLLDKDMNP------KISDFGLARMFGGDEL 670
++ GL Y+H R IIH D+K NVL++ +P KI+D G A + +
Sbjct: 137 SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY 192
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 34/186 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV----AVKRLSSQSGQGLKEF-----------K 557
ENF + LG G +G V+ R +G + A+K L K +
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKTTEHTR 106
Query: 558 NEMMLIAELQHRN-LVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARI 615
E ++ ++ LV L + K+ LIL+Y+ L +L ++ E +
Sbjct: 107 TERQVLEHIRQSPFLVT-LHYAFQTETKLHLILDYINGGELFTHLS---QRERFT-EHEV 161
Query: 616 RI-IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
+I + I L +LH+ L II+RD+K N+LLD + + ++DFGL++ F DE +
Sbjct: 162 QIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-A 217
Query: 675 KRIVGT 680
GT
Sbjct: 218 YDFCGT 223
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 38/159 (23%), Positives = 62/159 (38%), Gaps = 17/159 (10%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG---QGLKEFK--NEMMLIAELQH 568
+ + +G+G FG V K + VA+K + ++ Q E + M
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK---RLLDWEARIRIIQGIAQGL 625
+V + + + L+ E L L+D ++ R + + Q + L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNP--KISDFGLA 662
L+L L IIH DLK N+LL KI DFG +
Sbjct: 171 LFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 27/157 (17%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHR------N 570
+G+G FG V K Q VA+K + ++ Q +E + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK---RLLDWEARIRIIQGIAQGLLY 627
++ +L + + E L + L++ IKK + + I Q L
Sbjct: 161 VIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNP--KISDFGLA 662
LH + RIIH DLK N+LL + K+ DFG +
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-06
Identities = 13/81 (16%), Positives = 30/81 (37%), Gaps = 8/81 (9%)
Query: 83 ISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAE 142
+S +A + + NLVL + + +N + +L + G L I +S++
Sbjct: 17 LSYESAAFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPV- 73
Query: 143 SYLWQSFDHPSDT----LLQD 159
+++ + L
Sbjct: 74 -WVYPRSVNTVRGNYAATLGP 93
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 8e-06
Identities = 15/81 (18%), Positives = 33/81 (40%), Gaps = 13/81 (16%)
Query: 71 DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGT---IWSTNVSSDVKNPVAQLRDD 127
+ + +N G + L ++N G L + S + T ++ +V++ N A L D
Sbjct: 37 EAGGFQSNTHG--RGVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPD 94
Query: 128 GNLVIRDNSSDSTAESYLWQS 148
++ I + +W +
Sbjct: 95 QHVTIYGPA--------IWST 107
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.9 bits (115), Expect = 2e-06
Identities = 17/117 (14%), Positives = 32/117 (27%), Gaps = 15/117 (12%)
Query: 42 SSSQRFELGFFSPGKSKSRYLGIWFRRVP----DTVVWVANRDRPISGRNAVLTISNNGN 97
+ G + V W A +GN
Sbjct: 150 APGSELVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQ---GKGAVRAVFQGDGN 206
Query: 98 LVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSD 154
LV+ N +W ++ + + V +L+ +G++ I D +W F
Sbjct: 207 LVVYGAGNAVLWHSH-TGGHASAVLRLQANGSIAILDEKP-------VWARFGFQPT 255
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.0 bits (110), Expect = 8e-06
Identities = 33/171 (19%), Positives = 53/171 (30%), Gaps = 20/171 (11%)
Query: 21 ASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRD 80
+ + + G+ L S +QRF+L G L I VWVAN
Sbjct: 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQD---NGATVWVANEQ 61
Query: 81 RPISG------RNAVLTISNNGNLVLLSQTNGTIW-----STNVSSDVKNPVAQLRDDGN 129
+P S + A L L + +W + + L+DDGN
Sbjct: 62 QPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGN 121
Query: 130 LVIRDNSSDSTAESYLWQSFDH-PSDTLLQDMKLGWDFKSGLERLLSSWQS 179
+V+ D+ + + S L +L G +Q
Sbjct: 122 IVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQG 172
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 3e-06
Identities = 44/320 (13%), Positives = 97/320 (30%), Gaps = 105/320 (32%)
Query: 397 DLLDSRRPIRNFTGQSV--YLQVPTSESGNKKLLWIL-------VVLVLPLVLLPSF-YI 446
D+ D + I + + + + + SG +L W L V + VL ++ ++
Sbjct: 37 DVQDMPKSI--LSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFL 94
Query: 447 FCRRRRKCKEKE--TENTETNQDLLAFDINMGIT----TRTNEFGEVN------------ 488
+ + ++ T +D L ++ N +R + ++
Sbjct: 95 MSPIKTEQRQPSMMTRMYIEQRDRL-YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV 153
Query: 489 ------GDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAV 542
G GK +W+ ++ +QCK+ F +
Sbjct: 154 LIDGVLGSGK-----TWV-------ALDVCLSYKVQCKMDFKIF---W------------ 186
Query: 543 KRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD 602
L+ LK + ++ LQ L+ + ++ N
Sbjct: 187 --LN------LKNCNSPETVLEMLQ--KLLYQIDPNWTSRS-----DHSSN--------- 222
Query: 603 PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI----SD 658
IK R+ +A +R LL Y ++ +++ + +++ KI
Sbjct: 223 -IKLRIHSIQAELRR-------LLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRF 274
Query: 659 FGLARMFGGDELQGNTKRIV 678
+ D L T +
Sbjct: 275 KQVT-----DFLSAATTTHI 289
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 2e-05
Identities = 41/304 (13%), Positives = 94/304 (30%), Gaps = 93/304 (30%)
Query: 15 FLFSMKASLAADTMTTASFIR--DGEKLTSSSQRFELGFFSPGKSKSRY--LGIWFRRVP 70
S+ A D + T + + +KLT+ + L P + + + L + F P
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS-LNVLEPAEYRKMFDRLSV-F---P 382
Query: 71 DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNL 130
+ I +L++ IW + SDV V +L L
Sbjct: 383 PSA--------HIP--TILLSL---------------IWFDVIKSDVMVVVNKLHKYS-L 416
Query: 131 VIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLER-LLSSWQSA-----EDPS 184
V + + + ++ ++K+ + + L R ++ + +D
Sbjct: 417 VEKQPKEST---ISI-----P---SIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI 465
Query: 185 PGR-----YTYGLDIHVLP-----KMCTFN----------GSVKFTCSGQWDGTGFVSAL 224
P Y++ + H+ +M F ++ + W+ +G +
Sbjct: 466 PPYLDQYFYSH-IGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTA-WNASGSILNT 523
Query: 225 SYTNFIYKQFMTENKD----------EFVYWYEA--YNRP--SIMTLKL-NPSGFV---- 265
YK ++ +N +F+ E ++ + L +
Sbjct: 524 LQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEA 583
Query: 266 TRQI 269
+Q+
Sbjct: 584 HKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 1e-04
Identities = 40/336 (11%), Positives = 87/336 (25%), Gaps = 116/336 (34%)
Query: 14 IFLFSM----KASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRV 69
+ + + K +A D S + +
Sbjct: 153 VLIDGVLGSGKTWVALDVC--------------LSYKVQCKM------------------ 180
Query: 70 PDTVVW--VANRDRPISGRNAVLTISNN------GNLV-LLSQTNGTIWSTNVSSDVKNP 120
+ W + N + P VL + N ++ +
Sbjct: 181 DFKIFWLNLKNCNSP----ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236
Query: 121 VAQLRDDGN-LVIRDNSSDSTAESYLWQSFDHPSDTLL--QDMKLGWDFKSGLERLLSSW 177
+ + + N L++ N ++ W +F+ LL + ++ DF S +
Sbjct: 237 LLKSKPYENCLLVLLNVQNAK----AWNAFNLSCKILLTTRFKQVT-DFLSAATT---TH 288
Query: 178 QSAEDPSPG-----------RYTYGLDIHVLPK-MCTFNGSVKFTCS----------GQW 215
S + S +Y LP+ + T N S W
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYL-DCRPQDLPREVLTTN---PRRLSIIAESIRDGLATW 344
Query: 216 DGT-------------GFVSALSYTNF--IYKQFMTENKDEFV-------YWYEA-YNRP 252
D ++ L + ++ + + W++ +
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 253 SIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYC 288
++ KL+ V +Q E++ S+P Y
Sbjct: 405 MVVVNKLHKYSLVEKQ-PKEST------ISIPSIYL 433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 39/178 (21%), Positives = 64/178 (35%), Gaps = 32/178 (17%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHR- 569
F + K+G+G FG V + + N + AVK + + E ++ ++Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDD 92
Query: 570 ----NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK---RLLDWEARIRIIQGIA 622
N+V+ G + LI E L L++ I + I I+
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFH----IEDIKLYC 143
Query: 623 QGLL----YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR 676
+L YL ++ + H DLK N+LLD K G TK
Sbjct: 144 IEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 34/155 (21%), Positives = 56/155 (36%), Gaps = 40/155 (25%)
Query: 515 FSMQCKLGEGGFGPVYKG--RLFNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQH- 568
+ + LGEG FG V + G+ VAVK + + E I L+H
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-------IQVLEHL 68
Query: 569 --------RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK---RLLDWEARIRI 617
V++L G ++ E L + +D IK+ +
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFR----LDH 119
Query: 618 IQGIAQGLL----YLHQYSRLRIIHRDLKASNVLL 648
I+ +A + +LH ++ H DLK N+L
Sbjct: 120 IRKMAYQICKSVNFLH---SNKLTHTDLKPENILF 151
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 38/151 (25%), Positives = 60/151 (39%), Gaps = 36/151 (23%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVK---RLSSQSGQGLKEFKNEMML--IAELQ-----H 568
KLG G F V+ + + VA+K + L E + +L +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIR---LLKSVRNSDPNDPNR 100
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEAR-----------IRI 617
+V++L G N + +F+ + LL W + +I
Sbjct: 101 EMVVQLLDDFKISG---------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648
IQ + QGL YLH ++ RIIH D+K N+LL
Sbjct: 152 IQQVLQGLDYLH--TKCRIIHTDIKPENILL 180
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 31/149 (20%), Positives = 55/149 (36%), Gaps = 30/149 (20%)
Query: 529 VYKGRLFNGQEVAVK--RLSSQSGQGLKE--------FKNEMMLIAELQHRNLVRILGCC 578
V+ E VK ++ S + +KE F + A + R L ++ G
Sbjct: 106 VFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 165
Query: 579 V----EQGEKILILEYMPNKSL-DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
V +++E + K L V + +P +LD L + ++
Sbjct: 166 VPKVYAWEGNAVLMELIDAKELYRVRVENP--DEVLD------------MILEEVAKFYH 211
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLA 662
I+H DL NVL+ ++ I DF +
Sbjct: 212 RGIVHGDLSQYNVLVSEEG-IWIIDFPQS 239
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 32/186 (17%), Positives = 57/186 (30%), Gaps = 59/186 (31%)
Query: 515 FSMQCKLGEGGFGPVYKG--RLFNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQH- 568
+ + LGEG FG V + +VA+K + + E I L+
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-------INVLKKI 73
Query: 569 --------RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK---RLLDWEARIRI 617
V + G + E L F+ +K+ + +
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYP----LPH 124
Query: 618 IQGIAQGLL----YLHQYSRLRIIHRDLKASNVLLDKDMNP------------------- 654
++ +A L +LH ++ H DLK N+L
Sbjct: 125 VRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 655 KISDFG 660
+++DFG
Sbjct: 182 RVADFG 187
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 680 | |||
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.98 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.97 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.97 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.97 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.96 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.96 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.95 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.95 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.94 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.94 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.94 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.93 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.93 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.93 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.93 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.93 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.93 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.93 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.93 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.93 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.93 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.93 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.93 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.93 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.93 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.93 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.92 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.92 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.92 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.92 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.92 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.92 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.92 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.92 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.92 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.92 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.92 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.92 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.92 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.92 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.92 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.92 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.92 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.92 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.92 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.92 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.92 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.92 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.92 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.92 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.92 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.92 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.92 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.92 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.92 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.92 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.92 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.92 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.92 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.92 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.91 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.91 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.91 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.91 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.91 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.91 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.91 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.91 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.91 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.91 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.91 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.91 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.91 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.91 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.91 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.91 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.91 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.91 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.91 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.91 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.91 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.91 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.91 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.91 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.91 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.91 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.91 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.91 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.91 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.91 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.91 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.91 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.91 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.91 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.91 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.91 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.91 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.91 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.91 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.91 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.91 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.91 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.91 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.91 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.91 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.91 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.91 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.91 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.91 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.91 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.9 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.9 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.9 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.9 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.9 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.9 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.9 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.9 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.9 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.9 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.9 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.9 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.9 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.9 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.9 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.9 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.9 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.9 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.9 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.9 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.9 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.9 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.9 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.9 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.9 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.9 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.9 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.9 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.9 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.9 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.9 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.9 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.9 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.9 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.9 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.9 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.9 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.9 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.9 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.9 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.9 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.9 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.9 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.9 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.9 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.9 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.9 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.9 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.9 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.9 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.9 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.9 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.89 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.89 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.89 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.89 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.89 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.89 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.89 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.89 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.89 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.89 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.89 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.89 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.89 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.89 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.89 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.89 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.89 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.89 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.89 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.89 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.89 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.89 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.89 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.89 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.89 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.89 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.89 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.89 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.89 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.89 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.89 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.89 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.89 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.89 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.89 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.89 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.89 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.89 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.89 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.88 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.88 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.88 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.88 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.88 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.88 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.88 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.88 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.88 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.88 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.88 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.88 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.88 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.87 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.87 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.87 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.87 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.87 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.87 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.87 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.87 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.87 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.87 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.87 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.87 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.86 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.86 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.86 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.86 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.85 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.85 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.85 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.85 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.85 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.84 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.84 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.84 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.82 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.81 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.78 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.74 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.73 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.69 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.64 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.59 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.58 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.57 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.36 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.29 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.28 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.18 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.14 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.98 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.86 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.55 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.48 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.2 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.19 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.85 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.81 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.74 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.59 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.43 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.2 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.94 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.86 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.85 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.85 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.81 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.77 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.42 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.02 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.17 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.07 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.64 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 89.02 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 82.77 |
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=356.02 Aligned_cols=232 Identities=19% Similarity=0.218 Sum_probs=178.9
Q ss_pred hccccccccCCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCC-CceEEecCCCCCCCCC----CceEEEeeC
Q 005731 21 ASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVP-DTVVWVANRDRPISGR----NAVLTISNN 95 (680)
Q Consensus 21 ~~~~~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~-~tvVW~anr~~pv~~~----~~~l~~~~~ 95 (680)
.+++.|+|.+||+|.+|++|+|++|.|+||||+++ ++|| |+ + + |||+|||++|+.++ +++|+|+.|
T Consensus 10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~ 80 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFY 80 (276)
T ss_dssp CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEE
T ss_pred ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCC
Confidence 35678999999999999999999999999999554 5676 66 6 7 99999999999764 789999999
Q ss_pred CeEEE--EecCCCeeEeecccCC-----CCCceEEEccCCCEEEEeCCCCCccccceeeecCCCcccccccccccceeec
Q 005731 96 GNLVL--LSQTNGTIWSTNVSSD-----VKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKS 168 (680)
Q Consensus 96 g~l~l--~~~~~~~~w~~~~~~~-----~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~l~~~~~~ 168 (680)
|+||| .|++|.+||+|+++.. ..++.|+|+|+|||||++ . .+|||| ||||||||||+++.++++
T Consensus 81 G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~-~------~~lWqS--~ptdtlLpg~~~~~~l~~ 151 (276)
T 3m7h_A 81 VQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD-S------LALWNG--TPAIPLVPGAIDSLLLAP 151 (276)
T ss_dssp ESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE-E------EEEEES--CTTSCCCCSCTTCEEECS
T ss_pred CcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC-C------ceeeCc--cccccccccccccccccc
Confidence 99999 7888999999997642 235789999999999998 2 489999 999999999999999998
Q ss_pred CCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEc-CCeEEEeeCCCCCceeeeeecccceeEEEEEeeecCeEEEEEE
Q 005731 169 GLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFN-GSVKFTCSGQWDGTGFVSALSYTNFIYKQFMTENKDEFVYWYE 247 (680)
Q Consensus 169 g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~-~~~~~~~~g~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (680)
|++ | ++.+||++|.|+++|+++|.. ++++ +..+||++|+|++... ...+...+.+ .+.++++. .+.++
T Consensus 152 g~~--L---~S~~dps~G~fsl~l~~dGnl--vLy~~~~~~yW~Sgt~~~~~~-~l~l~~dGnL--vl~d~~~~-~vWsS 220 (276)
T 3m7h_A 152 GSE--L---VQGVVYGAGASKLVFQGDGNL--VAYGPNGAATWNAGTQGKGAV-RAVFQGDGNL--VVYGAGNA-VLWHS 220 (276)
T ss_dssp SEE--E---CTTCEEEETTEEEEECTTSCE--EEECTTSSEEEECCCTTTTCC-EEEECTTSCE--EEECTTSC-EEEEC
T ss_pred Ccc--c---ccCCCCCCceEEEeecCCceE--EEEeCCCeEEEECCCCCCccE-EEEEcCCCeE--EEEeCCCc-EEEEe
Confidence 865 5 678999999999999999964 4454 4689999999976532 2223322222 12233221 22233
Q ss_pred eeCCCeEEEEEEccCCcEEEEEEcCCCCceEEEEeec
Q 005731 248 AYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVP 284 (680)
Q Consensus 248 ~~~~~~~~r~~L~~~G~l~~~~~~~~~~~W~~~~~~~ 284 (680)
.......+|++|+.||++++|.| ...|..++..|
T Consensus 221 ~t~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P 254 (276)
T 3m7h_A 221 HTGGHASAVLRLQANGSIAILDE---KPVWARFGFQP 254 (276)
T ss_dssp SCTTCTTCEEEECTTSCEEEEEE---EEEEESSSCCT
T ss_pred cCCCCCCEEEEEcCCccEEEEcC---CCeEEccCccC
Confidence 22233458999999999999998 23455444433
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=300.64 Aligned_cols=216 Identities=15% Similarity=0.183 Sum_probs=164.8
Q ss_pred cccccccCCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEe
Q 005731 23 LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLS 102 (680)
Q Consensus 23 ~~~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~ 102 (680)
++.|+|.+||+|.+|++| ++|.|+|||+.+++ +.+ |.. +|+||+|||+.| .+++|+|+.||+|||+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~~--~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FDS--DVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EES--SSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEE-EEC--CEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 457999999999999999 59999999998775 233 433 699999999988 46899999999999999
Q ss_pred cCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCcccc-ccccccccee-ecCC-----ceeEE
Q 005731 103 QTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTL-LQDMKLGWDF-KSGL-----ERLLS 175 (680)
Q Consensus 103 ~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTl-Lpgq~l~~~~-~~g~-----~~~l~ 175 (680)
++|.+||+|++....+...|+|+|+|||||++ .++||||||||||+ ||+| +.+. .+|+ ++.|+
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~--------~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG--------PGLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC--------SEEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEec--------CCEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE
Confidence 99999999998654455689999999999994 26999999999887 5665 5554 5554 46776
Q ss_pred EeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeCCCCCceeeeee-cccceeEEEEEeeecCeEEEEEEeeCCCeE
Q 005731 176 SWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFVSAL-SYTNFIYKQFMTENKDEFVYWYEAYNRPSI 254 (680)
Q Consensus 176 S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~w~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (680)
+.+||++|.|+|+|+++| +++++++..+||++++|++. +...+ +..++.+ ..+..++++.++.+...+ ...
T Consensus 143 ---s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl-~ly~~~~~~vw~s~~~~~-~~~ 214 (236)
T 1dlp_A 143 ---ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRM-DVLTNQNIAVWTSGNSRS-AGR 214 (236)
T ss_dssp ---SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEE-EEEETTTEEEEECCCCCS-SSC
T ss_pred ---cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcE-EEEeCCCcEEEEeCCCCC-CCC
Confidence 588999999999999998 57778888899999999653 33333 4333321 122223333444333322 246
Q ss_pred EEEEEccCCcEEEEE
Q 005731 255 MTLKLNPSGFVTRQI 269 (680)
Q Consensus 255 ~r~~L~~~G~l~~~~ 269 (680)
+|++||+||++++|.
T Consensus 215 ~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 215 YVFVLQPDRNLAIYG 229 (236)
T ss_dssp CEEEECSSSCEEEEC
T ss_pred EEEEEcCCCcEEEeC
Confidence 899999999999984
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=298.78 Aligned_cols=166 Identities=31% Similarity=0.510 Sum_probs=141.2
Q ss_pred cCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
.++|.+.++||+|+||.||+|+.. +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 357899999999999999999853 47789999998766667789999999999999999999999999999999
Q ss_pred EEEEccCCCChhhHhcccc----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeE
Q 005731 586 LILEYMPNKSLDVYLFDPI----------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPK 655 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 655 (680)
||||||++|+|.++|.... ....+++.+++.|+.||++||+|||+++ ||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999996432 2357899999999999999999999987 99999999999999999999
Q ss_pred EeeeccceecCCCccccCccccccC
Q 005731 656 ISDFGLARMFGGDELQGNTKRIVGT 680 (680)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~Gt 680 (680)
|+|||+|+..........+...+||
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt 193 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLP 193 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEEC
T ss_pred ECCcccceecCCCCceeecCceecC
Confidence 9999999987554433223334444
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=299.81 Aligned_cols=166 Identities=28% Similarity=0.487 Sum_probs=134.5
Q ss_pred cCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
.++|.+.++||+|+||.||+|+.. +++.||||+++.......++|++|++++++++|||||+++|+|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 357888899999999999999853 47899999998766667789999999999999999999999999999999
Q ss_pred EEEEccCCCChhhHhcccc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC
Q 005731 586 LILEYMPNKSLDVYLFDPI------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN 653 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 653 (680)
||||||++|+|.++|.... ....++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 9999999999999986532 1246899999999999999999999987 999999999999999999
Q ss_pred eEEeeeccceecCCCccccCccccccC
Q 005731 654 PKISDFGLARMFGGDELQGNTKRIVGT 680 (680)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~Gt 680 (680)
+||+|||+|+.+........+.+.+||
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt 223 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLP 223 (329)
T ss_dssp EEECCCC----------------CCCC
T ss_pred EEEcccccceeccCCCcceecCccccc
Confidence 999999999987554433333445554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.15 Aligned_cols=162 Identities=31% Similarity=0.426 Sum_probs=145.4
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.++||+|+||.||+|+. .+++.||||++.+. .....+.+.+|++++++++|||||++++++.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999984 56899999999743 2345678999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++|+|.+++. +.+.+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..+
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999984 3457899999999999999999999988 999999999999999999999999999998766
Q ss_pred ccccCccccccC
Q 005731 669 ELQGNTKRIVGT 680 (680)
Q Consensus 669 ~~~~~~~~~~Gt 680 (680)
.....+.+++||
T Consensus 186 ~~~~~~~~~~GT 197 (311)
T 4aw0_A 186 SKQARANSFVGT 197 (311)
T ss_dssp TTCCCBCCCCSC
T ss_pred CCcccccCcccC
Confidence 555566678887
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.91 Aligned_cols=165 Identities=33% Similarity=0.485 Sum_probs=139.7
Q ss_pred CCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
.++++.++||+|+||.||+|++. +++.||||+++... ....++|++|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677899999999999999852 46799999997543 345678999999999999999999999999999999
Q ss_pred EEEEccCCCChhhHhcccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC
Q 005731 586 LILEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 652 (680)
||||||++|+|.++|.... ....+++.++++|+.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999996432 1346899999999999999999999987 99999999999999999
Q ss_pred CeEEeeeccceecCCCccccCccccccC
Q 005731 653 NPKISDFGLARMFGGDELQGNTKRIVGT 680 (680)
Q Consensus 653 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt 680 (680)
.+||+|||+|+.+...+....+...+||
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt 210 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLP 210 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred CEEECCcccceeccCCCceeEecccccC
Confidence 9999999999987554433334445554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=293.27 Aligned_cols=159 Identities=27% Similarity=0.414 Sum_probs=141.8
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
+.|++.++||+|+||.||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 5699999999999999999985 469999999997655555677899999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCccc
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (680)
++|+|.+++.+ ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..+..
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999998832 45899999999999999999999988 99999999999999999999999999998865433
Q ss_pred cCccccccC
Q 005731 672 GNTKRIVGT 680 (680)
Q Consensus 672 ~~~~~~~Gt 680 (680)
....++||
T Consensus 226 -~~~~~~GT 233 (346)
T 4fih_A 226 -RRKSLVGT 233 (346)
T ss_dssp -CBCCCCSC
T ss_pred -cccccccC
Confidence 23456777
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=288.48 Aligned_cols=161 Identities=29% Similarity=0.481 Sum_probs=132.2
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.+++++.++||+|+||.||+|++. ..||||+++.. ..+..++|.+|++++++++|||||+++|++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 467889999999999999999864 36999998743 33456789999999999999999999998864 56899999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
||++|+|.++|... ...+++.+++.|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999998542 346899999999999999999999987 9999999999999999999999999999876544
Q ss_pred cccCccccccC
Q 005731 670 LQGNTKRIVGT 680 (680)
Q Consensus 670 ~~~~~~~~~Gt 680 (680)
....+...+||
T Consensus 187 ~~~~~~~~~GT 197 (307)
T 3omv_A 187 GSQQVEQPTGS 197 (307)
T ss_dssp -------CCCC
T ss_pred cceeecccccC
Confidence 33344456676
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=293.37 Aligned_cols=162 Identities=25% Similarity=0.422 Sum_probs=134.9
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|++.++||+|+||.||+|+. .+++.||||++... .....++|++|++++++++|||||++++++.+.+..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999985 56899999999753 23346789999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
|+++|+|.++|... +...+++.++..|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999998532 3345788899999999999999999988 9999999999999999999999999999875432
Q ss_pred cccCccccccC
Q 005731 670 LQGNTKRIVGT 680 (680)
Q Consensus 670 ~~~~~~~~~Gt 680 (680)
. .++.++||
T Consensus 180 ~--~~~~~~GT 188 (350)
T 4b9d_A 180 E--LARACIGT 188 (350)
T ss_dssp H--HHHHHHSC
T ss_pred c--cccccCCC
Confidence 2 23346676
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=295.23 Aligned_cols=160 Identities=27% Similarity=0.411 Sum_probs=142.7
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.+.|++.++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 36799999999999999999985 56899999999865555667799999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCcc
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (680)
|++|+|.+++. ...+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..+..
T Consensus 230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999883 245899999999999999999999988 99999999999999999999999999998865443
Q ss_pred ccCccccccC
Q 005731 671 QGNTKRIVGT 680 (680)
Q Consensus 671 ~~~~~~~~Gt 680 (680)
....++||
T Consensus 303 --~~~~~~GT 310 (423)
T 4fie_A 303 --RRKSLVGT 310 (423)
T ss_dssp --CBCCCEEC
T ss_pred --cccccccC
Confidence 23456777
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-32 Score=279.91 Aligned_cols=154 Identities=25% Similarity=0.425 Sum_probs=127.0
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC--------
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-------- 582 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-------- 582 (680)
++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999985 568999999997533 334567999999999999999999999987654
Q ss_pred ----eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEee
Q 005731 583 ----EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISD 658 (680)
Q Consensus 583 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 658 (680)
..||||||+++|+|.+++.........++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999965444445567778899999999999999988 99999999999999999999999
Q ss_pred eccceecCCCc
Q 005731 659 FGLARMFGGDE 669 (680)
Q Consensus 659 FGla~~~~~~~ 669 (680)
||+|+.+..+.
T Consensus 162 FGla~~~~~~~ 172 (299)
T 4g31_A 162 FGLVTAMDQDE 172 (299)
T ss_dssp CCCC-------
T ss_pred CccceecCCCc
Confidence 99999886543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=279.71 Aligned_cols=162 Identities=30% Similarity=0.398 Sum_probs=130.6
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC----eEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG----EKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 588 (680)
++|.+.++||+|+||.||+|+. +|+.||||+++... .....+.+|+..+.+++|||||+++|+|.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4688899999999999999986 68999999997532 22223345666777899999999999998764 589999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS-----RLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
|||++|+|.++|.. ..++++.+.+++.|+++||+|||+++ .++||||||||+||||+.++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999843 45899999999999999999999862 3459999999999999999999999999999
Q ss_pred ecCCCccc--cCccccccC
Q 005731 664 MFGGDELQ--GNTKRIVGT 680 (680)
Q Consensus 664 ~~~~~~~~--~~~~~~~Gt 680 (680)
........ ..+.+.+||
T Consensus 157 ~~~~~~~~~~~~~~~~~GT 175 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp EEETTTTEESCC-----CC
T ss_pred cccCCCCceeeeccccccc
Confidence 88654322 223345665
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=276.38 Aligned_cols=158 Identities=30% Similarity=0.462 Sum_probs=133.1
Q ss_pred cceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeEEEE
Q 005731 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE----QGEKILI 587 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV 587 (680)
|++.++||+|+||.||+|.. .+++.||||++... .....++|.+|++++++++|||||++++++.. ....+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 36678899999999999985 45889999999643 33346789999999999999999999999865 2457999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-CCCeEEeeeccceecC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFG 666 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~ 666 (680)
||||++|+|.+++. +...+++..+..++.||+.||+|||+++ ++||||||||+||||+. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999984 3457899999999999999999999874 46999999999999984 7899999999998654
Q ss_pred CCccccCccccccC
Q 005731 667 GDELQGNTKRIVGT 680 (680)
Q Consensus 667 ~~~~~~~~~~~~Gt 680 (680)
.. .+..++||
T Consensus 184 ~~----~~~~~~GT 193 (290)
T 3fpq_A 184 AS----FAKAVIGT 193 (290)
T ss_dssp TT----SBEESCSS
T ss_pred CC----ccCCcccC
Confidence 32 23456776
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=273.42 Aligned_cols=158 Identities=29% Similarity=0.509 Sum_probs=125.7
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+|+. .+++.||||+++.. .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999984 56899999999653 2234567999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+ +|+|.+++. +...+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 689988883 3457999999999999999999999988 999999999999999999999999999977543
Q ss_pred ccccCccccccC
Q 005731 669 ELQGNTKRIVGT 680 (680)
Q Consensus 669 ~~~~~~~~~~Gt 680 (680)
.. ....+||
T Consensus 166 ~~---~~~~~GT 174 (275)
T 3hyh_A 166 NF---LKTSCGS 174 (275)
T ss_dssp ------------
T ss_pred Cc---cCCeeEC
Confidence 32 2235665
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=282.25 Aligned_cols=160 Identities=29% Similarity=0.358 Sum_probs=131.1
Q ss_pred CCcceeeeeccCCceeEEEEEE----cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~----~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
++|++.+.||+|+||.||+|+. .+++.||||+++... .....++.+|++++++++|||||++++++.+.+..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999974 247899999997532 2334578899999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+++|+|.+++. +...+++.++..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999984 3457899999999999999999999988 9999999999999999999999999999765
Q ss_pred CCccccCccccccC
Q 005731 667 GDELQGNTKRIVGT 680 (680)
Q Consensus 667 ~~~~~~~~~~~~Gt 680 (680)
.... ....++||
T Consensus 178 ~~~~--~~~~~~GT 189 (304)
T 3ubd_A 178 DHEK--KAYSFCGT 189 (304)
T ss_dssp ---C--CCCSCCCC
T ss_pred CCCc--cccccccC
Confidence 4432 23346776
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=281.27 Aligned_cols=157 Identities=28% Similarity=0.344 Sum_probs=132.5
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
+.|++.++||+|+||.||+|+. .+|+.||||+++.... +.+|+.++++++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 5688889999999999999985 5689999999975322 246999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC-CeEEeeeccceecCCCcc
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMFGGDEL 670 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 670 (680)
++|+|.++|. +.+.+++.++..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+..+..
T Consensus 133 ~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999984 3457899999999999999999999987 99999999999999887 699999999998865432
Q ss_pred c---cCccccccC
Q 005731 671 Q---GNTKRIVGT 680 (680)
Q Consensus 671 ~---~~~~~~~Gt 680 (680)
. .....++||
T Consensus 207 ~~~~~~~~~~~GT 219 (336)
T 4g3f_A 207 GKSLLTGDYIPGT 219 (336)
T ss_dssp -------CCCCCC
T ss_pred ccceecCCccccC
Confidence 1 122346776
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=284.25 Aligned_cols=172 Identities=29% Similarity=0.416 Sum_probs=142.8
Q ss_pred HHHHHhcCCcceeeeeccCCceeEEEEEEcC------CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCC-CceeeEEEE
Q 005731 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQH-RNLVRILGC 577 (680)
Q Consensus 506 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H-~niv~l~g~ 577 (680)
...+...++|++.++||+|+||.||+|+... ++.||||++.... ....++|.+|++++.++.| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 4445567899999999999999999998532 3689999997643 3346789999999999955 999999999
Q ss_pred EEeC-CeEEEEEEccCCCChhhHhccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCC
Q 005731 578 CVEQ-GEKILILEYMPNKSLDVYLFDPIK-------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKA 643 (680)
Q Consensus 578 ~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp 643 (680)
|.+. ...+||||||++|+|.++|..... ...+++.+++.|+.|||+||+|||+++ ||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCc
Confidence 9775 568999999999999999964321 345899999999999999999999987 99999999
Q ss_pred CcEEEcCCCCeEEeeeccceecCCCccccCccccccC
Q 005731 644 SNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680 (680)
Q Consensus 644 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt 680 (680)
+||||++++.+||+|||+|+.+..+.....+...+||
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt 250 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence 9999999999999999999988655443334445554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=271.43 Aligned_cols=161 Identities=27% Similarity=0.433 Sum_probs=135.4
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEe------CCe
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVE------QGE 583 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~ 583 (680)
++|++.+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999985 569999999997542 2345678999999999999999999998764 357
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.|||||||+ |+|.+++. +.+.+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 67988883 3467999999999999999999999988 9999999999999999999999999999
Q ss_pred ecCCCc--cccCccccccC
Q 005731 664 MFGGDE--LQGNTKRIVGT 680 (680)
Q Consensus 664 ~~~~~~--~~~~~~~~~Gt 680 (680)
.+.... .......++||
T Consensus 207 ~~~~~~~~~~~~~~~~~GT 225 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVAT 225 (398)
T ss_dssp CC-------CCCCCSSCCC
T ss_pred ecccCccccccccccceeC
Confidence 875432 22334456776
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-28 Score=260.93 Aligned_cols=147 Identities=23% Similarity=0.393 Sum_probs=131.0
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEc----CCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 584 (680)
...++|++.++||+|+||.||+|+.. +++.||||++... ....++.+|++++..+ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34578999999999999999999742 4678999998753 2346788999999998 699999999999999999
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC-CCeEEeeeccce
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLAR 663 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~ 663 (680)
+|||||+++|+|.+++ +.+++.++..++.||+.||+|||+++ ||||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999887 24889999999999999999999988 9999999999999877 799999999999
Q ss_pred ecCC
Q 005731 664 MFGG 667 (680)
Q Consensus 664 ~~~~ 667 (680)
....
T Consensus 167 ~~~~ 170 (361)
T 4f9c_A 167 GTHD 170 (361)
T ss_dssp ECTT
T ss_pred ccCC
Confidence 7654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=276.73 Aligned_cols=158 Identities=28% Similarity=0.357 Sum_probs=135.0
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHH---HHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLK---EFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~---~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
++|++.++||+|+||.||+|+. .+|+.||||++++.. ..... +.+.++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 6799999999999999999985 468999999996421 12222 3344567778889999999999999999999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|||||++||+|..+|. +...+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999984 3457899999999999999999999988 999999999999999999999999999988
Q ss_pred CCCccccCccccccC
Q 005731 666 GGDELQGNTKRIVGT 680 (680)
Q Consensus 666 ~~~~~~~~~~~~~Gt 680 (680)
.... +.+++||
T Consensus 343 ~~~~----~~t~~GT 353 (689)
T 3v5w_A 343 SKKK----PHASVGT 353 (689)
T ss_dssp SSCC----CCSCCSC
T ss_pred CCCC----CCCccCC
Confidence 5543 3446777
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=273.15 Aligned_cols=160 Identities=23% Similarity=0.406 Sum_probs=140.3
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+....+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 6899999999999999999985 568999999998755556678999999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC--CCeEEeeeccceecCCCc
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD--MNPKISDFGLARMFGGDE 669 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~~ 669 (680)
++|+|.++|.+ +...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999988843 2346889999999999999999999988 9999999999999854 899999999999986543
Q ss_pred cccCccccccC
Q 005731 670 LQGNTKRIVGT 680 (680)
Q Consensus 670 ~~~~~~~~~Gt 680 (680)
. ....+||
T Consensus 312 ~---~~~~~GT 319 (573)
T 3uto_A 312 S---VKVTTGT 319 (573)
T ss_dssp E---EEEECSS
T ss_pred c---eeeeEEC
Confidence 2 2234565
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-27 Score=246.14 Aligned_cols=159 Identities=42% Similarity=0.713 Sum_probs=143.2
Q ss_pred HHHHHhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 506 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
.++...+++|++.+.||+|+||.||+|+..+++.||||++........+++.+|++++++++||||+++++++.+.+..+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 34455678999999999999999999998889999999998766667788999999999999999999999999999999
Q ss_pred EEEEccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 586 LILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
+||||+++|+|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999985432 2235899999999999999999999987 99999999999999999999999999997
Q ss_pred cCC
Q 005731 665 FGG 667 (680)
Q Consensus 665 ~~~ 667 (680)
...
T Consensus 189 ~~~ 191 (321)
T 2qkw_B 189 GTE 191 (321)
T ss_dssp CSS
T ss_pred ccc
Confidence 654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-26 Score=235.68 Aligned_cols=151 Identities=27% Similarity=0.443 Sum_probs=137.2
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999984 56899999999765555677899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
+++|+|.+++.+ ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999998843 35889999999999999999999987 9999999999999999999999999999876544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.5e-26 Score=236.77 Aligned_cols=152 Identities=28% Similarity=0.479 Sum_probs=137.6
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.++|++.+.||+|+||.||++.. .+++.||+|++........+.|.+|++++.+++||||+++++++.+....++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 36799999999999999999985 45899999999776666778899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+++++|.+++... ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999998432 356899999999999999999999988 999999999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=236.60 Aligned_cols=161 Identities=28% Similarity=0.406 Sum_probs=142.7
Q ss_pred CcccHHHHHHhcCC----------cceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCC
Q 005731 501 PLFSLASVAAATEN----------FSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHR 569 (680)
Q Consensus 501 ~~~~~~~~~~~~~~----------f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ 569 (680)
+.++.+++..+++. |+..+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34667776666653 777889999999999999865 6999999999876666678899999999999999
Q ss_pred ceeeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc
Q 005731 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (680)
Q Consensus 570 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 649 (680)
||+++++++...+..++||||+++++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 99999999999999999999999999999873 246899999999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccceecCCC
Q 005731 650 KDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 650 ~~~~~kl~DFGla~~~~~~ 668 (680)
.++.+||+|||+++.+..+
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp TTCCEEECCCTTCEECCSS
T ss_pred CCCcEEEeeeeeeeecccC
Confidence 9999999999999987554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=251.30 Aligned_cols=160 Identities=20% Similarity=0.272 Sum_probs=139.1
Q ss_pred HHHHHHhcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 005731 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVE 580 (680)
Q Consensus 505 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 580 (680)
+.++....++|++.++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3445556789999999999999999999865 47899999996421 1223448899999999999999999999999
Q ss_pred CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeec
Q 005731 581 QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (680)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 660 (680)
.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999998432 356899999999999999999999987 9999999999999999999999999
Q ss_pred cceecCCCc
Q 005731 661 LARMFGGDE 669 (680)
Q Consensus 661 la~~~~~~~ 669 (680)
+|+.+..+.
T Consensus 221 la~~~~~~~ 229 (437)
T 4aw2_A 221 SCLKLMEDG 229 (437)
T ss_dssp TCEECCTTS
T ss_pred hhhhcccCC
Confidence 998875543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=237.33 Aligned_cols=153 Identities=24% Similarity=0.396 Sum_probs=134.3
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC--------
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-------- 582 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-------- 582 (680)
++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 57999999999999999999865 7899999999743 3345678999999999999999999999987654
Q ss_pred -------------------------------------------------eEEEEEEccCCCChhhHhcccccCCCCCHHH
Q 005731 583 -------------------------------------------------EKILILEYMPNKSLDVYLFDPIKKRLLDWEA 613 (680)
Q Consensus 583 -------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~ 613 (680)
..++||||+++++|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 2799999999999999997655555567778
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 614 ~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 8999999999999999987 999999999999999999999999999988654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.93 E-value=7.3e-26 Score=239.17 Aligned_cols=151 Identities=31% Similarity=0.492 Sum_probs=136.1
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+++++.++||||+++++++......++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999985 67899999999653 3344667899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999998843 356899999999999999999999987 999999999999999999999999999877543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-26 Score=238.33 Aligned_cols=151 Identities=32% Similarity=0.434 Sum_probs=132.6
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 68999999999999999999854 68999999986432 23346789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999998883 3446899999999999999999999987 9999999999999999999999999999875433
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-26 Score=240.53 Aligned_cols=169 Identities=44% Similarity=0.729 Sum_probs=147.8
Q ss_pred CCcccHHHHHHhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEE
Q 005731 500 LPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCC 578 (680)
Q Consensus 500 ~~~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~ 578 (680)
+..+++.++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|++++.+++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456888999999999999999999999999999977899999999975432 2334789999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEe
Q 005731 579 VEQGEKILILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (680)
Q Consensus 579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 657 (680)
......++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+....+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999986543 23458999999999999999999999822339999999999999999999999
Q ss_pred eeccceecCCC
Q 005731 658 DFGLARMFGGD 668 (680)
Q Consensus 658 DFGla~~~~~~ 668 (680)
|||+++.+...
T Consensus 177 Dfg~~~~~~~~ 187 (326)
T 3uim_A 177 DFGLAKLMDYK 187 (326)
T ss_dssp CCSSCEECCSS
T ss_pred cCccccccCcc
Confidence 99999987543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=233.06 Aligned_cols=165 Identities=41% Similarity=0.629 Sum_probs=147.3
Q ss_pred CCcccHHHHHHhcCCccee------eeeccCCceeEEEEEEcCCcEEEEEEccCC----CcccHHHHHHHHHHHhhcCCC
Q 005731 500 LPLFSLASVAAATENFSMQ------CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ----SGQGLKEFKNEMMLIAELQHR 569 (680)
Q Consensus 500 ~~~~~~~~~~~~~~~f~~~------~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~----~~~~~~~f~~E~~~l~~l~H~ 569 (680)
...|++.++..++++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568899999999998877 8999999999999985 6889999998643 233467899999999999999
Q ss_pred ceeeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc
Q 005731 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (680)
Q Consensus 570 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 649 (680)
||+++++++.+.+..++||||+++++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999865545567899999999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccceecCCC
Q 005731 650 KDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 650 ~~~~~kl~DFGla~~~~~~ 668 (680)
.++.+||+|||+++.....
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKF 186 (307)
T ss_dssp TTCCEEECCCTTCEECCSC
T ss_pred CCCcEEEeecccccccccc
Confidence 9999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=241.63 Aligned_cols=154 Identities=31% Similarity=0.532 Sum_probs=135.3
Q ss_pred cCCcceeeeeccCCceeEEEEEEc--------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ 581 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 581 (680)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ....+++.+|++++.++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999742 35679999997643 33467899999999999 899999999999999
Q ss_pred CeEEEEEEccCCCChhhHhcccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE
Q 005731 582 GEKILILEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 648 (680)
+..++||||+++|+|.+++.... ....+++.+++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999986432 1235789999999999999999999987 9999999999999
Q ss_pred cCCCCeEEeeeccceecCCC
Q 005731 649 DKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~ 668 (680)
+.++.+||+|||+|+.+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~ 256 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNI 256 (370)
T ss_dssp CTTCCEEECCCSSCEETTCC
T ss_pred CCCCCEEEccccCCcccCcc
Confidence 99999999999999987544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-26 Score=239.66 Aligned_cols=148 Identities=27% Similarity=0.332 Sum_probs=133.5
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+++.. +++.||||+++.. .....+.+.+|+.++..++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 67999999999999999999854 6899999999753 2334677899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||+++|+|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 85 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 9999999998883 3456899999999999999999999987 9999999999999999999999999998653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=236.70 Aligned_cols=163 Identities=30% Similarity=0.479 Sum_probs=135.2
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC----eEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG----EKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 587 (680)
.++|++.++||+|+||.||+|+.. ++.||||++... ......+.+|+.++.+++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999864 789999999753 233455677999999999999999999998754 47999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCceEeCCCCCCcEEEcCCCCeEEeeec
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS-------RLRIIHRDLKASNVLLDKDMNPKISDFG 660 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------~~~iiHrDlkp~NILl~~~~~~kl~DFG 660 (680)
|||+++|+|.+++.. ..+++..+..++.|+++||+|||+.. ..+|+||||||+|||++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999843 35899999999999999999999870 0139999999999999999999999999
Q ss_pred cceecCCCccccCccccccC
Q 005731 661 LARMFGGDELQGNTKRIVGT 680 (680)
Q Consensus 661 la~~~~~~~~~~~~~~~~Gt 680 (680)
+|+.+............+||
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt 196 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGT 196 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCC
T ss_pred cccccccccCccccccCccC
Confidence 99988655443333333443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=240.37 Aligned_cols=150 Identities=28% Similarity=0.405 Sum_probs=133.0
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 585 (680)
..++|++.+.||+|+||.||+++. .+++.||||+++.. .....+.+.+|..++..+ +||||+++++++...+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 347899999999999999999985 45899999999753 233456788999999988 7999999999999999999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+||||+++|+|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999884 3356899999999999999999999987 999999999999999999999999999865
Q ss_pred C
Q 005731 666 G 666 (680)
Q Consensus 666 ~ 666 (680)
.
T Consensus 175 ~ 175 (353)
T 3txo_A 175 I 175 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-26 Score=247.30 Aligned_cols=156 Identities=23% Similarity=0.275 Sum_probs=136.5
Q ss_pred HHHHhcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 005731 507 SVAAATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG 582 (680)
Q Consensus 507 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 582 (680)
++....++|++.++||+|+||.||+++.. +++.||||++... .....+.+.+|+.++..++||||+++++++.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34455678999999999999999999864 5889999998642 1123345889999999999999999999999999
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999998832 35889999999999999999999987 999999999999999999999999999
Q ss_pred eecCCCc
Q 005731 663 RMFGGDE 669 (680)
Q Consensus 663 ~~~~~~~ 669 (680)
+.+....
T Consensus 216 ~~~~~~~ 222 (410)
T 3v8s_A 216 MKMNKEG 222 (410)
T ss_dssp EECCTTS
T ss_pred EeeccCC
Confidence 9875543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-26 Score=246.81 Aligned_cols=160 Identities=21% Similarity=0.295 Sum_probs=139.2
Q ss_pred HHHHHHhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 005731 505 LASVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVE 580 (680)
Q Consensus 505 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 580 (680)
+.+.....++|++.+.||+|+||.||+++. .+++.||||++++.. ....+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 344455678999999999999999999986 468999999996421 2234458899999999999999999999999
Q ss_pred CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeec
Q 005731 581 QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (680)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 660 (680)
.+..++||||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999998432 246899999999999999999999987 9999999999999999999999999
Q ss_pred cceecCCCc
Q 005731 661 LARMFGGDE 669 (680)
Q Consensus 661 la~~~~~~~ 669 (680)
+|+.+..+.
T Consensus 208 la~~~~~~~ 216 (412)
T 2vd5_A 208 SCLKLRADG 216 (412)
T ss_dssp TCEECCTTS
T ss_pred hheeccCCC
Confidence 999876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=241.95 Aligned_cols=148 Identities=25% Similarity=0.386 Sum_probs=130.7
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 586 (680)
.++|++.++||+|+||.||+++.. +++.||||++++. .....+.+.+|..++.++ +||||+++++++...+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999854 5789999999753 223345688899999887 89999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
||||+++|+|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+..
T Consensus 131 V~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999998884 3456899999999999999999999988 999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=231.67 Aligned_cols=150 Identities=29% Similarity=0.490 Sum_probs=133.7
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|++.+.||+|+||.||+++. .+++.||||.+... .....+.|.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 36899999999999999999984 46889999998543 233457899999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++++|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999843 346899999999999999999999987 99999999999999999999999999987754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=233.71 Aligned_cols=149 Identities=29% Similarity=0.431 Sum_probs=134.0
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+++.. +++.||||+++.. .....+.+.+|+.++..++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 67999999999999999999854 6899999999753 1234677889999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++|+|.+++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999984 3456889999999999999999999887 99999999999999999999999999997643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-25 Score=234.94 Aligned_cols=151 Identities=28% Similarity=0.406 Sum_probs=134.8
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 584 (680)
.++|++.+.||+|+||.||+++.. +++.||||.+..... ...+++.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 367999999999999999999854 689999999975322 2357899999999999999999999999999999
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC----CeEEeeec
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM----NPKISDFG 660 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFG 660 (680)
++||||+++|+|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999983 3456899999999999999999999987 99999999999998877 79999999
Q ss_pred cceecCCC
Q 005731 661 LARMFGGD 668 (680)
Q Consensus 661 la~~~~~~ 668 (680)
+++.+...
T Consensus 165 ~a~~~~~~ 172 (361)
T 2yab_A 165 LAHEIEDG 172 (361)
T ss_dssp SCEECCTT
T ss_pred CceEcCCC
Confidence 99987553
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=236.56 Aligned_cols=151 Identities=26% Similarity=0.376 Sum_probs=133.4
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 584 (680)
...++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999864 58999999997531 23456788899999877 999999999999999999
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999843 356899999999999999999999987 99999999999999999999999999986
Q ss_pred cC
Q 005731 665 FG 666 (680)
Q Consensus 665 ~~ 666 (680)
..
T Consensus 168 ~~ 169 (345)
T 1xjd_A 168 NM 169 (345)
T ss_dssp CC
T ss_pred cc
Confidence 53
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=239.59 Aligned_cols=150 Identities=24% Similarity=0.380 Sum_probs=135.0
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||++.. .+++.||||.+... .....+.+.+|+.++..++||||+++++++......++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 6799999999999999999985 45889999998642 2334678899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 95 e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999884 3456899999999999999999999988 999999999999999999999999999987543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=239.64 Aligned_cols=151 Identities=19% Similarity=0.226 Sum_probs=132.2
Q ss_pred HhcCCcceeeeeccCCceeEEEEE------EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC---CCceeeEEEEEEe
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGR------LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ---HRNLVRILGCCVE 580 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~------~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~ 580 (680)
...++|++.+.||+|+||.||+|. ..+++.||||++... ...++..|++++.+++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999993 456889999999753 3567788888888887 9999999999999
Q ss_pred CCeEEEEEEccCCCChhhHhcccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC--------
Q 005731 581 QGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-------- 650 (680)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-------- 650 (680)
.+..++||||+++|+|.+++.... ....+++..+..|+.||++||+|||+.+ |+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999985422 3456899999999999999999999987 999999999999998
Q ss_pred ---CCCeEEeeeccceecC
Q 005731 651 ---DMNPKISDFGLARMFG 666 (680)
Q Consensus 651 ---~~~~kl~DFGla~~~~ 666 (680)
++.+||+|||+|+.+.
T Consensus 216 ~~~~~~~kl~DFG~a~~~~ 234 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMK 234 (365)
T ss_dssp ---CTTEEECCCTTCEEGG
T ss_pred ccccCCEEEeeCchhhhhh
Confidence 8999999999998764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=235.56 Aligned_cols=148 Identities=26% Similarity=0.374 Sum_probs=132.4
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 587 (680)
++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|..++.++ +||||+++++++......++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999864 5889999999753 223456788999999988 899999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999998843 356899999999999999999999987 9999999999999999999999999998643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-25 Score=233.12 Aligned_cols=152 Identities=30% Similarity=0.552 Sum_probs=134.4
Q ss_pred cCCcceeeeeccCCceeEEEEEEc----CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
.++|++.+.||+|+||.||+|... .+..||||+++.. .....+.|.+|+.++.+++||||+++++++.+....++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 367999999999999999999863 3556999999764 33446789999999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+++++|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999843 2346899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 005731 667 GD 668 (680)
Q Consensus 667 ~~ 668 (680)
..
T Consensus 203 ~~ 204 (325)
T 3kul_A 203 DD 204 (325)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=232.99 Aligned_cols=156 Identities=31% Similarity=0.544 Sum_probs=131.7
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
...++|++.+.||+|+||.||+|+. .++.||||++.... ....++|.+|++++++++||||+++++++......++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3457899999999999999999975 68899999987543 33456899999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++|+|.+++........+++..+..++.||++||+|||+.+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999999865433345899999999999999999999864 3499999999999999999999999999986644
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-25 Score=233.69 Aligned_cols=150 Identities=29% Similarity=0.405 Sum_probs=125.2
Q ss_pred cCCcceeeeeccCCceeEEEEEE----cCCcEEEEEEccCCC----cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~----~~~~~VAVK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 583 (680)
.++|++.+.||+|+||.||+++. .+++.||||+++... ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36899999999999999999986 478999999997532 2345568899999999999999999999999999
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999998843 356889999999999999999999987 9999999999999999999999999998
Q ss_pred ecCC
Q 005731 664 MFGG 667 (680)
Q Consensus 664 ~~~~ 667 (680)
....
T Consensus 170 ~~~~ 173 (327)
T 3a62_A 170 ESIH 173 (327)
T ss_dssp ----
T ss_pred cccc
Confidence 6543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=239.90 Aligned_cols=163 Identities=30% Similarity=0.469 Sum_probs=138.4
Q ss_pred ccHHHHHHhcCCcceeeeeccCCceeEEEEEE------cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeE
Q 005731 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRI 574 (680)
Q Consensus 503 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l 574 (680)
+.........++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34455566778999999999999999999973 245799999997643 33456799999999999 89999999
Q ss_pred EEEEEeCCe-EEEEEEccCCCChhhHhccccc------------------------------------------------
Q 005731 575 LGCCVEQGE-KILILEYMPNKSLDVYLFDPIK------------------------------------------------ 605 (680)
Q Consensus 575 ~g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------ 605 (680)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999865322
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 606 ---------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 606 ---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122888999999999999999999987 999999999999999999999999999977443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-25 Score=228.62 Aligned_cols=150 Identities=25% Similarity=0.415 Sum_probs=128.4
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc--------------------------ccHHHHHHHHHHHh
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG--------------------------QGLKEFKNEMMLIA 564 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~--------------------------~~~~~f~~E~~~l~ 564 (680)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ...+++.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999985 4688999999864321 12356899999999
Q ss_pred hcCCCceeeEEEEEEe--CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCC
Q 005731 565 ELQHRNLVRILGCCVE--QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642 (680)
Q Consensus 565 ~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 642 (680)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++.++..++.||++||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56899999999999997654 3456899999999999999999999987 9999999
Q ss_pred CCcEEEcCCCCeEEeeeccceecCCC
Q 005731 643 ASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|+|||++.++.+||+|||+++.+...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHHEEECCCCCEEEecCCCccccccc
Confidence 99999999999999999999987543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-25 Score=235.24 Aligned_cols=149 Identities=24% Similarity=0.329 Sum_probs=134.5
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++..++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999854 6899999998643 2234678899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999843 346899999999999999999999988 99999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.7e-25 Score=225.13 Aligned_cols=151 Identities=30% Similarity=0.553 Sum_probs=136.4
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.++|++.+.||+|+||.||++...+++.||||++... ....+++.+|++++.+++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 3679999999999999999999888899999999863 334578999999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999843 2346899999999999999999999988 999999999999999999999999999876543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=239.35 Aligned_cols=152 Identities=32% Similarity=0.585 Sum_probs=127.9
Q ss_pred cCCcceeeeeccCCceeEEEEEEc----CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
.++|++.+.||+|+||.||+|+.. .+..||||+++.. .....++|.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999854 4678999999754 33456789999999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+++|+|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999853 2346899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 005731 667 GD 668 (680)
Q Consensus 667 ~~ 668 (680)
.+
T Consensus 199 ~~ 200 (373)
T 2qol_A 199 DD 200 (373)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=228.55 Aligned_cols=154 Identities=27% Similarity=0.429 Sum_probs=136.2
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC--eEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG--EKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 588 (680)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57999999999999999999864 48999999997532 344678899999999999999999999998765 789999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE----cCCCCeEEeeecccee
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARM 664 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla~~ 664 (680)
||+++++|.+++........+++.++..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999966544455899999999999999999999987 9999999999999 7888899999999998
Q ss_pred cCCCc
Q 005731 665 FGGDE 669 (680)
Q Consensus 665 ~~~~~ 669 (680)
+....
T Consensus 166 ~~~~~ 170 (319)
T 4euu_A 166 LEDDE 170 (319)
T ss_dssp CCTTC
T ss_pred cCCCC
Confidence 75543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=239.86 Aligned_cols=152 Identities=28% Similarity=0.479 Sum_probs=135.2
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
..++|++.+.||+|+||.||+|+.. +++.||||.++... ....++|.+|++++++++||||+++++++...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3468999999999999999999865 68999999997542 233457899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++|+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 192 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999853 2345889999999999999999999988 99999999999999999999999999987644
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.6e-25 Score=223.19 Aligned_cols=152 Identities=31% Similarity=0.500 Sum_probs=137.2
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.++|++.+.||+|+||.||+++..++..||||++... ....+++.+|++++.+++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 4689999999999999999999888889999999763 334578999999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
++++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999998442 345899999999999999999999987 9999999999999999999999999999775543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.6e-25 Score=234.07 Aligned_cols=150 Identities=25% Similarity=0.325 Sum_probs=133.2
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 585 (680)
..++|++.+.||+|+||.||+++.. +++.||||+++.. .....+.+.+|..++..+ +||||+++++++...+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3478999999999999999999865 4789999999753 223467788999999988 8999999999999999999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999843 346899999999999999999999987 999999999999999999999999999865
Q ss_pred C
Q 005731 666 G 666 (680)
Q Consensus 666 ~ 666 (680)
.
T Consensus 172 ~ 172 (353)
T 2i0e_A 172 I 172 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=225.53 Aligned_cols=149 Identities=30% Similarity=0.476 Sum_probs=130.5
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999985 458899999997532 2345778999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+++ +|.+.+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9986 45444422 2456899999999999999999999987 99999999999999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=227.92 Aligned_cols=151 Identities=21% Similarity=0.320 Sum_probs=134.7
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.++|++.+.||+|+||.||++... +++.+|+|.+... ....+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 368999999999999999999854 5889999998753 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC--CCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK--DMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 668 (680)
+++++|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999998843 2346899999999999999999999987 999999999999987 789999999999987554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=228.58 Aligned_cols=150 Identities=29% Similarity=0.415 Sum_probs=134.0
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
++|++.+.||+|+||.||++... +++.||||.+..... ...+++.+|+.++.+++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56999999999999999999854 589999999865321 24678999999999999999999999999999999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC----CeEEeeecc
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM----NPKISDFGL 661 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGl 661 (680)
+||||+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999983 3456899999999999999999999987 99999999999999887 799999999
Q ss_pred ceecCCC
Q 005731 662 ARMFGGD 668 (680)
Q Consensus 662 a~~~~~~ 668 (680)
++.+...
T Consensus 165 a~~~~~~ 171 (326)
T 2y0a_A 165 AHKIDFG 171 (326)
T ss_dssp CEECCTT
T ss_pred CeECCCC
Confidence 9987543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=235.06 Aligned_cols=157 Identities=31% Similarity=0.508 Sum_probs=137.4
Q ss_pred HHHhcCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 005731 508 VAAATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVE 580 (680)
Q Consensus 508 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 580 (680)
.....++|++.+.||+|+||.||+++.. +++.||||.++... ....++|.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445688999999999999999999864 34789999997643 3346789999999999999999999999999
Q ss_pred CCeEEEEEEccCCCChhhHhccccc---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeC
Q 005731 581 QGEKILILEYMPNKSLDVYLFDPIK---------------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHR 639 (680)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHr 639 (680)
.+..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+.+ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999999854321 156899999999999999999999987 9999
Q ss_pred CCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 640 DLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 640 Dlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||||+|||++.++.+||+|||+++.+..
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 226 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYS 226 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred CCCcceEEECCCCeEEEeecCCCccccc
Confidence 9999999999999999999999987643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=230.17 Aligned_cols=152 Identities=34% Similarity=0.589 Sum_probs=132.1
Q ss_pred cCCcceeeeeccCCceeEEEEEE-----cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 584 (680)
.++|++.+.||+|+||.||+++. .+++.||||++........++|.+|++++.+++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36899999999999999999974 35889999999876666678899999999999999999999998653 458
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998543 235899999999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 005731 665 FGGD 668 (680)
Q Consensus 665 ~~~~ 668 (680)
+..+
T Consensus 164 ~~~~ 167 (295)
T 3ugc_A 164 LPQD 167 (295)
T ss_dssp ----
T ss_pred ccCC
Confidence 7543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=231.66 Aligned_cols=153 Identities=25% Similarity=0.385 Sum_probs=133.5
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC-----CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
++|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5799999999999999999985 46899999998532 22346789999999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC---eEEeeeccc
Q 005731 587 ILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN---PKISDFGLA 662 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGla 662 (680)
||||+++++|.+.+.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999988775432 2345889999999999999999999987 999999999999987654 999999999
Q ss_pred eecCCC
Q 005731 663 RMFGGD 668 (680)
Q Consensus 663 ~~~~~~ 668 (680)
+.+...
T Consensus 181 ~~~~~~ 186 (351)
T 3c0i_A 181 IQLGES 186 (351)
T ss_dssp EECCTT
T ss_pred eEecCC
Confidence 988654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.8e-25 Score=235.88 Aligned_cols=155 Identities=33% Similarity=0.516 Sum_probs=135.7
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc--------CCcEEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEe
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE 580 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~--------~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 580 (680)
..++|.+.+.||+|+||.||+|+.. .+..||||++... .....+++.+|++++.++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3478999999999999999999842 2357999999764 334457899999999999 99999999999999
Q ss_pred CCeEEEEEEccCCCChhhHhccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEE
Q 005731 581 QGEKILILEYMPNKSLDVYLFDPIK-------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647 (680)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 647 (680)
.+..++||||+++|+|.+++..... ...+++.++..++.||++||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999864321 245899999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeeeccceecCCC
Q 005731 648 LDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~ 668 (680)
++.++.+||+|||+|+.+...
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~ 244 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHI 244 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCC
T ss_pred EcCCCcEEEcccCcccccccc
Confidence 999999999999999977543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8e-25 Score=228.96 Aligned_cols=156 Identities=33% Similarity=0.542 Sum_probs=136.1
Q ss_pred hcCCcceeeeeccCCceeEEEEEE------cCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 583 (680)
..++|.+.+.||+|+||.||+++. .+++.||||++... .....+++.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 347899999999999999999975 23578999999754 33456789999999999999999999999999999
Q ss_pred EEEEEEccCCCChhhHhccccc---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCC
Q 005731 584 KILILEYMPNKSLDVYLFDPIK---------------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 642 (680)
.++||||+++++|.+++..... ...+++.++..++.||++||+|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999864322 234788999999999999999999987 9999999
Q ss_pred CCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 643 ASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
|+|||++.++.+||+|||+++.+....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~ 204 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEED 204 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTS
T ss_pred hheEEEcCCCCEEEccccccccccccc
Confidence 999999999999999999999875443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=227.63 Aligned_cols=150 Identities=33% Similarity=0.463 Sum_probs=131.8
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.++|++.+.||+|+||.||+++..+++.||||++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 36899999999999999999998889999999997532 2335678999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 9985 77777643 2345899999999999999999999987 99999999999999999999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=224.18 Aligned_cols=151 Identities=29% Similarity=0.491 Sum_probs=133.9
Q ss_pred hcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
..++|++.+.||+|+||.||++...++..||||++... ....+++.+|++++.+++||||+++++++.+....++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 34689999999999999999999888889999999864 33457899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 9999999998542 345899999999999999999999987 99999999999999999999999999987644
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-25 Score=237.05 Aligned_cols=152 Identities=33% Similarity=0.514 Sum_probs=132.1
Q ss_pred cCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 584 (680)
.++|++.+.||+|+||.||+|+.. +++.||||++... ......++.+|+.++.+++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367999999999999999999842 4678999999753 344566799999999999999999999999999999
Q ss_pred EEEEEccCCCChhhHhcccc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC---CeEEe
Q 005731 585 ILILEYMPNKSLDVYLFDPI----KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM---NPKIS 657 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~ 657 (680)
++||||+++|+|.+++.... ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986432 1245899999999999999999999988 99999999999999554 59999
Q ss_pred eeccceecC
Q 005731 658 DFGLARMFG 666 (680)
Q Consensus 658 DFGla~~~~ 666 (680)
|||+|+.+.
T Consensus 227 DFG~a~~~~ 235 (367)
T 3l9p_A 227 DFGMARDIY 235 (367)
T ss_dssp CCHHHHHHH
T ss_pred CCccccccc
Confidence 999998653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7.9e-25 Score=244.32 Aligned_cols=153 Identities=32% Similarity=0.547 Sum_probs=137.3
Q ss_pred hcCCcceeeeeccCCceeEEEEEEcC-CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
..++|++.+.||+|+||.||+|.... +..||||.++.. ....++|.+|+.++++++||||+++++++......++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34679999999999999999998654 889999999764 3457889999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999998542 2346889999999999999999999987 999999999999999999999999999987544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=244.06 Aligned_cols=150 Identities=26% Similarity=0.313 Sum_probs=124.6
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|++.+.||+|+||.||++.. .+++.||||++... .......+.+|+.++..++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 36799999999999999999984 56899999999743 233456788999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|||+++|+|..++. ....+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999998883 34568999999999999999999997 66 9999999999999999999999999998653
Q ss_pred C
Q 005731 667 G 667 (680)
Q Consensus 667 ~ 667 (680)
.
T Consensus 301 ~ 301 (446)
T 4ejn_A 301 K 301 (446)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=232.09 Aligned_cols=151 Identities=26% Similarity=0.385 Sum_probs=129.0
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC----e
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG----E 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~ 583 (680)
.++|++.+.||+|+||.||+++. .+++.||||++.... ......+.+|+.++.+++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36899999999999999999985 678999999997542 233567899999999999999999999987654 3
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.++||||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 4999999999999999843 346899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCC
Q 005731 664 MFGGD 668 (680)
Q Consensus 664 ~~~~~ 668 (680)
.+...
T Consensus 165 ~~~~~ 169 (311)
T 3ork_A 165 AIADS 169 (311)
T ss_dssp -----
T ss_pred ccccc
Confidence 77543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.92 E-value=7.9e-25 Score=241.75 Aligned_cols=152 Identities=30% Similarity=0.472 Sum_probs=135.8
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
...++|++.+.||+|+||.||+|...++..||||+++.. ....++|.+|+.++++++||||+++++++. .+..++|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 345789999999999999999999888899999999864 345788999999999999999999999986 667899999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+++|+|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 263 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 263 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred ecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999998543 2235788999999999999999999987 99999999999999999999999999997754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-24 Score=232.88 Aligned_cols=152 Identities=25% Similarity=0.385 Sum_probs=135.5
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..........+.+|++++..++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 36799999999999999999985 46889999999865555567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC--CCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK--DMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 668 (680)
+++|+|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.+..+
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998843 2346899999999999999999999987 999999999999974 467999999999988654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=231.97 Aligned_cols=151 Identities=26% Similarity=0.436 Sum_probs=133.5
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
.++|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46799999999999999999985 45899999999753 2334567899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC---CCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD---MNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla~~~ 665 (680)
||+++|+|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+++.+
T Consensus 108 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999988884 3456899999999999999999999987 9999999999999865 45999999999887
Q ss_pred CCC
Q 005731 666 GGD 668 (680)
Q Consensus 666 ~~~ 668 (680)
...
T Consensus 182 ~~~ 184 (362)
T 2bdw_A 182 NDS 184 (362)
T ss_dssp TTC
T ss_pred cCC
Confidence 543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=225.04 Aligned_cols=149 Identities=29% Similarity=0.465 Sum_probs=132.6
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.+.||+|+||.||+|+..+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998789999999986532 23357789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++ +|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 985 88888743 2346889999999999999999999987 99999999999999999999999999987653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=221.27 Aligned_cols=152 Identities=24% Similarity=0.425 Sum_probs=136.6
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 357999999999999999999854 4779999999765556678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE---cCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 667 (680)
+++++|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999888743 356899999999999999999999988 9999999999999 7889999999999998754
Q ss_pred Cc
Q 005731 668 DE 669 (680)
Q Consensus 668 ~~ 669 (680)
..
T Consensus 162 ~~ 163 (277)
T 3f3z_A 162 GK 163 (277)
T ss_dssp TS
T ss_pred cc
Confidence 43
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=238.53 Aligned_cols=150 Identities=32% Similarity=0.525 Sum_probs=135.3
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 68999999999999999999864 68999999996431 234567899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++|+|.+++. +...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999984 3456899999999999999999999987 999999999999999999999999999987543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.4e-25 Score=234.99 Aligned_cols=149 Identities=27% Similarity=0.324 Sum_probs=123.2
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHH-HhhcCCCceeeEEEEEEeCCeEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMML-IAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|..+ ++.++||||+++++++...+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367999999999999999999864 58899999997532 2234556777776 577899999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+++|+|..++. +...+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 117 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999884 3456888999999999999999999988 9999999999999999999999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=230.91 Aligned_cols=150 Identities=29% Similarity=0.484 Sum_probs=133.2
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|.+.+.||+|+||.||+|+. .+++.||||++... .......+.+|+.+++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999985 57899999998642 122346789999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+ +|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 7888888743 356899999999999999999999988 99999999999999999999999999997754
Q ss_pred C
Q 005731 668 D 668 (680)
Q Consensus 668 ~ 668 (680)
.
T Consensus 161 ~ 161 (336)
T 3h4j_B 161 G 161 (336)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=230.77 Aligned_cols=155 Identities=34% Similarity=0.496 Sum_probs=133.0
Q ss_pred hcCCcceeeeeccCCceeEEEEEE------cCCcEEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 582 (680)
..++|++.+.||+|+||.||+|+. .+++.||||.+... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457899999999999999999985 24568999999753 233467899999999999 8999999999999999
Q ss_pred eEEEEEEccCCCChhhHhcccccC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCC
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKK--------------------RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 642 (680)
..++||||+++|+|.+++...... ..+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999998653221 34789999999999999999999987 9999999
Q ss_pred CCcEEEcCCCCeEEeeeccceecCCC
Q 005731 643 ASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|+|||++.++.+||+|||+++.+...
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~ 225 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSD 225 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccC
Confidence 99999999999999999999877543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=228.85 Aligned_cols=155 Identities=30% Similarity=0.528 Sum_probs=122.2
Q ss_pred hcCCcceeeeeccCCceeEEEEEEcC-C---cEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLFN-G---QEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-~---~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 584 (680)
..++|++.+.||+|+||.||+|+... + ..||||.+... .....+++.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45789999999999999999998543 3 27999999754 334567899999999999999999999999877655
Q ss_pred ------EEEEEccCCCChhhHhccccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeE
Q 005731 585 ------ILILEYMPNKSLDVYLFDPIK---KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPK 655 (680)
Q Consensus 585 ------~lV~Ey~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 655 (680)
++||||+++|+|.+++..... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 999999999999999854321 225899999999999999999999987 99999999999999999999
Q ss_pred EeeeccceecCCC
Q 005731 656 ISDFGLARMFGGD 668 (680)
Q Consensus 656 l~DFGla~~~~~~ 668 (680)
|+|||+|+.+...
T Consensus 178 l~Dfg~a~~~~~~ 190 (323)
T 3qup_A 178 VADFGLSRKIYSG 190 (323)
T ss_dssp ECCCCC-------
T ss_pred Eeecccccccccc
Confidence 9999999877543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=231.34 Aligned_cols=147 Identities=26% Similarity=0.351 Sum_probs=130.1
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.++|++.+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999864 6899999999753 23446789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC--eEEeeeccceec
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN--PKISDFGLARMF 665 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DFGla~~~ 665 (680)
+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+|+..
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 999999998843 346899999999999999999999988 999999999999987765 999999999854
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=238.52 Aligned_cols=152 Identities=28% Similarity=0.444 Sum_probs=132.7
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
.++|++.+.||+|+||.||++.. .+++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 46799999999999999999974 568999999987542 234567899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc---CCCCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD---KDMNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~~ 665 (680)
||+++|+|.+.+.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+|+.+
T Consensus 90 E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999888843 456899999999999999999999988 99999999999998 4678999999999887
Q ss_pred CCCc
Q 005731 666 GGDE 669 (680)
Q Consensus 666 ~~~~ 669 (680)
....
T Consensus 164 ~~~~ 167 (444)
T 3soa_A 164 EGEQ 167 (444)
T ss_dssp CTTC
T ss_pred cCCC
Confidence 6543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=242.72 Aligned_cols=153 Identities=27% Similarity=0.349 Sum_probs=136.0
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999864 6899999999642 223456789999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++|+|..++... ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999988543 2345899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 005731 668 D 668 (680)
Q Consensus 668 ~ 668 (680)
.
T Consensus 339 ~ 339 (576)
T 2acx_A 339 G 339 (576)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=220.10 Aligned_cols=149 Identities=32% Similarity=0.435 Sum_probs=134.1
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.+.||+|+||.||++... +++.||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 57999999999999999999864 6899999998643 234467899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred cCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999998883 3356899999999999999999999987 99999999999999999999999999987643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=231.50 Aligned_cols=149 Identities=31% Similarity=0.448 Sum_probs=127.1
Q ss_pred ceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCCC
Q 005731 516 SMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (680)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 594 (680)
...+.||+|+||.||+|+. .+++.||||+++.......+++.+|++++.+++||||+++++++...+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3357899999999999985 568999999998765556788999999999999999999999999999999999999999
Q ss_pred ChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE--cCCCCeEEeeeccceecCCCc
Q 005731 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL--DKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl--~~~~~~kl~DFGla~~~~~~~ 669 (680)
+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 172 ~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 172 ELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred cHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 99888743 2345889999999999999999999988 9999999999999 567889999999999886543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=227.10 Aligned_cols=155 Identities=31% Similarity=0.535 Sum_probs=134.6
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc--------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEe
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE 580 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~--------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 580 (680)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|++++.++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478999999999999999999852 46789999997542 34467899999999999 89999999999999
Q ss_pred CCeEEEEEEccCCCChhhHhccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEE
Q 005731 581 QGEKILILEYMPNKSLDVYLFDPIK-------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647 (680)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 647 (680)
.+..++||||+++|+|.+++..... ...+++.++..++.||++||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999864321 234889999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeeeccceecCCC
Q 005731 648 LDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~ 668 (680)
++.++.+||+|||+++.+...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~ 210 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNI 210 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTT
T ss_pred EcCCCCEEEcccccccccccc
Confidence 999999999999999987554
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-24 Score=236.39 Aligned_cols=150 Identities=31% Similarity=0.526 Sum_probs=133.0
Q ss_pred hcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-eEEEEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-EKILILE 589 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E 589 (680)
..++|++.+.||+|+||.||+|... ++.||||+++... ..++|.+|+.++++++||||+++++++.+.. ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3467999999999999999999864 7899999998643 5678999999999999999999999988765 7999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+++|+|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 99999999998543 2334789999999999999999999987 99999999999999999999999999986643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=229.92 Aligned_cols=151 Identities=25% Similarity=0.376 Sum_probs=130.8
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCC--CceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQH--RNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV 587 (680)
.++|++.+.||+|+||.||++...+++.||||++... ..+..+.+.+|+.++.+++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999888999999998643 33446789999999999976 9999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|| +.+++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+|+.+..
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 568899999843 456899999999999999999999987 99999999999997 57899999999998765
Q ss_pred Ccc
Q 005731 668 DEL 670 (680)
Q Consensus 668 ~~~ 670 (680)
+..
T Consensus 160 ~~~ 162 (343)
T 3dbq_A 160 DTT 162 (343)
T ss_dssp ---
T ss_pred ccc
Confidence 443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=240.75 Aligned_cols=155 Identities=29% Similarity=0.388 Sum_probs=137.1
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++.+++||||+++++++......++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999864 6899999999643 123457789999999999999999999999999999999
Q ss_pred EEccCCCChhhHhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 588 LEYMPNKSLDVYLFDPIK-KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|||+++|+|..++..... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999998865322 346899999999999999999999987 9999999999999999999999999999876
Q ss_pred CCc
Q 005731 667 GDE 669 (680)
Q Consensus 667 ~~~ 669 (680)
...
T Consensus 341 ~~~ 343 (543)
T 3c4z_A 341 AGQ 343 (543)
T ss_dssp TTC
T ss_pred CCC
Confidence 543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=232.75 Aligned_cols=150 Identities=28% Similarity=0.378 Sum_probs=133.5
Q ss_pred CCcceeeeeccCCceeEEEEEE----cCCcEEEEEEccCCC----cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCe
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGE 583 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~----~~~~~VAVK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 583 (680)
++|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6899999999999999999986 368999999987532 23456678899999999 79999999999999999
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.++||||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999843 346889999999999999999999987 9999999999999999999999999999
Q ss_pred ecCCC
Q 005731 664 MFGGD 668 (680)
Q Consensus 664 ~~~~~ 668 (680)
.+...
T Consensus 208 ~~~~~ 212 (355)
T 1vzo_A 208 EFVAD 212 (355)
T ss_dssp ECCGG
T ss_pred ecccC
Confidence 87543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.5e-24 Score=221.19 Aligned_cols=147 Identities=34% Similarity=0.486 Sum_probs=126.8
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhh--cCCCceeeEEEEEEeC----CeEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAE--LQHRNLVRILGCCVEQ----GEKI 585 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~ 585 (680)
.++|++.+.||+|+||.||+|+. +++.||||++... ..+.+.+|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999986 6899999998653 34556667776666 7999999999997653 4589
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEeCCCCCCcEEEcCCCCeEEe
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH--------QYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiHrDlkp~NILl~~~~~~kl~ 657 (680)
+||||+++|+|.+++. ...+++..+..++.||+.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999983 346899999999999999999999 665 9999999999999999999999
Q ss_pred eeccceecCCCc
Q 005731 658 DFGLARMFGGDE 669 (680)
Q Consensus 658 DFGla~~~~~~~ 669 (680)
|||+|+......
T Consensus 156 Dfg~a~~~~~~~ 167 (301)
T 3q4u_A 156 DLGLAVMHSQST 167 (301)
T ss_dssp CCTTCEEEETTT
T ss_pred eCCCeeeccccc
Confidence 999998775443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-24 Score=222.16 Aligned_cols=152 Identities=34% Similarity=0.584 Sum_probs=132.2
Q ss_pred CCcceeeeeccCCceeEEEEEE-----cCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEK 584 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 584 (680)
+.|++.+.||+|+||.||+++. .+++.||||++... .....+.+.+|++++.+++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5689999999999999999983 46889999999753 334567899999999999999999999999876 668
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999998432 345899999999999999999999987 99999999999999999999999999998
Q ss_pred cCCCc
Q 005731 665 FGGDE 669 (680)
Q Consensus 665 ~~~~~ 669 (680)
+....
T Consensus 176 ~~~~~ 180 (302)
T 4e5w_A 176 IETDK 180 (302)
T ss_dssp CCTTC
T ss_pred ccCCC
Confidence 76543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=236.43 Aligned_cols=150 Identities=27% Similarity=0.449 Sum_probs=131.2
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-----Ce
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-----GE 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 583 (680)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+++.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999985 45889999999753 233467899999999999999999999999876 57
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.++||||++ ++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 59988883 3456899999999999999999999988 9999999999999999999999999999
Q ss_pred ecCCC
Q 005731 664 MFGGD 668 (680)
Q Consensus 664 ~~~~~ 668 (680)
.+...
T Consensus 178 ~~~~~ 182 (432)
T 3n9x_A 178 TINSE 182 (432)
T ss_dssp EC---
T ss_pred ccccc
Confidence 87543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=229.11 Aligned_cols=151 Identities=35% Similarity=0.573 Sum_probs=127.5
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCc----EEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~----~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
++|++.+.||+|+||.||+|+.. +++ +||+|.+... .....++|.+|+.++++++||||+++++++.+. ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 57999999999999999999843 344 4688888643 334567899999999999999999999999875 4789
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|+||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999998542 356899999999999999999999987 9999999999999999999999999999876
Q ss_pred CCc
Q 005731 667 GDE 669 (680)
Q Consensus 667 ~~~ 669 (680)
...
T Consensus 169 ~~~ 171 (327)
T 3poz_A 169 AEE 171 (327)
T ss_dssp TTC
T ss_pred CCc
Confidence 544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=227.49 Aligned_cols=150 Identities=23% Similarity=0.315 Sum_probs=132.3
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.++|++.+.||+|+||.||+|+. .+++.||||.+.... ..+++.+|+++++++ +||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36899999999999999999984 678999999987532 234688999999999 99999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC-----eEEeeecccee
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN-----PKISDFGLARM 664 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~DFGla~~ 664 (680)
|+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+|+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998532 357899999999999999999999987 999999999999998887 99999999998
Q ss_pred cCCCc
Q 005731 665 FGGDE 669 (680)
Q Consensus 665 ~~~~~ 669 (680)
+....
T Consensus 160 ~~~~~ 164 (330)
T 2izr_A 160 YIDPE 164 (330)
T ss_dssp SBCTT
T ss_pred eecCC
Confidence 75543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=225.91 Aligned_cols=156 Identities=32% Similarity=0.466 Sum_probs=136.3
Q ss_pred hcCCcceeeeeccCCceeEEEEEE------cCCcEEEEEEccCCCc-ccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 582 (680)
..++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346899999999999999999974 3467999999975432 3457899999999999 9999999999999999
Q ss_pred eEEEEEEccCCCChhhHhccccc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEE
Q 005731 583 EKILILEYMPNKSLDVYLFDPIK---------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 647 (680)
..++||||+++|+|.+++..... ...+++..+..++.||++||+|||+.+ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999854321 124899999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeeeccceecCCCc
Q 005731 648 LDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~~ 669 (680)
++.++.+||+|||+++.+....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~ 199 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDS 199 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCT
T ss_pred EcCCCCEEEccccccccccccc
Confidence 9999999999999999876543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=239.89 Aligned_cols=149 Identities=24% Similarity=0.432 Sum_probs=122.1
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-----Ce
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-----GE 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 583 (680)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+++.+|++++.+++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36899999999999999999984 46899999999653 233467899999999999999999999998543 46
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.|+||||+ +++|..++. ....+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 578988873 3456899999999999999999999987 9999999999999999999999999999
Q ss_pred ecCC
Q 005731 664 MFGG 667 (680)
Q Consensus 664 ~~~~ 667 (680)
.+..
T Consensus 205 ~~~~ 208 (458)
T 3rp9_A 205 TVDY 208 (458)
T ss_dssp CTTS
T ss_pred hccC
Confidence 8753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.3e-24 Score=231.66 Aligned_cols=154 Identities=27% Similarity=0.429 Sum_probs=135.8
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC--eEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG--EKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 588 (680)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 57999999999999999999864 48999999997532 344678899999999999999999999998765 789999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE----cCCCCeEEeeecccee
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARM 664 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla~~ 664 (680)
||+++|+|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999966544455899999999999999999999987 9999999999999 7788899999999998
Q ss_pred cCCCc
Q 005731 665 FGGDE 669 (680)
Q Consensus 665 ~~~~~ 669 (680)
+....
T Consensus 166 ~~~~~ 170 (396)
T 4eut_A 166 LEDDE 170 (396)
T ss_dssp CCCGG
T ss_pred ccCCC
Confidence 75543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4e-24 Score=224.65 Aligned_cols=152 Identities=34% Similarity=0.501 Sum_probs=119.7
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 36799999999999999999984 468999999987532 3345778999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 590 YMPNKSLDVYLFDPI---KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 590 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
|++ ++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 68988875432 1245889999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 005731 667 G 667 (680)
Q Consensus 667 ~ 667 (680)
.
T Consensus 160 ~ 160 (317)
T 2pmi_A 160 I 160 (317)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=224.07 Aligned_cols=150 Identities=27% Similarity=0.271 Sum_probs=128.2
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.++||+|+||.||+|+.. +++.||||++.... .....++..|+..+.++ +||||+++++++.++...++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999865 68999999986532 23344566666666665 8999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 67898887442 346899999999999999999999987 999999999999999999999999999887543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-24 Score=218.93 Aligned_cols=155 Identities=25% Similarity=0.374 Sum_probs=134.5
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|++.+.||+|+||.||++... +++.||||++... ......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999864 6899999998753 233466788999999999 999999999999999999999
Q ss_pred EEccCCCChhhHhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC---------------
Q 005731 588 LEYMPNKSLDVYLFDPIK-KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD--------------- 651 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~--------------- 651 (680)
|||+++++|.+++..... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999854322 256899999999999999999999987 9999999999999844
Q ss_pred ----CCeEEeeeccceecCCCc
Q 005731 652 ----MNPKISDFGLARMFGGDE 669 (680)
Q Consensus 652 ----~~~kl~DFGla~~~~~~~ 669 (680)
..+||+|||+++......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~ 188 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ 188 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC
T ss_pred cCCceEEEEcccccccccCCcc
Confidence 479999999999886544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=229.70 Aligned_cols=148 Identities=23% Similarity=0.326 Sum_probs=126.2
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCC--------cccHHHHHHHHHHHhhcC---------CCceeeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAELQ---------HRNLVRI 574 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~--------~~~~~~f~~E~~~l~~l~---------H~niv~l 574 (680)
.++|++.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999986 78999999997532 233578899999999886 8888888
Q ss_pred EEEEE------------------------------eCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHH
Q 005731 575 LGCCV------------------------------EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624 (680)
Q Consensus 575 ~g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 624 (680)
.+++. .....+|||||+++|++.+.+. ...+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 88754 1678999999999997765552 2467899999999999999
Q ss_pred HHHHH-hCCCCceEeCCCCCCcEEEcCCC--------------------CeEEeeeccceecCC
Q 005731 625 LLYLH-QYSRLRIIHRDLKASNVLLDKDM--------------------NPKISDFGLARMFGG 667 (680)
Q Consensus 625 L~yLH-~~~~~~iiHrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~ 667 (680)
|+||| +.+ |+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 99999 887 99999999999999887 899999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=7.6e-25 Score=230.19 Aligned_cols=156 Identities=31% Similarity=0.482 Sum_probs=135.7
Q ss_pred HHhcCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC
Q 005731 509 AAATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ 581 (680)
Q Consensus 509 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 581 (680)
....++|++.+.||+|+||.||+|... +++.||||.+.... .....++.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345578999999999999999999743 36789999997543 23456799999999999999999999999999
Q ss_pred CeEEEEEEccCCCChhhHhccccc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCe
Q 005731 582 GEKILILEYMPNKSLDVYLFDPIK-------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 654 (680)
...++||||+++|+|.+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 999999999999999999854221 145688999999999999999999987 9999999999999999999
Q ss_pred EEeeeccceecCC
Q 005731 655 KISDFGLARMFGG 667 (680)
Q Consensus 655 kl~DFGla~~~~~ 667 (680)
||+|||+++.+..
T Consensus 178 kl~Dfg~~~~~~~ 190 (322)
T 1p4o_A 178 KIGDFGMTRDIYE 190 (322)
T ss_dssp EECCTTCCCGGGG
T ss_pred EECcCcccccccc
Confidence 9999999987644
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=239.34 Aligned_cols=152 Identities=30% Similarity=0.537 Sum_probs=132.4
Q ss_pred hcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
..++|++.+.||+|+||.||+|....+..||||+++... ...++|.+|++++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 446799999999999999999998888889999998643 346789999999999999999999999866 678999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+++|+|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999998532 2345889999999999999999999987 999999999999999999999999999987543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=7.3e-24 Score=221.54 Aligned_cols=149 Identities=30% Similarity=0.414 Sum_probs=133.2
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|++.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|++++.+++||||+++++++......++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 68999999999999999999864 589999999865322 235678899999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+++++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 999999988873 3356899999999999999999999987 99999999999999999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.7e-24 Score=222.89 Aligned_cols=148 Identities=28% Similarity=0.387 Sum_probs=130.3
Q ss_pred CCccee-eeeccCCceeEEEEE-EcCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQ-CKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~-~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 589 (680)
+.|++. +.||+|+||.||++. ..+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 568874 789999999999998 456899999999766556678899999999985 79999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC---eEEeeeccceecC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN---PKISDFGLARMFG 666 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGla~~~~ 666 (680)
|+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.+.
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999843 356889999999999999999999987 999999999999998776 9999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.9e-24 Score=229.89 Aligned_cols=151 Identities=20% Similarity=0.280 Sum_probs=134.8
Q ss_pred cCCcceeeeeccC--CceeEEEEEEc-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 512 TENFSMQCKLGEG--GFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 512 ~~~f~~~~~LG~G--~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
.++|++.++||+| +||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3689999999999 99999999864 68999999997532 3345678899999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999998543 2345899999999999999999999987 9999999999999999999999999987653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=228.14 Aligned_cols=151 Identities=30% Similarity=0.499 Sum_probs=129.8
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCc----EEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~----~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
++|++.+.||+|+||.||+|+.. +++ .||+|.+... .....+++.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57999999999999999999853 444 3888887643 2334567789999999999999999999885 567899
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999998542 346788999999999999999999987 9999999999999999999999999999875
Q ss_pred CCc
Q 005731 667 GDE 669 (680)
Q Consensus 667 ~~~ 669 (680)
...
T Consensus 167 ~~~ 169 (325)
T 3kex_A 167 PDD 169 (325)
T ss_dssp CCT
T ss_pred ccc
Confidence 544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=222.04 Aligned_cols=151 Identities=28% Similarity=0.450 Sum_probs=133.9
Q ss_pred cCCcceeeeeccCCceeEEEEEEcC-C-------cEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFN-G-------QEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~-------~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 583 (680)
.++|++.+.||+|+||.||+|+... + ..||+|.+........+.+.+|+.++.+++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3679999999999999999997432 3 5799999987666667889999999999999999999999999999
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC--------eE
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN--------PK 655 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~k 655 (680)
.++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999998542 234889999999999999999999988 999999999999998887 99
Q ss_pred EeeeccceecCC
Q 005731 656 ISDFGLARMFGG 667 (680)
Q Consensus 656 l~DFGla~~~~~ 667 (680)
|+|||+++....
T Consensus 162 l~Dfg~~~~~~~ 173 (289)
T 4fvq_A 162 LSDPGISITVLP 173 (289)
T ss_dssp ECCCCSCTTTSC
T ss_pred eccCcccccccC
Confidence 999999976543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5e-24 Score=224.72 Aligned_cols=151 Identities=30% Similarity=0.496 Sum_probs=135.1
Q ss_pred CCcceeeeeccCCceeEEEEEE-----cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEE--eCCeEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV--EQGEKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 585 (680)
++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6899999999999999999983 468899999998766666778999999999999999999999987 445789
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999998432 235899999999999999999999987 999999999999999999999999999987
Q ss_pred CCC
Q 005731 666 GGD 668 (680)
Q Consensus 666 ~~~ 668 (680)
...
T Consensus 178 ~~~ 180 (327)
T 3lxl_A 178 PLD 180 (327)
T ss_dssp CTT
T ss_pred ccC
Confidence 543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-24 Score=228.00 Aligned_cols=149 Identities=26% Similarity=0.406 Sum_probs=121.7
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++.+++||||+++++++......++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3468999999999999999999865 57899999997532 34678899999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC---CCCeEEeeeccceecC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLARMFG 666 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~~~ 666 (680)
|+++++|.+++. ....+++.++..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999884 3456899999999999999999999987 999999999999975 8899999999999775
Q ss_pred C
Q 005731 667 G 667 (680)
Q Consensus 667 ~ 667 (680)
.
T Consensus 203 ~ 203 (349)
T 2w4o_A 203 H 203 (349)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4e-24 Score=231.32 Aligned_cols=160 Identities=25% Similarity=0.362 Sum_probs=131.8
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcC--CCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQ--HRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||++....++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999777999999998643 3345678999999999996 599999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
| +.+++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+|+.+..+
T Consensus 136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 578899999843 346888999999999999999999987 99999999999995 579999999999987654
Q ss_pred ccccCccccccC
Q 005731 669 ELQGNTKRIVGT 680 (680)
Q Consensus 669 ~~~~~~~~~~Gt 680 (680)
.........+||
T Consensus 208 ~~~~~~~~~~gt 219 (390)
T 2zmd_A 208 TTSVVKDSQVGA 219 (390)
T ss_dssp ------CCSCCC
T ss_pred CccccCCCCCcC
Confidence 432222334444
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=228.21 Aligned_cols=152 Identities=26% Similarity=0.397 Sum_probs=133.8
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc--------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeC
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQ 581 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 581 (680)
..++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346899999999999999999984 5688999999875321 1334678899999999999999999999999
Q ss_pred CeEEEEEEccCCC-ChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeec
Q 005731 582 GEKILILEYMPNK-SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (680)
Q Consensus 582 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 660 (680)
+..++||||+..| +|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9988883 3446899999999999999999999987 9999999999999999999999999
Q ss_pred cceecCCC
Q 005731 661 LARMFGGD 668 (680)
Q Consensus 661 la~~~~~~ 668 (680)
+++.+...
T Consensus 176 ~a~~~~~~ 183 (335)
T 3dls_A 176 SAAYLERG 183 (335)
T ss_dssp TCEECCTT
T ss_pred cceECCCC
Confidence 99987554
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=228.17 Aligned_cols=156 Identities=24% Similarity=0.340 Sum_probs=131.9
Q ss_pred HHhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC-----CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 005731 509 AAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG 582 (680)
Q Consensus 509 ~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 582 (680)
....++|++.+.||+|+||.||++.. .+++.||||++... .....+++.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 34557899999999999999999985 46889999998642 2345678999999999999999999999999999
Q ss_pred eEEEEEEccCCCChhhHhccccc-------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 005731 583 EKILILEYMPNKSLDVYLFDPIK-------------------------------------KRLLDWEARIRIIQGIAQGL 625 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~~L 625 (680)
..++||||+++|+|.+++..... ...+++..+..++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999998842100 11235667788999999999
Q ss_pred HHHHhCCCCceEeCCCCCCcEEEcCCC--CeEEeeeccceecCC
Q 005731 626 LYLHQYSRLRIIHRDLKASNVLLDKDM--NPKISDFGLARMFGG 667 (680)
Q Consensus 626 ~yLH~~~~~~iiHrDlkp~NILl~~~~--~~kl~DFGla~~~~~ 667 (680)
+|||+.+ |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 9999987 99999999999998776 899999999997643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.8e-24 Score=224.22 Aligned_cols=150 Identities=25% Similarity=0.349 Sum_probs=134.4
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999854 5789999998643 233467789999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999988733 356899999999999999999999987 99999999999999999999999999998753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=8.6e-24 Score=217.45 Aligned_cols=151 Identities=34% Similarity=0.544 Sum_probs=134.1
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.++|++.+.||+|+||.||+|...+++.||||.+... ....+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 4689999999999999999999888889999999753 335678999999999999999999999876 45689999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
++++|.+++... ....+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999998432 2236889999999999999999999987 999999999999999999999999999987544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.7e-24 Score=217.67 Aligned_cols=150 Identities=30% Similarity=0.536 Sum_probs=135.7
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.++|++.+.||+|+||.||++...+++.||||++.... ...+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 36799999999999999999998888999999998643 34578999999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999998432 346889999999999999999999987 99999999999999999999999999987644
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.6e-24 Score=218.92 Aligned_cols=150 Identities=25% Similarity=0.355 Sum_probs=134.1
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367999999999999999999864 5789999998653 233456789999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++++|.+++. ....+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 94 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999998873 3356899999999999999999999987 99999999999999999999999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=8.5e-24 Score=217.33 Aligned_cols=151 Identities=31% Similarity=0.536 Sum_probs=134.4
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|++.+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999985 578999999986431 23357899999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999843 2356899999999999999999999987 99999999999999999999999999998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=246.16 Aligned_cols=162 Identities=27% Similarity=0.333 Sum_probs=137.9
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 585 (680)
..++|++.++||+|+||.||+++. .+++.||||+++.. .....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457899999999999999999985 45889999998742 233456788999999987 7999999999999999999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
|||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999843 356899999999999999999999987 999999999999999999999999999975
Q ss_pred CCCccccCccccccC
Q 005731 666 GGDELQGNTKRIVGT 680 (680)
Q Consensus 666 ~~~~~~~~~~~~~Gt 680 (680)
..+.. .+..++||
T Consensus 493 ~~~~~--~~~~~~GT 505 (674)
T 3pfq_A 493 IWDGV--TTKTFCGT 505 (674)
T ss_dssp CCTTC--CBCCCCSC
T ss_pred ccCCc--ccccccCC
Confidence 43322 23345555
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=227.08 Aligned_cols=150 Identities=32% Similarity=0.492 Sum_probs=131.8
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
+.|+..+.||+|+||.||+|+. .+++.||||++.... ....+++.+|++++.+++||||+++++++......++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999985 578999999997532 223467899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+. |+|.+++.. ....+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 677777632 2356899999999999999999999987 999999999999999999999999999877543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.3e-24 Score=222.13 Aligned_cols=150 Identities=29% Similarity=0.414 Sum_probs=134.1
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
++|++.+.||+|+||.||+++.. +++.||||.+..... ...+++.+|+.++.+++||||+++++++.+....+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 57999999999999999999854 689999999865321 23678999999999999999999999999999999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC----CeEEeeecc
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM----NPKISDFGL 661 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGl 661 (680)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999843 456889999999999999999999987 99999999999999887 799999999
Q ss_pred ceecCCC
Q 005731 662 ARMFGGD 668 (680)
Q Consensus 662 a~~~~~~ 668 (680)
++.+...
T Consensus 166 ~~~~~~~ 172 (321)
T 2a2a_A 166 AHEIEDG 172 (321)
T ss_dssp CEECCTT
T ss_pred ceecCcc
Confidence 9987553
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.5e-24 Score=219.95 Aligned_cols=153 Identities=24% Similarity=0.426 Sum_probs=132.7
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|.+.+.||+|+||.||+++. .+++.||+|++.... ....+++.+|++++++++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5799999999999999999985 468899999987542 34568899999999999999999999999999999999999
Q ss_pred cCCCChhhHhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE---cCCCCeEEeeeccceecC
Q 005731 591 MPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFG 666 (680)
Q Consensus 591 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 666 (680)
+++++|.+++... .....+++..+..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999888543 23456899999999999999999999987 9999999999999 456789999999998775
Q ss_pred CC
Q 005731 667 GD 668 (680)
Q Consensus 667 ~~ 668 (680)
..
T Consensus 179 ~~ 180 (285)
T 3is5_A 179 SD 180 (285)
T ss_dssp --
T ss_pred Cc
Confidence 43
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.7e-24 Score=229.43 Aligned_cols=149 Identities=29% Similarity=0.525 Sum_probs=123.1
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCC--eE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQG--EK 584 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~~ 584 (680)
..++|++.+.||+|+||.||+|.. .+++.||||++... .....+++.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999984 56899999998643 2344567889999999997 999999999998654 68
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||||++ ++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 688888732 46889999999999999999999988 99999999999999999999999999998
Q ss_pred cCC
Q 005731 665 FGG 667 (680)
Q Consensus 665 ~~~ 667 (680)
+..
T Consensus 159 ~~~ 161 (388)
T 3oz6_A 159 FVN 161 (388)
T ss_dssp SSS
T ss_pred ccc
Confidence 743
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.4e-24 Score=242.64 Aligned_cols=151 Identities=30% Similarity=0.536 Sum_probs=134.8
Q ss_pred hcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
..++|++.++||+|+||.||+|....+..||||+++... ...++|.+|++++++++||||+++++++.+ +..+|||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 346799999999999999999998888899999998643 346789999999999999999999999866 678999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++|+|.+++... ....+++.+++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+++.+..
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999998532 2345889999999999999999999987 99999999999999999999999999987754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.90 E-value=8.7e-24 Score=216.32 Aligned_cols=152 Identities=33% Similarity=0.538 Sum_probs=125.2
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCC----cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|++.+.||+|+||.||++.. .++.||||++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 36899999999999999999986 48899999987532 23457899999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC--------CCCeEEeee
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK--------DMNPKISDF 659 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--------~~~~kl~DF 659 (680)
|||+++++|.+++. ...+++..+..++.|+++||+|||+.+..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999998883 346899999999999999999999987556999999999999986 678999999
Q ss_pred ccceecCCC
Q 005731 660 GLARMFGGD 668 (680)
Q Consensus 660 Gla~~~~~~ 668 (680)
|+++.+...
T Consensus 161 g~~~~~~~~ 169 (271)
T 3dtc_A 161 GLAREWHRT 169 (271)
T ss_dssp CC-------
T ss_pred Ccccccccc
Confidence 999876543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.8e-24 Score=226.28 Aligned_cols=159 Identities=27% Similarity=0.298 Sum_probs=137.1
Q ss_pred ccHHHHHHhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-----CCceeeEEE
Q 005731 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-----HRNLVRILG 576 (680)
Q Consensus 503 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-----H~niv~l~g 576 (680)
+++.+.....++|++.++||+|+||.||+|+. .+++.||||++.. .....+.+..|++++..++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 44444445568999999999999999999985 5688999999975 3345567888999999986 999999999
Q ss_pred EEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC------
Q 005731 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK------ 650 (680)
Q Consensus 577 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~------ 650 (680)
++...+..++||||+ +++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 999999999999999 99999988542 2345889999999999999999999987 999999999999975
Q ss_pred -------------------CCCeEEeeeccceecCC
Q 005731 651 -------------------DMNPKISDFGLARMFGG 667 (680)
Q Consensus 651 -------------------~~~~kl~DFGla~~~~~ 667 (680)
++.+||+|||+|+....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 78999999999997644
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.8e-24 Score=233.01 Aligned_cols=150 Identities=25% Similarity=0.367 Sum_probs=127.4
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--------cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ 581 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 581 (680)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 457899999999999999999985 458899999986421 112335889999999999999999999974 5
Q ss_pred CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC---CeEEee
Q 005731 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM---NPKISD 658 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~D 658 (680)
+..++||||+++|+|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 67899999999999988873 3456899999999999999999999987 99999999999997544 599999
Q ss_pred eccceecCC
Q 005731 659 FGLARMFGG 667 (680)
Q Consensus 659 FGla~~~~~ 667 (680)
||+|+.+..
T Consensus 286 FG~a~~~~~ 294 (419)
T 3i6u_A 286 FGHSKILGE 294 (419)
T ss_dssp SSTTTSCC-
T ss_pred cccceecCC
Confidence 999998754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-24 Score=224.32 Aligned_cols=161 Identities=30% Similarity=0.463 Sum_probs=136.6
Q ss_pred HHHHHHhcCCcceeeeeccCCceeEEEEEE------cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeEEE
Q 005731 505 LASVAAATENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILG 576 (680)
Q Consensus 505 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g 576 (680)
........++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344455668899999999999999999973 346899999997643 23456799999999999 7999999999
Q ss_pred EEEeCC-eEEEEEEccCCCChhhHhccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCC
Q 005731 577 CCVEQG-EKILILEYMPNKSLDVYLFDPIK-------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642 (680)
Q Consensus 577 ~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 642 (680)
++...+ ..++||||+++++|.+++..... ...+++..+..++.||++||+|||+.+ |+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence 988755 48999999999999999854322 123788999999999999999999987 9999999
Q ss_pred CCcEEEcCCCCeEEeeeccceecCCC
Q 005731 643 ASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|+|||++.++.+||+|||+++.+...
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 201 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKD 201 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTC
T ss_pred cceEEECCCCCEEECCCccccccccC
Confidence 99999999999999999999877543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=215.72 Aligned_cols=152 Identities=27% Similarity=0.443 Sum_probs=133.8
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
.++|++.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++.+++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 47899999999999999999985 45889999998653 2334577899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC---eEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN---PKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGla~~~ 665 (680)
||+++++|.+.+.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888743 356899999999999999999999987 999999999999986655 999999999887
Q ss_pred CCCc
Q 005731 666 GGDE 669 (680)
Q Consensus 666 ~~~~ 669 (680)
....
T Consensus 159 ~~~~ 162 (284)
T 3kk8_A 159 NDSE 162 (284)
T ss_dssp CSSC
T ss_pred ccCc
Confidence 5443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.1e-24 Score=218.98 Aligned_cols=151 Identities=27% Similarity=0.439 Sum_probs=123.7
Q ss_pred cCCcceeeeeccCCceeEEEEEEcC----CcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
.++|++.+.||+|+||.||+|.... +..||||++... .....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 4689999999999999999998532 457999998753 334466799999999999999999999997 4567899
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999843 2346899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 005731 667 GD 668 (680)
Q Consensus 667 ~~ 668 (680)
..
T Consensus 168 ~~ 169 (281)
T 1mp8_A 168 DS 169 (281)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=216.93 Aligned_cols=151 Identities=31% Similarity=0.461 Sum_probs=131.6
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
.|.....||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 444456899999999999985 5688999999987655567889999999999999999999999999999999999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-CCCeEEeeeccceecCC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFGG 667 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~ 667 (680)
+++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||+++.+..
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999865433445678888999999999999999987 999999999999987 89999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=6.2e-24 Score=219.44 Aligned_cols=154 Identities=32% Similarity=0.544 Sum_probs=137.4
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
..++|++.+.||+|+||.||+|... +++.||||.+... ....+++.+|++++++++||||+++++++......++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4578999999999999999999865 4889999999753 3456789999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
|+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999998542 3356899999999999999999999988 9999999999999999999999999998775443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-24 Score=226.39 Aligned_cols=156 Identities=33% Similarity=0.491 Sum_probs=135.2
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEcC------CcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ 581 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 581 (680)
...++|++.+.||+|+||.||+|.... ...||||.+.... ....+.+.+|+.++.++ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345789999999999999999998532 2479999997643 33467799999999999 899999999999999
Q ss_pred CeEEEEEEccCCCChhhHhccccc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC
Q 005731 582 GEKILILEYMPNKSLDVYLFDPIK-----------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK 650 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~ 650 (680)
+..++||||+++|+|.+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 999999999999999999854321 345789999999999999999999987 999999999999999
Q ss_pred CCCeEEeeeccceecCCC
Q 005731 651 DMNPKISDFGLARMFGGD 668 (680)
Q Consensus 651 ~~~~kl~DFGla~~~~~~ 668 (680)
++.+||+|||+++.+...
T Consensus 200 ~~~~kl~Dfg~~~~~~~~ 217 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMND 217 (333)
T ss_dssp GGEEEBCCCGGGCCGGGC
T ss_pred CCeEEECccccccccccc
Confidence 999999999999977443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-23 Score=218.15 Aligned_cols=147 Identities=37% Similarity=0.549 Sum_probs=130.3
Q ss_pred cceeeeeccCCceeEEEEEE-----cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEE
Q 005731 515 FSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKIL 586 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~-----~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 586 (680)
|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48999999999999988863 368899999998643 34467799999999999999999999999884 67899
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999833 34899999999999999999999988 9999999999999999999999999999875
Q ss_pred CC
Q 005731 667 GD 668 (680)
Q Consensus 667 ~~ 668 (680)
..
T Consensus 186 ~~ 187 (318)
T 3lxp_A 186 EG 187 (318)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=7e-24 Score=219.57 Aligned_cols=148 Identities=34% Similarity=0.541 Sum_probs=122.9
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.++|++.+.||+|+||.||+|+.. ..||||+++.. .....+.|.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 468999999999999999999743 46999998754 234467899999999999999999999965 5567899999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+++++|.+++.. ....+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999998843 2356899999999999999999999987 99999999999999999999999999987653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-23 Score=216.22 Aligned_cols=150 Identities=29% Similarity=0.448 Sum_probs=135.4
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.+.|++.+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.++.+++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35799999999999999999985 468899999997543 3456889999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|+++++|.+++. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999883 346899999999999999999999987 999999999999999999999999999887554
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=221.90 Aligned_cols=152 Identities=35% Similarity=0.605 Sum_probs=134.2
Q ss_pred cCCcceeeeeccCCceeEEEEEE-----cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC--eE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG--EK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 584 (680)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35799999999999999999983 368899999998766666788999999999999999999999987654 67
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||||+++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998432 345899999999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 005731 665 FGGD 668 (680)
Q Consensus 665 ~~~~ 668 (680)
+...
T Consensus 195 ~~~~ 198 (326)
T 2w1i_A 195 LPQD 198 (326)
T ss_dssp CCSS
T ss_pred cccc
Confidence 7544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.90 E-value=8.5e-24 Score=223.02 Aligned_cols=141 Identities=26% Similarity=0.351 Sum_probs=124.7
Q ss_pred eeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEEccCCCCh
Q 005731 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILEYMPNKSL 596 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (680)
+.||+|+||.||++.. .+++.||||++... ....+.+|+.++..+. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 7899999999999986 46899999999642 4567889999999997 99999999999999999999999999999
Q ss_pred hhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC---CeEEeeeccceecCCC
Q 005731 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM---NPKISDFGLARMFGGD 668 (680)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~ 668 (680)
.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999843 456899999999999999999999987 99999999999998765 8999999999977543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=7.3e-24 Score=218.05 Aligned_cols=150 Identities=30% Similarity=0.418 Sum_probs=132.0
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 468999999999999999999854 5779999998642 123356789999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999988843 356899999999999999999999887 99999999999999999999999999876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=220.42 Aligned_cols=153 Identities=27% Similarity=0.395 Sum_probs=133.3
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE----QGEKI 585 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 585 (680)
..++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346899999999999999999985 6789999999876556667889999999999999999999999873 34789
Q ss_pred EEEEccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 586 LILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
+||||+++++|.+++.... ....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999885422 2456899999999999999999999987 99999999999999999999999999886
Q ss_pred cC
Q 005731 665 FG 666 (680)
Q Consensus 665 ~~ 666 (680)
..
T Consensus 184 ~~ 185 (317)
T 2buj_A 184 AC 185 (317)
T ss_dssp SC
T ss_pred cc
Confidence 53
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=214.70 Aligned_cols=149 Identities=29% Similarity=0.462 Sum_probs=132.9
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC------cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS------GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
++|++.+.||+|+||.||+++.. +++.||||.+.... ....+++.+|+.++.+++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56999999999999999999865 68999999986432 124678999999999999999999999999999999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC----CeEEeeecc
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM----NPKISDFGL 661 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGl 661 (680)
+||||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999843 356899999999999999999999987 99999999999998877 899999999
Q ss_pred ceecCC
Q 005731 662 ARMFGG 667 (680)
Q Consensus 662 a~~~~~ 667 (680)
++.+..
T Consensus 159 ~~~~~~ 164 (283)
T 3bhy_A 159 AHKIEA 164 (283)
T ss_dssp CEECC-
T ss_pred ceeccC
Confidence 998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=222.08 Aligned_cols=152 Identities=29% Similarity=0.436 Sum_probs=126.5
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhc--CCCceeeEEEEEEeC----Ce
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL--QHRNLVRILGCCVEQ----GE 583 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l--~H~niv~l~g~~~~~----~~ 583 (680)
...++|++.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++..+ +||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34468999999999999999999864 899999998642 234445555555554 999999999999987 78
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEeCCCCCCcEEEcCCCCeEEee
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS-----RLRIIHRDLKASNVLLDKDMNPKISD 658 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~kl~D 658 (680)
.++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ +.+|+||||||+|||++.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 9999999999999999833 35889999999999999999999871 11399999999999999999999999
Q ss_pred eccceecCCCc
Q 005731 659 FGLARMFGGDE 669 (680)
Q Consensus 659 FGla~~~~~~~ 669 (680)
||+|+.+....
T Consensus 186 fg~a~~~~~~~ 196 (337)
T 3mdy_A 186 LGLAVKFISDT 196 (337)
T ss_dssp CTTCEECC---
T ss_pred CCCceeecccc
Confidence 99998775443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.7e-23 Score=222.78 Aligned_cols=155 Identities=23% Similarity=0.369 Sum_probs=136.3
Q ss_pred HHHhcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc--------ccHHHHHHHHHHHhhc-CCCceeeEEEE
Q 005731 508 VAAATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAEL-QHRNLVRILGC 577 (680)
Q Consensus 508 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--------~~~~~f~~E~~~l~~l-~H~niv~l~g~ 577 (680)
.....++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3444578999999999999999999874 699999999865321 1245688999999999 79999999999
Q ss_pred EEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEe
Q 005731 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (680)
Q Consensus 578 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 657 (680)
+......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999843 356899999999999999999999987 9999999999999999999999
Q ss_pred eeccceecCCC
Q 005731 658 DFGLARMFGGD 668 (680)
Q Consensus 658 DFGla~~~~~~ 668 (680)
|||+++.+...
T Consensus 243 DfG~~~~~~~~ 253 (365)
T 2y7j_A 243 DFGFSCHLEPG 253 (365)
T ss_dssp CCTTCEECCTT
T ss_pred ecCcccccCCC
Confidence 99999987654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=222.39 Aligned_cols=147 Identities=21% Similarity=0.373 Sum_probs=127.5
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.++|++.+.||+|+||.||++... +++.||||++..... .+.+|++++.++ +||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467999999999999999999854 688999999976432 235688888887 79999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC----CCeEEeeeccceec
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD----MNPKISDFGLARMF 665 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~~ 665 (680)
|+++|+|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++.+
T Consensus 97 ~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999884 3456899999999999999999999988 9999999999998543 35999999999987
Q ss_pred CCC
Q 005731 666 GGD 668 (680)
Q Consensus 666 ~~~ 668 (680)
...
T Consensus 171 ~~~ 173 (342)
T 2qr7_A 171 RAE 173 (342)
T ss_dssp BCT
T ss_pred cCC
Confidence 554
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=218.89 Aligned_cols=151 Identities=23% Similarity=0.276 Sum_probs=130.3
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999854 68899999997532 22357799999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++++|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999843 346899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 005731 668 D 668 (680)
Q Consensus 668 ~ 668 (680)
.
T Consensus 187 ~ 187 (309)
T 2h34_A 187 E 187 (309)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=220.06 Aligned_cols=155 Identities=31% Similarity=0.555 Sum_probs=125.9
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEc----CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 583 (680)
...++|.+.+.||+|+||.||+|... .++.||||++... .....+++.+|+.++.+++||||+++++++.+...
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34578999999999999999999753 3458999999753 23345779999999999999999999999987653
Q ss_pred -----EEEEEEccCCCChhhHhccc---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeE
Q 005731 584 -----KILILEYMPNKSLDVYLFDP---IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPK 655 (680)
Q Consensus 584 -----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 655 (680)
.++||||+++++|.+++... .....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 49999999999999988432 23356899999999999999999999987 99999999999999999999
Q ss_pred EeeeccceecCC
Q 005731 656 ISDFGLARMFGG 667 (680)
Q Consensus 656 l~DFGla~~~~~ 667 (680)
|+|||+++.+..
T Consensus 188 l~Dfg~~~~~~~ 199 (313)
T 3brb_A 188 VADFGLSKKIYS 199 (313)
T ss_dssp ECSCSCC-----
T ss_pred EeecCcceeccc
Confidence 999999987744
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.7e-23 Score=232.57 Aligned_cols=151 Identities=29% Similarity=0.461 Sum_probs=131.5
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc-------------ccHHHHHHHHHHHhhcCCCceeeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-------------QGLKEFKNEMMLIAELQHRNLVRILGC 577 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-------------~~~~~f~~E~~~l~~l~H~niv~l~g~ 577 (680)
.++|++.++||+|+||.||+++.. +++.||||++..... ...+++.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 478999999999999999999854 578999999865321 345789999999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC---Ce
Q 005731 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM---NP 654 (680)
Q Consensus 578 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~ 654 (680)
+.+....++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999888843 356899999999999999999999987 99999999999998776 69
Q ss_pred EEeeeccceecCCC
Q 005731 655 KISDFGLARMFGGD 668 (680)
Q Consensus 655 kl~DFGla~~~~~~ 668 (680)
||+|||+|+.+...
T Consensus 189 kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD 202 (504)
T ss_dssp EECCCTTCEECCTT
T ss_pred EEEECCCCEEcCCC
Confidence 99999999988654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.2e-23 Score=215.21 Aligned_cols=152 Identities=26% Similarity=0.355 Sum_probs=134.6
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC---------cccHHHHHHHHHHHhhcC-CCceeeEEEEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---------GQGLKEFKNEMMLIAELQ-HRNLVRILGCCV 579 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---------~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~ 579 (680)
..++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3478999999999999999999864 68999999986432 122456889999999995 999999999999
Q ss_pred eCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeee
Q 005731 580 EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659 (680)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 659 (680)
.....++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999843 356899999999999999999999987 999999999999999999999999
Q ss_pred ccceecCCC
Q 005731 660 GLARMFGGD 668 (680)
Q Consensus 660 Gla~~~~~~ 668 (680)
|+++.+...
T Consensus 169 g~~~~~~~~ 177 (298)
T 1phk_A 169 GFSCQLDPG 177 (298)
T ss_dssp TTCEECCTT
T ss_pred cchhhcCCC
Confidence 999987543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-23 Score=214.33 Aligned_cols=150 Identities=30% Similarity=0.536 Sum_probs=131.7
Q ss_pred CCcceee-eeccCCceeEEEEEEc---CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQC-KLGEGGFGPVYKGRLF---NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~-~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
++|.+.+ .||+|+||.||+|... +++.||||+++.. .....+++.+|++++.+++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 5677666 9999999999999743 5788999999864 334567899999999999999999999998 56679999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999843 2346899999999999999999999987 99999999999999999999999999998854
Q ss_pred C
Q 005731 668 D 668 (680)
Q Consensus 668 ~ 668 (680)
.
T Consensus 163 ~ 163 (287)
T 1u59_A 163 D 163 (287)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.4e-24 Score=233.93 Aligned_cols=148 Identities=30% Similarity=0.421 Sum_probs=124.5
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------C
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------G 582 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 582 (680)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999974 46899999999753 334467889999999999999999999999654 3
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
..++||||++++ |...+. ..+++.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 679999999865 555542 23889999999999999999999987 999999999999999999999999999
Q ss_pred eecCCC
Q 005731 663 RMFGGD 668 (680)
Q Consensus 663 ~~~~~~ 668 (680)
+.....
T Consensus 212 ~~~~~~ 217 (464)
T 3ttj_A 212 RTAGTS 217 (464)
T ss_dssp -----C
T ss_pred eecCCC
Confidence 977543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=214.51 Aligned_cols=150 Identities=31% Similarity=0.485 Sum_probs=134.7
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|++.+.||+|+||.||+++.. +++.||||.+... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999864 6899999998643 223456889999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999843 346889999999999999999999988 99999999999999999999999999987754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.3e-24 Score=223.41 Aligned_cols=151 Identities=32% Similarity=0.472 Sum_probs=127.3
Q ss_pred HhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
...++|++.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3457899999999999999999984 5689999999975422 235578899999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc-----CCCCeEEeeecc
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-----KDMNPKISDFGL 661 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-----~~~~~kl~DFGl 661 (680)
||||++ |+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999998 59988883 3346899999999999999999999987 99999999999994 455699999999
Q ss_pred ceecCC
Q 005731 662 ARMFGG 667 (680)
Q Consensus 662 a~~~~~ 667 (680)
|+.+..
T Consensus 184 a~~~~~ 189 (329)
T 3gbz_A 184 ARAFGI 189 (329)
T ss_dssp HHHHC-
T ss_pred ccccCC
Confidence 987753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=233.03 Aligned_cols=150 Identities=27% Similarity=0.410 Sum_probs=128.9
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 57999999999999999999854 68899999987532 3346789999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC---CCeEEeeeccceecC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD---MNPKISDFGLARMFG 666 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla~~~~ 666 (680)
|+++|+|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.. +.+||+|||+|+.+.
T Consensus 117 ~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 117 CYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999888743 356889999999999999999999987 9999999999999764 459999999999876
Q ss_pred CC
Q 005731 667 GD 668 (680)
Q Consensus 667 ~~ 668 (680)
..
T Consensus 191 ~~ 192 (494)
T 3lij_A 191 NQ 192 (494)
T ss_dssp TT
T ss_pred CC
Confidence 54
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.7e-23 Score=216.03 Aligned_cols=152 Identities=32% Similarity=0.517 Sum_probs=126.5
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-----cccHHHHHHHHHHHhhc---CCCceeeEEEEEEeC
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAEL---QHRNLVRILGCCVEQ 581 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-----~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~ 581 (680)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999984 568999999986321 12235667788777766 499999999999876
Q ss_pred C-----eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEE
Q 005731 582 G-----EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656 (680)
Q Consensus 582 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 656 (680)
. ..++||||+. ++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5799999997 5999988543 2334899999999999999999999988 999999999999999999999
Q ss_pred eeeccceecCC
Q 005731 657 SDFGLARMFGG 667 (680)
Q Consensus 657 ~DFGla~~~~~ 667 (680)
+|||+|+.+..
T Consensus 162 ~Dfg~a~~~~~ 172 (308)
T 3g33_A 162 ADFGLARIYSY 172 (308)
T ss_dssp CSCSCTTTSTT
T ss_pred eeCccccccCC
Confidence 99999987754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=221.57 Aligned_cols=152 Identities=33% Similarity=0.555 Sum_probs=128.8
Q ss_pred cCCcceeeeeccCCceeEEEEEEcC-----CcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFN-----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
.++|++.+.||+|+||.||+|.... +..||||.+.... .....++.+|+.++.+++||||+++++++......+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678889999999999999997543 2469999997542 334567999999999999999999999999999999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999843 2346899999999999999999999987 999999999999999999999999999987
Q ss_pred CCC
Q 005731 666 GGD 668 (680)
Q Consensus 666 ~~~ 668 (680)
...
T Consensus 198 ~~~ 200 (333)
T 1mqb_A 198 EDD 200 (333)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=221.34 Aligned_cols=149 Identities=30% Similarity=0.477 Sum_probs=129.5
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|++.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 68999999999999999999864 589999999865322 235668899999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 105 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 105 FVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp CCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999988763 2346899999999999999999999987 99999999999999999999999999987644
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=218.09 Aligned_cols=149 Identities=29% Similarity=0.521 Sum_probs=131.7
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.++|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++.+++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468999999999999999999864 5889999999876666778999999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+++++|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 98 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 98 CPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 999999988743 2346899999999999999999999987 999999999999999999999999998643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=214.55 Aligned_cols=149 Identities=28% Similarity=0.500 Sum_probs=131.0
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----------
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE---------- 580 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~---------- 580 (680)
.++|++.+.||+|+||.||++... +++.||||++.... +.+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 357999999999999999999865 68999999997543 356789999999999999999998864
Q ss_pred ------CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCe
Q 005731 581 ------QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (680)
Q Consensus 581 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 654 (680)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 34579999999999999998542 2356899999999999999999999987 9999999999999999999
Q ss_pred EEeeeccceecCCC
Q 005731 655 KISDFGLARMFGGD 668 (680)
Q Consensus 655 kl~DFGla~~~~~~ 668 (680)
||+|||+++.+...
T Consensus 162 kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 162 KIGDFGLVTSLKND 175 (284)
T ss_dssp EECCCTTCEESSCC
T ss_pred EECcchhheecccc
Confidence 99999999987554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=222.82 Aligned_cols=152 Identities=25% Similarity=0.399 Sum_probs=134.5
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcc-----------------cHHHHHHHHHHHhhcCCCceeeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ-----------------GLKEFKNEMMLIAELQHRNLVRI 574 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~-----------------~~~~f~~E~~~l~~l~H~niv~l 574 (680)
.++|++.+.||+|+||.||++.. +++.||||.+...... ..+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 8999999998642111 12889999999999999999999
Q ss_pred EEEEEeCCeEEEEEEccCCCChhhH------hcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCcEE
Q 005731 575 LGCCVEQGEKILILEYMPNKSLDVY------LFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVL 647 (680)
Q Consensus 575 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NIL 647 (680)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||+|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999988 422 124678999999999999999999998 77 999999999999
Q ss_pred EcCCCCeEEeeeccceecCCC
Q 005731 648 LDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~ 668 (680)
++.++.+||+|||+++.+...
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~ 205 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK 205 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT
T ss_pred EcCCCcEEEeccccccccccc
Confidence 999999999999999987443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=239.06 Aligned_cols=150 Identities=29% Similarity=0.527 Sum_probs=129.8
Q ss_pred CCcceee-eeccCCceeEEEEEEc---CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQC-KLGEGGFGPVYKGRLF---NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~-~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
+++.+.+ .||+|+||.||+|... ++..||||+++... ....++|.+|++++++++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4455555 8999999999999753 45689999998643 3457889999999999999999999999876 569999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++|+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999853 2456899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 005731 668 D 668 (680)
Q Consensus 668 ~ 668 (680)
+
T Consensus 489 ~ 489 (613)
T 2ozo_A 489 D 489 (613)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-23 Score=219.72 Aligned_cols=149 Identities=32% Similarity=0.534 Sum_probs=129.3
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--------
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-------- 581 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-------- 581 (680)
++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|++++.+++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6899999999999999999986 568999999986532 23356788999999999999999999999873
Q ss_pred CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecc
Q 005731 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 661 (680)
+..++||||+++ +|...+.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999985 67666633 2345899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCC
Q 005731 662 ARMFGG 667 (680)
Q Consensus 662 a~~~~~ 667 (680)
|+.+..
T Consensus 171 a~~~~~ 176 (351)
T 3mi9_A 171 ARAFSL 176 (351)
T ss_dssp CEECCC
T ss_pred cccccc
Confidence 998753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=217.82 Aligned_cols=149 Identities=32% Similarity=0.528 Sum_probs=131.4
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----------
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE---------- 580 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~---------- 580 (680)
.++|++.+.||+|+||.||+|+. .+++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 35799999999999999999985 4789999999964 33456789999999999999999999999875
Q ss_pred ---CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEe
Q 005731 581 ---QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (680)
Q Consensus 581 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 657 (680)
....++||||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3467999999999999999853 2345678899999999999999999987 9999999999999999999999
Q ss_pred eeccceecC
Q 005731 658 DFGLARMFG 666 (680)
Q Consensus 658 DFGla~~~~ 666 (680)
|||+++.+.
T Consensus 159 dfg~~~~~~ 167 (303)
T 1zy4_A 159 DFGLAKNVH 167 (303)
T ss_dssp CCCCCSCTT
T ss_pred eCcchhhcc
Confidence 999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-23 Score=214.57 Aligned_cols=149 Identities=28% Similarity=0.425 Sum_probs=133.1
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+++.. +++.||||.+... .....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999864 5789999998642 1233567899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999998843 346889999999999999999999987 99999999999999999999999999987654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.7e-23 Score=214.61 Aligned_cols=150 Identities=20% Similarity=0.334 Sum_probs=132.0
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 36799999999999999999984 678999999986432 335678899999999 89999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC-----eEEeeecccee
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN-----PKISDFGLARM 664 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~DFGla~~ 664 (680)
|+ +++|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+|+.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998432 345899999999999999999999887 999999999999987766 99999999998
Q ss_pred cCCCc
Q 005731 665 FGGDE 669 (680)
Q Consensus 665 ~~~~~ 669 (680)
+....
T Consensus 161 ~~~~~ 165 (298)
T 1csn_A 161 YRDPV 165 (298)
T ss_dssp SBCTT
T ss_pred ccccc
Confidence 86543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=221.61 Aligned_cols=151 Identities=34% Similarity=0.553 Sum_probs=126.1
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCc----EEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~----~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
.++|++.+.||+|+||.||+|.. .+++ .||+|.+... .....+++.+|+.++.+++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 36899999999999999999984 3444 4688877543 3456788999999999999999999999998754 88
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+|+||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999988542 346889999999999999999999987 999999999999999999999999999987
Q ss_pred CCC
Q 005731 666 GGD 668 (680)
Q Consensus 666 ~~~ 668 (680)
...
T Consensus 168 ~~~ 170 (327)
T 3lzb_A 168 GAE 170 (327)
T ss_dssp ---
T ss_pred cCc
Confidence 543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3e-23 Score=216.84 Aligned_cols=152 Identities=26% Similarity=0.453 Sum_probs=127.3
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||++.. .+++.||||++... .....+++.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5799999999999999999985 57899999998753 2334567899999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++++|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999885422 2456889999999999999999999987 99999999999999999999999999987754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=223.31 Aligned_cols=151 Identities=34% Similarity=0.482 Sum_probs=125.8
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc-----ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG-----QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 584 (680)
..++|++.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|++++.+++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 457899999999999999999985 4589999999974321 1234688999999999999999999999999999
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||||+++ +|..++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 88887743 2345788899999999999999999988 99999999999999999999999999997
Q ss_pred cCC
Q 005731 665 FGG 667 (680)
Q Consensus 665 ~~~ 667 (680)
+..
T Consensus 162 ~~~ 164 (346)
T 1ua2_A 162 FGS 164 (346)
T ss_dssp TTS
T ss_pred ccC
Confidence 754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=216.85 Aligned_cols=151 Identities=29% Similarity=0.517 Sum_probs=130.2
Q ss_pred CCcceeeeeccCCceeEEEEEEcC----CcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe-CCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE-QGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l 586 (680)
.+|++.+.||+|+||.||+|+..+ ...+|||.+... .....+++.+|+.++++++||||+++++++.+ ....++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 568899999999999999998532 236899998753 33446789999999999999999999999755 457899
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+++++|.+++.. ....+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999843 2346789999999999999999999987 9999999999999999999999999998775
Q ss_pred CC
Q 005731 667 GD 668 (680)
Q Consensus 667 ~~ 668 (680)
..
T Consensus 180 ~~ 181 (298)
T 3f66_A 180 DK 181 (298)
T ss_dssp CG
T ss_pred cc
Confidence 43
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=224.01 Aligned_cols=152 Identities=21% Similarity=0.345 Sum_probs=126.1
Q ss_pred hcCCcceeeeeccCCceeEEEEEEcC------CcEEEEEEccCCCccc-----------HHHHHHHHHHHhhcCCCceee
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQG-----------LKEFKNEMMLIAELQHRNLVR 573 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~~~~-----------~~~f~~E~~~l~~l~H~niv~ 573 (680)
..++|++.+.||+|+||.||+|.... ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998654 4789999987543211 122445666777889999999
Q ss_pred EEEEEEeC----CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc
Q 005731 574 ILGCCVEQ----GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (680)
Q Consensus 574 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~ 649 (680)
+++++... ...+|||||+ +++|.+++.. ....+++..+..|+.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 4589999999 9999999843 2356899999999999999999999987 99999999999999
Q ss_pred --CCCCeEEeeeccceecCCC
Q 005731 650 --KDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 650 --~~~~~kl~DFGla~~~~~~ 668 (680)
.++.+||+|||+|+.+...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGG
T ss_pred cCCCCeEEEEECCcceecccC
Confidence 8899999999999987543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=226.29 Aligned_cols=150 Identities=29% Similarity=0.527 Sum_probs=123.1
Q ss_pred CCcceeeeeccCCceeEEEEEEc--CC--cEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-CeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF--NG--QEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-GEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~--~~--~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~l 586 (680)
..|++.+.||+|+||.||+|+.. ++ ..||||.++.. .....++|.+|+.++++++||||+++++++.+. +..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35778899999999999999853 22 36899998753 334567899999999999999999999997654 57899
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+++|+|.+++.. ....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999843 2345788999999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 005731 667 G 667 (680)
Q Consensus 667 ~ 667 (680)
.
T Consensus 244 ~ 244 (373)
T 3c1x_A 244 D 244 (373)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=5.4e-23 Score=216.83 Aligned_cols=146 Identities=24% Similarity=0.404 Sum_probs=130.0
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEe--CCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVE--QGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV 587 (680)
.++|++.+.||+|+||.||+|.. .+++.||||+++.. ..+.+.+|++++.+++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999984 56899999999743 3577899999999997 9999999999988 5678999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC-CeEEeeeccceecC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMFG 666 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~ 666 (680)
|||+++++|..++. .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999988872 3788999999999999999999988 99999999999999776 89999999999875
Q ss_pred CCc
Q 005731 667 GDE 669 (680)
Q Consensus 667 ~~~ 669 (680)
...
T Consensus 183 ~~~ 185 (330)
T 3nsz_A 183 PGQ 185 (330)
T ss_dssp TTC
T ss_pred CCC
Confidence 443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=223.73 Aligned_cols=147 Identities=26% Similarity=0.368 Sum_probs=132.8
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57999999999999999999864 6889999999754 334467899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+++++|.+++.. ...+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 113 ~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 113 MDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999843 34688999999999999999999985 6 999999999999999999999999999765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=215.81 Aligned_cols=149 Identities=30% Similarity=0.456 Sum_probs=129.3
Q ss_pred CcceeeeeccCCceeEEEEEEc-CC---cEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE-EEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLF-NG---QEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK-ILI 587 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~-~~---~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV 587 (680)
.|...+.||+|+||.||+|+.. ++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 5667799999999999999843 22 379999997533 34567899999999999999999999999876655 999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+.+++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999854 2456789999999999999999999987 99999999999999999999999999987644
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=220.92 Aligned_cols=153 Identities=32% Similarity=0.504 Sum_probs=129.8
Q ss_pred cCCcceeeeeccCCceeEEEEEE------cCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 584 (680)
.++|++.+.||+|+||.||+|+. .+++.||||.+... ......++.+|+.++.+++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999973 34678999999753 334566899999999999999999999999999999
Q ss_pred EEEEEccCCCChhhHhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC---CCCeEEe
Q 005731 585 ILILEYMPNKSLDVYLFDPIK----KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKIS 657 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~ 657 (680)
++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999864321 245889999999999999999999987 999999999999984 4569999
Q ss_pred eeccceecCC
Q 005731 658 DFGLARMFGG 667 (680)
Q Consensus 658 DFGla~~~~~ 667 (680)
|||+++.+..
T Consensus 186 Dfg~~~~~~~ 195 (327)
T 2yfx_A 186 DFGMARDIYR 195 (327)
T ss_dssp CCHHHHHHHC
T ss_pred cccccccccc
Confidence 9999986643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-23 Score=223.13 Aligned_cols=158 Identities=26% Similarity=0.363 Sum_probs=132.2
Q ss_pred cHHHHHHhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCc-----------ccHHHHHHHHHHHhhcCCCcee
Q 005731 504 SLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG-----------QGLKEFKNEMMLIAELQHRNLV 572 (680)
Q Consensus 504 ~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~-----------~~~~~f~~E~~~l~~l~H~niv 572 (680)
...++....++|++.+.||+|+||.||+|...+++.||||++..... ...+.+.+|++++.+++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35667788899999999999999999999987899999999864211 1237899999999999999999
Q ss_pred eEEEEEEeC-----CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEE
Q 005731 573 RILGCCVEQ-----GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647 (680)
Q Consensus 573 ~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 647 (680)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998653 36899999998 678777743 3346899999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeeeccceecCC
Q 005731 648 LDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~ 667 (680)
++.++.+||+|||+++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~ 186 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTA 186 (362)
T ss_dssp ECTTCCEEECCTTC------
T ss_pred EcCCCCEEEEecCccccccc
Confidence 99999999999999986544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=216.40 Aligned_cols=151 Identities=26% Similarity=0.372 Sum_probs=128.8
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC----cccHHHHHHHHHHHhhcCCCceeeEEEEEE--eCCeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAELQHRNLVRILGCCV--EQGEK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~ 584 (680)
.++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36899999999999999999985 468899999997531 244678999999999999999999999985 44578
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||||++++ |.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999877 6666543 23456899999999999999999999987 99999999999999999999999999998
Q ss_pred cCC
Q 005731 665 FGG 667 (680)
Q Consensus 665 ~~~ 667 (680)
+..
T Consensus 159 ~~~ 161 (305)
T 2wtk_C 159 LHP 161 (305)
T ss_dssp CCT
T ss_pred cCc
Confidence 753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.5e-24 Score=219.48 Aligned_cols=155 Identities=26% Similarity=0.413 Sum_probs=120.5
Q ss_pred HhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
...++|++.+.||+|+||.||++.. .+++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 4457899999999999999999984 468899999987532 33467789999999999999999999999999999999
Q ss_pred EEccCCCChhhHhccc-----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 588 LEYMPNKSLDVYLFDP-----IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
|||+++++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999988531 12346899999999999999999999987 999999999999999999999999999
Q ss_pred eecCC
Q 005731 663 RMFGG 667 (680)
Q Consensus 663 ~~~~~ 667 (680)
+.+..
T Consensus 169 ~~~~~ 173 (303)
T 2vwi_A 169 AFLAT 173 (303)
T ss_dssp HHCC-
T ss_pred heecc
Confidence 87643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.3e-24 Score=230.06 Aligned_cols=152 Identities=15% Similarity=0.232 Sum_probs=124.8
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHH---HHHhhcCCCceeeEE-------EE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEM---MLIAELQHRNLVRIL-------GC 577 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~---~~l~~l~H~niv~l~-------g~ 577 (680)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.|.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999984 56899999999732 334567899999 556666899999998 66
Q ss_pred EEeCC-----------------eEEEEEEccCCCChhhHhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 005731 578 CVEQG-----------------EKILILEYMPNKSLDVYLFDPIK----KRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636 (680)
Q Consensus 578 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 636 (680)
+...+ ..++||||+ +|+|.+++..... ...+++..+..|+.||++||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 65543 278999999 6899999854211 112335788889999999999999987 9
Q ss_pred EeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 637 IHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 637 iHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+||||||+||||+.++.+||+|||+|+..+.
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~ 258 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC
Confidence 9999999999999999999999999997543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-23 Score=216.62 Aligned_cols=148 Identities=30% Similarity=0.439 Sum_probs=124.7
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEE-----------
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV----------- 579 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~----------- 579 (680)
.++|++.+.||+|+||.||+|... +++.||||++........+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 368999999999999999999865 48999999998666666788999999999999999999999873
Q ss_pred ---eCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc-CCCCeE
Q 005731 580 ---EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPK 655 (680)
Q Consensus 580 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~k 655 (680)
+....++||||++ |+|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 69988873 346889999999999999999999987 99999999999997 567999
Q ss_pred EeeeccceecCC
Q 005731 656 ISDFGLARMFGG 667 (680)
Q Consensus 656 l~DFGla~~~~~ 667 (680)
|+|||+++.+..
T Consensus 162 l~Dfg~~~~~~~ 173 (320)
T 2i6l_A 162 IGDFGLARIMDP 173 (320)
T ss_dssp ECCCTTCBCC--
T ss_pred EccCccccccCC
Confidence 999999997753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-23 Score=218.48 Aligned_cols=149 Identities=36% Similarity=0.579 Sum_probs=122.1
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHH--HhhcCCCceeeEEEEEEeC-----CeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMML--IAELQHRNLVRILGCCVEQ-----GEK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~--l~~l~H~niv~l~g~~~~~-----~~~ 584 (680)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.++ +..++||||+++++.+... ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999975 6899999999643 23444444444 5568999999999866532 256
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCceEeCCCCCCcEEEcCCCCeEEee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS------RLRIIHRDLKASNVLLDKDMNPKISD 658 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~iiHrDlkp~NILl~~~~~~kl~D 658 (680)
++||||+++|+|.+++.. ...++..+..++.||++||+|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 899999999999999833 23488899999999999999999871 01399999999999999999999999
Q ss_pred eccceecCCC
Q 005731 659 FGLARMFGGD 668 (680)
Q Consensus 659 FGla~~~~~~ 668 (680)
||+|+.+...
T Consensus 164 FG~a~~~~~~ 173 (336)
T 3g2f_A 164 FGLSMRLTGN 173 (336)
T ss_dssp CTTCEECSSS
T ss_pred ccceeecccc
Confidence 9999987543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=221.14 Aligned_cols=155 Identities=30% Similarity=0.487 Sum_probs=133.6
Q ss_pred HHHhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEe-----
Q 005731 508 VAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE----- 580 (680)
Q Consensus 508 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----- 580 (680)
+....++|++.+.||+|+||.||+|+. .+++.||||++... ....+++.+|+.++.++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 344568899999999999999999985 46899999998753 33457889999999999 89999999999987
Q ss_pred -CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeee
Q 005731 581 -QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659 (680)
Q Consensus 581 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 659 (680)
....++||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeC
Confidence 46789999999999999998543 2356889999999999999999999987 999999999999999999999999
Q ss_pred ccceecCC
Q 005731 660 GLARMFGG 667 (680)
Q Consensus 660 Gla~~~~~ 667 (680)
|+++.+..
T Consensus 174 g~~~~~~~ 181 (326)
T 2x7f_A 174 GVSAQLDR 181 (326)
T ss_dssp TTTC----
T ss_pred cCceecCc
Confidence 99987643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=217.76 Aligned_cols=150 Identities=23% Similarity=0.404 Sum_probs=131.0
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.++|++.+.||+|+||.||+++.. +++.||||.+........+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 357999999999999999999854 6899999999865444556789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE---cCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 667 (680)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999988843 346889999999999999999999987 9999999999999 7889999999999986543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=219.07 Aligned_cols=150 Identities=29% Similarity=0.454 Sum_probs=125.4
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
++|++.+.||+|+||.||+++. .++.||||++... ...+.|.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5789999999999999999986 4789999999743 35678999999999999999999999876 45789999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC-eEEeeeccceecCC
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN-PKISDFGLARMFGG 667 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-~kl~DFGla~~~~~ 667 (680)
+++|.+++........+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||+++.+..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999865444445788999999999999999999932234999999999999998886 79999999987643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-23 Score=218.14 Aligned_cols=150 Identities=33% Similarity=0.590 Sum_probs=129.8
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcE--EEEEEccCC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQE--VAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~--VAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 587 (680)
++|++.+.||+|+||.||+++. .++.. ||||.+... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5799999999999999999985 45664 499988753 334456799999999999 999999999999999999999
Q ss_pred EEccCCCChhhHhcccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCe
Q 005731 588 LEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 654 (680)
|||+++++|.+++.... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999985432 2346899999999999999999999987 9999999999999999999
Q ss_pred EEeeeccceec
Q 005731 655 KISDFGLARMF 665 (680)
Q Consensus 655 kl~DFGla~~~ 665 (680)
||+|||+++..
T Consensus 182 kL~Dfg~~~~~ 192 (327)
T 1fvr_A 182 KIADFGLSRGQ 192 (327)
T ss_dssp EECCTTCEESS
T ss_pred EEcccCcCccc
Confidence 99999999854
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.9e-23 Score=214.44 Aligned_cols=151 Identities=30% Similarity=0.504 Sum_probs=130.2
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
..++|++.+.||+|+||.||+|... +++.||||.+... ...+++.+|+.++.+++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999864 5899999999753 345788999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+...
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999998842 2456899999999999999999999987 999999999999999999999999999887543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-23 Score=214.33 Aligned_cols=150 Identities=32% Similarity=0.510 Sum_probs=130.6
Q ss_pred cCCcceee-eeccCCceeEEEEEE---cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 512 TENFSMQC-KLGEGGFGPVYKGRL---FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 512 ~~~f~~~~-~LG~G~fG~Vy~~~~---~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
.++|++.+ .||+|+||.||+|.. ..++.||||++.... ....+++.+|+.+++.++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788888 999999999999953 346889999997542 23367899999999999999999999998 667889
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999843 346889999999999999999999987 999999999999999999999999999987
Q ss_pred CCC
Q 005731 666 GGD 668 (680)
Q Consensus 666 ~~~ 668 (680)
...
T Consensus 168 ~~~ 170 (291)
T 1xbb_A 168 RAD 170 (291)
T ss_dssp CTT
T ss_pred ccC
Confidence 544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=221.43 Aligned_cols=148 Identities=30% Similarity=0.487 Sum_probs=127.4
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++......++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999864 6889999999753221 222456799999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
++ ++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 97 5888887432 346889999999999999999999988 9999999999999999999999999998764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=232.69 Aligned_cols=150 Identities=30% Similarity=0.512 Sum_probs=133.0
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|++++++++||||+++++++......++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 57999999999999999999854 6899999998642 23356789999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc---CCCCeEEeeeccceecC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD---KDMNPKISDFGLARMFG 666 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~~~ 666 (680)
|+++++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 102 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 102 LYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999888743 356899999999999999999999987 99999999999995 45679999999998775
Q ss_pred CC
Q 005731 667 GD 668 (680)
Q Consensus 667 ~~ 668 (680)
..
T Consensus 176 ~~ 177 (486)
T 3mwu_A 176 QN 177 (486)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=223.63 Aligned_cols=148 Identities=28% Similarity=0.423 Sum_probs=124.4
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------ 582 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 582 (680)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+++.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999985 56899999999653 2334567899999999999999999999997653
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 8899988743 45889999999999999999999988 999999999999999999999999999
Q ss_pred eecCC
Q 005731 663 RMFGG 667 (680)
Q Consensus 663 ~~~~~ 667 (680)
+....
T Consensus 176 ~~~~~ 180 (367)
T 1cm8_A 176 RQADS 180 (367)
T ss_dssp EECCS
T ss_pred ccccc
Confidence 98754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-23 Score=224.45 Aligned_cols=146 Identities=23% Similarity=0.322 Sum_probs=123.6
Q ss_pred CCccee-eeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHh-hcCCCceeeEEEEEEe----CCeEE
Q 005731 513 ENFSMQ-CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIA-ELQHRNLVRILGCCVE----QGEKI 585 (680)
Q Consensus 513 ~~f~~~-~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~----~~~~~ 585 (680)
++|.+. +.||+|+||.||++.. .+++.||||++... ..+.+|++++. ..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 567766 6899999999999985 46889999998642 45678888874 4589999999999875 55789
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC---CCCeEEeeeccc
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLA 662 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla 662 (680)
|||||+++|+|.+++... ....+++.++..|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999998542 2346899999999999999999999987 999999999999997 789999999999
Q ss_pred eecCC
Q 005731 663 RMFGG 667 (680)
Q Consensus 663 ~~~~~ 667 (680)
+....
T Consensus 212 ~~~~~ 216 (400)
T 1nxk_A 212 KETTS 216 (400)
T ss_dssp EECC-
T ss_pred cccCC
Confidence 97754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.3e-23 Score=217.32 Aligned_cols=150 Identities=31% Similarity=0.460 Sum_probs=131.8
Q ss_pred HHhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhh--cCCCceeeEEEEEEeCC----
Q 005731 509 AAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAE--LQHRNLVRILGCCVEQG---- 582 (680)
Q Consensus 509 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~---- 582 (680)
....++|++.+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34457899999999999999999986 5899999999642 34677889888887 79999999999998876
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEeCCCCCCcEEEcCCCCe
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH--------QYSRLRIIHRDLKASNVLLDKDMNP 654 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiHrDlkp~NILl~~~~~~ 654 (680)
..++||||+++|+|.+++.. ..+++.++..++.|++.||+||| +.+ |+||||||+|||++.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999843 35889999999999999999999 555 9999999999999999999
Q ss_pred EEeeeccceecCCCc
Q 005731 655 KISDFGLARMFGGDE 669 (680)
Q Consensus 655 kl~DFGla~~~~~~~ 669 (680)
||+|||+++.+....
T Consensus 187 kL~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 187 CIADLGLAVRHDSAT 201 (342)
T ss_dssp EECCCTTCEEEETTT
T ss_pred EEEECCCceeccccc
Confidence 999999998875543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=231.25 Aligned_cols=151 Identities=31% Similarity=0.485 Sum_probs=134.6
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357999999999999999999854 68999999986432 34567899999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE---cCCCCeEEeeecccee
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARM 664 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~ 664 (680)
|||+.+|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 105 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999988884 3456899999999999999999999987 9999999999999 5678999999999988
Q ss_pred cCCC
Q 005731 665 FGGD 668 (680)
Q Consensus 665 ~~~~ 668 (680)
+...
T Consensus 179 ~~~~ 182 (484)
T 3nyv_A 179 FEAS 182 (484)
T ss_dssp BCCC
T ss_pred cccc
Confidence 7544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4e-23 Score=217.28 Aligned_cols=150 Identities=26% Similarity=0.385 Sum_probs=127.2
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--------cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG 582 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 582 (680)
.++|++.+.||+|+||.||++.. .+++.||||.+.... ......+.+|++++.+++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 36799999999999999999985 458899999986431 12234588999999999999999999998665
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC---eEEeee
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN---PKISDF 659 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DF 659 (680)
..++||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp SEEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4899999999999998883 3456899999999999999999999987 999999999999987654 999999
Q ss_pred ccceecCCC
Q 005731 660 GLARMFGGD 668 (680)
Q Consensus 660 Gla~~~~~~ 668 (680)
|+++.+...
T Consensus 162 g~~~~~~~~ 170 (322)
T 2ycf_A 162 GHSKILGET 170 (322)
T ss_dssp TTCEECCCC
T ss_pred ccceecccc
Confidence 999987543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7.8e-23 Score=211.63 Aligned_cols=143 Identities=13% Similarity=0.087 Sum_probs=126.7
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ....++|.+|+.++.+++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999864 48999999997642 233578999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
||+++++|.+++.. . ....+..+++.||+.||+|||+++ |+||||||+|||++.++.+||+++|...
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence 99999999999832 2 355678899999999999999988 9999999999999999999999877543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.6e-23 Score=222.44 Aligned_cols=153 Identities=25% Similarity=0.378 Sum_probs=125.9
Q ss_pred HHhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------
Q 005731 509 AAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------ 581 (680)
Q Consensus 509 ~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 581 (680)
....++|++.+.||+|+||.||+|.. .+++.||||++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999985 5789999999865322 224799999999999999999998543
Q ss_pred --------------------------------CeEEEEEEccCCCChhhHhccc-ccCCCCCHHHHHHHHHHHHHHHHHH
Q 005731 582 --------------------------------GEKILILEYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYL 628 (680)
Q Consensus 582 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yL 628 (680)
...++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999998 5887776532 2345789999999999999999999
Q ss_pred HhCCCCceEeCCCCCCcEEEc-CCCCeEEeeeccceecCCCc
Q 005731 629 HQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 629 H~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~ 669 (680)
|+.+ |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 196 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence 9887 99999999999998 68899999999999875443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.2e-23 Score=211.93 Aligned_cols=151 Identities=30% Similarity=0.593 Sum_probs=128.9
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcc-------cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQ-------GLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 583 (680)
.++|++.+.||+|+||.||+|+. .+++.||||++...... ..+++.+|++++.+++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36899999999999999999985 56899999998653221 1267999999999999999999999986554
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC-----eEEee
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN-----PKISD 658 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~D 658 (680)
++||||+++++|.+++.+ ....+++..+..++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999888754 3346899999999999999999999864 34999999999999988776 99999
Q ss_pred eccceecCC
Q 005731 659 FGLARMFGG 667 (680)
Q Consensus 659 FGla~~~~~ 667 (680)
||+++....
T Consensus 173 fg~~~~~~~ 181 (287)
T 4f0f_A 173 FGLSQQSVH 181 (287)
T ss_dssp CTTCBCCSS
T ss_pred CCccccccc
Confidence 999986544
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-23 Score=238.36 Aligned_cols=151 Identities=19% Similarity=0.241 Sum_probs=115.7
Q ss_pred eeeccCCceeEEEEE-EcCCcEEEEEEccCCC----------cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEE
Q 005731 519 CKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQS----------GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~----------~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 586 (680)
...+.|++|.+..++ ..-|+.+|||.+.... ....++|.+|+++|+++ +|+||+++++++.+....||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 346677777777665 4568899999986431 23456799999999999 79999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||++|++|.+.|.+ ...++.. +|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+.
T Consensus 320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999943 3456554 48899999999999998 9999999999999999999999999999875
Q ss_pred CCccccCccccccC
Q 005731 667 GDELQGNTKRIVGT 680 (680)
Q Consensus 667 ~~~~~~~~~~~~Gt 680 (680)
.+... +...+||
T Consensus 391 ~~~~~--~~t~vGT 402 (569)
T 4azs_A 391 QDCSW--PTNLVQS 402 (569)
T ss_dssp ---CC--SHHHHHH
T ss_pred CCCcc--ccCceec
Confidence 54322 3334554
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=5.4e-23 Score=220.33 Aligned_cols=149 Identities=28% Similarity=0.419 Sum_probs=130.5
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-----CeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-----GEK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 584 (680)
.++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 36899999999999999999985 468899999997533 33457899999999999999999999998765 368
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||||++ ++|.+++. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 58988873 245899999999999999999999988 99999999999999999999999999998
Q ss_pred cCCC
Q 005731 665 FGGD 668 (680)
Q Consensus 665 ~~~~ 668 (680)
....
T Consensus 178 ~~~~ 181 (364)
T 3qyz_A 178 ADPD 181 (364)
T ss_dssp CCGG
T ss_pred cCCC
Confidence 7544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.4e-23 Score=220.18 Aligned_cols=150 Identities=19% Similarity=0.303 Sum_probs=123.5
Q ss_pred cCCcceeeeeccCCceeEEEEEEc----CCcEEEEEEccCCCcc-----------cHHHHHHHHHHHhhcCCCceeeEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQSGQ-----------GLKEFKNEMMLIAELQHRNLVRILG 576 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~~~~-----------~~~~f~~E~~~l~~l~H~niv~l~g 576 (680)
.++|++.+.||+|+||.||+|... .+..+|||++...... ..+.+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999864 5778999998754321 1234667888999999999999999
Q ss_pred EEEe----CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC
Q 005731 577 CCVE----QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (680)
Q Consensus 577 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 652 (680)
++.. ....++||||+ +++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 9999999843 237899999999999999999999987 99999999999999887
Q ss_pred --CeEEeeeccceecCCC
Q 005731 653 --NPKISDFGLARMFGGD 668 (680)
Q Consensus 653 --~~kl~DFGla~~~~~~ 668 (680)
.+||+|||+|+.+..+
T Consensus 189 ~~~~kL~Dfg~a~~~~~~ 206 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPN 206 (345)
T ss_dssp TTSEEECCCTTCEESSGG
T ss_pred CCcEEEEeCCCceecccc
Confidence 9999999999987543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.8e-23 Score=216.75 Aligned_cols=156 Identities=28% Similarity=0.393 Sum_probs=133.5
Q ss_pred HHhcCCccee-eeeccCCceeEEEEEEc-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCe
Q 005731 509 AAATENFSMQ-CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGE 583 (680)
Q Consensus 509 ~~~~~~f~~~-~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 583 (680)
....+.|.+. +.||+|+||.||++... +++.||||++... ......++.+|+.++.++ +||||+++++++.....
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 4445678777 89999999999999854 5899999998753 234467899999999999 56999999999999999
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC---CCCeEEeeec
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFG 660 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFG 660 (680)
.++||||+++|+|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 99999999999999887432 2356899999999999999999999987 999999999999987 7899999999
Q ss_pred cceecCCC
Q 005731 661 LARMFGGD 668 (680)
Q Consensus 661 la~~~~~~ 668 (680)
+++.+...
T Consensus 180 ~a~~~~~~ 187 (327)
T 3lm5_A 180 MSRKIGHA 187 (327)
T ss_dssp GCEEC---
T ss_pred cccccCCc
Confidence 99987543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=238.47 Aligned_cols=144 Identities=33% Similarity=0.517 Sum_probs=125.9
Q ss_pred eeeccCCceeEEEEEEc---CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRLF---NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
++||+|+||.||+|... .++.||||+++... ....++|.+|++++.+++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 48999999999999643 46789999997532 334678999999999999999999999986 4568999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
|+|.+++. ....+++..+..|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+..+.
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 99999983 3456899999999999999999999987 9999999999999999999999999999875543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=219.62 Aligned_cols=155 Identities=28% Similarity=0.389 Sum_probs=133.9
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEe--------
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVE-------- 580 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~-------- 580 (680)
...+|++.++||+|+||.||+++. .+++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 346899999999999999999985 468999999987655566778999999999996 9999999999953
Q ss_pred CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeec
Q 005731 581 QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (680)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 660 (680)
....++||||+. |+|.+++........+++.++..++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 235789999996 789888855444567999999999999999999999863 359999999999999999999999999
Q ss_pred cceecCC
Q 005731 661 LARMFGG 667 (680)
Q Consensus 661 la~~~~~ 667 (680)
+++.+..
T Consensus 184 ~~~~~~~ 190 (337)
T 3ll6_A 184 SATTISH 190 (337)
T ss_dssp TCBCCSS
T ss_pred cceeccc
Confidence 9987754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7.8e-23 Score=211.57 Aligned_cols=152 Identities=30% Similarity=0.435 Sum_probs=130.4
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE----QGEKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 585 (680)
+.|++.+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4588889999999999999985 45789999998643 33446779999999999999999999999876 34689
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc-CCCCeEEeeecccee
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARM 664 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~ 664 (680)
+||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ .+|+||||||+|||++ .++.+||+|||+++.
T Consensus 106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999843 356889999999999999999999864 3599999999999998 789999999999976
Q ss_pred cCCC
Q 005731 665 FGGD 668 (680)
Q Consensus 665 ~~~~ 668 (680)
....
T Consensus 182 ~~~~ 185 (290)
T 1t4h_A 182 KRAS 185 (290)
T ss_dssp CCTT
T ss_pred cccc
Confidence 5443
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=8.1e-23 Score=212.22 Aligned_cols=150 Identities=31% Similarity=0.508 Sum_probs=130.1
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 67999999999999999999864 68999999987532 2335778999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|++ ++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~-~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 155 (299)
T 2r3i_A 83 FLH-QDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155 (299)
T ss_dssp CCS-EEHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ccc-CCHHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence 997 6998887442 2345789999999999999999999987 99999999999999999999999999987753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.1e-23 Score=211.96 Aligned_cols=152 Identities=30% Similarity=0.472 Sum_probs=130.0
Q ss_pred hcCCcceeeeeccCCceeEEEEEEcC----CcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
..++|++.+.||+|+||.||+|.... +..||||.+... .....+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34689999999999999999998543 346999999764 33456789999999999999999999999764 5678
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+||||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999843 2345889999999999999999999987 999999999999999999999999999877
Q ss_pred CCC
Q 005731 666 GGD 668 (680)
Q Consensus 666 ~~~ 668 (680)
...
T Consensus 164 ~~~ 166 (281)
T 3cc6_A 164 EDE 166 (281)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6e-23 Score=209.65 Aligned_cols=151 Identities=26% Similarity=0.451 Sum_probs=132.1
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 588 (680)
++|++.+.||+|+||.||+|+. .++.||||++.... ....++|.+|+.++.+++||||+++++++... ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 5799999999999999999996 48899999997542 34456899999999999999999999999877 6789999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||+++|+|.+++... ....+++.++..++.||++||+|||+.+ .+|+||||||+|||++.++.+||.|||++....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999998542 2335899999999999999999999863 359999999999999999999999999876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-23 Score=213.74 Aligned_cols=153 Identities=28% Similarity=0.374 Sum_probs=121.3
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-ccc-HHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQG-LKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
.++|++.+.||+|+||.||+++. .+++.||||++.... ... .+.+..+...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46899999999999999999985 578999999997542 222 333445555688889999999999999999999999
Q ss_pred EccCCCChhhHhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 589 EYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||++ |+|.+++... .....+++..+..++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 5887776432 2345789999999999999999999997 7 9999999999999999999999999998775
Q ss_pred CC
Q 005731 667 GD 668 (680)
Q Consensus 667 ~~ 668 (680)
..
T Consensus 162 ~~ 163 (290)
T 3fme_A 162 DD 163 (290)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.9e-23 Score=222.51 Aligned_cols=150 Identities=26% Similarity=0.411 Sum_probs=124.9
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe------EEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE------KIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l 586 (680)
.+|++.+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 57999999999999999999987777799998864322 12369999999999999999999976543 789
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc-CCCCeEEeeeccceec
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMF 665 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~ 665 (680)
||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+|+.+
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999987655443322233457899999999999999999999987 99999999999999 7999999999999987
Q ss_pred CCCc
Q 005731 666 GGDE 669 (680)
Q Consensus 666 ~~~~ 669 (680)
....
T Consensus 193 ~~~~ 196 (394)
T 4e7w_A 193 IAGE 196 (394)
T ss_dssp CTTC
T ss_pred cCCC
Confidence 5443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-23 Score=211.97 Aligned_cols=157 Identities=29% Similarity=0.466 Sum_probs=131.6
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe--CCeEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE--QGEKIL 586 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 586 (680)
.++|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 368999999999999999999854 6899999999753 23345679999999999999999999998865 568899
Q ss_pred EEEccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 587 ILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYS--RLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999985432 2345899999999999999999999865 1349999999999999999999999999998
Q ss_pred ecCCC
Q 005731 664 MFGGD 668 (680)
Q Consensus 664 ~~~~~ 668 (680)
.+...
T Consensus 165 ~~~~~ 169 (279)
T 2w5a_A 165 ILNHD 169 (279)
T ss_dssp HC---
T ss_pred eeccc
Confidence 77543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-23 Score=221.95 Aligned_cols=148 Identities=32% Similarity=0.435 Sum_probs=115.8
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------C
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------G 582 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 582 (680)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999984 56899999999753 233466788999999999999999999998754 5
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
..++|+||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 788987773 246899999999999999999999987 999999999999999999999999999
Q ss_pred eecCC
Q 005731 663 RMFGG 667 (680)
Q Consensus 663 ~~~~~ 667 (680)
+....
T Consensus 180 ~~~~~ 184 (367)
T 2fst_X 180 RHTAD 184 (367)
T ss_dssp -----
T ss_pred ccccc
Confidence 87643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.9e-23 Score=217.24 Aligned_cols=148 Identities=27% Similarity=0.433 Sum_probs=130.0
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-----CeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-----GEK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 584 (680)
.++|++.+.||+|+||.||+|... +++.||||++... ......++.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999854 6899999999753 233456788999999999999999999998764 678
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||||+. ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 689888732 46899999999999999999999987 99999999999999999999999999998
Q ss_pred cCC
Q 005731 665 FGG 667 (680)
Q Consensus 665 ~~~ 667 (680)
+..
T Consensus 162 ~~~ 164 (353)
T 2b9h_A 162 IDE 164 (353)
T ss_dssp CC-
T ss_pred ccc
Confidence 754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.88 E-value=8.6e-23 Score=236.79 Aligned_cols=147 Identities=23% Similarity=0.356 Sum_probs=128.0
Q ss_pred CCcceeeeeccCCceeEEEEEEc--CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe-----E
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF--NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE-----K 584 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~--~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-----~ 584 (680)
++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|++++.+++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 68999999999999999999864 5899999998753 33445678999999999999999999999987665 7
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
+|||||+++++|.+++. ..+++.++..++.||++||+|||+.+ |+||||||+|||++.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 99999999999987662 26899999999999999999999988 9999999999999886 999999999998
Q ss_pred cCCC
Q 005731 665 FGGD 668 (680)
Q Consensus 665 ~~~~ 668 (680)
+...
T Consensus 231 ~~~~ 234 (681)
T 2pzi_A 231 INSF 234 (681)
T ss_dssp TTCC
T ss_pred cccC
Confidence 7543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.6e-23 Score=211.93 Aligned_cols=149 Identities=32% Similarity=0.553 Sum_probs=125.5
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-CeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-GEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey 590 (680)
.++|++.+.||+|+||.||+++. .++.||||.++.. ...+.+.+|++++.+++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46899999999999999999986 5889999999753 3567899999999999999999999997655 468999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999998432 2234788999999999999999999987 99999999999999999999999999987644
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-22 Score=209.78 Aligned_cols=147 Identities=24% Similarity=0.348 Sum_probs=127.3
Q ss_pred CCccee-eeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHH-hhcCCCceeeEEEEEEe----CCeEE
Q 005731 513 ENFSMQ-CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLI-AELQHRNLVRILGCCVE----QGEKI 585 (680)
Q Consensus 513 ~~f~~~-~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 585 (680)
++|.+. +.||+|+||.||++.. .+++.||||++.. ...+.+|++++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567776 7899999999999985 5689999999864 24567888887 55699999999999987 66789
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC---CCCeEEeeeccc
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLA 662 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla 662 (680)
+||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999998542 2346899999999999999999999987 999999999999998 788999999999
Q ss_pred eecCCC
Q 005731 663 RMFGGD 668 (680)
Q Consensus 663 ~~~~~~ 668 (680)
+.+.+.
T Consensus 168 ~~~~~~ 173 (299)
T 3m2w_A 168 KETTGE 173 (299)
T ss_dssp EECTTC
T ss_pred cccccc
Confidence 987543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.8e-23 Score=213.36 Aligned_cols=153 Identities=24% Similarity=0.364 Sum_probs=131.1
Q ss_pred HHhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcC--CCceeeEEEEEEeCCeE
Q 005731 509 AAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQ--HRNLVRILGCCVEQGEK 584 (680)
Q Consensus 509 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~ 584 (680)
....++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++ ||||+++++++......
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3445789999999999999999999888999999998643 3345678999999999997 59999999999999999
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||| +.+++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++ +.+||+|||+++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccc
Confidence 99999 568899999843 356889999999999999999999987 999999999999964 8999999999998
Q ss_pred cCCCc
Q 005731 665 FGGDE 669 (680)
Q Consensus 665 ~~~~~ 669 (680)
+....
T Consensus 176 ~~~~~ 180 (313)
T 3cek_A 176 MQPDT 180 (313)
T ss_dssp -----
T ss_pred ccCcc
Confidence 75443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=218.15 Aligned_cols=147 Identities=30% Similarity=0.418 Sum_probs=124.2
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------ 582 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 582 (680)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36899999999999999999984 46889999999753 2334567899999999999999999999997654
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999974 6777762 34788999999999999999999987 999999999999999999999999999
Q ss_pred eecCC
Q 005731 663 RMFGG 667 (680)
Q Consensus 663 ~~~~~ 667 (680)
+....
T Consensus 175 ~~~~~ 179 (371)
T 2xrw_A 175 RTAGT 179 (371)
T ss_dssp -----
T ss_pred ccccc
Confidence 87754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=8.7e-23 Score=211.02 Aligned_cols=151 Identities=32% Similarity=0.469 Sum_probs=124.0
Q ss_pred cCCcceeeeeccCCceeEEEEEEc--CCc--EEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF--NGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~--~~~--~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 584 (680)
.++|++.+.||+|+||.||+|+.. +++ .||||+++.. .....+++.+|++++.+++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 368999999999999999999853 233 6899998753 2345678999999999999999999999987654 8
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++||||+++++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999988542 345889999999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 005731 665 FGGD 668 (680)
Q Consensus 665 ~~~~ 668 (680)
+...
T Consensus 171 ~~~~ 174 (291)
T 1u46_A 171 LPQN 174 (291)
T ss_dssp CCC-
T ss_pred cccc
Confidence 7544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=9.5e-23 Score=222.76 Aligned_cols=148 Identities=28% Similarity=0.432 Sum_probs=121.9
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC----C--eEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ----G--EKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~----~--~~~ 585 (680)
.+|++.+.||+|+||.||+|+.. +++.||||++.... +.+.+|++++++++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46999999999999999999864 58999999986532 2234799999999999999999998652 1 367
Q ss_pred EEEEccCCCChhhHhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC-CCeEEeeeccce
Q 005731 586 LILEYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLAR 663 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~ 663 (680)
+||||+++ +|...+... .....+++..+..++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+|+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 555554321 23457899999999999999999999987 9999999999999965 678999999999
Q ss_pred ecCCC
Q 005731 664 MFGGD 668 (680)
Q Consensus 664 ~~~~~ 668 (680)
.+...
T Consensus 206 ~~~~~ 210 (420)
T 1j1b_A 206 QLVRG 210 (420)
T ss_dssp ECCTT
T ss_pred hcccC
Confidence 87543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=208.71 Aligned_cols=151 Identities=28% Similarity=0.494 Sum_probs=133.4
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
.++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 468999999999999999999864 6899999998643 2345678999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC---CCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD---MNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla~~~ 665 (680)
||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+||+++.+ +.+||+|||+++.+
T Consensus 101 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999888743 346899999999999999999999987 9999999999999764 46999999999877
Q ss_pred CCC
Q 005731 666 GGD 668 (680)
Q Consensus 666 ~~~ 668 (680)
...
T Consensus 175 ~~~ 177 (287)
T 2wei_A 175 QQN 177 (287)
T ss_dssp CCC
T ss_pred cCC
Confidence 543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.3e-23 Score=220.01 Aligned_cols=146 Identities=17% Similarity=0.272 Sum_probs=127.0
Q ss_pred CCcceeeeeccCCceeEEEEEEc---------CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceee----------
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF---------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVR---------- 573 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~---------~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~---------- 573 (680)
++|++.+.||+|+||.||+|+.. +++.||||.+... +.+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 68999999999999999999865 3789999998753 46789999999999999987
Q ss_pred -----EEEEEEe-CCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEE
Q 005731 574 -----ILGCCVE-QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647 (680)
Q Consensus 574 -----l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 647 (680)
+++++.. ....++||||+ +++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 6778876 67899999999 99999998542 2357899999999999999999999987 999999999999
Q ss_pred EcCCC--CeEEeeeccceecCCC
Q 005731 648 LDKDM--NPKISDFGLARMFGGD 668 (680)
Q Consensus 648 l~~~~--~~kl~DFGla~~~~~~ 668 (680)
++.++ .+||+|||+++.+...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~ 214 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPS 214 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGG
T ss_pred EcCCCCceEEEecCcceeeccCC
Confidence 99998 8999999999887543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=216.93 Aligned_cols=158 Identities=25% Similarity=0.341 Sum_probs=119.8
Q ss_pred HHHHhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe--
Q 005731 507 SVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE-- 583 (680)
Q Consensus 507 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-- 583 (680)
......++|++.+.||+|+||.||+|+. .+++.||||++... ......+.+|++.+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 4455678999999999999999999986 46899999998653 2334456788888999999999999999976443
Q ss_pred -----EEEEEEccCCCChhhHhcc-cccCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceEeCCCCCCcEEEcC-CCCe
Q 005731 584 -----KILILEYMPNKSLDVYLFD-PIKKRLLDWEARIRIIQGIAQGLLYLH--QYSRLRIIHRDLKASNVLLDK-DMNP 654 (680)
Q Consensus 584 -----~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~iiHrDlkp~NILl~~-~~~~ 654 (680)
.++||||++++ |...+.. ......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 78999999864 4443322 134456888999999999999999999 776 999999999999997 8999
Q ss_pred EEeeeccceecCCCc
Q 005731 655 KISDFGLARMFGGDE 669 (680)
Q Consensus 655 kl~DFGla~~~~~~~ 669 (680)
||+|||+|+.+....
T Consensus 172 kl~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE 186 (360)
T ss_dssp EECCCTTCBCCCTTS
T ss_pred EEeeCCCceecCCCC
Confidence 999999999875443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.2e-22 Score=218.22 Aligned_cols=150 Identities=23% Similarity=0.275 Sum_probs=129.7
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhc------CCCceeeEEEEEEeCCeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL------QHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l------~H~niv~l~g~~~~~~~~ 584 (680)
..+|++.+.||+|+||.||+|.. .+++.||||++... ....+++.+|++++..+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 46799999999999999999975 45899999999753 34456788888888877 577999999999999999
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC--eEEeeeccc
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN--PKISDFGLA 662 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DFGla 662 (680)
++||||+. ++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+|
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 6888887442 2345899999999999999999999987 999999999999999887 999999999
Q ss_pred eecCC
Q 005731 663 RMFGG 667 (680)
Q Consensus 663 ~~~~~ 667 (680)
+....
T Consensus 250 ~~~~~ 254 (429)
T 3kvw_A 250 CYEHQ 254 (429)
T ss_dssp EETTC
T ss_pred eecCC
Confidence 87643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=233.55 Aligned_cols=154 Identities=27% Similarity=0.427 Sum_probs=132.8
Q ss_pred HHhcCCcceeeeeccCCceeEEEEEEcC----CcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 005731 509 AAATENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (680)
Q Consensus 509 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 583 (680)
....++|++.+.||+|+||.||+|.... +..||||++... .....+.|.+|+.++++++||||+++++++. .+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3445789999999999999999998532 467999998754 3334578999999999999999999999984 467
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.++||||+++|+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 465 ~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 8999999999999999843 2345899999999999999999999987 9999999999999999999999999999
Q ss_pred ecCCC
Q 005731 664 MFGGD 668 (680)
Q Consensus 664 ~~~~~ 668 (680)
.+...
T Consensus 540 ~~~~~ 544 (656)
T 2j0j_A 540 YMEDS 544 (656)
T ss_dssp SCCC-
T ss_pred ecCCC
Confidence 87543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.6e-22 Score=206.77 Aligned_cols=151 Identities=24% Similarity=0.398 Sum_probs=125.3
Q ss_pred hcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEE-EeCCeEEEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC-VEQGEKILIL 588 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 588 (680)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|++++.+++|++++..+..+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 347899999999999999999985 678999999876432 224578899999999988877666655 5677889999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE---cCCCCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~ 665 (680)
||+ +++|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999998843 2346899999999999999999999988 9999999999999 78999999999999987
Q ss_pred CCCc
Q 005731 666 GGDE 669 (680)
Q Consensus 666 ~~~~ 669 (680)
....
T Consensus 159 ~~~~ 162 (296)
T 4hgt_A 159 RDAR 162 (296)
T ss_dssp BCTT
T ss_pred cCcc
Confidence 6543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=6.1e-22 Score=205.18 Aligned_cols=150 Identities=24% Similarity=0.400 Sum_probs=128.5
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEE-EeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC-VEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 589 (680)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+.++..++|++++..+..+ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999985 678999999986533 235688999999999988866665555 56778899999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE---cCCCCeEEeeeccceecC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFG 666 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 666 (680)
|+ +++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999842 2346899999999999999999999987 9999999999999 488999999999999876
Q ss_pred CCc
Q 005731 667 GDE 669 (680)
Q Consensus 667 ~~~ 669 (680)
...
T Consensus 160 ~~~ 162 (296)
T 3uzp_A 160 DAR 162 (296)
T ss_dssp CTT
T ss_pred ccc
Confidence 543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-22 Score=217.88 Aligned_cols=151 Identities=13% Similarity=0.126 Sum_probs=113.2
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc---ccHHHHHHHHHHHhhc--CCCceeeEE-------EEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAEL--QHRNLVRIL-------GCC 578 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~---~~~~~f~~E~~~l~~l--~H~niv~l~-------g~~ 578 (680)
..+|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+++|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 35699999999999999999985 4789999999986432 3355677885544444 699988755 455
Q ss_pred EeC-----------------CeEEEEEEccCCCChhhHhcccccCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCc
Q 005731 579 VEQ-----------------GEKILILEYMPNKSLDVYLFDPIKKRLLDWEAR------IRIIQGIAQGLLYLHQYSRLR 635 (680)
Q Consensus 579 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~ 635 (680)
... ...++||||++ |+|.+++.... ..+++..+ ..++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 23799999999 89999985432 23455555 678899999999999988
Q ss_pred eEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 636 iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|+||||||+||||+.++.+||+|||+|+..+..
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~ 247 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR 247 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC
Confidence 999999999999999999999999999987543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-22 Score=211.56 Aligned_cols=152 Identities=30% Similarity=0.499 Sum_probs=127.4
Q ss_pred hcCCcceeeeeccCCceeEEEEEE--cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhc---CCCceeeEEEEEE----
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL--FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAEL---QHRNLVRILGCCV---- 579 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~--~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~---- 579 (680)
..++|++.+.||+|+||.||+++. .+++.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 347899999999999999999986 468899999986422 22234566777777666 8999999999987
Q ss_pred -eCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEee
Q 005731 580 -EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISD 658 (680)
Q Consensus 580 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 658 (680)
.....++||||++ |+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 6999888542 2345889999999999999999999987 99999999999999999999999
Q ss_pred eccceecCC
Q 005731 659 FGLARMFGG 667 (680)
Q Consensus 659 FGla~~~~~ 667 (680)
||+++.+..
T Consensus 164 fg~~~~~~~ 172 (326)
T 1blx_A 164 FGLARIYSF 172 (326)
T ss_dssp CCSCCCCCG
T ss_pred CcccccccC
Confidence 999987653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-22 Score=213.07 Aligned_cols=154 Identities=25% Similarity=0.405 Sum_probs=124.7
Q ss_pred HHhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc------ccHHHHHHHHHHHhhc----CCCceeeEEEE
Q 005731 509 AAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG------QGLKEFKNEMMLIAEL----QHRNLVRILGC 577 (680)
Q Consensus 509 ~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~------~~~~~f~~E~~~l~~l----~H~niv~l~g~ 577 (680)
....++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 33457899999999999999999984 5688999999975422 1223466799999888 89999999999
Q ss_pred EEeCCeEEEEEEc-cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc-CCCCeE
Q 005731 578 CVEQGEKILILEY-MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPK 655 (680)
Q Consensus 578 ~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~k 655 (680)
+...+..++|||| +.+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 789999999843 346899999999999999999999987 99999999999999 889999
Q ss_pred EeeeccceecCCC
Q 005731 656 ISDFGLARMFGGD 668 (680)
Q Consensus 656 l~DFGla~~~~~~ 668 (680)
|+|||+++.+...
T Consensus 181 l~dfg~~~~~~~~ 193 (312)
T 2iwi_A 181 LIDFGSGALLHDE 193 (312)
T ss_dssp ECCCSSCEECCSS
T ss_pred EEEcchhhhcccC
Confidence 9999999987554
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=219.87 Aligned_cols=148 Identities=28% Similarity=0.453 Sum_probs=115.5
Q ss_pred Ccce-eeeeccCCceeEEEEEEc---CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe--CCeEEEE
Q 005731 514 NFSM-QCKLGEGGFGPVYKGRLF---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE--QGEKILI 587 (680)
Q Consensus 514 ~f~~-~~~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 587 (680)
.|++ .++||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 4554 458999999999999865 57899999997532 33578899999999999999999999965 5689999
Q ss_pred EEccCCCChhhHhcccc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE----cCCCCeEEe
Q 005731 588 LEYMPNKSLDVYLFDPI------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKIS 657 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~ 657 (680)
|||++ ++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99997 47777664221 1224899999999999999999999988 9999999999999 678899999
Q ss_pred eeccceecCC
Q 005731 658 DFGLARMFGG 667 (680)
Q Consensus 658 DFGla~~~~~ 667 (680)
|||+|+.+..
T Consensus 175 Dfg~a~~~~~ 184 (405)
T 3rgf_A 175 DMGFARLFNS 184 (405)
T ss_dssp CTTCCC----
T ss_pred ECCCceecCC
Confidence 9999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-22 Score=216.00 Aligned_cols=147 Identities=28% Similarity=0.457 Sum_probs=126.0
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE----
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK---- 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 584 (680)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .....+++.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 47899999999999999999985 46899999999753 233457889999999999999999999999876654
Q ss_pred --EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 585 --ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 585 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
++||||+. ++|.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 68877762 34899999999999999999999987 999999999999999999999999999
Q ss_pred eecCC
Q 005731 663 RMFGG 667 (680)
Q Consensus 663 ~~~~~ 667 (680)
+....
T Consensus 192 ~~~~~ 196 (371)
T 4exu_A 192 RHADA 196 (371)
T ss_dssp -----
T ss_pred ccccc
Confidence 87654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.8e-22 Score=208.13 Aligned_cols=150 Identities=22% Similarity=0.339 Sum_probs=130.4
Q ss_pred cCCcceeeeeccCCceeEEEEEE--cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCc------eeeEEEEEEeCCe
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL--FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN------LVRILGCCVEQGE 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~--~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 583 (680)
.++|++.+.||+|+||.||++.. .+++.||||+++.. ....+.+.+|++++..++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36899999999999999999985 36889999999753 345677899999999887654 9999999999999
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-------------
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK------------- 650 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~------------- 650 (680)
.++||||+ +++|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88999888442 2346889999999999999999999987 999999999999987
Q ss_pred ------CCCeEEeeeccceecCC
Q 005731 651 ------DMNPKISDFGLARMFGG 667 (680)
Q Consensus 651 ------~~~~kl~DFGla~~~~~ 667 (680)
++.+||+|||+++....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS
T ss_pred ccccccCCCceEeeCcccccCcc
Confidence 66899999999997644
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.8e-22 Score=215.57 Aligned_cols=135 Identities=25% Similarity=0.337 Sum_probs=113.8
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC--------CCceeeEEEEEE---
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ--------HRNLVRILGCCV--- 579 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~--------H~niv~l~g~~~--- 579 (680)
.++|++.++||+|+||.||+|+. .+++.||||++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36899999999999999999984 56889999999753 345677899999999985 788999999987
Q ss_pred -eCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeCCCCCCcEEEcCCC
Q 005731 580 -EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDM 652 (680)
Q Consensus 580 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~ 652 (680)
.....++||||+ +++|.+.+... ....+++..+..++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 455789999999 55665555332 234689999999999999999999997 6 99999999999999775
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.87 E-value=5.6e-22 Score=219.83 Aligned_cols=150 Identities=24% Similarity=0.383 Sum_probs=128.7
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCC-CceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH-RNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 589 (680)
.++|++.++||+|+||.||+|+. .+++.||||++.... ...++.+|++++..++| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36899999999999999999985 568999999876532 23457889999999977 556667777788889999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE---cCCCCeEEeeeccceecC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFG 666 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 666 (680)
|+ +++|.+++.. ....+++.+++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+|+.+.
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999843 2346899999999999999999999987 9999999999999 688999999999999886
Q ss_pred CCc
Q 005731 667 GDE 669 (680)
Q Consensus 667 ~~~ 669 (680)
...
T Consensus 158 ~~~ 160 (483)
T 3sv0_A 158 DTS 160 (483)
T ss_dssp CTT
T ss_pred CCc
Confidence 543
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=169.90 Aligned_cols=104 Identities=17% Similarity=0.407 Sum_probs=91.3
Q ss_pred ccccCCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEecCC
Q 005731 26 DTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTN 105 (680)
Q Consensus 26 ~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~~ 105 (680)
++|.+||.|.+|++|.| |.|.|.|+.+|+ |.++.. .++||+|||+.|.. ..+.|+|+.||+|||+|+++
T Consensus 2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~~---~~~vW~ant~~~~~-~~~~L~l~~dGnLvL~d~~~ 70 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYDH---STSTWASNTEIGGK-SGCSAVLQSDGNFVVYDSSG 70 (105)
T ss_dssp CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET---TEEEEECCCCCTTC-CSCEEEECTTSCEEEECTTC
T ss_pred CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEEC---CEEEEEecCCCCCC-ccEEEEEeCCccEEEECCCc
Confidence 68999999999999987 789999999987 556543 58999999999974 46899999999999999999
Q ss_pred CeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeee
Q 005731 106 GTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148 (680)
Q Consensus 106 ~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (680)
.+||+|++.+..+...|+|+|+|||||++. +||||
T Consensus 71 ~~vWss~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S 105 (105)
T 4h3o_A 71 RSLWASHSTRGSGNYILILQDDGNVIIYGS--------DIWST 105 (105)
T ss_dssp CEEEECCCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred EEEEEecCCCCCCCEEEEEeCCCeEEEECC--------cEecC
Confidence 999999987655667899999999999963 59998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.4e-22 Score=213.09 Aligned_cols=147 Identities=28% Similarity=0.455 Sum_probs=126.6
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe-----
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE----- 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----- 583 (680)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .....+++.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 36899999999999999999985 46899999999753 22345678999999999999999999999987653
Q ss_pred -EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 584 -KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 584 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
.++||||++ ++|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 68877662 24889999999999999999999987 999999999999999999999999999
Q ss_pred eecCC
Q 005731 663 RMFGG 667 (680)
Q Consensus 663 ~~~~~ 667 (680)
+....
T Consensus 174 ~~~~~ 178 (353)
T 3coi_A 174 RHADA 178 (353)
T ss_dssp TC---
T ss_pred cCCCC
Confidence 87643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-22 Score=209.93 Aligned_cols=153 Identities=23% Similarity=0.374 Sum_probs=132.3
Q ss_pred HhcCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc------ccHHHHHHHHHHHhhcC--CCceeeEEEEEEe
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG------QGLKEFKNEMMLIAELQ--HRNLVRILGCCVE 580 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~------~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~ 580 (680)
...++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.++.+++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999984 5689999999865321 12345778999999996 5999999999999
Q ss_pred CCeEEEEEEccCC-CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc-CCCCeEEee
Q 005731 581 QGEKILILEYMPN-KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKISD 658 (680)
Q Consensus 581 ~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~D 658 (680)
.+..++|||++.+ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 899998843 356889999999999999999999987 99999999999999 788999999
Q ss_pred eccceecCCC
Q 005731 659 FGLARMFGGD 668 (680)
Q Consensus 659 FGla~~~~~~ 668 (680)
||+++.+...
T Consensus 194 fg~~~~~~~~ 203 (320)
T 3a99_A 194 FGSGALLKDT 203 (320)
T ss_dssp CTTCEECCSS
T ss_pred Cccccccccc
Confidence 9999987543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.6e-22 Score=208.94 Aligned_cols=152 Identities=27% Similarity=0.393 Sum_probs=126.6
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHH-HHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMM-LIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
.++|++.+.||+|+||.||++.. .+++.||||++.... .....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 36899999999999999999986 468999999997542 233456666666 777789999999999999999999999
Q ss_pred EccCCCChhhHhccc--ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 589 EYMPNKSLDVYLFDP--IKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
||+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 777776421 1245688999999999999999999997 7 999999999999999999999999999877
Q ss_pred CC
Q 005731 666 GG 667 (680)
Q Consensus 666 ~~ 667 (680)
..
T Consensus 177 ~~ 178 (327)
T 3aln_A 177 VD 178 (327)
T ss_dssp --
T ss_pred cc
Confidence 54
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-22 Score=213.38 Aligned_cols=150 Identities=33% Similarity=0.553 Sum_probs=127.6
Q ss_pred HHhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 509 AAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 509 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
....++|++.+.||+|+||.||+|.... .+|||.++.. .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3445789999999999999999998643 5999998753 23345668899999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++...
T Consensus 107 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp ECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999999843 2346888999999999999999999987 99999999999998 6799999999988664
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.2e-22 Score=217.24 Aligned_cols=150 Identities=29% Similarity=0.333 Sum_probs=120.9
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
+.|...+.||+|+||+||.+...+++.||||++... ..+.+.+|++++.++ +||||+++++++.+....++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345667889999999998777778999999998642 346678999999886 8999999999999999999999999
Q ss_pred CCCChhhHhcccccCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC-------------CCe
Q 005731 592 PNKSLDVYLFDPIKKR----LLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-------------MNP 654 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-------------~~~ 654 (680)
. |+|.+++....... ...+..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999985432111 1123345789999999999999987 9999999999999754 489
Q ss_pred EEeeeccceecCCCc
Q 005731 655 KISDFGLARMFGGDE 669 (680)
Q Consensus 655 kl~DFGla~~~~~~~ 669 (680)
||+|||+|+.+....
T Consensus 168 kL~DFG~a~~~~~~~ 182 (434)
T 2rio_A 168 LISDFGLCKKLDSGQ 182 (434)
T ss_dssp EECCCTTCEECCC--
T ss_pred EEcccccceecCCCC
Confidence 999999999886543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=8.5e-22 Score=215.82 Aligned_cols=148 Identities=27% Similarity=0.387 Sum_probs=120.9
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
..+|++.+.||+|+||.|+.....+++.||||++..... ..+.+|++++..+ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 356999999999999997665567899999999975332 2356799999999 799999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-----CCCeEEeeeccceec
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-----DMNPKISDFGLARMF 665 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DFGla~~~ 665 (680)
+. |+|.+++.... ......++..++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+|+.+
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 69998885432 22344456789999999999999987 999999999999953 336889999999987
Q ss_pred CCC
Q 005731 666 GGD 668 (680)
Q Consensus 666 ~~~ 668 (680)
...
T Consensus 174 ~~~ 176 (432)
T 3p23_A 174 AVG 176 (432)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.1e-21 Score=203.38 Aligned_cols=148 Identities=24% Similarity=0.302 Sum_probs=120.0
Q ss_pred cCCcceee-eeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeEE
Q 005731 512 TENFSMQC-KLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE----QGEKI 585 (680)
Q Consensus 512 ~~~f~~~~-~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 585 (680)
.++|.+.+ .||+|+||.||++... +++.||||++... ....+ .....+..+.||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46898855 6999999999999865 6899999998652 21222 22234566799999999999876 44589
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC---CCCeEEeeeccc
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLA 662 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla 662 (680)
+||||+++|+|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999998543 2346899999999999999999999987 999999999999976 455999999999
Q ss_pred eecCC
Q 005731 663 RMFGG 667 (680)
Q Consensus 663 ~~~~~ 667 (680)
+....
T Consensus 179 ~~~~~ 183 (336)
T 3fhr_A 179 KETTQ 183 (336)
T ss_dssp EEC--
T ss_pred eeccc
Confidence 87754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.9e-21 Score=204.26 Aligned_cols=150 Identities=22% Similarity=0.343 Sum_probs=127.7
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CC-cEEEEEEccCCCcccHHHHHHHHHHHhhcCCCc------eeeEEEEEEeCCe
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NG-QEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN------LVRILGCCVEQGE 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~-~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 583 (680)
.++|++.+.||+|+||.||++... ++ +.||||+++.. ....+.+.+|+.++.+++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 368999999999999999999853 34 78999999753 345677889999999997766 9999999999999
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE---------------
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL--------------- 648 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl--------------- 648 (680)
.++||||+ +++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 56666666432 2346899999999999999999999987 9999999999999
Q ss_pred ----cCCCCeEEeeeccceecCC
Q 005731 649 ----DKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 649 ----~~~~~~kl~DFGla~~~~~ 667 (680)
+.++.+||+|||+++....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~ 194 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE 194 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS
T ss_pred cccccCCCcEEEeecCccccccc
Confidence 6788999999999987644
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.4e-21 Score=206.85 Aligned_cols=153 Identities=26% Similarity=0.348 Sum_probs=128.4
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CC-----ceeeEEEEEEeCCe
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HR-----NLVRILGCCVEQGE 583 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~-----niv~l~g~~~~~~~ 583 (680)
..++|++.+.||+|+||.||+|... +++.||||+++.. ....+++.+|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999854 6889999999753 344677888999888884 55 49999999999999
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc--CCCCeEEeeecc
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD--KDMNPKISDFGL 661 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGl 661 (680)
.++||||++ ++|.+++... ....+++..+..++.||+.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 5998888543 224589999999999999999999953 13499999999999995 478899999999
Q ss_pred ceecCC
Q 005731 662 ARMFGG 667 (680)
Q Consensus 662 a~~~~~ 667 (680)
|+.+..
T Consensus 208 a~~~~~ 213 (382)
T 2vx3_A 208 SCQLGQ 213 (382)
T ss_dssp CEETTC
T ss_pred ceeccc
Confidence 998754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.2e-21 Score=203.08 Aligned_cols=151 Identities=22% Similarity=0.371 Sum_probs=115.4
Q ss_pred cCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc-cc-HHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-QG-LKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
.++|++.+.||+|+||.||++... +++.||||++..... .. .+.+..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 367999999999999999999864 689999999975422 22 233445556788889999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+ ++.+..+. . .....+++..+..++.||++||+|||+. + |+||||||+|||++.++.+||+|||+++.+..
T Consensus 104 e~~-~~~~~~l~-~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLK-K-RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHH-H-HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHH-H-HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 44554443 2 1235689999999999999999999985 7 99999999999999999999999999987644
Q ss_pred C
Q 005731 668 D 668 (680)
Q Consensus 668 ~ 668 (680)
.
T Consensus 178 ~ 178 (318)
T 2dyl_A 178 D 178 (318)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.7e-22 Score=226.75 Aligned_cols=153 Identities=29% Similarity=0.396 Sum_probs=131.4
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe------CCeE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE------QGEK 584 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 584 (680)
++|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|++++.+++||||+++++++.. ....
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6899999999999999999985 56889999998754 33446779999999999999999999998755 5678
Q ss_pred EEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCC---eEEeeecc
Q 005731 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN---PKISDFGL 661 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGl 661 (680)
++||||+++|+|.+++........+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999866444456888999999999999999999987 999999999999997665 99999999
Q ss_pred ceecCCC
Q 005731 662 ARMFGGD 668 (680)
Q Consensus 662 a~~~~~~ 668 (680)
++.+...
T Consensus 171 a~~~~~~ 177 (676)
T 3qa8_A 171 AKELDQG 177 (676)
T ss_dssp CCBTTSC
T ss_pred ccccccc
Confidence 9987543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.9e-21 Score=208.49 Aligned_cols=150 Identities=23% Similarity=0.380 Sum_probs=128.4
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-----------CCceeeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-----------HRNLVRILGCCV 579 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~ 579 (680)
.++|++.+.||+|+||.||+|+. .+++.||||++.. .....+.+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36899999999999999999985 5689999999975 3344567889999999886 899999999988
Q ss_pred eCC----eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeCCCCCCcEEEc-----
Q 005731 580 EQG----EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLD----- 649 (680)
Q Consensus 580 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~----- 649 (680)
... ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 89999988542 234588999999999999999999997 7 99999999999995
Q ss_pred -CCCCeEEeeeccceecCC
Q 005731 650 -KDMNPKISDFGLARMFGG 667 (680)
Q Consensus 650 -~~~~~kl~DFGla~~~~~ 667 (680)
..+.+||+|||+|+.+..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE 190 (373)
T ss_dssp TTEEEEEECCCTTCEETTB
T ss_pred cCcceEEEcccccccccCC
Confidence 344799999999998754
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.7e-21 Score=197.66 Aligned_cols=145 Identities=19% Similarity=0.180 Sum_probs=116.3
Q ss_pred HHHHHhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCc------------------ccHHHHHHHHHHHhhcC
Q 005731 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG------------------QGLKEFKNEMMLIAELQ 567 (680)
Q Consensus 506 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~------------------~~~~~f~~E~~~l~~l~ 567 (680)
..+......|++.+.||+|+||.||+|...+++.||||.++.... .....+.+|++++.+++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344455667888899999999999999987799999999964221 13456899999999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEE
Q 005731 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647 (680)
Q Consensus 568 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 647 (680)
| +++.+++.. +..++||||+++++|.+ +.. .....++.||++||.|||+.+ |+||||||+|||
T Consensus 163 ~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 G---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp T---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred C---CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 4 555554433 45699999999999977 411 223469999999999999987 999999999999
Q ss_pred EcCCCCeEEeeeccceecCCC
Q 005731 648 LDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~ 668 (680)
++ ++.+||+|||+|+.....
T Consensus 226 l~-~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp EE-TTEEEECCCTTCEETTST
T ss_pred EE-CCcEEEEECCCCeECCCC
Confidence 99 999999999999977543
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-20 Score=165.34 Aligned_cols=110 Identities=25% Similarity=0.445 Sum_probs=95.4
Q ss_pred cccccCCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEecC
Q 005731 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQT 104 (680)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~ 104 (680)
+|+|.+||.|.+|++|+ ++|.|.|+|+.+|+ | ++|+ ..++||.+|++.|. .++.|+|+.||||||+|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECCC
Confidence 47899999999999999 99999999999886 2 6676 37999999998763 4689999999999999999
Q ss_pred CCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCc
Q 005731 105 NGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPS 153 (680)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~Pt 153 (680)
|.++|+|.+....+...++|+|+|||||++. ++||||+||.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~ 110 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP--------VVWATGSGPA 110 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEECSCCC-
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEECC--------CEecCCCcCC
Confidence 9999999987555567899999999999962 5999999984
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.7e-21 Score=219.05 Aligned_cols=136 Identities=22% Similarity=0.278 Sum_probs=109.3
Q ss_pred eeeeeccCCceeEEEEEEcCCcEEEEEEccCCCc--------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
..+.||+|+||.||++. ..++.+++|+...... ...++|.+|++++++++||||+++..++...++.+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 35789999999999995 4578899998643211 12345899999999999999997777777888889999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||++. .+||+|||+|+.+...
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999833 4689999999999999988 999999999999998 9999999999998654
Q ss_pred c
Q 005731 669 E 669 (680)
Q Consensus 669 ~ 669 (680)
+
T Consensus 483 ~ 483 (540)
T 3en9_A 483 E 483 (540)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=167.38 Aligned_cols=108 Identities=19% Similarity=0.392 Sum_probs=94.7
Q ss_pred cccccccCCccccCCCEEE--ecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEE
Q 005731 23 LAADTMTTASFIRDGEKLT--SSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVL 100 (680)
Q Consensus 23 ~~~~~l~~~~~l~~~~~l~--s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l 100 (680)
++.++|.+|++|.+|++|+ |++|.|+|+|+.+|+ | +||+. .++||+||++.| +.++.|+|+.||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 4578999999999999999 999999999999886 2 57875 799999999876 3468999999999999
Q ss_pred EecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeee
Q 005731 101 LSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148 (680)
Q Consensus 101 ~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (680)
+|.++.++|+|++....+...++|+|+|||||++. ++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~~--------~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEECc--------cEeCC
Confidence 99999999999876545567899999999999962 59998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=7e-20 Score=161.84 Aligned_cols=110 Identities=21% Similarity=0.399 Sum_probs=93.8
Q ss_pred cccccCCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEecC
Q 005731 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQT 104 (680)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~ 104 (680)
.|+|.+||+|.+|++|+ +|.|+|+|+.+|+ | ++|. ..++||.+|++.|. .++.|.|+.||+|||+|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----l-vly~--~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----L-VKYQ--NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----E-EEEE--TTEEEEECSCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----E-EEEe--CCEEEEeCCCCCCC--CceEEEECCCCcEEEECCC
Confidence 47899999999999998 8999999998885 2 2354 37899999999884 4689999999999999998
Q ss_pred CCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCcc
Q 005731 105 NGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSD 154 (680)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtD 154 (680)
+.++|+|++....+...++|+|+|||||++. ++||||.++..
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYGP--------VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEECC--------CEEECCCCCCc
Confidence 9999999886444567899999999999952 59999998765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-19 Score=159.10 Aligned_cols=110 Identities=25% Similarity=0.477 Sum_probs=93.4
Q ss_pred cccccCCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEecC
Q 005731 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQT 104 (680)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~ 104 (680)
+|+|.+||+|.+|++| ++|.|+|+|+.+|+ | ++|.. .++||++|+..+ +.++.|.|+.||||||+| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 4789999999999999 68999999999986 2 45655 689999999754 346899999999999999 8
Q ss_pred CCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCC
Q 005731 105 NGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHP 152 (680)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~P 152 (680)
+.++|+|.+....+...++|+++|||||++.. +.++||||++.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~-----~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEECCC-----CceEEECCCcc
Confidence 88999998765455678999999999999743 45899999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.80 E-value=6.5e-20 Score=199.82 Aligned_cols=153 Identities=16% Similarity=0.224 Sum_probs=115.3
Q ss_pred hcCCcceeeeeccCCceeEEEEE-EcCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCC-Cce---------e----
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQH-RNL---------V---- 572 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H-~ni---------v---- 572 (680)
..++|...+.||+|+||.||+|+ ..+++.||||++.... ....+.|++|+.++..++| +|. +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34568888999999999999998 4568999999987432 2336789999999999987 221 1
Q ss_pred --eE------EEEEEe-----CCeEEEEEEccCCCChhhHhcc----cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 005731 573 --RI------LGCCVE-----QGEKILILEYMPNKSLDVYLFD----PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635 (680)
Q Consensus 573 --~l------~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 635 (680)
.+ ..+... ....+++|+++ +++|.+++.. ......+++..++.++.||++||+|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 11 111111 12356677754 6899888731 112345778889999999999999999987
Q ss_pred eEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 636 iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+||||||+||||+.++.+||+|||+|+..+.
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~ 263 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCC
Confidence 99999999999999999999999999987643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.5e-19 Score=179.79 Aligned_cols=140 Identities=16% Similarity=0.181 Sum_probs=107.8
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcE--EEEEEccCCCcc------------------------cHHHHHHHHHHHhhc
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQE--VAVKRLSSQSGQ------------------------GLKEFKNEMMLIAEL 566 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~--VAVK~l~~~~~~------------------------~~~~f~~E~~~l~~l 566 (680)
-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999986 68888 999987542111 113688999999999
Q ss_pred CCCce--eeEEEEEEeCCeEEEEEEccCC-C----ChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEe
Q 005731 567 QHRNL--VRILGCCVEQGEKILILEYMPN-K----SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH-QYSRLRIIH 638 (680)
Q Consensus 567 ~H~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiH 638 (680)
+|+++ ...+.. ...+|||||+.+ | +|.+.... .++.+...++.|++.+|.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88764 334432 356899999942 4 56555421 123456789999999999999 877 999
Q ss_pred CCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 639 RDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 639 rDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|||||+|||++. .+||+|||+|......
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 999999999988 9999999999987543
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-18 Score=151.87 Aligned_cols=104 Identities=26% Similarity=0.456 Sum_probs=88.0
Q ss_pred ccccCCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEecCC
Q 005731 26 DTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTN 105 (680)
Q Consensus 26 ~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~~ 105 (680)
++|.+||.|.+|++|+ +|.|.|.|+.+|+ |.+ |.. .++||.+|+..+ +.++.|.|+.||+|||+|.++
T Consensus 2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~~ 69 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPRN 69 (109)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTTS
T ss_pred CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCCC
Confidence 6899999999999996 7999999999986 222 543 689999999876 346899999999999999999
Q ss_pred CeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeec
Q 005731 106 GTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSF 149 (680)
Q Consensus 106 ~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSF 149 (680)
.++|+|++.+......|+|+|+|||||++. ++|||=
T Consensus 70 ~~~W~S~t~~~~~~~~~~L~ddGNlvly~~--------~~W~s~ 105 (109)
T 3dzw_A 70 NPIWASNTGGENGNYVCVLQKDRNVVIYGT--------ARWATG 105 (109)
T ss_dssp CEEEECCCCCSSSCEEEEECTTSCEEEEES--------CCCCCC
T ss_pred CEEEECCCCCCCCCEEEEEeCCCEEEEECC--------CEEeCC
Confidence 999999987544456899999999999973 599983
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.1e-17 Score=146.26 Aligned_cols=105 Identities=22% Similarity=0.371 Sum_probs=87.1
Q ss_pred cccccccCCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEe
Q 005731 23 LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLS 102 (680)
Q Consensus 23 ~~~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~ 102 (680)
++.|+|.+||.|.+|+.|+|. .|.|.|+.+|+ |.+ |.. .+||.+|+... +.++.|.|+.||+|||+|
T Consensus 4 ~~~dtL~~gq~L~~g~~L~sg--~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp CBTTEEETTCEEETTEEEECS--SCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred cccCEECCCCEecCCCEEEeC--CEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEEe
Confidence 578999999999999999985 58888877775 444 544 58999999763 345799999999999999
Q ss_pred cCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeee
Q 005731 103 QTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148 (680)
Q Consensus 103 ~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (680)
.++.++|+|++.+..+...|+|+|+|||||++. ++|+|
T Consensus 71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~~--------~~W~t 108 (110)
T 3r0e_B 71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGP--------AIFET 108 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred CCCCEEEEcCCcCCCCCEEEEEcCCccEEEecC--------CEecC
Confidence 999999999986544557899999999999962 59997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.73 E-value=2.8e-17 Score=144.35 Aligned_cols=108 Identities=15% Similarity=0.314 Sum_probs=90.0
Q ss_pred cccccccCCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEe
Q 005731 23 LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLS 102 (680)
Q Consensus 23 ~~~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~ 102 (680)
.+.++|.+||.|.+|+.|. +|.|.|.|+.+|+ |.++.. -..++||.+|+..+ +.++.|.|+.||+|||+|
T Consensus 4 ~~~~tL~~gq~L~~g~~L~--~g~~~L~~q~dGN-----LvL~~~-~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLA--TRDYSLVMRDDCN-----LVLTKG-SKTNIVWESGTSGR--GQHCFMRLGHSGELDITD 73 (113)
T ss_dssp CCSSEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEET-TTTEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCEeCCCCEECCCCEeE--cCCEEEEEcCCCE-----EEEEEC-CCCEEEEECCcccC--CcCEEEEEeCCCcEEEEC
Confidence 3578999999999999996 4889999988886 555432 13689999999866 346899999999999999
Q ss_pred cCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeee
Q 005731 103 QTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148 (680)
Q Consensus 103 ~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (680)
.++.++|+|++.+..+...|+|+|+|||||++ .++|+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~--------~~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYG--------PAVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEec--------CCEecC
Confidence 99999999998654455789999999999996 259997
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.69 E-value=1e-16 Score=139.79 Aligned_cols=109 Identities=22% Similarity=0.422 Sum_probs=90.2
Q ss_pred cccccccCCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEe
Q 005731 23 LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLS 102 (680)
Q Consensus 23 ~~~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~ 102 (680)
+|.|+|.+||.|.+|+.| .+|.|.|.|+.+|+ | +.|.. +|.+|+..+ +.++.|+|+.||+|||+|
T Consensus 1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----L-vl~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----L-VLYNG-----NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCCSEEETTCEECTTCEE--EETTEEEEECTTSC-----E-EEETT-----TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----E-EEEeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 367999999999999999 67999999998886 2 33443 799998765 346899999999999999
Q ss_pred cCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCccccccc
Q 005731 103 QTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQD 159 (680)
Q Consensus 103 ~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg 159 (680)
.++.++|++++.+......|+|+|+|||||++ .++|+| .|.+||
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~--------~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG--------PSVFKI-----DPWVRG 109 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC--------SEEEEE-----CTTSCC
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe--------cCEECC-----CCccCC
Confidence 99999999998654456789999999999996 259996 666654
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.3e-16 Score=138.49 Aligned_cols=96 Identities=22% Similarity=0.394 Sum_probs=78.1
Q ss_pred CCCCCCceEEEeeCCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCccccccccc
Q 005731 82 PISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMK 161 (680)
Q Consensus 82 pv~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~ 161 (680)
|+.+...+|.|+.||+|||++. +.+||++++.+......|+|+++|||||++ + +.++||||+
T Consensus 15 ~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~-----~~~~W~S~~----------- 76 (112)
T 1xd5_A 15 SLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-G-----SRAIWASNT----------- 76 (112)
T ss_dssp EEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-T-----TEEEEECCC-----------
T ss_pred EEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-C-----CEEEEECCc-----------
Confidence 3334567899999999999987 789999998654445789999999999998 4 468999994
Q ss_pred ccceeecCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEc-CCeEEEeeCCCCC
Q 005731 162 LGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFN-GSVKFTCSGQWDG 217 (680)
Q Consensus 162 l~~~~~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~-~~~~~~~~g~w~~ 217 (680)
++++|.|++.|+++|+ ++++. +..+||++++|+|
T Consensus 77 --------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 --------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp --------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred --------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 3457889999999998 44454 5679999999986
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-16 Score=169.83 Aligned_cols=141 Identities=12% Similarity=0.135 Sum_probs=100.0
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCc--------------ccHHH--------HHHHHHHHhhcCCCc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG--------------QGLKE--------FKNEMMLIAELQHRN 570 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~--------------~~~~~--------f~~E~~~l~~l~H~n 570 (680)
.-|++.+.||+|+||.||+|...+|+.||||+++.... ..... ..+|...|.++++..
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34899999999999999999988899999998753100 01111 234555555554443
Q ss_pred eeeEEEEEEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC
Q 005731 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK 650 (680)
Q Consensus 571 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~ 650 (680)
+....-+... ..+|||||+++++|..... .+....++.||+.+|.|||..+ ||||||||.|||+++
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 3211111112 2379999999988854431 1223567899999999999987 999999999999988
Q ss_pred CCC----------eEEeeeccceecCC
Q 005731 651 DMN----------PKISDFGLARMFGG 667 (680)
Q Consensus 651 ~~~----------~kl~DFGla~~~~~ 667 (680)
++. +.|+||+-+.....
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred CCCcccccccccceEEEEeCCcccCCC
Confidence 763 89999998876543
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.3e-15 Score=133.18 Aligned_cols=89 Identities=21% Similarity=0.342 Sum_probs=73.8
Q ss_pred CCceEEEeeCCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCcccccccccccce
Q 005731 86 RNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWD 165 (680)
Q Consensus 86 ~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~l~~~ 165 (680)
...+|.|+.||+|||++ .+.+||++++.+......++|+++|||||++.+ +.++||||
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~-----~~~~W~S~---------------- 77 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS-----NRVIWQTK---------------- 77 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECC----------------
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC-----CcEEEecC----------------
Confidence 45789999999999998 588999999875444678999999999999865 46899999
Q ss_pred eecCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeCCC
Q 005731 166 FKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQW 215 (680)
Q Consensus 166 ~~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~w 215 (680)
+++++|.|++.|+++|+ ++++++ .||+++++
T Consensus 78 ---------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ---------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ---------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ---------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 24467899999999998 444555 89999875
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.59 E-value=7e-15 Score=130.14 Aligned_cols=87 Identities=25% Similarity=0.314 Sum_probs=72.0
Q ss_pred CceEEEeeCCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCccccccccccccee
Q 005731 87 NAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (680)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~l~~~~ 166 (680)
..+|.|+.||+|||++. +.+||++++.+......++|+|+|||||++.+ +.++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~-----~~~lW~S~----------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSP----------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECS-----------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCC-----CcEEEcCC-----------------
Confidence 36799999999999987 88999999865444578999999999999865 46899999
Q ss_pred ecCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeCC
Q 005731 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQ 214 (680)
Q Consensus 167 ~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 214 (680)
++|++|.|++.++++|+. ++++ ..||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gnl--vl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRNV--VIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSCE--EEEE--SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCcE--EEEC--ccEeCCCC
Confidence 345678999999999984 4444 38999886
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.58 E-value=9.5e-15 Score=127.68 Aligned_cols=103 Identities=19% Similarity=0.317 Sum_probs=83.6
Q ss_pred cccccCCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEecC
Q 005731 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQT 104 (680)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~ 104 (680)
.++|.+||.|.+|+.| .+|.|.|.|+.+|+ |.+ |.. .. ||.+|+..+ +.++.|.|+.||||||+|.+
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~--~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----LVL-YNE--AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ECS--SC-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----EEE-ECC--CC-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence 4789999999999999 57899999998886 333 432 34 999999876 34689999999999999988
Q ss_pred CC-eeEeeccc--CCCCCceEEEccCCCEEEEeCCCCCccccceeee
Q 005731 105 NG-TIWSTNVS--SDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148 (680)
Q Consensus 105 ~~-~~w~~~~~--~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (680)
+. ++|+|++. ...+...++|+++|||||++ .++|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG--------PAIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC--------SEEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEec--------cCEEcc
Confidence 76 59999963 22345789999999999996 259997
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=9.1e-15 Score=128.90 Aligned_cols=91 Identities=26% Similarity=0.330 Sum_probs=74.8
Q ss_pred CceEEEeeCCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCccccccccccccee
Q 005731 87 NAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (680)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~l~~~~ 166 (680)
..+|.|+.||+|||++ .+.+||++++.+......++|+++|||||++.+ +.++||||++|
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~-----~~~vW~S~~~~-------------- 80 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN-----NNDVWGSACWG-------------- 80 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC-----ceEEEEcCCCC--------------
Confidence 4679999999999998 578999999865444578999999999999864 46899999982
Q ss_pred ecCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeCCCCCc
Q 005731 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQWDGT 218 (680)
Q Consensus 167 ~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~w~~~ 218 (680)
++|.|++.++++|+ ++++++ .||++++|...
T Consensus 81 -----------------~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 81 -----------------DNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp -----------------SSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred -----------------CCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 46788999999998 444554 89999999654
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.36 E-value=2.3e-12 Score=112.89 Aligned_cols=95 Identities=19% Similarity=0.277 Sum_probs=72.4
Q ss_pred CCCCCCCCceEEEeeCCeEEEEec-CCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCcccccc
Q 005731 80 DRPISGRNAVLTISNNGNLVLLSQ-TNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQ 158 (680)
Q Consensus 80 ~~pv~~~~~~l~~~~~g~l~l~~~-~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLp 158 (680)
+.|+.....+|.|+.||+|||++. .+.++|++++.+...+..++|+++|||||++.+ +.++|||-.+
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~-----~~~iW~S~t~------- 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR-----LNTVFVSNTV------- 85 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEECSCC-------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC-----CCEEEECCCc-------
Confidence 344444567899999999999998 588999999875444678999999999999865 4579997211
Q ss_pred cccccceeecCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeCC
Q 005731 159 DMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQ 214 (680)
Q Consensus 159 gq~l~~~~~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 214 (680)
...|.|.+.++.+|+..++ + .+.|.+|+
T Consensus 86 ------------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 86 ------------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp ------------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred ------------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 0134588999999997766 3 57888764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=1e-11 Score=125.91 Aligned_cols=146 Identities=16% Similarity=0.116 Sum_probs=114.4
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEE
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 588 (680)
.....|++...++.|+.+.||+... .++.+++|............+.+|+++++.+. |..+.++++++...+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3446788888899899999999974 36889999987532223346888999999884 677889999999888999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS------------------------------------ 632 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------ 632 (680)
||++|.+|...+. +......++.+++++|..||...
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999976531 11223467889999999999811
Q ss_pred --------------------CCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 633 --------------------RLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 633 --------------------~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998776678999998864
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.29 E-value=8.9e-12 Score=108.73 Aligned_cols=91 Identities=16% Similarity=0.217 Sum_probs=70.1
Q ss_pred CCCceEEEeeCCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCcccccccccccc
Q 005731 85 GRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGW 164 (680)
Q Consensus 85 ~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~l~~ 164 (680)
....+|.|+.||+|||++..+ +|++++.+......++|+++|||||++.++ ..++|||..+
T Consensus 19 ~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~----~~~vW~S~t~------------- 79 (111)
T 3mez_A 19 YESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS----NTPVWVYPRS------------- 79 (111)
T ss_dssp ETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC----SSCSEEESSS-------------
T ss_pred cCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC----CEEEEEeccc-------------
Confidence 345789999999999999876 999998754445789999999999998752 2359998521
Q ss_pred eeecCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeCC
Q 005731 165 DFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQ 214 (680)
Q Consensus 165 ~~~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 214 (680)
.....|.|.+.++.+|+..++ . .++|.+++
T Consensus 80 ----------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 80 ----------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp ----------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred ----------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 011347889999999997766 2 67898764
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.7e-11 Score=124.64 Aligned_cols=111 Identities=19% Similarity=0.366 Sum_probs=86.2
Q ss_pred cccccccCCcc----ccCCCEEEec----CCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEee
Q 005731 23 LAADTMTTASF----IRDGEKLTSS----SQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISN 94 (680)
Q Consensus 23 ~~~~~l~~~~~----l~~~~~l~s~----~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~ 94 (680)
...|++.+|+. |..|+.|.|+ .|.|.|.|.+.+ .++ ++.. ..+++|.+++..+- . +.|.++.
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~~dps~G~fsl~l~~dG---nlv--Ly~~--~~~~yW~Sgt~~~~--~-~~l~l~~ 203 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDG---NLV--AYGP--NGAATWNAGTQGKG--A-VRAVFQG 203 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTTCEEEETTEEEEECTTS---CEE--EECT--TSSEEEECCCTTTT--C-CEEEECT
T ss_pred ccccccccccccccccccCcccccCCCCCCceEEEeecCCc---eEE--EEeC--CCeEEEECCCCCCc--c-EEEEEcC
Confidence 45789999999 8888888654 356666665444 233 3322 25889999998763 2 7899999
Q ss_pred CCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCC
Q 005731 95 NGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDH 151 (680)
Q Consensus 95 ~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (680)
||+|+++|.++.++|++++.+ .....|+|+++|||||++. .++||||||
T Consensus 204 dGnLvl~d~~~~~vWsS~t~~-~~~~rl~Ld~dGnLvly~~-------~~~Wqsf~~ 252 (276)
T 3m7h_A 204 DGNLVVYGAGNAVLWHSHTGG-HASAVLRLQANGSIAILDE-------KPVWARFGF 252 (276)
T ss_dssp TSCEEEECTTSCEEEECSCTT-CTTCEEEECTTSCEEEEEE-------EEEEESSSC
T ss_pred CCeEEEEeCCCcEEEEecCCC-CCCEEEEEcCCccEEEEcC-------CCeEEccCc
Confidence 999999999889999999764 3457899999999999974 369999998
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.18 E-value=8.3e-11 Score=102.37 Aligned_cols=85 Identities=21% Similarity=0.333 Sum_probs=65.5
Q ss_pred CceEEEeeCCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCccccccccccccee
Q 005731 87 NAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (680)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~l~~~~ 166 (680)
...|.|+.||+|||++. .++|++++.+......++|+++|||||++.+ +.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~-----~~~iW~S~t~~-------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD-----FKTIWSSRSSS-------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTT-----CCEEEECCCCC--------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC-----CCEEEEcCCcC--------------
Confidence 46799999999999976 5999999875434568999999999999865 46899973210
Q ss_pred ecCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeC
Q 005731 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSG 213 (680)
Q Consensus 167 ~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g 213 (680)
..|.|.+.++.+|+..++ + .+.|.+|
T Consensus 84 -----------------~~~~~~~~L~~dGNlvly--~--~~~W~t~ 109 (110)
T 3r0e_B 84 -----------------KQGEYVLILQDDGFGVIY--G--PAIFETS 109 (110)
T ss_dssp -----------------SSSCCEEEECTTSCEEEE--C--SEEEESC
T ss_pred -----------------CCCCEEEEEcCCccEEEe--c--CCEecCC
Confidence 134588899999997665 3 3778776
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=1.3e-10 Score=101.00 Aligned_cols=87 Identities=23% Similarity=0.330 Sum_probs=66.6
Q ss_pred CceEEEeeCCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCccccccccccccee
Q 005731 87 NAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (680)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~l~~~~ 166 (680)
..+|.|+.||+|||++. +.++|++++.+......++|+++|||||++.+ +.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~-----~~~~W~S~t~~-------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR-----NNPIWASNTGG-------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTT-----SCEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCC-----CCEEEECCCCC--------------
Confidence 47899999999999987 78999999865434578999999999999865 45899973211
Q ss_pred ecCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeCC
Q 005731 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQ 214 (680)
Q Consensus 167 ~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 214 (680)
..+.|.+.++.+|+..++ +. +.|.++.
T Consensus 80 -----------------~~~~~~~~L~ddGNlvly--~~--~~W~s~t 106 (109)
T 3dzw_A 80 -----------------ENGNYVCVLQKDRNVVIY--GT--ARWATGT 106 (109)
T ss_dssp -----------------SSSCEEEEECTTSCEEEE--ES--CCCCCCC
T ss_pred -----------------CCCCEEEEEeCCCEEEEE--CC--CEEeCCC
Confidence 124578899999997665 32 5676653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=5.2e-11 Score=120.09 Aligned_cols=139 Identities=18% Similarity=0.173 Sum_probs=102.7
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCc--eeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN--LVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey 590 (680)
..+.+....+.|..+.||+....+|+.+++|..... ....+.+|+++++.+.+.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345553333456669999998777788999997643 2345778999998886544 55688888877789999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS-------------------------------------- 632 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------- 632 (680)
++|.+|. .. ..+ ...++.++++.|..||...
T Consensus 97 i~G~~l~--~~------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SS------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TS------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cC------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 21 111 2256777888888888642
Q ss_pred -----------------CCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 633 -----------------RLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 633 -----------------~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+..++|+|++|.|||++++..++|+||+.|...
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999988777789999998754
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.1e-10 Score=101.38 Aligned_cols=90 Identities=21% Similarity=0.338 Sum_probs=68.6
Q ss_pred CCCCCCceEEEeeCCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCccccccccc
Q 005731 82 PISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMK 161 (680)
Q Consensus 82 pv~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~ 161 (680)
|+......|.|+.||||||+++ +|++++.+......++|+++|||||++.+ +.++|+|- |
T Consensus 17 ~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~-----~~~vWss~-----t------ 76 (109)
T 3r0e_A 17 HLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGD-----GSTVWKSG-----A------ 76 (109)
T ss_dssp EEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEECC-----C------
T ss_pred EeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC-----CCEEEcCC-----C------
Confidence 3334457899999999999984 79999876444678999999999999865 45799751 1
Q ss_pred ccceeecCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeCCC
Q 005731 162 LGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQW 215 (680)
Q Consensus 162 l~~~~~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~w 215 (680)
....+.|.+.++++|+..++ . .+.|.+++|
T Consensus 77 --------------------~~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~ 106 (109)
T 3r0e_A 77 --------------------QSVKGNYAAVVHPDGRLVVF--G--PSVFKIDPW 106 (109)
T ss_dssp --------------------CCSSSCCEEEEETTTEEEEE--C--SEEEEECTT
T ss_pred --------------------cCCCcCEEEEEcCCCeEEEE--e--cCEECCCCc
Confidence 00235678999999987665 3 688999987
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.98 E-value=2.5e-09 Score=92.03 Aligned_cols=77 Identities=26% Similarity=0.393 Sum_probs=60.2
Q ss_pred ceEEEeeCCeEEEEecCCCeeEeecccCC-CCCceEEEccCCCEEEEeCCCCCccccceeeecCCCccccccccccccee
Q 005731 88 AVLTISNNGNLVLLSQTNGTIWSTNVSSD-VKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (680)
Q Consensus 88 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~l~~~~ 166 (680)
-+|.++.||||||++. +.+||++++... .....++|+++|||||+|.+ +.++|+|-
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~-----~~~vWss~----------------- 77 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS-----GRSLWASH----------------- 77 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTT-----CCEEEECC-----------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCC-----cEEEEEec-----------------
Confidence 5799999999999984 579999998643 24568999999999999876 46899861
Q ss_pred ecCCceeEEEeCCCCCCCCCceeeeeccCCCceEE
Q 005731 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMC 201 (680)
Q Consensus 167 ~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~ 201 (680)
+....+.|.+.++++|+..++
T Consensus 78 --------------t~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 78 --------------STRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp --------------CCCCSSCEEEEECTTSCEEEE
T ss_pred --------------CCCCCCCEEEEEeCCCeEEEE
Confidence 111345688999999997665
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=2.1e-09 Score=114.15 Aligned_cols=142 Identities=15% Similarity=0.236 Sum_probs=106.4
Q ss_pred eeeeeccCCceeEEEEEEcCCcEEEEEEcc--CCC-cccHHHHHHHHHHHhhcC--CCceeeEEEEEEeC---CeEEEEE
Q 005731 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLS--SQS-GQGLKEFKNEMMLIAELQ--HRNLVRILGCCVEQ---GEKILIL 588 (680)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~--~~~-~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 588 (680)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|.+++..+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4578999999999999865 4678888776 321 123456788999999987 45678889888766 3489999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS------------------------------------ 632 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------ 632 (680)
||++|..+.+.. ...++..++..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874321 123677888899999999999999731
Q ss_pred -------------------CCceEeCCCCCCcEEEcCCCC--eEEeeecccee
Q 005731 633 -------------------RLRIIHRDLKASNVLLDKDMN--PKISDFGLARM 664 (680)
Q Consensus 633 -------------------~~~iiHrDlkp~NILl~~~~~--~kl~DFGla~~ 664 (680)
+..++|+|++|.|||++.++. +.|+||+++..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997653 69999999874
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.86 E-value=5.7e-09 Score=104.01 Aligned_cols=88 Identities=25% Similarity=0.332 Sum_probs=68.0
Q ss_pred CceEEEeeCCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCccccccccccccee
Q 005731 87 NAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (680)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~l~~~~ 166 (680)
.-+|.|+.||+|+|++. +.+||.+++.+. ....++|+++|||||+|.+ +.++|+|+++.
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~-~~~~l~l~~dGnLvl~d~~-----~~~vW~s~~~~-------------- 85 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRAVLQSDGLLVILTAQ-----NTIRWSSGTKG-------------- 85 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSC-SCCBCCBCSSSCBCCBCTT-----TCCSCCCCCCC--------------
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCC-CCeEEEEcCCCcEEEEcCC-----CcEEEeCCccc--------------
Confidence 35688888999999986 789999997654 5678899999999999875 46899998651
Q ss_pred ecCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeCCCC
Q 005731 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQWD 216 (680)
Q Consensus 167 ~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~w~ 216 (680)
++|.|.+.|+.+|+.+++ .. .+|.+..+.
T Consensus 86 -----------------~~~~~~~~l~d~Gnlvl~--~~--~~W~S~~~p 114 (236)
T 1dlp_A 86 -----------------SIGNYVLVLQPDRTVTIY--GP--GLWDSGTSN 114 (236)
T ss_dssp -----------------CSSCCEEEECSSSCEEEE--CS--EEEECSCCC
T ss_pred -----------------cCCcEEEEEeCCCCEEEe--cC--CEEECCCCC
Confidence 235567888888886664 22 788887664
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.43 E-value=3.4e-07 Score=94.70 Aligned_cols=136 Identities=18% Similarity=0.197 Sum_probs=98.6
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCc--eeeEEEEEEeCC---eEEEEEEccC
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRN--LVRILGCCVEQG---EKILILEYMP 592 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~Ey~~ 592 (680)
+.++.|....||+.. ..+++|.... ......+.+|.+++..+. +.. +.+.+....... ..|+|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 568999999999864 4588888653 234567899999998883 333 344444433322 3488999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY----------------------------------------- 631 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------------- 631 (680)
|..|..... ..++.+++..++.++++.|+.||..
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988864331 2356777778888888888888851
Q ss_pred --------------CCCceEeCCCCCCcEEEcC--CCCeEEeeeccceec
Q 005731 632 --------------SRLRIIHRDLKASNVLLDK--DMNPKISDFGLARMF 665 (680)
Q Consensus 632 --------------~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~ 665 (680)
....++|+|++|.||++++ ...+.|+||+.+..-
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1235899999999999998 566899999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=3.3e-06 Score=87.33 Aligned_cols=137 Identities=22% Similarity=0.197 Sum_probs=94.1
Q ss_pred eeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCC---ceeeEEEEEE-eCCeEEEEEEccCC
Q 005731 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHR---NLVRILGCCV-EQGEKILILEYMPN 593 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~~ 593 (680)
.+.++.|....||+. +..+++|+-. .......+.+|.+++..+.+. .+.+.+.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888888899987 4668888743 233456789999999999653 3556666664 34457899999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY------------------------------------------ 631 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------ 631 (680)
..+..... ..++..++..++.++++.|+.||..
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88865321 1123444445555555555555532
Q ss_pred ---------------CCCceEeCCCCCCcEEEcC---CCC-eEEeeeccceec
Q 005731 632 ---------------SRLRIIHRDLKASNVLLDK---DMN-PKISDFGLARMF 665 (680)
Q Consensus 632 ---------------~~~~iiHrDlkp~NILl~~---~~~-~kl~DFGla~~~ 665 (680)
.+..++|+|++|.|||++. ++. +.|+||+.+..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2335799999999999987 355 589999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=9.3e-06 Score=82.00 Aligned_cols=141 Identities=18% Similarity=0.174 Sum_probs=97.9
Q ss_pred CcceeeeeccCCce-eEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEEc
Q 005731 514 NFSMQCKLGEGGFG-PVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 514 ~f~~~~~LG~G~fG-~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.|+. +.+..|..+ .||+.... ++..+++|+-.. ....++.+|..+|+.+. +--+-++++++...+..++|||+
T Consensus 26 g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~ 101 (272)
T 4gkh_A 26 GYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA 101 (272)
T ss_dssp TCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred CCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence 3443 345555554 68987643 466788888653 23567888999988874 33467788999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY--------------------------------------- 631 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------- 631 (680)
+++.++.+.... .......+..++++.|.-||..
T Consensus 102 l~G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 102 IPGKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp CCSEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred eCCccccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 999887655411 1122234555666666666632
Q ss_pred ----------------CCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 632 ----------------SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 632 ----------------~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
....++|+|+.+.|||++.++.+-|+||+.+..-
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 0123799999999999998877889999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=3.5e-06 Score=88.98 Aligned_cols=80 Identities=8% Similarity=0.030 Sum_probs=55.2
Q ss_pred eeee-ccCCceeEEEEEEc-------CCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCC---CceeeEEEEEEeC--
Q 005731 518 QCKL-GEGGFGPVYKGRLF-------NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQH---RNLVRILGCCVEQ-- 581 (680)
Q Consensus 518 ~~~L-G~G~fG~Vy~~~~~-------~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~~-- 581 (680)
.+.| +.|....+|+.... +++.+++|...... ......+.+|+.+++.+.. ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3677 88989999998754 26678888765422 1112456788888887742 3567788777554
Q ss_pred -CeEEEEEEccCCCChh
Q 005731 582 -GEKILILEYMPNKSLD 597 (680)
Q Consensus 582 -~~~~lV~Ey~~~gsL~ 597 (680)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.85 E-value=8.4e-05 Score=77.48 Aligned_cols=141 Identities=14% Similarity=0.162 Sum_probs=80.3
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-----CCCceeeEE-E--EEEeCCeEEEEEEc
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-----QHRNLVRIL-G--CCVEQGEKILILEY 590 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-----~H~niv~l~-g--~~~~~~~~~lV~Ey 590 (680)
+.|+.|..+.||+....++ .+++|+.... ..++..|..++..+ ..|.++... | +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999986554 5889988752 23333445544444 234444310 1 12346678999999
Q ss_pred cCCCChhh--------------Hhccccc----C-------CCCCHHHHH------------------------------
Q 005731 591 MPNKSLDV--------------YLFDPIK----K-------RLLDWEARI------------------------------ 615 (680)
Q Consensus 591 ~~~gsL~~--------------~l~~~~~----~-------~~l~~~~~~------------------------------ 615 (680)
++|..+.. .++.... . ....|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99865420 0111000 0 011232110
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 616 -RIIQGIAQGLLYLHQ----------YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 616 -~i~~~ia~~L~yLH~----------~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
.+..++.+++.+|+. ..+..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111234456677763 1245699999999999998888999999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=8e-05 Score=79.78 Aligned_cols=75 Identities=9% Similarity=0.153 Sum_probs=49.9
Q ss_pred eeeeccCCceeEEEEEEc-CCcEEEEEEccCCCc-------ccHHHHHHHHHHHhhcCC--Cc-eeeEEEEEEeCCeEEE
Q 005731 518 QCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-------QGLKEFKNEMMLIAELQH--RN-LVRILGCCVEQGEKIL 586 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-------~~~~~f~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~l 586 (680)
.+.||.|..+.||+++.. +++.++||....... ...+++..|.+++..+.+ +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999743 467899998653211 234567788888887742 33 3455543 4455689
Q ss_pred EEEccCCC
Q 005731 587 ILEYMPNK 594 (680)
Q Consensus 587 V~Ey~~~g 594 (680)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00018 Score=73.45 Aligned_cols=80 Identities=16% Similarity=0.249 Sum_probs=59.5
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCC---ceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHR---NLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lV~E 589 (680)
....-.+.+|.|..+.||+.++.+|+.+.||+-..........|..|.+.|+.+... -+.+.+++ . ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEE
Confidence 456667889999999999999999999999987654444456788999988887422 24445543 2 3478999
Q ss_pred ccCCCCh
Q 005731 590 YMPNKSL 596 (680)
Q Consensus 590 y~~~gsL 596 (680)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00035 Score=72.13 Aligned_cols=140 Identities=21% Similarity=0.139 Sum_probs=92.8
Q ss_pred ceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC---CCceeeEEEEEEeCCeEEEEEEccC
Q 005731 516 SMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ---HRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
...+.|+.|....+|+... ++..+++|+.... ....|..|.+.|+.+. ...+.+.++++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3447899999999999875 4678888886532 3567889999888874 3568888888887788999999999
Q ss_pred CCChhh-----------Hhccccc-C------------------CCCCHHHHH---HHHH----------------HHHH
Q 005731 593 NKSLDV-----------YLFDPIK-K------------------RLLDWEARI---RIIQ----------------GIAQ 623 (680)
Q Consensus 593 ~gsL~~-----------~l~~~~~-~------------------~~l~~~~~~---~i~~----------------~ia~ 623 (680)
+..+.. .|+.... . -.-+|.+.. ++.. .+..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 876521 1111110 0 012454322 1111 1111
Q ss_pred H-HHHHHh-CCCCceEeCCCCCCcEEEcCCCCeEEeeec
Q 005731 624 G-LLYLHQ-YSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (680)
Q Consensus 624 ~-L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 660 (680)
. ...|.. ..++.++|+|+.+.|++++.++ +.|.||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 223422 2346799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00062 Score=73.41 Aligned_cols=73 Identities=12% Similarity=0.180 Sum_probs=45.7
Q ss_pred eeeeccCCceeEEEEEEcCCcEEEEEEccCC------C-c--ccHHHHHHHHHHHh-hcCCCceeeEEEEEEeCCeEEEE
Q 005731 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ------S-G--QGLKEFKNEMMLIA-ELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~------~-~--~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 587 (680)
.+.||.|....||+... +++.++||..... . . .....+..|+..+. ...+..+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 47899999999999964 5678999943211 1 1 12334444444332 22234566676664 5667999
Q ss_pred EEcc-CC
Q 005731 588 LEYM-PN 593 (680)
Q Consensus 588 ~Ey~-~~ 593 (680)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0024 Score=65.90 Aligned_cols=157 Identities=14% Similarity=0.108 Sum_probs=84.7
Q ss_pred HHHHHHhcCCcce-----eeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-----CCceeeE
Q 005731 505 LASVAAATENFSM-----QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-----HRNLVRI 574 (680)
Q Consensus 505 ~~~~~~~~~~f~~-----~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-----H~niv~l 574 (680)
.+++...-.+|.+ .+.|+.|....+|+....++ .+++|..... ...+++..|+.++..+. -|.++..
T Consensus 9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~ 85 (322)
T 2ppq_A 9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPR 85 (322)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence 3444444444543 35677788889999986655 5788887652 12234455666666553 2333321
Q ss_pred E-E--EEEeCCeEEEEEEccCCCChhh----H----------hcccc---c-C--CC---CCHHHHHH------------
Q 005731 575 L-G--CCVEQGEKILILEYMPNKSLDV----Y----------LFDPI---K-K--RL---LDWEARIR------------ 616 (680)
Q Consensus 575 ~-g--~~~~~~~~~lV~Ey~~~gsL~~----~----------l~~~~---~-~--~~---l~~~~~~~------------ 616 (680)
. | +....+..+++|||++|..+.. . ++... . . .. ..|.....
T Consensus 86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 165 (322)
T 2ppq_A 86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 165 (322)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence 0 1 1123456789999999865421 0 11100 0 0 00 11222110
Q ss_pred HHHHHHHHHHHHHhC----CCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 617 IIQGIAQGLLYLHQY----SRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 617 i~~~ia~~L~yLH~~----~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
+...+.+.++.++.. .+..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244555666532 234589999999999998876668999998763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0019 Score=69.87 Aligned_cols=73 Identities=19% Similarity=0.310 Sum_probs=49.2
Q ss_pred eeeeccCCceeEEEEEEcC--------CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCce-eeEEEEEEeCCeEEEEE
Q 005731 518 QCKLGEGGFGPVYKGRLFN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-VRILGCCVEQGEKILIL 588 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~--------~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 588 (680)
.+.|+.|-...+|+....+ ++.+++|+.... ...+.+.+|..++..+...++ .++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 3678888889999998653 478889887431 122556678888888743333 56666543 2 2899
Q ss_pred EccCCCCh
Q 005731 589 EYMPNKSL 596 (680)
Q Consensus 589 Ey~~~gsL 596 (680)
||+++..|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.011 Score=64.22 Aligned_cols=74 Identities=14% Similarity=0.121 Sum_probs=47.2
Q ss_pred eeeeccCCceeEEEEEEcC-CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCce-eeEEEEEEeCCeEEEEEEccCCCC
Q 005731 518 QCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-VRILGCCVEQGEKILILEYMPNKS 595 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gs 595 (680)
.+.|+.|-...+|+....+ ++.+++|+.......... -.+|..++..+...++ .++++.+. +. +||||+++..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN-REREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCcc
Confidence 3678888889999998755 477888876432221111 1578888888865444 46676652 22 5999998755
Q ss_pred h
Q 005731 596 L 596 (680)
Q Consensus 596 L 596 (680)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0027 Score=64.90 Aligned_cols=138 Identities=14% Similarity=0.113 Sum_probs=73.7
Q ss_pred eeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCce-eeEEEEEEeCCeEEEEEEcc-CCCC
Q 005731 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-VRILGCCVEQGEKILILEYM-PNKS 595 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~-~~gs 595 (680)
.+.|+.|....+|+. +.+++|+........ ....+|+.++..+....+ .+++++ ..+.-++++||+ ++..
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 478988999999998 457888775422111 122457776666532222 345543 344457899999 6654
Q ss_pred hhhH------------------hccccc--CCCCCHHH-HHHHHH--------------HHHHHHH----HHHh-CCCCc
Q 005731 596 LDVY------------------LFDPIK--KRLLDWEA-RIRIIQ--------------GIAQGLL----YLHQ-YSRLR 635 (680)
Q Consensus 596 L~~~------------------l~~~~~--~~~l~~~~-~~~i~~--------------~ia~~L~----yLH~-~~~~~ 635 (680)
+... ++.... ........ ...+.. .+.+.+. .|.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4311 000000 00011111 111110 0111111 1111 22345
Q ss_pred eEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 636 IIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 636 iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
++|+|+.+.||+ ..++.+.|+||..|..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667789999998874
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0061 Score=63.16 Aligned_cols=33 Identities=27% Similarity=0.401 Sum_probs=28.2
Q ss_pred CCceEeCCCCCCcEEEcCC----CCeEEeeeccceec
Q 005731 633 RLRIIHRDLKASNVLLDKD----MNPKISDFGLARMF 665 (680)
Q Consensus 633 ~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~~ 665 (680)
...++|+|+.+.|||++.+ ..+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3469999999999999874 68999999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0091 Score=61.59 Aligned_cols=142 Identities=13% Similarity=0.134 Sum_probs=81.2
Q ss_pred eeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCC--CceeeEEEE-----EEeCCeEEEEEEcc
Q 005731 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH--RNLVRILGC-----CVEQGEKILILEYM 591 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~-----~~~~~~~~lV~Ey~ 591 (680)
+.++ |....||+....+|+.+++|...... ...+++..|..++..+.. -.+.+++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 77789998876677789999986421 234566678777776632 123333332 22345678999999
Q ss_pred CCCChhh----H----------hcccc------cCCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 005731 592 PNKSLDV----Y----------LFDPI------KKRLLDWEAR----IRI---------------IQGIAQGLLYLHQ-- 630 (680)
Q Consensus 592 ~~gsL~~----~----------l~~~~------~~~~l~~~~~----~~i---------------~~~ia~~L~yLH~-- 630 (680)
+|..+.. . ++... .....++... ..+ ...+.+.++.+..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8754421 0 11000 0111222211 000 1111222333322
Q ss_pred --CCCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 631 --YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 631 --~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234589999999999998 4 899999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0047 Score=65.44 Aligned_cols=141 Identities=19% Similarity=0.270 Sum_probs=81.3
Q ss_pred eeeccCCceeEEEEEEc--------CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCc-eeeEEEEEEeCCeEEEEEE
Q 005731 519 CKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN-LVRILGCCVEQGEKILILE 589 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~--------~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 589 (680)
+.|..|-...+|+.... +++.+++|+... .........+|.++++.+.-.. ..++++.+.+ . +|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g--~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE--G--RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--E--EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--c--cEEE
Confidence 56777888889998764 246888888633 2234556678998888774222 3556665533 2 8999
Q ss_pred ccCCCChhhH-h----------------ccc-cc-CCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 005731 590 YMPNKSLDVY-L----------------FDP-IK-KRLLD--WEARIRIIQGIA-------------------QGLLYLH 629 (680)
Q Consensus 590 y~~~gsL~~~-l----------------~~~-~~-~~~l~--~~~~~~i~~~ia-------------------~~L~yLH 629 (680)
|++|..|..- + +.. .. .+... +.++.++..++. +.+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665321 0 000 00 11112 344444443332 1233332
Q ss_pred ----h-CCCCceEeCCCCCCcEEEcCC----CCeEEeeecccee
Q 005731 630 ----Q-YSRLRIIHRDLKASNVLLDKD----MNPKISDFGLARM 664 (680)
Q Consensus 630 ----~-~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~ 664 (680)
. ..+..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 123468999999999999876 7899999999874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0056 Score=64.52 Aligned_cols=73 Identities=12% Similarity=0.102 Sum_probs=42.5
Q ss_pred eeeccCCceeEEEEEEcC---------CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCc-eeeEEEEEEeCCeEEEEE
Q 005731 519 CKLGEGGFGPVYKGRLFN---------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN-LVRILGCCVEQGEKILIL 588 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~---------~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 588 (680)
+.|+.|....+|+....+ ++.+++|+...... .......|.+++..+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 567888888999987643 26788887654222 1112356777777764333 33566543 2 26899
Q ss_pred EccCCCCh
Q 005731 589 EYMPNKSL 596 (680)
Q Consensus 589 Ey~~~gsL 596 (680)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.02 E-value=0.037 Score=57.49 Aligned_cols=33 Identities=24% Similarity=0.373 Sum_probs=28.7
Q ss_pred CCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 633 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+..++|+|+.+.||+++.++.+.|+||..+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 346999999999999998888999999887753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.07 E-value=0.25 Score=52.85 Aligned_cols=74 Identities=15% Similarity=0.134 Sum_probs=46.2
Q ss_pred eeeeccCCceeEEEEEEcC--------CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCc-eeeEEEEEEeCCeEEEEE
Q 005731 518 QCKLGEGGFGPVYKGRLFN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN-LVRILGCCVEQGEKILIL 588 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~--------~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 588 (680)
.+.|..|-...+|+....+ ++.+++|+........ -.-.+|.++++.+...+ ..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3677778888999988653 5788888865432211 12246777777764222 34555432 2 27899
Q ss_pred EccCCCCh
Q 005731 589 EYMPNKSL 596 (680)
Q Consensus 589 Ey~~~gsL 596 (680)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.64 E-value=0.76 Score=48.69 Aligned_cols=30 Identities=23% Similarity=0.391 Sum_probs=25.5
Q ss_pred ceEeCCCCCCcEEE------cCCCCeEEeeecccee
Q 005731 635 RIIHRDLKASNVLL------DKDMNPKISDFGLARM 664 (680)
Q Consensus 635 ~iiHrDlkp~NILl------~~~~~~kl~DFGla~~ 664 (680)
.++|+|+.+.|||+ +++..++++||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999998874
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=89.02 E-value=18 Score=35.45 Aligned_cols=65 Identities=12% Similarity=0.301 Sum_probs=40.7
Q ss_pred CceEEecCCCCC--CC----CCCceEEEeeCCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeC
Q 005731 71 DTVVWVANRDRP--IS----GRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDN 135 (680)
Q Consensus 71 ~tvVW~anr~~p--v~----~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~ 135 (680)
..++|...+..+ +. ..++.+.++.++.+..+|++|..+|.-..........+..+.+||+++-+.
T Consensus 25 G~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~ 95 (276)
T 3no2_A 25 KEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC 95 (276)
T ss_dssp TEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred CeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence 567887766531 11 123445556666677778889999988753212234566778888877654
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=82.77 E-value=0.82 Score=36.35 Aligned_cols=34 Identities=24% Similarity=0.484 Sum_probs=28.0
Q ss_pred CCCHHHHHHHHhcCCccccccccccCCCceeEEEcC
Q 005731 361 SMNLEQCAAECLKNCTCKAYANSNVTEGSGCLMWYG 396 (680)
Q Consensus 361 ~~~~~~C~~~Cl~nCsC~A~~~~~~~~g~~C~~w~~ 396 (680)
..++++|+..|+.+=.|.||.|... ...|++..+
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~~--s~~CflKs~ 62 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNVK--SGLCYPKRG 62 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEETT--TTEEEEEES
T ss_pred CCCHHHHHHHhhccCCCCeEEeccC--CCceEcccC
Confidence 4689999999999999999999742 345988654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 680 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-24 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-19 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 5e-16 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 4e-10 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 1e-15 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 2e-04 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 3e-14 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 2e-13 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 3e-05 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-10 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 9e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-48
Identities = 47/168 (27%), Positives = 86/168 (51%), Gaps = 6/168 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
++ ++G G FG VYKG+ V + +++ + Q L+ FKNE+ ++ + +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
+G + ++ ++ SL +L + + I I + AQG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
IIHRDLK++N+ L +D+ KI DFGLA + +++ G+
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 5e-47
Identities = 42/172 (24%), Positives = 75/172 (43%), Gaps = 11/172 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAELQH 568
++F +LG G G V+K +G +A K + + + + E+ ++ E
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+V G GE + +E+M SLD L K + + ++ + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ +I+HRD+K SN+L++ K+ DFG++ VGT
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGT 166
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 1e-46
Identities = 41/164 (25%), Positives = 82/164 (50%), Gaps = 6/164 (3%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ + + +LG+G FG VYK + A K + ++S + L+++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+V++L + +++E+ ++D + + +R L + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
+IIHRDLKA N+L D + K++DFG++ + ++
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 2e-45
Identities = 52/173 (30%), Positives = 84/173 (48%), Gaps = 16/173 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQ 567
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + +L+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H N ++ GC + + L++EY + D+ + K+ L + G QGL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 130
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
LH +IHRD+KA N+LL + K+ DFG A + VGT
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGT 174
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-44
Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 8/170 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQHR 569
E++ + +G G +G K R +G+ + K L S + + +E+ L+ EL+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 570 NLVRILGCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKKR-LLDWEARIRIIQGIAQGLL 626
N+VR +++ L ++EY L + K+R LD E +R++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 627 YLHQYSR--LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
H+ S ++HRDLK +NV LD N K+ DFGLAR+ D
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-44
Identities = 54/168 (32%), Positives = 81/168 (48%), Gaps = 7/168 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
R+ Q +I EYM N SL +L P +L + + IA+G+ ++ +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEE-- 127
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
IHRDL+A+N+L+ ++ KI+DFGLAR+ +E
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFP 173
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-44
Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 7/168 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
+ ++G G FG V+ G N +VA+K + + ++F E ++ +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ G C+EQ L+ E+M + L YL ++ L E + + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+IHRDL A N L+ ++ K+SDFG+ R D+ ++
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 165
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 7e-44
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 8/170 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRN 570
E++ + LGEG +G V + VAVK + ++ + K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+V+ G E + L LEY L + + R + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ I HRD+K N+LLD+ N KISDFGLA +F + + ++ GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-43
Identities = 49/172 (28%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV 579
+G+G FG V++G+ G+EVAVK SS+ + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 580 EQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ----- 630
+ L+ +Y + S LFD + + + E I++ A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF--GGDELQGNTKRIVGT 680
+ I HRDLK+ N+L+ K+ I+D GLA D + VGT
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-43
Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 7/168 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
++ + +LG G FG V G+ +VA+K + S EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ G C +Q +I EYM N L YL + + + + + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ +HRDL A N L++ K+SDFGL+R DE +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 164
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 155 bits (392), Expect = 4e-43
Identities = 50/163 (30%), Positives = 86/163 (52%), Gaps = 6/163 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
+ +M+ KLG G +G VY+G VAVK L + + ++EF E ++ E++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
V++LG C + +I E+M +L YL + ++ + + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE-- 132
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
+ IHRDL A N L+ ++ K++DFGL+R+ GD +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 155 bits (392), Expect = 5e-43
Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 19/191 (9%)
Query: 503 FSLASVAAATENFS---------MQCKLGEGGFGPVYKGRLF----NGQEVAVKRL-SSQ 548
F+ A F+ ++ +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 549 SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRL 608
+ + ++F +E ++ + H N++ + G + ++I E+M N SLD +L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 609 LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
+ +++GIA G+ YL +HRDL A N+L++ ++ K+SDFGL+R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 669 ELQGNTKRIVG 679
+G
Sbjct: 182 TSDPTYTSALG 192
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 8e-43
Identities = 48/163 (29%), Positives = 81/163 (49%), Gaps = 8/163 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
+ + +G+G FG V G G +VAVK + + + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 573 RILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
++LG VE+ + ++ EYM SL YL + +L + ++ + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
+HRDL A NVL+ +D K+SDFGL + + G
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 162
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 7e-42
Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 6/162 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ +L+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ + ++ EYM SL +L + L + + IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM- 132
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
+HRDL+A+N+L+ +++ K++DFGLAR+ +E
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 12/176 (6%)
Query: 511 ATENFSMQ-CKLGEGGFGPVYKGRLF---NGQEVAVKRLSSQSGQG-LKEFKNEMMLIAE 565
+N + +LG G FG V +G +VA+K L + + +E E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
L + +VR++G C + +L++E L +L K+ + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR-IVGT 680
YL + +HRDL A NVLL KISDFGL++ G D+ +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 49/178 (27%), Positives = 90/178 (50%), Gaps = 10/178 (5%)
Query: 504 SLASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMML 562
S+ SV + ++ K+G+G G VY + GQEVA+++++ Q + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 563 IAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIA 622
+ E ++ N+V L + E +++EY+ S L D + + +D + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECL 126
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
Q L +LH ++IHRD+K+ N+LL D + K++DFG + Q +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (379), Expect = 3e-41
Identities = 49/196 (25%), Positives = 80/196 (40%), Gaps = 31/196 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQGL-KEFKNEMMLIAE 565
N +GEG FG V++ R VAVK L ++ + +F+ E L+AE
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRL----------------- 608
+ N+V++LG C L+ EYM L+ +L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 609 ----LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664
L ++ I + +A G+ YL + + +HRDL N L+ ++M KI+DFGL+R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 665 FGGDELQGNTKRIVGT 680
+
Sbjct: 190 IYSADYYKADGNDAIP 205
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 8e-41
Identities = 50/191 (26%), Positives = 71/191 (37%), Gaps = 26/191 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQG-LKEFKNEMMLIAE 565
S LG G FG V + + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 566 L-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRL---------------L 609
L H N+V +LG C G ++I EY L +L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
D E + +A+G+ +L IHRDL A N+LL KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 670 LQGNTKRIVGT 680
Sbjct: 200 NYVVKGNARLP 210
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 52/196 (26%), Positives = 73/196 (37%), Gaps = 31/196 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAE 565
EN LG G FG V +VAVK L ++ + +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 566 L-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK------------------ 606
L H N+V +LG C G LI EY L YL +K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 607 --RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664
+L +E + +A+G+ +L +HRDL A NVL+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 665 FGGDELQGNTKRIVGT 680
D
Sbjct: 214 IMSDSNYVVRGNARLP 229
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 14/172 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQH 568
E+F + LG+G FG VY R + +A+K L + + + E+ + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
N++R+ G + LILEY P ++ L K D + I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H R+IHRD+K N+LL KI+DFG + + GT
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGT 167
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-39
Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 16/169 (9%)
Query: 520 KLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILG 576
++G G F VYKG EVA L + + + FK E ++ LQH N+VR
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 577 CCVEQGEK----ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
+ +L+ E M + +L YL + +++ + + I +GL +LH +
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 633 RLRIIHRDLKASNVLL-DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
IIHRDLK N+ + + KI D GLA + K ++GT
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 176
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 145 bits (366), Expect = 5e-39
Identities = 34/170 (20%), Positives = 71/170 (41%), Gaps = 8/170 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
+++ + +LG G FG V++ G A K + + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
V + + E ++I E+M L + D + + + + ++ + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 632 SRLRIIHRDLKASNVLLDKDMNP--KISDFGLARMFGGDELQGNTKRIVG 679
+H DLK N++ + K+ DFGL + T
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 190
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 6e-39
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 520 KLGEGGFGPVYKGRLFN---GQEVAVKRLSSQSGQG--LKEFKNEMMLIAELQHRNLVRI 574
+LG G FG V KG + VAVK L +++ E E ++ +L + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+G C E +L++E L+ YL + R + + I ++ ++ G+ YL +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK-RIVGT 680
+HRDL A NVLL KISDFGL++ DE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 9e-39
Identities = 50/171 (29%), Positives = 71/171 (41%), Gaps = 10/171 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQH 568
E+F LGEG F V R L +E A+K L + E +++ L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
V++ + + L Y N L Y+ K D I L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYL 124
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVG 679
H IIHRDLK N+LL++DM+ +I+DFG A++ + Q VG
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 142 bits (360), Expect = 4e-38
Identities = 38/161 (23%), Positives = 73/161 (45%), Gaps = 8/161 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
+ + + +LG G FG V++ G+ K +++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
+ + ++ E +LILE++ L + + + I ++ +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 632 SRLRIIHRDLKASNVLLDKDMNP--KISDFGLARMFGGDEL 670
I+H D+K N++ + KI DFGLA DE+
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 49/175 (28%), Positives = 71/175 (40%), Gaps = 13/175 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAE 565
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
L HRNL+R+ G ++ E P SL L + R +A+G+
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
YL R IHRDL A N+LL KI DFGL R ++ +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 5/165 (3%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQHR 569
++ +GEG +G V N VA+K++S Q + E+ ++ +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N++ I + + Y+ + L+ +K + L + + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
++HRDLK SN+LL+ + KI DFGLAR+ D
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-37
Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 12/174 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE-----VAVKRLS-SQSGQGLKEFKNEMMLIAEL 566
F LG G FG VYKG E VA+K L + S + KE +E ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
+ ++ R+LG C+ LI + MP L Y+ + K + + + IA+G+
Sbjct: 69 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 125
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
YL R++HRDL A NVL+ + KI+DFGLA++ G +E + + +
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 5e-37
Identities = 49/186 (26%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG---QEVAVKRLS-SQSGQGLKEFKNEMMLIAEL-Q 567
+ Q +GEG FG V K R+ + A+KR+ S ++F E+ ++ +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------------FDPIKKRLLDWEAR 614
H N++ +LG C +G L +EY P+ +L +L L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 615 IRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
+ +A+G+ YL Q + IHRDL A N+L+ ++ KI+DFGL+R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 675 KRIVGT 680
Sbjct: 184 TMGRLP 189
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 6e-37
Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 11/163 (6%)
Query: 520 KLGEGGFGPVYKGRLFN----GQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQHRNLVRI 574
+G G FG VY G L + AVK L+ + G + +F E +++ + H N++ +
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 575 LGCCVE-QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
LG C+ +G +++L YM + L + + + I +A+G+ +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNF--IRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR 676
+ +HRDL A N +LD+ K++DFGLAR E +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 17/182 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLS-SQSGQGLKEFKNEMMLIAE 565
E +M +LG+G FG VY+G VA+K ++ + S + EF NE ++ E
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRL-------LDWEARIRII 618
++VR+LG + ++I+E M L YL I++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
IA G+ YL+ + +HRDL A N ++ +D KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 679 GT 680
Sbjct: 197 LP 198
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-36
Identities = 51/190 (26%), Positives = 78/190 (41%), Gaps = 25/190 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQG-LKEFKNEM-MLIA 564
+ + LG G FG V + F + VAVK L + + +E+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 565 ELQHRNLVRILGCCVEQGEKILIL-EYMPNKSLDVYLF-------------DPIKKRLLD 610
H N+V +LG C + G ++++ E+ +L YL + + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 611 WEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670
E I +A+G+ +L + IHRDL A N+LL + KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 671 QGNTKRIVGT 680
Sbjct: 190 YVRKGDARLP 199
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-36
Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 12/173 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQ 567
E + +GEG FG V++G + VA+K + + ++E F E + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H ++V+++G E +I+E L +L LD + I ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
L R +HRD+ A NVL+ + K+ DFGL+R +
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLP 172
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (346), Expect = 4e-36
Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 13/166 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNE---MMLIAE 565
+FS+ +G GGFG VY R G+ A+K L + QG NE + L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
+V + + IL+ M L +L + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671
++H +++RDLK +N+LLD+ + +ISD GLA F +
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 163
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-35
Identities = 51/168 (30%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE-----VAVKRLSSQSGQG-LKEFKNEMMLIAEL 566
+ Q +G G FG VYKG L VA+K L + + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
H N++R+ G + ++I EYM N +LD +L + K + +++GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
YL + +HRDL A N+L++ ++ K+SDFGL+R+ D T
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 131 bits (330), Expect = 8e-35
Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 20/179 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--------SSQSGQGLKE-FKNEMML 562
EN+ + LG G V + +E AVK + S++ Q L+E E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 563 IAELQ-HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGI 621
+ ++ H N++++ L+ + M L YL +K L + +I++ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ + LH +L I+HRDLK N+LLD DMN K++DFG + E + + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGT 172
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 4e-34
Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 15/169 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
+++ +G G FG VY+ +L +G+ VA+K++ + E+ ++ +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 573 RILGCCVEQGEK------ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
R+ GEK L+L+Y+P V K+ L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLARMFGGDELQGNT 674
Y+H I HRD+K N+LLD D K+ DFG A+ E +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 129 bits (325), Expect = 4e-34
Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRN 570
E + K+GEG +G VYK + G+ A+K RL + E+ ++ EL+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+V++ + +L+ E++ + + L+ + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
R++HRDLK N+L++++ KI+DFGLAR FG +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 8e-34
Identities = 31/160 (19%), Positives = 65/160 (40%), Gaps = 9/160 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
E + + LG G FG V++ + + K + + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
+ + E ++I E++ + + L+ + + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 632 SRLRIIHRDLKASNVLLDKDMNP--KISDFGLARMFGGDE 669
I H D++ N++ + KI +FG AR +
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 129 bits (324), Expect = 1e-33
Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQH 568
++F + LG G FG V+ R NG+ A+K L + ++ +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
++R+ G + + +I++Y+ LF ++K + A+ L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGG----ELFSLLRKSQRFPNPVAKFY--AAEVCLAL 117
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
II+RDLK N+LLDK+ + KI+DFG A+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-33
Identities = 52/191 (27%), Positives = 82/191 (42%), Gaps = 26/191 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL--------FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLI 563
+ + LGEG FG V +VAVK L S + + L + +EM ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 564 AEL-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLF-------------DPIKKRLL 609
+ +H+N++ +LG C + G +I+EY +L YL + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ + +A+G+ YL + IHRDL A NVL+ +D KI+DFGLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 670 LQGNTKRIVGT 680
T
Sbjct: 190 YYKKTTNGRLP 200
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (323), Expect = 2e-33
Identities = 36/171 (21%), Positives = 70/171 (40%), Gaps = 8/171 (4%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQHR 569
+ + + LG G F V + VA+K ++ ++ +G +NE+ ++ +++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N+V + G LI++ + L + ++K R+I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ + LD+D ISDFGL++M + GT
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGT 172
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-32
Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 8/160 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHR 569
ENF K+GEG +G VYK R G+ VA+K RL +++ E+ L+ EL H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N+V++L + + L+ E++ D + + + QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ R++HRDLK N+L++ + K++DFGLAR FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 124 bits (311), Expect = 3e-32
Identities = 42/178 (23%), Positives = 76/178 (42%), Gaps = 15/178 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQ 567
++ + + LG GG V+ R L ++VAVK L ++ F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 568 HRNLVRILGCCVEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
H +V + + +++EY+ +L + + + + I +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG-GDELQGNTKRIVGT 680
L + H + IIHRD+K +N+++ K+ DFG+AR T ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-32
Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 13/173 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN----EMMLIAELQ 567
E+F + LG+G FG V+ Q A+K L + + + +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H L + + ++EY+ L ++ D I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
LH I++RDLK N+LLDKD + KI+DFG+ + + + NT GT
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 8e-31
Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-----FKNEMMLIAELQHRNLVR 573
LGEG F VYK R Q VA+K++ K+ E+ L+ EL H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
+L + L+ ++M + +L + QGL YLHQ+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
I+HRDLK +N+LLD++ K++DFGLA+ FG
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 8e-31
Identities = 47/181 (25%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQHR 569
+ K+G+G FG V+K R GQ+VA+K++ ++ E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 570 NLVRILGCCVEQGEKI--------LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGI 621
N+V ++ C + L+ ++ + + +K R++Q +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR--IVG 679
GL Y+H+ +I+HRD+KA+NVL+ +D K++DFGLAR F + + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 680 T 680
T
Sbjct: 184 T 184
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 3e-30
Identities = 42/172 (24%), Positives = 69/172 (40%), Gaps = 12/172 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQH 568
+F LG+G FG V R G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
L + ++EY LF + + + E R R A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFY--GAEIVSAL 118
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+++RD+K N++LDKD + KI+DFGL + D K GT
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 168
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-29
Identities = 46/180 (25%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR--LFNGQEVAVKRLSSQSGQG--LKEFKNE---MMLI 563
A + + ++GEG +G V+K R G+ VA+KR+ Q+G+ E + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLD---VYLFDPIKKRLLDWEARIRIIQG 620
+H N+VR+ C + + +D D + + + E ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ +GL +LH R++HRDLK N+L+ K++DFGLAR++ Q +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 116 bits (292), Expect = 1e-29
Identities = 32/179 (17%), Positives = 75/179 (41%), Gaps = 18/179 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
++ + ++GEG FG +++G L N Q+VA+K +S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
+ + ++G +++ + SL+ L R + + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 632 SRLRIIHRDLKASNVLLDKDMNP-----KISDFGLARMFGGDELQGN-----TKRIVGT 680
+++RD+K N L+ + + + DFG+ + + + + K + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 5e-29
Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 9/160 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHR 569
+ + K+GEG +G V+K + + VA+K RL E+ L+ EL+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N+VR+ + L+ E+ + LD E + + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
++HRDLK N+L++++ K+++FGLAR FG
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 2e-28
Identities = 37/176 (21%), Positives = 63/176 (35%), Gaps = 19/176 (10%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ------ 567
+ + LG GGFG VY G + + VA+K + E N + E+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 568 --HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
++R+L +LILE ++ L E + + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAV 123
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ H ++HRD+K N+L+D + K+ DFG + GT
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGT 172
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 4e-28
Identities = 42/165 (25%), Positives = 72/165 (43%), Gaps = 17/165 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQHR 569
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 570 NLVRILGCCVEQG------EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
N++ +L + L++ +M + +K L + ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL-----MKHEKLGEDRIQFLVYQMLK 132
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
GL Y+H IIHRDLK N+ +++D KI DFGLAR +
Sbjct: 133 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-28
Identities = 49/179 (27%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL------SSQSGQGLKEFKNEMMLIAE 565
+ + +LG G F V K R G + A K + SS+ G ++ + E+ ++ E
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
+QH N++ + + + ILILE + L +K L E ++ I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNG- 125
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNP----KISDFGLARMFGGDELQGNTKRIVGT 680
++ L+I H DLK N++L P KI DFGLA K I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 179
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (281), Expect = 1e-27
Identities = 37/160 (23%), Positives = 66/160 (41%), Gaps = 10/160 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQH 568
+ F LG G FG V + +G A+K L Q + ++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
LV++ + +++EY+ + +L + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
H L +I+RDLK N+L+D+ +++DFG A+ G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-27
Identities = 33/158 (20%), Positives = 62/158 (39%), Gaps = 18/158 (11%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEM-MLIAELQHRNLVRILGCC 578
LG G G V + ++ A+K L + + E+ + Q ++VRI+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 579 ----VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+ ++++E + L + D + I++ I + + YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHS---I 130
Query: 635 RIIHRDLKASNVLLDKDMNP---KISDFGLARMFGGDE 669
I HRD+K N+L K++DFG A+
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-27
Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLS----SQSGQGLKEFKNEMMLIA 564
ENF + LG G +G V+ R G+ A+K L Q + + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 565 ELQHR-NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
++ LV + + + LIL+Y+ L +L ++R + E +I + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYV----GE 137
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671
+L L +L II+RD+K N+LLD + + ++DFGL++ F DE +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 109 bits (274), Expect = 5e-27
Identities = 38/173 (21%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRN 570
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 571 LVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
++ + + + L+ E++ N + L D++ R + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIR-FYMYEILKALDYC 145
Query: 629 HQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
H + I+HRD+K NV++D + ++ D+GLA + + V +
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVAS 192
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (272), Expect = 7e-27
Identities = 38/170 (22%), Positives = 68/170 (40%), Gaps = 16/170 (9%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
K+G G FG +Y G + G+EVA+K ++ + E + +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
+G+ +++ + SL+ R + + + + + Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 639 RDLKASNVL---LDKDMNPKISDFGLARMFGGDELQGN-----TKRIVGT 680
RD+K N L K I DFGLA+ + + K + GT
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (254), Expect = 2e-25
Identities = 29/158 (18%), Positives = 54/158 (34%), Gaps = 28/158 (17%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVK--RLSSQSGQGLK--------EFKNEMMLIAELQHR 569
+GEG V+ E VK ++ S + +K F + A + R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 570 NLVRILGCCV----EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
L ++ G V +++E + K + + E ++ I + +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEEV 116
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ I+H DL NVL+ + I DF +
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 2e-24
Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 21/177 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAELQHR 569
+ + +G G G V + VA+K+LS Q+ K E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 570 NLVRILGCCVEQG------EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
N++ +L Q + L++E M V + LD E ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 130
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
G+ +LH IIHRDLK SN+++ D KI DFGLAR G + V T
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVT 181
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 2e-24
Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAELQH 568
E + +G G +G V G VAVK+LS QS K E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 569 RNLVRILGCCVEQ-----GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
N++ +L + ++ ++ L+ + +K + L + +I I +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILR 132
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
GL Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 133 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 91.2 bits (226), Expect = 1e-22
Identities = 22/118 (18%), Positives = 49/118 (41%), Gaps = 13/118 (11%)
Query: 34 IRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTIS 93
+ +GE L + Q ++ + + L ++ T VW +N + +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYDH---STSVWASNTGILG-KKGCKAVLQ 58
Query: 94 NNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDH 151
++GN V+ ++W+++ N V L++DGN+VI + +W + +
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------IWSTGTY 108
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.4 bits (215), Expect = 4e-19
Identities = 32/175 (18%), Positives = 65/175 (37%), Gaps = 18/175 (10%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
KLG G F V+ + + N VA+K + + ++E+ L+ + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 579 VEQGEKIL-------------ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
K+L ++ + + L + R + +I + + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFGGDELQGNTKRIVG 679
Y+H+ R IIH D+K NVL++ D + +A + + +
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 72.6 bits (178), Expect = 5e-16
Identities = 17/97 (17%), Positives = 36/97 (37%), Gaps = 9/97 (9%)
Query: 64 IWFRRVP-DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVA 122
I + D + + + L++ + NLVL + + +WSTN + A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA 70
Query: 123 QLRDDGNLVIRDNSSDSTAESYLWQSFD--HPSDTLL 157
L+ +G + + N + +W S + +
Sbjct: 71 VLQPNGRMDVLTNQN-----IAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 55.7 bits (134), Expect = 4e-10
Identities = 22/99 (22%), Positives = 38/99 (38%), Gaps = 5/99 (5%)
Query: 42 SSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLL 101
++Q +L + L ++ R D VW N G + NG + +L
Sbjct: 27 HATQSLQLSPYRLSMETDCNLVLFDR---DDRVWSTNT--AGKGTGCRAVLQPNGRMDVL 81
Query: 102 SQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDST 140
+ N +W++ S V L+ D NL I + +T
Sbjct: 82 TNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGGALWTT 120
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 70.8 bits (173), Expect = 1e-15
Identities = 27/126 (21%), Positives = 46/126 (36%), Gaps = 20/126 (15%)
Query: 26 DTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISG 85
+ + + + GE L F L ++ D +W N
Sbjct: 2 NILYSGETLSTGEFLNY--GSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49
Query: 86 RNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYL 145
R+ L++ +GNLV+ + +N IW++N N V L+ D N+VI
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------R 101
Query: 146 WQSFDH 151
W + H
Sbjct: 102 WATGTH 107
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 39.2 bits (91), Expect = 2e-04
Identities = 18/80 (22%), Positives = 35/80 (43%), Gaps = 1/80 (1%)
Query: 83 ISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAE 142
++ + V + + NLVL + IW+TN ++ ++ DGNLV+ + S+
Sbjct: 16 LNYGSFVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWA 74
Query: 143 SYLWQSFDHPSDTLLQDMKL 162
S + L +D +
Sbjct: 75 SNTGGQNGNYVCILQKDRNV 94
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 67.1 bits (163), Expect = 3e-14
Identities = 25/130 (19%), Positives = 49/130 (37%), Gaps = 18/130 (13%)
Query: 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPIS 84
+D + + + G L + + + VW + +
Sbjct: 1 SDRLNSGHQLDTGGSLAEG--GYLFIIQNDCNLVLYD--------NNRAVWASGTNGK-- 48
Query: 85 GRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESY 144
VL + N+GNLV+ + IW++N + N L+ D N+VI DNS+ +
Sbjct: 49 ASGCVLKMQNDGNLVIY-SGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 145 LWQSFDHPSD 154
+W + + +
Sbjct: 103 IWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 65.4 bits (159), Expect = 2e-13
Identities = 19/109 (17%), Positives = 41/109 (37%), Gaps = 18/109 (16%)
Query: 40 LTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLV 99
+ + + + L ++ + +W N G + +G LV
Sbjct: 25 ILFGTHVYRFIMQTDCN-----LVLY---DNNNPIWATNTGGL--GNGCRAVLQPDGVLV 74
Query: 100 LLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148
+++ N T+W + V+ + V L+ D N+VI ++ LW +
Sbjct: 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA--------LWAT 115
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 41.5 bits (97), Expect = 3e-05
Identities = 21/102 (20%), Positives = 35/102 (34%), Gaps = 1/102 (0%)
Query: 61 YLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNP 120
+ P + + + + + NLV L N IW+TN
Sbjct: 5 FSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLV-LYDNNNPIWATNTGGLGNGC 63
Query: 121 VAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKL 162
A L+ DG LV+ N + + +S + H L D +
Sbjct: 64 RAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNV 105
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 56.1 bits (135), Expect = 2e-10
Identities = 23/126 (18%), Positives = 39/126 (30%), Gaps = 20/126 (15%)
Query: 16 LFSM-KASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVV 74
LF + T+ A + F S L ++ D V
Sbjct: 4 LFGLSHEGSHPQTLHAAQSLELS--------SFRFTMQSDCN-----LVLFD---SDVRV 47
Query: 75 WVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRD 134
W +N + ++G LV+L+ N WS+ + N V L+ D + I
Sbjct: 48 WASNTA---GATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG 104
Query: 135 NSSDST 140
+
Sbjct: 105 PGLWDS 110
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 51.5 bits (123), Expect = 9e-09
Identities = 22/131 (16%), Positives = 38/131 (29%), Gaps = 39/131 (29%)
Query: 64 IWFRRVPD-TVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVA 122
I F + + + + + + T+ ++ NLVL + +W++N + A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRA 60
Query: 123 QLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAED 182
L+ DG LVI + W S
Sbjct: 61 VLQSDGLLVILTAQNTIR------------------------------------WSSGTK 84
Query: 183 PSPGRYTYGLD 193
S G Y L
Sbjct: 85 GSIGNYVLVLQ 95
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 680 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.98 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.97 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.97 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.97 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.96 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.96 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.96 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.96 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.96 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.96 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.96 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.96 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.96 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.96 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.96 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.96 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.96 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.95 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.95 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.95 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.95 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.95 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.95 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.95 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.95 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.95 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.95 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.95 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.95 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.95 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.95 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.95 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.95 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.94 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.94 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.94 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.94 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.94 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.94 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.93 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.93 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.93 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.92 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.92 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.92 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.92 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.91 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.86 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.85 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.85 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.83 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.69 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.65 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.59 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.48 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.31 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.15 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.03 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.97 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.79 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.81 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.15 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.05 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.36 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.66 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 87.6 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 85.37 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 81.34 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.3e-32 Score=279.90 Aligned_cols=162 Identities=31% Similarity=0.430 Sum_probs=140.0
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.++||+|+||.||+|+. .+++.||||++.... ....+++++|++++++++||||+++++++.+.+..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5799999999999999999985 568999999987542 33456799999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCcc
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (680)
+++|+|.+++. +...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..+..
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999883 3457899999999999999999999988 99999999999999999999999999998865544
Q ss_pred ccCccccccC
Q 005731 671 QGNTKRIVGT 680 (680)
Q Consensus 671 ~~~~~~~~Gt 680 (680)
....+..+||
T Consensus 159 ~~~~~~~~GT 168 (271)
T d1nvra_ 159 ERLLNKMCGT 168 (271)
T ss_dssp ECCBCCCCSC
T ss_pred cccccceeeC
Confidence 4444456776
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-31 Score=274.22 Aligned_cols=150 Identities=27% Similarity=0.442 Sum_probs=136.7
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
++|++.++||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++.+.+..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999984 569999999997655556778999999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
++|+|.+++. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..+.
T Consensus 100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 9999988763 246899999999999999999999988 9999999999999999999999999999885543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=3.8e-32 Score=279.10 Aligned_cols=154 Identities=32% Similarity=0.544 Sum_probs=138.5
Q ss_pred hcCCcceeeeeccCCceeEEEEEEc-CCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
..++|++.++||+|+||.||+|+.. +++.||||+++.. ....++|++|++++++++|||||++++++.+.+..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 4568999999999999999999864 5889999999763 3456789999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
|+++|+|..++... ....+++..+..|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+..+.
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999998543 3457899999999999999999999987 9999999999999999999999999999876544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-31 Score=271.29 Aligned_cols=151 Identities=30% Similarity=0.556 Sum_probs=131.3
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
++|++.++||+|+||.||+|+..+++.||||+++.. ....++|.+|++++++++|||||+++|+|...+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 579999999999999999999888899999999763 4456789999999999999999999999999999999999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
+|+|.+++.. ....++++.++.++.||++||+|||+.+ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999998843 3356889999999999999999999987 9999999999999999999999999999875543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.1e-31 Score=270.17 Aligned_cols=152 Identities=34% Similarity=0.546 Sum_probs=135.4
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
.++|++.+.||+|+||.||+|+..+++.||||+++.. ....++|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 4689999999999999999999888899999999753 3456789999999999999999999998754 5679999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
++|+|.+++... ....+++.+++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999887443 2335899999999999999999999987 9999999999999999999999999999886544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-31 Score=273.80 Aligned_cols=150 Identities=27% Similarity=0.459 Sum_probs=136.9
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
+.|++.+.||+|+||.||+|+. .+++.||||+++.......++|.+|++++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5689999999999999999985 568999999998766667788999999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
++|+|.+++.+ ....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999988743 2356899999999999999999999988 99999999999999999999999999987643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-31 Score=271.50 Aligned_cols=161 Identities=32% Similarity=0.500 Sum_probs=131.5
Q ss_pred cCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.++|++.+.||+|+||.||+|+.. ..||||+++.. .....++|++|++++.+++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 468999999999999999999854 46999999743 34567889999999999999999999998754 56899999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
|+++|+|.+++.. ....+++..++.|+.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999853 2346899999999999999999999987 9999999999999999999999999999876544
Q ss_pred cccCccccccC
Q 005731 670 LQGNTKRIVGT 680 (680)
Q Consensus 670 ~~~~~~~~~Gt 680 (680)
......++.||
T Consensus 159 ~~~~~~~~~gt 169 (276)
T d1uwha_ 159 GSHQFEQLSGS 169 (276)
T ss_dssp -------CCCC
T ss_pred CcccccccccC
Confidence 33333445554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.1e-31 Score=271.98 Aligned_cols=162 Identities=31% Similarity=0.426 Sum_probs=137.5
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999985 56899999998642 2345678999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||+.+ ||||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999998873 3457899999999999999999999988 999999999999999999999999999988655
Q ss_pred ccccCccccccC
Q 005731 669 ELQGNTKRIVGT 680 (680)
Q Consensus 669 ~~~~~~~~~~Gt 680 (680)
......+..+||
T Consensus 162 ~~~~~~~~~~GT 173 (288)
T d1uu3a_ 162 SKQARANSFVGT 173 (288)
T ss_dssp --------CCCC
T ss_pred CcccccccccCC
Confidence 444444456666
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-31 Score=277.38 Aligned_cols=150 Identities=25% Similarity=0.350 Sum_probs=135.3
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.++|++.++||+|+||.||+|+. .+++.||||+++.. .....+++.+|+.++++++|||||++++++.+..+.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46899999999999999999985 56899999999754 33446789999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|+++|+|.+++.+ ...+++..+..++.|+++||.|||+. + |+||||||+||||++++.+||+|||+|+.+..
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999843 35689999999999999999999974 6 99999999999999999999999999997743
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.7e-31 Score=265.54 Aligned_cols=150 Identities=31% Similarity=0.430 Sum_probs=135.0
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+|+. .+++.||||++... .....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4799999999999999999986 46889999998642 2334678999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++|+|.+++. +...+++.++..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999984 3456899999999999999999999987 999999999999999999999999999877543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=6.9e-31 Score=271.20 Aligned_cols=152 Identities=31% Similarity=0.551 Sum_probs=126.3
Q ss_pred CCcceeeeeccCCceeEEEEEEcC-C---cEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN-G---QEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~-~---~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 587 (680)
++|++.++||+|+||+||+|+... + ..||||++... .....++|.+|++++++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 568888999999999999998642 2 36899998754 344567899999999999999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++|+|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998743 2346899999999999999999999987 99999999999999999999999999998865
Q ss_pred Cc
Q 005731 668 DE 669 (680)
Q Consensus 668 ~~ 669 (680)
+.
T Consensus 181 ~~ 182 (299)
T d1jpaa_ 181 DT 182 (299)
T ss_dssp --
T ss_pred CC
Confidence 44
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-30 Score=261.52 Aligned_cols=151 Identities=30% Similarity=0.512 Sum_probs=137.4
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
++|++.++||+|+||.||+|+.+++++||||+++.. ....++|++|+.++++++||||++++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 689999999999999999999888889999999863 3456789999999999999999999999999999999999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
+|+|..++.. ....+.+..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999988744 3346789999999999999999999987 9999999999999999999999999999875543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.8e-31 Score=266.12 Aligned_cols=157 Identities=29% Similarity=0.465 Sum_probs=126.8
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe--CCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE--QGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 587 (680)
++|++.+.||+|+||.||+|+. .+|+.||||.+... .....+.|.+|++++++++|||||++++++.+ ....|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999985 56899999998754 23345679999999999999999999999875 3568999
Q ss_pred EEccCCCChhhHhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 588 LEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYS--RLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
|||+++|+|.+++.+.. ....+++..+..++.||+.||+|||+++ ..+||||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999885432 3457899999999999999999999864 23599999999999999999999999999998
Q ss_pred cCCCc
Q 005731 665 FGGDE 669 (680)
Q Consensus 665 ~~~~~ 669 (680)
+..+.
T Consensus 164 ~~~~~ 168 (269)
T d2java1 164 LNHDT 168 (269)
T ss_dssp C----
T ss_pred cccCC
Confidence 76543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-30 Score=264.71 Aligned_cols=151 Identities=30% Similarity=0.539 Sum_probs=131.9
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 592 (680)
++|++.+.||+|+||+||+|+..+++.||||+++.. ....++|.+|+.++++++|||||+++|++. .++.++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 679999999999999999999888889999999753 445678999999999999999999999985 456899999999
Q ss_pred CCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
+|+|..++... ....+++.+++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999887543 3346899999999999999999999987 9999999999999999999999999999875443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.96 E-value=7.8e-30 Score=268.72 Aligned_cols=152 Identities=22% Similarity=0.411 Sum_probs=137.0
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5899999999999999999985 568999999998765566778999999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC--CCCeEEeeeccceecCCCc
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK--DMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~ 669 (680)
++|+|.+++.+ ....+++.++..|+.||+.||+|||+++ ||||||||+|||++. ++.+||+|||+|+.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999988843 2346899999999999999999999988 999999999999964 5789999999999886543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.5e-30 Score=260.94 Aligned_cols=152 Identities=30% Similarity=0.527 Sum_probs=131.6
Q ss_pred cCCcceee-eeccCCceeEEEEEEc---CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 512 TENFSMQC-KLGEGGFGPVYKGRLF---NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 512 ~~~f~~~~-~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
.++|.+.+ +||+|+||.||+|... ++..||||+++.. .....++|++|++++++++|||||+++|++. .+..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec-cCeEEE
Confidence 35677777 4999999999999743 3558999999754 3345678999999999999999999999985 457899
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+++|+|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998743 2356899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCc
Q 005731 667 GDE 669 (680)
Q Consensus 667 ~~~ 669 (680)
...
T Consensus 161 ~~~ 163 (285)
T d1u59a_ 161 ADD 163 (285)
T ss_dssp TCS
T ss_pred ccc
Confidence 543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=2.8e-30 Score=267.51 Aligned_cols=150 Identities=31% Similarity=0.507 Sum_probs=133.5
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc---ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
+.|+..+.||+|+||.||+|+. .+++.||||++..... ...++|.+|++++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4599999999999999999984 5688999999875432 33567999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++|+|..++. ....+++.++..++.||+.||.|||+++ ||||||||+||||++++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999976652 3457899999999999999999999988 999999999999999999999999999976543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.9e-30 Score=268.66 Aligned_cols=160 Identities=28% Similarity=0.343 Sum_probs=140.2
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+|+. .+++.||||++++. .....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999985 57999999999753 2335678999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
||+++|+|.+++. +...++++.+..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999883 3457889999999999999999999988 999999999999999999999999999977543
Q ss_pred ccccCccccccC
Q 005731 669 ELQGNTKRIVGT 680 (680)
Q Consensus 669 ~~~~~~~~~~Gt 680 (680)
.. ....++||
T Consensus 159 ~~--~~~~~~GT 168 (337)
T d1o6la_ 159 GA--TMKTFCGT 168 (337)
T ss_dssp TC--CBCCCEEC
T ss_pred Cc--ccccceeC
Confidence 32 23346666
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.96 E-value=9.6e-30 Score=268.23 Aligned_cols=152 Identities=26% Similarity=0.404 Sum_probs=136.6
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 591 (680)
++|++.+.||+|+||.||+|+. .+++.||||+++.......+.+.+|++++++++|||||++++++.+....+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999985 569999999998755555678899999999999999999999999999999999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc--CCCCeEEeeeccceecCCCc
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD--KDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~~ 669 (680)
++|+|.+++.. ....+++.++..|+.||+.||+|||+.+ ||||||||+||||+ .++.+||+|||+|+.+..+.
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999887632 2346899999999999999999999988 99999999999998 57899999999999886544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.9e-30 Score=268.12 Aligned_cols=157 Identities=33% Similarity=0.500 Sum_probs=132.6
Q ss_pred hcCCcceeeeeccCCceeEEEEEEcC-C-----cEEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRLFN-G-----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-~-----~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 582 (680)
..++|++.++||+|+||.||+|+... + ..||||.+... .......|.+|+.++.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34689999999999999999998543 2 36999998653 334456899999999998 8999999999999999
Q ss_pred eEEEEEEccCCCChhhHhccccc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCC
Q 005731 583 EKILILEYMPNKSLDVYLFDPIK--------------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 642 (680)
..++||||+++|+|.++|..... ...+++.+++.|+.||++||+|||+++ |||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999999865321 235889999999999999999999987 9999999
Q ss_pred CCcEEEcCCCCeEEeeeccceecCCCcc
Q 005731 643 ASNVLLDKDMNPKISDFGLARMFGGDEL 670 (680)
Q Consensus 643 p~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (680)
|+|||++.++.+||+|||+|+.......
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~ 219 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSN 219 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTT
T ss_pred hhccccccCCeEEEeeccccccccCCCc
Confidence 9999999999999999999998755443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.8e-30 Score=259.14 Aligned_cols=150 Identities=30% Similarity=0.453 Sum_probs=128.6
Q ss_pred cceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeEEEE
Q 005731 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE----QGEKILI 587 (680)
Q Consensus 515 f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV 587 (680)
|++.++||+|+||.||+|+. .+++.||||++... .....+.|.+|++++++++|||||++++++.. ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 36678999999999999985 46889999998653 33446679999999999999999999999875 3457999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc-CCCCeEEeeeccceecC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMFG 666 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~ 666 (680)
|||+++|+|.+++. +...+++.++..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999984 3456899999999999999999999864 4599999999999996 57899999999998754
Q ss_pred CC
Q 005731 667 GD 668 (680)
Q Consensus 667 ~~ 668 (680)
..
T Consensus 167 ~~ 168 (270)
T d1t4ha_ 167 AS 168 (270)
T ss_dssp TT
T ss_pred CC
Confidence 43
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=3.4e-30 Score=266.47 Aligned_cols=162 Identities=31% Similarity=0.498 Sum_probs=139.8
Q ss_pred HHHHHhcCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEE
Q 005731 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCC 578 (680)
Q Consensus 506 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 578 (680)
.+++.++++|++.+.||+|+||.||+|+.. +++.||||+++... .+..++|.+|++++++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344556788999999999999999999853 35789999997543 33467899999999999999999999999
Q ss_pred EeCCeEEEEEEccCCCChhhHhcccc---------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 005731 579 VEQGEKILILEYMPNKSLDVYLFDPI---------------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRII 637 (680)
Q Consensus 579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 637 (680)
......+++|||+++|+|.+++.... ....+++..++.|+.||+.||+|||+++ ||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999985321 1234789999999999999999999987 99
Q ss_pred eCCCCCCcEEEcCCCCeEEeeeccceecCCCcc
Q 005731 638 HRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (680)
Q Consensus 638 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (680)
||||||+||||+.++.+||+|||+|+.+.....
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~ 195 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCcc
Confidence 999999999999999999999999998755443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.96 E-value=2.2e-29 Score=256.80 Aligned_cols=151 Identities=28% Similarity=0.390 Sum_probs=135.0
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc---------ccHHHHHHHHHHHhhcC-CCceeeEEEEEEeC
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG---------QGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQ 581 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~---------~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~ 581 (680)
++|++.+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999985 5789999999865321 12346889999999997 99999999999999
Q ss_pred CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeecc
Q 005731 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 661 (680)
+..||||||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999843 456899999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCc
Q 005731 662 ARMFGGDE 669 (680)
Q Consensus 662 a~~~~~~~ 669 (680)
|+.+..+.
T Consensus 157 a~~~~~~~ 164 (277)
T d1phka_ 157 SCQLDPGE 164 (277)
T ss_dssp CEECCTTC
T ss_pred eeEccCCC
Confidence 99886543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1e-29 Score=260.44 Aligned_cols=152 Identities=33% Similarity=0.564 Sum_probs=128.1
Q ss_pred CCcceeeeeccCCceeEEEEEEcCC-----cEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNG-----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~-----~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
+.|++.++||+|+||.||+|..... ..||||++... ......+|++|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5788999999999999999986542 47999999754 33345679999999999999999999999999999999
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+.++++..++.. ....+++.+++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999887743 3356899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCc
Q 005731 667 GDE 669 (680)
Q Consensus 667 ~~~ 669 (680)
.+.
T Consensus 162 ~~~ 164 (283)
T d1mqba_ 162 DDP 164 (283)
T ss_dssp ---
T ss_pred CCC
Confidence 543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=1.2e-29 Score=263.74 Aligned_cols=149 Identities=29% Similarity=0.440 Sum_probs=134.3
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999985 56899999998642 2345678999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+++|+|..++ .....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 84 E~~~gg~l~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLL---RKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHH---HHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccc---cccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999998887 34456788888899999999999999987 99999999999999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.7e-29 Score=257.82 Aligned_cols=144 Identities=33% Similarity=0.516 Sum_probs=125.2
Q ss_pred eeeccCCceeEEEEEEcC---CcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEccCC
Q 005731 519 CKLGEGGFGPVYKGRLFN---GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (680)
Q Consensus 519 ~~LG~G~fG~Vy~~~~~~---~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 593 (680)
++||+|+||.||+|.... ++.||||+++.. .....++|.+|++++++++|||||+++|+|. .+..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence 479999999999997543 468999999753 2334578999999999999999999999985 4567999999999
Q ss_pred CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
|+|.+++. +...+++.+++.++.||++||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 99999984 3456899999999999999999999987 9999999999999999999999999999876543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=9.2e-30 Score=263.51 Aligned_cols=151 Identities=26% Similarity=0.388 Sum_probs=123.0
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
.+.|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++++++||||+++++++.+.+..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35799999999999999999985 468999999997543 2234568899999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEc---CCCCeEEeeeccceecC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD---KDMNPKISDFGLARMFG 666 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~~~ 666 (680)
|+++|+|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999984 3457899999999999999999999988 99999999999995 57899999999999775
Q ss_pred CC
Q 005731 667 GD 668 (680)
Q Consensus 667 ~~ 668 (680)
..
T Consensus 162 ~~ 163 (307)
T d1a06a_ 162 PG 163 (307)
T ss_dssp --
T ss_pred CC
Confidence 44
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.3e-29 Score=255.90 Aligned_cols=151 Identities=30% Similarity=0.436 Sum_probs=134.7
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC------CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ------SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~------~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
++|++.+.||+|+||.||+|+. .+|+.||||+++.. .....+.|.+|++++++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5799999999999999999985 56899999998642 1224678999999999999999999999999999999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC----CeEEeeecc
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM----NPKISDFGL 661 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGl 661 (680)
|||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999843 356899999999999999999999988 99999999999998776 499999999
Q ss_pred ceecCCCc
Q 005731 662 ARMFGGDE 669 (680)
Q Consensus 662 a~~~~~~~ 669 (680)
|+.+....
T Consensus 164 a~~~~~~~ 171 (293)
T d1jksa_ 164 AHKIDFGN 171 (293)
T ss_dssp CEECTTSC
T ss_pred hhhcCCCc
Confidence 99885543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.7e-28 Score=255.69 Aligned_cols=152 Identities=20% Similarity=0.307 Sum_probs=134.2
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.++|++.+.||+|+||+||+|.. .+++.||||.++... .....+.+|++++++++||||+++++++.+.+..||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 36899999999999999999985 468899999997643 3345688999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCC--CCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD--MNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~ 668 (680)
+++|+|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999998843 2336899999999999999999999988 9999999999999854 58999999999987554
Q ss_pred c
Q 005731 669 E 669 (680)
Q Consensus 669 ~ 669 (680)
.
T Consensus 158 ~ 158 (321)
T d1tkia_ 158 D 158 (321)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.95 E-value=6.9e-29 Score=261.55 Aligned_cols=149 Identities=24% Similarity=0.334 Sum_probs=135.0
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 588 (680)
++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999985 56999999998642 2234678999999999999999999999999999999999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
||+.+|+|..++. +...+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999884 3356899999999999999999999987 99999999999999999999999999998854
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.8e-29 Score=258.55 Aligned_cols=162 Identities=33% Similarity=0.514 Sum_probs=131.0
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCc----EEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~----~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
.+|++.++||+|+||.||+|+.. +++ +||||+++.. ..+..++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999853 343 6899998653 445678899999999999999999999999864 5788
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
++||+.+|+|.+++.. ....+++..++.++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999888743 3457899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCccccCccccccC
Q 005731 667 GDELQGNTKRIVGT 680 (680)
Q Consensus 667 ~~~~~~~~~~~~Gt 680 (680)
.......+....||
T Consensus 163 ~~~~~~~~~~~~gt 176 (317)
T d1xkka_ 163 AEEKEYHAEGGKVP 176 (317)
T ss_dssp TTCC--------CC
T ss_pred cccccccccccccC
Confidence 65544333334443
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.9e-29 Score=258.31 Aligned_cols=168 Identities=30% Similarity=0.434 Sum_probs=130.3
Q ss_pred HhcCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 005731 510 AATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ 581 (680)
Q Consensus 510 ~~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 581 (680)
...++|++.++||+|+||.||+|+.. +++.||||+++.. .....+++.+|+.++.++ +|+||+++++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 44578999999999999999999843 3468999999753 334466788888888877 789999999998765
Q ss_pred C-eEEEEEEccCCCChhhHhccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEE
Q 005731 582 G-EKILILEYMPNKSLDVYLFDPIK-------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647 (680)
Q Consensus 582 ~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 647 (680)
+ ..++||||+++|+|.+++..... ...+++.++..++.||++||+|||+++ ||||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence 4 68999999999999999864321 235889999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeeeccceecCCCccccCccccccC
Q 005731 648 LDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680 (680)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt 680 (680)
|++++.+||+|||+|+..............+||
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 199 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 199 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeC
Confidence 999999999999999987655444444445554
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=1.1e-28 Score=261.25 Aligned_cols=151 Identities=28% Similarity=0.331 Sum_probs=130.5
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHH---HHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFK---NEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~---~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
++|++.++||+|+||.||+|+. .+|+.||||++... .......+. +|+.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 6899999999999999999985 46899999998642 112233344 4477788889999999999999999999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+||||+++|+|.+++. +...+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999984 3456789999999999999999999988 999999999999999999999999999988
Q ss_pred CCCc
Q 005731 666 GGDE 669 (680)
Q Consensus 666 ~~~~ 669 (680)
....
T Consensus 158 ~~~~ 161 (364)
T d1omwa3 158 SKKK 161 (364)
T ss_dssp SSSC
T ss_pred CCCc
Confidence 6543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.1e-28 Score=255.82 Aligned_cols=156 Identities=31% Similarity=0.483 Sum_probs=135.5
Q ss_pred cCCcceeeeeccCCceeEEEEEEc------CCcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 584 (680)
.++|++.+.||+|+||.||+|+.. +++.||||+++.. .......|.+|+.++++++||||+++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 468999999999999999999753 3578999999754 333456799999999999999999999999999999
Q ss_pred EEEEEccCCCChhhHhcccc-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEe
Q 005731 585 ILILEYMPNKSLDVYLFDPI-------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (680)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 657 (680)
++||||+++|+|.+++.... ....+++..+..++.|+++||.|||+++ |+||||||+||||+.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999885421 1234688999999999999999999987 9999999999999999999999
Q ss_pred eeccceecCCCcc
Q 005731 658 DFGLARMFGGDEL 670 (680)
Q Consensus 658 DFGla~~~~~~~~ 670 (680)
|||+|+.+.....
T Consensus 176 DFGla~~~~~~~~ 188 (308)
T d1p4oa_ 176 DFGMTRDIYETDY 188 (308)
T ss_dssp CTTCCCGGGGGGC
T ss_pred ecccceeccCCcc
Confidence 9999998755443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.7e-28 Score=253.34 Aligned_cols=151 Identities=30% Similarity=0.489 Sum_probs=130.1
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|++.++||+|+||.||+|+. .+++.||||+++... ....+++.+|++++++++||||+++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999985 568999999996432 2346789999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
|+.++.+ .++.. .....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....+
T Consensus 82 ~~~~~~~-~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLK-KFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHH-HHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchh-hhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 9976544 34322 23456899999999999999999999988 999999999999999999999999999987543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.4e-28 Score=254.32 Aligned_cols=151 Identities=26% Similarity=0.383 Sum_probs=132.6
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC---CcccHHHHHHHHHHHh-hcCCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIA-ELQHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 587 (680)
++|++.++||+|+||+||+|+. .+++.||||++++. .....+.+..|..++. .++||||+++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999985 46899999999642 2334566777777765 68999999999999999999999
Q ss_pred EEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCC
Q 005731 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 667 (680)
|||+++|+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999984 3456889999999999999999999987 99999999999999999999999999997754
Q ss_pred Cc
Q 005731 668 DE 669 (680)
Q Consensus 668 ~~ 669 (680)
..
T Consensus 156 ~~ 157 (320)
T d1xjda_ 156 GD 157 (320)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.2e-28 Score=250.89 Aligned_cols=151 Identities=32% Similarity=0.469 Sum_probs=124.1
Q ss_pred CCcceeeeeccCCceeEEEEEEcC--C--cEEEEEEccCC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFN--G--QEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~--~--~~VAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 585 (680)
++|++.+.||+|+||.||+|+... + .+||||+++.. ..+..++|.+|+.++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 579999999999999999998532 2 37899998753 23446789999999999999999999999965 5678
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+||||+++|++.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999888743 2346899999999999999999999987 999999999999999999999999999988
Q ss_pred CCCc
Q 005731 666 GGDE 669 (680)
Q Consensus 666 ~~~~ 669 (680)
....
T Consensus 162 ~~~~ 165 (273)
T d1u46a_ 162 PQND 165 (273)
T ss_dssp CC-C
T ss_pred ccCC
Confidence 5544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.7e-28 Score=250.07 Aligned_cols=151 Identities=27% Similarity=0.439 Sum_probs=123.9
Q ss_pred cCCcceeeeeccCCceeEEEEEEcC----CcEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 586 (680)
.++|++.+.||+|+||.||+|+... +..||||.++.. .....+.|.+|++++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4689999999999999999998532 357999998754 3334567999999999999999999999985 467899
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecC
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 666 (680)
||||+++|+|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999988643 3456899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 005731 667 GD 668 (680)
Q Consensus 667 ~~ 668 (680)
..
T Consensus 160 ~~ 161 (273)
T d1mp8a_ 160 DS 161 (273)
T ss_dssp --
T ss_pred CC
Confidence 44
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.95 E-value=3.1e-28 Score=248.61 Aligned_cols=151 Identities=26% Similarity=0.374 Sum_probs=132.4
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC----e
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG----E 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~ 583 (680)
.++|++.+.||+|+||.||+|+. .+++.||||+++... ....++|.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999984 579999999997532 234567999999999999999999999998654 3
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.||||||+++++|..++. ..+.+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999998873 3456899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCC
Q 005731 664 MFGGD 668 (680)
Q Consensus 664 ~~~~~ 668 (680)
.....
T Consensus 160 ~~~~~ 164 (277)
T d1o6ya_ 160 AIADS 164 (277)
T ss_dssp ECC--
T ss_pred hhccc
Confidence 76443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2e-28 Score=254.19 Aligned_cols=167 Identities=30% Similarity=0.394 Sum_probs=140.1
Q ss_pred hcCCcceeeeeccCCceeEEEEEE------cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 005731 511 ATENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (680)
Q Consensus 511 ~~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 582 (680)
..++|++.++||+|+||.||+|+. .+++.||||+++... .....+|.+|+.++.++ +|||||++++++.+..
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 347899999999999999999975 245789999997543 33456799999999999 7999999999999999
Q ss_pred eEEEEEEccCCCChhhHhcccc---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEE
Q 005731 583 EKILILEYMPNKSLDVYLFDPI---------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NIL 647 (680)
..++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ ||||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 9999999999999999986432 1235889999999999999999999988 999999999999
Q ss_pred EcCCCCeEEeeeccceecCCCccccCccccccC
Q 005731 648 LDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680 (680)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt 680 (680)
++.++.+||+|||+++...............||
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt 210 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred ccccCcccccccchheeccCCCcceEeeecccC
Confidence 999999999999999987654433333334443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.8e-28 Score=251.09 Aligned_cols=151 Identities=30% Similarity=0.420 Sum_probs=126.1
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC----eEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG----EKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 588 (680)
++|.+.+.||+|+||.||+|+. +|+.||||+++... .....+..|+..+..++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5688899999999999999985 68899999996532 11222334555666789999999999998754 689999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS-----RLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
||+++|+|.++|.+ ..+++..++.++.|++.||+|||+.. ..+||||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999943 35899999999999999999999741 2359999999999999999999999999999
Q ss_pred ecCCCc
Q 005731 664 MFGGDE 669 (680)
Q Consensus 664 ~~~~~~ 669 (680)
.+....
T Consensus 157 ~~~~~~ 162 (303)
T d1vjya_ 157 RHDSAT 162 (303)
T ss_dssp EEETTT
T ss_pred cccCCC
Confidence 885543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.2e-28 Score=252.60 Aligned_cols=147 Identities=33% Similarity=0.424 Sum_probs=125.7
Q ss_pred eeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc-----ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 517 MQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG-----QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 517 ~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
.+++||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+.++++++|||||++++++...+..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 458999999999999985 5689999999964321 1235689999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
+.++++.... .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..+.
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9988776655 33456888899999999999999999988 9999999999999999999999999998775543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.95 E-value=3.5e-28 Score=249.43 Aligned_cols=150 Identities=27% Similarity=0.456 Sum_probs=134.7
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.++||+|+||.||+|+..+++.||||++... .....+++.+|+.++++++||||+++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 589999999999999999999888999999999653 233467899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
+.++.+..+. ...+.+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|..+...
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9887776665 33467899999999999999999999987 999999999999999999999999999887543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.6e-28 Score=251.25 Aligned_cols=151 Identities=33% Similarity=0.591 Sum_probs=131.1
Q ss_pred CCcceeeeeccCCceeEEEEEEc-CCc--EEEEEEccCC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILI 587 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~--~VAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 587 (680)
++|++.++||+|+||.||+|+.. ++. .||||++... .....++|.+|++++.++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67999999999999999999854 444 5788888643 334566899999999999 799999999999999999999
Q ss_pred EEccCCCChhhHhccc-------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCe
Q 005731 588 LEYMPNKSLDVYLFDP-------------IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (680)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 654 (680)
|||+++|+|.++|... .....+++..+.+++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23457899999999999999999999987 9999999999999999999
Q ss_pred EEeeeccceecC
Q 005731 655 KISDFGLARMFG 666 (680)
Q Consensus 655 kl~DFGla~~~~ 666 (680)
||+|||+|+...
T Consensus 167 kl~DfG~a~~~~ 178 (309)
T d1fvra_ 167 KIADFGLSRGQE 178 (309)
T ss_dssp EECCTTCEESSC
T ss_pred EEcccccccccc
Confidence 999999998664
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.4e-27 Score=247.51 Aligned_cols=147 Identities=30% Similarity=0.543 Sum_probs=127.8
Q ss_pred eeeeccCCceeEEEEEEcCC----cEEEEEEccCC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-CeEEEEEEcc
Q 005731 518 QCKLGEGGFGPVYKGRLFNG----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-GEKILILEYM 591 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~~----~~VAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~ 591 (680)
.++||+|+||+||+|+...+ ..||||+++.. .....++|.+|++++++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999986432 36899999753 444567899999999999999999999998875 5889999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCCc
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 669 (680)
++|+|.+++.. ....+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++.+....
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999998743 3445778899999999999999999987 9999999999999999999999999999875543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.8e-28 Score=246.46 Aligned_cols=149 Identities=32% Similarity=0.554 Sum_probs=126.2
Q ss_pred CCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-CeEEEEEEcc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-GEKILILEYM 591 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~ 591 (680)
++|++.+.||+|+||.||+|+. .+.+||||+++.. ...++|.+|++++++++||||++++|+|.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5788999999999999999997 5789999999753 3457899999999999999999999999764 5679999999
Q ss_pred CCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
++|+|.++|... ....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999998543 2235899999999999999999999987 999999999999999999999999999976543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7.3e-28 Score=248.53 Aligned_cols=157 Identities=32% Similarity=0.510 Sum_probs=131.4
Q ss_pred cCCcceeeeeccCCceeEEEEEEcC--------CcEEEEEEccCCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRLFN--------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ 581 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~~~--------~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 581 (680)
.++|++.+.||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4689999999999999999997432 2479999997643 34467899999999888 899999999999999
Q ss_pred CeEEEEEEccCCCChhhHhcccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEE
Q 005731 582 GEKILILEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648 (680)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl 648 (680)
...++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999996442 1246899999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeeccceecCCCccc
Q 005731 649 DKDMNPKISDFGLARMFGGDELQ 671 (680)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~ 671 (680)
+.++.+||+|||+++........
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~ 191 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYY 191 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTT
T ss_pred cCCCCeEeccchhhccccccccc
Confidence 99999999999999988655443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.7e-27 Score=246.82 Aligned_cols=148 Identities=23% Similarity=0.331 Sum_probs=126.5
Q ss_pred CCcceee-eeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEe----CCeEE
Q 005731 513 ENFSMQC-KLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE----QGEKI 585 (680)
Q Consensus 513 ~~f~~~~-~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~ 585 (680)
++|++.+ .||+|+||.||+|+. .+++.||||+++. ...+.+|++++.++ +|||||++++++.. ....|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5798765 599999999999985 5689999999864 25677899887655 89999999999875 35689
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC---CCCeEEeeeccc
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLA 662 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla 662 (680)
+||||+++|+|.+++.+. ....+++.++..++.||+.||+|||+.+ |+||||||+|||+++ .+.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 999999999999998542 2346899999999999999999999988 999999999999985 457999999999
Q ss_pred eecCCCc
Q 005731 663 RMFGGDE 669 (680)
Q Consensus 663 ~~~~~~~ 669 (680)
+......
T Consensus 162 ~~~~~~~ 168 (335)
T d2ozaa1 162 KETTSHN 168 (335)
T ss_dssp EECCCCC
T ss_pred eeccCCC
Confidence 9876543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.4e-27 Score=243.04 Aligned_cols=150 Identities=23% Similarity=0.374 Sum_probs=128.5
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCc------ccHHHHHHHHHHHhhcC--CCceeeEEEEEEeCCe
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG------QGLKEFKNEMMLIAELQ--HRNLVRILGCCVEQGE 583 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~------~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~ 583 (680)
++|++.+.||+|+||.||+|+. .+++.||||++..... ....++.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999985 5689999999864211 12244778999999986 8999999999999999
Q ss_pred EEEEEEccCC-CChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-CCCeEEeeecc
Q 005731 584 KILILEYMPN-KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGL 661 (680)
Q Consensus 584 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGl 661 (680)
.++||||+.+ +++.+++. ....++++++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 57777663 3457899999999999999999999988 999999999999985 47999999999
Q ss_pred ceecCCC
Q 005731 662 ARMFGGD 668 (680)
Q Consensus 662 a~~~~~~ 668 (680)
|+.....
T Consensus 158 a~~~~~~ 164 (273)
T d1xwsa_ 158 GALLKDT 164 (273)
T ss_dssp CEECCSS
T ss_pred ceecccc
Confidence 9976543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6.1e-27 Score=246.63 Aligned_cols=151 Identities=26% Similarity=0.402 Sum_probs=127.0
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC----eEE
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG----EKI 585 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 585 (680)
+.+|++.++||+|+||+||+|+. .+++.||||+++... ....+++.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35799999999999999999984 579999999997543 334668899999999999999999999987643 335
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceec
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 665 (680)
+++||+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55667789999998832 36899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCc
Q 005731 666 GGDE 669 (680)
Q Consensus 666 ~~~~ 669 (680)
....
T Consensus 160 ~~~~ 163 (345)
T d1pmea_ 160 DPDH 163 (345)
T ss_dssp CGGG
T ss_pred cCCC
Confidence 5443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.4e-26 Score=237.85 Aligned_cols=150 Identities=28% Similarity=0.438 Sum_probs=134.4
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 589 (680)
++|++.++||+|+||+||+|+. .+++.||||+++.. .....+++.+|+.+++.++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999985 57889999998643 23346789999999999999999999999999999999999
Q ss_pred ccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccceecCCC
Q 005731 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (680)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 668 (680)
++.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999887763 3456788999999999999999999987 999999999999999999999999999987543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=9.2e-27 Score=245.73 Aligned_cols=149 Identities=29% Similarity=0.429 Sum_probs=124.4
Q ss_pred CcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------CeEEE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------GEKIL 586 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 586 (680)
+|+..++||+|+||+||+|+. .+++.||||++..... .+.+|++++++++||||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 688889999999999999985 4689999999975432 224799999999999999999998653 24789
Q ss_pred EEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC-CeEEeeeccceec
Q 005731 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMF 665 (680)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~ 665 (680)
||||++++.+............+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987654444322234557899999999999999999999987 99999999999999765 8999999999987
Q ss_pred CCCc
Q 005731 666 GGDE 669 (680)
Q Consensus 666 ~~~~ 669 (680)
...+
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 5543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.94 E-value=2.1e-26 Score=240.87 Aligned_cols=145 Identities=24% Similarity=0.415 Sum_probs=127.4
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeC--CeEEEEE
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQ--GEKILIL 588 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 588 (680)
++|++.++||+|+||+||+|+. .+++.||||+++.. ..+++.+|++++.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999985 56899999999753 3567899999999995 99999999998754 4689999
Q ss_pred EccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCC-CeEEeeeccceecCC
Q 005731 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMFGG 667 (680)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 667 (680)
||+++++|..+. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999996653 35889999999999999999999988 99999999999998655 699999999998865
Q ss_pred Cc
Q 005731 668 DE 669 (680)
Q Consensus 668 ~~ 669 (680)
.+
T Consensus 183 ~~ 184 (328)
T d3bqca1 183 GQ 184 (328)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4.3e-26 Score=237.38 Aligned_cols=152 Identities=30% Similarity=0.502 Sum_probs=128.1
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-------
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------- 581 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------- 581 (680)
.++|++.++||+|+||+||+|+. .+++.||||++... .....+++.+|++++++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999985 57999999998643 333467789999999999999999999998653
Q ss_pred -CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeec
Q 005731 582 -GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (680)
Q Consensus 582 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 660 (680)
...++||||++++.+.... .....+....+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 4579999999988776554 33456888999999999999999999987 9999999999999999999999999
Q ss_pred cceecCCCc
Q 005731 661 LARMFGGDE 669 (680)
Q Consensus 661 la~~~~~~~ 669 (680)
+|+.+....
T Consensus 163 ~~~~~~~~~ 171 (318)
T d3blha1 163 LARAFSLAK 171 (318)
T ss_dssp TCEECCC--
T ss_pred eeeeccccc
Confidence 998876433
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.5e-26 Score=240.98 Aligned_cols=149 Identities=28% Similarity=0.442 Sum_probs=124.0
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------ 582 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 582 (680)
.++|++.++||+|+||.||+|+. .+++.||||+++.. .....+.+.+|+++|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 36899999999999999999985 56999999999753 2334567899999999999999999999997654
Q ss_pred eEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccc
Q 005731 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (680)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 662 (680)
+.++||||+ +.+|.... +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHH----HhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 579999999 56676655 2346899999999999999999999988 999999999999999999999999999
Q ss_pred eecCCC
Q 005731 663 RMFGGD 668 (680)
Q Consensus 663 ~~~~~~ 668 (680)
+.....
T Consensus 169 ~~~~~~ 174 (346)
T d1cm8a_ 169 RQADSE 174 (346)
T ss_dssp EECCSS
T ss_pred eccCCc
Confidence 987543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.2e-26 Score=239.66 Aligned_cols=151 Identities=28% Similarity=0.382 Sum_probs=132.2
Q ss_pred CCcceeeeeccCCceeEEEEEE----cCCcEEEEEEccCC----CcccHHHHHHHHHHHhhcCC-CceeeEEEEEEeCCe
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQ----SGQGLKEFKNEMMLIAELQH-RNLVRILGCCVEQGE 583 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~----~~~~~VAVK~l~~~----~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~ 583 (680)
++|++.++||+|+||+||+|+. .+|+.||||.++.. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5799999999999999999974 24789999998643 22345678899999999966 899999999999999
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.+++|||+.+|+|.+++. ....+.......++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999883 3345678888899999999999999987 9999999999999999999999999999
Q ss_pred ecCCCc
Q 005731 664 MFGGDE 669 (680)
Q Consensus 664 ~~~~~~ 669 (680)
.+....
T Consensus 178 ~~~~~~ 183 (322)
T d1vzoa_ 178 EFVADE 183 (322)
T ss_dssp ECCGGG
T ss_pred hhcccc
Confidence 875443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.92 E-value=1.9e-25 Score=229.58 Aligned_cols=148 Identities=20% Similarity=0.341 Sum_probs=127.7
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCC-CceeeEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH-RNLVRILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.++||+|+||.||+|+. .+++.||||.+.... ..+.+++|++.+..++| +|++.+++++.++...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 6899999999999999999985 468999999886432 23456788888888865 8999999999999999999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC-----CCCeEEeeeccceec
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-----DMNPKISDFGLARMF 665 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DFGla~~~ 665 (680)
+ +++|.+++.. ....++..++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.+
T Consensus 83 ~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 8 6899888743 3346899999999999999999999987 999999999999974 568999999999988
Q ss_pred CCC
Q 005731 666 GGD 668 (680)
Q Consensus 666 ~~~ 668 (680)
...
T Consensus 157 ~~~ 159 (293)
T d1csna_ 157 RDP 159 (293)
T ss_dssp BCT
T ss_pred ccC
Confidence 644
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.2e-25 Score=232.47 Aligned_cols=152 Identities=28% Similarity=0.449 Sum_probs=123.9
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cC-CcEEEEEEccCC--CcccHHHHHHHHHHHhhc---CCCceeeEEEEEEeC---
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FN-GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAEL---QHRNLVRILGCCVEQ--- 581 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~-~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~--- 581 (680)
.++|++.++||+|+||.||+|+. .+ ++.||||+++.. .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999985 34 678999998642 222233456777776655 899999999998642
Q ss_pred --CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeee
Q 005731 582 --GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659 (680)
Q Consensus 582 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 659 (680)
...+++|||++++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 36789999999887754432 34456889999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCC
Q 005731 660 GLARMFGGD 668 (680)
Q Consensus 660 Gla~~~~~~ 668 (680)
|+++.....
T Consensus 161 g~~~~~~~~ 169 (305)
T d1blxa_ 161 GLARIYSFQ 169 (305)
T ss_dssp CSCCCCCGG
T ss_pred hhhhhhccc
Confidence 999876443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.4e-25 Score=236.47 Aligned_cols=149 Identities=30% Similarity=0.399 Sum_probs=126.2
Q ss_pred cCCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-----Ce
Q 005731 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-----GE 583 (680)
Q Consensus 512 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 583 (680)
.++|++.++||+|+||+||+|+. .+++.||||+++... ....+++.+|++++++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999984 579999999997542 23456789999999999999999999998643 34
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.++++||+.+|+|.+++. .+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 567788889999999883 246899999999999999999999988 9999999999999999999999999998
Q ss_pred ecCC
Q 005731 664 MFGG 667 (680)
Q Consensus 664 ~~~~ 667 (680)
....
T Consensus 170 ~~~~ 173 (348)
T d2gfsa1 170 HTDD 173 (348)
T ss_dssp CCTG
T ss_pred ccCc
Confidence 6643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.92 E-value=6.2e-25 Score=226.45 Aligned_cols=149 Identities=24% Similarity=0.392 Sum_probs=122.5
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCcee-eEEEEEEeCCeEEEEEEc
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV-RILGCCVEQGEKILILEY 590 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey 590 (680)
++|++.+.||+|+||.||+|+. .+++.||||.+.... ...++.+|+++++.++|+|++ .+..+..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999985 568999999887532 234578899999999877654 555666778889999999
Q ss_pred cCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcC---CCCeEEeeeccceecCC
Q 005731 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLARMFGG 667 (680)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~~~~ 667 (680)
+. ++|...+. .....+++..+..++.|++.||+|||+++ ||||||||+|||++. +..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 84 55655542 23456899999999999999999999988 999999999999863 55799999999998865
Q ss_pred Cc
Q 005731 668 DE 669 (680)
Q Consensus 668 ~~ 669 (680)
..
T Consensus 159 ~~ 160 (299)
T d1ckia_ 159 AR 160 (299)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1e-24 Score=230.39 Aligned_cols=146 Identities=31% Similarity=0.429 Sum_probs=120.7
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------Ce
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------GE 583 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~ 583 (680)
++|++.++||+|+||+||+|+. .+++.||||++... ......++.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6899999999999999999985 46999999999753 233456789999999999999999999998643 68
Q ss_pred EEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.|+||||+.++.+.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999766554332 35789999999999999999999988 9999999999999999999999999998
Q ss_pred ecCC
Q 005731 664 MFGG 667 (680)
Q Consensus 664 ~~~~ 667 (680)
....
T Consensus 168 ~~~~ 171 (355)
T d2b1pa1 168 TAGT 171 (355)
T ss_dssp ----
T ss_pred cccc
Confidence 7654
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.86 E-value=9.8e-22 Score=170.70 Aligned_cols=112 Identities=24% Similarity=0.447 Sum_probs=96.0
Q ss_pred cccccCCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEecC
Q 005731 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQT 104 (680)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~ 104 (680)
+|+|.+||.|.+|++|+ +|.|.|.|+.+|+ |.++.. .++||.||++.|. .++.|.|+.||+|||++.
T Consensus 1 tDtL~~gq~L~~g~~l~--~g~~~l~~q~DGN-----Lvly~~---~~~vW~s~~~~~~--~~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLA--EGGYLFIIQNDCN-----LVLYDN---NRAVWASGTNGKA--SGCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEET---TEEEEECCCTTSC--SSEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEE--ECCEEEEEcCCCC-----EEEEcC---CcEEEEccCccCC--CCcEEEEeccccEEEEec-
Confidence 48999999999999996 5999999999997 556553 5899999999875 457899999999999996
Q ss_pred CCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCcc
Q 005731 105 NGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSD 154 (680)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtD 154 (680)
+.++|++++.+..+...|+|+|+|||||++.+ +.++|||+.+|+|
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~-----~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECCC-----CcEEecCCCccCC
Confidence 57888888776566778999999999999865 4689999999985
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.85 E-value=2.5e-21 Score=166.52 Aligned_cols=107 Identities=25% Similarity=0.420 Sum_probs=93.1
Q ss_pred cccccCCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEecC
Q 005731 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQT 104 (680)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~ 104 (680)
.|+|.+||+|.+|+.| .+|.|.|.|+.+|+ |.++.. .++||.||+..|. ..+.|.|+.||+|||++++
T Consensus 1 ~~~L~~g~~L~~G~~l--~ng~~~l~~q~DGN-----Lvly~~---~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFL--NYGSFVFIMQEDCN-----LVLYDV---DKPIWATNTGGLS--RSCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----EEEEET---TEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCCccCCCEecCCCEE--EcCCEEEEECCCCe-----EEEEeC---CceeeEeCCCCCC--CccEEEEeccceEEEECCC
Confidence 4789999999999999 47999999999997 667654 5889999999884 4678999999999999999
Q ss_pred CCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCC
Q 005731 105 NGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDH 151 (680)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (680)
|.+||+|++.+.....+|+|+|+|||||++. ++||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC--------CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC--------CcccCCCC
Confidence 9999999987655566789999999999963 49999988
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.85 E-value=3.8e-21 Score=165.47 Aligned_cols=107 Identities=20% Similarity=0.366 Sum_probs=92.3
Q ss_pred ccccCCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEecCC
Q 005731 26 DTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTN 105 (680)
Q Consensus 26 ~~l~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~~ 105 (680)
|+|.+||+|.+|+.|. +|.|.|+|+.+|+ |.++.. .++||+||++.|+. ..+.|.|+.||+|||+|++|
T Consensus 2 ~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl~~~---~~~vW~ant~~~~~-~~~~l~l~~dGnLvl~~~~g 70 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVLYDH---STSVWASNTGILGK-KGCKAVLQSDGNFVVYDAEG 70 (109)
T ss_dssp CEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEET---TEEEEECCCCCTTC-CCCEEEECTTSCEEEECSSS
T ss_pred CCccCCCEEeCCCEEE--eCCEEEEecCCCe-----EEEEeC---CEEEEEeCCCCCCc-eeEEEEEcCCceEEEEeCCC
Confidence 6899999999999996 5889999999886 445543 58899999999984 56889999999999999999
Q ss_pred CeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCC
Q 005731 106 GTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDH 151 (680)
Q Consensus 106 ~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (680)
.+||+|+++...+...|+|+|+|||||++. .+|||+.|
T Consensus 71 ~~vW~s~t~~~~~~~~l~L~ddGNlvly~~--------~~W~S~t~ 108 (109)
T d1kj1a_ 71 RSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY 108 (109)
T ss_dssp CEEEECCCCCCSSCCEEEECTTSCEEEECC--------EEEECCCC
T ss_pred cEEEEEeeECCCCCEEEEEeCCCcEEEECC--------CEecCCCc
Confidence 999999987655677899999999999952 49999865
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=2.4e-21 Score=185.70 Aligned_cols=136 Identities=20% Similarity=0.229 Sum_probs=107.1
Q ss_pred ceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCc------------------ccHHHHHHHHHHHhhcCCCceeeEEEE
Q 005731 516 SMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG------------------QGLKEFKNEMMLIAELQHRNLVRILGC 577 (680)
Q Consensus 516 ~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~------------------~~~~~f~~E~~~l~~l~H~niv~l~g~ 577 (680)
.+.++||+|+||.||+|+..+|++||||+++.... .....+.+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46789999999999999988899999998753100 012335578889999999999988765
Q ss_pred EEeCCeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeCCCCCCcEEEcCCCCeEEe
Q 005731 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (680)
Q Consensus 578 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 657 (680)
. ..+++|||+++..+.. +.......++.|++++|+|||+.+ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 2379999998765532 223345678999999999999988 9999999999999865 58999
Q ss_pred eeccceecCCCc
Q 005731 658 DFGLARMFGGDE 669 (680)
Q Consensus 658 DFGla~~~~~~~ 669 (680)
|||+|+......
T Consensus 145 DFG~a~~~~~~~ 156 (191)
T d1zara2 145 DFPQSVEVGEEG 156 (191)
T ss_dssp CCTTCEETTSTT
T ss_pred ECCCcccCCCCC
Confidence 999998875443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.83 E-value=1e-20 Score=199.84 Aligned_cols=151 Identities=22% Similarity=0.310 Sum_probs=120.7
Q ss_pred CCcceeeeeccCCceeEEEEEE-cCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-----------CCceeeEEEEEEe
Q 005731 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-----------HRNLVRILGCCVE 580 (680)
Q Consensus 513 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~~ 580 (680)
.+|+++++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999985 57999999999763 334567888999888875 5789999988865
Q ss_pred C--CeEEEEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCcEEEcCCCC----
Q 005731 581 Q--GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDKDMN---- 653 (680)
Q Consensus 581 ~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~---- 653 (680)
. ...+++|+++..+..............+.+..+..++.||++||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4667777777655543333333445678889999999999999999997 55 999999999999986653
Q ss_pred --eEEeeeccceecCC
Q 005731 654 --PKISDFGLARMFGG 667 (680)
Q Consensus 654 --~kl~DFGla~~~~~ 667 (680)
+|++|||.|+....
T Consensus 169 ~~~kl~dfg~s~~~~~ 184 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE 184 (362)
T ss_dssp EEEEECCCTTCEETTB
T ss_pred ceeeEeeccccccccc
Confidence 99999999987643
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.69 E-value=1.8e-17 Score=144.54 Aligned_cols=102 Identities=22% Similarity=0.330 Sum_probs=85.9
Q ss_pred EEEecCCC-CceEEecCCCCCCCCCCceEEEeeCCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCcc
Q 005731 63 GIWFRRVP-DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTA 141 (680)
Q Consensus 63 ~iw~~~~~-~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~ 141 (680)
-|||..++ ++.+|++|++.|+....-+|.|+.||||||++. +.++|++++.+......|+|+++|||||++.+
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~----- 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ----- 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETT-----
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCC-----
Confidence 48999888 899999999999987777899999999999985 67899999876556778999999999999976
Q ss_pred ccceeeecCCCcccccccccccceeecCCceeEEEeCCCCCCCCCceeeeeccCCCceEE
Q 005731 142 ESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMC 201 (680)
Q Consensus 142 ~~~~WqSFd~PtDTlLpgq~l~~~~~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~ 201 (680)
+.++||||. +.++|.|.+.|++||+..++
T Consensus 85 ~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 85 NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 568999873 23678899999999997665
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.65 E-value=5.2e-16 Score=134.70 Aligned_cols=101 Identities=20% Similarity=0.367 Sum_probs=82.2
Q ss_pred ccccCCCEE--EecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEecCCCeeE
Q 005731 32 SFIRDGEKL--TSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIW 109 (680)
Q Consensus 32 ~~l~~~~~l--~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~~~~~w 109 (680)
|+|.++|.| .+..|.|.|.|+.+|+ |.++ . +.++||.+|+..|. ..+.|.|+.||+|+|+|++|.+||
T Consensus 15 ~~l~~~q~l~~~~~~~~y~l~mQ~DGN-----LVLy-~--~~~~vWssnt~~~~--~~~~l~l~~dGnLvL~d~~g~~vW 84 (119)
T d1b2pa_ 15 QILHATESLEILFGTHVYRFIMQTDCN-----LVLY-D--NNNPIWATNTGGLG--NGCRAVLQPDGVLVVITNENVTVW 84 (119)
T ss_dssp CEEETTCEEEEEETTEEEEEEECTTSC-----EEEE-E--TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTTCCEEE
T ss_pred CEEeCCCeEEEecCCceEEEEECCCCc-----EEEE-E--CCeEEEEecCCCCC--cceEEEEEeCCCEEEECCCCcEEE
Confidence 555555554 5679999999999997 4443 2 26889999998764 457899999999999999999999
Q ss_pred eecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecC
Q 005731 110 STNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFD 150 (680)
Q Consensus 110 ~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd 150 (680)
++++.+..+...|+|+|||||||++ .++|||-.
T Consensus 85 sS~t~~~~~~~~l~Lq~DGNlvlYg--------~~~W~S~T 117 (119)
T d1b2pa_ 85 QSPVAGKAGHYVLVLQPDRNVVIYG--------DALWATQT 117 (119)
T ss_dssp ECSCCCCSSCEEEEECTTSCEEEEE--------SEEEECCC
T ss_pred ECCCcCCCCceEEEEcCCCCEEEEC--------CCEeccCC
Confidence 9998765566779999999999995 35999854
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.59 E-value=3.2e-16 Score=135.03 Aligned_cols=109 Identities=22% Similarity=0.275 Sum_probs=89.1
Q ss_pred EEecCCC-CceEEecCCCCCCCCCCceEEEeeCCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccc
Q 005731 64 IWFRRVP-DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAE 142 (680)
Q Consensus 64 iw~~~~~-~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~ 142 (680)
|||.-.+ .+..|+.+++.++....-+|.|+.||||||++ .+.++|++++.+ ..+..+.|+++|||||++.+ +
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~~-----~ 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAG-ATGCRAVLQSDGLLVILTAQ-----N 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCS-CSCCBCCBCSSSCBCCBCTT-----T
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCC-CCceEEEEeccCCEEEEccC-----C
Confidence 5665434 67779999999998777899999999999998 578999999875 55788999999999999876 4
Q ss_pred cceeeecCCCcccccccccccceeecCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeCC
Q 005731 143 SYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQ 214 (680)
Q Consensus 143 ~~~WqSFd~PtDTlLpgq~l~~~~~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 214 (680)
.+||||+. +.++|.|.|.|+++|+..++ ..++|.+|.
T Consensus 76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGT 112 (115)
T ss_dssp CCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSC
T ss_pred CEEEEcCC-------------------------------CCCCCCEEEEECCCCcEEEe----CCCeecCCC
Confidence 68999753 34689999999999997654 347898875
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.48 E-value=3.1e-14 Score=122.43 Aligned_cols=101 Identities=23% Similarity=0.370 Sum_probs=81.6
Q ss_pred cCCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEecCCCee
Q 005731 29 TTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTI 108 (680)
Q Consensus 29 ~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~~~~~ 108 (680)
+..|+|.+++.| .+|.|.|.|+.+|+ |.++.. ..+||.+|...+ ..+.+.|+.||+|||+|.++.+|
T Consensus 12 ~~~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~~---~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~v 78 (115)
T d1dlpa1 12 SHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFDS---DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIR 78 (115)
T ss_dssp CSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEES---SSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCS
T ss_pred CCcceecCCCcE--EcCCEEEEECCCCe-----EEEEcC---CeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEE
Confidence 344667777777 67889999999997 556543 578999997542 35789999999999999999999
Q ss_pred EeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecC
Q 005731 109 WSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFD 150 (680)
Q Consensus 109 w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd 150 (680)
|++.+....+..+++|++||||||++ .++|+|-.
T Consensus 79 WsS~t~~~~g~y~l~Lq~DGNlvlY~--------~~~Wssgt 112 (115)
T d1dlpa1 79 WSSGTKGSIGNYVLVLQPDRTVTIYG--------PGLWDSGT 112 (115)
T ss_dssp CCCCCCCCSSCCEEEECSSSCEEEEC--------SEEEECSC
T ss_pred EEcCCCCCCCCEEEEECCCCcEEEeC--------CCeecCCC
Confidence 99998765667789999999999994 25999843
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.31 E-value=2.8e-12 Score=111.17 Aligned_cols=99 Identities=23% Similarity=0.387 Sum_probs=77.3
Q ss_pred CCccccCCCEEEecCCeEEEEeeCCCCCCCeEEEEEecCCCCceEEecCCCCCCCCCCceEEEeeCCeEEEEecCCCeeE
Q 005731 30 TASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIW 109 (680)
Q Consensus 30 ~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~l~iw~~~~~~tvVW~anr~~pv~~~~~~l~~~~~g~l~l~~~~~~~~w 109 (680)
+.+.|.+++.| ..|.|.|.|..+|+ |.++.. ..+||.++.. ..+..+.+.|+.+|+|||+|.++.++|
T Consensus 22 ~~~~l~~~q~l--~~g~y~L~~q~DGN-----LvL~~~---~~~vW~s~t~--~~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 22 HPQTLHATQSL--QLSPYRLSMETDCN-----LVLFDR---DDRVWSTNTA--GKGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp CCCEECSSCCC--BCSSCEEEEETTTE-----EEEEBT---TBCCSCCCCC--SSCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred cccEEcCCCee--EcCCEEEEEcCCCc-----EEEecC---CcEEEEEccc--cCCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 34566666666 46779999998886 555543 4678988753 334567899999999999999999999
Q ss_pred eecccCCCCCceEEEccCCCEEEEeCCCCCccccceeee
Q 005731 110 STNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148 (680)
Q Consensus 110 ~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (680)
+|++.+..+...++|+++|||||++ .++|.|
T Consensus 90 ~S~t~~~~~~~~l~Lq~DGnlvlY~--------~~~W~t 120 (120)
T d1dlpa2 90 TSGNSRSAGRYVFVLQPDRNLAIYG--------GALWTT 120 (120)
T ss_dssp ECCCCCSSSCCEEEECSSSCEEEEC--------CCCCBC
T ss_pred EeCCCCCCCcEEEEECCCCcEEEeC--------CCcccC
Confidence 9998765667789999999999994 258976
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.15 E-value=8.9e-11 Score=101.16 Aligned_cols=85 Identities=26% Similarity=0.322 Sum_probs=67.6
Q ss_pred eEEEeeCCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCcccccccccccceeec
Q 005731 89 VLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKS 168 (680)
Q Consensus 89 ~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~l~~~~~~ 168 (680)
+|.|+.||||||+++ +.++|++++.+...+..+.|+++|||||++.+ +.++|+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~-----g~~vWsS~------------------- 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSP------------------- 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECS-------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCC-----CcEEEECC-------------------
Confidence 689999999999975 56899999876556788999999999999876 46899851
Q ss_pred CCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeCC
Q 005731 169 GLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQ 214 (680)
Q Consensus 169 g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 214 (680)
+.-+.|.|.+.|+++|+..++ +.+.|.++.
T Consensus 88 ------------t~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~T 117 (119)
T d1b2pa_ 88 ------------VAGKAGHYVLVLQPDRNVVIY----GDALWATQT 117 (119)
T ss_dssp ------------CCCCSSCEEEEECTTSCEEEE----ESEEEECCC
T ss_pred ------------CcCCCCceEEEEcCCCCEEEE----CCCEeccCC
Confidence 112457788999999997765 246888764
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.03 E-value=4.2e-10 Score=95.40 Aligned_cols=85 Identities=25% Similarity=0.391 Sum_probs=65.9
Q ss_pred ceEEEeeCCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCcccccccccccceee
Q 005731 88 AVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFK 167 (680)
Q Consensus 88 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~l~~~~~ 167 (680)
-+|.++.||||||++ .+.+||++++.+......++|+++|||||++.+ +.++|+|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~-----g~~vWsS------------------- 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS-----NKPIWAS------------------- 75 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEEC-------------------
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCC-----ccceEEc-------------------
Confidence 579999999999987 457999999876555678999999999999876 5689986
Q ss_pred cCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeC
Q 005731 168 SGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSG 213 (680)
Q Consensus 168 ~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g 213 (680)
.+...++.|.+.|+++|+..++ . .+.|.++
T Consensus 76 ------------~t~~~~~~~~l~L~ddGNlVly--~--~~~W~S~ 105 (108)
T d1jpca_ 76 ------------NTGGQNGNYVCILQKDRNVVIY--G--TDRWATG 105 (108)
T ss_dssp ------------CCCCSCSCEEEEECTTSCEEEE--E--CCCCCCC
T ss_pred ------------cccCCCCcEEEEEcCCCCEEEe--C--CCcccCC
Confidence 1122456788999999997665 2 2456655
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.97 E-value=1.6e-09 Score=91.75 Aligned_cols=87 Identities=24% Similarity=0.364 Sum_probs=66.3
Q ss_pred ceEEEeeCCeEEEEecCCCeeEeecccCC-CCCceEEEccCCCEEEEeCCCCCccccceeeecCCCccccccccccccee
Q 005731 88 AVLTISNNGNLVLLSQTNGTIWSTNVSSD-VKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (680)
Q Consensus 88 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~l~~~~ 166 (680)
-.|.|+.||+|||+. .+.+||++++... .....+.|+++|||||++.+ +.++|+|
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~s------------------ 76 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE-----GRSLWAS------------------ 76 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS-----SCEEEEC------------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC-----CcEEEEE------------------
Confidence 578999999999986 5679999987643 23567999999999999876 5689986
Q ss_pred ecCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeCCC
Q 005731 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQW 215 (680)
Q Consensus 167 ~~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~w 215 (680)
.+....|.|.+.|+++|+..++ + .+.|.++.+
T Consensus 77 -------------~t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t~ 108 (109)
T d1kj1a_ 77 -------------HSVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGTY 108 (109)
T ss_dssp -------------CCCCCSSCCEEEECTTSCEEEE--C--CEEEECCCC
T ss_pred -------------eeECCCCCEEEEEeCCCcEEEE--C--CCEecCCCc
Confidence 1112356788999999997665 2 367887653
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.79 E-value=1.7e-08 Score=85.98 Aligned_cols=88 Identities=25% Similarity=0.412 Sum_probs=66.5
Q ss_pred ceEEEeeCCeEEEEecCCCeeEeecccCCCCCceEEEccCCCEEEEeCCCCCccccceeeecCCCcccccccccccceee
Q 005731 88 AVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFK 167 (680)
Q Consensus 88 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDTlLpgq~l~~~~~ 167 (680)
-.|.|+.||||||++ .+.+||++++.+...+..+.|+.+|||||++.. ..+|.|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~------~~~w~s------------------- 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGS------RAIWAS------------------- 74 (112)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEETT------EEEEEC-------------------
T ss_pred EEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEecC------CeEEEE-------------------
Confidence 579999999999987 567999999876556778999999999999853 356754
Q ss_pred cCCceeEEEeCCCCCCCCCceeeeeccCCCceEEEEcCCeEEEeeCC
Q 005731 168 SGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQ 214 (680)
Q Consensus 168 ~g~~~~l~S~~s~~d~s~G~~~l~~~~~~~~~~~~~~~~~~~~~~g~ 214 (680)
.+.-..|.|.+.|+.+|+..++- ....+.|.++.
T Consensus 75 ------------~t~~~~~~~~l~L~ddGNlvly~-~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 ------------NTNRQNGNYYLILQRDRNVVIYD-NSNNAIWATHT 108 (112)
T ss_dssp ------------CCCCSCCCCEEEECTTSCEEEEC-TTSCEEEECCC
T ss_pred ------------eeccCCCceEEEEcCCCCEEEEC-CCCcEEecCCC
Confidence 12223467889999999976652 22457888765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.42 E-value=7.7e-07 Score=87.16 Aligned_cols=149 Identities=16% Similarity=0.117 Sum_probs=100.9
Q ss_pred HHHHhcCCcceeeeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEE
Q 005731 507 SVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKI 585 (680)
Q Consensus 507 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 585 (680)
++......|+..+..+-++...||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+....+..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444456777666554455678998864 55667888876544334455678888877663 444667788888888999
Q ss_pred EEEEccCCCChhhHhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 005731 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS--------------------------------- 632 (680)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------- 632 (680)
+|||++++..+....... .. ...++.++++.|+.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998885543211 11 2234455555566666321
Q ss_pred -----------------------CCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 633 -----------------------RLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 633 -----------------------~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11379999999999999877778999998875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.81 E-value=5.3e-05 Score=73.15 Aligned_cols=131 Identities=20% Similarity=0.194 Sum_probs=85.6
Q ss_pred eeccCC-ceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcC--CCceeeEEEEEEeCCeEEEEEEccCCCCh
Q 005731 520 KLGEGG-FGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ--HRNLVRILGCCVEQGEKILILEYMPNKSL 596 (680)
Q Consensus 520 ~LG~G~-fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 596 (680)
.+..|. ...||+....++..+++|.-.... ...+..|+..++.+. ...+.+++++..+.+..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 455554 367999987778888889865432 234566777776663 33466778888888889999999988766
Q ss_pred hhHhcccccCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 005731 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH----------------------------------------------- 629 (680)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH----------------------------------------------- 629 (680)
.+.. .... .++.++++.|.-||
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3321 0100 11122222333333
Q ss_pred ----hC----CCCceEeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 630 ----QY----SRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 630 ----~~----~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
.. .++.++|+|+.|.|||++.+..+.|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 112379999999999999877788999999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.34 E-value=0.0004 Score=71.66 Aligned_cols=76 Identities=11% Similarity=0.142 Sum_probs=48.3
Q ss_pred eeeeccCCceeEEEEEEcC-CcEEEEEEccCC-------CcccHHHHHHHHHHHhhcC-C--CceeeEEEEEEeCCeEEE
Q 005731 518 QCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQ-------SGQGLKEFKNEMMLIAELQ-H--RNLVRILGCCVEQGEKIL 586 (680)
Q Consensus 518 ~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~-------~~~~~~~f~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~l 586 (680)
.+.||.|....||+....+ ++.++||.-... -+...++...|.+.+..+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3679999999999998544 678999964321 1123344566777776652 2 335556554 4556689
Q ss_pred EEEccCCCC
Q 005731 587 ILEYMPNKS 595 (680)
Q Consensus 587 V~Ey~~~gs 595 (680)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.15 E-value=0.01 Score=58.93 Aligned_cols=135 Identities=14% Similarity=0.160 Sum_probs=77.8
Q ss_pred eeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCce-----eeE--EEEEEeCCeEEEEEEccCCCChhh-
Q 005731 527 GPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-----VRI--LGCCVEQGEKILILEYMPNKSLDV- 598 (680)
Q Consensus 527 G~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-----v~l--~g~~~~~~~~~lV~Ey~~~gsL~~- 598 (680)
-.||+.+..+|+.+++|..+.. ....+++..|...+..|....+ +.. -......+..+.++++++|..++.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5799999999999999998653 2345777888888777642221 111 112244567889999998644321
Q ss_pred ---Hh----------cc------cccCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----CCCCce
Q 005731 599 ---YL----------FD------PIKKRLLDWE-------------------ARIRIIQGIAQGLLYLHQ----YSRLRI 636 (680)
Q Consensus 599 ---~l----------~~------~~~~~~l~~~-------------------~~~~i~~~ia~~L~yLH~----~~~~~i 636 (680)
.+ +. .......++. .+-.+...+.+.++.+.. ..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00 00 0001111111 111122222333333322 223458
Q ss_pred EeCCCCCCcEEEcCCCCeEEeeecccee
Q 005731 637 IHRDLKASNVLLDKDMNPKISDFGLARM 664 (680)
Q Consensus 637 iHrDlkp~NILl~~~~~~kl~DFGla~~ 664 (680)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 46899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.05 E-value=0.0078 Score=61.59 Aligned_cols=76 Identities=17% Similarity=0.301 Sum_probs=49.1
Q ss_pred CcceeeeeccCCceeEEEEEEcC--------CcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCce-eeEEEEEEeCCeE
Q 005731 514 NFSMQCKLGEGGFGPVYKGRLFN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-VRILGCCVEQGEK 584 (680)
Q Consensus 514 ~f~~~~~LG~G~fG~Vy~~~~~~--------~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~ 584 (680)
.+++ +.|+.|-.-.+|+....+ .+.|.+++.-. . .......+|..+++.+.-.++ .++++++..
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 4444 678888889999998653 24566665542 2 223345678888887743344 467776642
Q ss_pred EEEEEccCCCCh
Q 005731 585 ILILEYMPNKSL 596 (680)
Q Consensus 585 ~lV~Ey~~~gsL 596 (680)
.+|+||+++..|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 589999987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.36 E-value=0.2 Score=48.63 Aligned_cols=157 Identities=12% Similarity=0.038 Sum_probs=78.7
Q ss_pred cHHHHHHhcCCccee-----eeeccCCceeEEEEEEcCCcEEEEEEccCCCcccHHHHHHHHHHHhhcCCCc-----eee
Q 005731 504 SLASVAAATENFSMQ-----CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN-----LVR 573 (680)
Q Consensus 504 ~~~~~~~~~~~f~~~-----~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n-----iv~ 573 (680)
+.++++....+|.+. +.|..|---+.|+.+..+|+ +++|+..... ..++...|++++..+.+.+ .+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 345556566677654 33456666788998876664 7888876432 2234445566666553222 111
Q ss_pred EE---EEEEeCCeEEEEEEccCCCChhhHh--------------c------ccccCCCCCH------------------H
Q 005731 574 IL---GCCVEQGEKILILEYMPNKSLDVYL--------------F------DPIKKRLLDW------------------E 612 (680)
Q Consensus 574 l~---g~~~~~~~~~lV~Ey~~~gsL~~~l--------------~------~~~~~~~l~~------------------~ 612 (680)
.. .+.........++.++.+....... + .......... .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 10 0122344566677776654331100 0 0000000000 0
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCCceEeCCCCCCcEEEcCCCCeEEeeeccce
Q 005731 613 ARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (680)
Q Consensus 613 ~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 663 (680)
.....+..+...+.-.+. .-+..+||+|+.+.||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111112222222222221 123459999999999999988878999999886
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.66 E-value=0.023 Score=35.09 Aligned_cols=31 Identities=32% Similarity=0.590 Sum_probs=25.1
Q ss_pred CCCCCCcCCCCCcccCCC-CCCCCcccCCcccC
Q 005731 286 QYCGKYGYCGANTICSLD-QTPMCECLEGFKLK 317 (680)
Q Consensus 286 ~~C~~~g~CG~~giC~~~-~~~~C~C~~GF~~~ 317 (680)
|+|.+-..|| ||.|+.- ..-.|.|-.||+|.
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCC
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCC
Confidence 6899999999 5899743 34469999999984
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.60 E-value=0.081 Score=34.83 Aligned_cols=31 Identities=23% Similarity=0.518 Sum_probs=24.1
Q ss_pred CCCCC-CcCCCCCcccCCCC-CCCCcccCCccc
Q 005731 286 QYCGK-YGYCGANTICSLDQ-TPMCECLEGFKL 316 (680)
Q Consensus 286 ~~C~~-~g~CG~~giC~~~~-~~~C~C~~GF~~ 316 (680)
++|.. ...|..+|.|.... .-.|.|++||+-
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G 36 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYTG 36 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEES
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCcC
Confidence 56875 57899999997543 347999999974
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.37 E-value=0.19 Score=32.30 Aligned_cols=30 Identities=30% Similarity=0.631 Sum_probs=23.1
Q ss_pred CCCCCCcCCCCCcccCCC-CCCCCcccCCccc
Q 005731 286 QYCGKYGYCGANTICSLD-QTPMCECLEGFKL 316 (680)
Q Consensus 286 ~~C~~~g~CG~~giC~~~-~~~~C~C~~GF~~ 316 (680)
|+|. ...|...|.|... ..-.|.|++||+-
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G 31 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEG 31 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEET
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCc
Confidence 4565 5789999999764 3457999999974
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.34 E-value=0.22 Score=32.01 Aligned_cols=30 Identities=20% Similarity=0.506 Sum_probs=22.5
Q ss_pred CCCCCCcCCCCCcccCCC-CCCCCcccCCccc
Q 005731 286 QYCGKYGYCGANTICSLD-QTPMCECLEGFKL 316 (680)
Q Consensus 286 ~~C~~~g~CG~~giC~~~-~~~~C~C~~GF~~ 316 (680)
|+|. ...|...|.|... ..-.|.|++||+-
T Consensus 2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~G 32 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQIGEFQCICMPGYEG 32 (39)
T ss_dssp CTTT-TCCCCSSCEEEECSSCEEEECCTTEES
T ss_pred cCCc-CCCCCCCCEEECCCCCEEEeCCCCCcc
Confidence 4564 4679999999754 3447999999974
|